Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,protein targeting to ER (GO:0045047),-0.7513046711257813,-2.9472193128025665,0.0,0.0,0.0,71/99,15.60%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;SEC62;SRPRB;RPS26;SEC61G;RPS16;RPS5;UBA52;RPL13A;ZFAND2B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7653047269624532,-2.925852027261622,0.0,0.0,0.0,68/87,15.60%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RPS26;RPS16;RPS5;UBA52;RPL13A;ZFAND2B
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7566594449876922,-2.9231697151105007,0.0,0.0,0.0,72/91,17.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;SIL1;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;SEC62;RPS26;RPS16;RPS5;UBA52;RPL13A;RPL36A;ARL6IP1;RPL12
prerank,cytoplasmic translation (GO:0002181),-0.748720207054455,-2.870859616080986,0.0,0.0,0.0,67/91,15.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;EIF3I;RPL27;RPL31;RPS27;RPL29;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;RPS26;RPS16;RPS5;UBA52;RPL13A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7091606252154702,-2.8357065583674506,0.0,0.0,0.0,72/110,15.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;PABPC1;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;PYM1;RPLP2;RPLP0;RPL35A;EIF4G1;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;RPS5;UBA52;RPL13A
prerank,peptide biosynthetic process (GO:0043043),-0.6281069709783883,-2.632621319267976,0.0,0.0,0.0,79/153,15.49%,EEF1A1;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;WARS1;MRRF;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;EIF4G1;FURIN;MRPS14;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;RRBP1;MRPS16;RSL24D1;RPS26;RPS16;MRPS5;RPS5;MRPL23;RPL13A
prerank,translation (GO:0006412),-0.5853139467368063,-2.5425445578131356,0.0,0.0,0.0,95/208,17.49%,EEF1A1;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;EEF2;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;WARS2;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;LARS2;RPS20;WARS1;MRRF;EEF1D;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;NDUFA7;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;RPLP2;RPLP0;APEH;RPL35A;EIF4G1;MRPS14;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;YARS1;EEF1G;RRBP1;MRPS16;RSL24D1;RPS26;RPS16;MRPS5;RPS5;IARS1;MRPL23;UBA52;RPL13A;NARS1;EEF1E1;MRPL24;EEFSEC;RPL36A;EEF1B2;RPL12
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5726513231312688,-2.4216320538653973,0.0,0.0,0.0,86/168,18.21%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;PAN2;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;PABPC1;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;PATL1;RPL29;CNOT6L;DDX5;PYM1;RPLP2;RPLP0;RPL35A;EIF4G1;ZFP36L1;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;TNKS1BP1;RPS5;UBA52;RPL13A;POLR2G;PPP2R2A;RPL36A;DCPS;RPL12;ZC3H12A;PELO;SMG5
prerank,rRNA metabolic process (GO:0016072),-0.5358788758490776,-2.2786728068601323,0.0,0.0,0.0,82/160,21.82%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;TRIR;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DDX54;RPL30;DHX37;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;RPL36A;RPL12;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;RPL35;RPL22;PWP2;WDR74
prerank,ribosome biogenesis (GO:0042254),-0.49759029357044354,-2.167392057946818,0.0,0.0007821636369422881,0.007,87/187,21.82%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DDX54;RPL30;DHX37;RBIS;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;DHX29;RPL36A;EIF2A;RPL12;TBL3;UTP18;MRM2;HEATR3;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;RPL35;NOC2L;RPL22;EIF6;PWP2;WDR74
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.6664010791589285,-2.1664652777071534,0.0,0.0007110578517657164,0.007,22/39,15.08%,EFNA5;ACTN4;ACER2;THBS1;JAG1;ADAM15;CORO2B;NOTCH1;SEMA3E;FZD4;KANK1;CORO1C;AP1AR;NEXMIF;MYOC;AJAP1;RHOA;GCNT2;CASK;SPRY4;SPOCK1;RCC2
prerank,ncRNA processing (GO:0034470),-0.49114138628880005,-2.157737129772732,0.0,0.0008380324681524516,0.009,93/200,21.82%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;SARS1;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;ADAR;SSB;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DGCR8;DDX54;RPL30;INTS11;DHX37;WDR3;FBL;POP4;RPP21;RPF1;INTS6;RPS16;UBA52;RPL13A;LIN28B;INTS1;RPL36A;RPL12;RPP30;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;AGO3;RPL35;METTL3;RPL22;PWP2;WDR74
prerank,rRNA processing (GO:0006364),-0.4969347176607102,-2.1235772814179543,0.0,0.0008595204801563606,0.01,88/172,21.82%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;MAK16;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;RSL1D1;PIH1D1;RPS17;DDX54;RPL30;DHX37;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;TSR3;RPL36A;RPL12;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;THUMPD1;NOP53;RRP15;RPL35;NHP2;RPL22;EIF6;PWP2;WDR74
prerank,cellular response to copper ion (GO:0071280),-0.791074410017057,-2.061500854044786,0.0,0.0021549406323920182,0.026,9/16,6.77%,MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;MT2A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6253993309085406,-2.05554765484622,0.0,0.0021602614734596527,0.028,18/39,10.79%,SLIT2;COL4A1;TIE1;KDR;RASIP1;ENG;PKD1;SEMA3E;TGFBR2;CTNNB1;LRP5;MET;SIX1;VEGFA;NOTCH4;NPNT;PAK1;BMP2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.7827423778199796,2.048814054542901,0.0,0.11432745733196578,0.099,6/23,2.80%,TGFBR3;ADAMTS9;FGFR2;TPM1;TNNC1;TNNT2
prerank,cellular response to zinc ion (GO:0071294),-0.7809530467195955,-2.029475800198305,0.0,0.0038409821456987367,0.052,9/15,6.77%,MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;MT2A
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8107880491777238,2.029390268773409,0.0,0.08236978225098324,0.143,4/18,3.44%,IGF1;IGFBP2;IL18;IGF2
prerank,retinoid metabolic process (GO:0001523),0.6133222845284628,2.017663656756287,0.0,0.06751621495982231,0.174,12/71,6.18%,CYP26B1;ALDH1A1;ALDH1A2;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;SCPEP1;NAPEPLD
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7899286463421047,-2.0136123665286063,0.0,0.00499533079055579,0.069,8/14,9.24%,THBS1;KLF4;MEOX2;NOTCH1;HDAC5;CARD10;PDCD10;RHOA
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7132002364448286,-2.004448581301693,0.0,0.006331800870485189,0.089,11/22,9.59%,SLIT2;TMSB4X;KANK3;GSN;TMSB10;KANK1;HIP1R;CYRIB;SSH2;SSH1;KANK4
prerank,regulation of glucose import (GO:0046324),0.7305294178869985,2.001341205252746,0.0,0.07111707975767952,0.233,7/30,3.96%,IGF1;PRKAG2;OSBPL8;APPL2;PID1;SORBS1;GRB10
prerank,response to copper ion (GO:0046688),-0.7363735618387647,-2.0006948717689994,0.0,0.0064102132651661205,0.094,10/20,6.77%,MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;ATP5F1D;MT2A
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.443700642691435,-1.9971800625760643,0.0,0.006424915589168796,0.1,123/306,21.29%,ST3GAL4;EEF1A1;PTMA;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;EEF2;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;PTMS;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;B4GALT5;RPS20;WARS1;EXT1;MRRF;EEF1D;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;SET;ING4;RPLP2;RPLP0;RPL35A;EIF4G1;MRPS14;RPL7A;BCL3;RPS28;RPL7;KIN;RPS17;RPS10;RPA1;RPL30;RPS4X;GSPT2;EEF1G;RRBP1;POLR2C;DONSON;XAB2;RAD17;RNPS1;MCM4;MRPS16;RSL24D1;RPS26;TOPBP1;RPS16;MRPS5;RPS5;MRPL23;RPL13A;POLR2G;TOP3A;FAM111A;NR4A2;MRPL24;EEFSEC;RPL36A;EEF1B2;MCM8;POLA1;RPL12;RAD9A;CDK2;ATR;RPL9;INHA;MRPL13;MRPL35;POLE;RPL35;POLD3;RBBP8;GTPBP2;PAX8;RPL22
prerank,retinoic acid metabolic process (GO:0042573),0.8440304913563709,1.9920436156872285,0.0,0.06841643115928663,0.271,3/14,6.13%,CYP26B1;ALDH1A2;SCPEP1
prerank,response to progesterone (GO:0032570),-0.7253002265720274,-1.9913259742574594,0.0,0.006863884977248652,0.111,7/18,8.78%,ABHD2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,epithelial tube morphogenesis (GO:0060562),-0.6413504820233824,-1.9896297439824844,0.0,0.006805839438329001,0.114,14/32,8.40%,MEF2C;SLIT2;PODXL;COL4A1;ACVRL1;RASIP1;HES1;PKD1;SOX17;RHOB;CTNNB1;MET;RYR2;PAK1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.7927709871395558,-1.953598192883159,0.0,0.012922703566872588,0.214,4/12,2.20%,PODXL;PROM1;IQGAP1;JAG1
prerank,skeletal system morphogenesis (GO:0048705),0.6452132397523814,1.9472135676766857,0.0017667844522968198,0.12963113272285884,0.482,11/42,6.20%,CYP26B1;FGFR2;HOXC4;WWOX;FBN2;HOXB4;LTF;HOXB3;HOXA3;PDGFRA;ANKRD11
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5926527508772975,-1.9423795492166138,0.0,0.015270813864111341,0.256,18/39,16.23%,RPS24;RPS15;RPSA;RPS7;RPS19;RPS14;RPS6;RPS25;RPS27;DDX52;RPS28;RPS17;ERAL1;WDR3;RPS27L;RPS16;RPS5;TSR3
prerank,ribosome assembly (GO:0042255),-0.5739605303246991,-1.9335845843173096,0.0,0.01716290494776221,0.29,27/47,23.48%,RPL11;RPL6;RPS15;RPSA;RPS19;RPL24;RPS14;RPL23A;RPL3;RPL5;RPS27;RPLP0;RPS28;DHX37;ERAL1;RPS27L;RSL24D1;RPS5;DHX29;EIF2A;NOP53;NLE1;EIF6;PWP2;PPAN;MRPS2;MRPS11
prerank,regulation of activated T cell proliferation (GO:0046006),0.6933243728501265,1.9194308895355632,0.0,0.17399893112502782,0.625,4/30,3.44%,IGF1;IGFBP2;IL18;IGF2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.7369756765642496,1.914200346450647,0.0,0.14803555280079558,0.656,10/20,14.26%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.7369756765642496,1.914200346450647,0.0,0.14803555280079558,0.656,10/20,14.26%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6537388031503311,-1.9141870894586221,0.0,0.023121100916206103,0.377,17/26,16.20%,SLC39A10;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;SLC30A5;MT2A;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3;ATP13A2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6119666749271486,1.9128094667131696,0.0,0.13683286231857325,0.666,4/49,1.24%,IL31RA;IGF1;IL18;KIT
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6085962188776441,-1.9103515718015835,0.0,0.02425121117715243,0.399,20/33,27.77%,MEF2C;THBS1;ACVRL1;KLF4;MEOX2;NOTCH1;TGFB1;HDAC5;CARD10;PDCD10;RHOA;JUP;CSNK2B;DLL4;ATP2B4;GADD45A;RGCC;ANGPT4;FGF2;VASH1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5697201808240615,-1.9065481240876636,0.0,0.024702004656493696,0.415,20/47,15.08%,EFNA5;ACTN4;LIMS2;RAC1;CARMIL1;PTK2;DOCK1;LIMS1;FLNA;KANK1;CORO1C;AP1AR;CALR;FERMT2;MYOC;CRK;S100A10;SPRY4;NEDD9;RCC2
prerank,response to zinc ion (GO:0010043),-0.666832005346943,-1.8996687666297056,0.0,0.02589231349877919,0.439,11/25,6.77%,MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;SLC30A5;CRIP1;MT2A
prerank,organic anion transport (GO:0015711),-0.5080582158552801,-1.8979226836213912,0.0,0.02584864590656895,0.447,24/76,16.21%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8C;SLCO1C1;LRRC8D;SLCO2A1;SLCO2B1;CA4;SLC39A8;SLC4A8;SLCO3A1;LRRC8A;CA2;SLC4A2;SLC26A6;SLC52A3;CYB5R1;SLC25A42;SLC35B2;SLC16A2;CFTR;SLC17A9
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7701348551300061,-1.8945429245403522,0.0020325203252032522,0.026096150836231184,0.46,8/13,8.08%,COL4A1;KDR;ENG;SEMA3E;TGFBR2;CTNNB1;VEGFA;NOTCH4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.5111457140961915,-1.889464324089135,0.0,0.02807408768310713,0.493,31/71,22.89%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3;FCGR2B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.512715294805003,-1.8835025690475382,0.0,0.030372328239707036,0.537,31/70,22.89%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3;FCGR2B
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6862537311932235,-1.8833107585170485,0.0,0.029577616523027705,0.539,10/19,12.24%,TEK;PTPRJ;KDR;RAC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;S100A10
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.84216509319271,1.8653373494449645,0.0,0.25778918439204884,0.883,4/10,5.86%,APPL2;PID1;GRB10;PRKCB
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6040964481699407,1.8590533034214993,0.0,0.2580619771797653,0.91,17/50,11.24%,DCDC2;RORA;ZIC1;FGFR2;TULP3;INTU;MGRN1;TEDC2;TTC23;GPC3;GLI3;ARMC9;SUFU;HERC4;FBXL17;WDR11;IFT122
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5010264327045597,-1.853436258540678,0.0,0.04408848908642041,0.702,30/73,21.78%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3
prerank,energy reserve metabolic process (GO:0006112),0.7375369584355542,1.8486926920796685,0.006185567010309278,0.2776820738347564,0.94,4/19,1.70%,PRKAG2;LEPR;PID1;PHKB
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5041681176555339,-1.8456068292610996,0.0,0.0487921125902094,0.743,30/69,18.29%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;COX7C;NDUFS1;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;NDUFB4;COA6;NDUFS7;UQCRC2;UQCRC1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.6127169349007557,-1.8428546941942312,0.002188183807439825,0.049164571464943824,0.757,15/27,22.51%,MAP3K5;UBB;IKBKB;UBC;RPS27A;MAPK8;CHUK;MAP2K7;CUL1;MAP3K8;UBA52;CCDC88C;SKP1;MAPK3;MAPK11
prerank,sodium ion transport (GO:0006814),0.543289303780642,1.8401143565789426,0.0,0.2892266046564579,0.957,12/85,3.73%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC5A5;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,entry into host (GO:0044409),-0.7272015483982504,-1.8305484237105614,0.0,0.05757430079447369,0.807,5/13,6.69%,CDH1;CBL;PPIA;CTNNB1;MET
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7800481939616333,1.8288710966195394,0.003838771593090211,0.3149556409859089,0.973,3/13,3.44%,IGF1;SORBS1;IGF2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7233355584359052,1.8267594521675021,0.005802707930367505,0.28446831903071806,0.975,4/21,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7233355584359052,1.8267594521675021,0.005802707930367505,0.28446831903071806,0.975,4/21,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,vasodilation (GO:0042311),-0.7349174732333444,-1.8243885499064492,0.0019011406844106464,0.06088270067774221,0.824,7/13,12.75%,NOS3;KLF2;KCNMA1;SOD1;NOS1;GPER1;ADRB2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5725363777347298,1.8229829075858281,0.0,0.28141758635475567,0.978,4/57,1.24%,IL31RA;IGF1;IL18;KIT
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6787224513194351,1.822453102355801,0.0036496350364963502,0.26826442744036066,0.978,4/24,3.44%,IGF1;SORBS1;PPP1R3G;IGF2
prerank,modulation by symbiont of host process (GO:0044003),-0.7948433012984872,-1.8222330729215503,0.0,0.061008763681498476,0.831,7/10,15.45%,B2M;UBB;UBC;RPS27A;HGS;MRC1;UBA52
prerank,aerobic electron transport chain (GO:0019646),-0.4984238697141712,-1.8188276704695343,0.0,0.0618645106571078,0.84,29/68,18.29%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;COX7C;NDUFS1;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;NDUFB4;NDUFS7;UQCRC2;UQCRC1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7927387554281423,-1.817675981376468,0.001937984496124031,0.06137590171516526,0.844,6/10,9.97%,FAP;CST3;NOTCH1;TGFB1;TNFRSF1B;DPP4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7928362627415589,1.817392178867198,0.0038095238095238095,0.27123514089859285,0.983,3/12,3.44%,IGF1;SORBS1;IGF2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7637896564208129,1.817293426312719,0.006437768240343348,0.2584906515604626,0.983,2/14,0.70%,MOXD1;SLC22A2
prerank,neuron projection organization (GO:0106027),-0.71655741643486,-1.8143197336465173,0.001984126984126984,0.06288491699004442,0.856,11/15,23.28%,LGMN;GSK3B;ARF1;APP;ATP1A3;PICK1;ABCD2;PSEN1;INSR;DCTN1;MAP1A
prerank,negative regulation of growth (GO:0045926),-0.45040486292008386,-1.8105653192089357,0.0,0.06455389497101613,0.873,33/121,11.08%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;NOTCH1;NDRG3;RACK1;SH3BP4;FHL1;BMPR2;SOX17;CCDC85B;RERG;CCN3;TGFB1;OSGIN2;MT2A;APBB1;ING4;RTN4;SESN2;CDKN1B;NDUFA13
prerank,gene expression (GO:0010467),-0.39780117040450236,-1.8069125665517376,0.0,0.06629767970272728,0.882,126/348,19.64%,EEF1A1;PTMA;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;HNRNPK;RPL19;RPL21;RPS9;ADARB1;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;ADARB2;RPL34;RPL28;RPL18A;RPL26;RPL24;SRSF2;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;WARS1;MRRF;RPS25;RPS18;SRSF1;RPL3;SARS1;RPL32;RPL36;RPS27A;GALNT2;RPL14;RPL5;RPS2;HNRNPU;RPL27;MRPL32;RPL31;RPS27;RPL29;DDX20;TSPAN17;SRSF5;RPLP2;RPLP0;RPL35A;DDX39B;EIF4G1;ADAR;MRPS14;RPL7A;BCL3;RPS28;RPL7;CPSF3;HHEX;RPS17;SRSF9;RPS10;DDX54;RPL30;RPS4X;RBM8A;GSPT2;HSPD1;RRBP1;POLR2C;XAB2;DNAJB11;RNPS1;SRSF6;MRPS16;NUP37;RSL24D1;RPS26;AGFG1;RPS16;MRPS5;RPS5;SYMPK;MRPL23;RPL13A;CLP1;POLR2G;PRPF4;NXT1;BICD1;NR4A2;CPSF2;MRPL24;RPL36A;RPL12;NUP54;SMG5;NUP85;DDX17;RPL9;HNRNPUL1;YTHDC1;THOC3;MRPL13;MRPL35
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6195452306762497,-1.8065784191975218,0.0020920502092050207,0.06522078773882124,0.882,12/24,12.24%,TEK;PTPRJ;KDR;RAC1;IQSEC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;DUSP3;S100A10
prerank,negative regulation of vascular permeability (GO:0043116),-0.7324000816887595,-1.8064477803273291,0.001851851851851852,0.06407085111122998,0.882,10/12,7.87%,SLIT2;PTPRJ;CLDN5;PDE3A;RAMP2;FERMT2;CEACAM1;DDAH1;PDE2A;VEGFA
prerank,sodium ion transmembrane transport (GO:0035725),0.5342808723437595,1.8061104719875063,0.0,0.28545037306649723,0.993,11/84,3.73%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5915676284341702,-1.80143650895093,0.0,0.06706587613186703,0.896,14/28,23.48%,OCLN;RAC1;RPS3;CLIP1;MET;PAK1;NAV3;GIT1;TOGARAM1;CKAP5;MAPRE1;NUMA1;DCTN1;HSPA1B
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6483810482394443,-1.7995279867071141,0.006122448979591836,0.06754427675285882,0.904,7/18,11.02%,FN1;CD200;CD34;TGFB2;ITGB8;PTGS2;LTBP1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.656898786213718,-1.7894297119098344,0.006,0.07542292213372065,0.931,8/18,9.39%,SPTBN1;ACTB;STX7;VTI1B;VAMP8;ZDHHC2;ZDHHC7;APPL1
prerank,regulation of fatty acid oxidation (GO:0046320),0.7252807853430687,1.787221698651879,0.007920792079207921,0.3423952744745076,0.998,4/16,5.18%,PRKAG2;APPL2;PPARA;ACADL
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7046226832215318,-1.7853263000502315,0.0,0.0779972702385027,0.936,7/13,20.26%,NOS3;HSP90AA1;CALM1;GCH1;MTHFD1L;QDPR;AKT1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49315383534006907,-1.7834058693098978,0.0,0.07808743562220537,0.939,24/67,14.52%,UTRN;FN1;LIMS2;RAC1;VIT;CARMIL1;DOCK1;PTK2B;LIMS1;FLNA;CALR;FERMT2;FBLN2;GSK3B;MYOC;ECM2;EMP2;NPNT;CDK6;CRK;S100A10;CDH13;JUP;NEDD9
prerank,cell projection organization (GO:0030030),-0.5832393845091587,-1.7830586374636277,0.0,0.07701465675876491,0.939,7/30,4.32%,RHOJ;PARVB;RAC1;GSN;ITGB1;PACSIN2;NCKAP1
prerank,hemidesmosome assembly (GO:0031581),-0.7530584835757481,-1.7776276432803542,0.0,0.08092703661590712,0.95,4/11,6.24%,ITGA6;ITGB4;PLEC;LAMA3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7489054012472118,1.776744370617609,0.011494252873563218,0.3685635156640078,1.0,4/15,8.84%,IGF1;ROCK2;PRKCA;CAMK2D
prerank,regulation of small molecule metabolic process (GO:0062012),0.6416514515955148,1.7739534000912938,0.0019011406844106464,0.3641194483593191,1.0,6/28,6.13%,RORA;PPARA;PRKN;PDK1;ACADL;EPHX2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5707665752899166,1.773850987148396,0.0070921985815602835,0.35049571489142634,1.0,9/46,6.34%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,chloride transport (GO:0006821),-0.4742238649107186,-1.7723998156287044,0.0,0.08514409876428908,0.957,20/74,11.74%,SLC4A10;SLC12A7;SLC12A2;SLC26A7;ANO1;ANO4;CLIC4;GABRB3;SLC12A6;SLC1A1;CLIC5;GABRB1;TTYH3;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;SLC26A6
prerank,response to cadmium ion (GO:0046686),-0.5976659291959062,-1.771689738702384,0.0,0.08438188828135042,0.959,12/26,10.31%,MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;MT2A;JUN;MAPK8;CHUK
prerank,regulation of dendritic spine development (GO:0060998),-0.6429404274211132,-1.7709956779778073,0.0,0.0836464220258833,0.959,11/19,25.52%,MEF2C;SHANK3;PPFIA2;GRIN3A;LLPH;KIF1A;CAMK2B;PSEN1;FMR1;SHANK1;FOXO6
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6032317058652745,1.770060473197649,0.0018050541516245488,0.3520512166719822,1.0,9/40,3.12%,BMP6;ADGRV1;OSR1;WNT4;WNT6;BMP7;FBN2;SLC8A1;KL
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.5309070720172078,-1.7696064485267036,0.002325581395348837,0.08384177704366595,0.961,18/42,14.64%,RAC1;VIT;ATXN3;PTK2;CORO2B;NOTCH1;MINK1;FZD4;LIMS1;CORO1C;FBLN2;ECM2;EMP2;NPNT;RHOA;GCNT2;SPOCK1;NF1
prerank,cellular response to cadmium ion (GO:0071276),-0.6101103411788946,-1.7695893598714967,0.002257336343115124,0.08245860714883106,0.961,12/24,10.31%,MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;MT2A;JUN;MAPK8;CHUK
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6747000687832502,1.769074816976801,0.005660377358490566,0.3434003295170773,1.0,4/26,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,embryonic organ morphogenesis (GO:0048562),0.5844441064103757,1.763265753655955,0.006980802792321117,0.3537228825136438,1.0,10/42,4.40%,EFEMP1;FBN1;FGFR2;HOXC4;RBP4;FBN2;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,regulation of plasminogen activation (GO:0010755),-0.7270241166491827,-1.7613411478695624,0.0020964360587002098,0.0893901299362615,0.976,5/12,6.76%,THBS1;RUNX1;SERPINE2;PLGRKT;CLEC3B
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.7164800318463018,-1.758462907294465,0.0,0.09116694194524047,0.98,6/12,10.62%,ACTB;ACTG1;LAMA5;LAMA3;ZDHHC7;VANGL2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.594164833795501,-1.756643250166852,0.004149377593360996,0.09198532725699168,0.982,12/26,21.14%,OCLN;RAC1;RPS3;CLIP1;MET;STMN2;PAK1;NAV3;TOGARAM1;MAPRE1;NUMA1;DCTN1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5763100449967519,-1.7554023410281998,0.006060606060606061,0.09210375888075516,0.983,17/30,8.15%,SLC12A2;PECAM1;ACTB;CLDN5;ESAM;ACTG1;OCLN;TJP2;JAM2;LSR;ITGB1;MBP;F11R;SLC1A1;WNK3;TJP1;MFSD2A
prerank,neurotransmitter uptake (GO:0001504),0.7816767038550788,1.7526884122934006,0.002008032128514056,0.38400222348482055,1.0,3/12,2.16%,ATP1A2;SLC22A2;SLC1A3
prerank,thyroid hormone generation (GO:0006590),0.7826217720748692,1.750971898348617,0.012903225806451613,0.3782650391684497,1.0,3/10,2.60%,CPQ;SLC5A5;DUOX2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6429552946316606,-1.748559400995112,0.01,0.09836406094939401,0.988,9/18,11.74%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TGFBR2;TBX2;BMP2;HEYL
prerank,positive regulation of protein polymerization (GO:0032273),-0.48186967391336,-1.7466422387757186,0.0,0.0987932839891721,0.988,28/65,21.14%,OCLN;RAC1;CARMIL1;HSP90AA1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;NCK1;MET;BAIAP2L1;PAK1;NAV3;NCK2;BIN1;TOGARAM1;CDC42EP5;TPPP;TPPP3;PRKCE;CDC42EP2;EVL;PINK1;NCKAP1L;MAPRE1;NUMA1;DCTN1
prerank,carnitine shuttle (GO:0006853),0.769885250792689,1.7441816167744688,0.006122448979591836,0.39553249263962575,1.0,3/11,5.76%,PRKAG2;PRKAA2;CPT2
prerank,cellular amino acid catabolic process (GO:0009063),0.5109914594197326,1.742535616370825,0.00794912559618442,0.3903664792222454,1.0,27/87,15.20%,DDO;ALDH4A1;ABAT;ACADSB;CBS;MCCC2;AASS;FAH;ALDH7A1;IVD;DBT;HSD17B10;BCKDHA;HOGA1;HMGCL;GCDH;ALDH6A1;BCKDHB;PRODH;AUH;PIPOX;SHMT1;AADAT;HIBCH;HMGCLL1;ASPA;GSTZ1
prerank,glycerolipid catabolic process (GO:0046503),-0.6355074680868676,-1.742464205190801,0.011583011583011582,0.10203680172838032,0.989,9/19,15.14%,GPCPD1;ABHD2;MGLL;SMPD4;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6909715386358828,1.7410917888599802,0.007905138339920948,0.3837303934951784,1.0,6/17,7.40%,BMP6;SASH1;LTF;TRIM5;CACTIN;PRKCA
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5428161413451661,-1.740110108092038,0.006521739130434782,0.10334899910727846,0.989,12/34,14.52%,LIMS2;RAC1;CARMIL1;DOCK1;LIMS1;FLNA;CALR;FERMT2;MYOC;CRK;S100A10;NEDD9
prerank,endocardial cushion development (GO:0003197),-0.6176649348251004,-1.739050164346026,0.008032128514056224,0.10304512956439264,0.99,13/21,24.13%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;BMPR2;TBX2;BMP2;HEYL;ACVR1;BMP4;HEY1;FOXF1
prerank,bone development (GO:0060348),0.5906922974846479,1.736838939305401,0.005376344086021506,0.39010225992214287,1.0,10/39,5.41%,CYP26B1;RANBP3L;FGFR2;GNAS;LTF;SH3PXD2B;AKAP13;GJA1;SULF1;LRRC17
prerank,bicarbonate transport (GO:0015701),-0.587626751387865,-1.7364297918181524,0.004132231404958678,0.10474191312096728,0.993,10/25,15.43%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;CA2;SLC4A2;SLC26A6;CYB5R1;CFTR
prerank,alpha-amino acid catabolic process (GO:1901606),0.6333891611201534,1.7338914771921408,0.007042253521126761,0.3906938305675051,1.0,11/29,15.20%,DDO;ALDH4A1;ACADSB;CBS;FAH;HSD17B10;HOGA1;THNSL2;PRODH;AADAT;GSTZ1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.48567236927226787,-1.733348449471355,0.0,0.10714045573789056,0.993,24/57,23.06%,RPL11;RPS24;RPS15;RPL38;RPS7;RPS19;RPL26;RPS6;RPS25;RPL14;RPL5;RPL35A;RPS28;RPL7;RPS17;DHX37;RBIS;RPS16;HEATR3;EBNA1BP2;NOC2L;WDR74;NOP16;NIP7
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7099832920139384,1.7316234903058274,0.008048289738430584,0.3894529920222976,1.0,3/16,1.90%,RORA;PRKN;PDK1
prerank,mesoderm development (GO:0007498),-0.6417822405173598,-1.7281638985320842,0.001996007984031936,0.11243012117335424,0.994,7/18,11.94%,TIE1;TBX1;BMX;TBX3;VEGFA;IKZF1;MESD
prerank,positive regulation of bone mineralization (GO:0030501),0.6036479509842912,1.7270498198146174,0.0056179775280898875,0.3982035288630362,1.0,9/35,3.12%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;LTF;SLC8A1;KL
prerank,neutrophil degranulation (GO:0043312),-0.3680533983443706,-1.7267548007598477,0.0,0.11291711552365255,0.995,147/425,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.36671969351853206,-1.7239251481538935,0.0,0.11498264658924597,0.996,147/428,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,sterol metabolic process (GO:0016125),0.5426875329483053,1.723290847719463,0.005016722408026756,0.4036200118931464,1.0,12/60,12.24%,PRKAG2;CYP26B1;CYP27A1;LIPA;INSIG2;ABCA1;FDXR;ABCA5;PMVK;SOAT2;RXRA;GBA2
prerank,establishment of endothelial barrier (GO:0061028),-0.5764300463054608,-1.721121587470531,0.004319654427645789,0.11727924648901064,0.996,12/29,11.40%,PECAM1;RAP1A;TJP2;PDE4D;MSN;F11R;PPP1R16B;ROBO4;PDE2A;TJP1;SOX18;RAB1A
prerank,secretion (GO:0046903),0.716316735401684,1.7194861298673103,0.016293279022403257,0.40804549781217947,1.0,3/14,1.75%,SLC22A4;SLC22A2;FBLN5
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7718251923282831,1.713385980068813,0.016359918200409,0.42266248389482264,1.0,4/10,3.79%,ATP1A2;OSR1;NEDD4;PCSK9
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6001628545411333,1.7109297097396006,0.013157894736842105,0.42224426498682527,1.0,7/31,4.40%,OSR1;FGFR2;HOXC4;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.527060557027881,-1.7104706273672785,0.008264462809917356,0.13070326832180368,0.997,16/38,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,regulation of catabolic process (GO:0009894),-0.6276450444228496,-1.7074589005425975,0.0125,0.13365882750831468,0.997,9/18,10.91%,FAP;ITGB1;NEDD4L;FAF1;CHEK2;ZDHHC2;ZDHHC7;FURIN;HGS
prerank,regulation of Rac protein signal transduction (GO:0035020),0.694327238204633,1.7030047953604897,0.021611001964636542,0.44508363722351085,1.0,3/16,3.32%,ARHGAP24;AUTS2;ALS2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5852797391623098,-1.7023760339669447,0.004329004329004329,0.1393238047918907,0.998,6/24,5.90%,PECAM1;MSN;ITGB1;F11R;SEMA4D;ITGA4
prerank,macrophage differentiation (GO:0030225),0.7305385302389233,1.7022604935931909,0.02564102564102564,0.4379756404984595,1.0,3/13,7.99%,IL31RA;MMP9;CSF1
prerank,triglyceride homeostasis (GO:0070328),0.632682771049435,1.7019122746776147,0.0162748643761302,0.42980322323312076,1.0,5/26,7.52%,RORA;C1QTNF3;IL18;APOC4;LIPC
prerank,positive regulation of tissue remodeling (GO:0034105),0.7703416638616094,1.7011917982024363,0.020161290322580645,0.4231407535829792,1.0,2/10,1.22%,ROCK2;IL18
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6025498637693993,1.7007806052605072,0.01444043321299639,0.4159764982971408,1.0,6/32,5.20%,PRKAG2;PPARA;SORBS1;ZBTB20;AVIL;PRKAA2
prerank,cellular protein metabolic process (GO:0044267),-0.36285725822927617,-1.7006208891620989,0.0,0.14051727316422902,1.0,136/396,15.97%,FN1;ST3GAL6;EEF1A1;ST8SIA4;IGFBP6;STK38;RPL37A;RPL41;ADAM10;RPL11;RPL13;RPL27A;RPS21;RPLP1;GAS6;CST3;RPL17;RPL23;RPS24;SPARCL1;RPL19;RPL21;RPS9;CDH2;RPL6;RPS15;RPL38;RPL37;RPL4;DAB2IP;RPSA;RPS7;RPS8;SFTPA2;SFTPA1;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;MSLN;DENND3;RPL24;RPS29;RPS14;LGMN;RPL18;CKAP4;RPS6;RPL23A;RPS12;RPS20;WARS1;SPP1;IGFBP5;LAMB2;MRRF;PDIA6;RPS25;RPS18;HSP90B1;RPL3;CHRM3;SARS1;FBXW2;NEDD8;ADPRH;RPL32;LGALS1;RPL36;RPS27A;FAM20C;RPL14;PCMT1;RPL5;RPS2;APP;RPL27;MRPL32;RPL31;PRSS23;RPS27;CHEK2;RPL29;MSRB3;ZDHHC2;NUCB1;RPLP2;MAN2B1;RPLP0;RPL35A;EIF4G1;FURIN;MRPS14;RPL7A;RPS28;RPL7;RPN1;PLOD2;LTBP1;RPS17;SCG2;MEN1;RPS10;CHGB;STOML2;RPL30;FUCA2;CALU;RPS4X;MMP15;GSPT2;CDKL3;RRBP1;VCAN;ERO1A;IDE;MRPS16;CCN1;RSL24D1;RPS26;RPS16;MRPS5;RPS5;MRPL23;UBE2G1;UBA52;RPL13A;VGF;WFS1;FBXL2;ST8SIA2
prerank,neutrophil mediated immunity (GO:0002446),-0.3612225858856103,-1.699021567051365,0.0,0.14131278294196023,1.0,148/432,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;KMT2E;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6998736922259984,1.697964536606365,0.012474012474012475,0.4193132039088076,1.0,4/16,5.91%,SOX5;HOXB4;SOX6;PTN
prerank,ethanol metabolic process (GO:0006067),0.7386036756709331,1.6972060754423262,0.014,0.41373201657012204,1.0,1/12,0.14%,ALDH1A1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.5014285270232866,-1.6947230853999276,0.002232142857142857,0.1463065017316155,1.0,13/43,11.43%,MEF2C;MICAL2;ENG;NOTCH1;HES1;SOX17;TGFBR2;TBX2;TBX3;RYR2;VANGL2;SOX18;NDRG4
prerank,negative regulation of axon extension (GO:0030517),-0.5469530722767818,-1.6944151795027675,0.0087527352297593,0.14487270749855222,1.0,13/30,13.96%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;RTN4;SEMA6C;SEMA3G;CDKL3;MT3
prerank,sphingolipid metabolic process (GO:0006665),-0.42282196423340046,-1.6925660692036806,0.0,0.1460901803424786,1.0,25/108,9.70%,ST6GALNAC3;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ESYT2;ELOVL5;ACER2;SPTLC2;PLPP1;SERINC1;DEGS2;PSAP;KDSR;PRKD3;SUMF1;PPM1L;SMPD4;SPNS2;SGPL1;HEXB;HEXA;ELOVL6;CERK
prerank,macrophage activation involved in immune response (GO:0002281),-0.6787479444069191,-1.6924719173460088,0.009615384615384616,0.1445185308532782,1.0,8/13,19.89%,PLCG2;LBP;SBNO2;GRN;DYSF;IFI35;CX3CR1;TYROBP
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7011858757811674,-1.6916651650901655,0.016,0.14414158452222167,1.0,4/11,4.38%,NOS3;HSP90AA1;CALM1;GCH1
prerank,endothelial cell differentiation (GO:0045446),-0.6871385500383262,-1.6916144781747116,0.011131725417439703,0.14256411164099353,1.0,6/12,11.16%,TIE1;KDR;ACVRL1;JAG1;BMPR2;SOX18
prerank,negative regulation of protein polymerization (GO:0032272),-0.5644656902232138,-1.6910688269097174,0.002232142857142857,0.14171194000215176,1.0,13/27,20.87%,SLIT2;KANK3;KANK1;HIP1R;STMN2;CYRIB;SSH2;SSH1;KANK4;STMN1;TUBB4A;PRKCD;MAPRE1
prerank,arachidonate transport (GO:1903963),0.7604925215900378,1.6879588039434117,0.0189873417721519,0.43229794002117866,1.0,3/10,5.24%,BDKRB2;ANXA1;ACE
prerank,arachidonic acid secretion (GO:0050482),0.7604925215900378,1.6879588039434117,0.0189873417721519,0.43229794002117866,1.0,3/10,5.24%,BDKRB2;ANXA1;ACE
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6959974204017432,1.6878948301423575,0.0041841004184100415,0.42424419584753986,1.0,4/16,1.00%,IGF1;TGFBR3;RBPJ;FGFR2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.43979416591548426,-1.6873140239850963,0.0,0.14590113162010498,1.0,32/86,21.14%,OCLN;RAC1;CARMIL1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;WDR1;NCK1;MET;BAIAP2L1;STMN2;APP;PAK1;NAV3;COLGALT1;EDN1;NCK2;BIN1;CLU;TOGARAM1;CDC42EP5;PRKCE;CDC42EP2;CFL2;EVL;PSEN1;NCKAP1L;MAPRE1;NUMA1;DCTN1
prerank,mesenchyme morphogenesis (GO:0072132),-0.637752685533827,-1.687310039389619,0.003992015968063872,0.14424316421533107,1.0,8/17,11.74%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TBX2;BMP2;HEYL
prerank,body fluid secretion (GO:0007589),0.6938164940279019,1.6867723857649253,0.022727272727272728,0.42031603909327375,1.0,2/15,0.70%,SLC22A4;SLC22A2
prerank,negative regulation of metabolic process (GO:0009892),0.5348997082233048,1.686444581622416,0.010752688172043012,0.41389940370925143,1.0,9/54,6.34%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.53800429039478,-1.6856358536847067,0.004273504273504274,0.14525896114642495,1.0,16/32,12.33%,RHOJ;KDR;THBS1;KLF4;MEOX2;NOTCH1;GATA2;HDAC5;JCAD;CARD10;PDCD10;VEGFA;PTGS2;RHOA;PIK3C2A;MAP3K3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.5984788825488582,-1.682483627865998,0.008333333333333333,0.1488842275271733,1.0,11/20,25.52%,SHANK3;LRP8;LLPH;RELN;DBNL;CAMK2B;PSEN1;DBN1;FMR1;SHANK1;FOXO6
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6310219806074375,-1.6804426033041417,0.01020408163265306,0.15023190106732962,1.0,13/17,31.09%,RAB27A;KCNB1;STX1A;CACNA1G;SLC4A8;CACNA1H;SYT10;SYT4;CACNA1I;RAB3A;DOC2B;UNC13D;RAB15
prerank,substantia nigra development (GO:0021762),-0.5288992963309009,-1.678949053936545,0.0064794816414686825,0.15082155347126297,1.0,19/37,25.99%,ACTB;GNB4;CALM1;PLP1;MBP;NDRG2;RHOA;S100A1;HSPA5;INA;CKB;CALM2;YWHAQ;YWHAH;PADI2;CALM3;SEC16A;CNP;SYNGR3
prerank,positive regulation of T cell proliferation (GO:0042102),0.5324582346257204,1.6789471841562846,0.005084745762711864,0.435770110809772,1.0,8/55,7.56%,IGF1;IGFBP2;IL18;IGF2;ANXA1;IL6;PDCD1LG2;CCL19
prerank,regulation of cell junction assembly (GO:1901888),-0.5586075289520254,-1.6777202500723623,0.008620689655172414,0.15096599229154917,1.0,8/27,3.00%,MEF2C;PRKCH;CLDN5;RAP1A;OCLN;RUNX1;CBFB;F11R
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.5674451970149132,-1.6774381941558276,0.010869565217391304,0.1498711114676044,1.0,11/24,11.38%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;VEGFA;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4781035634367864,-1.6770551325996528,0.0049382716049382715,0.1489168993582904,1.0,19/56,12.24%,TEK;CAV1;PTPRJ;CLDN5;KDR;RAC1;LIMS1;FERMT2;CLSTN2;MYOC;VEGFA;IL1RAP;NRXN1;SYNDIG1;COL16A1;EPHB1;ACE2;CLSTN3;S100A10
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4675207915854542,-1.6765236889900124,0.004694835680751174,0.14816879610528763,1.0,18/58,9.43%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;KDSR;PRKD3;PPM1L;SPNS2;SGPL1;ELOVL6;ST8SIA6
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6253714109734276,1.6762819922203618,0.02095238095238095,0.4389839995530543,1.0,5/25,3.94%,ERRFI1;PPARA;SLC6A9;SNX6;CRHBP
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7524827567965469,1.67432379832252,0.026970954356846474,0.4390054332720891,1.0,3/11,5.40%,IGF1;PLCB1;IGF1R
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7332593997151027,1.6729803605142861,0.0175054704595186,0.4368997551503537,1.0,6/12,9.43%,DPYD;CTPS1;DPYSL3;CTPS2;DPYS;ALDH6A1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5913561633490674,-1.6727249913357762,0.008264462809917356,0.15248159149050175,1.0,10/20,11.38%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,mesonephros development (GO:0001823),0.7381794560364937,1.6718248074403497,0.014925373134328358,0.43388895024010565,1.0,3/11,5.51%,OSR1;BMP7;FGF1
prerank,diterpenoid metabolic process (GO:0016101),0.5308100773286853,1.6683843661067235,0.017241379310344827,0.44004068190147305,1.0,9/55,6.18%,ALDH1A1;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;NAPEPLD
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.43262743574433654,-1.6680873835346257,0.0,0.15760711302409983,1.0,33/91,10.00%,ABCG2;FTH1;SLC39A10;TFRC;SCARA5;FTL;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;ATOX1;IREB2;SLC40A1;SLC30A5;SOD1;NEDD8;SLC31A1;MT2A;SLC22A17;ARF1;APP;SLC39A8;ISCU;FBXL5;HMOX2;FRRS1;SLC30A1;SLC39A7;ATP6V1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6408525584700654,1.6674234805837167,0.026262626262626262,0.4292579309832661,1.0,5/20,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.6408525584700654,1.6674234805837167,0.026262626262626262,0.4292579309832661,1.0,5/20,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,cardiac muscle tissue development (GO:0048738),0.529297303907181,1.6669420078465225,0.011986301369863013,0.4243019020141722,1.0,12/50,7.19%,ADAMTS9;GJB6;NOTCH2;BMP7;RBP4;CSRP3;CBY1;AKAP13;SIK1;GJA1;MAML1;NDUFV2
prerank,zinc ion homeostasis (GO:0055069),-0.5605072035037695,-1.6669053301209678,0.0044943820224719105,0.15799028268280157,1.0,17/28,16.20%,SLC39A10;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;SLC30A5;MT2A;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3;ATP13A2
prerank,cardiac muscle contraction (GO:0060048),0.575613071531569,1.6610316117539523,0.011784511784511785,0.4402479191723914,1.0,7/34,3.07%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6504347476869912,-1.66022161566705,0.012939001848428836,0.16793053285150927,1.0,5/14,10.16%,GAB1;KDR;FLT4;VEGFA;PIK3CD
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6476697477983524,1.6600749274739042,0.024714828897338403,0.43704804009992065,1.0,2/22,0.39%,IGF1;ROCK2
prerank,negative regulation of response to stimulus (GO:0048585),-0.46972038346039996,-1.6596656140236714,0.007425742574257425,0.16728566271859036,1.0,26/60,20.05%,SLIT2;KLF7;CD34;KLF4;MCTP1;HHIP;VPS13C;UBASH3B;SOCS5;DDAH1;KIF26A;YBX1;AQP11;CDK6;LPCAT3;TLE5;PTPN1;MAP3K3;CASK;CLU;NR1H2;COL3A1;WFS1;ACVR1;SH2B3;THY1
prerank,myoblast differentiation (GO:0045445),0.6929804105185551,1.6577157546946284,0.028513238289205704,0.4393055053385772,1.0,3/14,1.05%,IGF1;TCF7L2;EPAS1
prerank,cellular glucan metabolic process (GO:0006073),0.7312953451730746,1.6570468742192146,0.032467532467532464,0.43566433235268426,1.0,2/11,1.70%,PRKAG2;PHKB
prerank,ketone body metabolic process (GO:1902224),0.757433083329926,1.6559450005462264,0.0163265306122449,0.43322904599219325,1.0,7/10,16.55%,ACSS3;HMGCL;BDH1;BDH2;HMGCLL1;HMGCS2;OXCT1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.6789489402069923,-1.654334113500998,0.009765625,0.17333440486912455,1.0,7/12,15.08%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.6789489402069923,-1.654334113500998,0.009765625,0.17333440486912455,1.0,7/12,15.08%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.449582628932544,-1.6527264223918992,0.002544529262086514,0.17449340147774317,1.0,26/73,20.30%,NTRK3;CAV1;FNIP2;TFRC;BCAR3;HSP90AA1;GAS6;HSP90AB1;NGF;TGFB1;MTCP1;CD44;APP;PDCD10;VEGFA;PAK1;EIF4G1;NOS1;TERF2IP;TNKS1BP1;RAF1;PRKD1;MIF;PINK1;AKT1;ATP2B4
prerank,cell junction assembly (GO:0034329),-0.42201010539903483,-1.6519602839205147,0.002824858757062147,0.17402342795805767,1.0,23/100,5.99%,DNM3;FN1;SHANK3;SPOCK2;ADGRL3;ACTB;CLDN5;ACTG1;ITGA6;LIMS2;CDH11;CTNND2;PKP4;CDH1;PLXND1;CDH2;GJC1;KIRREL3;LIMS1;FLNA;NRCAM;FERMT2;VMP1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6731404073211523,1.6518467798616983,0.029296875,0.44284113707850215,1.0,3/16,3.89%,IGF1;IGFBP2;IGFBP4
prerank,monocarboxylic acid metabolic process (GO:0032787),0.46441967307841714,1.6505073608350713,0.004615384615384616,0.4415303253743961,1.0,14/117,6.86%,IGF1;CYP26B1;ALDH1A2;PCCA;PPARA;ALDH4A1;ABAT;ACADSB;MCCC2;ACOT4;SCPEP1;ECHDC3;PTGR1;HOGA1
prerank,ganglion development (GO:0061548),-0.6914894162004539,-1.6504239570882886,0.005758157389635317,0.17498539586579495,1.0,4/11,6.01%,NRP2;UNC5C;TUBB3;CTNNB1
prerank,acylglycerol homeostasis (GO:0055090),0.6520951475888254,1.6478310906476799,0.029069767441860465,0.44498574276618297,1.0,4/20,7.52%,RORA;IL18;APOC4;LIPC
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5638598837024493,-1.6463074889338847,0.021611001964636542,0.18077482936058678,1.0,11/24,22.51%,MEF2C;CDH2;CDON;CTNNB1;OLFM2;BNIP2;BOC;TCF3;CTNNA1;SPAG9;MAPK11
prerank,glycolipid metabolic process (GO:0006664),-0.4983562664672844,-1.6460184163000997,0.007009345794392523,0.1795665619414068,1.0,12/47,10.98%,ST3GAL4;ST6GALNAC3;ST3GAL6;ESYT2;PSAP;SUMF1;SMPD4;HEXB;HEXA;ST8SIA6;CERK;GLTP
prerank,embryonic skeletal system development (GO:0048706),0.5581365511731452,1.6452370861339707,0.0150093808630394,0.4482201463138278,1.0,9/35,6.09%,OSR1;HOXC4;RBP4;HOXB4;HOXB3;HOXA3;PDGFRA;SULF1;SLC2A10
prerank,smooth muscle cell differentiation (GO:0051145),-0.6778992053557384,-1.6449731004261137,0.013207547169811321,0.17962085513109796,1.0,7/12,23.11%,MEF2C;MRTFB;TMEM204;HEY2;APLNR;BMP4;HEY1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6732204023169508,-1.6434196303329178,0.009560229445506692,0.18093374936644205,1.0,7/13,15.77%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;SYT4;CACNA1I
prerank,positive regulation of nuclear division (GO:0051785),0.6222953179102513,1.6433352056368007,0.021778584392014518,0.4494421863791204,1.0,7/25,11.42%,IGF1;DMRT1;PDGFRB;IGF2;PHIP;NPM2;TGFA
prerank,regulation of urine volume (GO:0035809),0.7540658068459182,1.6425371663335169,0.01956521739130435,0.4463855840965262,1.0,4/10,11.08%,NPR3;ADM;NPR1;TFAP2B
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6664515091905324,-1.642313658093253,0.01968503937007874,0.18129687389099883,1.0,9/12,18.75%,CAV1;CTNNA3;RYR2;CACNA1C;BIN1;JUP;DSG2;DSP;TRPM4
prerank,negative regulation of complement activation (GO:0045916),-0.712239685727144,-1.642069614768791,0.0099601593625498,0.18013707434476983,1.0,4/10,15.99%,CD55;SUSD4;A2M;CR2
prerank,negative regulation of cell development (GO:0010721),0.6067881944268594,1.6418323947262852,0.020146520146520148,0.4433264710295178,1.0,4/25,2.73%,IGF1;FBN1;APPL2;LTF
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5186276065010059,-1.6417647168989473,0.012345679012345678,0.1788890310483304,1.0,17/35,11.38%,SEMA6A;NRP2;SEMA7A;SEMA6D;RAC1;PLXND1;SEMA3C;SEMA4D;SEMA3E;PLXNA4;FLNA;ARHGDIA;MET;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5103487224922743,1.6407283585738026,0.010291595197255575,0.44147313118728726,1.0,18/61,16.40%,EYA4;EYA1;EYA2;FGFR4;SMOC2;PDGFRB;USP7;STPG4;CEBPG;RTEL1;NPAS2;PRKD2;MRE11;BABAM2;WRN;RAD51;PML;HGF
prerank,cellular response to organonitrogen compound (GO:0071417),-0.41591107503160923,-1.6406930223049645,0.008241758241758242,0.17931934508595443,1.0,31/99,15.43%,MEF2C;SLIT2;ACTB;RAP1A;PDE3A;CDH1;SH3BP4;GABRB3;IGFBP5;CAPN2;CTNNB1;HSP90B1;GABRB1;AHR;PDE2A;KCNQ1;MTOR;SSH1;SESN2;CPEB1;ZFP36L1;XBP1;LAMTOR1;SLC26A6;SPAAR;HCN1;HRH1;JUP;NR1H4;LAMTOR2;CFTR
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6112955955857637,1.640598429207046,0.029940119760479042,0.43627750539492455,1.0,5/23,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7238425032802782,1.6392738823422093,0.02127659574468085,0.4297563765391964,1.0,2/12,4.96%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7238425032802782,1.6392738823422093,0.02127659574468085,0.4297563765391964,1.0,2/12,4.96%,IGF1;CAMTA1
prerank,membrane organization (GO:0061024),-0.3736695207803269,-1.6388047261652063,0.0,0.1811510415795282,1.0,88/227,24.76%,DNM3;SPTBN1;CERT1;HIP1;SGIP1;ACTB;ACTG1;SH3KBP1;HSPA8;TFRC;FNBP1L;CBL;STON2;REEP3;REEP1;UBB;REPS2;SH3GLB1;FNBP1;PACSIN2;FZD4;CHMP5;CHMP2B;SYNJ1;CORO1C;AP2A2;ARPC3;ATP2C1;CCDC88A;VTI1B;VAMP8;ARRB1;UBC;RPS27A;CHP1;HIP1R;DNM2;LEMD2;AMPH;DYSF;AP2M1;TOR1B;LPCAT3;PIK3C2A;HGS;GLTP;NECAP1;TMEM43;NSFL1C;BIN1;DNM1;EPN2;ADRB2;ACTR2;PICK1;PIP5K1C;AGFG1;CFTR;UBA52;M6PR;TLCD2;DVL2;SYT2;SGCZ;ARPC4;CHMP1B;SUN1;SH3GL2;ARRB2;ARPC1A;AP2B1;ANK3;CHMP1A;CTDNEP1;VAPA;ACTR3;MFN2;CHMP3;GCA;AP2A1;CHRNB1;TIMM50;CHMP7;PDCD6IP;SCARB2;HUWE1;OTOF;SYP
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.58261143627895,1.6385042931091884,0.030303030303030304,0.42715258664580924,1.0,7/31,5.73%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2;LRP2
prerank,limb development (GO:0060173),0.5897029796189066,1.6376276876179094,0.01818181818181818,0.4245686327399395,1.0,7/28,6.81%,LRP4;DKK1;INTU;SMOC1;ZNRF3;GLI3;SALL1
prerank,positive regulation of ossification (GO:0045778),0.5525635654320465,1.635799263527542,0.014652014652014652,0.42599987078064144,1.0,8/39,3.12%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;SLC8A1;KL
prerank,cellular response to fluid shear stress (GO:0071498),-0.6713343592979165,-1.6349534357180953,0.009765625,0.1867078543701031,1.0,4/12,3.12%,MEF2C;KLF2;KLF4;SREBF2
prerank,neuromuscular junction development (GO:0007528),0.6264007470510767,1.6344162064345176,0.028901734104046242,0.42613848767412355,1.0,9/24,8.66%,UNC13C;PDZRN3;LRP4;NEDD4;PPFIBP2;CACNB4;LRRK2;DNAJA3;MUSK
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6749532700412685,1.634148573540981,0.03619047619047619,0.4219656266393721,1.0,3/15,5.02%,OSBPL8;PPARA;APOC4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5703784231890389,1.6339650583441305,0.023529411764705882,0.4175202733115412,1.0,3/29,3.68%,IL31RA;FER;STAT5B
prerank,modified amino acid transport (GO:0072337),0.681166939953285,1.6334883260835253,0.027450980392156862,0.41437161013946144,1.0,6/15,10.58%,SLC6A13;SLC16A12;PDPN;FOLR1;FOLR2;SLC19A1
prerank,presynapse assembly (GO:0099054),0.6579447950769657,1.6327137115002366,0.022222222222222223,0.41217485160299805,1.0,6/16,7.48%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;PTEN
prerank,endoderm formation (GO:0001706),-0.511180865109293,-1.6322646934956935,0.011160714285714286,0.18971527042562336,1.0,12/35,13.27%,COL8A1;FN1;COL12A1;COL6A1;SOX17;ITGA5;ITGA4;LAMA3;SOX7;MMP15;COL4A2;ITGA7
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6467017934079102,1.6320077200569232,0.020366598778004074,0.4099154923719757,1.0,2/20,6.22%,IGF1;NIBAN2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6702271092391421,-1.6316808047161093,0.0210727969348659,0.18906391253256324,1.0,4/12,3.07%,CAV1;PDE4D;CALM1;GJD3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.679680480829977,-1.630117703280403,0.009107468123861567,0.1903859532129872,1.0,6/12,11.43%,PTPRJ;APOD;CBL;F3;HGS;NDRG4
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4703636978083129,-1.6294169941216508,0.0024509803921568627,0.18985159992400374,1.0,27/54,24.46%,CAV1;RPL11;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;CTNNB1;ARRB1;RPL5;CHP1;OGT;ISG15;CAMLG;COPS9;NXN;PRMT3;SPOPL;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;TNFAIP3;HSPA1B;SPRY2
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.44424111243002345,-1.6292928829954938,0.007556675062972292,0.18851344137591347,1.0,26/64,12.45%,UTRN;LIMCH1;EFNA5;ACTG1;ACER2;THBS1;JAG1;PTK2;ADAM15;SLK;PTK2B;MINK1;SEMA3E;CORO1C;NEXMIF;GSK3B;GPM6B;MYOC;EMP2;AJAP1;PEAK1;RHOA;CDK6;DUSP3;CDH13;CASK
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5016277991129902,-1.6261876856221955,0.008368200836820083,0.19249102058098444,1.0,15/37,20.09%,RPL11;RPL23;HSP90AB1;RPS7;UCHL5;UBXN1;PDCL3;BAG6;RPL5;OGT;CAMLG;RYBP;N4BP1;TLK2;NOP53
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.41433654311283025,1.6258633992607723,0.0,0.42681374122241533,1.0,43/248,10.26%,BICC1;IGFBP2;RNF220;WLS;LRRK1;TCF7L2;PTK7;LGR4;FGFR2;MCC;PRKN;LRP4;ZEB2;DAB2;DKK3;RBMS3;DKK1;TBL1XR1;IGFBP4;PRICKLE1;INVS;LYPD6;TMEM64;TLE3;ZNRF3;GPC3;LRRK2;FRAT1;GLI3;PSME4;PSMA2;GNAQ;PSMA3;FOLR1;SIAH2;AMFR;TLE1;USP34;PSMD8;AXIN2;DVL3;LATS1;SMURF2
prerank,regulation of osteoblast differentiation (GO:0045667),0.4778071390918432,1.6256905894554696,0.006482982171799027,0.42265150564848775,1.0,15/82,7.50%,IGF1;RANBP3L;BMP6;WNT4;FGFR2;BMP7;FBN2;SMAD6;LTF;SMOC1;CCN4;TMEM64;SUFU;IL6;DDR2
prerank,mesenchymal cell differentiation (GO:0048762),0.5136280053393216,1.6255317988438793,0.015517241379310345,0.41862031772231517,1.0,8/51,2.97%,RANBP3L;TGFBR3;ROCK2;WNT4;RBPJ;FGFR2;BMP7;LOXL3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6928076021056382,1.6248915566841482,0.040339702760084924,0.4160857983676122,1.0,5/13,7.83%,SORBS1;IGF2;PRKCZ;ECHDC3;GKAP1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.67766671754566,1.6223346462660182,0.03065134099616858,0.41979114127277045,1.0,2/16,0.39%,IGF1;ROCK2
prerank,heart looping (GO:0001947),-0.4942034262727207,-1.6223089945644258,0.006756756756756757,0.198011855916737,1.0,11/39,11.43%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,receptor metabolic process (GO:0043112),-0.45588293420925186,-1.6203360481039069,0.0069605568445475635,0.20028074878662785,1.0,20/53,14.46%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;SH3GLB1;LGMN;TGFB1;DNM2;RAMP1;AP2M1;DNM1;LMTK2;EHD3;MVB12A;CD81;CALCRL
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5618643779179823,1.620014187526838,0.021442495126705652,0.42383902489033426,1.0,8/32,8.88%,IGF1;PPARA;PID1;ZBTB20;PRKAA2;PRKAA1;ARNT;NUPR1
prerank,myotube differentiation (GO:0014902),0.6357485195182552,1.6197966252443952,0.025193798449612403,0.42018301806995667,1.0,4/17,2.21%,IGF1;ADAM12;ADAMTS5;ADAMTS15
prerank,primary alcohol metabolic process (GO:0034308),0.6007879626130124,1.6178552655098568,0.02355072463768116,0.42205136151551154,1.0,3/25,6.18%,IGF1;RBP4;NAPEPLD
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5687734265108587,-1.6173736459485533,0.008456659619450317,0.20431008098231931,1.0,5/21,2.22%,PRKCH;FOXP1;SLC39A10;RUNX1;CBFB
prerank,receptor signaling pathway via STAT (GO:0097696),0.5763240332239785,1.61729105001938,0.03313840155945419,0.4196306770616256,1.0,2/25,3.68%,IL31RA;STAT5B
prerank,regulation of mitotic nuclear division (GO:0007088),0.5219152815245534,1.6160021834683396,0.015050167224080268,0.4198222547358856,1.0,12/55,11.42%,IGF1;BMP7;DMRT1;PDGFRB;IGF2;OBSL1;TOM1L2;CCDC8;CUL9;CUL7;PHIP;TGFA
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.690512011772094,-1.6157341371955372,0.025540275049115914,0.2059254173859056,1.0,4/11,9.21%,CD200;CD34;THBS1;PTGS2
prerank,cardiac myofibril assembly (GO:0055003),0.6831907154914758,1.6155576407485217,0.034552845528455285,0.41704561386091454,1.0,5/15,4.40%,CSRP3;PDGFRB;NEBL;OBSL1;PDGFRA
prerank,receptor internalization (GO:0031623),-0.4872705490910354,-1.6155054679863454,0.004705882352941176,0.2047350712221265,1.0,16/44,14.46%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;ARRB1;CEACAM1;DNM2;RAMP1;AP2M1;DNM1;CD81;CALCRL
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4609088628610205,1.6140449888956958,0.009022556390977444,0.4178353489813537,1.0,22/108,7.29%,DCDC2;WLS;PTK7;TRABD2B;FGFR2;RNF43;PRKN;WWOX;DKK1;MACF1;GRB10;VGLL4;CBY1;SULF1;GPC3;LRRK2;ITGA3;APCDD1;TCF7L1;GNAQ;SALL1;FOLR1
prerank,chloride transmembrane transport (GO:1902476),-0.47488249711755504,-1.6135928957470638,0.007317073170731708,0.20672340498248132,1.0,17/48,16.90%,SLC12A7;SLC12A2;ANO1;ANO4;GABRB3;SLC12A6;SLC1A1;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;ANO2;CFTR;GLRA3
prerank,dicarboxylic acid transport (GO:0006835),0.5934707102194381,1.6131278208275206,0.026615969581749048,0.4170140131122385,1.0,12/28,10.58%,SLC13A3;SLC1A3;PDPN;SLC25A18;GJA1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC25A22;SLC22A6;SLC19A1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.701062785140469,-1.6104033092734524,0.020637898686679174,0.21109756363145635,1.0,7/10,20.19%,PRKG1;CD9;SERPINE2;CEACAM1;ALOX12;SH2B3;PRKCD
prerank,regulation of bone mineralization (GO:0030500),0.5080162841034715,1.6093362914953406,0.0136986301369863,0.4255286672271677,1.0,14/55,8.63%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;BMP2K;SLC8A1;KL;ECM1;PTN;BCOR;DDR2;ATRAID
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6254917003957512,-1.6089279207122213,0.009900990099009901,0.21258520035707268,1.0,7/15,15.23%,NTRK3;KDR;F3;VEGFA;SCG2;CDH13;CXCL12
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.527880759152535,1.6087346324783505,0.01733102253032929,0.42319775334233745,1.0,10/43,8.63%,IGF1;BMP6;WNT4;BMP7;FBN2;LTF;CCN4;IL6;DDR2;ATRAID
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5867444076883116,1.6082656632549452,0.03260869565217391,0.4206433310496827,1.0,5/29,2.80%,TGFBR3;FGFR2;TPM1;TNNC1;TNNT2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.47096759223319595,1.60718003104237,0.004665629860031105,0.4200494521576552,1.0,8/85,1.29%,IGF1;TGFBR3;BMP6;TCF7L2;OSR1;FGFR2;MCC;ANGPT1
prerank,ear morphogenesis (GO:0042471),0.6233873406951392,1.6062295212073634,0.03481624758220503,0.41880435528662613,1.0,3/20,1.00%,OSR1;ZIC1;FGFR2
prerank,endothelial cell migration (GO:0043542),-0.5006740097217673,-1.6061615017335313,0.011337868480725623,0.21663459161461546,1.0,22/37,24.36%,NOS3;ID1;FAP;PLXND1;PXN;CCN3;MYH9;VEGFA;EMP2;NR4A1;RHOA;DPP4;SOX18;SCG2;CDH13;CYP1B1;ADGRA2;PLEKHG5;PRKX;PTP4A3;EGR3;STAT1
prerank,stem cell differentiation (GO:0048863),0.5426007597801984,1.6053543543193463,0.012727272727272728,0.41775920919999715,1.0,11/39,9.37%,OSR1;FGFR2;KIT;HOXB4;JARID2;EPOP;ACE;UFL1;SETD6;MTF2;FBXL17
prerank,regulation of receptor binding (GO:1900120),-0.7042150528522008,-1.6044473464028348,0.01646090534979424,0.2184809899294422,1.0,4/10,7.36%,B2M;ADAM15;ATP2A2;ATP2A3
prerank,acylglycerol metabolic process (GO:0006639),-0.5045990064826595,-1.6034820165312038,0.0136986301369863,0.21887979842381777,1.0,10/37,12.83%,ABHD2;CAV1;DGKH;MGLL;DGKB;DGKI;LYPLA2;DGKZ;DGKG;DGAT1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5921592551314877,-1.6010452814211151,0.017578125,0.22258309126759596,1.0,13/17,28.23%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;VPS9D1;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6686294557464175,1.600636407616742,0.04612159329140461,0.42915306708906314,1.0,2/15,5.21%,MOXD1;AANAT
prerank,positive regulation of glucose import (GO:0046326),0.627234790698898,1.6004138659081397,0.03130755064456722,0.425810521210828,1.0,3/21,2.08%,IGF1;OSBPL8;SORBS1
prerank,negative regulation of platelet activation (GO:0010544),-0.6088356739898731,-1.600132940818207,0.01730769230769231,0.22278006827448285,1.0,9/16,20.19%,PRKG1;NOS3;CD9;SERPINE2;CEACAM1;THBD;ALOX12;SH2B3;PRKCD
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6353458440898809,-1.6000367265488848,0.027722772277227723,0.221339163647324,1.0,5/13,11.81%,CAV1;NEDD4L;PTK2B;NOS1;BIN1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.6164685496947037,1.599998371474265,0.03474903474903475,0.4231670840172718,1.0,4/21,6.86%,CYP26B1;CEL;FAH;HOGA1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6091256525126271,1.598716406413257,0.028680688336520075,0.423409795870559,1.0,5/24,5.90%,SOX5;ADAMTS12;EFEMP1;SOX6;ADAMTS7
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4598615416509895,-1.5982185786634198,0.016129032258064516,0.22332036019934093,1.0,26/47,25.50%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;GHITM;CHCHD3;ATP5F1E;NDUFA13;TIMM9;ROMO1;ATP5PD;MTX3;TIMM10B;TIMM13;IMMT;UQCC3;APOO;ATP5F1B;LETM1;TIMM29;HSPA9;TIMM22;SPG7;ATP5MC2;ATP5MF;ATP5MC1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6599903623109856,1.5977007211060577,0.03515625,0.4227559950287827,1.0,5/16,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.506233903899016,-1.5973331213040043,0.00881057268722467,0.22325670767504877,1.0,11/34,8.44%,GAB1;SEMA6A;KDR;RAMP2;MT1G;DAB2IP;NOTCH1;HSPB1;FLT4;VEGFA;NR4A1
prerank,regulation of centrosome cycle (GO:0046605),-0.5687078963158939,-1.5964342399896552,0.022,0.22339493803315708,1.0,15/21,35.78%,CHMP5;CHMP2B;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CHMP4C;VPS4B;CEP131;AURKA;ATF5;NPM1;PKHD1;XRCC3
prerank,positive regulation of embryonic development (GO:0040019),0.612938992932137,1.5956778377324876,0.02459016393442623,0.42586599446692885,1.0,5/19,6.22%,OSR1;WNT4;SCX;PLCB1;NIBAN2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6548759316693308,1.5955287383437846,0.020491803278688523,0.4226515056484877,1.0,5/17,10.56%,IGF1;PDGFRB;CCN4;VTN;FGF9
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.591247508178546,-1.5955239042441651,0.02079002079002079,0.2235631187182697,1.0,10/18,27.92%,JAM2;ITGB1;ITGA4;ADD2;SLC39A8;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,T cell migration (GO:0072678),-0.6383507994748413,-1.5942945822427164,0.013409961685823755,0.22464024940631244,1.0,4/13,10.16%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,cell projection assembly (GO:0030031),-0.555278989714368,-1.5936413902225073,0.010101010101010102,0.22437237367980287,1.0,5/22,4.32%,RHOJ;PARVB;RAC1;GSN;NCKAP1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.4779020406009594,-1.5933095141080986,0.009280742459396751,0.22354564924357562,1.0,11/42,11.43%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,neurotransmitter secretion (GO:0007269),-0.4728536242085722,-1.589854621647112,0.0087527352297593,0.2293415521177209,1.0,24/44,32.67%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;SYT10;PCLO;GAD1;CPLX2;SNAP25;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;RIMS2;SNPH;SYT1;SLC32A1;GRM4;SYN1
prerank,heart contraction (GO:0060047),0.5333756277976662,1.5892030461657014,0.01020408163265306,0.43915677396649183,1.0,8/41,5.24%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ACE
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6536244610479405,-1.588638214030925,0.016701461377870562,0.23031829340818824,1.0,7/13,16.12%,SEMA7A;TGFB2;PLCG2;TGFB1;CD74;IRAK3;LAPTM5
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4384900071905839,-1.588457596811625,0.009925558312655087,0.22906986122621945,1.0,22/67,10.85%,ELMO1;NRP2;KDR;RAC1;HSP90AA1;PTK2;DOCK1;CLEC14A;FYN;PTK2B;DAB2IP;NCKAP1;PXN;HSPB1;BCAR1;NCK1;FLT4;VEGFA;RHOA;PAK2;NCK2;CRK
prerank,skeletal system development (GO:0001501),0.43221432249019776,1.586892802655573,0.0,0.4430848612794317,1.0,25/148,7.92%,IGF1;SOX5;BMP6;NPR3;FBN1;FGFR2;BMP7;RBP4;WWOX;GNAS;COL9A2;SOX6;IGF2;COL1A2;SH3PXD2B;COL13A1;AKAP13;GJA1;SULF1;PRELP;ANKRD11;SUFU;EN1;EXTL1;DYM
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6705298374439677,-1.586014462127327,0.019417475728155338,0.23264237388003567,1.0,3/11,1.99%,MECOM;CD34;RUNX1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.41800068036486615,1.5848395565346403,0.004322766570605188,0.44632257520106816,1.0,38/186,11.06%,BICC1;IGFBP2;TCF7L2;TRABD2B;MCC;RNF43;PRKN;WWOX;LRP4;DAB2;DKK3;RBMS3;DKK1;RNF213;IGFBP4;GRB10;VGLL4;PRICKLE1;CBY1;INVS;TMEM64;TLE3;ZNRF3;APCDD1;GLI3;PSME4;PSMA2;PSMA3;SIAH2;AMFR;TLE1;PSMD8;WIF1;AXIN2;DVL3;LATS1;HDAC1;PSMD3
prerank,positive regulation of protein secretion (GO:0050714),0.48664356740994996,1.5846574087023848,0.013050570962479609,0.44321152817015114,1.0,8/69,2.23%,IGF1;BMP6;WLS;TCF7L2;C1QTNF3;RBP4;FRMD4A;NLGN2
prerank,lipid oxidation (GO:0034440),-0.6492620694304654,-1.583409260819778,0.023255813953488372,0.236566750964765,1.0,3/12,12.63%,ADIPOR2;PPARGC1A;ALOX12
prerank,aspartate family amino acid catabolic process (GO:0009068),0.652153826776466,1.5831407813204124,0.028455284552845527,0.44453281116907994,1.0,7/19,14.80%,DDO;AASS;ALDH7A1;GCDH;PIPOX;AADAT;ASPA
prerank,liver development (GO:0001889),0.5522595006278868,1.5802381172421456,0.04331450094161959,0.45007059072383776,1.0,10/32,12.46%,TGFBR3;WNT4;ARID5B;ANXA1;PRKCSH;PCSK9;IL6;CEBPG;COBL;PKD2
prerank,striated muscle contraction (GO:0006941),0.4992962289709171,1.5792596539871795,0.02159468438538206,0.4496319523208619,1.0,13/53,13.74%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ARHGEF11;RCSD1;DTNA;SCN3B;SCN2B;CCDC78
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.406870418301803,-1.5788026500067962,0.0056179775280898875,0.2447279782164394,1.0,32/93,16.77%,NTRK3;CAV1;FNIP2;PDE4D;RASSF2;TFRC;BCAR3;HSP90AA1;GAS6;HSP90AB1;NGF;RACK1;TGFB1;NCK1;MTCP1;CD44;APP;PDCD10;VEGFA;PAK1;CNKSR3;DDIT4;EIF4G1;NCK2;NOS1;SPTBN4;NLRP2B;TERF2IP;TNKS1BP1;RAF1;PRKD1;MIF
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6916628860375924,-1.578340333832039,0.026881720430107527,0.2440946481459514,1.0,5/10,11.43%,PTPRJ;APOD;PTPN12;HGS;NDRG4
prerank,cellular response to sterol (GO:0036315),0.6753433880573061,1.577753938528434,0.05102040816326531,0.4508533606841643,1.0,3/13,3.74%,RORA;INSIG2;GRAMD1C
prerank,activation of protein kinase B activity (GO:0032148),0.5594090295859567,1.5776590006261,0.026565464895635674,0.4474952771044354,1.0,6/29,5.51%,IGF1;OSBPL8;IL18;PDPK1;RICTOR;FGF1
prerank,positive regulation of dendrite extension (GO:1903861),-0.6071839049319694,-1.5774876440989811,0.034274193548387094,0.24416529200139772,1.0,13/17,29.94%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;SMURF1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.6208198995185152,-1.5766076401617066,0.03131115459882583,0.24440408305846104,1.0,4/14,14.24%,ENTPD1;ENTPD7;ENTPD2;NUDT1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6787044524063321,-1.576035458305396,0.029850746268656716,0.24398977541181047,1.0,6/10,18.75%,KLF4;PTPRC;TLE5;IRAK3;SIGIRR;SH2B3
prerank,regulation of glycolytic process (GO:0006110),0.47721794432889575,1.575051039693912,0.02181208053691275,0.4523513804227494,1.0,10/68,10.15%,IGF1;PRKAG2;PPARA;ZBTB20;PRKAA2;NDC1;PRKAA1;ARNT;NUPR1;NUP107
prerank,platelet degranulation (GO:0002576),-0.38729030313174745,-1.5749621340587214,0.0029940119760479044,0.24451683269902696,1.0,31/118,9.01%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;LHFPL2;PSAP;TAGLN2;FLNA;ACTN1;WDR1;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;CLEC3B;APP;VEGFA;CYRIB;CD63;SRGN;A2M
prerank,retina homeostasis (GO:0001895),-0.5491332073232722,-1.572707055950767,0.031936127744510975,0.24795668623287506,1.0,6/23,6.09%,ACTB;POTEF;B2M;ACTG1;HSPB1;SOD1
prerank,regulation of dendrite extension (GO:1903859),-0.5950187696795263,-1.5717931547404076,0.030927835051546393,0.24810774926780144,1.0,13/18,29.94%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;SMURF1
prerank,thymus development (GO:0048538),-0.6280716724460824,-1.5716443364612807,0.017857142857142856,0.2467907759291245,1.0,4/13,6.87%,TBX1;HES1;SOD1;SIX1
prerank,regulation of cardiac conduction (GO:1903779),0.4941017268591457,1.5715260340706427,0.024955436720142603,0.46062982667148744,1.0,11/54,5.95%,ATP1A2;ITPR1;SLC8A3;STIM1;CORIN;ATP1B3;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.725386529644702,1.5708828188273307,0.0556792873051225,0.45916741831088476,1.0,5/10,9.30%,IVD;ACADL;ACAD11;ACADS;GCDH
prerank,regulation of intracellular pH (GO:0051453),-0.5029012930084888,-1.5708140406642168,0.013215859030837005,0.24711703404768873,1.0,12/34,18.99%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1;CFTR;ATP5F1B;TMEM165
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5832675831892107,-1.5708004668422106,0.028513238289205704,0.24558392144281402,1.0,6/18,11.15%,PLCG2;LBP;DOCK2;SBNO2;DYSF;IFI35
prerank,embryonic eye morphogenesis (GO:0048048),0.708587497653714,1.570548624381871,0.048672566371681415,0.4566435275739289,1.0,4/11,4.95%,EFEMP1;FBN1;FBN2;KDM2B
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6134051240466853,1.5704152085611442,0.047520661157024795,0.4533784163942651,1.0,3/20,4.99%,WNT4;C1QTNF3;SIK1
prerank,steroid metabolic process (GO:0008202),0.4804637866148094,1.570008542691753,0.009917355371900827,0.4511199706540273,1.0,8/72,5.73%,CYP26B1;CYP27A1;LIPA;HSD17B1;NR1I2;FDXR;HSD17B10;LRP2
prerank,manganese ion transport (GO:0006828),-0.611060910942228,-1.569823526485671,0.031936127744510975,0.24615108670807884,1.0,11/14,29.83%,TRPC3;TRPC6;ATP2C1;SLC39A8;TRPC4;SLC39A14;TRPC1;TMEM165;SLC11A1;TRPC7;ATP2C2
prerank,atrioventricular valve development (GO:0003171),-0.6083429104720113,-1.5687699693103705,0.03508771929824561,0.24678060871689336,1.0,12/14,31.95%,TGFB2;NOTCH1;BMPR2;TGFBR2;BMP2;HEYL;APLNR;ACVR1;GJA5;SLIT3;ZFPM1;TBX20
prerank,male meiosis I (GO:0007141),0.6359973735545983,1.567874949822756,0.03333333333333333,0.4540067283498288,1.0,3/16,6.30%,MYBL1;SLC25A31;HSF2BP
prerank,response to prostaglandin E (GO:0034695),0.7139492158161334,1.5675977634790337,0.04893617021276596,0.45138626929780046,1.0,5/10,18.81%,TGFBR3;CCL19;PTGER4;GNG2;SFRP1
prerank,proteoglycan metabolic process (GO:0006029),0.570269804848521,1.5673067762416222,0.040421792618629174,0.44882597362988147,1.0,4/26,5.24%,IGF1;ADAMTS12;GAL3ST3;SULF1
prerank,hepaticobiliary system development (GO:0061008),0.6015590427052184,1.5667548240500428,0.0471311475409836,0.4469674958483034,1.0,5/20,3.79%,TGFBR3;WNT4;ARID5B;PRKCSH;PCSK9
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5749224302243502,1.5665239160195414,0.04038461538461539,0.44435746490572015,1.0,3/26,4.96%,IGF1;FHL2;CAMTA1
prerank,lipid phosphorylation (GO:0046834),-0.6846871377965791,-1.566463281650791,0.02480916030534351,0.2502785690483939,1.0,7/10,24.15%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKE;DGKQ
prerank,negative regulation of cell adhesion (GO:0007162),-0.4216983147617102,-1.5659679641683895,0.010958904109589041,0.24990162475662678,1.0,20/72,6.03%,PODXL;SEMA6A;ACER2;ADAM10;ACVRL1;JAG1;CDH1;PLXND1;PTK2;CORO2B;NOTCH1;SEMA4D;TGFBI;ARHGDIB;FZD4;PLXNA4;TGFB1;ARHGDIA;NEXMIF;PTPRC
prerank,negative regulation of TOR signaling (GO:0032007),0.5383618176124064,1.5657158701225389,0.027726432532347505,0.44355319214641986,1.0,14/36,11.36%,NPRL3;FNIP1;DEPTOR;SZT2;SESN1;PRKAA2;NPRL2;PDCD6;UBR2;RNF152;PRKAA1;EPM2A;FLCN;AKT1S1
prerank,regulation of striated muscle contraction (GO:0006942),0.572398755786545,1.5655979019269688,0.028268551236749116,0.440702164295099,1.0,4/27,3.96%,ATP1A2;SLC8A3;DMD;ANK2
prerank,signal release from synapse (GO:0099643),-0.4688276638902216,-1.5639707156736569,0.015384615384615385,0.2524112914442591,1.0,23/43,32.67%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;SYT10;PCLO;GAD1;CPLX2;SNAP25;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;SNPH;SYT1;SLC32A1;GRM4;SYN1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5864561751066006,-1.5633901428685748,0.02702702702702703,0.25210725433841996,1.0,12/16,28.23%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,peptidyl-tyrosine modification (GO:0018212),0.49479769129776574,1.5613020264437583,0.026755852842809364,0.45117258896071244,1.0,11/56,4.40%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;TPST1;FER;EPHA4;ABI2;PDGFRA
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6602948542207093,1.5606747989920036,0.04356435643564356,0.45005591328580297,1.0,2/15,1.37%,IGF1;PRKN
prerank,negative regulation of reproductive process (GO:2000242),0.6293576208207348,1.5597558435789487,0.051923076923076926,0.4497130408244702,1.0,4/17,5.24%,IGF1;SPINK13;GJA1;SULF1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.7143292509955731,1.5597275882985127,0.04384133611691023,0.4465586758599753,1.0,2/10,2.75%,SOX5;SOX6
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6895393882102652,-1.5591796203335098,0.029906542056074768,0.25972275328242844,1.0,3/10,1.94%,IL33;KDR;NAMPT
prerank,neural crest cell migration (GO:0001755),-0.4915229326464871,-1.5581731473845308,0.015765765765765764,0.2603621351953401,1.0,13/36,11.38%,FN1;SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5045815218706938,-1.5550959588586073,0.017316017316017316,0.26562968819898897,1.0,13/30,22.91%,NOS3;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;TNFRSF10B;TNFAIP3;FAIM
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6596444899313981,-1.5546802467989345,0.038314176245210725,0.26504966929621676,1.0,8/10,25.50%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5PD;VPS9D1;ATP5MC2;ATP5MC1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6068411431106118,1.5544633670723733,0.032520325203252036,0.4598827876851973,1.0,4/18,8.62%,FBN1;LTF;LRRC17;FSTL3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6181813135775738,1.5541242724450333,0.04911591355599214,0.45757609045728215,1.0,1/19,0.03%,IGF1
prerank,regulation of focal adhesion assembly (GO:0051893),-0.4459699542214128,-1.5534684766720275,0.012437810945273632,0.2660736654374854,1.0,24/54,12.24%,TEK;LIMCH1;EFNA5;PTPRJ;APOD;ACTG1;KDR;THBS1;RAC1;ACVRL1;PTK2;SLK;LIMS1;CORO1C;FAM107A;FERMT2;GPM6B;MYOC;VEGFA;PEAK1;RHOA;COL16A1;DUSP3;S100A10
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5813427881694297,1.5525697090367756,0.037383177570093455,0.45932429914484624,1.0,7/22,12.63%,SH3D19;TIMP3;SNX9;SNX33;NRDC;PTPN3;PACSIN3
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.5414670647417433,1.5520997339564613,0.036036036036036036,0.4577161769178991,1.0,4/34,3.44%,IGF1;DMRT1;PDGFRB;IGF2
prerank,glycoprotein catabolic process (GO:0006516),0.6235316185618356,1.5518969463994443,0.045081967213114756,0.45526106142563405,1.0,6/17,13.42%,ADAMTS12;ADAMTS9;FBXO44;FBXO6;EDEM1;NGLY1
prerank,macrophage activation (GO:0042116),-0.4944044739441643,-1.550836931013264,0.035164835164835165,0.2704966241843188,1.0,11/34,14.27%,FOXP1;PLCG2;LBP;CD93;SBNO2;APP;DYSF;IFI35;CLU;C1QA;IFNGR1
prerank,maturation of SSU-rRNA (GO:0030490),-0.49080609330037106,-1.5501896551785537,0.024229074889867842,0.27034667567569204,1.0,14/34,23.48%,RPS8;RPS19;RPS14;DCAF13;DDX52;BMS1;RPS28;DHX37;WDR3;RPS16;TSR3;PWP2;TSR1;MRPS11
prerank,maturation of 5.8S rRNA (GO:0000460),0.626725384490402,1.549963762362941,0.03682170542635659,0.45795107922337197,1.0,5/17,10.51%,NSA2;MPHOSPH6;FTSJ3;NOL9;PRKDC
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.46918466533851294,-1.5495597992263388,0.016241299303944315,0.2701403312560793,1.0,18/42,14.36%,UTRN;TEK;PTPRJ;KDR;RAC1;PTK2B;LIMS1;FERMT2;GSK3B;MYOC;VEGFA;EMP2;COL16A1;CDK6;S100A10;CDH13;JUP;GFUS
prerank,regulation of acrosome reaction (GO:0060046),0.7115977388918004,1.5491379041656077,0.050314465408805034,0.457530290437936,1.0,3/10,3.93%,PLA2G10;PLCB1;SPINK13
prerank,cAMP biosynthetic process (GO:0006171),0.7113861130594363,1.5486207231080091,0.0536480686695279,0.4560933209502087,1.0,2/10,0.71%,ADCY5;ADCY1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5740710931180514,1.5472474977856614,0.05338078291814947,0.457454830594891,1.0,3/26,2.08%,IGF1;OSBPL8;SORBS1
prerank,regulation of phospholipase activity (GO:0010517),0.6988190891364627,1.546372172183843,0.04721030042918455,0.45699175293738575,1.0,2/10,1.89%,FGFR2;PDPK1
prerank,toxin transport (GO:1901998),0.6968993838618431,1.5456244084597042,0.05186721991701245,0.4561949920477319,1.0,3/10,2.94%,SLC22A2;ANTXR1;ANTXR2
prerank,purine ribonucleotide transport (GO:0015868),-0.5875087269371998,-1.5456058288814425,0.018404907975460124,0.2774818616771451,1.0,7/16,16.21%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5645670722077678,-1.5455404070418695,0.03556485355648536,0.27606864628958133,1.0,8/19,7.89%,PRKCH;CLDN5;OCLN;RUNX1;CBFB;F11R;IKBKB;TJP1
prerank,nucleoside catabolic process (GO:0009164),0.6936053909313507,1.5452833578360992,0.050200803212851405,0.4541413052047487,1.0,6/11,12.27%,DPYD;UPB1;NT5M;DPYS;DERA;UPP2
prerank,endoplasmic reticulum organization (GO:0007029),-0.4192893377836541,-1.5450808941940555,0.0025974025974025974,0.2756174510598665,1.0,39/72,33.56%,REEP3;REEP1;CAV2;RTN3;REEP5;SHTN1;STX1A;APP;SMPD4;CCDC47;TOR1B;RTN4;LPCAT3;LMAN2;BNIP1;LMAN2L;SEC61G;ATL2;SEC16B;SPTSSB;GET4;VAPA;TLE6;OTOF;SEC16A;REEP2;ZBED3;RNF112;SEC31A;WDR83OS;ATL3;TMEM33;STX5;SEC61B;UBE2J2;RAB18;TRDN;SEC31B;DOP1B
prerank,metal ion homeostasis (GO:0055065),-0.4696311131684232,-1.545070915155924,0.0182648401826484,0.2740792289062662,1.0,16/40,21.61%,TMTC2;SLC12A7;SLC12A2;CAV1;SLC12A6;SLC12A8;GRIN1;SLC12A4;KCNA1;MT3;WFS1;COX11;LETM1;JPH2;ANK3;KCNH2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4623438950163571,1.543752472347923,0.020833333333333332,0.45600951703974807,1.0,6/74,2.18%,IGF1;EYA4;EYA1;TCF7L2;EYA2;BCL2
prerank,regulation of DNA repair (GO:0006282),0.5057956719158447,1.54292164982382,0.029565217391304348,0.455713991519722,1.0,3/44,0.99%,EYA4;EYA1;EYA2
prerank,leukocyte tethering or rolling (GO:0050901),-0.5778086327497818,-1.542689035823092,0.03413654618473896,0.277825026033642,1.0,9/17,27.92%,JAM2;ITGB1;ITGA4;ADD2;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,lipoprotein catabolic process (GO:0042159),-0.6478544131262147,-1.542672650968256,0.03125,0.2762979002261737,1.0,4/11,10.46%,CTSD;ABHD17B;LYPLA2;ABHD17A
prerank,regulation of neuroinflammatory response (GO:0150077),0.6017577411563532,1.5424695908626058,0.05973025048169557,0.45418520793875483,1.0,6/19,8.88%,IGF1;IL18;SPHK1;IL6;MMP9;NUPR1
prerank,bone morphogenesis (GO:0060349),0.6562817796024801,1.5423717046298355,0.06418219461697723,0.4516084600645893,1.0,3/14,2.73%,CYP26B1;FGFR2;LTF
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4380979320425188,-1.5376730691652318,0.017369727047146403,0.2865884811644017,1.0,22/54,21.26%,MEF2C;TMSB4X;NOS3;KDR;THBS1;ACVRL1;ETS1;ATP5F1A;HSPB1;GATA2;TGFB1;VEGFA;JUP;CSNK2B;NF1;PRKD1;PRCP;CD40;ATP5F1B;AKT1;ATP2B4;GADD45A
prerank,regulation of cellular pH (GO:0030641),-0.5071397463694556,-1.536876657382811,0.027896995708154508,0.2867460045172245,1.0,9/29,12.01%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.41367636782616807,-1.5342582218368774,0.0078125,0.29137130334100514,1.0,26/73,16.17%,FN1;SEMA7A;ADAM10;PTK2;ITGB1;ITGB4;ITGB8;ADAM15;DOCK1;PTK2B;ITGA5;BCAR1;LAMA5;FERMT2;LAMA3;CEACAM1;MYH9;CUL3;COL16A1;ISG15;ERBIN;CD47;NEDD9;RCC2;COL3A1;PRKD1
prerank,cristae formation (GO:0042407),-0.5068051814334658,-1.5333427492730025,0.019650655021834062,0.2922214637035204,1.0,18/27,30.48%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;CHCHD3;ATP5F1E;ATP5PD;IMMT;UQCC3;APOO;ATP5F1B;LETM1;SPG7;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF;MICOS13
prerank,response to muramyl dipeptide (GO:0032495),-0.6418134982919885,-1.5326294168616323,0.03180914512922465,0.29227293231673435,1.0,6/12,18.70%,VIM;NOD1;CHMP5;ARHGEF2;ERBIN;IRF5
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6273755389230559,1.5313988529383535,0.06551059730250482,0.48327275258375063,1.0,5/16,8.35%,DPYD;UPB1;DPYSL3;NT5M;DPYS
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.4887164662139037,-1.5306163408464715,0.026845637583892617,0.29550685792307635,1.0,17/33,12.44%,SEMA6A;RHOJ;BMPER;KLF2;THBS1;KLF4;PKM;PPP1R16B;CREB3L1;ITGA5;CEMIP2;CEACAM1;VEGFA;TJP1;S100A1;SYNJ2BP;EPN2
prerank,regulation of GTPase activity (GO:0043087),-0.354780646508263,-1.529555951977938,0.00641025641025641,0.29636913106690355,1.0,32/177,4.41%,DOCK9;PRKG1;CHN2;FGD5;EFNA5;LRCH1;FGD6;RAP1A;SIPA1L1;RGS6;ITGA6;BCAR3;TBC1D30;PKP4;PLXND1;PTK2;ITGB1;AGRN;F11R;RASIP1;ARHGAP27;CAV2;DAB2IP;CHN1;RACK1;SH3BP4;SEMA4D;NET1;DOCK10;LIMS1;TGM2;PLXNA4
prerank,kidney development (GO:0001822),0.4738889615019012,1.5285990501114552,0.028960817717206135,0.4894213388226782,1.0,13/65,7.04%,OSR1;GREB1L;WNT4;BMP7;LRP4;CTSH;PCSK9;PYGO1;ARL3;ACE;SULF1;SALL1;KANK2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.4980549674083183,-1.5285385544672243,0.02795698924731183,0.2972520584183958,1.0,16/30,28.21%,TPT1;ACKR3;RPS3;CD44;BCL2L1;DDX39B;CD74;CLU;CXCL12;MIF;CDKN2D;PTTG1IP;SNAI2;PSMD10;YJU2;TMEM161A
prerank,adenine nucleotide transport (GO:0051503),-0.5759181472717013,-1.5279342031353191,0.026859504132231406,0.2971686906039321,1.0,7/17,16.21%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,negative regulation of cilium assembly (GO:1902018),-0.6178911159441036,-1.5274653847462862,0.04030710172744722,0.29680833884392016,1.0,4/12,13.86%,TBC1D30;MAP4;LIMK2;ODF2L
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5076591415519728,-1.527433922325345,0.02702702702702703,0.29530499898812074,1.0,18/29,34.18%,RPS21;RPS8;RPS19;RPS14;DCAF13;BMS1;DHX37;RPS16;TBL3;KRI1;PWP2;TSR1;MRPS11;ABT1;UTP20;UTP4;HELB;RPP40
prerank,positive regulation of behavior (GO:0048520),-0.6645720897715823,-1.5274117572313122,0.03495145631067961,0.2938115507715224,1.0,3/10,4.40%,MEF2C;SGIP1;STRA6
prerank,endothelial cell proliferation (GO:0001935),-0.5703964663224216,-1.5272140064193342,0.03861788617886179,0.29268865917216147,1.0,5/17,3.91%,TEK;BMPER;CD34;ACVRL1;BMPR2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.533197343376502,-1.526975465560745,0.04310344827586207,0.29179740537030546,1.0,9/23,23.03%,SLC12A7;SLC12A2;SLC12A6;SLC12A8;SLC12A4;PDK2;ATP6V0A4;KCNH2;CLCN3
prerank,blood vessel morphogenesis (GO:0048514),-0.43386017570658053,-1.5264143222338797,0.02729528535980149,0.2916756166302976,1.0,21/54,9.36%,CAV1;ID1;COL4A1;KDR;ITGB8;CDH2;LAMA1;RAMP2;RASIP1;ENG;TBX1;HES1;SOX17;SLC1A1;STRA6;TGFBR2;TGFB1;LRP5;FLT4;VEGFA;HEY2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5322127803556295,-1.5258983103015138,0.034261241970021415,0.29130295099805936,1.0,11/22,18.58%,RPL23;RPS15;RPL37;RPS7;UBB;RPS20;SPRED2;DDX5;EEF1E1;EIF5A;ATR
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.41613514580909344,1.5254789725963074,0.0075528700906344415,0.49638147707945507,1.0,30/138,11.42%,IL31RA;EPHA7;EPHA3;FGFR2;FGFR4;BDKRB2;KIT;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;DDR1;NPR2;IGF1R;PTN;CLNK;FRS2;PTPRD;DDR2;RYK;MTSS1;CSF1;MUSK;FRK;AXL;NPR1;EPHA2;JAK2;ERBB2
prerank,monocyte differentiation (GO:0030224),0.6820123193838822,1.525063246710487,0.06911447084233262,0.49456190093194513,1.0,1/10,0.01%,IL31RA
prerank,dopamine metabolic process (GO:0042417),0.6071997832324069,1.5238703245203586,0.054878048780487805,0.4954711682181976,1.0,3/18,2.45%,MOXD1;PRKN;SNCAIP
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6573647146300282,-1.5238126544435868,0.03389830508474576,0.2944629458844247,1.0,3/10,9.76%,FN1;HSP90AB1;FURIN
prerank,negative regulation of leukocyte activation (GO:0002695),0.6201471798941248,1.5227426167970155,0.06611570247933884,0.49596911389374665,1.0,1/15,0.01%,IL31RA
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5710676561684113,1.522400906047709,0.0546448087431694,0.49403644114649864,1.0,6/23,8.84%,ATP1A2;CACNG1;NOS1AP;ANK2;CACNA2D1;CAMK2D
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4015852266902143,-1.5205071332387077,0.0056022408963585435,0.30059699976091697,1.0,29/88,16.17%,TEK;CAV1;PTPRM;NRP2;TIE1;KDR;THBS1;ACVRL1;F3;CAV2;BMPR2;PPP1R16B;ATP5F1A;NRAS;PDCL3;EMC10;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;XDH;SYNJ2BP;CDH13;SPARC;NF1;ATP5IF1;PRKD1
prerank,endodermal cell differentiation (GO:0035987),-0.4899205149970514,-1.5187364165224508,0.04328018223234624,0.30336211015490366,1.0,10/31,13.27%,COL8A1;FN1;COL12A1;COL6A1;ITGA5;ITGA4;LAMA3;MMP15;COL4A2;ITGA7
prerank,adherens junction organization (GO:0034332),-0.44324459369393865,-1.518102058355177,0.020361990950226245,0.3035277797716387,1.0,16/48,14.51%,ACTB;CADM1;CDH11;CDH1;CDH2;RAMP2;FERMT2;CTNNB1;CSK;TJP1;PVR;PAK2;CADM3;CDH13;JUP;PIP5K1C
prerank,regulation of protein dephosphorylation (GO:0035304),-0.46515775038595,-1.5178823961297763,0.03956043956043956,0.30257441606800317,1.0,19/37,24.07%,CALM1;PPIA;PPP1R16B;TIPRL;TGFB1;PPP1R2;HSP90B1;YWHAB;PPP6R1;PPP1R16A;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;CALM3;PPP1R15A
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5790521877415016,1.5172350807641741,0.05502846299810247,0.5081775337207635,1.0,4/23,4.46%,PRKAG2;CEMIP;BMP7;SPHK1
prerank,positive regulation of protein processing (GO:0010954),-0.5508188787048671,-1.516957571667679,0.03512396694214876,0.3032482330860115,1.0,6/19,10.21%,GSN;PLGRKT;NKD2;CLEC3B;MYH9;LPCAT3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.40473999567852026,-1.5165061624226261,0.00975609756097561,0.3028643808335513,1.0,19/71,9.02%,CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;ST6GALNAC5;KDSR;PRKD3;PPM1L;ST8SIA1;SMPD4;SPNS2;SGPL1;ELOVL6
prerank,protein localization to cell periphery (GO:1990778),-0.36652657336537575,-1.5160480517106094,0.005797101449275362,0.302610909698636,1.0,38/133,13.95%,SPTBN1;BSG;CAV1;RAP1A;EFR3B;LIN7A;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;NKD2;EHD1;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;TTC7A;TSPAN17;C2CD5;RAB3B;MYO5A;S100A10;SPTBN4;EHD3;CACNB2;CD81;JUP
prerank,platelet aggregation (GO:0070527),-0.48358103043340034,-1.5151238993108531,0.02262443438914027,0.30340061748954644,1.0,9/33,7.18%,FN1;ACTB;ACTG1;PPIA;FLNA;ACTN1;HSPB1;UBASH3B;MYH9
prerank,negative regulation of cartilage development (GO:0061037),0.6578406521539416,1.5133295734084347,0.06846473029045644,0.5180880624310891,1.0,3/13,5.90%,ADAMTS12;EFEMP1;ADAMTS7
prerank,ceramide metabolic process (GO:0006672),-0.4393029647791319,-1.5121319198666445,0.026785714285714284,0.3090990779606984,1.0,11/49,9.70%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;SPTLC2;PLPP1;DEGS2;SMPD4;SGPL1;CERK
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.520994687997537,-1.5120679292796773,0.04835164835164835,0.30774504927571195,1.0,6/25,6.03%,SPTBN1;PDE4D;RUNX1;PLCG2;RPS3;PTPRC
prerank,response to iron ion (GO:0010039),0.6665970740516707,1.5118076113659833,0.06818181818181818,0.5199670460062397,1.0,3/12,3.64%,BMP6;BCL2;TFR2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6644311588021122,1.5108202343935444,0.08501118568232663,0.5200230943851544,1.0,8/12,22.99%,SORBS1;IGF2;PRKCZ;GKAP1;PTPN11;C1QTNF12;IRS1;SNX5
prerank,lung development (GO:0030324),0.5198743764671314,1.5104392861489957,0.052805280528052806,0.5182512509737409,1.0,7/33,5.54%,ERRFI1;FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.580895485745937,1.5101442834564855,0.068359375,0.5161434856774677,1.0,6/21,7.35%,SNTA1;KCNA5;NOS1AP;ANK2;CACNA1D;CACNA2D1
prerank,ribosomal small subunit assembly (GO:0000028),-0.5715860669909667,-1.5098058863949977,0.0421455938697318,0.31169949656035534,1.0,12/16,25.60%,RPS15;RPSA;RPS19;RPS14;RPS27;RPS28;ERAL1;RPS27L;RPS5;PWP2;MRPS11;ABT1
prerank,regulation of microtubule polymerization (GO:0031113),-0.45931077177631263,-1.5091014474778581,0.024553571428571428,0.31185551821273155,1.0,17/40,25.08%,OCLN;RAC1;RPS3;CLIP1;MET;PRUNE1;STMN2;PAK1;NAV3;STMN1;TOGARAM1;TUBB4A;MAPRE1;NUMA1;DCTN1;CAMSAP3;CAMSAP1
prerank,regulation of heart contraction (GO:0008016),0.437521408105816,1.508547041171393,0.018779342723004695,0.5183974415456286,1.0,14/90,5.95%,CELF2;ATP1A2;ITPR1;SLC8A3;TPM1;STIM1;CORIN;ATP1B3;TNNT2;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,protein localization to membrane (GO:0072657),-0.35432267845970017,-1.5074752131944815,0.0,0.3141752981880626,1.0,53/187,13.95%,SPTBN1;BSG;SHANK3;CAV1;RAP1A;DLG2;EFR3B;LIN7A;GAS6;CDH1;SLMAP;AGRN;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;SH3GLB1;KCNB1;FLNA;RFTN1;MAP7;IKBKB;ZDHHC15;NKD2;FERMT2;ITGA4;EHD1;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;NRXN1;TTC7A;TSPAN17;RAB38;C2CD5;ABHD17A;RAB3B;HGS;MYO5A;TM9SF3;S100A10;SPTBN4;SYNJ2BP;EHD3;PICK1;CACNB2;CD81;JUP
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6419131733293066,-1.5073278887347203,0.05321100917431193,0.31306232589641775,1.0,8/11,22.97%,UQCRH;UQCR11;UQCRQ;UQCC3;UQCRC2;UQCRC1;CYCS;UQCR10
prerank,sensory perception of sound (GO:0007605),0.4359463761151645,1.50731052541387,0.022988505747126436,0.5194458047797761,1.0,16/88,10.88%,DCDC2;EYA1;ADGRV1;CEMIP;KIT;CCDC50;ALDH7A1;RIPOR2;CACNA1D;LRP2;TMC2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,metanephric mesenchyme development (GO:0072075),0.683777387672941,1.5069283979686354,0.06896551724137931,0.5177289909942344,1.0,2/10,0.73%,OSR1;WNT4
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5552811209329968,1.5068875106188961,0.06367041198501873,0.5148768340369586,1.0,7/24,10.73%,ARHGAP28;ARHGAP6;CGNL1;PHLDB2;RHPN2;ARHGEF18;PIK3R1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6453583683318752,1.506242269999783,0.06693711967545639,0.5140493181757078,1.0,5/13,9.66%,IGF1;PLCB1;SLC2A10;CCL19;GOLGA2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5478596435102305,1.5060143801261205,0.05272407732864675,0.5119349483113568,1.0,9/28,11.11%,PRKAG2;FGFR4;AVIL;NOS1AP;PRKAA2;MITF;SIRPA;MED1;JAK2
prerank,ganglioside biosynthetic process (GO:0001574),-0.5820922490863472,-1.5053502623869952,0.047524752475247525,0.3167471470306641,1.0,8/15,18.54%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;B4GALT5;ST8SIA6;ST8SIA2;B4GALT6;ST3GAL1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5426244722003324,-1.5044537679192662,0.05179282868525897,0.3175088925407034,1.0,5/21,6.03%,PRKCH;FOXP1;SLC39A10;RPS3;PTPRC
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6426124228522277,1.5042699896244565,0.07364341085271318,0.5149696998765053,1.0,5/13,11.76%,BMP6;DAB2;RBPMS;JAK2;BMPR1A
prerank,ceramide biosynthetic process (GO:0046513),-0.4551515768903755,-1.5034961581708,0.013574660633484163,0.3183369281057604,1.0,14/40,19.44%,ST6GALNAC3;SGMS1;SGMS2;ST8SIA4;SPTLC2;DEGS2;ST6GALNAC5;SMPD4;ST8SIA6;CERS4;ST8SIA2;CLN8;B4GALT6;SPTSSB
prerank,carnitine metabolic process (GO:0009437),0.6559567764378236,1.502410167694807,0.0782608695652174,0.5181685131854326,1.0,6/12,13.70%,ACADL;CPT2;BBOX1;TMLHE;SHMT1;CPT1C
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5942763561003302,1.499548105502664,0.08057851239669421,0.5244871988642916,1.0,7/18,19.77%,KMT2A;SETD7;SETD1A;ASH1L;KMT2B;SETD2;SETD4
prerank,positive regulation of DNA repair (GO:0045739),0.4874072164330624,1.499415012187507,0.043478260869565216,0.5220097254513726,1.0,6/46,8.99%,EYA4;EYA1;EYA2;SLF1;SPIRE2;CEBPG
prerank,regulation of microtubule depolymerization (GO:0031114),-0.5204668999536411,-1.4978841337789437,0.03386454183266932,0.3307069310615067,1.0,14/25,27.61%,MAP1B;STMN2;NAV3;APC;ARHGEF2;APC2;TTBK2;MAP1A;CLASP2;SPEF1;CAMSAP3;CAMSAP1;TRPV4;FGF13
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.4750402492674079,-1.4975678181979621,0.031185031185031187,0.32995352147635876,1.0,14/30,24.86%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT5;ALG5;MGAT2;ALG8;DPM1;UBE2J1
prerank,diacylglycerol metabolic process (GO:0046339),-0.5148963545736005,-1.497427265128462,0.043137254901960784,0.32880876383151936,1.0,11/23,24.15%,DGKH;DGKB;DGKI;LIPE;DGKZ;DGKG;DGAT1;ANG;GPAM;DGKE;DGKQ
prerank,regulation of amyloid-beta formation (GO:1902003),0.5283504752625279,1.4960828365511636,0.05303030303030303,0.5299872838312808,1.0,3/34,3.71%,IGF1;ROCK2;EPHA4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6187923822398051,-1.4956367455275672,0.050387596899224806,0.33176817176977336,1.0,4/13,9.30%,IL33;KDR;NAMPT;EDN1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5548709586934454,-1.4956278796118898,0.049689440993788817,0.3302668017455855,1.0,5/19,9.37%,SLCO1C1;KLF2;KLF4;APP;MAPK8
prerank,microtubule bundle formation (GO:0001578),-0.4492963777526949,-1.4953920289930895,0.024271844660194174,0.32927915614706105,1.0,22/42,35.92%,NAV1;CLIP1;RP1;CHP1;MTCL1;TOGARAM1;CCDC66;TPPP;TPPP3;LRGUK;GAS2L1;NUMA1;SPEF1;FOXJ1;CFAP46;NCKAP5L;PLK1;DCX;PSRC1;CFAP206;CLASP1;CCDC40
prerank,embryonic heart tube development (GO:0035050),-0.5956746849243096,-1.4953857589379143,0.04417670682730924,0.32780274864865083,1.0,9/14,26.87%,HES1;SOX17;TBX2;RYR2;SOX18;NDRG4;ACVR1;MEGF8;CITED2
prerank,negative regulation of anoikis (GO:2000811),-0.5928858111956906,-1.4952783255655795,0.046966731898238745,0.3265217184057525,1.0,5/14,4.87%,CAV1;PTK2;ITGB1;NOTCH1;ITGA5
prerank,nuclear migration (GO:0007097),0.6440467304138209,1.4948293377621358,0.06995884773662552,0.5313662890517493,1.0,7/13,18.51%,SYNE2;CLMN;SYNE3;PAFAH1B1;SUN2;CEP120;TMEM201
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.5401114812996767,-1.494724712384557,0.03917525773195876,0.3263796720561305,1.0,10/20,21.85%,FAR2;ACSL4;ACACA;FAR1;DGAT1;FASN;ACSL3;SCD5;ACLY;SCD
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6391823756712887,-1.494719831388102,0.043560606060606064,0.32493612871281513,1.0,4/11,13.76%,RAC1;BCAR1;PAK1;STMN1
prerank,vascular transport (GO:0010232),0.44227214462726916,1.493462350186621,0.02258064516129032,0.5329873449971145,1.0,16/81,7.75%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,negative regulation of chemotaxis (GO:0050922),-0.47792875150387515,-1.4934303182685116,0.03571428571428571,0.32683266257945615,1.0,14/31,11.38%,SLIT2;SEMA6A;SEMA7A;SEMA6D;THBS1;SEMA3C;NOTCH1;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;DUSP3;SEMA3G
prerank,regulation of blood circulation (GO:1903522),0.5170181857257947,1.4933405513931515,0.042735042735042736,0.5305421711935735,1.0,6/34,5.24%,CELF2;BDKRB2;TPM1;TNNT2;DMPK;ACE
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6434245604201388,1.4930487720905259,0.06652806652806653,0.5286323932180291,1.0,3/14,5.90%,ADAMTS12;EFEMP1;ADAMTS7
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5342309070890634,-1.4923450843760953,0.045275590551181105,0.32800218344612225,1.0,12/21,30.27%,CAV1;PLTP;NFKBIA;PTCH1;NR1H2;ABCA3;ZDHHC8;NR1H3;TREM2;GPS2;ABCA7;PPARG
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5855282889424814,1.4920116404267465,0.04892367906066536,0.5291762782461779,1.0,5/19,4.16%,TGFBR3;RBPJ;FGFR2;RBP4;VGLL4
prerank,clathrin coat assembly (GO:0048268),-0.5771933079253645,-1.4914485679394078,0.05702647657841141,0.3286273869802782,1.0,5/15,11.65%,HIP1;SGIP1;HIP1R;PIK3C2A;NSG2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5787435698679718,-1.4906675600751107,0.04238921001926782,0.32900588627807176,1.0,9/15,27.24%,APP;CRYAB;CLU;IAPP;PFDN6;PFDN5;PSEN1;PFDN4;TREM2
prerank,basement membrane organization (GO:0071711),0.6293507947629925,1.4904391729331632,0.07261410788381743,0.5314663487267447,1.0,5/14,5.00%,NID2;FLRT2;PXDN;NID1;NTNG2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5356153760705521,1.4897787630706103,0.07262569832402235,0.5306509726371604,1.0,4/27,1.37%,ARHGAP28;ARHGAP6;CGNL1;PRKN
prerank,steroid biosynthetic process (GO:0006694),0.47543482410597204,1.489292075512666,0.03914590747330961,0.5294659884221584,1.0,6/56,5.65%,PRKAG2;CYP27A1;INSIG2;HSD17B1;FDXR;HSD17B10
prerank,regulation of multicellular organism growth (GO:0040014),0.612118313271755,1.4890790384412806,0.06470588235294118,0.527293303501032,1.0,2/15,3.68%,IGF1;STAT5B
prerank,negative regulation of cell growth (GO:0030308),-0.37181401792680047,-1.4885712776287026,0.0029498525073746312,0.3328753177445554,1.0,42/121,25.57%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;NDRG3;RACK1;SH3BP4;FHL1;BMPR2;SOX17;CCDC85B;RERG;CCN3;TGFB1;OSGIN2;DCC;APBB1;RTN4;SESN2;CDKN1B;NDUFA13;SEMA3G;CDKL3;MT3;JADE1;CDA;BST2;WFDC1;RTN4R;BTG1;ESR2;CDKN1A;CDKN2D;OSGIN1;HYAL2;SIPA1;HSPA1B;DACT3;SPHK2;ULK2
prerank,transport across blood-brain barrier (GO:0150104),0.4378546325586089,1.4883996868487979,0.02247191011235955,0.5265696209266479,1.0,16/83,7.75%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5096799470365609,-1.487901224211207,0.06485355648535565,0.3330416658733368,1.0,11/24,21.04%,UBE3A;PTK2B;UBB;PKD1;UCHL5;TMF1;PSME3;PSME1;ATP5IF1;PINK1;CTSC
prerank,regulation of T cell migration (GO:2000404),-0.5382387173187324,-1.48786348616715,0.04789272030651341,0.3317151126113008,1.0,5/18,9.24%,LRCH1;APOD;CD200;APP;RHOA
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6455150451168132,-1.4864946925150453,0.043151969981238276,0.33209203875889565,1.0,2/10,2.97%,KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6455150451168132,-1.4864946925150453,0.043151969981238276,0.33209203875889565,1.0,2/10,2.97%,KLF4;MBP
prerank,detection of mechanical stimulus (GO:0050982),-0.5373170501375664,-1.485481675204159,0.056338028169014086,0.3331125110317916,1.0,6/19,7.01%,PIEZO2;PTK2;CDH2;PKD1;CTNNB1;PIEZO1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6021726365723713,-1.4834457228615983,0.044061302681992334,0.3369606789039652,1.0,10/13,28.67%,CSPG4;BGN;HEXB;HEXA;IDS;VCAN;DCN;ARSB;IDUA;NCAN
prerank,extracellular structure organization (GO:0043062),0.38874460895661594,1.4834343628916384,0.009695290858725761,0.5403041071098884,1.0,34/204,6.29%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;NID1;NDNF;SMOC1;MMP2;ITGAX;COL1A2;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,regulated exocytosis (GO:0045055),-0.34799880787480325,-1.4829846367421342,0.0064516129032258064,0.33671074741682755,1.0,50/173,14.62%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;LHFPL2;RAB31;PSAP;TAGLN2;FLNA;ACTN1;WDR1;STX1A;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;RAB11FIP1;CLEC3B;MYH9;APP;VEGFA;CYRIB;CD63;SRGN;A2M;SYT10;PCLO;CYB5R1;CPLX2;SYT4;CLU;SDF4;CDC37L1;MAGED2;SNAP25;RAB11FIP5;TMED10;ALDOA;PIP5K1C;SPARC
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.49143686525680885,1.482407526694479,0.05090909090909091,0.5410674448863538,1.0,5/44,5.65%,PRKAG2;CYP27A1;INSIG2;HSD17B1;HSD17B10
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5660081454592667,1.4820924509571094,0.07386363636363637,0.5393554404603864,1.0,7/20,12.56%,IGF1;PDGFRB;CCN4;ACE;VTN;BMPR1A;SERPINE1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3670221673282763,-1.481347901675661,0.002857142857142857,0.3390953975654157,1.0,28/114,15.79%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;NFKBIA;LIMS1;IKBKB;EDA;ST18;TNFRSF11A;TNFRSF1B;CARD14;BIRC3;PSMD13;AIM2;PSMF1;COMMD7;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;TRAF1;PSME1;PSMB3
prerank,ribosomal large subunit assembly (GO:0000027),-0.5147350440788432,-1.481290043604254,0.045064377682403435,0.33775890868321595,1.0,11/24,21.82%,RPL11;RPL6;RPL24;RPL23A;RPL3;RPL5;RPLP0;RSL24D1;NOP53;NLE1;PPAN
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6322125357971434,1.4810616707783868,0.07869481765834933,0.5400647556229471,1.0,5/14,12.27%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,positive regulation of cell aging (GO:0090343),-0.616207263422041,-1.4805380547786828,0.055984555984555984,0.33835384844414024,1.0,5/11,16.94%,B2M;YPEL3;ABI3;LMNA;EEF1E1
prerank,actin filament bundle organization (GO:0061572),0.5159012140388615,1.4802535395866383,0.05693950177935943,0.5398988950120492,1.0,9/33,7.18%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.6054749087311532,-1.4797746031731895,0.05162523900573614,0.3387755018536287,1.0,5/13,15.39%,CAV1;ATXN3;BAG6;HERPUD1;BCAP31
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5620311841764459,1.4797444593934046,0.07894736842105263,0.5389860776700754,1.0,5/21,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5144419390681786,-1.479475686178211,0.041749502982107355,0.3381228222198433,1.0,10/24,15.89%,PDE4D;PDE3A;GNAI1;PEX5L;PDE2A;RNF157;UBE2B;PRKAR1A;PDE11A;APLNR
prerank,prostanoid biosynthetic process (GO:0046457),-0.5821096793448212,-1.4794252176180855,0.0625,0.33680327847302094,1.0,7/15,16.77%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5761783905653092,1.4793382074419155,0.07879924953095685,0.5376438434729512,1.0,5/20,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,external encapsulating structure organization (GO:0045229),0.38773222150801184,1.4791963000860493,0.011126564673157162,0.5354194975440077,1.0,34/205,6.29%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;NID1;NDNF;SMOC1;MMP2;ITGAX;COL1A2;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,anterior/posterior pattern specification (GO:0009952),0.47400659082178975,1.4776170112764981,0.03304347826086956,0.5380352468124883,1.0,8/53,4.23%,WLS;HOXC6;HOXC4;HOXB4;HOXB3;HOXA3;HOXC5;HOXA7
prerank,urogenital system development (GO:0001655),0.6585659522822771,1.4766369205340653,0.07658643326039387,0.5385138316005401,1.0,2/11,3.48%,OSR1;ANXA1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.618904348985335,-1.4762162969601986,0.055776892430278883,0.34315467235862374,1.0,6/11,7.87%,ADIPOR2;CD34;KDR;GATA2;MCAM;VEGFA
prerank,regulation of monooxygenase activity (GO:0032768),-0.5081957300830068,-1.4757650074740027,0.046610169491525424,0.3428506933218927,1.0,8/23,11.41%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;DDAH1;DNM2;CYGB
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4649207242382216,-1.474409505610251,0.05032822757111598,0.3446191003188229,1.0,11/35,8.30%,TEK;NTRK3;ESAM;F11R;PTK2B;ARHGDIB;SEMA3E;ARHGDIA;BAIAP2L1;TJP1;ABI3
prerank,cellular response to acid chemical (GO:0071229),-0.4847700309869984,-1.4737806236823783,0.03879310344827586,0.3447905011827229,1.0,16/27,27.05%,KLF2;SH3BP4;CAPN2;VEGFA;MTOR;SESN2;CPEB1;XBP1;LAMTOR1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;GLRA1;RPTOR
prerank,peptide catabolic process (GO:0043171),0.5559192726131178,1.4737563752658958,0.07971014492753623,0.5452085513710786,1.0,5/23,7.13%,CPQ;CTSH;ACE;TPP1;NPEPPS
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4094316951175905,-1.4731393852690025,0.009950248756218905,0.3450922318042413,1.0,23/63,16.90%,SLC12A7;SLC12A2;SLC26A2;ANO1;ANO4;SLC5A6;GABRB3;SLC12A6;SLC1A1;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;SLC37A3;SLC25A30;XPR1;ANO2;CFTR;SLC25A3;GLRA3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6837828998391249,1.4721016116345058,0.07370517928286853,0.5480444918085221,1.0,5/10,12.27%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,negative regulation of macrophage activation (GO:0043031),0.5943147081578527,1.4712225132252017,0.09110169491525423,0.5483336604126128,1.0,2/16,4.13%,IL31RA;SYT11
prerank,positive regulation of cartilage development (GO:0061036),0.5986024532440374,1.4702636089080607,0.09552845528455285,0.5485273247157382,1.0,3/17,2.75%,SOX5;SCX;SOX6
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5125834822644222,-1.4701906044438693,0.056451612903225805,0.35135387711991695,1.0,12/22,34.90%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5;THY1;CD300A;FCGR2B;EZR;GPS2;PTPN22;PHPT1
prerank,cell-substrate junction assembly (GO:0007044),-0.46846496653857017,-1.4697360917831805,0.04103671706263499,0.35113560415587725,1.0,10/33,9.16%,FN1;THSD1;ITGA6;ITGB4;PLEC;ACTN1;FERMT2;LAMA3;BCR;PEAK1
prerank,ceramide catabolic process (GO:0046514),-0.5901220036191477,-1.4696104927849474,0.04590818363273453,0.35007993005610283,1.0,5/14,15.92%,ACER3;ACER2;HEXB;HEXA;GM2A
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6586586221941076,1.46919611328496,0.09349593495934959,0.5493558378984541,1.0,4/10,8.84%,OSR1;NEDD4;PCSK9;CAMK2D
prerank,regulation of glucose metabolic process (GO:0010906),0.5173106722634578,1.4684112954716855,0.043557168784029036,0.5491581015625263,1.0,4/34,3.92%,RORA;PRKN;PDK1;SLC45A3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4181592663587905,-1.4683496519775232,0.01834862385321101,0.3504378002282124,1.0,27/56,34.26%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7;NDUFAF8;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A;NDUFA3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4181592663587905,-1.4683496519775232,0.01834862385321101,0.3504378002282124,1.0,27/56,34.26%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7;NDUFAF8;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A;NDUFA3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6577901053743831,1.468149044022082,0.09803921568627451,0.547374937979581,1.0,2/10,8.60%,ADGRV1;WHRN
prerank,alcohol catabolic process (GO:0046164),0.648694775500051,1.4680071443456244,0.09815950920245399,0.5452973069005034,1.0,2/10,2.04%,CYP27A1;CEL
prerank,intraciliary retrograde transport (GO:0035721),0.6374805606912507,1.4678181736836222,0.06626506024096386,0.543403233131176,1.0,6/12,16.40%,DYNC2H1;WDR19;WDR35;IFT122;IFT140;DYNC2I1
prerank,regulation of spindle assembly (GO:0090169),-0.49897205733104666,-1.467559150634922,0.06679764243614932,0.35114447222432327,1.0,16/25,33.16%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;NUMA1;CHMP3;SPAG5;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;DYNC1H1;HSPA1A
prerank,cellular response to glucose starvation (GO:0042149),0.48949818856495436,1.466097846274516,0.039285714285714285,0.5461783151902172,1.0,11/41,8.90%,PRKAG2;PRKAG3;SZT2;SIK1;CPEB4;SESN1;PRKAA2;MTMR3;PRKAA1;ATG14;PIK3R4
prerank,myotube cell development (GO:0014904),0.6718322439399064,1.464282360283373,0.07851239669421488,0.5493964001773296,1.0,1/10,0.03%,IGF1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5749690927680977,-1.4642762461875454,0.0546875,0.3578475927907899,1.0,4/15,7.27%,RPL11;RPL23;RPS7;RPL5
prerank,regulation of actomyosin structure organization (GO:0110020),0.6283591019203668,1.4637465092602198,0.09505703422053231,0.5486265716367298,1.0,5/13,6.35%,ROCK2;FHOD1;ALMS1;AKAP13;ASAP3
prerank,carbohydrate homeostasis (GO:0033500),0.4512161793887093,1.4637406073936046,0.03425774877650897,0.5460593127670688,1.0,11/67,7.95%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5690653889709721,-1.4623384643861739,0.05394190871369295,0.361462539688622,1.0,4/15,9.23%,ENTPD1;CMPK1;ENTPD7;ENTPD2
prerank,ganglioside metabolic process (GO:0001573),-0.5282331224952292,-1.4620847209543468,0.06765327695560254,0.3607067017692732,1.0,9/20,18.69%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;HEXA;ST8SIA6;GM2A;ST8SIA2;ABCA2
prerank,response to amino acid (GO:0043200),-0.4716261415134801,-1.462048748814924,0.04680851063829787,0.3593675272544998,1.0,18/31,27.05%,SH3BP4;CAPN2;MTOR;SESN2;CPEB1;XBP1;GRIN1;LAMTOR1;SPAAR;LAMTOR2;GLRA3;RRAGB;TMBIM6;NSMF;LAMTOR4;GLRA1;MEAK7;RPTOR
prerank,purine nucleotide catabolic process (GO:0006195),-0.5844412335383176,-1.4612577559533861,0.06134969325153374,0.35996918375208337,1.0,6/13,15.56%,NT5C2;GDA;NT5C;HINT1;XDH;NT5E
prerank,muscle cell development (GO:0055001),0.5253528444644073,1.4608138677288665,0.05419580419580419,0.5528883913279955,1.0,6/30,3.96%,IGF1;DMD;SLC8A1;MEGF10;NEBL;ANK2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.416593118769098,-1.460090428021041,0.03902439024390244,0.3614540142611652,1.0,28/54,23.06%,RPL11;RPL6;RPL26;RPL24;RPL23A;RPL3;RPL14;RPL5;MAK16;RPLP0;RPL35A;RPL7A;RPL7;RSL1D1;RSL24D1;RPF1;HEATR3;EBNA1BP2;NOP53;NLE1;RRP15;NOC2L;NHP2;EIF6;WDR74;PPAN;NOP16;NIP7
prerank,protein localization to cilium (GO:0061512),0.5202038347935284,1.4591538167330174,0.06181818181818182,0.5556218124135456,1.0,14/32,18.85%,TULP3;TULP1;ARL3;INVS;WDR19;WDR35;ARL6;TCTN1;IFT122;IFT140;ATP6V1D;TULP2;BBS1;RAB29
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3630092589181007,-1.459137648226556,0.005698005698005698,0.3624312464196618,1.0,41/110,22.98%,FNIP2;HSPA8;TFRC;HSP90AA1;GSN;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;HJURP;MPP7;FAF1;GSK3B;GFAP;VEGFA;CRYAB;NAPB;SPIDR;HSPA5;RALB;PIH1D1;TAL1;CLU;SVIP;IAPP;TPPP;RAF1;CDC42EP2;PREB;PINK1;TIRAP;NOP53;PEX5;MMP1;BIK;VCP;HDAC6;BMF;MTLN
prerank,peptidyl-asparagine modification (GO:0018196),-0.4585637030495591,-1.45831823532308,0.037815126050420166,0.3632548429260819,1.0,14/31,24.86%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT5;ALG5;MGAT2;ALG8;DPM1;UBE2J1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.4598004853418049,1.456610016276987,0.05414551607445008,0.5610555786485333,1.0,4/53,2.53%,EYA4;EYA1;EYA2;PLA2R1
prerank,filopodium assembly (GO:0046847),-0.5555401589286487,-1.4565840080011652,0.05765407554671968,0.36618700977481455,1.0,4/16,5.04%,DNM3;FGD5;FGD6;SPATA13
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5954105928754342,1.456507703706387,0.1016260162601626,0.5587729067771617,1.0,1/17,0.03%,IGF1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.48285410894209935,1.4558879600234036,0.059964726631393295,0.5581670791247256,1.0,10/40,12.29%,SLC7A11;SLC13A3;SLC38A3;SLC38A9;SLC25A11;SLC27A1;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,negative regulation of nuclear division (GO:0051784),0.6560964359907574,1.4552052127350914,0.10020449897750511,0.557953178312721,1.0,3/11,4.75%,BMP7;DMRT1;TOM1L2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6695739724025179,1.455163036458137,0.10677618069815195,0.5555602437157598,1.0,1/10,0.21%,ATP1A2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4528553575696919,-1.4547275258676653,0.042986425339366516,0.36969386514908537,1.0,13/35,15.88%,MEF2C;CAV1;PTPRM;THBS1;CAV2;ATP5F1A;PDCD10;SCG2;XDH;SYNJ2BP;SPARC;NF1;ATP5IF1
prerank,positive regulation of kinase activity (GO:0033674),0.4212305830583884,1.4540775403492059,0.0336,0.5567450222922204,1.0,22/107,8.66%,PRKAG2;EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;ALS2;EPHA8;EPHA4;PDGFRA;DDR1;MRNIP;IGF1R;SNX9;XRCC5;DDR2;CCL19;RYK;CSF1;MUSK
prerank,regulation of establishment of protein localization (GO:0070201),-0.580488676902209,-1.4539691915397426,0.06470588235294118,0.37030626070553957,1.0,7/13,27.24%,CORO2B;DNAJA1;CTSD;SPIDR;PTP4A3;CEP295;TREM2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6083399055628417,-1.4535971460207735,0.07592592592592592,0.3698389651496433,1.0,5/11,20.30%,NOTCH1;FOXO1;LMNA;GLRX3;ATP2B4
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3710783572536364,-1.4534373990506917,0.005494505494505495,0.36892824570297816,1.0,40/94,23.41%,RPS6KA5;UBB;NFKBIA;NOD1;IKBKB;ST18;IL1R1;UBC;RPS27A;IL1RAP;PSMD13;PSMF1;RBX1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;MAP3K3;PSMC3;IRAK3;PSMD12;PSMB8;CUL1;MAP3K8;TAB3;PSME1;UBA52;PSMB3;RPS6KA4;IRAK1;PSMD5;MYD88;SKP1;MAPK3;PSMD9;PELI1;PSMB4;RELA
prerank,synaptic vesicle cycle (GO:0099504),-0.47883423939314007,-1.4534063489993982,0.043568464730290454,0.367625310690877,1.0,17/30,34.60%,STX1A;SLC17A6;SYNDIG1;SYT10;PCLO;CPLX2;SNAP25;PIP5K1C;SYT7;CDK5;RAB3A;OTOF;CPLX1;SNAPIN;SLC32A1;WNT7A;SLC17A8
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5040251900793885,-1.4529381578722103,0.03413654618473896,0.36740766280403586,1.0,7/25,9.12%,RPL11;RPL23;HSP90AB1;RPS7;PDCL3;RPL5;PSMF1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4643904160234663,1.45274768007293,0.039473684210526314,0.5586449771864794,1.0,8/61,4.86%,IGF1;ROBO1;AUTS2;NOTCH2;LPAR1;ALS2;AKAP13;MAPRE2
prerank,response to amyloid-beta (GO:1904645),0.48142906294421894,1.451994668209276,0.06118881118881119,0.558670943912388,1.0,8/44,7.35%,IGF1;SNX6;MMP2;EPHA4;GJA1;IGF1R;MMP9;CACNA2D1
prerank,positive regulation of chemotaxis (GO:0050921),-0.4342644810202205,-1.4518326985646404,0.03926096997690531,0.36905115398498717,1.0,11/43,7.87%,NTRK3;TMSB4X;KDR;THBS1;STX3;F3;LGMN;HSPB1;TGFB1;MET;VEGFA
prerank,positive regulation of DNA binding (GO:0043388),0.5178222734814479,1.4517565698850508,0.0873015873015873,0.5568600769927297,1.0,5/31,8.99%,IGF1;PRKN;NIBAN2;MMP9;CEBPG
prerank,odontogenesis (GO:0042476),0.5005367529958222,1.4511644461414943,0.07256637168141593,0.5562815987774112,1.0,8/35,10.71%,OSR1;FGFR2;WNT6;COL1A2;ANKRD11;BCOR;AXIN2;HDAC1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6193040621877363,-1.4510355924239182,0.06500956022944551,0.36973950956721696,1.0,7/11,20.51%,NDUFA13;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22
prerank,eye development (GO:0001654),0.46870941706848923,1.4509152694247447,0.05555555555555555,0.5545929277328036,1.0,11/54,8.52%,EFEMP1;FBN1;RBP4;MEIS1;FBN2;SLC39A5;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5889754618496674,-1.4506999748393679,0.07648183556405354,0.3691398523173451,1.0,7/13,30.77%,TMSB4X;HEY2;PSEN1;SOX11;HEY1;PER2;SIN3A
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.44757432467114855,1.449838650303049,0.04384485666104553,0.5554968464315484,1.0,12/67,5.40%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA4;ABI2;PDGFRA;DDR1;IGF1R
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5803269786411871,-1.4488177129198274,0.09018036072144289,0.37282033851322427,1.0,3/13,9.23%,ENTPD1;ENTPD7;ENTPD2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.5281675889515884,1.4484630247756798,0.07235621521335807,0.5573878118183085,1.0,8/28,13.05%,ARHGAP28;NAA80;ARHGAP40;COTL1;ARHGAP35;LATS1;GBA2;FCHSD2
prerank,regulation of osteoblast proliferation (GO:0033688),0.5922838215829043,1.4482750360257917,0.08982035928143713,0.5555277408720356,1.0,3/17,2.73%,NPR3;FGFR2;LTF
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5922445033936863,1.4477192407076058,0.1079429735234216,0.5549284912010763,1.0,3/15,5.21%,DAB2;BMP2K;WASL
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5690377370875901,1.4476651657790274,0.07142857142857142,0.5527093642321315,1.0,4/21,6.11%,DCDC2;TEDC2;TTC23;ARMC9
prerank,regulation of muscle contraction (GO:0006937),0.53405249640151,1.4476644829377892,0.0691588785046729,0.5503308765250943,1.0,3/26,2.30%,ATP1A2;TPM1;TNNC1
prerank,sodium ion export across plasma membrane (GO:0036376),0.6201004631646418,1.4461947823737347,0.11181434599156118,0.5527288828822398,1.0,2/13,2.26%,ATP1A2;ATP1B3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5983940158163826,1.446094142433013,0.08731808731808732,0.5507014894056209,1.0,4/15,6.34%,SH3D19;SNX9;SNX33;NRDC
prerank,membrane depolarization during action potential (GO:0086010),0.5305719930339511,1.4457799313027806,0.09578544061302682,0.5493962004722132,1.0,4/26,4.74%,SCN7A;ATP1A2;SLC8A1;CACNA1D
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6297068569257139,-1.4452209253759287,0.06031128404669261,0.38068446466284095,1.0,6/10,24.46%,SEMA6A;DAB2IP;XDH;CADM4;DCN;SPRY2
prerank,heart morphogenesis (GO:0003007),-0.4162906783307734,-1.4445799375477641,0.03712871287128713,0.3809967781706428,1.0,16/50,11.74%,NOS3;ACVRL1;TGFB2;PTK2;ENG;NOTCH1;TBX1;HES1;SOX17;TBX2;TBX3;VEGFA;RYR2;HEY2;BMP2;HEYL
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4390177691762813,-1.4436077339750215,0.04367816091954023,0.38224067788255767,1.0,14/39,11.75%,PODXL;FXYD5;JAG1;CDH1;KLF4;PTK2;MBP;NOTCH1;TGFB1;NEXMIF;VEGFA;NOTCH4;BMP2;SPINT2
prerank,lamellipodium assembly (GO:0030032),-0.48365626419443664,-1.443414467817537,0.06711409395973154,0.3813545470589891,1.0,11/26,12.41%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A;WHAMM;CDH13
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.49497477405601037,1.442464929172316,0.06422018348623854,0.5574283657148947,1.0,5/38,7.68%,BMP6;SASH1;DDX60;PRKCA;POLR3G
prerank,response to ATP (GO:0033198),-0.5317693577667305,-1.4419316855299666,0.07392197125256673,0.3838026765497039,1.0,13/18,42.72%,ABCC9;TRPC3;HSP90B1;SSH1;DGKQ;P2RY12;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;CIB2;KCNJ11
prerank,response to unfolded protein (GO:0006986),-0.42339236747487885,-1.4406457951951448,0.03153153153153153,0.3857369663878613,1.0,16/48,13.06%,HSPA8;HSP90AA1;HSP90AB1;DAB2IP;DNAJA1;STT3B;HSPB1;HSPA14;DERL1;ERP44;TOR1B;HSPA5;PTPN1;HSPB8;HSPD1;HERPUD1
prerank,long-chain fatty acid transport (GO:0015909),0.5053753157267501,1.4400017130614224,0.07102803738317758,0.5629579870152048,1.0,6/30,10.77%,PRKAG2;ACSL1;PRKAA2;CPT2;SLC27A1;RPS6KB1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.5044244904034948,-1.4398608301087332,0.07773109243697479,0.3863229194673431,1.0,5/22,12.42%,B2M;STX7;CD55;CYRIB;HSPD1
prerank,positive regulation of blood coagulation (GO:0030194),-0.5441454771880019,-1.4393509511619598,0.07306889352818371,0.3862598777702812,1.0,3/17,2.38%,ST3GAL4;THBS1;F3
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.3991264639282555,-1.4392202493915012,0.041463414634146344,0.38521160056327614,1.0,34/68,35.90%,IL33;PLCG2;MBP;LBP;APP;XBP1;STAT3;CD74;HSPD1;ARHGEF2;IFIH1;TIRAP;MYD88;TYROBP;HYAL2;AGER;RAB7B;SPHK2;TLR7;TLR4;LPL;C1QTNF4;IL16;TLR6;DHX9;MAVS;NOD2;TLR1;NOS2;IL1A;TSLP;SYK;F2R;TLR8
prerank,regulation of cell growth (GO:0001558),-0.33229371695157855,-1.4381545964209712,0.0033222591362126247,0.3867594398572332,1.0,62/204,22.84%,APBB2;SLIT2;PTPRJ;LTBP4;TFRC;ADAM10;ACVRL1;TGFB2;ADAM15;NDRG3;RACK1;SH3BP4;NET1;FHL1;BMPR2;CDK11B;SOX17;CCDC85B;SOCS2;RERG;BCAR1;CCN3;TGFB1;FAM107A;OSGIN2;CEACAM1;KIF26A;APBB1;MTOR;MFSD2A;H3-3A;RTN4;SESN2;EIF4G1;CDKN1B;LAMTOR1;NDUFA13;RPS6KA1;EGLN2;MT3;SPOCK1;NRG3;JADE1;LAMTOR2;CDA;CISH;SGK1;AGTR1;BST2;SUPV3L1;AKT1;WFDC1;PAPPA2;PAK5;BTG1;ESR2;CDKN1A;CDKN2D;PTCH2;OSGIN1;HYAL2;SIPA1
prerank,cell junction organization (GO:0034330),-0.3876069744586298,-1.4377855666067565,0.015503875968992248,0.38654495239060244,1.0,20/71,9.24%,APBB2;ACTB;ACTG1;OCLN;TJP2;LIMS2;TGFB2;CTNND2;AGRN;CXADR;SEMA3E;LIMS1;FLNA;TGFB1;FERMT2;VMP1;PPFIA2;APP;TJP1;RHOA
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6032298285708078,1.437690636015767,0.10272536687631027,0.5679985976519103,1.0,3/13,1.00%,TGFBR3;RBPJ;FGFR2
prerank,T cell homeostasis (GO:0043029),-0.6183766227761625,-1.4362760522232743,0.0745697896749522,0.38909580984225983,1.0,8/10,30.53%,ZC3H8;FAS;JAK3;PPP2R3C;AKT1;NCKAP1L;FADD;PMAIP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.461448611677432,-1.4354288974220435,0.06157112526539278,0.389936900873809,1.0,19/31,30.53%,PPP1R13B;NMT1;YWHAB;GSK3B;HIP1R;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;CHCHD10;BAX;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,lymphocyte mediated immunity (GO:0002449),-0.6041308722230593,-1.435267525139696,0.0778688524590164,0.38900781063183343,1.0,4/12,16.99%,JAG1;CD55;MSH2;BTN3A3
prerank,regulation of hydrolase activity (GO:0051336),-0.3850615236614241,-1.4352290629562814,0.032171581769437,0.3877062471308936,1.0,14/71,4.41%,PRKG1;CHN2;FGD5;EFNA5;CAV1;FGD6;SIPA1L1;PLXND1;PTK2;RASIP1;ARHGAP27;DAB2IP;CHN1;PLXNA4
prerank,regulation of macrophage migration (GO:1905521),-0.609665597214452,-1.4352282263286775,0.09386973180076628,0.3863553542837477,1.0,5/10,15.75%,MTUS1;CD200;PTK2B;CD81;CX3CR1
prerank,activation of protein kinase A activity (GO:0034199),0.5827752665500623,1.435009005178189,0.11570247933884298,0.5746204298814847,1.0,2/16,0.71%,ADCY5;ADCY1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.5136534452525132,-1.4348652448069414,0.05496828752642706,0.3859333504839297,1.0,9/21,15.56%,PDE4D;NT5C2;NUDT3;HPRT1;PDE2A;NUDT4;HINT1;XDH;NT5E
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5959578707715554,-1.4347376866120651,0.08348794063079777,0.3849575119910819,1.0,3/12,2.97%,FOXP1;KLF4;MBP
prerank,positive regulation of GTPase activity (GO:0043547),-0.333136265817457,-1.4344358809398323,0.006920415224913495,0.38443150104571355,1.0,48/188,12.37%,DOCK9;NTRK3;RAP1A;SIPA1L1;RGS6;ITGA6;TIAM1;BCAR3;TBC1D30;PKP4;ARHGAP42;ITGB1;AGRN;TBC1D8;SIPA1L2;F11R;ARHGAP27;CAV2;RACK1;SEMA4D;SIPA1L3;NET1;DOCK10;ARHGEF15;CCDC125;RABGAP1L;LIMS1;TGM2;CORO1C;FERMT2;ADPRH;ABR;GRTP1;GSK3B;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;S100A10;TBC1D10A
prerank,cellular response to BMP stimulus (GO:0071773),0.43908636563311826,1.4334750357253747,0.04384485666104553,0.5772073743940143,1.0,10/66,7.68%,ADAMTS12;TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX;ADAMTS7;SMAD3;RGMB
prerank,amino acid transmembrane transport (GO:0003333),0.47083357973552475,1.4331072379424963,0.0711743772241993,0.5760561902447513,1.0,8/45,6.64%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC25A18;SLC38A9;LRRC8E
prerank,renal system development (GO:0072001),0.4595709512444344,1.4321180149760264,0.06491228070175438,0.5768302693641767,1.0,13/52,11.08%,GREB1L;WNT4;RBP4;LRP4;PCSK9;PYGO1;ARL3;ACE;SULF1;SALL1;IFT27;TFAP2A;TFAP2B
prerank,catecholamine metabolic process (GO:0006584),0.6008472724643,1.4320501815780695,0.10105263157894737,0.5747120991929787,1.0,5/14,16.97%,PRKN;SNCAIP;RNF180;LRTOMT;DRD2
prerank,positive regulation of neuron migration (GO:2001224),-0.6198993791041663,-1.4318055837338381,0.08888888888888889,0.38997212141136833,1.0,7/11,22.66%,SEMA6A;DAB2IP;SHTN1;ARHGEF2;NSMF;SEMA3A;PLAA
prerank,ureteric bud development (GO:0001657),0.5652076307307285,1.4313061603254575,0.11270491803278689,0.5746847398596548,1.0,5/17,6.81%,OSR1;FGFR2;BMP7;GPC3;SALL1
prerank,positive regulation of cell migration (GO:0030335),-0.3196054883363783,-1.4308042457373025,0.0,0.3912348837621308,1.0,66/253,12.50%,LEF1;GAB1;NTRK3;FN1;PECAM1;PODXL;CAV1;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;TGFB2;CARMIL1;SEMA3C;F3;PTK2;ITGB1;DOCK1;PLCG2;ROR2;PTK2B;DAB2IP;NOTCH1;RACK1;SEMA4D;BMPR2;SEMA3E;SHTN1;BCAR1;TGFB1;FAM107A;FERMT2;PTPRC;PDGFC;MYOC;PDCD10;VEGFA;TJP1;MTOR;PAK1;CPNE3;GRN;SEMA4B;EDN1;SEMA5B;RTN4;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;SEMA3G;TWIST2;GPER1;RIPOR1;CDH13;ARHGEF2
prerank,transcription by RNA polymerase II (GO:0006366),0.35654679968387826,1.4305526269568463,0.009247027741083224,0.5747274165526839,1.0,52/305,14.28%,GLIS3;RORA;SOX5;MAF;RBPJ;PPARA;NOTCH2;POLR2D;PRRX1;PHAX;ESRRG;CCN2;NR1I2;TBL1XR1;PAX5;CDK7;MAML3;ELOA;SSU72;TEAD1;MAML1;HSF2BP;INTS8;NR6A1;NRBP1;POLR2A;CCNT2;TEAD3;RPRD1B;CCNT1;GTF2F1;SNAPC5;MED1;TAF8;HDAC1;TAF1A;DTX1;RPRD2;RXRA;TAF3;CDC73;ICE2;GMEB2;GTF2I;AR;MAML2;NR1I3;WDR33;TRIM24;CREBBP;MNAT1;NELFB
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.4200045281935172,-1.4303475134881332,0.03537735849056604,0.39113902205258794,1.0,23/50,24.46%,CAV1;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;ARRB1;CHP1;OGT;ISG15;CAMLG;NXN;PRMT3;SPOPL;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;TNFAIP3;HSPA1B;SPRY2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.47108559193251603,1.4299191852983402,0.05536332179930796,0.5745392031076956,1.0,8/46,7.05%,IGF1;TCF7L2;IL18;OGN;PDGFRB;CCN4;IL6;XRCC5
prerank,granulocyte differentiation (GO:0030851),-0.5349254455569539,-1.429732114681464,0.07039337474120083,0.3912680479085113,1.0,8/18,22.87%,LEF1;CBFA2T3;LBR;TAL1;CDK2;SPI1;CDKN1A;CEBPA
prerank,epithelial cell morphogenesis (GO:0003382),0.5662795263825902,1.4297123734218102,0.08582834331337326,0.5729019628590764,1.0,1/17,0.01%,COL22A1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5682124536149736,-1.4295936278413985,0.07170542635658915,0.39025988380181487,1.0,4/14,5.70%,PRKG1;MEF2C;SLIT2;IGFBP5
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3491919358336379,-1.4294249182682046,0.006024096385542169,0.3894284030610054,1.0,33/118,10.03%,FMNL2;MEF2C;EFNA5;SHANK3;SIPA1L1;BMPER;PLXND1;NEDD4L;ETS1;CDH2;PHLDB1;CHN1;SEMA4D;TBX1;WARS1;INF2;TGFB1;ZDHHC15;FERMT2;CTNNB1;PPFIA2;GSK3B;CEACAM1;ZRANB1;FLT4;EMP2;ABI3;PAK1;CYRIB;LFNG;SRCIN1;PAK2;KIF1A
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.48983795441309874,1.4284674372436568,0.08084358523725835,0.5746864060451113,1.0,5/37,4.46%,PRKAG2;CEMIP;BMP7;PARD3;SPHK1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4382873478530931,-1.42840695814684,0.05895691609977324,0.3907958904460955,1.0,23/42,28.63%,UBB;TRIM25;UBC;RPS27A;WRNIP1;ISG15;RPA1;UBA52;USP43;POLK;POLA1;FAAP20;POLN;SPRTN;POLE;POLD3;VCP;CDKN2D;POLD1;POLI;DTL;RFC5;USP10
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4960335996911234,-1.4282488597495173,0.05450733752620545,0.3899006988851574,1.0,10/23,17.98%,UBB;COPS7A;UBC;RPS27A;DDB1;RBX1;UBA52;COPS8;COPS6;CETN2
prerank,positive regulation of cell differentiation (GO:0045597),0.3636633010680998,1.4279983150468927,0.012145748987854251,0.5738824041693362,1.0,35/237,8.63%,IGF1;RANBP3L;SOX5;BMP6;TCF4;RIN2;WNT4;IL18;BMP7;MEDAG;FBN2;DAB2;HOXB4;CCN2;ZEB1;PLA2G10;LTF;SOX6;PLCB1;CCN4;PDPN;RIPOR2;MAPK9;GLIPR2;GJA1;TMEM64;PTN;IL6;SMAD3;NBL1;LMO3;DDR2;CSF1;SYAP1;ATRAID
prerank,organic cation transport (GO:0015695),0.5584842181176126,1.4273704608069475,0.11133200795228629,0.573552946732289,1.0,2/19,0.70%,SLC22A4;SLC22A2
prerank,negative regulation of locomotion (GO:0040013),-0.590668258898787,-1.4253187294532144,0.08349514563106795,0.3960334038459579,1.0,5/12,11.75%,FRMD5;CCDC125;CRK;DUSP3;SPINT2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3939055595662632,1.4252304068795807,0.0243531202435312,0.5782221350351933,1.0,19/129,10.26%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;LYPD6;GPC3;LRRK2;FRAT1;PSME4;PSMA2;PSMA3;USP34;PSMD8;AXIN2;SMURF2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6051819074040417,1.424232436071241,0.08384458077709611,0.5789033174126479,1.0,2/13,3.75%,B3GALT1;GAL3ST3
prerank,actin filament bundle assembly (GO:0051017),0.5009706388347995,1.4240288512101664,0.08170515097690942,0.5772449575308002,1.0,9/33,7.18%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.3959794746420868,-1.4234341435528224,0.03139013452914798,0.39975638566370875,1.0,34/69,33.97%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;PSEN1;TIRAP;TYROBP;FRMD8;DDT;AGER;CCR2;SPHK2;TLR4;RASGRP1;LPL;FADD;C1QTNF4;DHX9;MAVS;NOD2;TLR1;IL1A;SYK
prerank,positive regulation of programmed cell death (GO:0043068),-0.3169813450358006,-1.4233450784550759,0.0,0.39872898074974455,1.0,67/272,15.45%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;ARHGEF3;ITGB1;KCNMA1;DAB2IP;NGF;RASGRF2;UBB;RACK1;DNAJA1;CTSD;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;RPS6;ARHGEF17;SOX4;ARHGEF6;RHOB;CTNNB1;SOD1;FAF1;ABR;UBC;RPS27A;APBB1;HIP1R;DNM2;JUN;FOXO1;ARHGEF19;DDX20;ARHGEF26;MAPK8;ING4;APC;ARHGEF5;ATF4;BMP2;BIN1;GPER1;RYBP;REST;HSPD1;ARHGEF2;CLU;RNPS1;GADD45G;NLRP2B;IAPP;PLEKHN1;NF1;FAS;CYP1B1;CASP8;UBA52
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.557581191603998,-1.4230852596577024,0.08125,0.39805617256592274,1.0,6/15,17.34%,REEP3;REEP1;RTN3;RTN4;ATL2;ARL6IP1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5501139594569365,-1.4228902618855697,0.08159392789373814,0.39723660918333964,1.0,8/15,9.55%,ACTB;ACTG1;TJP2;LSR;F11R;MPP7;TJP1;PAK2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6247500879205448,1.4221529057254791,0.12101910828025478,0.580972599531439,1.0,3/10,7.52%,PLA2G10;ENPP2;LIPC
prerank,regulation of stress fiber assembly (GO:0051492),0.4318017909858676,1.4218589361719716,0.05815831987075929,0.5797039298589503,1.0,17/74,10.73%,ARHGAP28;ROCK2;ARHGAP6;CGNL1;TPM1;LPAR1;FHOD1;CCN2;ALMS1;PPM1E;PHLDB2;ASAP3;RHPN2;ARHGEF10L;ARHGEF18;ABL1;PIK3R1
prerank,amino acid import across plasma membrane (GO:0089718),0.5369014856719085,1.4217738015174943,0.09611829944547134,0.5777102295366838,1.0,5/24,2.16%,SLC22A4;SLC6A13;SLC22A2;SLC6A9;SLC1A3
prerank,regulation of blood coagulation (GO:0030193),-0.4780920360825716,-1.4213050240908969,0.04932735426008968,0.39981499892873273,1.0,6/27,3.49%,ST3GAL4;CAV1;CD34;THBS1;FAP;SERPINE2
prerank,regulation of cell migration (GO:0030334),-0.2978828746731083,-1.4212747857747121,0.0,0.3986030453875025,1.0,100/382,12.41%,LEF1;FRMD5;NTRK3;SLIT2;PECAM1;LIMCH1;PODXL;CAV1;PTPRJ;TMSB4X;CLDN5;TMEFF2;ACTG1;SEMA6A;ACTN4;SEMA7A;PRR5L;ITGA6;TIAM1;CLIC4;SEMA6D;KDR;THBS1;ADAM10;RAC1;ACVRL1;CARMIL1;DACH1;JAG1;CDH1;PLXND1;SEMA3C;F3;PTK2;ITGB1;ADAM15;ADARB1;ROR2;SLK;ENG;PTK2B;NOTCH1;SERPINE2;RACK1;SEMA4D;DOCK10;MCTP1;TMSB10;MINK1;SEMA3E;PLXNA4;SRGAP1;FLNA;KANK1;CORO1C;BCAR1;SPATA13;RHOB;TGFB1;FAM107A;IGFBP5;FERMT2;ROBO4;GNA12;CEACAM1;PDGFC;MYOC;PDCD10;VEGFA;TJP1;ABI3;PAK1;CYRIB;NAV3;FGF7;SRCIN1;CPNE3;GRN;SEMA4B;RHOA;PODN;EDN1;APPL1;SEMA5B;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;YTHDF3;DUSP3;SEMA3G;TWIST2;GPER1;RIPOR1;CD74;CDH13
prerank,response to metal ion (GO:0010038),-0.38815084012380807,-1.420136545500124,0.029612756264236904,0.4003494716483594,1.0,21/67,15.64%,CAV1;THBS1;TRPC3;CALM1;NEDD4L;MT1X;MT1A;KCNMA1;HOMER1;SLC30A5;CRIP1;ATP5F1D;MT2A;GPHN;PPP1CA;PPP3CA;MT3;ITPR3;AHCYL1;CALM2;TRPC1
prerank,nitric oxide metabolic process (GO:0046209),-0.555645751459307,-1.419489587017849,0.08055009823182711,0.4007414847924323,1.0,7/14,22.39%,NOS3;GCH1;NOS1;CYP1B1;CYB5R3;AKT1;DDAH2
prerank,B cell receptor signaling pathway (GO:0050853),-0.4544562152042521,-1.418983750471044,0.0547945205479452,0.4008552360867402,1.0,10/32,10.16%,MEF2C;PLCG2;BMX;RFTN1;BCAR1;NFATC2;CD38;PTPRC;PLEKHA1;PIK3CD
prerank,regulation of interleukin-2 production (GO:0032663),-0.4257583229364992,-1.4184862536623255,0.06398104265402843,0.4008416874314179,1.0,8/43,8.53%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;RPS3;PTPRC;NAV3
prerank,negative regulation of receptor binding (GO:1900121),-0.6169037614306487,-1.4171480141398418,0.08498023715415019,0.4030413527908423,1.0,4/10,7.36%,B2M;ADAM15;ATP2A2;ATP2A3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5287634892612291,-1.4166807961613064,0.07920792079207921,0.4029418192315782,1.0,6/17,20.05%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5;THY1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5680002623517798,-1.41549747608974,0.06827309236947791,0.4045333139855911,1.0,7/13,22.39%,NOS3;GCH1;NOS1;CYP1B1;CYB5R3;AKT1;DDAH2
prerank,regulation of proteolysis (GO:0030162),-0.41239190234302847,-1.4138793128513099,0.03015075376884422,0.40733197308256036,1.0,19/48,21.93%,CAV1;LTBP4;CST3;SERPINE2;PERP;NEDD8;BAG6;DNAJC1;OGT;TBC1D10A;CASP8;SPOPL;CLN8;CDK5;PLAUR;CAMK2N1;CYFIP2;AKT1;HDAC6
prerank,midbody abscission (GO:0061952),-0.5292356608471166,-1.4135096049370526,0.07385229540918163,0.406974187909653,1.0,10/17,30.92%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;VPS4B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5219007829488487,1.4132732298726243,0.10256410256410256,0.6034215737957785,1.0,7/25,8.55%,WNK4;DMD;SLC6A9;ATP1B3;ANK2;TCAF1;COX17
prerank,protein-containing complex disassembly (GO:0032984),-0.4050439187987827,-1.4132048239681323,0.037825059101654845,0.40645195470185125,1.0,17/54,22.45%,CAV1;HSPA8;RPL23;CTNNB1;VTI1B;VAMP8;GSK3B;MAP1LC3B;PYM1;APC;PPP1CA;SNX14;DVL2;GABARAPL1;VCP;CHMP3;LIX1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5292470358082344,-1.4131928840033368,0.08634538152610442,0.40521168236454996,1.0,10/18,29.96%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF;HPGDS;PRXL2B;CBR1
prerank,cellular response to glucagon stimulus (GO:0071377),0.5722510577364917,1.413135649622744,0.12190082644628099,0.6015223709559985,1.0,2/17,0.71%,ADCY5;ADCY1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6200866205435083,-1.4131116171600993,0.08527131782945736,0.40415195261166686,1.0,7/10,15.89%,PDE4D;PDE3A;PDE2A;RNF157;UBE2B;PDE11A;APLNR
prerank,cellular glucose homeostasis (GO:0001678),-0.4299159261460418,-1.4121245369951845,0.07932692307692307,0.4052422832369905,1.0,14/41,13.37%,UNC13B;LRRC8D;GAS6;PPARGC1A;RACK1;KCNB1;SOX4;HK1;FOXO1;LRRC8A;XBP1;GPER1;SLC39A14;FOXK1
prerank,regulation of membrane repolarization (GO:0060306),-0.5683381528276938,-1.4117389811804146,0.10943396226415095,0.4049597061987095,1.0,4/13,7.61%,CAV1;KCNJ2;NEDD4L;KCNQ1
prerank,regulation of protein localization to membrane (GO:1905475),-0.4661609926769628,-1.4113733214888207,0.058695652173913045,0.4046788952669176,1.0,11/28,12.06%,SPTBN1;ACTB;GSN;FYN;STX7;VTI1B;VAMP8;ZDHHC2;ZDHHC7;APPL1;GPC1
prerank,extracellular matrix organization (GO:0030198),0.3563542049512188,1.4109862637211896,0.015873015873015872,0.6062452121349873,1.0,40/276,6.29%,COL22A1;ADAMTS12;NID2;COL26A1;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;KLK2;FLRT2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;SCX;NID1;LOXL3;NDNF;SMOC1;MMP2;ITGAX;COL1A2;SH3PXD2B;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6336114776467696,-1.410598485273409,0.0851063829787234,0.4054023400660732,1.0,6/10,15.45%,UBB;NEDD8;UBC;RPS27A;ISG15;UBA52
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.38066883602064655,1.41053500873414,0.029411764705882353,0.6053676951797566,1.0,32/161,12.56%,BICC1;IGFBP2;TCF7L2;MCC;PRKN;LRP4;DAB2;DKK3;RBMS3;DKK1;IGFBP4;PRICKLE1;INVS;TMEM64;TLE3;ZNRF3;GLI3;PSME4;PSMA2;PSMA3;SIAH2;AMFR;TLE1;PSMD8;AXIN2;DVL3;LATS1;HDAC1;PSMD3;CYLD;SOX13;TMEM170B
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6332845662936946,1.4103621591761832,0.11663066954643629,0.6036001353971302,1.0,5/11,18.00%,C1QTNF3;SIK1;CRY1;GCK;C1QTNF12
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4573728661084695,-1.4101793065368677,0.0696629213483146,0.4051739503683164,1.0,12/32,9.05%,APOD;ACER2;THBS1;ACVRL1;JAG1;ADAM15;SEMA3E;CORO1C;FAM107A;NEXMIF;MYOC;AJAP1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.511909029840036,-1.4100385381829168,0.06288032454361055,0.40430007259213696,1.0,8/19,18.75%,LIFR;RUNX1;CBFB;KLF4;TLE5;IFIH1;IRAK1;SH2B3
prerank,aminoglycan biosynthetic process (GO:0006023),0.4608509569693356,1.4098795844307088,0.08084358523725835,0.6029043378625966,1.0,14/49,12.62%,B3GALT1;HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;B3GALT6;NDST2;HS6ST1;UGDH;GPC4
prerank,negative regulation of histone methylation (GO:0031061),0.6507718271720571,1.4097577084741812,0.13813229571984437,0.6010705912195,1.0,4/10,7.80%,AASS;JARID2;BCOR;MTF2
prerank,protein localization to plasma membrane (GO:0072659),-0.3431937278184979,-1.4096780972632026,0.015151515151515152,0.4040144182883115,1.0,37/129,13.95%,SPTBN1;BSG;RAP1A;EFR3B;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;NKD2;EHD1;CCDC88A;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;TTC7A;TSPAN17;C2CD5;RAB3B;MYO5A;S100A10;SPTBN4;EHD3;CACNB2;CD81;JUP
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5421126428198172,1.409243033404319,0.11132437619961612,0.6003930563949896,1.0,7/21,13.12%,BMP6;DAB2;RBPMS;SLC2A10;JAK2;BMPR1A;VEPH1
prerank,glycoprotein biosynthetic process (GO:0009101),0.4180944584805288,1.4090948995666344,0.04709576138147567,0.5985860229253017,1.0,9/79,3.93%,IGF1;B3GALT1;ST3GAL3;GALNTL5;LARGE1;B3GNT5;GAL3ST3;GAL3ST2;ST3GAL5
prerank,intestinal absorption (GO:0050892),-0.5823448349835868,-1.4090729642834003,0.09683794466403162,0.40422216757177454,1.0,4/13,11.74%,TJP2;F11R;KCNQ1;SLC26A6
prerank,glial cell development (GO:0021782),-0.4834985653245571,-1.4081804469077708,0.06526315789473684,0.40539863491070555,1.0,13/25,22.64%,SOX4;APP;CDK6;NRROS;PICK1;MT3;NF1;EIF2B5;TPPP;EIF2B2;SOX10;DLL1;SOX11
prerank,aorta development (GO:0035904),0.5972147195792967,1.4067844360549044,0.11157894736842106,0.6040518383833968,1.0,3/14,2.95%,ADAMTS9;ROBO1;PDGFRB
prerank,pore complex assembly (GO:0046931),0.551019199302964,1.4065810447548162,0.09671179883945841,0.60233904213669,1.0,5/19,10.15%,PLEKHA7;AFDN;NDC1;GSDMD;NUP107
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31923869728396037,1.4061844863503257,0.0010504201680672268,0.6013377032108115,1.0,288/1668,13.21%,IGF1;GLIS3;CREB5;PRDM6;RORA;SOX5;BMP6;MAF;VGLL3;TCF4;TCF7L2;OSR1;AUTS2;AEBP1;ARNT2;RBPJ;ZIC1;ZNF462;HOXC6;FGFR2;FHL2;EPAS1;HLF;PPARA;KDM7A;NR2F2;PID1;NPAS3;IKZF2;IL18;KIT;HOXC4;CDK8;PRKN;WWOX;ATXN1;BRD8;ZEB2;ZKSCAN2;KCNIP3;KMT2A;PRRX1;MEIS1;DAB2;HOXB4;ESRRG;ARID5B;FHOD1;CSRP3;MXI1;FNIP1;CUX1;SMAD6;AASS;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DKK1;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;CITED4;ZBTB20;SP100;PPARGC1B;HOXB3;RNASEL;TSHZ3;HIF3A;PAX5;NFYB;EPOP;MIDEAS;ZIC5;HOXA3;CDK7;BBX;IGF2;SSBP2;HOXC5;PKNOX2;TFR2;VSX2;NCOA2;STAT5B;JAZF1;MAML3;NFAT5;ELOA;ZFP90;HDAC8;HOXA7;FOXD1;ZHX2;SSU72;NFIB;TEAD1;ELF4;MGA;BAZ1B;ARID4A;TEF;ZNF367;RNF2;ARID1B;FIZ1;TNRC6B;IKZF4;GMEB1;KDM2B;CAMTA1;SOX1;SIX5;SALL4;ZFHX2;WASL;DPF2;IRF8;SP110;TNRC6A;ZNF250;FGF1;GLI3;PRKCB;ZNF569;TET1;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZMIZ1;ZFP37;BAZ1A;MAML1;PHF8;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;IL6;WWC2;SALL1;NCOA3;RFXAP;ZNF23;KANK2;SMAD3;SSBP3;PHF14;EN1;PBX4;CHD4;PTEN;NCOA7;NR6A1;GABPB1;GABPB2;MTF2;PHF21A;ZKSCAN5;KDM2A;TCF12;ABRA;CCNT2;TEAD3;PER3;WWP2;LYAR;PIAS1;CBX8;RPRD1B;DNAJA3;RSF1;CCNT1;NFIA;PCGF5;ARNT;CBX2;GTF2F1;FSTL3;KAT8;KDM5B;CDK1;CAMK2D;MITF;KDM6B;KAT6B;CEBPG;KDM3B;EBF4;MDM2;IER5;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;BCL9;MED1;AKAP8L;BBS7;DVL3;AGO2;ZSCAN29;FRK;SMURF2;IRX1;PHIP;ASXL2;ABL1;MED13;PRKDC;PARP9;SMARCA5;ATOH8;NEUROD2;HDAC1;PIK3R1;TSHZ1;FLCN;TFAP2A;TADA2A;CBX7;SMARCE1;ZNF8;HOXC8;TFAP2B;ARID3A;ZIC4;ZNF568;RXRA;ERBB2;TGFA;ZBTB38;MYB;ZBTB39;NPAS2;TAF3;BMPR1A;BCLAF3;ZBTB37;CRY1;CNOT2;ZNF177;RNF14;CDC73;E2F6;ORC2;SOX13;GMEB2;HSF1;PRKD2;PKD2;AR;HIVEP1;SERPINE1;PHF6;KLF5;CRTC1;MAML2;EZH1;SEBOX;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;PPIL4;CGGBP1;IFI27;HOXD4;NFATC4;TBK1;HOXA6;BCL2L12;NR1I3;EPC2;FOXK2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.45923574483019663,-1.4054009329958792,0.06956521739130435,0.41144404264125806,1.0,13/30,23.87%,CAV1;SEMA4D;PTPRC;SRCIN1;CADM4;SAMSN1;SH2B3;INPP5F;THY1;PRKCD;CD300A;HYAL2;SOCS1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.547842862536871,1.4048995782305636,0.08743169398907104,0.6031515466983244,1.0,9/23,10.26%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;BCL9;LATS1;SMURF2
prerank,positive regulation of macrophage activation (GO:0043032),-0.5426932363421845,-1.4038050723797217,0.08447937131630648,0.4145160678549681,1.0,9/17,31.10%,IL33;THBS1;LBP;HSPD1;CEBPA;TREM2;KARS1;TLR4;TLR6
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3909988234576961,1.4031534972028763,0.03328050713153724,0.6066790357574948,1.0,12/121,6.79%,IL31RA;IGF1;BMP6;IL34;IL18;KIT;ANGPT1;IGF2;EPHA4;ACE;IL6;ENPP2
prerank,circulatory system development (GO:0072359),-0.3494363290099396,-1.4025252247779878,0.012195121951219513,0.41664562956651796,1.0,38/118,17.66%,MEF2C;TEK;NTRK3;FN1;HEG1;MICAL2;ACVRL1;TGFB2;RAMP2;NOTCH1;TBX1;CXADR;PKD1;SOX17;STRA6;TGFBR2;SOX4;TGFB1;CRIP1;PDLIM7;FLT4;NOTCH4;LDB3;HEY2;ECE1;CDKN1B;CACNA1C;BMP2;SOX18;SMYD4;NF1;NXN;COL3A1;CASP8;APLNR;DVL2;ACVR1;ID2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.37050775953178106,-1.4022186350453572,0.036458333333333336,0.4161449147510004,1.0,25/88,13.88%,STXBP6;FTH1;HSPA8;EXOC6;FTL;MON2;CLINT1;EXOC4;VPS13A;VPS13C;CLVS2;CLVS1;VAMP8;ARRB1;GOPC;ARF1;DNM2;APP;GOLGA7;EXOC5;SCAMP1;HGS;MYO5A;SCAMP2;AP1S2
prerank,embryonic limb morphogenesis (GO:0030326),0.4911142427391913,1.4021344481071967,0.08287292817679558,0.6078186698501062,1.0,9/34,10.88%,CYP26B1;OSR1;INTU;FBXW4;GLI3;SALL1;WDPCP;HDAC1;TFAP2A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43572747836199616,1.4019172465541547,0.06372549019607843,0.6063287065230083,1.0,11/65,9.50%,RORA;SLC8A3;EPAS1;BMP7;NDNF;CPEB2;CPEB4;BNIP3;NPEPPS;ACAA2;MDM2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4243647314420017,-1.400273206025142,0.05855855855855856,0.42008635005771355,1.0,12/40,12.65%,RPL11;RPL23;PTK2;UBE3A;PTK2B;RPS7;PDCL3;GNA12;RPL5;FOXF2;UBQLN4;CLU
prerank,proteasome assembly (GO:0043248),-0.5800585426147737,-1.3988945903209211,0.0925553319919517,0.422428944609184,1.0,7/11,33.26%,PSMD13;POMP;PSMD5;OTUD6B;PSMD9;PSMD10;PSMG1
prerank,cytoplasmic translational initiation (GO:0002183),-0.5248040017800899,-1.3988459777896909,0.08058608058608059,0.42125098732463234,1.0,9/17,23.60%,EIF3I;EIF4G1;EIF3D;EIF4H;DHX29;EIF2D;EIF3A;EIF4B;EIF5
prerank,negative regulation of viral transcription (GO:0032897),-0.5658143546722476,-1.3983824547687647,0.08396946564885496,0.42119746030071836,1.0,7/13,20.75%,TRIM14;LARP7;TRIM13;MID2;TRIM27;IFITM3;UBP1
prerank,neural crest cell development (GO:0014032),-0.4156746114450053,-1.3979328703542582,0.034722222222222224,0.42112757557807856,1.0,13/44,11.38%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;CDH2;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,bile acid and bile salt transport (GO:0015721),-0.4672220291456712,-1.39791482485172,0.0642570281124498,0.4199207770577237,1.0,5/24,6.94%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,regulation of fibroblast migration (GO:0010762),-0.5118239291634452,-1.397269101576454,0.06790123456790123,0.420422072914986,1.0,9/20,9.39%,PRR5L;THBS1;RAC1;PTK2;ITGB1;CORO1C;TGFB1;GNA12;APPL1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5843753112550873,1.3970888535829569,0.13131313131313133,0.6200544092119692,1.0,5/14,11.50%,IL18;ANXA1;PRKCZ;CCL19;MYB
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.5087606469089759,-1.3970795924943895,0.12048192771084337,0.41965426274034184,1.0,13/19,33.16%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;CHMP3;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;HSPA1A
prerank,establishment of skin barrier (GO:0061436),-0.5585036552520026,-1.3966851269500031,0.07735849056603773,0.4180927551603401,1.0,9/15,32.66%,LSR;MET;HRNR;ALOX12;STMN1;UGCG;SFN;ALOXE3;TMEM79
prerank,regulation of water loss via skin (GO:0033561),-0.5585036552520026,-1.3966851269500031,0.07735849056603773,0.4180927551603401,1.0,9/15,32.66%,LSR;MET;HRNR;ALOX12;STMN1;UGCG;SFN;ALOXE3;TMEM79
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4813217022238249,-1.39618739983673,0.06846473029045644,0.41821015005993845,1.0,11/23,19.58%,ELOVL7;FAR2;ELOVL5;ACSL4;FAR1;ELOVL6;DGAT1;ELOVL1;ACSL3;TECR;ACSL5
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5536567196564828,1.396078066645465,0.12475247524752475,0.6213265925017927,1.0,1/19,0.03%,IGF1
prerank,retrograde axonal transport (GO:0008090),-0.5412367832827693,-1.3960766272112504,0.0958904109589041,0.417294428576357,1.0,10/16,32.71%,DLG2;ACTR10;SOD1;KIF1A;TMEM108;NEFL;MAP1A;HAP1;KIF5B;DYNC1H1
prerank,positive regulation of cellular senescence (GO:2000774),-0.591451236904775,-1.395885689185696,0.10266159695817491,0.4165469294664705,1.0,4/10,16.94%,B2M;YPEL3;ABI3;EEF1E1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.34104008281083553,-1.395494838158161,0.02023121387283237,0.4163007490243829,1.0,35/137,15.65%,DOCK9;RAP1A;RGS6;ITGA6;CD200;BCAR3;TBC1D30;PKP4;CALM1;ITGB1;AGRN;F11R;ARHGAP27;CAV2;PSAP;RPS3;RACK1;SEMA4D;NET1;DOCK10;LIMS1;TGM2;FERMT2;GSK3B;RHOA;MAPK8;BMP2;NDUFA13;EVI5;S100A10;MTMR9;MTCL1;NF1;CALM2;RGS10
prerank,positive regulation of signal transduction (GO:0009967),0.3572888512220971,1.3950461477226257,0.018207282913165267,0.6224389419306887,1.0,37/238,7.87%,IGF1;DCDC2;ROBO1;BMP6;SASH1;WLS;RBPJ;FGFR2;SMOC2;SORBS1;NLGN2;BMP2K;LOXL3;IGF2;MAML3;MACF1;GRB10;CCBE1;TEDC2;TTC23;SULF1;LRRK2;PRKCZ;FGF1;PRKCB;PDE6G;ARMC9;ZMIZ1;MAML1;IL6;SALL1;LMO3;PRKCA;PTEN;RWDD3;GKAP1;VTN
prerank,protein insertion into ER membrane (GO:0045048),-0.42619586807411053,-1.3934669858280218,0.06310679611650485,0.4203959512991551,1.0,20/37,32.47%,STX1A;EMC10;BAG6;APP;CCDC47;EMC7;EMC1;CAMLG;SEC61G;EMC3;EMC6;EMC9;GET4;VAPA;OTOF;WDR83OS;STX5;SEC61B;UBE2J2;EMC4
prerank,heart process (GO:0003015),-0.5429590229070056,-1.3933079345676225,0.09343936381709742,0.4195942988615795,1.0,3/14,6.09%,SGCD;FYN;SOD1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.602239531852533,-1.3932450158842,0.08037383177570094,0.418575079616526,1.0,2/10,6.20%,CAV1;KCNAB1
prerank,regulation of histone methylation (GO:0031060),0.6084399198345545,1.3931673823583195,0.14105263157894737,0.6264363169757697,1.0,7/13,17.84%,AASS;JARID2;MTHFR;TET1;NSD1;CTR9;NNMT
prerank,response to ketone (GO:1901654),-0.4820623552112418,-1.3928531827311543,0.07952286282306163,0.418463967468861,1.0,8/24,8.78%,ABHD2;SLIT2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5643077463993206,1.3927813579177373,0.1264591439688716,0.6254000180235036,1.0,3/17,1.28%,ATP1A2;TFPI;BMP7
prerank,positive regulation of histone methylation (GO:0031062),0.5281204967674314,1.3909863151138,0.11068702290076336,0.6289855920285797,1.0,9/24,17.40%,AUTS2;KMT2A;JARID2;TET1;MTF2;MYB;SMAD4;PHF1;CTR9
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.5170804541760271,-1.39079056804591,0.10294117647058823,0.42240038047101913,1.0,9/17,19.98%,EMC10;BAG6;EMC7;EMC1;CAMLG;EMC3;EMC6;EMC9;GET4
prerank,intestinal lipid absorption (GO:0098856),0.6194421334955797,1.39028769268239,0.12631578947368421,0.6288639336623336,1.0,3/11,10.19%,CEL;LIMA1;SOAT2
prerank,receptor-mediated endocytosis (GO:0006898),-0.3315532570435895,-1.390255215626586,0.011461318051575931,0.4225758767504733,1.0,37/132,15.68%,DNM3;CAV1;SGIP1;TFRC;FNBP1L;HSP90AA1;CD9;SCARB1;ITGB1;RAMP2;ARHGAP27;CAV2;RAB31;ACKR3;SCARF1;AP2A2;STAB1;CALR;HSP90B1;PDLIM7;HIP1R;DNM2;RAMP1;AP2M1;LMBR1L;LRP3;DNM1;CANX;ADRB2;CD81;MRC1;CALCRL;PIP5K1C;SPARC;PI4KB;M6PR;TMEM108
prerank,diol metabolic process (GO:0034311),-0.5058230204857953,-1.389334796656852,0.09341825902335456,0.42379134785487227,1.0,6/19,4.38%,NOS3;PLPP1;HSP90AA1;CALM1;DEGS2;GCH1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6243909498708207,1.389116449742829,0.13692946058091288,0.6305017809312283,1.0,2/11,1.01%,WNT4;FGFR4
prerank,carboxylic acid transport (GO:0046942),0.4403099807548438,1.3887391497081905,0.07653061224489796,0.6295042091186318,1.0,7/55,3.98%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;SLC6A9;LLGL2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5451430077401078,1.3885777286817813,0.10934393638170974,0.6277890701654212,1.0,6/21,11.76%,IGF1;MMP2;GJA1;MMP9;FGF9;BMPR1A
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36350244561988565,1.3874712834454463,0.028089887640449437,0.6291493321945091,1.0,27/199,6.78%,ALDH1A1;ROBO1;ROCK2;NPR3;LGR4;RBPJ;MCC;LRP4;ADAMTS5;NOVA1;SMAD6;DKK1;SLAMF8;ADM;CRHBP;SYT11;HOXA7;DUSP10;MAP2K6;NFIB;GJA1;TLE3;CHSY1;SFMBT1;NRDC;WWC1;WWC2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5870243450034821,-1.3873137608625186,0.11776061776061776,0.42798699072394863,1.0,5/10,23.87%,CD55;TGFBR2;CD81;NCKAP1L;SOCS1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5928031063344201,1.3868719886489824,0.14343434343434344,0.6290197298249776,1.0,2/13,1.91%,ERRFI1;SNX6
prerank,cellular response to amyloid-beta (GO:1904646),0.47590709498514056,1.386437246207905,0.08093525179856115,0.6282087678261643,1.0,6/35,7.35%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,positive regulation of apoptotic process (GO:0043065),-0.3032426508200871,-1.386167372484484,0.0,0.42981332094636,1.0,75/293,15.45%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;TGFB2;FAP;ARHGEF3;ITGB1;KCNMA1;DAB2IP;NGF;RASGRF2;UBB;RPS3;RACK1;DNAJA1;CTSD;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;RPS6;ARHGEF17;TPD52L1;SOX4;ARHGEF6;RHOB;CTNNB1;SOD1;FAF1;ABR;UBC;RPS27A;APBB1;HIP1R;DNM2;JUN;FOXO1;ARHGEF19;GRN;PTGIS;DDX20;ARHGEF26;MAPK8;ING4;APC;ARHGEF5;TLE5;ATF4;BMP2;BIN1;GPER1;RYBP;REST;MYBBP1A;HSPD1;ARHGEF2;CLU;RNPS1;GADD45G;NLRP2B;IAPP;PLEKHN1;NF1;FAS;CYP1B1;CASP8;UBA52
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5078847033972638,1.3856923990417396,0.09340659340659341,0.6284390402805727,1.0,2/29,1.17%,IGF1;NOTCH2
prerank,fat cell differentiation (GO:0045444),0.43745224469321653,1.385395599648319,0.060658578856152515,0.627215442890867,1.0,11/57,11.08%,TCF7L2;OSBPL8;C1QTNF3;PID1;SMAD6;CBY1;WNT5B;TMEM120B;MED1;BBS7;TFAP2B
prerank,microvillus organization (GO:0032528),-0.5663663140749123,-1.3851545268527068,0.09127789046653144,0.43119374542135636,1.0,3/13,4.05%,RAP1A;FXYD5;MINK1
prerank,positive regulation of developmental growth (GO:0048639),-0.4070356145870402,-1.384469401761499,0.06542056074766354,0.4319620652180513,1.0,25/49,29.94%,SEMA7A;AGRN;NEDD4L;NGF;SEMA4D;SHTN1;ITSN2;RNF157;PPIB;DBNL;SYT4;CPNE9;SYT2;RASAL1;DBN1;INSR;L1CAM;DLL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;ISLR2;SMURF1
prerank,cellular copper ion homeostasis (GO:0006878),-0.5528619850900307,-1.3841265357441284,0.08712871287128712,0.4316306628758689,1.0,5/14,7.70%,ATOX1;SLC31A1;MT2A;ARF1;APP
prerank,cation transport (GO:0006812),0.36840568162073806,1.3840525518272033,0.04057971014492753,0.6296480937635022,1.0,13/166,4.07%,TRPM3;SCN7A;ATP1A2;SLC22A4;SLC22A2;SLC8A3;SLC5A5;SLC6A9;KCNQ4;KCNA5;SLC41A1;SLC8A1;KCND3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5203781893581596,-1.3837640382019318,0.095703125,0.43133867600756554,1.0,2/16,2.52%,CLDN5;CLDN11
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4994984217999779,-1.3834106870568752,0.09406952965235174,0.43102647220453355,1.0,7/19,16.68%,BAG6;DDIT4;BCL3;MSH2;AEN;RPS27L;USP28
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.37710851498422393,-1.3825934515294585,0.04218362282878412,0.43190497112587967,1.0,35/72,27.67%,SLIT2;SHANK3;KANK3;HSPA8;KANK1;HIP1R;STMN2;CRYAB;CYRIB;NAV3;SSH2;SSH1;KANK4;APC;ARHGEF2;CLU;STMN1;IAPP;APC2;TUBB4A;PFDN6;PFDN5;PRKCD;MAPRE1;TTBK2;CLASP2;SHANK1;SPEF1;CAMSAP3;PFDN4;CAMSAP1;EMILIN1;TREM2;FGF13;SSH3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.529224846258795,-1.3821313180403711,0.0975103734439834,0.431881584374344,1.0,9/16,28.21%,TPT1;ACKR3;RPS3;BCL2L1;CLU;CXCL12;CDKN2D;SNAI2;TMEM161A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4438288199138597,-1.3806245640479702,0.0759493670886076,0.43504641007829986,1.0,12/32,16.68%,PPP1R13B;BAG6;DDX5;DDIT4;BCL3;HINT1;MSH2;PDK2;MYBBP1A;AEN;RPS27L;USP28
prerank,protein targeting to mitochondrion (GO:0006626),-0.4067456410806829,-1.3805398120450485,0.0412621359223301,0.43407303842115275,1.0,23/52,29.75%,HSP90AA1;FBXO7;TOMM20;NDUFA13;TOMM22;HSPD1;TIMM9;ROMO1;TIMM10B;TIMM13;BCAP31;TIMM29;TIMM22;TOMM7;MFN2;TIMM50;FIS1;TIMM44;TSPO;AIP;CHCHD4;DNLZ;TOMM34
prerank,regulation of steroid metabolic process (GO:0019218),0.5176192364818134,1.3804792161860406,0.10495049504950495,0.6389821801976079,1.0,3/23,6.13%,RORA;ACADL;EPHX2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.43927382915575697,-1.380189417539787,0.08333333333333333,0.4336929606442732,1.0,15/35,18.96%,ESR1;PLPP1;UBE3A;RBFOX2;KDM3A;DDX5;WBP2;TMF1;DDX54;GPER1;EGLN2;NCOA4;NR3C2;DDX17;PADI2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.37723408650365536,-1.3801188944881535,0.0420353982300885,0.43265805198270746,1.0,34/73,33.97%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;PSEN1;TIRAP;TYROBP;FRMD8;DDT;AGER;CCR2;SPHK2;TLR4;RASGRP1;LPL;FADD;C1QTNF4;DHX9;MAVS;NOD2;TLR1;IL1A;SYK
prerank,regulation of intracellular protein transport (GO:0033157),-0.4465206669274263,-1.3794400331754915,0.06306306306306306,0.43326661266709215,1.0,11/32,21.68%,PRR5L;PTPN14;TGFB1;PDCD10;OAZ1;PTPN1;RIPOR1;ATP13A2;BMP4;SIRT7;UHMK1
prerank,regulation of kinase activity (GO:0043549),0.40487062442545574,1.3792910245982928,0.04966887417218543,0.6406435146394542,1.0,18/89,8.66%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;SLAMF8;EPHA8;EPHA4;PDGFRA;DDR1;NPRL2;IGF1R;DDR2;RBL2;RYK;MUSK
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3752817477723445,1.3790394130149493,0.03560830860534125,0.6392215592017414,1.0,23/152,10.26%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;MACF1;LYPD6;SULF1;GPC3;LRRK2;FRAT1;PSME4;PSMA2;SALL1;PSMA3;WNT5B;USP34;PSMD8;AXIN2;SMURF2
prerank,cardiac cell development (GO:0055006),-0.579772719554847,-1.3786397346125137,0.1217564870259481,0.43413440086052796,1.0,5/11,7.87%,JAG1;NOTCH1;CXADR;MYH11;VEGFA
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5392502399079786,-1.3783596711384607,0.09867172675521822,0.4336486919942664,1.0,9/15,21.78%,ARPC1B;ARPC3;WHAMM;ACTR2;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.43114977948890787,-1.3781406723071614,0.06278026905829596,0.43305935061682393,1.0,11/36,11.41%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;SCARB1;GCH1;DDAH1;DNM2;S100A1;CYGB
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5404507953683401,1.3781246418156097,0.1252408477842004,0.6400413860903558,1.0,2/19,1.05%,BMP6;AFDN
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4967433160471969,1.3778297105234074,0.08732876712328767,0.6387479434683568,1.0,12/30,13.00%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;FSTL3;BCL9;LATS1;SMURF2;TFAP2B;FSTL1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5127070622259525,1.3774948700110012,0.1138996138996139,0.6376715130463835,1.0,5/26,5.20%,PRKAG2;LPGAT1;SLC45A3;ACADL;PRKAA2
prerank,activation of protein kinase activity (GO:0032147),0.3898506452001309,1.3771286395966338,0.0630048465266559,0.6367610626353122,1.0,8/106,1.89%,IGF1;ADCY5;OSBPL8;ADCY1;NRK;IL18;ANGPT1;PDPK1
prerank,T-helper cell differentiation (GO:0042093),-0.5433636050482239,-1.3758956940752587,0.08867924528301886,0.4376058684826861,1.0,2/14,0.81%,LEF1;FOXP1
prerank,protein O-linked mannosylation (GO:0035269),0.5572383925103939,1.3757890823848575,0.12836438923395446,0.6390500984075507,1.0,4/18,4.37%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3495850334114236,-1.375624289159569,0.022099447513812154,0.4370784762096306,1.0,44/107,24.26%,MAP3K5;THBS1;NIBAN1;DAB2IP;RASGRF2;CREB3L1;NCK1;TMEM117;HSP90B1;BAG6;GSK3B;ATP2A2;ATP2A3;JUN;TMX1;DERL1;ERP44;CCDC47;UBXN6;HSPA5;ATF4;SELENOK;ERO1A;HERPUD1;ERLEC1;BBC3;EIF2B5;BCAP31;CFTR;DNAJC10;WFS1;RNF5;DNAJB9;TNFRSF10B;ATF3;VCP;MBTPS1;BRSK2;CEBPB;TRIB3;BAX;PPP1R15A;THBS4;PPP1R15B
prerank,negative regulation of ossification (GO:0030279),0.5282091395792702,1.3755652306941193,0.11222444889779559,0.6377380101545003,1.0,7/23,6.35%,RBPJ;LRP4;SMAD6;DKK1;ECM1;CHSY1;BCOR
prerank,response to glucagon (GO:0033762),0.549239368315491,1.3754469662717386,0.13043478260869565,0.6359695154644991,1.0,2/19,0.71%,ADCY5;ADCY1
prerank,transepithelial transport (GO:0070633),-0.5321869429234842,-1.375327493362759,0.08829174664107485,0.4366954814726494,1.0,4/15,4.32%,ABCG2;SLC12A2;CXADR;SLC1A1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.525255153235958,1.374876554130872,0.09074410163339383,0.6356610240565121,1.0,3/22,5.73%,ALDH1A2;RBP1;LRP2
prerank,metal ion export (GO:0070839),0.49244964735633157,1.3747254259919115,0.11423220973782772,0.6340612786513482,1.0,5/31,4.07%,ATP1A2;KCNA5;ATP1B3;KCNT2;KCND3
prerank,monosaccharide transmembrane transport (GO:0015749),0.5510765091625063,1.3743440462713736,0.12524461839530332,0.633240785917522,1.0,3/16,6.09%,SLC2A12;SLC45A3;SLC2A10
prerank,toll-like receptor signaling pathway (GO:0002224),-0.36231029268879794,-1.3736490253710647,0.02702702702702703,0.43993400507340746,1.0,29/84,21.03%,PLCG2;LBP;SFTPA2;SFTPA1;UBB;LGMN;RFTN1;IKBKB;CTSB;HSP90B1;UBC;RPS27A;BIRC3;MAP3K1;S100A1;CHUK;HSPD1;IRAK3;PIK3C3;PIK3AP1;TAB3;NR1H4;CASP8;UBA52;UBE2D1;IRAK1;TIRAP;MYD88;CTSL
prerank,membrane fusion (GO:0061025),-0.4389203645971117,-1.37364852999681,0.08639308855291576,0.43875455733862617,1.0,8/33,11.96%,DNM3;NSF;VTI1B;CHP1;DNM2;DYSF;NSFL1C;DNM1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41384170379846386,1.3734545205492288,0.07653910149750416,0.633969806351875,1.0,16/72,14.51%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;KL;FGF1;HNRNPH1;FRS2;POLR2A;GTF2F1;FGF9;CEP57;MAPK1;FIBP;FGF20
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5224715438189684,-1.3730533291981,0.09448818897637795,0.43905730999910153,1.0,9/16,21.67%,ESR1;RBFOX2;DDX5;DDX54;EGLN2;NCOA4;DDX17;PADI2;ESR2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.518862396878714,1.3727135378105098,0.12593984962406016,0.6342364791440295,1.0,3/22,1.27%,FGFR2;NOTCH2;STXBP4
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4221285755527079,1.372477226164401,0.06578947368421052,0.6327838797609416,1.0,15/63,13.13%,IGF1;TCF7L2;WWOX;DEPTOR;SP100;SH3RF1;NOL3;SIAH2;BIRC6;FEM1B;PHIP;CYLD;CFLAR;AR;BCL2L12
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.47567764611612656,-1.3720194232656013,0.10944206008583691,0.4406158691398244,1.0,5/22,7.64%,NTRK3;RAP1A;NGF;EHD1;STMN2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.610347750107718,1.3719137271590505,0.11513859275053305,0.6326512842838485,1.0,1/12,0.09%,CYP26B1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5171441099002996,1.371185201036535,0.12754158964879853,0.6328696395214298,1.0,4/23,6.25%,IGF1;EFNB2;NIBAN2;MAML1
prerank,Rac protein signal transduction (GO:0016601),-0.5010515805158565,-1.3711327540315024,0.11363636363636363,0.4417649523163216,1.0,8/18,15.96%,ELMO1;TIAM1;RAC1;NCKAP1;EPS8;DBNL;CDH13;RHOG
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.3876140971544703,-1.3708669591636635,0.07363420427553444,0.44132820019559504,1.0,11/56,6.64%,PLCG2;LBP;SFTPA2;SFTPA1;UBB;NOD1;LGMN;CTSB;HSP90B1;UBC;RPS27A
prerank,positive regulation of cell motility (GO:2000147),-0.31500745476571923,-1.3707674052584953,0.0071174377224199285,0.4404858277841315,1.0,63/205,15.23%,LEF1;NTRK3;PECAM1;PODXL;CAV1;SPOCK2;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;CARMIL1;CAVIN1;SEMA3C;F3;PTK2;ITGB1;ROR2;PTK2B;NOTCH1;RACK1;SEMA4D;SEMA3E;BCAR1;TGFB1;FAM107A;FERMT2;PDGFC;MYOC;PDCD10;VEGFA;TJP1;PAK1;CPNE3;GRN;SEMA4B;EDN1;SEMA5B;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;SEMA3G;TWIST2;GPER1;RIPOR1;CDH13;CCN1;PPP3CA;RET;COL1A1;NEDD9;CSF1R;CXCL12
prerank,negative regulation of mRNA processing (GO:0050686),-0.5392524463996302,-1.3706838259976863,0.09523809523809523,0.4395388163482019,1.0,7/15,28.92%,SRSF9;RNPS1;SRSF6;PCBP4;PTBP1;BARD1;SRSF7
prerank,neuron development (GO:0048666),-0.3330198219232899,-1.3701567132686137,0.012779552715654952,0.43971416580719114,1.0,23/141,7.71%,FRY;MEF2C;PTPRM;PBX3;TGFB2;RUNX1;STX3;PLP1;MAP4;TENM2;VSX1;B4GALT5;BLOC1S2;EHD1;GSK3B;RP1;ETV1;GPM6B;ATP8A2;TENM4;STMN2;APP;MYOC
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.489739511997735,-1.37001972406049,0.10082304526748971,0.43894131750099485,1.0,3/18,3.28%,MTUS1;SLIT2;PTK2B
prerank,cholesterol homeostasis (GO:0042632),0.42257181379459846,1.3698271567876048,0.075,0.6353708342017069,1.0,10/64,8.39%,RORA;FGFR4;IL18;PLA2G10;PCSK9;ABCA1;EPHX2;LIMA1;LIPC;ABCA5
prerank,epithelial to mesenchymal transition (GO:0001837),0.44338508143952116,1.369037627463775,0.11016949152542373,0.6357864592112653,1.0,6/47,2.97%,TGFBR3;ROCK2;WNT4;RBPJ;BMP7;LOXL3
prerank,negative regulation of signal transduction (GO:0009968),0.34827226958868385,1.3689904455973918,0.028037383177570093,0.6338862171904233,1.0,48/249,11.42%,CYP26B1;ADAMTS12;LEPROT;TRABD2B;LGR4;RNF43;PID1;WWOX;TULP3;DKK3;BCL2;DKK1;LTF;MGRN1;NEDD4;CRHBP;GRB10;VGLL4;CBY1;CACTIN;SULF1;GPC3;LRRK2;PRKCZ;APCDD1;GLI3;PRKCB;SLC2A10;NIBAN2;SUFU;PDCD6;KANK2;NTN1;HERC4;PTEN;SIAH2;WWP2;TLE1;FSTL3;YTHDF2;RPGRIP1L;PTGIR;WIF1;TNS2;RPS6KB1;APLN;IFT122;ERBB2
prerank,catecholamine biosynthetic process (GO:0042423),0.6145533712243196,1.368919116230354,0.1459227467811159,0.6320708328761241,1.0,1/11,0.10%,MOXD1
prerank,sterol homeostasis (GO:0055092),0.4198378729138795,1.3686715942644754,0.08099173553719008,0.6307186784516803,1.0,10/65,8.39%,RORA;FGFR4;IL18;PLA2G10;PCSK9;ABCA1;EPHX2;LIMA1;LIPC;ABCA5
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.5248054370613634,-1.3679123072480968,0.11650485436893204,0.44337621451173576,1.0,9/14,31.43%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRUB2;TRMT10C;MRPS27;COA3;MPV17L2
prerank,cognition (GO:0050890),-0.40868450150412655,-1.3677477933529731,0.06572769953051644,0.4426620239957232,1.0,12/42,15.99%,ST3GAL4;SHROOM4;MAGT1;STRA6;CHMP2B;FAM107A;APP;MFSD2A;SLC1A4;DGCR2;NF1;PTCHD1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5754207327088382,1.3671853698982936,0.14548802946593,0.6333944261897451,1.0,6/15,18.18%,ALDH4A1;GGACT;HOGA1;PRODH;ABHD12;ABHD16A
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.44536752001332164,-1.3658109497879007,0.06889352818371608,0.44662765800087373,1.0,12/30,20.09%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;OGT;CAMLG;RYBP;SVIP;N4BP1;TLK2;NOP53
prerank,histone H3-K36 demethylation (GO:0070544),0.6269052054532124,1.3653058260356057,0.1394335511982571,0.6372926713287458,1.0,4/10,7.94%,KDM7A;KDM2B;PHF8;KDM2A
prerank,ERK1 and ERK2 cascade (GO:0070371),0.527443065257166,1.3651677461546918,0.13271028037383178,0.6356759148363704,1.0,2/21,3.31%,IGF1;CTSH
prerank,regulation of ERAD pathway (GO:1904292),-0.5740513509775185,-1.3646232176525537,0.11657559198542805,0.448857445634818,1.0,5/11,13.06%,ATXN3;UBXN1;BAG6;AQP11;HERPUD1
prerank,regulation of protein metabolic process (GO:0051246),-0.4054874607119016,-1.3642520628412866,0.06798245614035088,0.4486730307471131,1.0,14/44,10.91%,LTBP4;KLF2;HSP90AB1;KLF4;NEDD4L;FAF1;NEDD8;APP;CHEK2;ZDHHC2;SSH1;MAPK8;FURIN;HGS
prerank,diol biosynthetic process (GO:0034312),-0.5257935745758439,-1.3636584885043799,0.11704312114989733,0.44921716298879993,1.0,4/15,4.38%,ACER3;ACER2;SPTLC2;GCH1
prerank,positive regulation of histone acetylation (GO:0035066),-0.46709376969941735,-1.3633390928089129,0.10612244897959183,0.4489262176302855,1.0,7/23,11.15%,RPS6KA5;PPARGC1A;ARRB1;WBP2;GLYR1;NOS1;PIH1D1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6040739578481549,1.362704325306521,0.1517094017094017,0.6417312635622443,1.0,2/10,3.19%,OXSR1;CXCL13
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3455505060801724,-1.3625864177204643,0.013550135501355014,0.4497024409563376,1.0,46/107,21.38%,CAV1;SLC39A10;TPT1;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;ATP1B1;SLC10A7;SLC30A5;CALR;ATP2C1;MT2A;ATP2A2;ATP2A3;SLC39A8;RYR2;HTR2A;SLC24A2;ATP13A4;EDN1;SLC30A1;SLC39A7;STIM2;RMDN3;STOML2;ATP2B1;SLC39A14;ATP13A5;MT3;SLC24A5;CXCL12;ATP13A2;CD40;CCL13;NPTN;TMEM165;ATP2B2;ATP2B4;SLC39A6;SLC11A1;TMEM203
prerank,fatty acid beta-oxidation (GO:0006635),0.4352950982109247,1.3622776513899475,0.0784313725490196,0.6410650366507923,1.0,16/51,14.17%,IVD;EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;ACAA2;GCDH;ACAT2;AUH;AMACR;ACOX1;BDH2
prerank,T cell mediated immunity (GO:0002456),-0.551958225432044,-1.3621568111631255,0.10456273764258556,0.4498357734263657,1.0,4/13,8.12%,CADM1;JAG1;CD55;EMP2
prerank,sodium-independent organic anion transport (GO:0043252),-0.596503942462885,-1.3617487367608563,0.08678500986193294,0.4497912439638089,1.0,6/10,18.04%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1;SLC16A2;SLCO4A1
prerank,positive regulation of phospholipase activity (GO:0010518),0.5188689297066784,1.3615922662866884,0.12007874015748031,0.6412890302694846,1.0,5/22,4.40%,FGFR2;KIT;PDPK1;PDGFRB;PDGFRA
prerank,stress-activated MAPK cascade (GO:0051403),-0.3842492854582812,-1.3614128345172387,0.06084656084656084,0.4496015687132184,1.0,22/61,23.58%,MAP3K5;UBB;NOD1;MINK1;IKBKB;ARHGEF6;UBC;RPS27A;MAPK8;ZFP36L1;CHUK;MAP2K7;MAP3K12;CUL1;MAP3K8;TAB3;UBA52;IRAK1;SKP1;MAPK3;MAPK11;MAPK10
prerank,positive regulation of coagulation (GO:0050820),-0.5907899749789587,-1.3605747611504948,0.10121457489878542,0.44968453563494193,1.0,2/10,1.81%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.5907899749789587,-1.3605747611504948,0.10121457489878542,0.44968453563494193,1.0,2/10,1.81%,ST3GAL4;THBS1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.41829417444603095,-1.3603732029579856,0.08035714285714286,0.4490863948744049,1.0,13/39,19.49%,EFR3B;SOCS2;SOCS5;PIK3C2B;TTC7A;PIK3CD;PIK3C2A;PIK3C3;ITPKB;PI4KB;CISH;PIK3R3;PIP4K2A
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5799086215679814,-1.360192836643722,0.11351351351351352,0.4484150902569679,1.0,4/11,9.36%,TGFB2;JAG1;SOX4;HEY2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.4809247176933574,-1.3600508777194218,0.1125,0.4476908765129585,1.0,6/20,18.11%,HSP90AA1;HSP90AB1;HSPD1;CLU;TMEM35A;PFDN6
prerank,cation transmembrane transport (GO:0098655),0.4578393829266883,1.359053047456046,0.10758377425044091,0.6474621008191095,1.0,3/44,1.60%,TRPM3;ATP1A2;SLC6A9
prerank,intracellular lipid transport (GO:0032365),0.5141153611472181,1.3588999823081709,0.11970534069981584,0.6458754921748988,1.0,4/21,6.60%,PRKAG2;PRKAA2;CPT2;SGPP1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5732499399914911,-1.3587212175948045,0.1183206106870229,0.4500023793057019,1.0,3/11,11.81%,CAV1;NEDD4L;BIN1
prerank,striated muscle tissue development (GO:0014706),-0.4464682843158541,-1.3586123119816527,0.09871244635193133,0.44914899717504075,1.0,9/29,6.87%,MEF2C;PGM5;CAV1;SGCD;BMP5;MYL6;BMPR2;TBX2;SIX1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6079110063859539,1.3585783632494035,0.16421052631578947,0.6448980062424828,1.0,3/10,8.46%,IGF2;PCGF5;PRMT7
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5906141980427745,1.358467293032485,0.12684989429175475,0.6432703781953945,1.0,4/12,15.87%,ROCK2;PICALM;RANBP9;FLOT2
prerank,organic hydroxy compound transport (GO:0015850),-0.422070751578273,-1.3578789060209482,0.07110091743119266,0.45004857637191115,1.0,7/36,6.94%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;STRA6;CEACAM1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5770998951165641,-1.3574683937368783,0.11764705882352941,0.4488824326510122,1.0,3/11,1.86%,ACER3;ACER2;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5770998951165641,-1.3574683937368783,0.11764705882352941,0.4488824326510122,1.0,3/11,1.86%,ACER3;ACER2;SPTLC2
prerank,regulation of macrophage activation (GO:0043030),0.48244568605307314,1.356813065908682,0.12424849699398798,0.6464586722072296,1.0,5/30,6.76%,IL31RA;PLA2G10;SPHK1;MYO18A;IL6
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.38521452987541427,1.356255383279665,0.05837173579109063,0.6461322674507924,1.0,15/113,8.79%,IGF1;BMP6;TCF7L2;OSR1;FGFR2;NOTCH2;STXBP4;JAML;ECM1;FGF1;PTN;PDCD6;PRKCA;ARNT;VEGFB
prerank,melanocyte differentiation (GO:0030318),0.6045542473089198,1.356044033815143,0.13473684210526315,0.6449271104544871,1.0,2/11,1.24%,LRMDA;KIT
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5047469398777975,1.3559966617555077,0.13619402985074627,0.6430950636253058,1.0,3/22,2.78%,PPARA;SORBS1;ZBTB20
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4481748816961088,-1.3548053257907842,0.06636155606407322,0.45470296988297587,1.0,11/29,20.81%,MEF2C;TFRC;NFATC2;CD38;PTPRC;CD74;CD81;MIF;CD40;TIRAP;NCKAP1L
prerank,myelination (GO:0042552),-0.39961977141851013,-1.35407477599572,0.0535279805352798,0.4555301107909079,1.0,21/46,19.12%,ADGRG6;ACER3;PLP1;MAL;MBP;MARVELD1;B4GALT5;TNFRSF21;CMTM8;SCN8A;MYOC;PLLP;ARHGEF10;GPC1;ABCD2;NF1;EIF2B5;TPPP;EIF2B2;B4GALT6;SOX10
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5160299158122079,1.3537323509525714,0.13572854291417166,0.6484097123577014,1.0,10/23,18.58%,C1QTNF3;PPARA;SIK1;NUPR1;CRY1;PFKFB1;GCK;C1QTNF12;NCOR1;HDAC4
prerank,response to ethanol (GO:0045471),-0.5434696190466433,-1.3537199473515307,0.10612244897959183,0.45536270234105014,1.0,5/14,12.88%,SOD1;GRIN3A;ADCY7;GRIN1;SDF4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5094594013279554,1.3536625076766275,0.10714285714285714,0.6466085030513006,1.0,5/24,8.42%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,renal water homeostasis (GO:0003091),0.5111598185496258,1.3529957187841282,0.141747572815534,0.6467971056303465,1.0,2/23,0.71%,ADCY5;ADCY1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5891139210521117,1.352947726542383,0.16334661354581673,0.6449843852702848,1.0,3/12,2.26%,WNK4;DMD;ATP1B3
prerank,protein K11-linked ubiquitination (GO:0070979),0.49390669844807294,1.3528693024696288,0.13282732447817835,0.6432999519929413,1.0,10/27,19.95%,PRKN;UBE2E2;ANAPC13;UBE2L3;CDC26;UBE2A;UBE2H;ANAPC2;ANAPC5;CDC23
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5057614947203285,1.3522186007129318,0.1350806451612903,0.6433581367990223,1.0,1/25,0.03%,IGF1
prerank,proteoglycan biosynthetic process (GO:0030166),0.4823014651303157,1.3512588369171172,0.1323024054982818,0.6443649941960681,1.0,4/31,3.75%,IGF1;PXYLP1;HS3ST3B1;GAL3ST3
prerank,neutrophil activation (GO:0042119),-0.5456369163795832,-1.3508771561689163,0.12525667351129363,0.4620489949039162,1.0,5/12,20.19%,PREX1;KMT2E;IL15;TYROBP;PRKCD
prerank,acidic amino acid transport (GO:0015800),0.551517960076193,1.3503889196699714,0.1482213438735178,0.6451981965806187,1.0,7/17,9.27%,SLC6A13;SLC1A3;SLC6A1;SLC25A18;GJA1;LRRC8E;SLC25A22
prerank,keratan sulfate catabolic process (GO:0042340),0.6168529100273005,1.3501958119584763,0.15876288659793814,0.6438728985216333,1.0,4/11,5.37%,FMOD;OGN;OMD;PRELP
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.39188464514096566,1.3499801251515033,0.07852564102564102,0.6426979349542584,1.0,26/95,12.62%,HS3ST3A1;CEMIP;PXYLP1;ANGPT1;ST3GAL3;FMOD;UST;SDC2;HS3ST3B1;OGN;GPC6;OMD;B4GALT1;PRELP;GPC3;CHSY1;CHST3;HAS1;XYLT2;B3GALT6;NDST2;CHST15;HS6ST1;UGDH;B4GALT2;GPC4
prerank,regulation of fatty acid metabolic process (GO:0019217),0.547268865566394,1.3498788338630408,0.1411530815109344,0.6410905739774271,1.0,3/17,5.20%,PRKAG2;PPARA;PRKAA2
prerank,activation of adenylate cyclase activity (GO:0007190),0.47151901912352573,1.3493605964586128,0.12389380530973451,0.6408363983723591,1.0,3/35,0.84%,ADCY5;ADCY1;LGR4
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.5828785602302846,-1.349296866699791,0.140625,0.4651141969681105,1.0,8/10,38.20%,NCK1;JUN;DNAJB1;VHL;CITED2;HIF1AN;HSPA1A;BAG3
prerank,actin polymerization or depolymerization (GO:0008154),0.43215767218720647,1.3491162833007349,0.08433734939759036,0.6397580846885222,1.0,13/50,11.11%,MICAL3;ARHGAP6;GAS7;AVIL;ABI2;WASF1;WASL;WASF3;SPIRE2;CORO7;PSTPIP2;COBL;JAK2
prerank,embryonic digit morphogenesis (GO:0042733),0.5382512692329823,1.3487608577425658,0.1509433962264151,0.6389198171784924,1.0,6/18,10.71%,OSR1;INTU;GLI3;SALL1;WDPCP;HDAC1
prerank,regulation of MAPK cascade (GO:0043408),0.35966781558096333,1.3481207969450226,0.0469208211143695,0.6390105261056187,1.0,18/157,6.76%,IGF1;EPHA7;TGFBR3;ROCK2;KSR1;FGFR2;NRK;KIT;PELI2;LPAR1;TRIM5;IGF2;EPHA8;GFRAL;IGF1R;WWC1;ADRA1D;IL6
prerank,amino sugar metabolic process (GO:0006040),-0.5885214210814895,-1.3480095151942986,0.1100196463654224,0.46762759456546116,1.0,2/10,0.56%,CSGALNACT1;ST6GAL1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5783612857215948,-1.3472862058127189,0.13123844731977818,0.4684458068432423,1.0,2/10,3.36%,RAP1A;NGF
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5164270817560468,-1.346868836854319,0.11485148514851486,0.4684015555571708,1.0,6/15,7.87%,TMSB4X;KDR;LGMN;HSPB1;MET;VEGFA
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5754729324769575,1.3464478820675616,0.1544885177453027,0.6423478171661375,1.0,5/13,13.00%,FBN1;FBN2;NBL1;CHRDL1;FSTL1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6065259377629688,1.3462784350140307,0.17842323651452283,0.6410144748740993,1.0,2/10,5.49%,IL18;PRKCZ
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.416082562168737,-1.34587064691883,0.09352517985611511,0.4699860076785686,1.0,12/38,15.46%,NOS3;THBS1;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;MADD
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4535779953008998,-1.3457625498750645,0.116600790513834,0.46915444196857004,1.0,8/25,12.65%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGS2;EDN1;CLU
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5088969744717864,-1.3454302442711112,0.13457556935817805,0.4689599931144639,1.0,9/18,13.76%,HEG1;RASIP1;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;STMN1
prerank,negative regulation of cell motility (GO:2000146),-0.34405624966467097,-1.3446186456906444,0.03125,0.4699108500245375,1.0,20/108,5.70%,FRMD5;SLIT2;LIMCH1;PTPRJ;CLDN5;TMEFF2;CLIC4;ACVRL1;DACH1;JAG1;CDH1;ADAM15;ADARB1;ENG;MCTP1;CCDC125;SRGAP1;KANK1;RHOB;IGFBP5
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4924871363621893,1.3444132801581932,0.10989010989010989,0.6450980779805453,1.0,5/26,6.35%,ROCK2;PRKN;FHOD1;ALMS1;ASAP3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.45305742046718983,-1.3442097024957338,0.09188034188034189,0.4698474468191981,1.0,13/26,25.12%,NOS3;ACER3;ACER2;SPTLC2;GCH1;NOS1;CYP1B1;CYB5R3;ABCA2;AKT1;DDAH2;SPTLC1;SPHK2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5534179446587181,1.3436908488680945,0.16216216216216217,0.6454419304781184,1.0,2/14,4.13%,IGF1;SYT11
prerank,regulation of platelet aggregation (GO:0090330),-0.4936508362512718,-1.3426974176356825,0.12244897959183673,0.47283564614151646,1.0,5/17,6.94%,PRKG1;CD9;F11R;SERPINE2;CEACAM1
prerank,response to acidic pH (GO:0010447),-0.5390079991248423,-1.3423969369491249,0.12452107279693486,0.47255116830873684,1.0,4/13,13.52%,GPR4;LGMN;CHP1;RAB11FIP5
prerank,cyclooxygenase pathway (GO:0019371),-0.586476269167664,-1.3418030144606352,0.12921348314606743,0.4729871289151349,1.0,5/10,29.96%,PTGIS;PTGS2;PTGDS;HPGDS;CBR1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.45047025684898534,1.341674037504183,0.13157894736842105,0.6499143468561462,1.0,7/40,6.43%,ARHGAP6;KIT;LPAR1;PDGFRB;PDGFRA;LPAR2;GNAQ
prerank,smooth muscle contraction (GO:0006939),0.571139754743768,1.3414691744087393,0.16346153846153846,0.6486343913041828,1.0,4/14,3.07%,ROCK2;BDKRB2;MYLK;SLC8A1
prerank,histone monoubiquitination (GO:0010390),0.5051546964317242,1.3409847244276352,0.12884615384615383,0.64833985770698,1.0,11/24,17.62%,DDB2;RNF2;KDM2B;BCOR;CUL4B;CDC73;RNF20;PCGF1;CTR9;UBE2E1;DTX3L
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5870379376477388,1.3408751999337796,0.17708333333333334,0.6468208602840542,1.0,8/12,19.44%,SZT2;EPHA4;NFIB;PAFAH1B1;MYCBP2;GLI2;CHRNB2;EPHB2
prerank,activation of GTPase activity (GO:0090630),-0.3459199710055258,-1.3403157232676572,0.047493403693931395,0.47572243106204515,1.0,28/89,12.37%,NTRK3;SIPA1L1;TIAM1;TBC1D30;ARHGAP42;TBC1D8;SIPA1L2;SIPA1L3;ARHGEF15;CCDC125;RABGAP1L;CORO1C;ADPRH;ABR;GRTP1;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;TBC1D10A
prerank,regulation of cartilage development (GO:0061035),0.5377265611779822,1.3401403834473062,0.16962524654832348,0.6472631856629628,1.0,3/18,2.75%,SOX5;SCX;SOX6
prerank,positive regulation of B cell activation (GO:0050871),-0.3887034399114207,-1.3400253571417333,0.07371007371007371,0.47533467635660437,1.0,25/50,34.70%,MEF2C;SH3KBP1;TFRC;NFATC2;CD38;PTPRC;XBP1;CD74;CD81;MIF;CD40;TIRAP;PPP2R3C;NCKAP1L;KMT5C;CLCF1;SHLD3;RIF1;SHLD2;NOD2;BST1;VAV3;IL7;SYK;SASH3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5426394255404163,1.3399647148950888,0.15821501014198783,0.6459591360876015,1.0,4/17,7.35%,SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.5465653432694447,-1.3397427388800291,0.1342685370741483,0.4749673424249885,1.0,4/12,10.15%,NOTCH1;CCN3;HDAC5;XBP1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5505898576928181,-1.3395381283698957,0.12548262548262548,0.4743872766481186,1.0,4/12,15.23%,JAM2;APP;RHOA;CXCL12
prerank,positive regulation of phosphorylation (GO:0042327),0.3417773718381955,1.3392769392064237,0.04728789986091794,0.6463347134672297,1.0,44/240,11.69%,IGF1;EPHA7;LEPR;ROCK2;IL34;EPHA3;FGFR2;FGFR4;KIT;ANGPT1;PELI2;DAB2;LMO4;FNIP1;ZBTB20;PDGFRB;IGF2;EPHA8;EPHA4;FAM20A;PDGFRA;DDR1;PRKAA2;IGF1R;LRRK2;FGF1;MMP9;DDR2;PRKAA1;ATG14;RYK;ARNT;MUSK;VEGFB;AXIN2;DVL3;AXL;ABL1;FGF9;FLCN;EPHA2;FXR1;ERBB2;RAP2A
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3368110685269733,-1.3387798161964681,0.03927492447129909,0.4752522410565175,1.0,30/113,12.86%,UNC13B;FNIP2;ESR1;TFRC;HSP90AA1;RASIP1;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;FERMT2;MPP7;FAF1;GSK3B;PIEZO1;VEGFA;SPIDR;DDB1;RBX1;EIF4G1;ISG15;GBP5;PIH1D1;USP50;RPA1;TAL1;CLU;PSMC3
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3615383538433752,-1.3386711034932728,0.06153846153846154,0.47441070728554824,1.0,28/72,16.13%,ARHGEF28;HEG1;RAC1;ARHGEF3;PRAG1;F11R;RASIP1;NET1;ARHGDIB;CCDC125;GPR4;EPS8L2;KANK1;ARHGDIA;ARRB1;MET;BCR;CUL3;MYOC;PDCD10;EPS8;KCTD13;LPAR6;ARHGEF2;STMN1;COL3A1;ADGRG1;RAF1
prerank,cellular response to ketone (GO:1901655),0.46210836190635307,1.3378947451748462,0.12252252252252252,0.6488589575201257,1.0,3/35,0.71%,ROCK2;ADCY5;ADCY1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4509529232203422,-1.3377897033807324,0.1125,0.47570798030609657,1.0,14/27,23.45%,CALM1;PPIA;PPP1R16B;TGFB1;BMP2;MTMR9;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;CALM3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.42268950533383054,-1.3377310940219427,0.07675438596491228,0.4747617866447518,1.0,14/36,20.09%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;AQP11;PSMF1;OGT;CAMLG;RYBP;N4BP1;PRKCG;TLK2;NOP53
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5286628562640889,-1.3372059616537755,0.13152804642166344,0.4750316064830061,1.0,7/14,26.34%,THBS1;ITGA4;PDCD4;GPER1;CD40;RGCC;CCL2
prerank,connective tissue development (GO:0061448),0.4683714261917095,1.336979400801802,0.13092979127134724,0.649905092262545,1.0,6/35,5.24%,SOX5;ARID5B;SCX;SOX6;SH3PXD2B;SULF1
prerank,cardiac conduction system development (GO:0003161),0.49310934279998875,1.3369099744639843,0.13518886679920478,0.6483031566639239,1.0,4/24,6.25%,GJB6;NOTCH2;GJA1;MAML1
prerank,peptide metabolic process (GO:0006518),0.39945453034092077,1.3369036267927261,0.08360128617363344,0.6464997729713361,1.0,10/75,8.19%,CPQ;AEBP1;DMD;GSTM2;GSTT4;GSTT1;ACE;TPP1;NPEPPS;CPXM1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.45436364208368113,1.336774700830372,0.11934900542495479,0.6450757104374755,1.0,6/41,2.80%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.33134058553861107,-1.3367135074898957,0.031446540880503145,0.4752818906295643,1.0,53/132,23.60%,RPL11;HSP90AA1;HSP90AB1;RPL6;RPS15;RPL38;RPSA;RPS19;RPL24;LUC7L2;RPS14;RPL23A;SRSF1;RPL3;RPL5;SF3B1;CPSF7;RPS27;KHDC4;DDX20;SRSF5;RPLP0;DDX39B;RPS28;SRSF9;CPSF6;CLNS1A;USP39;STRAP;XAB2;PRPF18;ERAL1;SNRPC;SRSF6;EIF4H;RPS27L;SRPK1;RSL24D1;RPS5;CLP1;DHX29;YTHDC1;NOP53;NLE1;EIF2D;EIF3A;EIF6;PWP2;PPAN;EIF4B;SNRPG;MRPS11;EIF5
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3635417571624004,1.3365075977806613,0.06055900621118013,0.6440353463315922,1.0,28/138,14.19%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;NR6A1;NRBP1;POLR2A;TEAD3;GTF2F1;MED1;TAF8;HDAC1;RXRA;TAF3;AR;MAML2;NR1I3;CREBBP;MNAT1
prerank,lysine metabolic process (GO:0006553),0.6001468083678456,1.3360612051491874,0.18661257606490872,0.6418691956141355,1.0,5/12,13.42%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,lysine catabolic process (GO:0006554),0.6001468083678456,1.3360612051491874,0.18661257606490872,0.6418691956141355,1.0,5/12,13.42%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5706410857979035,-1.334983874569979,0.1138996138996139,0.4787919765598272,1.0,5/12,12.32%,JAG1;NOTCH1;HES1;HNRNPU;REST
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4322373709577926,-1.3339926372319875,0.09421841541755889,0.48041478030105106,1.0,11/27,18.75%,CAV1;PDE4D;ATP2A2;CTNNA3;RYR2;CACNA1C;JUP;DSG2;PLN;DSP;TRPM4
prerank,glucose homeostasis (GO:0042593),0.39557143659830596,1.3338020243079343,0.07234726688102894,0.6470804053760453,1.0,12/83,7.95%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;HK2;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3063151102797302,1.3335900385911585,0.0032397408207343412,0.6459263193419367,1.0,173/1082,13.21%,IL31RA;IGF1;GLIS3;CREB5;RORA;BMP6;TCF4;TCF7L2;OSR1;AUTS2;WNT4;ARNT2;RBPJ;ZIC1;ZNF462;FGFR2;EPAS1;HLF;PPARA;NR2F2;PID1;NPAS3;IL18;HOXC4;CDK8;BMP7;PRKN;WWOX;BRD8;ZEB2;KMT2A;MEIS1;DAB2;HOXB4;ESRRG;FHOD1;CSRP3;ZIC2;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;PLCB1;SP100;PPARGC1B;HOXB3;RNASEL;NFYB;CDK7;IGF2;TP53INP2;SSBP2;TFR2;NCOA2;STAT5B;MAML3;NFAT5;MYRFL;ZFP90;HDAC8;HOXA7;NFIB;TEAD1;ELF4;ARID1B;FIZ1;SOX1;NDP;WASL;DPF2;IRF8;FGF1;MSANTD1;GLI3;TET1;ZMIZ1;NIBAN2;MAML1;PHF8;ARHGEF11;IL6;SALL1;NCOA3;RFXAP;SMAD3;SSBP3;BLM;PBX4;NCOA7;NEK4;GABPB1;GABPB2;RGMB;MTF2;TRIM56;TCF12;ABRA;CCNT2;LYAR;RPRD1B;RSF1;CCNT1;NFIA;PCGF5;ARNT;GTF2F1;FSTL3;KAT8;BRCA2;MITF;KDM6B;KAT6B;CEBPG;RASL11A;MAP3K2;PICALM;IER5;CREB3L2;NSD1;IRF3;BCL9;MED1;AKAP8L;DVL3;AGO2;PHIP;ASXL2;ABL1;MED13;PRKDC;PARP9;SMARCA5;ATOH8;HDAC1;PIK3R1;FLCN;TFAP2A;TFAP2B;TRIM45;RXRA;ERBB2;ZBTB38;MYB;NPAS2;BMPR1A;KMT2B;BCLAF3;RNF14;ICE2;HSF1;RNF20;PRKD2;PKD2;AR;HIVEP1;SERPINE1;KLF5;CRTC1;MAML2;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;FZD2;HOXD4;TBK1;BCL2L12;NR1I3;FOXK2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.44554543974977007,-1.333195201760609,0.11976047904191617,0.4815582147775707,1.0,8/26,12.65%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGS2;EDN1;CLU
prerank,visual perception (GO:0007601),0.3958232476529936,1.3329557012868058,0.08225806451612903,0.6460990923519822,1.0,18/84,16.67%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;EML2;DHRS3;IMPG2;CRYZ;MYO9A;RGS16;TULP2;KIFC3;CHRNB2;DNAJC19
prerank,regulation of mitotic spindle organization (GO:0060236),-0.4232452039521066,-1.3328372421158379,0.1022964509394572,0.4814341338338029,1.0,18/35,33.86%,CHMP5;CHMP2B;GNAI1;HNRNPU;CHMP1B;CHMP1A;NUMA1;DCTN1;CHMP3;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;DYNC1H1;HSPA1A;PSRC1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5158448493367072,-1.332576343521147,0.11969111969111969,0.48105515191103126,1.0,9/16,24.17%,TRIB2;TNFRSF21;CD274;JAK3;TYROBP;DLL1;FCGR2B;AGER;VSIR
prerank,iron ion transmembrane transport (GO:0034755),-0.57665159218771,-1.3325492724177574,0.1405940594059406,0.48001109491493466,1.0,4/10,13.34%,SCARA5;SLC40A1;SLC39A8;SLC39A14
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.38839953498665475,1.3324186559784241,0.07804878048780488,0.6459956407224667,1.0,15/90,6.84%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;IGF1R;CPT2;PTH2R
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3817353655813652,-1.3323359589808665,0.05778894472361809,0.4794804371960436,1.0,22/57,22.25%,MAP3K5;FYN;CTSD;TNFSF10;NOD1;LGMN;PERP;AIM2;SOX7;GRIN1;NDUFA13;USP50;GPER1;REST;TBC1D10A;BCAP31;CASP8;FOXL2;CYFIP2;ACVR1C;CYCS;CASP1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5210339308906644,1.332166746152705,0.13009708737864079,0.6449381326376376,1.0,6/20,11.92%,OSR1;NEDD4;PCSK9;MMP9;CAMK2D;ACTN2
prerank,positive regulation of protein binding (GO:0032092),-0.38627384613332827,-1.3320703451537477,0.09951456310679611,0.47910854390264385,1.0,16/56,13.03%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;PKD1;GSK3B;ADD2;HIP1R;APP;DERL1;RALB;BMP2;MEN1;IDE
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.548420295650038,-1.3315395816534217,0.12825278810408922,0.4794210518569535,1.0,10/12,42.68%,CRYAB;CLU;IAPP;PFDN6;PFDN5;PFDN4;TREM2;VBP1;LDLR;PFDN1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.600851625235191,1.3314433440784523,0.19047619047619047,0.6454229525211259,1.0,6/11,20.04%,PARP4;PARP10;PARP12;PARP9;TIPARP;PARP14
prerank,anion transmembrane transport (GO:0098656),0.4087020102843546,1.331229922229372,0.09932659932659933,0.6443285149630198,1.0,15/67,11.51%,SLC6A13;SLC13A3;SLC13A4;SLC16A12;SLC6A9;SLC1A3;SLC25A18;SLC13A5;LRRC8E;SLC25A11;SLC25A22;SLC27A1;SLC13A1;SLC19A1;SLC35A1
prerank,regulation of adaptive immune response (GO:0002819),-0.4951673567604682,-1.3309369176338,0.12184873949579832,0.48012755150268543,1.0,10/18,35.66%,AHR;ADCY7;SAMSN1;TRIM27;FCGR2B;SKAP1;FADD;IL4I1;SASH3;IL6ST
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5142696007322799,1.3300723803102925,0.173828125,0.646134469749557,1.0,1/23,0.03%,IGF1
prerank,epithelial cell-cell adhesion (GO:0090136),0.5951306949735901,1.3298523595241858,0.1489795918367347,0.6450049069161692,1.0,2/11,1.24%,PLEKHA7;KIT
prerank,cellular response to lipid (GO:0071396),0.34878255819474474,1.329113987093511,0.03526093088857546,0.6455428409865809,1.0,19/191,7.27%,RORA;ATP1A2;ROCK2;ADCY5;PTK7;ADCY1;TFPI;EPHA3;WNT6;PID1;CXCL13;CRHBP;CACTIN;SSTR2;IL6;NCOA3;PDCD1LG2;UBE2L3;WNT5B
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5080769646790302,-1.329014532239799,0.1366223908918406,0.48412187569466636,1.0,13/16,34.29%,SRSF1;SFPQ;DDX5;SRSF9;SRSF6;DDX17;RBM17;HNRNPM;PUF60;SCNM1;CELF4;DHX9;PQBP1
prerank,regulation of cellular senescence (GO:2000772),-0.43979000402218615,-1.3279146456791306,0.125,0.48588360655780827,1.0,8/28,16.94%,B2M;YPEL3;YBX1;ABI3;CDK6;RSL1D1;MAP3K3;EEF1E1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5569855938704049,-1.327124639470539,0.12024048096192384,0.487008981719071,1.0,2/11,2.22%,RUNX1;CBFB
prerank,chondrocyte differentiation (GO:0002062),0.47230609979252186,1.3267458006574675,0.1213768115942029,0.6507176302576345,1.0,7/32,7.27%,SOX5;OSR1;SCX;SOX6;NFIB;SULF1;WNT5B
prerank,lipid translocation (GO:0034204),-0.4806639984142036,-1.3267342586478383,0.11663066954643629,0.486948688025525,1.0,8/21,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11B;TMEM30A;ATP11A
prerank,tight junction assembly (GO:0120192),-0.38458468112860533,-1.3265017857609795,0.09813084112149532,0.4864623987064638,1.0,9/49,3.00%,PECAM1;CLDN5;ESAM;ACTG1;OCLN;CLDN11;LSR;RAMP2;F11R
prerank,genitalia development (GO:0048806),-0.54914649482905,-1.326459936099247,0.13572854291417166,0.4854699438480986,1.0,4/12,11.20%,PKD1;STRA6;TBX3;FOXF2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4552718015118401,1.3261784024651952,0.10452961672473868,0.6506816071820635,1.0,8/43,7.32%,IGF1;IL18;PDGFRB;CCN4;MMP2;GJA1;IL6;MMP9
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5361135604417587,1.3261134846182325,0.13821138211382114,0.6491308978303806,1.0,7/17,12.39%,ATP1A2;SLC8A1;ANK2;CACNA1D;CACNA2D1;SCN3B;SCN2B
prerank,regulation of protein kinase A signaling (GO:0010738),0.5194973020667931,1.3261072843006096,0.15151515151515152,0.6474195618962336,1.0,3/20,5.48%,ADGRV1;AKAP7;LRRK2
prerank,cardiac muscle cell action potential (GO:0086001),0.47309578977268796,1.3257069428510122,0.13714285714285715,0.6468655141947413,1.0,7/30,7.35%,ATP1A2;DMD;SLC8A1;ANK2;KCND3;CACNA1D;CACNA2D1
prerank,histone modification (GO:0016570),0.37671276537478965,1.325488947055556,0.07401574803149606,0.6458151014956871,1.0,14/109,10.71%,EYA4;EYA1;EYA2;BRD8;PRDM5;TBL1XR1;MIDEAS;BAZ1B;UFL1;PRMT7;KAT8;KAT6B;NSD1;HDAC1
prerank,vasculogenesis (GO:0001570),-0.42439508547479377,-1.324642771366145,0.12244897959183673,0.48947122440997753,1.0,13/32,11.16%,CAV1;KDR;ITGB8;RAMP2;RASIP1;ENG;NOTCH1;SOX17;TGFBR2;TGFB1;VEGFA;HEY2;SOX18
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.36689489248550916,-1.3241851293680975,0.05128205128205128,0.48965898894765986,1.0,18/65,13.25%,HIP1;PTPRJ;SH3KBP1;BCAR3;CBL;DAB2IP;MVB12B;PTPN12;CCDC88A;CEACAM1;RHBDF2;HIP1R;SHKBP1;HGS;DUSP3;GPER1;CDH13;MVB12A
prerank,regulation of T cell chemotaxis (GO:0010819),0.5768773568753137,1.3241703462490162,0.1740976645435244,0.6481867881105524,1.0,2/11,3.19%,OXSR1;CXCL13
prerank,amino acid import (GO:0043090),0.515096108510098,1.3240024964944082,0.14145383104125736,0.6470429295321979,1.0,5/21,3.73%,SLC22A4;SLC6A13;SLC22A2;SLC1A3;SLC6A1
prerank,positive regulation of metabolic process (GO:0009893),0.3774780588180314,1.3237587723681663,0.08860759493670886,0.6460503961002031,1.0,16/103,6.84%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;CAMK1D;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;IGF1R;CPT2;PTH2R
prerank,response to interleukin-4 (GO:0070670),-0.5801683934927149,-1.3231305009947931,0.137546468401487,0.4914432370061263,1.0,4/10,19.40%,LEF1;XBP1;TCF7;JAK3
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3515185126397817,-1.3229010245520507,0.05630026809651475,0.4910146961540735,1.0,22/76,21.08%,TEK;NTRK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;WDR1;NCK1;BAIAP2L1;EDN1;NCK2;BIN1;SORBS3;NES;CDC42EP5;PRKCE;CDC42EP2;CFL2;CDK5;EVL;NCKAP1L;NUMA1
prerank,cellular response to hexose stimulus (GO:0071331),-0.46057674458927456,-1.3227653421612116,0.12153518123667377,0.49026454755270593,1.0,9/23,13.34%,UNC13B;GAS6;RACK1;KCNB1;SOX4;XBP1;SLC26A6;GPER1;SLC39A14
prerank,regulation of cell differentiation (GO:0045595),-0.3141018309196542,-1.3221857263778911,0.02108433734939759,0.4907865761783842,1.0,42/148,18.71%,SLC6A6;SPOCK2;LTBP4;TRPS1;ZFHX3;TIAM1;RUNX1;CBFB;HSP90AB1;KLF4;PTK2;PHLDB1;NGF;TBX1;TGFB1;SIX1;NOTCH4;EMP2;PTHLH;RUNX2;DDX5;HEY2;ZFP36L1;APC;CDK6;YWHAG;UQCC2;ATF4;MCRIP1;RPS6KA1;BIN1;REST;NF1;NR1D2;RAF1;BCL6B;APC2;YWHAH;ID2;CASZ1;GREM1;DDX17
prerank,regulation of B cell proliferation (GO:0030888),-0.3886071089558491,-1.3221488938156531,0.07334963325183375,0.4898172801734693,1.0,15/44,20.83%,MEF2C;TFRC;NFATC2;CD38;PTPRC;TNFRSF21;AHR;CD74;CD81;MIF;CD40;TIRAP;TYROBP;NCKAP1L;CD300A
prerank,actin filament polymerization (GO:0030041),0.4721561828103212,1.322115964121645,0.1347248576850095,0.6495071755338067,1.0,10/29,11.11%,ARHGAP6;GAS7;WASF1;WASL;WASF3;SPIRE2;CORO7;PSTPIP2;COBL;JAK2
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.4784092650800076,-1.321999963462952,0.11627906976744186,0.48911925688409374,1.0,11/21,27.61%,STMN2;NAV3;APC;ARHGEF2;APC2;TTBK2;CLASP2;SPEF1;CAMSAP3;CAMSAP1;FGF13
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.48850069951702363,1.3213726921207305,0.1431297709923664,0.6500840214731467,1.0,5/24,10.79%,LEPR;PID1;COQ10A;GFPT2;ADRB3
prerank,JNK cascade (GO:0007254),-0.4033286959628451,-1.321283927382824,0.10336538461538461,0.489904284413925,1.0,12/40,15.45%,MAP3K5;UBB;NOD1;MINK1;ARHGEF6;UBC;RPS27A;MAPK8;MAP2K7;MAP3K12;TAB3;UBA52
prerank,camera-type eye development (GO:0043010),0.4956120988917555,1.3205847814423481,0.170018281535649,0.6508279589465623,1.0,4/25,2.90%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3195168191493181,-1.3204781829634729,0.052805280528052806,0.491003346149621,1.0,45/149,19.88%,PRKCH;CAV1;TFRC;RPS6KA5;UBB;NFKBIA;RPS3;PPIA;NOD1;ROR1;TRIM14;IKBKB;EDA;TRIM25;UBC;RPS27A;TNFRSF11A;APP;CARD14;IL1RAP;AIM2;SLCO3A1;ZBTB7A;CHUK;RTKN2;STAT3;ARHGEF2;CLU;IRAK3;TAB3;TERF2IP;TRIM13;TRAF1;UBA52;CX3CR1;CARD16;PRKD1;RPS6KA4;CD40;IRAK1;RNF25;TIRAP;MID2;TRIM27;MYD88
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4546765234233753,1.319082921281495,0.1336996336996337,0.6536795033303788,1.0,7/37,7.00%,ALCAM;ADGRL1;JAML;FAT4;IL1RAPL1;AMIGO3;PTPRD
prerank,sensory perception of light stimulus (GO:0050953),0.38957992692456794,1.3180836406012284,0.09838709677419355,0.6552234184753626,1.0,19/87,16.67%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;WHRN;EML2;DHRS3;IMPG2;CRYZ;MYO9A;RGS16;TULP2;KIFC3;CHRNB2;DNAJC19
prerank,mesonephric tubule development (GO:0072164),0.5457860599252062,1.3177216122076871,0.18859649122807018,0.6546775424343716,1.0,3/15,1.28%,OSR1;FGFR2;BMP7
prerank,protein prenylation (GO:0018342),-0.5610710406156734,-1.3174501618870431,0.1450381679389313,0.4983131378026512,1.0,5/10,21.06%,PGGT1B;RABGGTB;PTAR1;RCE1;RABGGTA
prerank,cAMP metabolic process (GO:0046058),0.5574518888613658,1.3171936016247345,0.17373737373737375,0.6545904557725429,1.0,2/13,0.71%,ADCY5;ADCY1
prerank,protein hydroxylation (GO:0018126),-0.5049373119889466,-1.3171131608210025,0.14078674948240166,0.49818089766862717,1.0,8/15,29.23%,P3H2;EGLN3;PLOD2;PLOD3;JMJD7;PLOD1;VPS33B;HIF1AN
prerank,positive regulation of angiogenesis (GO:0045766),-0.33490703128519106,-1.3169841009612517,0.04533333333333334,0.4974453149833773,1.0,30/108,10.16%,GAB1;TEK;NOS3;BMPER;TIE1;CD34;KDR;THBS1;RUNX1;F3;KLF4;ITGB1;ETS1;ITGB8;RAMP2;PKM;PIK3R6;HSPB1;ITGA5;GATA2;RHOB;PDCL3;EMC10;VEGFA;TJP1;GRN;PTGIS;S100A1;XBP1;PIK3CD
prerank,negative regulation of lipid storage (GO:0010888),0.5088771705948738,1.3165298563682946,0.15247524752475247,0.6548163306238021,1.0,4/19,6.76%,OSBPL8;PPARA;ABCA1;IL6
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4111759198213333,-1.3158111701359017,0.11040339702760085,0.49940635884505097,1.0,9/37,8.54%,CAV1;RPS7;UBB;RPS3;RACK1;NCK1;SOD1;BCL2L1;SFPQ
prerank,positive regulation of phosphatase activity (GO:0010922),-0.46935164981393934,-1.3154662987057983,0.11462450592885376,0.4992506919348653,1.0,11/21,24.26%,MEF2C;CALM1;HSP90AB1;MTOR;BMP2;MTMR9;CALM2;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,regulation of cholesterol efflux (GO:0010874),-0.43059424001014923,-1.3154246907185656,0.1292372881355932,0.49828196016535853,1.0,18/30,30.79%,CAV1;PLTP;SREBF2;NFKBIA;PTCH1;LAMTOR1;NR1H2;ABCA3;ABCA2;ZDHHC8;NR1H3;TTC39B;TREM2;GPS2;ABCA7;PPARG;NAXE;SHH
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4119763921734937,1.3153121990868157,0.0962566844919786,0.6568135568814935,1.0,9/66,5.51%,ROBO1;SASH1;IL34;KIT;DKK1;PDGFRB;PDGFD;LRRK2;FGF1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.31185348637760096,1.3152140747847538,0.01079136690647482,0.655436278134704,1.0,103/572,13.16%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;RBPJ;FGFR2;FHL2;PPARA;NR2F2;PRKN;WWOX;ATXN1;ZEB2;KCNIP3;DAB2;ARID5B;MXI1;FNIP1;CUX1;AASS;SATB1;PRDM5;ZEB1;DKK1;DMRT1;NR1I2;ASCL2;TBL1XR1;SP100;IGF2;NEDD4;VSX2;JAZF1;ZFP90;HDAC8;HOXA7;ZHX2;NFIB;RNF2;KDM2B;SOX1;DPF2;IRF8;GLI3;MXD1;ZBTB32;ZFP37;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;WWC2;SALL1;KANK2;SMAD3;EN1;NR6A1;MTF2;PHF21A;PER3;WWP2;LYAR;CBX8;DNAJA3;CBX2;MITF;MDM2;NSD1;MED1;FRK;SMURF2;IRX1;PARP9;HDAC1;FLCN;TFAP2A;CBX7;ZNF8;TFAP2B;ZNF568;RXRA;MYB;TAF3;CRY1;CNOT2;ZNF177;CDC73;E2F6;ORC2;SOX13;HSF1;AR;HIVEP1;PHF6;EZH1;CGGBP1;IFI27;NFATC4;NR1I3
prerank,negative regulation of cell migration (GO:0030336),-0.32249150795157944,-1.3150881261031393,0.04573170731707317,0.4982505981656073,1.0,25/137,5.73%,SLIT2;LIMCH1;PTPRJ;PTPRG;CLDN5;TMEFF2;CLIC4;RAC1;ACVRL1;DACH1;JAG1;CDH1;ADAM15;ADARB1;ENG;DAB2IP;MCTP1;ARHGDIB;SRGAP1;KANK1;CORO1C;RHOB;CALR;IGFBP5;NEXMIF
prerank,calcium-mediated signaling (GO:0019722),0.3790113827068803,1.3149988994935493,0.08917197452229299,0.6543530388897837,1.0,16/93,8.22%,RCAN2;ADGRL1;ACKR2;CCR9;CXCR5;PDPK1;SLC8A1;DMPK;ANK2;CXCR6;SPHK1;LRRK2;PPP1R9A;PRKAA1;MCU;GPR143
prerank,fatty acid transmembrane transport (GO:1902001),0.5090605109644087,1.3148079327058335,0.16831683168316833,0.6532753547179143,1.0,3/19,5.76%,PRKAG2;PRKAA2;CPT2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.38608521395260925,1.3146898090166967,0.0859504132231405,0.6520097861664764,1.0,14/85,10.88%,DCDC2;EYA1;ADGRV1;CEMIP;CCDC50;ALDH7A1;RIPOR2;CACNA1D;LRP2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,regulation of interleukin-4 production (GO:0032673),-0.46002436080750175,-1.314486887253268,0.14285714285714285,0.49878531593655523,1.0,2/21,1.62%,LEF1;SLC7A5
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.6028963891631723,1.314084470261047,0.1762114537444934,0.6521607071139518,1.0,3/10,10.86%,PRKAA2;PRKAA1;FLCN
prerank,inorganic cation transmembrane transport (GO:0098662),0.33205751844520126,1.3140350694167202,0.045205479452054796,0.6506318308194365,1.0,19/268,4.74%,TRPM3;SCN7A;ATP1A2;SLC6A13;SLC24A3;KCNK2;SLC8A3;SLC6A12;SLC6A9;KCNQ4;NALCN;KCNA5;SLC41A1;SLC1A3;ATP1B3;SLC8A1;SLC6A1;KCND3;CACNA1D
prerank,regulation of organelle assembly (GO:1902115),0.39578491583469116,1.3140103619484527,0.09120521172638436,0.6490673038772036,1.0,9/72,6.56%,DCDC2;NPRL3;SPICE1;ODAD3;ALMS1;NPRL2;MTMR3;TBC1D9B;SDCCAG8
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.47475006548765486,-1.3139476166669741,0.14538310412573674,0.4992115369321105,1.0,8/19,11.74%,TGFB2;NOTCH1;BMPR2;TGFBR2;SOX4;HEY2;BMP2;HEYL
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.4201146136767874,-1.3135974378404485,0.10782241014799154,0.4990916812917583,1.0,15/32,33.49%,CEPT1;MFSD2A;LPCAT3;GPAT4;LPCAT1;LPIN3;CSNK2B;LPIN1;LCAT;SLC44A5;SLC44A2;PEMT;CHPT1;STARD10;ACHE
prerank,"transcription, DNA-templated (GO:0006351)",0.3413828521005546,1.31350259427839,0.048295454545454544,0.6489875089631664,1.0,28/207,12.36%,GLIS3;SOX5;MAF;POLR2D;SCX;PAX5;CDK7;ELOA;GTF3C5;HSF2BP;THAP1;POLR3GL;POLR3G;POLR2A;CCNT2;RSF1;CCNT1;GTF2F1;SMN1;SMARCA5;TAF1A;DTX1;GTF3C3;TAF3;CDC73;GMEB2;HIPK3;HSF1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5574129171441611,1.3132170092541346,0.1875,0.6481943092592207,1.0,2/14,1.68%,AUTS2;KMT2A
prerank,serine family amino acid catabolic process (GO:0009071),0.5948737469188834,1.3129735824946331,0.1791044776119403,0.6473030659039704,1.0,4/10,18.83%,CBS;THNSL2;SHMT1;DLD
prerank,histone H3-K4 trimethylation (GO:0080182),0.5797675766518438,1.3127244481807272,0.19153225806451613,0.6463868971118293,1.0,6/11,21.65%,KMT2A;SETD1A;CTR9;WDR82;BEND3;TET3
prerank,cellular response to glucose stimulus (GO:0071333),-0.4271506434604028,-1.3125124421677579,0.11037527593818984,0.5009043213871914,1.0,10/30,13.52%,UNC13B;GAS6;RACK1;PTPRN2;KCNB1;SOX4;XBP1;GPER1;SLC39A14;RAB11FIP5
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5301624193127658,-1.3113745821106133,0.15180265654648956,0.5028266743032147,1.0,3/13,7.85%,CAV1;ADRA1B;ADRA1A
prerank,positive regulation of MAPK cascade (GO:0043410),0.3329917473727641,1.3111989295612303,0.04336043360433604,0.6492566799184009,1.0,32/245,7.93%,IGF1;ROBO1;ROCK2;IL34;KSR1;FGFR2;FGFR4;NOTCH2;KIT;ANGPT1;PELI2;MTURN;LPAR1;CCN2;PDGFRB;TRIM5;IGF2;EPHA8;GFRAL;PDGFRA;GLIPR2;PDGFD;IGF1R;LRRK2;PRKCZ;FGF1;WWC1;ADRA1D;IL6;PRKCA;CCL19;RYK
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.563077001611684,-1.3110760586178318,0.14722753346080306,0.5025945699649718,1.0,5/10,22.89%,PTPRC;CEACAM1;CX3CR1;ARRB2;FCGR2B
prerank,positive regulation of telomerase activity (GO:0051973),-0.4180781045277283,-1.310789514318457,0.10538116591928251,0.5023539072980528,1.0,7/33,10.52%,NEK7;HSP90AA1;HSP90AB1;KLF4;CTNNB1;PARM1;MAP2K7
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4269274320758725,-1.3107064296002744,0.1399548532731377,0.5014876823137958,1.0,10/29,9.59%,SLIT2;SHANK3;KANK3;KANK1;HIP1R;TJP1;CYRIB;SSH2;SSH1;KANK4
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4543039870319626,-1.3104148329237526,0.1120162932790224,0.5012218700585676,1.0,17/24,36.54%,UBB;UBC;RPS27A;RPA1;UBA52;POLK;LIG4;POLE;POLD3;POLB;POLD1;LIG3;RFC5;RPA3;RPA2;XRCC1;RFC2
prerank,eye morphogenesis (GO:0048592),0.5192992217027966,1.3093343362464749,0.16952380952380952,0.6530415870368868,1.0,4/19,2.90%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,negative regulation of angiogenesis (GO:0016525),-0.3454215788997584,-1.309294157622142,0.06036745406824147,0.5031563545233964,1.0,23/84,14.62%,TEK;SLC12A2;CLDN5;PTPRM;SEMA6A;KLF2;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;CREB3L1;STAB1;CTNNB1;SARS1;SERPINF1;HGS;HHEX;SYNJ2BP;EPN2;COL4A2;ISM1;SPARC
prerank,negative regulation of cell differentiation (GO:0045596),0.3469133659127928,1.3084575795051216,0.053314121037463975,0.6539588029549804,1.0,24/181,8.93%,RANBP3L;RORA;ADAMTS12;ADGRV1;OSR1;EFEMP1;PPARA;BMP7;MEIS1;RUNX1T1;SMAD6;IGF2;ANKRD26;ABCA1;TMEM64;ADAMTS7;SUFU;IL6;SMAD3;PTEN;IQCB1;ABCA5;YTHDF2;USF3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4313690272737792,1.3084003127837667,0.1223021582733813,0.6524999905470324,1.0,16/42,17.79%,RBBP4;HNRNPC;ARID1B;CECR2;NASP;CHD4;SMARCA5;HDAC1;SMARCE1;INO80;SMARCB1;SRCAP;SMARCA2;SMARCC1;ACTR6;SMARCA1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5236834677252122,-1.3078042638612142,0.13799621928166353,0.5062260592012771,1.0,6/14,28.92%,SRSF9;RNPS1;SRSF6;PCBP4;PTBP1;SRSF7
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.48367423443089197,-1.3074954627566593,0.15274949083503056,0.5059471905118623,1.0,9/18,30.67%,CD34;PTPRC;NAV3;LAPTM5;TRIM27;HDAC7;TNFAIP3;EZR;ZFP36
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3905217904801992,-1.3066931043448649,0.09927360774818401,0.5070226085728093,1.0,24/43,36.09%,TFRC;LIMK2;TGFB1;FERMT2;GSK3B;CARD10;SESN2;WWTR1;ATP13A2;SUMO3;CTNNA1;AKT1;BMP4;OTUD7B;BYSL;SIN3A;SHH;MFHAS1;PLK1;NGFR;PARK7;CDK5RAP3;TESK1;LIF
prerank,embryonic appendage morphogenesis (GO:0035113),0.555826585635809,1.3066695641043253,0.19718309859154928,0.6560476334225012,1.0,2/12,4.65%,CYP26B1;FBXW4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5600306621860245,-1.3065585309645695,0.13333333333333333,0.5063456862802724,1.0,5/11,23.02%,CREB3L1;HSPA5;ATF4;ATF3;CEBPB
prerank,potassium ion homeostasis (GO:0055075),-0.4553311319846053,-1.30649152799326,0.1350210970464135,0.50545329721995,1.0,10/23,11.53%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3
prerank,negative regulation of secretion by cell (GO:1903531),-0.3961603568809014,-1.3063654777169516,0.11210762331838565,0.5047403379812964,1.0,11/38,13.87%,STXBP6;GRM7;NOTCH1;VAMP8;RHBDF2;TNFRSF1B;SLC30A1;RSAD2;SYT4;CHGA;CYP51A1
prerank,lipoxygenase pathway (GO:0019372),-0.5127969785385017,-1.3062518473332003,0.16082474226804125,0.5039836096756827,1.0,4/14,12.63%,GPX4;PTGS2;PON2;ALOX12
prerank,histone lysine demethylation (GO:0070076),0.4765776409149317,1.3060725124376142,0.14119922630560927,0.656253152893634,1.0,12/25,18.40%,KDM7A;KDM2B;PHF8;KDM2A;KDM5B;KDM6B;KDM3B;KDM5C;KDM6A;PHF2;RIOX2;KDM4D
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.42029835985614306,-1.3060377446003952,0.10759493670886076,0.5034819755914162,1.0,20/33,39.62%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;CD81;LAPTM5;THY1;CD300A;RELA;EZR;CARD11;PTPN22;KCNN4;PHPT1;RC3H1;TRAT1;CD226;TESPA1;LCK
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5957704767767291,1.3058057913861363,0.20575221238938052,0.6554129621112103,1.0,3/10,5.28%,HOXB4;ACE;UFL1
prerank,lamellipodium organization (GO:0097581),-0.42833812840913743,-1.3056055889227876,0.125,0.5035783658487424,1.0,9/29,6.15%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A
prerank,regulation of angiogenesis (GO:0045765),-0.3030152321389269,-1.3053663811765959,0.02142857142857143,0.50319581148008,1.0,41/192,8.87%,GAB1;TEK;CLDN5;PTPRM;NOS3;SEMA6A;RHOJ;BMPER;TIE1;CD34;KDR;THBS1;TGFB2;RUNX1;PLXND1;F3;KLF4;ITGB1;ETS1;ITGB8;RAMP2;DAB2IP;SEMA3E;PPP1R16B;PIK3R6;HSPB1;WARS1;STAB1;GATA2;RHOB;PDCL3;CTNNB1;SARS1;CEMIP2;EMC10;CEACAM1;SERPINF1;VEGFA;EMP2;GRN;PTGIS
prerank,histone H2A monoubiquitination (GO:0035518),0.5133076831714829,1.3049764681803577,0.18128654970760233,0.6562243501902809,1.0,7/17,14.82%,DDB2;RNF2;KDM2B;BCOR;PCGF5;CUL4B;PCGF1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.49309955839671316,-1.3048397921397834,0.1425531914893617,0.5035983990361438,1.0,10/18,33.76%,IL33;THBS1;LBP;HSPD1;CEBPA;CRLF2;KARS1;TLR4;TLR6;TSLP
prerank,regulation of protein kinase C signaling (GO:0090036),0.5439104828469703,1.3047979067695656,0.17008196721311475,0.6551008205339942,1.0,2/14,2.01%,ADGRV1;GPD1L
prerank,vitamin transport (GO:0051180),0.47926935576696533,1.304467241066887,0.15157116451016636,0.6544439385370228,1.0,9/29,10.58%,SLC35F3;PDPN;TCN2;SLC2A10;FOLR1;FOLR2;SLC27A1;SLC19A2;SLC19A1
prerank,xenobiotic transport (GO:0042908),0.5386174787598654,1.3042711984147095,0.2202020202020202,0.6534226987373214,1.0,5/16,7.33%,SLC22A4;SLC22A2;NR1I2;GJA1;ABCC2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.43970144743748507,1.3040254215759397,0.14513274336283186,0.652615027275543,1.0,5/40,7.32%,IGF1;PRKN;BNIP3;NOL3;MMP9
prerank,regulation of cellular component size (GO:0032535),-0.42386551446830983,-1.3037988108116325,0.12307692307692308,0.505352663921497,1.0,17/30,27.52%,MSN;RAC1;RIN3;MTOR;EPS8;AP2M1;PPP1CA;RAB3B;ATP13A2;PEX11B;RAP1GAP2;HP1BP3;LAMTOR4;PPP1R15A;EZR;RPTOR;NEB
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29714687474911194,1.3036562892625376,0.0,0.6521201193832246,1.0,283/1646,14.19%,IL31RA;IGF1;GLIS3;CREB5;RORA;SOX5;MAF;VGLL3;TCF4;TCF7L2;OSR1;EFEMP1;WNT4;ARNT2;RBPJ;DENND4A;ZIC1;HOXC6;EPAS1;HLF;PPARA;KDM7A;NR2F2;NPAS3;IKZF2;KIT;HOXC4;BMP7;ATXN1;ZEB2;TULP3;ZKSCAN2;KMT2A;PRRX1;MEIS1;HOXB4;SNX6;DKK3;ESRRG;ARID5B;RUNX1T1;MXI1;CUX1;SMAD6;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;PLCB1;SP100;LOXL3;PPARGC1B;HOXB3;TSHZ3;HIF3A;PAX5;NFYB;JARID2;EPOP;MIDEAS;ZIC5;HOXA3;BBX;IGF2;TP53INP2;SSBP2;HOXC5;PKNOX2;VSX2;NCOA2;STAT5B;NFAT5;ELOA;MYRFL;VGLL4;ZFP90;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;NFIB;BEND5;TEAD1;ELF4;L3MBTL2;MGA;BAZ1B;ARID4A;TEF;ZNF367;ARID1B;IKZF4;GMEB1;KDM2B;CAMTA1;SOX1;SIX5;SALL4;ZFHX2;NDP;DPF2;PERM1;IRF8;SP110;ZNF250;MSANTD1;GLI3;PRKCB;ZNF569;METTL4;SFMBT1;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZMIZ1;NIBAN2;ZFP37;BAZ1A;PHF8;BCOR;ARHGEF11;SUFU;THAP1;WWC1;TYMS;IL6;WWC2;SALL1;GPBP1;UBE2L3;RFXAP;ZNF23;XRCC5;SMAD3;BLM;PHF14;EN1;GPBP1L1;PBX4;CHD4;NCOA7;NR6A1;NEK4;POLR3G;RGMB;MTF2;ZKSCAN5;TRIM56;KDM2A;TCF12;POLR2A;CCNT2;BIRC5;TEAD3;WWP2;PIAS1;RSF1;CCNT1;NFIA;PCGF5;ARNT;ZMYND15;TLE1;FSTL3;ZNF628;KAT8;KDM5B;CAMK2D;BRCA2;MITF;KAT6B;CEBPG;KDM3B;MAP3K2;PICALM;EBF4;MDM2;MBTD1;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;MED1;BBS7;DVL3;NUP107;ZSCAN29;SMURF2;IRX1;PHIP;ABL1;MED13;SCMH1;PARP9;L3MBTL3;SMARCA5;ATOH8;NEUROD2;ASCC2;HDAC1;ZBTB11;TSHZ1;TFAP2A;TADA2A;SMARCE1;ZNF8;HOXC8;TFAP2B;ARID3A;ZIC4;ZNF568;TRIM45;RXRA;ERBB2;TGFA;ZBTB38;MYB;ZBTB39;NPAS2;KMT2B;ZBTB37;CRY1;CNOT2;ZNF177;RNF14;E2F6;SOX13;GMEB2;HSF1;RNF20;CCNE1;CBFA2T2;PSPC1;AR;HIVEP1;PHF6;KLF5;SEBOX;ZMIZ2;SMARCB1;FZD2;HOXD4;NFATC4;HOXA6;NONO;EPC2;FOXK2;SRCAP;SNAI1;ZNF697;HOXB9;SCML4;TFDP2;RRP8;MLXIP;CLOCK;ZNF148;ZFX;SRF;POLR3C;DMRTA2;KDM5C;UBE2V1;MTDH;CDKN1C;BATF;CREBBP;NLK;MNAT1
prerank,protein polymerization (GO:0051258),0.41703096844418464,1.3036537065906975,0.10160427807486631,0.6505504135041313,1.0,13/55,11.11%,ARHGAP6;PRKN;GAS7;WASF1;WASL;ARL6;WASF3;SPIRE2;RNF135;CORO7;PSTPIP2;COBL;JAK2
prerank,membrane repolarization (GO:0086009),0.5293880576555837,1.303588343127445,0.1862348178137652,0.6491953806291718,1.0,3/15,4.07%,ATP1A2;ATP1B3;KCND3
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3624434256783507,1.3033562504393061,0.0755287009063444,0.6483600605291485,1.0,22/132,9.79%,IGF1;SH3D19;PPARA;DAPK1;ZBTB20;TRIM5;VGLL4;PRKAA2;UFL1;NPRL2;LRRK2;SNX9;SNX33;NRDC;BNIP3;OPTN;RNF152;PRKAA1;DAGLB;ARNT;PLEKHF1;ITCH
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5163816661037386,1.3032954338085472,0.1732283464566929,0.6469929747398054,1.0,8/17,20.59%,PPARA;PID1;NUPR1;FLCN;PFKFB1;NCOR1;HDAC4;PDE12
prerank,membrane repolarization during action potential (GO:0086011),-0.5421657180928644,-1.3031706104641378,0.16666666666666666,0.5058737975729192,1.0,5/13,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNIP2
prerank,negative regulation of interferon-beta production (GO:0032688),0.5813433571908595,1.302992190947033,0.20910973084886128,0.6463638871403605,1.0,3/10,9.05%,CACTIN;NLRC3;SIRPA
prerank,oligodendrocyte development (GO:0014003),-0.5083052291383847,-1.3028789273374315,0.15768463073852296,0.5056509362958953,1.0,7/15,19.12%,PLP1;B4GALT5;EIF2B5;TPPP;EIF2B2;B4GALT6;SOX10
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5531763117018399,-1.3026529133104938,0.14031620553359683,0.5053025400563671,1.0,4/11,17.61%,FAP;BCL2L1;PTGIS;ZC3H12A
prerank,protein K48-linked deubiquitination (GO:0071108),-0.4514408175933436,-1.3025383315249797,0.13114754098360656,0.5045586420437217,1.0,14/23,25.91%,ATXN3;OTUD7A;MINDY2;MINDY1;USP50;USP37;OTUD3;OTUB1;USP8;OTUD7B;TNFAIP3;USP5;USP33;YOD1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5036791954865508,-1.3024406076231896,0.1588785046728972,0.5037880266128604,1.0,4/15,13.20%,GRM3;GRM7;HOMER1;GRM8
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4221151010721444,1.3018218735210176,0.13089005235602094,0.6480887410670919,1.0,6/48,3.96%,JPH1;CEMIP;DMD;PDPK1;GSTM2;ANK2
prerank,fatty acid catabolic process (GO:0009062),0.39752021366479867,1.3015188279681742,0.10296684118673648,0.647348053387502,1.0,17/67,14.65%,PCCA;CEL;EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3517152120566158,-1.3012725599081605,0.05938242280285035,0.5058951228877441,1.0,19/70,10.97%,MEF2C;TEK;FN1;TMEFF2;PARVB;RAC1;SIPA1L3;ACTN1;PXN;LAMA5;LAMB2;FERMT2;ITGA4;SRCIN1;PEAK1;RHOA;RELN;ATF4;ITGA8
prerank,mononuclear cell differentiation (GO:1903131),0.4947832914287983,1.3011849499321537,0.19517102615694165,0.6467419589382859,1.0,1/24,0.01%,IL31RA
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4684838095583168,1.3011313992886808,0.14862385321100918,0.645364993395955,1.0,5/26,12.46%,ATP1A2;GSTM2;THADA;GNB5;PKD2
prerank,negative regulation of cellular protein localization (GO:1903828),0.4612723638585177,1.300964652771497,0.13837638376383765,0.6443195879329665,1.0,9/34,11.92%,LEPROT;ROCK2;RIPOR2;SNX33;UBXN2B;PICALM;LATS1;FLCN;ACTN2
prerank,regulation of T cell cytokine production (GO:0002724),-0.5036176884623386,-1.3006489500155982,0.138,0.5065706738441533,1.0,3/15,7.06%,B2M;CD55;TNFRSF1B
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4860537347182091,1.300074581774538,0.16318785578747627,0.6453334218325614,1.0,6/24,11.08%,EPHA7;PCSK9;SRPK2;NUPR1;TFAP2A;TFAP2B
prerank,myoblast fusion (GO:0007520),0.5546576648695393,1.2999217666277305,0.1962809917355372,0.6442121633362627,1.0,3/12,2.21%,ADAM12;ADAMTS5;ADAMTS15
prerank,endoderm development (GO:0007492),-0.5228860880534052,-1.2994403918556219,0.15413533834586465,0.5088364743627407,1.0,8/13,40.59%,SOX17;SOX7;DUSP1;DUSP4;TBX20;DUSP5;DUSP2;GATA4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.41893018119271874,-1.2991112930876154,0.11814345991561181,0.5086561839894433,1.0,14/31,20.59%,SHANK3;SIPA1L1;ZDHHC15;PPFIA2;LRP8;ABI3;SRCIN1;KIF1A;RELN;DBNL;CAMK2B;CDK5;CFL1;DBN1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3469699559938352,1.2986626894869029,0.06599713055954089,0.6463616006696072,1.0,18/170,9.06%,IGF1;PRDM6;ROCK2;AFF2;ZNF462;IGF2BP1;NOVA1;PRDM5;DKK1;SLC8A1;TRIM5;CACTIN;MTMR3;ZUP1;ATRAID;KDM6B;SIRPA;FUBP1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5137607023846619,1.2982907329417945,0.1782178217821782,0.645914654816569,1.0,2/17,2.68%,LPGAT1;PLA2G10
prerank,mesenchyme development (GO:0060485),0.5323809235977689,1.2977530648719766,0.18218623481781376,0.6460171218446749,1.0,2/15,1.28%,FGFR2;BMP7
prerank,respiratory tube development (GO:0030323),0.47466187674252086,1.2973869510202303,0.1436265709156194,0.6456299984926123,1.0,6/28,5.54%,FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5230302919677547,-1.2971229992162474,0.16155419222903886,0.5129393320619935,1.0,7/13,30.32%,LGMN;PERP;TBC1D10A;CASP8;CYFIP2;NLRC4;FADD
prerank,apoptotic process (GO:0006915),-0.2991833097405918,-1.2967582527189678,0.023026315789473683,0.5128984894693045,1.0,68/203,22.37%,HIP1;EFNA5;ELMO1;SEMA6A;FAP;ADAM15;MAL;PPARD;PTK2B;NFKBIA;PPIA;TBX1;CDK11B;NCKAP1;MAGI3;CIT;TGFBR2;ARHGEF6;RHOB;TNFRSF21;DCC;BCL2L1;BAG6;EGLN3;PLAGL1;AHR;GAPDH;PDCD4;APP;ADRA1A;MTOR;FOXO1;DDIT4;ING4;PAEP;RTN4;BNIP2;OGT;NDUFS1;YARS1;HSPD1;BNIP1;BBC3;DAP;IAPP;PRUNE2;FAS;JADE1;RFK;CASP8;AHCYL1;AKAP1;RAF1;PRKCE;CDK5;LIG4;TNFRSF10B;CYFIP2;MYD88;PDE1B;PRKCD;AKT1;GADD45A;PAK5;BIK;BMF;CASP1;TRAIP
prerank,negative regulation by host of viral process (GO:0044793),0.5935993624491805,1.2961404864271013,0.2037037037037037,0.6477013488968076,1.0,2/10,2.73%,PRKN;LTF
prerank,regulation of cell killing (GO:0031341),-0.49316429753325963,-1.2959075493133383,0.158,0.5140090484190984,1.0,5/16,16.37%,RAC1;TGFB2;CD55;MAPK8;DVL2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5302789457610297,1.2958134506992338,0.18951612903225806,0.6471715111724556,1.0,3/16,3.63%,RANBP3L;PLCB1;RIPOR2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5460949718819479,-1.2948680104910781,0.16796875,0.5159216229204351,1.0,6/11,18.32%,CAV1;ATG7;FOXO1;ATP6V1A;FAS;ATP6V0A2
prerank,anterior/posterior axis specification (GO:0009948),0.5469959497074224,1.2938864317663374,0.17218543046357615,0.651241521005016,1.0,1/15,0.46%,WLS
prerank,glycogen metabolic process (GO:0005977),0.47358207576684164,1.292885607321726,0.156,0.6526316805875007,1.0,4/27,9.46%,PRKAG2;PHKB;GYS1;NHLRC1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.34592814655316007,-1.2927889720031982,0.06340057636887608,0.5206210666267657,1.0,27/84,10.16%,TEK;TMSB4X;FOXP1;NOS3;NRP2;KDR;THBS1;RAC1;SCARB1;ETS1;PTK2B;BMPR2;LGMN;ATP5F1A;HSPB1;BCAR1;GATA2;RHOB;TGFB1;CALR;EMC10;MET;FLT4;VEGFA;GRN;EDN1;PIK3CD
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.46976174301425544,1.2920744553207144,0.16727941176470587,0.6534152601130162,1.0,7/27,8.39%,PPARA;IL18;PLA2G10;ABCA1;MAPK9;CSF1;ABCA5
prerank,cardiac ventricle development (GO:0003231),-0.4656878406932072,-1.2918826225982283,0.1392156862745098,0.5220841308822526,1.0,7/20,11.74%,ENG;NOTCH1;HES1;STRA6;PDE2A;HEY2;HEYL
prerank,regulation of protein modification process (GO:0031399),-0.37608400705149414,-1.2918808497929848,0.11316397228637413,0.5210401093306333,1.0,17/50,15.52%,FN1;FNIP2;PTK2;ATG7;PPP1R16B;HSPB1;CORO1C;WARS1;CCDC88A;SPRED2;PPIB;SESN2;CADM4;MT3;RABL3;PPP1R16A;CCDC88C
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.4551690520847035,-1.2917886915807926,0.14959016393442623,0.5202550257355388,1.0,11/23,23.79%,HSP90AA1;NDUFA13;TOMM22;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22;BMF;BAX
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5606697123200056,1.291620283645832,0.1702127659574468,0.6532638188154116,1.0,1/12,0.68%,B3GALT1
prerank,heart development (GO:0007507),-0.3037973525927386,-1.2914310697737834,0.046052631578947366,0.5201867698588778,1.0,34/150,11.43%,MEF2C;TEK;NTRK3;FN1;HEG1;SGCD;MEF2D;MICAL2;BMP5;ACVRL1;TGFB2;PTK2;RAMP2;NOTCH1;TBX1;BMPR2;CXADR;PKD1;SOX17;STRA6;TGFBR2;TBX2;SOX4;TGFB1;CRIP1;PDLIM7;VEGFA;LDB3;ECE1;CDKN1B;CACNA1C;BMP2;SOX18;NDRG4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.30575525378811547,-1.29133161468956,0.03125,0.5194131915158442,1.0,51/163,23.41%,MEF2C;PTPRJ;PDE4D;PLCG2;FYN;INPP5D;BMX;DENND1B;RFTN1;BCAR1;IKBKB;NCK1;NFATC2;CD38;PTPRC;TNFRSF21;CSK;PAK1;PSMD13;PSMF1;PAK2;PSMB10;PLEKHA1;PIK3CD;CHUK;PSMB6;STOML2;PSME3;PSMB5;MOG;PSMC3;PSMD12;PSMB8;CUL1;NFKBIZ;PSME1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;THY1;SKP1;TXK;NCKAP1L;FYB2;RBCK1;PSMD9;PSMB4;RELA
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.32331789578841735,-1.2908809448619967,0.05698005698005698,0.5196756515166289,1.0,36/101,22.08%,MSN;THBS1;NIBAN1;HSP90AA1;KLF4;EEF2;VIM;NFKBIA;ATG7;RPL26;SOX4;TGFB1;PERP;FAF1;RPL5;MTOR;PYM1;EIF4G1;EIF3D;BCL3;OGT;YTHDF3;RPS4X;TBC1D10A;RPS27L;NR1H2;CASP8;EIF3C;VPS11;AGTR1;CYFIP2;AKT1;METTL3;FMR1;EIF6;NR1H3
prerank,histone H3-K4 methylation (GO:0051568),0.4760263498526496,1.290603159513367,0.16380952380952382,0.6549052108794021,1.0,12/26,22.91%,KMT2A;ASH2L;SETD1A;KMT2B;KDM6A;CTR9;WDR82;DYDC2;SETD4;BEND3;TET3;DPY30
prerank,copper ion homeostasis (GO:0055070),-0.4897442983371282,-1.29019081660952,0.16532258064516128,0.5205467497151404,1.0,5/17,7.70%,ATOX1;SLC31A1;MT2A;ARF1;APP
prerank,phospholipid catabolic process (GO:0009395),-0.4464124054660256,-1.290166672710005,0.162217659137577,0.5195911933894131,1.0,6/24,15.14%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.4981959713355193,1.2901578801696585,0.1676190476190476,0.6546392897129647,1.0,3/21,5.30%,ADCY5;ADCY1;NPR2
prerank,intracellular pH reduction (GO:0051452),-0.4116174924175222,-1.2899398354198748,0.11752136752136752,0.5191738114820824,1.0,19/33,26.57%,DMXL1;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;DMXL2;ATP6V0A4;ATP6V0A2;RAB39A;SLC11A1;ATP6V0D2;CLCN3;RAB7A;ATP6V0E2;ATP6V1B2;TMEM9;ATP6V1H
prerank,homocysteine metabolic process (GO:0050667),0.5685353859636882,1.289456136364506,0.2194616977225673,0.6552128630862414,1.0,2/11,5.54%,CBS;MTHFR
prerank,Rho protein signal transduction (GO:0007266),0.4111992531030443,1.2892324082777995,0.11858407079646018,0.654350057462782,1.0,10/53,7.96%,ROCK2;ARHGAP6;ARHGAP29;RHOD;PDPN;COL1A2;ARHGEF11;NTN1;EPS8L1;MYO9B
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5431771846040664,-1.289187888655644,0.16261682242990655,0.5201575517052918,1.0,5/11,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNIP2
prerank,insulin receptor signaling pathway (GO:0008286),-0.35258470930201263,-1.2888879027947635,0.06718346253229975,0.5199650533041964,1.0,21/69,13.34%,GAB1;GRB14;BCAR3;NAMPT;AP3S1;CAV2;BCAR1;ATP6V0A1;GSK3B;FOXO1;APPL1;C2CD5;ATP6V1A;APC;ATP6V0C;PIK3C2A;PDK2;TCIRG1;ATP6V1E1;IDE;SLC39A14
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4952732160210119,-1.2886004314544919,0.17120622568093385,0.5197733112818872,1.0,4/16,8.51%,STX7;PTPRC;CEACAM1;CYRIB
prerank,nucleus organization (GO:0006997),-0.3864105062914104,-1.2883762530610865,0.09345794392523364,0.5193895189480383,1.0,21/47,26.80%,SYNE1;REEP3;RPS19;CHMP5;CHMP2B;LEMD2;BIN1;NUP54;CHMP1B;SUN1;PITPNB;IRAG2;CHMP1A;CTDNEP1;NUP133;NUMA1;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55
prerank,wound healing (GO:0042060),0.40090868931443757,1.288318218724291,0.13559322033898305,0.6556081383614576,1.0,10/62,8.87%,IGF1;TPM1;JAML;MACF1;SYT11;PDGFRA;FGF1;SMAD3;MIA3;DCBLD2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5354005802209593,1.2882271003366828,0.19381443298969073,0.6543669503299603,1.0,6/16,17.40%,AUTS2;KMT2A;BCOR;MYB;SMAD4;CTR9
prerank,postreplication repair (GO:0006301),-0.3911643555056043,-1.2878401309006275,0.10714285714285714,0.5197856750738451,1.0,21/45,24.81%,UBB;TRIM25;UBC;RPS27A;UBE2B;ISG15;RPA1;MSH2;UBA52;USP43;POLK;FAAP20;UBE2V2;POLN;SPRTN;POLD3;VCP;POLD1;NSMCE1;POLI;DTL
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.44254220076893686,1.2876568873839944,0.14205607476635515,0.6545492445763987,1.0,5/35,3.00%,ADCY1;KSR1;IRAG1;PDE7B;PDE7A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5184723259148697,-1.287524668969052,0.16729323308270677,0.5196106835215881,1.0,4/14,6.19%,TMSB4X;NFKBIA;PKD1;FAF1
prerank,T cell receptor signaling pathway (GO:0050852),-0.3141397515634005,-1.2872726658191993,0.042682926829268296,0.5192643025537217,1.0,45/138,23.41%,PTPRJ;PDE4D;PLCG2;FYN;INPP5D;DENND1B;RFTN1;BCAR1;IKBKB;NCK1;PTPRC;TNFRSF21;CSK;PAK1;PSMD13;PSMF1;PAK2;PSMB10;PIK3CD;CHUK;PSMB6;STOML2;PSME3;PSMB5;MOG;PSMC3;PSMD12;PSMB8;CUL1;NFKBIZ;PSME1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;THY1;SKP1;TXK;FYB2;RBCK1;PSMD9;PSMB4;RELA
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.40519633293918067,-1.2871568765084225,0.11677282377919321,0.5185410134717006,1.0,8/35,7.60%,HIP1;SGIP1;B2M;RAC1;CBL;HNRNPK;ARF1;HIP1R
prerank,central nervous system myelination (GO:0022010),-0.551351542774732,-1.2865042137997018,0.16635514018691588,0.5191440279215785,1.0,7/11,19.12%,PLP1;B4GALT5;TENM4;CLU;B4GALT6;ABCA2;SOX10
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3824805761054971,1.2861906647305312,0.1111111111111111,0.6573129649086182,1.0,14/77,12.49%,IGF1;TCF7L2;PRKN;BCL2;SH3RF1;NOL3;MMP9;SIAH2;BIRC6;ACAA2;BCL2L2;PHIP;CFLAR;AR
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.4461127230684099,-1.2859745856566671,0.13737373737373737,0.5194978428287067,1.0,13/24,28.97%,ABCG2;ABCB10;SUCLA2;RSAD1;ATP5IF1;UROD;UROS;FECH;FLVCR1;HMBS;COX15;TSPO;ABCB6
prerank,detection of visible light (GO:0009584),0.5303189862957106,1.2857920676217167,0.17682926829268292,0.6569602668502312,1.0,3/16,6.43%,ABCA4;TULP1;GNAQ
prerank,cellular response to interleukin-4 (GO:0071353),-0.5642652596949393,-1.2854486770183886,0.17439703153988867,0.5199453848957005,1.0,4/10,19.40%,LEF1;XBP1;TCF7;JAK3
prerank,aorta morphogenesis (GO:0035909),0.5197572584731655,1.2851277813281339,0.18674698795180722,0.6574667034019814,1.0,4/17,2.95%,ADAMTS9;RBPJ;MYLK;PDGFRB
prerank,protein oxidation (GO:0018158),0.5791453749542698,1.2846803951109793,0.18541666666666667,0.6573321918097343,1.0,2/11,2.97%,LOXL1;LOXL3
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.3281838601263163,-1.2841935293211721,0.05080213903743316,0.5222484601466811,1.0,31/95,24.31%,MEF2C;LBP;DAB2IP;VIM;CHMP5;SBNO2;TNFRSF1B;DEFA6;PDCD4;CYRIB;RHOA;MAPK8;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;ZC3H12A;ADAM9;IRAK1;TIRAP;MYD88;NR1H3;CASP1;TNFAIP3;PLAA;FCGR2B;RELA;CD80;CD68
prerank,Golgi localization (GO:0051645),-0.5390778573055144,-1.2834016497167302,0.1739961759082218,0.523313330767754,1.0,4/11,12.04%,COPG1;PDCD10;STK25;RIPOR1
prerank,SNARE complex assembly (GO:0035493),-0.5492598725243596,-1.2832951001863304,0.17829457364341086,0.5226163863506724,1.0,2/10,6.22%,STXBP6;VAMP8
prerank,carbohydrate transport (GO:0008643),-0.5476217023795895,-1.2830221960342625,0.17870722433460076,0.5223489080315764,1.0,3/11,11.74%,AQP11;SLC50A1;SLC26A6
prerank,homeostasis of number of cells (GO:0048872),-0.5363767103012228,-1.2828953506400476,0.1702127659574468,0.5216693248622257,1.0,5/12,15.75%,NOS3;NOTCH1;CCN3;LPCAT3;CX3CR1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4288692199468308,-1.2824975119142572,0.16806722689075632,0.5218063376014029,1.0,11/25,20.76%,CD200;ITGB1;CXADR;ITGA5;ITGA4;CTNNA3;ITGA7;JUP;DSG2;DSP;JAM3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.45633142636163265,1.2809745316164685,0.15789473684210525,0.6666657270414815,1.0,6/33,10.86%,IGF1;PRKN;BNIP3;NOL3;ACAA2;FLCN
prerank,regulation of ossification (GO:0030278),0.437898653376776,1.28083546858025,0.14821763602251406,0.6655907926075063,1.0,9/36,7.50%,RBPJ;LRP4;BMP2K;SMAD6;DKK1;ECM1;CHSY1;PTN;DDR2
prerank,neuron projection morphogenesis (GO:0048812),0.34497522053426244,1.2804424674678865,0.0784313725490196,0.665304077346819,1.0,22/137,9.11%,DCDC2;ALCAM;FGFR2;NRK;BMP7;LRP4;GAS7;SDC2;PARD3;ALS2;DTNBP1;BAIAP2;NTNG2;WASL;LRRK2;LRP2;ARC;NBL1;PTEN;RYK;FARP1;MYO16
prerank,regulation of protein catabolic process (GO:0042176),-0.327824299566706,-1.2790344627802224,0.07466666666666667,0.530289033702514,1.0,26/99,13.87%,EEF1A1;WWP1;NSF;NEDD4L;DAB2IP;ATG7;FLNA;PLK2;FAF1;GSK3B;GFAP;FOXO1;CHEK2;ZDHHC2;DDB1;FURIN;OAZ1;APC;CDKN1B;HGS;NDUFA13;AZIN1;EGLN2;IRAK3;IDE;CYP51A1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3490055316804243,1.2788361580679957,0.1,0.6683763681125292,1.0,16/141,7.29%,RORA;ATP1A2;ROCK2;ADCY5;ADCY1;TFPI;IL18;SLC5A5;CRHBP;AANAT;SSTR2;LRRK2;NCOA3;UBE2L3;BLM;FOLR1
prerank,organonitrogen compound catabolic process (GO:1901565),0.4053584485750979,1.2784633632904217,0.14285714285714285,0.667992498976209,1.0,9/57,7.52%,CPQ;CLPX;PLA2G10;GGACT;ACE;TPP1;ENPP2;NPEPPS;LIPC
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.44879434949993424,1.2783941857414762,0.17567567567567569,0.6667221226081346,1.0,5/33,3.11%,TCF7L2;PPARA;ANGPT1;PDPK1;NDNF
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4651165829346156,-1.2782465165968429,0.18724279835390947,0.5314924292367403,1.0,9/19,28.94%,LBP;PIK3AP1;NR1H4;PRKCE;IRAK1;TIRAP;TRIL;ITGB2;TLR4
prerank,negative regulation of calcium ion transport (GO:0051926),0.530397868298932,1.2774117152592017,0.21694214876033058,0.6681021391824687,1.0,1/15,0.21%,ATP1A2
prerank,regulation of nervous system process (GO:0031644),0.505057743389185,1.276821289762522,0.1785028790786948,0.6683607373832441,1.0,2/18,0.88%,ROCK2;SLC8A3
prerank,regulation of histone modification (GO:0031056),0.5464325214464859,1.2767174963940282,0.21063394683026584,0.667167514343378,1.0,6/13,19.38%,IGF2;MTHFR;AKAP8L;FLCN;NNMT;CDK9
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4669774837352416,1.276444047004222,0.16666666666666666,0.6665248329355217,1.0,5/26,8.42%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,gland development (GO:0048732),0.39639976192549387,1.27640597743564,0.13973063973063973,0.6651509540613235,1.0,10/59,7.10%,TGFBR3;WNT4;FGFR2;DKK3;ARID5B;ANXA1;PRKCSH;PCSK9;SALL1;ARHGAP35
prerank,sulfur amino acid metabolic process (GO:0000096),0.4784799856645481,1.276223876525427,0.17777777777777778,0.6642193899630683,1.0,5/24,10.60%,CBS;MSRA;MTHFR;AHCY;CDO1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4921866513517774,-1.2753283890957796,0.18108651911468812,0.5386265158298176,1.0,7/15,30.25%,TGFB2;TGFB1;IRAK3;JAK3;TGFB3;SMAD7;CUEDC2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2966603965229736,1.2746796511334528,0.007909604519774011,0.6672788558777503,1.0,137/834,13.21%,IGF1;GLIS3;RORA;BMP6;TCF4;TCF7L2;OSR1;AUTS2;ARNT2;RBPJ;ZNF462;FGFR2;EPAS1;HLF;PPARA;NR2F2;PID1;IL18;HOXC4;CDK8;PRKN;WWOX;BRD8;ZEB2;KMT2A;MEIS1;DAB2;HOXB4;FHOD1;CSRP3;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;PPARGC1B;HOXB3;RNASEL;NFYB;CDK7;IGF2;SSBP2;TFR2;NCOA2;STAT5B;MAML3;NFAT5;HDAC8;HOXA7;NFIB;TEAD1;ELF4;FIZ1;SOX1;WASL;DPF2;IRF8;FGF1;GLI3;TET1;ZMIZ1;MAML1;WWC1;IL6;SALL1;NCOA3;RFXAP;SMAD3;SSBP3;NCOA7;GABPB1;GABPB2;MTF2;TCF12;ABRA;CCNT2;RPRD1B;RSF1;CCNT1;NFIA;PCGF5;ARNT;GTF2F1;FSTL3;KAT8;MITF;KDM6B;KAT6B;CEBPG;IER5;IRF3;BCL9;MED1;AKAP8L;DVL3;AGO2;PHIP;ASXL2;ABL1;MED13;PRKDC;SMARCA5;ATOH8;HDAC1;PIK3R1;FLCN;TFAP2A;APLN;TFAP2B;RXRA;ZBTB38;MYB;NPAS2;BMPR1A;BCLAF3;CDC73;HSF1;PRKD2;PKD2;AR;HIVEP1;SERPINE1;KLF5;CRTC1;MAML2;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;HOXD4;TBK1;BCL2L12;NR1I3;FOXK2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.42659169842275546,1.2744790735192828,0.1564748201438849,0.6664135419479709,1.0,6/43,9.05%,IGF1;LTF;SYT11;CACTIN;NLRC3;SIRPA
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3943683283422663,-1.273975733807619,0.12415349887133183,0.54126402159366,1.0,19/38,22.39%,CAV1;KLF2;CD34;RAC1;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGIS;PTGS2;EDN1;CLU;CD47;CX3CR1;ZC3H12A;AKT1;ATP2B4;INSR;DDAH2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.4042608650227034,-1.2739136187432538,0.14112903225806453,0.5404399434832541,1.0,17/32,24.26%,CALM1;HSP90AB1;PPIA;PPP1R16B;TGFB1;MTOR;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;CD300A;NSMF;CALM3;PPP1R15A;PPP1R15B
prerank,regulation of fibrinolysis (GO:0051917),-0.5131970037300301,-1.2738658814615391,0.166,0.5395577259288385,1.0,3/13,12.47%,THBS1;FAP;THBD
prerank,vacuolar acidification (GO:0007035),-0.4476907644134261,-1.2732999583909,0.15637860082304528,0.5400934784686668,1.0,13/21,26.57%,DMXL1;ATP6V0A1;GRN;TCIRG1;DMXL2;ATP6V0A4;ATP6V0A2;SLC11A1;ATP6V0D2;CLN5;ATP6V0E2;TMEM9;ATP6V1H
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3484448442571067,-1.2725763946779416,0.10050251256281408,0.5411111992165687,1.0,28/72,24.60%,LIFR;RUNX1;GAS6;CBFB;HSP90AB1;RACK1;IKBKB;PTPRC;CDC37;BIRC3;CHUK;PTPN1;CD74;IRAK3;IFNGR1;TRAF1;CASP8;MADD;SIGIRR;IRAK1;SHARPIN;JAK1;RBCK1;TNFAIP3;OTULIN;SOCS1;STAT1;TRIM44
prerank,regulation of neuron migration (GO:2001222),-0.4343975571486694,-1.2720329415568685,0.15644820295983086,0.5416084122745273,1.0,12/26,22.66%,SEMA6A;DAB2IP;SHTN1;NEXMIF;ARHGEF2;CAMK2B;COL3A1;ADGRG1;NTNG1;NSMF;SEMA3A;PLAA
prerank,activation of phospholipase C activity (GO:0007202),0.4521772341632563,1.2717745175450919,0.17830882352941177,0.6729459310679516,1.0,4/29,6.43%,ARHGAP6;LPAR1;LPAR2;GNAQ
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4060546723044671,-1.2717330854465387,0.1309255079006772,0.5414412999303018,1.0,12/34,17.61%,PDE4D;CALM1;ATP1B1;ATP2A2;KCNQ1;ADRA1A;RYR2;NOS1;CHGA;CALM2;PLN;ZC3H12A
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4441630033365807,-1.2708936376300708,0.1496881496881497,0.5416979217504314,1.0,15/23,30.53%,PPP1R13B;NMT1;YWHAB;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4441630033365807,-1.2708936376300708,0.1496881496881497,0.5416979217504314,1.0,15/23,30.53%,PPP1R13B;NMT1;YWHAB;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,negative regulation of cellular process (GO:0048523),-0.26629814488588566,-1.270573527337865,0.0,0.541529493083319,1.0,105/521,12.79%,ZBTB7C;APBB2;SLIT2;PODXL;PTPRJ;FTH1;NOS3;IGFBP6;CD200;CD34;JAM2;ADAM10;BMP5;PLPP1;ACVRL1;TGFB2;PTPN14;CD9;CBFA2T3;PLXND1;TES;KLF4;PPP2R5C;ETS1;ADAM15;PPP1R13B;ADARB1;WNT9A;ROR2;PDE8A;PTK2B;DAB2IP;NGF;NOTCH1;NDRG3;RACK1;SH3BP4;SEMA4D;TGFBI;TBX1;FHL1;ARHGDIB;P3H2;BMPR2;SFRP4;SOX17;PLXNA4;CCDC85B;ACTN1;RERG;VPS13C;CCN3;WARS1;PINX1;SOX4;RHOB;TGFB1;NCK1;ARHGDIA;OSGIN2;FERMT2;CTNNB1;VAMP8;TNFRSF21;ST18;TOB1;TNFRSF1B;ATP8A2;DDAH1;MYH9;APBB1;PDCD4;APP;ADRA1A;CRYAB;NOTCH4;PTHLH;WNT16;AQP11;NR4A1;PODN;DYSF;ING4;RTN4;SESN2;APC;CDK6;SOX7;LPCAT3;CDKN1B;NCK2;BTG3;BMP2;NOS1;HGS;NDUFA13;IFI35;MEN1;PBRM1;GPER1;REST;CDH13;CASK;CLU;LMNA
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.49970341884153424,-1.2704119614361777,0.17716535433070865,0.5410183636980326,1.0,6/15,6.69%,TMSB4X;THBS1;NOTCH1;LGMN;HSPB1;MET
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4170991129755001,-1.269719531117554,0.14414414414414414,0.5418715862165528,1.0,10/29,18.41%,UBB;IKBKB;UBC;RPS27A;BIRC3;CHUK;CASP8;UBA52;CD40;UBE2D1
prerank,phosphate ion homeostasis (GO:0055062),0.5830218518594239,1.2694773571179303,0.22107438016528927,0.678324648246776,1.0,3/10,11.08%,FGFR4;SLC34A3;TFAP2B
prerank,ERBB signaling pathway (GO:0038127),-0.347527170385903,-1.2694313913126982,0.10422535211267606,0.5415876817249131,1.0,15/64,10.64%,GAB1;RPS6KA5;HSP90AA1;IQGAP1;CBL;PTK2;PTK2B;REPS2;PTPN12;BCAR1;TGFB1;CDC37;CPNE3;NCK2;PIK3C2A
prerank,exit from mitosis (GO:0010458),-0.5089759422602058,-1.2691331091108626,0.17680608365019013,0.5413731128584253,1.0,8/12,40.22%,EPS8;PPP2R2D;SIRT7;CHMP7;CLASP2;CLASP1;UBE2C;UBE2S
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3861500136224108,-1.2688999500637654,0.10377358490566038,0.5409610596699584,1.0,9/39,8.75%,UTRN;FXYD5;NEDD4L;FHL1;HOMER1;TRPC6;CHRM3;WNK3;FXYD6
prerank,negative regulation of developmental process (GO:0051093),-0.34938253230616045,-1.2688895847687884,0.09137055837563451,0.5399897770803731,1.0,18/69,10.79%,KLF7;NOS3;TFRC;GAS6;CST3;NOTCH1;TBX1;ARHGEF15;KANK1;TBX2;VAT1;TGFB1;DCC;GRIN3A;NOTCH4;HEY2;CDK6;BMP2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5601249709715805,1.2683582367934132,0.22350674373795762,0.6800654964026804,1.0,1/12,0.06%,UNC13C
prerank,positive regulation of vacuole organization (GO:0044090),-0.5505922157365956,-1.2682095064037198,0.17025440313111545,0.5407917660598374,1.0,4/10,19.49%,SH3GLB1;GRN;RALB;PIP4K2A
prerank,brain development (GO:0007420),0.35299736833130524,1.2678921352984929,0.09239940387481371,0.6800276038191373,1.0,21/136,8.84%,EPHA7;AFF2;ARNT2;ZIC1;ATXN1;MEIS1;ZIC2;B3GNT5;SOX6;SHROOM2;PAFAH1B3;NFIB;ZFHX2;SYNJ2;PHF8;SETD1A;AMIGO3;PBX4;PTEN;CDK5RAP1;PAFAH1B1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3770647797613245,-1.2672462239354636,0.1182033096926714,0.5423097069520079,1.0,17/44,20.81%,CARMIL1;GSN;PTK2B;CDC42EP3;NCKAP1;NCK1;BAIAP2L1;NCK2;BIN1;WHAMM;CDC42EP5;SPIRE1;PRKCE;ARPC4;CDC42EP2;EVL;NCKAP1L
prerank,cellular defense response (GO:0006968),0.4344548806995789,1.2672260984742736,0.15555555555555556,0.6805731683522387,1.0,2/40,1.52%,DCDC2;CCR9
prerank,cell-cell junction assembly (GO:0007043),-0.35145230944546896,-1.2671680896511825,0.09268292682926829,0.5415504199883956,1.0,17/63,9.55%,ACTB;CLDN5;ACTG1;CDH11;CTNND2;CD9;PKP4;CLDN11;CDH2;RAMP2;GJC1;GJD3;WDR1;CTNNB1;TJP1;RHOA;PAK2
prerank,cell chemotaxis (GO:0060326),0.39494727631483795,1.2670273232183822,0.14411247803163443,0.6796612904744251,1.0,9/60,4.40%,KIT;ACKR2;CCR9;LPAR1;CXCR5;PDGFRB;RAB13;CXCR6;PDGFRA
prerank,protein deneddylation (GO:0000338),-0.558394613292679,-1.266896715071331,0.1891385767790262,0.5412809759011344,1.0,3/10,17.77%,COPS7A;COPS8;COPS6
prerank,protein mannosylation (GO:0035268),0.48625745065941905,1.2666416627532933,0.19556451612903225,0.6793825180172172,1.0,4/22,4.37%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,response to sterol (GO:0036314),0.5652754589131775,1.2661991734528553,0.20350109409190373,0.6792807353004933,1.0,1/11,0.14%,RORA
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3705125679836614,-1.2659485164212472,0.1206896551724138,0.542863235853549,1.0,15/48,12.33%,TMSB4X;NOS3;RHOJ;KDR;THBS1;ETS1;ATP5F1A;HSPB1;GATA2;TGFB1;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,postsynaptic membrane organization (GO:0001941),0.49577741786805035,1.265491521132866,0.2056451612903226,0.6798694899817176,1.0,6/17,11.34%,LRP4;CEL;NLGN2;DNAJA3;MUSK;DLG4
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5586175147543475,1.2650896528898063,0.23481781376518218,0.679526659334515,1.0,5/13,17.36%,DDO;ACOT4;ASPA;MTHFS;QPRT
prerank,positive regulation of response to stimulus (GO:0048584),-0.3930124235945567,-1.2650023656112543,0.12559241706161137,0.5444356431177277,1.0,26/40,40.11%,B2M;TGFB2;YPEL3;HOMER1;ABI3;RSAD2;IFIH1;EEF1E1;IL15;PRKCD;FMR1;NSMCE4A;NSMCE1;FCGR2B;CD80;CGAS;DHX9;ACOX2;MAVS;ILK;BCLAF1;ARG2;ANKLE1;GATA3;HMGA1;CDKN2AIP
prerank,lipid catabolic process (GO:0016042),0.4939366804197328,1.2649917051154835,0.18773946360153257,0.6783925629536569,1.0,4/18,7.52%,CEL;ACADL;LIPH;LIPC
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.34040322221879166,-1.2649651309766212,0.11083123425692695,0.5435131570742034,1.0,27/72,23.41%,CARD10;CARD14;BIRC3;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;COPS8;PSMB3;IRAK1;TNFRSF10B;TIRAP;PSMD5;AKT1;SKP1;PSMD9;PSMB4;NFKB2;RELA
prerank,protein autoubiquitination (GO:0051865),0.3951774793694648,1.2648263572966272,0.1423670668953688,0.6773801290854139,1.0,18/61,18.37%,RNF220;PRKN;RNF213;DDB2;SH3RF1;RNF181;WWP2;AMFR;MDM2;ITCH;SH3RF2;UBE2A;RNF122;RAD18;TRIM17;OBI1;DTX3L;TRAF6
prerank,B cell activation (GO:0042113),-0.34631365813529214,-1.264708516735831,0.10471204188481675,0.5431933457147283,1.0,24/68,21.42%,MEF2C;PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;PIK3CD;HHEX;MSH2;HSPD1;RABL3;CASP8;FLT3;TCF3;CR2;CD40;DNAJB9;JAK3;ADGRG3;HDAC9
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5525949900324444,1.2643093862864518,0.20242914979757085,0.6773696861383107,1.0,1/11,0.45%,COLEC12
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3372162647899994,-1.264218136214332,0.07417582417582418,0.5436290765093778,1.0,34/79,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;MFSD6;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.49878325668965107,-1.2639424481954418,0.19646365422396855,0.5424186618700164,1.0,4/14,15.56%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.49878325668965107,-1.2639424481954418,0.19646365422396855,0.5424186618700164,1.0,4/14,15.56%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5106867461620475,-1.2637115375030064,0.1895551257253385,0.54209305061437,1.0,10/13,29.24%,RACK1;NCK1;HSPA5;PTPN1;WFS1;DNAJB9;PPP1R15A;PPP1R15B;BFAR;ABCA7
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.47255972768759724,1.2624877701524062,0.1947565543071161,0.6813549504449617,1.0,3/22,4.78%,ROCK2;PPP4R4;PTPA
prerank,response to peptide hormone (GO:0043434),0.41580702532900093,1.2620841229363153,0.15156794425087108,0.6811610533206576,1.0,4/43,3.68%,TGFBR3;ROCK2;ANXA1;STAT5B
prerank,regulation of lipid metabolic process (GO:0019216),0.37346724195644726,1.2619341772558008,0.1260096930533118,0.6801437257399844,1.0,14/88,11.41%,PRKAG2;RORA;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;CHD9;PMVK;APOC1;NFYC;MED1;FDPS;RXRA
prerank,regulation of mitochondrial fusion (GO:0010635),0.5694983758880318,1.261351969128441,0.22012578616352202,0.6804269929710901,1.0,3/11,6.51%,PID1;PRKN;BNIP3
prerank,nucleocytoplasmic transport (GO:0006913),0.4259416800598181,1.2612759231011987,0.1619217081850534,0.6792433818638617,1.0,10/40,19.87%,ATXN1;PHAX;NUTF2;SMN1;NEMF;NXT2;LSG1;RSRC1;GEMIN5;SNRPF
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5210013602478869,-1.2611502048133698,0.196,0.5478930446079805,1.0,3/12,9.30%,TMEFF2;TGFB1;EDN1
prerank,regulation of wound healing (GO:0061041),-0.3795484255736774,-1.2608816878087523,0.1308641975308642,0.5476672807938452,1.0,12/42,13.40%,CAV1;ACTG1;OCLN;PTK2;ITGB1;KANK1;CD109;AJAP1;CRK;CASK;SRSF6;CADM4
prerank,muscle tissue morphogenesis (GO:0060415),0.520234325284715,1.260655787650708,0.19607843137254902,0.6795650938190833,1.0,2/16,2.34%,TGFBR3;MYLK
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.425155941205057,-1.260623001229426,0.1726315789473684,0.5474002003163708,1.0,11/25,25.99%,HSPA8;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1
prerank,regulation of postsynapse organization (GO:0099175),-0.4150830093030067,-1.2601859961367656,0.15271966527196654,0.5475786248057926,1.0,10/28,10.46%,SHANK3;SIPA1L1;HOMER1;ZDHHC15;PPFIA2;ABHD17B;ABI3;SRCIN1;KIF1A;ABHD17A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3896895134130308,-1.2596470810590763,0.13245033112582782,0.548098220232173,1.0,10/39,7.89%,RAP1A;MSN;HSPA8;TIE1;HSP90AA1;DAB2IP;NOTCH1;HJURP;GFAP;TJP1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.40720402546463474,-1.2596340375222235,0.15894039735099338,0.5471434171951342,1.0,10/30,18.41%,UBB;IKBKB;UBC;RPS27A;BIRC3;CHUK;CASP8;UBA52;CD40;UBE2D1
prerank,organic acid transport (GO:0015849),0.36479654910630616,1.25928899041897,0.1234375,0.6820361854309527,1.0,21/94,11.41%,SLC7A11;SLC6A13;SLC13A3;SLC38A3;SLC6A12;ACSL1;PDPN;NCOA2;SLCO1B1;SLC43A1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC1A5;SLC25A11;SLC27A1;SLC22A6;SLC19A1;SLC36A2;RXRA
prerank,import into cell (GO:0098657),0.42421948648021957,1.258946235694103,0.18804920913884007,0.6816459614732792,1.0,5/41,2.16%,ATP1A2;SLC22A4;SLC6A13;SLC22A2;SLC1A3
prerank,regulation of cellular localization (GO:0060341),0.40661000655602625,1.2589230732211534,0.1681109185441941,0.6803027591872474,1.0,10/46,11.21%,ADCY5;STXBP4;PARD6G;PRKN;FER;LRRK2;WWC1;CAMK2D;DVL3;MAD1L1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.33591503656991106,1.2586839524313662,0.09457364341085271,0.6795921116442356,1.0,34/166,14.19%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;NR6A1;NRBP1;POLR2A;TEAD3;RSF1;GTF2F1;MED1;TAF8;SMARCA5;HDAC1;TAF1A;POLR1F;RXRA;POLR1A;TAF3;AR;MAML2;NR1I3;TAF1D;CREBBP;MNAT1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.3430306897030559,-1.2580636146369288,0.10687022900763359,0.5505320602725571,1.0,18/70,15.79%,B2M;IKBKB;CALR;VAMP8;MFSD6;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CYBB;PSMB3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.43048563248882477,-1.2569557455386813,0.16427104722792607,0.5524671885124316,1.0,9/24,20.48%,B2M;CALR;MFSD6;CANX;IDE;SEC23A;BCAP31;TAPBP;TAPBPL
prerank,regulation of mononuclear cell migration (GO:0071675),-0.4303814293419173,-1.25678399667314,0.17429193899782136,0.5518987109801434,1.0,9/23,14.98%,SLIT2;MSN;THBS1;BMP5;PTK2;STK10;CMKLR1;CSF1R;AKIRIN1
prerank,B cell differentiation (GO:0030183),-0.37298707087076066,-1.2566345212032,0.12807881773399016,0.5512767767272647,1.0,20/46,21.42%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;HHEX;MSH2;RABL3;FLT3;TCF3;CR2;IRF2BP2;DNAJB9;JAK3;ADGRG3;HDAC9
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4647860993677158,-1.256475260226753,0.1782178217821782,0.5507480162676943,1.0,10/17,28.36%,COX4I1;COX6C;NDUFA4;COX6A1;COX7C;COX8A;COX5A;CYCS;COX15;COX4I2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4828113570806025,-1.2562001470339261,0.2037037037037037,0.5505902928216313,1.0,11/16,32.69%,NOS3;GUCY1B1;GUCY1A1;DDAH1;NOS1;KCNC2;DDAH2;MAFA;CD36;AGT;NOS2
prerank,negative regulation of protein binding (GO:0032091),-0.3402778399876137,-1.2561156723605993,0.10722610722610723,0.5498498038837303,1.0,26/71,21.71%,CAV1;ACTB;B2M;ADAM15;RACK1;ITGA4;GSK3B;ATP2A2;ATP2A3;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;NES;ADRB2;DISC1;CTSZ;SYMPK;CARD16;TMBIM6;ARRB2;PRKCD;AKT1;TTBK2;CDKN1A
prerank,serine family amino acid metabolic process (GO:0009069),0.5264089711644714,1.2556311761261398,0.2076271186440678,0.6871077570915295,1.0,5/16,13.02%,CBS;SRR;THNSL2;CDO1;SHMT1
prerank,cellular component assembly (GO:0022607),-0.2820585300687072,-1.2551469260974601,0.027237354085603113,0.551509954176075,1.0,49/253,11.66%,SPTBN1;ACTB;SLC2A1;ACTG1;OCLN;RHOJ;PARVB;LIMS2;RAC1;LIN7A;GAS6;GSN;PPARGC1A;PTK2B;STX7;REPS2;RTN3;HES1;NCKAP1;LIMS1;WIPF1;FLNA;PLS3;CAPZA2;TGFB1;FAM107A;SKAP2;FERMT2;VMP1;BAG6;RP1;GPM6B;BAIAP2L1;LRRTM3;ADD2;CARD10;PDCD10;IL1RAP;SHROOM1;STK25;MICAL1;EPS8;RHOA;RTN4;APC;CD2AP;ST13;YTHDF3;PCLO
prerank,lipid transport (GO:0006869),-0.32403399552041723,-1.254763030856256,0.09863013698630137,0.5515461349799696,1.0,31/97,19.44%,ABCC4;PITPNC1;CERT1;ATP8B1;SLCO1C1;ATP8A1;PLTP;SCARB1;SLCO2A1;SLCO2B1;PPARD;LBP;TNFAIP8L3;CEACAM1;SPNS2;MFSD2A;SLCO3A1;GLTP;ABCD3;ABCD2;STARD5;NR1H4;GM2A;ABCA3;PRELID3B;MTTP;CLN8;ABCA2;PITPNA;PITPNB;ABCG1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4933776911974155,-1.2541549451131573,0.19583333333333333,0.5522761385266013,1.0,7/15,10.14%,BMPER;KLF4;PKM;ITGA5;VEGFA;TJP1;S100A1
prerank,lipid modification (GO:0030258),-0.39487144838966326,-1.2539189679211298,0.1650485436893204,0.551907734163168,1.0,10/37,12.63%,DGKH;PLPP1;MBOAT1;DGKB;DGKI;LPCAT3;PORCN;DGKZ;DGKG;ALOX12
prerank,meiosis I (GO:0007127),0.4579392901911488,1.253732084211289,0.19439252336448598,0.6912020266429224,1.0,3/23,6.30%,MYBL1;SLC25A31;HSF2BP
prerank,electron transport chain (GO:0022900),-0.48581577111109786,-1.2529854319062168,0.19291338582677164,0.553525328853786,1.0,8/15,32.57%,PDIA5;PPARGC1A;NDUFA5;ENOX2;CYB561;ETFB;POR;ETFA
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3848123838638851,-1.2520530965595542,0.13839285714285715,0.5550904763744877,1.0,12/41,13.92%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3;KCNJ8;KCNJ15
prerank,ERBB2 signaling pathway (GO:0038128),-0.40015731600768983,-1.2507442423520305,0.16820276497695852,0.5576546413917879,1.0,7/31,12.98%,GAB1;HSP90AA1;PTPN12;CDC37;MYOC;CPNE3;ERBIN
prerank,synapse assembly (GO:0007416),-0.3433445849184012,-1.250485249559162,0.11868686868686869,0.5573960417449472,1.0,12/67,8.78%,DNM3;SHANK3;SPOCK2;ADGRL3;CDH1;PLXND1;CDH2;GABRB3;KIRREL3;NRCAM;LRRTM3;NRXN1
prerank,negative regulation of transposition (GO:0010529),0.5043827215570597,1.2497052120436534,0.23421588594704684,0.7019361417289847,1.0,7/16,21.93%,MYBL1;UBR2;MOV10;TUT4;DDX4;PIWIL4;TUT7
prerank,heart trabecula morphogenesis (GO:0061384),0.4988687365026869,1.2495391659056574,0.21497120921305182,0.700967728610908,1.0,4/18,1.34%,TGFBR3;RBPJ;BMP7;RBP4
prerank,translesion synthesis (GO:0019985),-0.3892285693234686,-1.2494715525681752,0.15130023640661938,0.5592644594234891,1.0,20/42,28.63%,UBB;REV3L;TRIM25;UBC;RPS27A;ISG15;RPA1;UBA52;USP43;POLK;FAAP20;POLN;SPRTN;POLD3;VCP;POLD1;POLI;DTL;RFC5;USP10
prerank,regulation of anoikis (GO:2000209),-0.45728231433254724,-1.249423646601832,0.192,0.5584094520775698,1.0,8/19,16.06%,CAV1;PTK2;ITGB1;NOTCH1;ITGA5;TLE5;MYBBP1A;BRMS1
prerank,regulation of metal ion transport (GO:0010959),0.5112611740532873,1.2485241931174507,0.21161048689138576,0.7025001966926545,1.0,5/16,7.35%,STIM1;BCL2;ANK2;DLG1;CACNA2D1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.38651041470847364,1.248490881531874,0.16412859560067683,0.701155661296102,1.0,7/59,8.27%,ALDH1A2;CYP27A1;HSD17B10;HOGA1;LIPH;LIPC;SRR
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5314898198487095,-1.2483282257663926,0.19349005424954793,0.560495833111375,1.0,5/11,24.02%,P3H2;EGLN3;EGLN2;P4HA2;P4HA1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.462076168831783,-1.2475655603351254,0.21115537848605578,0.561669912938239,1.0,9/18,33.01%,ATXN3;NCK1;BAG6;XBP1;FCGR2B;BAX;ERN1;PMAIP1;RNF185
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3859093802757653,1.2471241093783954,0.1508828250401284,0.7038694538934351,1.0,16/66,12.12%,TGFBR3;ROBO1;FGFR2;MCC;NR2F2;DUSP10;NFIB;SULF1;NLRC3;MTSS1;NUPR1;BRCA2;MED1;ATOH8;CDC73;APOH
prerank,protein heterooligomerization (GO:0051291),-0.45993777702257754,-1.2468026803357828,0.1825726141078838,0.5627378391086607,1.0,8/17,21.70%,PKD1;MAT2A;CPSF7;GRIN1;CPSF6;TMEM120A;FARSA;KCNC2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.29976487566690213,1.2466053170529992,0.056558363417569195,0.7040114094383152,1.0,67/476,11.89%,IL31RA;IGF1;CREB5;RORA;TCF4;WNT4;ARNT2;ZIC1;PPARA;NR2F2;NPAS3;BMP7;KMT2A;ESRRG;ZIC2;MYBL1;SCX;NR1I2;TBL1XR1;PLCB1;SP100;TP53INP2;MYRFL;ZFP90;NFIB;TEAD1;ELF4;ARID1B;NDP;MSANTD1;GLI3;ZMIZ1;NIBAN2;PHF8;ARHGEF11;IL6;SALL1;SMAD3;BLM;PBX4;NEK4;RGMB;TRIM56;RSF1;KAT8;BRCA2;MITF;KAT6B;MAP3K2;PICALM;CREB3L2;NSD1;MED1;DVL3;PHIP;MED13;PARP9;ATOH8;HDAC1;TFAP2A;TFAP2B;TRIM45;RXRA;MYB;NPAS2;KMT2B;RNF14
prerank,mitochondrial fusion (GO:0008053),-0.4521056395279557,-1.2462625099437963,0.21138211382113822,0.5631943593142131,1.0,8/18,27.16%,CHCHD3;MIEF1;STOML2;MIEF2;MFN2;BAX;SPG7;FIS1
prerank,calcium ion import across plasma membrane (GO:0098703),0.524446054685775,1.2461466274199762,0.23109243697478993,0.704059089601027,1.0,3/14,7.35%,SLC8A3;SLC8A1;CACNA2D1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4573502446288905,1.2451903333183711,0.19489981785063754,0.7055238201952269,1.0,3/25,3.96%,CEMIP;PDPK1;ANK2
prerank,respiratory system development (GO:0060541),0.4390453893690566,1.244877908109019,0.20588235294117646,0.7049443021971671,1.0,6/32,5.54%,FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,dendrite morphogenesis (GO:0048813),0.42275544428722167,1.2444873477133047,0.17485265225933203,0.7046739025713306,1.0,8/35,9.00%,DCDC2;LRP4;SDC2;WASL;PTN;ARC;PTEN;FARP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4652709067200582,-1.2438255203812059,0.17706237424547283,0.5688426161659146,1.0,4/17,8.27%,TGFB2;MID1;PDCD10;STK25
prerank,BMP signaling pathway (GO:0030509),0.3846691945910534,1.2438176853734382,0.157439446366782,0.705277479380302,1.0,6/62,2.67%,TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX
prerank,regulation of vacuole organization (GO:0044088),0.4816981356834973,1.243700584217073,0.21414141414141413,0.7042127628714406,1.0,3/20,5.39%,NPRL3;NPRL2;MTMR3
prerank,cellular response to ATP (GO:0071318),-0.49967636449837377,-1.2429335643979817,0.1859504132231405,0.5702549809302223,1.0,9/14,42.36%,HSP90B1;SSH1;P2RY12;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;CIB2
prerank,protein K63-linked ubiquitination (GO:0070534),0.42151360030544527,1.242724526443513,0.18505338078291814,0.7057041621074677,1.0,9/41,9.79%,PRKN;UBE2E2;TRIM5;NEDD4;RNF152;TRIM56;RNF135;WWP2;ITCH
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.49879817730047216,-1.2421519467198088,0.18452380952380953,0.5714195176794572,1.0,4/14,19.40%,THBS1;IRAK3;CMKLR1;JAK3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4197201031005963,1.242136494316904,0.1766848816029144,0.7059433851992217,1.0,6/38,9.38%,LEPROT;PRKN;LRRK2;UBE2L3;NPEPPS;HSPA1L
prerank,response to lipopolysaccharide (GO:0032496),-0.299969994738807,-1.2414167974408308,0.0718954248366013,0.5724712005123195,1.0,43/138,24.31%,MEF2C;FOXP1;NOS3;SCARB1;LBP;DAB2IP;VIM;CHMP5;GCH1;SBNO2;TNFRSF11A;TNFRSF1B;DEFA6;PDCD4;RHOA;MAPK8;XBP1;NOS1;CD180;GIT1;IRAK3;ERBIN;HNRNPA0;CX3CR1;CARD16;CD274;ZC3H12A;ADAM9;IRAK1;TIRAP;MYD88;SLC11A1;LIAS;NR1H3;CASP1;TNFAIP3;GGT1;PLAA;PELI1;IFNAR1;RELA;CD80;CD68
prerank,calcium ion transmembrane transport (GO:0070588),0.36203376066409265,1.2411695766875972,0.1282051282051282,0.7074958185938414,1.0,13/86,10.46%,TRPM3;SLC24A3;SLC8A3;NALCN;SLC8A1;CACNA1D;MAIP1;TRPC4AP;CACNA2D1;MCU;YME1L1;MCOLN3;MICU1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5415171094375117,-1.2404633166032426,0.19626168224299065,0.5730562145879824,1.0,4/10,18.42%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5415171094375117,-1.2404633166032426,0.19626168224299065,0.5730562145879824,1.0,4/10,18.42%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.39604739034588643,-1.2403954027087352,0.1762208067940552,0.5722716592271531,1.0,15/30,33.16%,HSPA8;SELENOF;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1;CHCHD4;UGGT1;HSPA1A
prerank,metanephros development (GO:0001656),0.4557792254591264,1.2401265329153819,0.20309477756286268,0.7091286237535613,1.0,4/26,4.24%,OSR1;BMP7;CTSH;FOXD1
prerank,autophagosome maturation (GO:0097352),-0.3967507922673549,-1.2394027786251642,0.16812227074235808,0.5740394354344915,1.0,11/32,22.45%,CALM1;VMP1;VTI1B;VAMP8;ATP2A2;MAP1LC3B;SNX14;GABARAPL1;VCP;CHMP3;LIX1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.40510501035774665,-1.2393859215391458,0.18082788671023964,0.5731005766951714,1.0,14/29,24.27%,ELOVL7;ELOVL5;ACSL4;ACACA;ELOVL6;ELOVL1;FASN;ACSL3;TECR;SCD5;ACLY;ACSL5;SCD;ACSF3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.30745657340693267,-1.2391338540403032,0.09803921568627451,0.5718420244227029,1.0,31/104,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,cellular response to lectin (GO:1990858),-0.30745657340693267,-1.2391338540403032,0.09803921568627451,0.5718420244227029,1.0,31/104,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.32804416480133086,-1.239059359823283,0.12010443864229765,0.5711170072335817,1.0,28/84,23.01%,UBB;BUB3;UBC;RPS27A;CUL3;ECRG4;PSMD13;PSMF1;PSMB10;FBXO31;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PTTG1;PSME1;ANAPC16;UBA52;PSMB3;CDK2;BUB1B;UBE2D1;PSMD5;ANAPC7;PSMD9;PSMB4
prerank,negative regulation of protein secretion (GO:0050709),-0.385997831586064,-1.2387905863042434,0.164079822616408,0.5708647075367653,1.0,11/38,14.02%,CD200;KCNB1;CCN3;RAB11FIP1;RHBDF2;REST;RSAD2;CHGA;RAB11FIP5;CYP51A1;SIRT4
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4595115786037275,1.2385238929019364,0.19924812030075187,0.7124923149576087,1.0,5/24,6.88%,ERRFI1;ROCK2;HOXA7;SGPP1;NCOA3
prerank,translational elongation (GO:0006414),-0.31879999507403967,-1.2378213441112476,0.10479041916167664,0.5724442512147251,1.0,38/101,29.09%,EEF1A1;EEF2;RACK1;EEF1D;GFM1;MRPL32;MRPL33;MRPS14;MRPL38;EEF1G;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;EEFSEC;EEF1B2;MRPS35;MRPS28;MRPL13;MRPL35;GTPBP2;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;EEF1A2;AURKAIP1;GTPBP1;CHCHD1
prerank,regulation of developmental growth (GO:0048638),0.44228481816748444,1.237708402905663,0.208955223880597,0.7134815321726257,1.0,6/29,10.44%,IGF1;PLCB1;STAT5B;MUSK;LATS1;ABL1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4579526757736602,-1.2376601882745824,0.20512820512820512,0.5719524725315641,1.0,11/17,35.63%,PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PSRC1;PROX1;CCND1;ADAM17;CCND3
prerank,muscle tissue development (GO:0060537),-0.4955924843765078,-1.2372296511042442,0.19373776908023482,0.5721904142239165,1.0,5/13,7.93%,PGM5;ENG;STRA6;PTCH1;CSRP2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5127150192372488,-1.2365294651418086,0.20973782771535582,0.5731469413960907,1.0,3/12,5.70%,PRKG1;MEF2C;IGFBP5
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4404305487500554,-1.2363055284059568,0.18712273641851107,0.5728318005235196,1.0,12/20,35.63%,HSP90AB1;PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PSRC1;PROX1;CCND1;ADAM17;CCND3
prerank,cellular sodium ion homeostasis (GO:0006883),0.5152431773730177,1.2360005716150628,0.24849699398797595,0.717334230002211,1.0,3/15,3.07%,ATP1A2;ATP1B3;SLC8A1
prerank,gonad development (GO:0008406),0.41079594367713923,1.2353920427387501,0.19326241134751773,0.7177085506118708,1.0,8/41,12.49%,WNT4;NR2F2;KIT;LRP2;SALL1;NUP107;FGF9;AR
prerank,microvillus assembly (GO:0030033),-0.4931496326074379,-1.2347329798468487,0.2020618556701031,0.576342862764046,1.0,3/14,4.05%,RAP1A;FXYD5;MINK1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5066505205687307,1.2347195485224227,0.21748400852878466,0.7183332320209456,1.0,7/14,16.87%,FTSJ3;DDX18;NOL9;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5085215261350767,-1.2341321110818744,0.21083172147001933,0.5769865163202843,1.0,7/12,36.47%,PLCG2;RAB27A;GRIN1;TLR4;CD36;TLR6;ADGRB1
prerank,axonogenesis (GO:0007409),-0.280470857455739,-1.2339253008200217,0.0627177700348432,0.5766183090946636,1.0,55/237,12.43%,SPTBN1;GAB1;SLIT2;BSG;EFNA5;SHANK3;KLF7;ACTB;SEMA6A;NRP2;SEMA7A;SH3KBP1;SEMA6D;RPS6KA5;HSP90AA1;MAP1B;SEMA3C;HSP90AB1;S100A6;PTK2;UNC5C;LAMA1;TNR;UNC5D;FYN;NOTCH3;NOTCH1;SEMA4D;SEMA3E;SHTN1;B4GALT5;NRCAM;LAMA5;TUBB3;ROBO4;LAMA3;DCC;PDLIM7;APBB1;APP;NRXN1;GFRA2;SEMA4B;SEMA5B;SEMA6C;PIK3CD;LYPLA2;RELN;SEMA3G;EPHB1;SLITRK5;EFNB3;GPC1;SPTBN4;LMTK2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.30567143357205506,-1.233197211224427,0.09217877094972067,0.577735599531461,1.0,31/105,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,microtubule anchoring at centrosome (GO:0034454),0.5601873233182706,1.233054827429843,0.2405857740585774,0.7218165226128362,1.0,2/10,7.13%,NINL;CEP19
prerank,histone lysine methylation (GO:0034968),0.43138473891768014,1.2330444770906082,0.19540229885057472,0.7204131358301885,1.0,10/33,18.52%,KMT2A;PRDM5;ASH2L;SETD6;SMYD3;KMT2B;KDM6A;N6AMT1;WDR82;DYDC2
prerank,regulation of endothelial cell migration (GO:0010594),-0.3222917196261937,-1.2330383670518494,0.12401055408970976,0.5773007727243316,1.0,28/85,10.16%,TEK;SLIT2;FOXP1;PTPRM;NRP2;RHOJ;BMPER;KDR;THBS1;RAC1;ACVRL1;SCARB1;PTK2;ETS1;PTK2B;DAB2IP;BMPR2;BCAR1;RHOB;CALR;EMC10;CEACAM1;FLT4;VEGFA;EMP2;GRN;EDN1;PIK3CD
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4932166367648223,-1.2329736725930793,0.20112781954887218,0.5765053902730211,1.0,5/13,6.37%,NFKBIA;PKD1;FLNA;YWHAB;GOPC
prerank,regulation of actin nucleation (GO:0051125),-0.5152919820943543,-1.2320957166844,0.19797979797979798,0.5779971702017279,1.0,8/12,34.40%,GSN;ARF1;WHAMM;PICK1;ARFIP2;ARFIP1;CORO1A;SCIN
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4051221444965901,-1.2320637939630008,0.17758985200845667,0.5771075386284514,1.0,11/25,18.75%,CAV1;CALM1;CXADR;ATP2A2;CTNNA3;RYR2;CACNA1C;JUP;DSG2;DSP;TRPM4
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3779197858406021,-1.2317495822038298,0.14220183486238533,0.5769890299039635,1.0,11/42,10.98%,ST6GALNAC3;ESYT2;PSAP;ST6GALNAC5;SUMF1;ST8SIA1;SMPD4;HEXB;HEXA;CERK;GLTP
prerank,vasoconstriction (GO:0042310),-0.5205242280290974,-1.2315705502814418,0.21264367816091953,0.5765498251338491,1.0,4/11,10.64%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,tyrosine metabolic process (GO:0006570),0.5435756287408257,1.230994613974766,0.24307036247334754,0.7251552212197553,1.0,3/11,15.20%,FAH;DCT;GSTZ1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3629046636693627,-1.2306769101403183,0.15473441108545036,0.5780976935935326,1.0,15/46,22.25%,PIEZO2;F11R;PIEZO1;PDE2A;MAPK8;MAP3K1;CASP8AP2;FAS;CASP8;CD40;TNFRSF10B;MYD88;GADD45A;MAPK3;CASP1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5393547845926501,-1.2302051285327098,0.24478178368121442,0.5784517968442936,1.0,4/10,24.04%,TNFRSF1B;TRPM4;AGER;CCR2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.43887078573206045,-1.230169899486609,0.19322709163346613,0.577599728888395,1.0,6/20,10.82%,RPS6KA5;PPARGC1A;SOX4;ARRB1;GLYR1;NOS1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5329794915524178,1.230123621253286,0.22350674373795762,0.7263911852484464,1.0,4/13,13.42%,ADHFE1;IDH2;PHYH;AADAT
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3282493323443129,-1.2300563948384653,0.10597826086956522,0.5760185687665982,1.0,33/78,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3282493323443129,-1.2300563948384653,0.10597826086956522,0.5760185687665982,1.0,33/78,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,lymphocyte differentiation (GO:0030098),-0.3372432928796199,-1.2295186880196172,0.1272264631043257,0.5765100150395367,1.0,27/68,21.42%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;SOX4;HDAC5;ITGA4;PTPRC;JAG2;LFNG;ZBTB7A;LMBR1L;PIK3CD;HHEX;IKZF1;MSH2;RABL3;FLT3;TCF3;CR2;TOX;DNAJB9;JAK3;DLL4;ADGRG3;HDAC9
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4475170284404332,1.2294582664145892,0.20964749536178107,0.727036887017648,1.0,5/29,3.92%,PPARA;LPGAT1;SORBS1;ZBTB20;SLC45A3
prerank,regulation of telomerase activity (GO:0051972),-0.3679834000508029,-1.2293621256615148,0.1510791366906475,0.5759350928531355,1.0,9/45,11.31%,NEK7;HSP90AA1;HSP90AB1;KLF4;PINX1;CTNNB1;PARM1;MAP2K7;MEN1
prerank,heterochromatin organization (GO:0070828),-0.4826773887791138,-1.2292777035307045,0.19734345351043645,0.5752316434826665,1.0,4/14,11.47%,MECOM;PRDM16;SMCHD1;BAHD1
prerank,mitochondrion morphogenesis (GO:0070584),0.5538608911902555,1.2292358095854259,0.25260960334029225,0.7262873692085838,1.0,2/11,4.45%,PID1;WASF1
prerank,protein dephosphorylation (GO:0006470),0.33649260223296235,1.2287642986253091,0.15088757396449703,0.7263088754671996,1.0,15/135,5.50%,EYA4;EYA1;PTPN13;PPP2R2B;EYA2;LHPP;PPM1M;PTPN4;DUSP10;SSU72;PPM1E;CDC14B;PTPRA;MTMR3;PTPN9
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4432995217029423,1.2287276081141398,0.2202729044834308,0.7250133798783233,1.0,4/27,7.50%,IGF1;PDGFRA;SPHK1;DDR2
prerank,regulation of transmembrane transport (GO:0034762),-0.40066391645705707,-1.2282459801074759,0.20374220374220375,0.5772425498323366,1.0,5/31,2.60%,ACTB;SLC2A1;OCLN;KCNJ2;NEDD4L
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.33073782699042936,-1.2270774751191578,0.13924050632911392,0.5796296468631564,1.0,26/75,20.49%,TEK;NRP2;KDR;F3;BMPR2;PPP1R16B;NRAS;GATA2;PDCL3;ITGA4;EMC10;JCAD;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;CDH13;APLNR;PRKD1;AGTR1;PLXNB3;ANG;AKT1;BMP4
prerank,regulation of cellular respiration (GO:0043457),-0.46645695200986426,-1.22705175425107,0.219959266802444,0.5787488269468063,1.0,9/17,35.50%,CBFA2T3;PRDM16;IDE;NOP53;VCP;IFNAR1;NOS2;PRELID1;IFNLR1
prerank,regulation of interleukin-12 production (GO:0032655),-0.35868253925128274,-1.2267698466158945,0.1583710407239819,0.5785761765578643,1.0,14/47,23.69%,FOXP1;THBS1;PLCG2;HSPD1;IRAK3;CD47;CMKLR1;LAPTM5;CD40;IRF5;JAK3;TIRAP;MAPK11;AGER
prerank,cellular response to inorganic substance (GO:0071241),-0.43757639077713484,-1.2266187112506015,0.19838056680161945,0.5780304248231724,1.0,8/21,21.98%,GUCY1B1;FOXO1;SPIDR;MT3;CDK2;FMR1;KCNC2;RTF2
prerank,amide transport (GO:0042886),-0.4113692169303279,-1.2259422682210321,0.2074235807860262,0.5789176715629325,1.0,7/26,10.98%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11;GLTP
prerank,supramolecular fiber organization (GO:0097435),-0.26364567799050614,-1.22566555773942,0.027906976744186046,0.5787330459659474,1.0,106/333,19.34%,COL8A1;PGM5;HIP1;COL25A1;MYO1D;ELMO1;COL6A3;COL12A1;B2M;TLL1;SHROOM4;ITGA6;COL8A2;COL4A1;ADAM10;RAC1;TGFB2;CARMIL1;ITM2B;CST3;GSN;HSP90AB1;ITGB4;COL5A2;COL6A2;PLEC;SLK;VIM;UBB;TGFBI;P3H2;COL15A1;CLIP1;COL6A1;ACTN1;TNXB;MYH11;CORO1C;BCAR1;COLGALT2;CLIP2;RHOB;LUM;CCDC88A;LAMA3;COL27A1;UBC;RPS27A;COL14A1;ADAMTS14;GFAP;MARCKS;CHP1;HIP1R;STMN2;APP;EMP2;SHROOM1;COLGALT1;H3-3A;RHOA;PPIB;FURIN;ARHGAP25;COL16A1;CD2AP;MFAP4;PLOD2;MTM1;ERMN;MYO5A;WHAMM;ARHGEF2;COL4A2;STMN1;IAPP;ALDOA;INPPL1;COL1A1;NF1;HOOK1;MARCKSL1;TPM3;CYP1B1;TPM4;COL3A1;UBA52;CCDC88C;TPPP;RHOG;STMN4;P4HA2;COL5A3;TPPP3;TMOD1;USP9X;COL28A1;DSP;GREM1;PLOD3;CDC42EP2;STMN3;EVL;ADAMTS3;CKAP5;FLII
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4412354396915976,-1.224941616417717,0.20315581854043394,0.5798737728965284,1.0,5/20,12.75%,CAV1;KCNB2;CHRM3;ATP2B1;ADRB2
prerank,metal ion transport (GO:0030001),-0.3205452106063553,-1.2248518304058755,0.11944444444444445,0.5791973495011481,1.0,32/86,19.27%,CAV1;TPT1;TRPC3;RAMP2;MAGT1;FYN;SLC30A5;ATP2C1;SLC3A2;GRIN3A;CACNA1E;ATP2A3;NIPAL3;RAMP1;SLC39A8;TRPC4;RYR2;CACNG3;SLC30A1;CACNA1C;NDFIP2;NIPAL4;SELENOK;PANX1;MT3;CALCRL;TRPC1;CACNA1B;NIPAL2;NIPA2;CACNB3;PSEN1
prerank,positive regulation of proteolysis (GO:0045862),0.39014678509628986,1.224712890145873,0.19833333333333333,0.7357187983844092,1.0,8/55,7.78%,SH3D19;FGFR4;CTSH;CCBE1;SNX9;SNX33;NRDC;WDR48
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3037782318486322,1.2243568263562314,0.08145363408521303,0.7353715513592808,1.0,34/348,6.13%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;RBPJ;FGFR4;AFDN;WNT6;PID1;BMP7;ANGPT1;PRKN;RBMS3;DKK1;SCX;NOS1AP;CTSH;DTNBP1;PCSK9;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;GJA1;TNRC6A;FGF1;SLC2A10;EPHX2
prerank,protein heterotetramerization (GO:0051290),-0.48546503575051836,-1.2242203584972726,0.20669291338582677,0.580084203250254,1.0,8/13,33.59%,PKD1;CPSF7;GRIN1;CPSF6;FARSA;HSD17B8;GRIN2B;KRT10
prerank,regulation of protein binding (GO:0043393),-0.3085082196055304,-1.224141943714963,0.11049723756906077,0.5793580003872544,1.0,31/114,16.04%,CAV1;ACTB;CLDN5;B2M;EPB41;TIAM1;RPL11;RACK1;PKD1;HDAC5;GSK3B;ADD2;HIP1R;APP;PRMT8;DERL1;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;BMP2;CRK;MEN1;MARK2;NES;IDE;DISC1;CTSZ;SYMPK;CARD16
prerank,sphingolipid catabolic process (GO:0030149),-0.48104050580627206,-1.2241028850061786,0.24271844660194175,0.57855594352467,1.0,4/15,7.97%,ACER3;ACER2;SMPD4;SGPL1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.479079404545663,1.223814401723286,0.2250996015936255,0.7356339542981599,1.0,5/20,10.46%,SLC8A3;MAIP1;MCU;YME1L1;MICU1
prerank,negative regulation of secretion (GO:0051048),-0.5412439365337567,-1.2236967602386541,0.23210831721470018,0.5788738094985509,1.0,7/10,30.72%,VAMP8;CD74;PTGER3;NR1H3;SPX;VAMP3;EGF
prerank,response to X-ray (GO:0010165),0.5207837771441941,1.2236912639954536,0.23461538461538461,0.7346235230988852,1.0,4/14,7.25%,ANXA1;XRCC5;BLM;XRCC4
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3910835314136247,-1.2235851157726156,0.1875,0.5782946417104754,1.0,13/34,25.74%,MEF2C;GSK3B;GRIN1;GABRG3;INSYN2A;ARRB2;AKT1;GABRA5;GRID2;GABRE;MAPK8IP2;GABRG2;GLRA1
prerank,potassium ion transport (GO:0006813),0.3406941642039066,1.2234476913204777,0.14285714285714285,0.7339530582224254,1.0,9/120,4.07%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3;KCND3
prerank,regulation of signal transduction (GO:0009966),0.3245686269107099,1.2229361286116487,0.12283236994219653,0.7339959704798145,1.0,32/190,11.33%,DCDC2;IGFBP2;RORA;SLC8A3;ZIC1;FGFR2;TULP3;NCAM1;PLCB1;INTU;SP100;TRIM5;DTNBP1;IRAK2;IGFBP4;LLGL2;SULF1;LRRK2;ITGA3;TCF7L1;GRK3;ZDHHC3;AMFR;GRK5;GRK4;FBXL17;IGFBP7;WDR11;DHRS3;GNG7;DTX1;LLGL1
prerank,histone H2B ubiquitination (GO:0033523),0.5542497710276423,1.2226082171539736,0.25149700598802394,0.7335946800944722,1.0,7/10,22.89%,CDC73;RNF20;CTR9;UBE2E1;DTX3L;PAF1;WAC
prerank,positive regulation of cell projection organization (GO:0031346),0.3418982914870244,1.2220927951927505,0.13746223564954682,0.7337021703383871,1.0,17/115,7.10%,PLXNA2;ROBO1;PTK7;EPHA3;CAMK1D;CUX1;DPYSL3;AVIL;IL1RAPL1;NDNF;GRIP1;OBSL1;PLXNC1;PLK5;PTN;PTPRD;ARHGAP35
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3135308465584045,-1.221858753087906,0.1171875,0.582158525212866,1.0,40/98,22.08%,SLCO1C1;NSF;THBS1;KLF4;PPARD;NFKBIA;SFRP4;CHCHD2;TGFBR2;TGFB1;ARRB1;GHITM;ACACA;VEGFA;CD63;ECE1;EIF4G1;RAB1A;XDH;ACE2;PICK1;ROMO1;MT3;NR1H2;FASN;ZC3H12A;AGTR1;GREM1;RAB1B;INPP5F;ARRB2;ACLY;AKT1;INSR;FMR1;ATAD1;PAX8;GADD45A;CDKN1A;NR1H3
prerank,synapse organization (GO:0050808),0.33930705932242994,1.221378258951397,0.14727540500736377,0.7345539565544349,1.0,21/125,9.00%,UNC13C;PDZRN3;SDK1;SLC8A3;LRP4;NLGN2;GPC6;DKK1;NEDD4;SLC6A1;OBSL1;PPFIBP2;IGFN1;CACNB4;LRRK2;PTPRD;PTEN;RYK;MUSK;PCDHB10;FARP1
prerank,microglial cell activation (GO:0001774),-0.43454658396462986,-1.2211968957323778,0.19832985386221294,0.5830340599705309,1.0,10/21,27.83%,APP;GRN;CLU;C1QA;IFNGR1;CX3CR1;TYROBP;AGER;TREM2;ITGB2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4047162082711752,1.2208090002546823,0.1996527777777778,0.7347626703903422,1.0,3/41,5.83%,PRKAG2;LACC1;NDC1
prerank,regulation of extracellular matrix organization (GO:1903053),0.501394887308573,1.2207988429660466,0.23391812865497075,0.7333887530312599,1.0,6/15,9.87%,AEBP1;FGFR4;DDR1;SLC2A10;DDR2;RIC1
prerank,pancreas development (GO:0031016),0.5239187092061592,1.2207896542813423,0.25833333333333336,0.7320200796315637,1.0,1/12,0.51%,TCF7L2
prerank,positive regulation of translation (GO:0045727),-0.31310537183945425,-1.2204482520533604,0.11320754716981132,0.5841976326989816,1.0,32/94,22.07%,THBS1;NIBAN1;RPS9;EEF2;VIM;PKM;RPL26;SOX4;YBX3;RPL5;MTOR;RCC1L;PYM1;EIF3D;UQCC2;BCL3;YTHDF3;RPUSD4;RPS4X;RPS27L;EIF2B5;EIF3C;POLR2G;EIF5A;EIF5AL1;FASTKD3;TRUB2;METTL3;FMR1;EIF6;UHMK1;TRMT10C
prerank,histone H2A ubiquitination (GO:0033522),0.48330276260820265,1.220093902565679,0.24266144814090018,0.7327571246911876,1.0,9/17,17.62%,DDB2;RNF2;KDM2B;BCOR;UBR2;CUL4B;UBE2A;PCGF1;DTX3L
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.332716159894105,1.2198730118827388,0.1240981240981241,0.7320366453027812,1.0,19/140,7.96%,ARHGAP28;ARHGAP24;ARHGAP6;GMIP;ARHGAP29;CGNL1;FGD4;RHOD;ARHGAP20;SYDE2;ARHGAP26;SOS2;AKAP13;ARHGAP12;ARHGAP40;ARHGEF11;ARHGAP35;ARHGAP9;MYO9B
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.392094086500238,-1.2198290310776334,0.19246031746031747,0.5850161688753813,1.0,15/32,27.61%,STMN2;NAV3;APC;ARHGEF2;STMN1;APC2;TUBB4A;FKBP4;MAPRE1;TTBK2;CLASP2;SPEF1;CAMSAP3;CAMSAP1;FGF13
prerank,telomere maintenance (GO:0000723),0.39915725893706555,1.2193795330130905,0.1855123674911661,0.7321559133460909,1.0,19/50,21.86%,SP100;HUS1B;ACD;XRCC5;BLM;TEP1;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1;RAD51;TPRKB;POLD2;RAD50;NBN;TERF2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5054286343485553,1.2193489001901296,0.24733475479744135,0.730851092255614,1.0,4/15,8.60%,ADGRV1;KIT;TMC2;WHRN
prerank,nucleotide catabolic process (GO:0009166),-0.46749407490992423,-1.219321462237146,0.21237113402061855,0.5854719703343055,1.0,8/16,26.75%,NT5C2;NUDT3;GDA;NT5C;XDH;NT5E;VCP;NT5C1A
prerank,regulation of programmed cell death (GO:0043067),-0.29300754310351595,-1.2190330627915085,0.08064516129032258,0.5853229222459082,1.0,48/161,22.42%,MECOM;HIP1;ACTN4;ACER3;ACER2;TPT1;HSP90AA1;TARDBP;PPP1R13B;SLK;RPS3;TGM2;ACTN1;BCAR1;PERP;CALR;CTSB;LGALS1;LRP8;BIRC3;MAGED1;ZBTB7A;RTN4;BCL3;RSL1D1;CLU;FAS;MADD;FLT3;WFS1;BRMS1;RAF1;SGK1;RTKN;DCPS;RABGGTB;CDK5;TIGAR;PINK1;TNFRSF10B;JAK3;NOP53;AKT1;RABGGTA;PAX8;VCP;CASP1;OSGIN1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3172781971025949,-1.2184174580052036,0.13984168865435356,0.5861498567215517,1.0,37/87,33.04%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;UQCC2;NDUFA13;NDUFS1;NDUFB11;SDHAF2;SMIM20;NDUFB10;NDUFA1;UQCC3;NDUFB4;NDUFS7;FASTKD3;NDUFAF8;BCS1L;DMAC2;COA3;COA8;NDUFAF3;COX16;COA5;CHCHD4;SDHAF1;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A
prerank,calcium ion import into cytosol (GO:1902656),0.5068841379952567,1.2182601636656056,0.24,0.7326823911069051,1.0,3/15,7.35%,SLC8A3;SLC8A1;CACNA2D1
prerank,monocarboxylic acid transport (GO:0015718),-0.3503669062872595,-1.217675047971031,0.16381418092909536,0.5873029460272405,1.0,17/51,14.60%,ABCC4;ABCG2;ATP8B1;SLCO1C1;SLC16A9;SLCO2A1;SLCO2B1;SLC16A1;SLC5A6;CEACAM1;SLC6A8;SLCO3A1;SLC16A4;SLC26A6;STARD5;SLC16A2;NR1H4
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4951776737719741,-1.2176661510256066,0.22634508348794063,0.5863922687779742,1.0,7/12,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,zinc ion transport (GO:0006829),-0.4401669251353123,-1.2174187471934448,0.22016460905349794,0.586098031351201,1.0,6/21,13.96%,SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4290624805676494,-1.2173814832713876,0.23076923076923078,0.5852756100943589,1.0,5/21,10.32%,CAV1;CTNNB1;GSK3B;APC;PPP1CA
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5183076345788844,-1.2173748650894163,0.2438095238095238,0.5843897122135573,1.0,3/11,7.28%,PTPRC;CEACAM1;AHR
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4943772788177086,-1.2165254889145898,0.220675944333996,0.5857690797267348,1.0,8/12,38.91%,HSPA5;SEC62;SEC61G;SEC63;SEC61B;SEC61A2;SGTB;SEC61A1
prerank,ATP transport (GO:0015867),-0.5308784511522985,-1.2165017286422186,0.24349442379182157,0.5849076845160786,1.0,5/10,27.58%,SLC25A42;CD47;SLC17A9;SLC25A4;ABCC6
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5227432381312661,-1.2162177657448374,0.2509578544061303,0.5847961801600309,1.0,4/10,19.59%,ACTN4;TBX1;RARB;RXRB
prerank,chordate embryonic development (GO:0043009),0.38950941764805724,1.2156803828125367,0.18027210884353742,0.7389246328583925,1.0,7/55,5.24%,ALDH1A2;ARNT2;FGFR2;BMP7;RBP4;IGF2;SULF1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.503480336698019,-1.2146267148456638,0.21414913957934992,0.5881804923358217,1.0,6/12,29.10%,MAOA;DDC;AMD1;SRM;SMS;ODC1
prerank,regulation of MAP kinase activity (GO:0043405),0.34881680857003056,1.2145646796358969,0.1614420062695925,0.7409711748916414,1.0,9/92,5.51%,ROBO1;IL34;KSR1;KIT;BMP7;PDGFRB;PDGFD;LRRK2;FGF1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5353923110984578,1.2145267582947707,0.2515592515592516,0.7396815922098288,1.0,4/11,11.92%,LEPROT;SNX33;PICALM;ACTN2
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2927979520937095,-1.2141951313399266,0.09259259259259259,0.58838845866842,1.0,42/151,11.33%,MEF2C;NTRK3;EEF1A1;RAP1A;SEMA6A;PDE3A;KDR;ACVRL1;IQGAP1;KLF4;RAMP2;MT1G;PDE8A;DAB2IP;NOTCH1;RACK1;TBX1;BMPR2;PTPN12;LIMS1;LGMN;HSPB1;BCAR1;TGFBR2;TGFB1;CD44;EHD1;CTNNB1;CLEC3B;PDE2A;SMAD9;STMN2;FLT4;VEGFA;RUNX2;NR4A1;CPNE3;APPL1;ZFP36L1;BMP2;NOS1;DUSP3
prerank,"phototransduction, visible light (GO:0007603)",0.5065793238972018,1.2139166066039164,0.25,0.7401263445254178,1.0,3/14,6.43%,ABCA4;PDE6G;GNAQ
prerank,inner ear morphogenesis (GO:0042472),0.46906915245727776,1.2137636682026756,0.22648752399232247,0.7392241641971797,1.0,2/22,1.00%,ZIC1;FGFR2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.40011592825433,-1.2137630086200974,0.21893491124260356,0.5885923407392101,1.0,13/27,30.27%,CAV1;PLTP;NFKBIA;PTCH1;LPCAT3;NR1H2;ABCA3;ZDHHC8;NR1H3;TREM2;GPS2;ABCA7;PPARG
prerank,carbohydrate derivative catabolic process (GO:1901136),0.49248146290538813,1.21362704116994,0.229957805907173,0.7381890620904367,1.0,5/18,13.42%,ADAMTS9;FBXO44;FBXO6;DERA;NGLY1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.35200604797623847,-1.213555486151573,0.17233560090702948,0.5882334690865292,1.0,25/49,35.95%,F3;LBP;NOD1;STAT3;RAB1A;CD74;TIRAP;MYD88;HYAL2;AFAP1L2;RELA;HSPA1B;TLR7;TLR4;FADD;MAVS;NOD2;TLR1;NOS2;HSPA1A;SYK;PARK7;F2R;TLR8;RIPK1
prerank,ameboidal-type cell migration (GO:0001667),-0.35418780487065926,-1.213391880659031,0.163855421686747,0.5877092091247201,1.0,15/51,11.38%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;CCN3;ITGA4;SGPL1;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.36478579303812303,-1.2131990087741664,0.17620137299771166,0.5873133761416147,1.0,19/39,32.12%,UBB;UBC;RPS27A;DDB1;RBX1;RPA1;OGG1;UBA52;POLK;POLD3;NTHL1;POLD1;GTF2H2;XPA;ERCC5;RFC5;ERCC3;GTF2H5;RPA3
prerank,stabilization of membrane potential (GO:0030322),0.49656677556051193,1.21311762331371,0.23173277661795408,0.7383418753285365,1.0,1/16,0.38%,KCNK2
prerank,phospholipid transport (GO:0015914),-0.3543576127895456,-1.2127653831610676,0.19477434679334918,0.5875997905741281,1.0,19/52,19.44%,ATP10A;PITPNC1;ATP8B1;ATP8A1;PLTP;SCARB1;TNFAIP8L3;ATP8A2;MFSD2A;ATP11C;ATP11B;TMEM30A;ATP11A;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB;ABCG1
prerank,regulation of mitochondrial translation (GO:0070129),-0.4276545016298199,-1.2127134063644183,0.21638655462184875,0.586849961790843,1.0,9/21,26.01%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRUB2;MTG1;TRMT10C;MRPS27;COA3
prerank,positive regulation of immune response (GO:0050778),-0.333329000265487,-1.2124452735775706,0.15051020408163265,0.5866534342399004,1.0,26/64,35.90%,TGFB2;PTPRC;GRN;XBP1;GBP5;IFI35;CD74;RSAD2;CD81;IL15;POLR3D;FCGR2B;POLR3F;SPHK2;SKAP1;SLC15A4;ITGB2;KARS1;FADD;DHX9;NOD2;NLRP3;SASH3;CCL5;IL6ST;TLR8
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.38308263281590454,-1.212440022114598,0.1774193548387097,0.5857744753304154,1.0,8/33,10.61%,TGFB2;KLF4;ETS1;GATA2;TGFB1;GNL3;JUN;STAT3
prerank,axon guidance (GO:0007411),-0.2789526677036602,-1.2122284749934624,0.07636363636363637,0.5854628329461277,1.0,50/201,12.31%,SPTBN1;GAB1;SLIT2;BSG;EFNA5;SHANK3;KLF7;PTPRM;SEMA6A;NRP2;SEMA7A;SH3KBP1;SEMA6D;RPS6KA5;RAC1;PLXND1;SEMA3C;PTK2;UNC5C;LAMA1;TNR;UNC5D;FYN;NOTCH3;CHN1;NOTCH1;SEMA4D;SEMA3E;PLXNA4;LAMA5;TUBB3;ROBO4;LAMA3;DCC;PDLIM7;TMEFF1;VEGFA;NRXN1;GFRA2;SEMA4B;SEMA5B;SEMA6C;PIK3CD;LYPLA2;RELN;SEMA3G;EPHB1;EFNB3;GPC1;SPTBN4
prerank,protein phosphorylation (GO:0006468),0.2934673845215966,1.2117591745226892,0.06064356435643564,0.741142800240151,1.0,93/478,14.24%,PRKAG2;TGFBR3;ROCK2;OXSR1;EFEMP1;EPHA3;FGFR2;FGFR4;NRK;WNK4;KIT;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;CAMK1D;BMP2K;PDGFRB;RNASEL;DMPK;FER;MAP4K5;CDK7;EPHA8;EPHA4;FAM20A;SRPK2;ABI2;MAP2K6;PDGFRA;MAPK9;BAZ1B;DDR1;SIK1;RICTOR;PRKAA2;IGF1R;LRRK2;PRKCZ;PRKCB;MAML1;STK17B;TTK;PRKCA;GRK3;DDR2;PRKAA1;NEK4;NRBP1;RYK;BIRC5;GRK5;BIRC6;CCNT1;PKN2;MUSK;CDK1;CAMK2D;PIK3R4;NEK10;GRK4;CLSPN;VRK2;LATS1;FRK;ABL1;PRKDC;RPS6KB1;JAK2;COQ8B;ERBB2;IKBKE;BMPR1A;MAPKAPK2;CRY1;PRKAG1;HIPK3;CCNE1;PRKD2;STK24;TBK1;ROS1;MAPK1;DCLK1;MAP3K7;PRKACB;MORC3;STK26;NIM1K;CDKL5;NLK;CDK15
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.29674253828622776,-1.2116146820457177,0.09627329192546584,0.5862440423158387,1.0,36/151,14.86%,TEK;NTRK3;RAP1A;SEMA7A;BMPER;KDR;GAS6;ROR2;PDE8A;PTK2B;NOTCH1;ACKR3;ROR1;TNFAIP8L3;TGFB1;CD44;FERMT2;PTPRC;ARRB1;TNFRSF11A;PDGFC;APP;FLT4;ADRA1A;NPNT;HTR2A;MAP2K7;BMP2;GCNT2;NDRG4;GPER1;CD74;MAP3K12;MT3;DSTYK;CSF1R
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.363002781646433,-1.2115045533132438,0.168141592920354,0.5856426917601463,1.0,13/40,10.84%,LEF1;TIAM1;TGFB2;JAG1;NOTCH1;TGFBR2;TGFB1;FERMT2;CTNNB1;MTOR;WWTR1;BMP2;GCNT2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4438876854269954,1.2114544951372426,0.22053231939163498,0.7406336355696711,1.0,3/26,5.06%,LGR4;APPL2;CACTIN
prerank,sensory organ development (GO:0007423),0.38646492423081924,1.2112917351473595,0.19015280135823429,0.7397739564488277,1.0,9/51,8.52%,RBP4;MEIS1;SLC39A5;ASCL2;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,sterol biosynthetic process (GO:0016126),0.4374854532392439,1.210772776774769,0.2222222222222222,0.7400093902333374,1.0,6/33,11.27%,PRKAG2;INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,positive regulation of cell population proliferation (GO:0008284),0.29461183164383964,1.2101625880625269,0.08859223300970874,0.7405085273600761,1.0,48/423,8.55%,IL31RA;IGF1;TGFBR3;BMP6;TCF7L2;OSR1;IL34;RBPJ;FGFR2;FGFR4;PID1;EFNB2;IL18;MEIS1;BCL2;SCX;LTF;PDGFRB;FER;MEGF10;CTSH;IGF2;CCN4;SRPK2;ITGAX;IL13RA1;ASH2L;PDGFRA;SPHK1;GJA1;PDGFD;UFL1;IGF1R;FGF1;PTN;TET1;TTK;ADRA1D;CDC123;IL6;FOLR2;PTEN;DDR2;CSF1;BIRC5;GRK5;RPRD1B;COX17
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.5158370739006981,-1.2100877832284755,0.22736030828516376,0.5887575942568984,1.0,5/11,17.34%,RTN4;LPCAT3;BNIP1;ATL2;ARL6IP1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.282489107943161,1.2098750358445687,0.0384180790960452,0.7399826987061441,1.0,149/807,14.12%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;WNT4;RBPJ;FGFR2;FHL2;PPARA;NR2F2;BMP7;PRKN;WWOX;ATXN1;ZEB2;KCNIP3;DAB2;SNX6;DKK3;ARID5B;RUNX1T1;MXI1;FNIP1;CUX1;AASS;SATB1;PRDM5;ZEB1;ZIC2;DKK1;DMRT1;NR1I2;ASCL2;TBL1XR1;PLCB1;SP100;LOXL3;TSHZ3;JARID2;MIDEAS;IGF2;VSX2;JAZF1;VGLL4;ZFP90;PRICKLE1;HDAC8;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;RNF2;IKZF4;KDM2B;SOX1;DPF2;IRF8;GLI3;SFMBT1;MXD1;ZBTB32;NIBAN2;ZFP37;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;WWC2;SALL1;KANK2;XRCC5;SMAD3;EN1;NR6A1;MTF2;PHF21A;KDM2A;BIRC5;PER3;WWP2;LYAR;CBX8;DNAJA3;RSF1;CBX2;ZMYND15;TLE1;KAT8;MITF;KAT6B;MDM2;MBTD1;NSD1;MED1;FRK;SMURF2;IRX1;SCMH1;PARP9;L3MBTL3;ATOH8;HDAC1;FLCN;TFAP2A;CBX7;SMARCE1;ZNF8;TFAP2B;ZNF568;RXRA;ZBTB38;MYB;TAF3;CRY1;CNOT2;ZNF177;CDC73;E2F6;ORC2;SOX13;HSF1;CBFA2T2;PSPC1;AR;HIVEP1;PHF6;EZH1;CGGBP1;IFI27;NONO;NR1I3;FOXK2;SNAI1;SCML4;TFDP2;CLOCK;DICER1;ZNF148;KDM5C;MTDH;CDKN1C;CREBBP
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.44369776246028075,1.2094574947516075,0.22592592592592592,0.7397771152964203,1.0,11/26,21.21%,LTF;CACTIN;NLRC3;LYAR;ITCH;PCBP2;MAPKBP1;TRAFD1;TRAF3IP1;ILRUN;NFKBIL1
prerank,regulation of secretion (GO:0051046),-0.4828969672371055,-1.2093918714235303,0.24066390041493776,0.5896959360316806,1.0,5/13,17.76%,KCNQ1;OAS2;POFUT2;SGK1;ACSL3
prerank,limb morphogenesis (GO:0035108),0.47646417998518664,1.2093222151052037,0.24253731343283583,0.7388574101378929,1.0,3/20,5.68%,CYP26B1;FBXW4;GLI3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5042561249408823,1.2090329102692436,0.23984526112185686,0.7383275948894419,1.0,3/15,3.92%,PPARA;ADM;SLC45A3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4290859664035922,1.2087389413794656,0.21708185053380782,0.7378178565799854,1.0,11/32,14.10%,SDC2;CUX1;IL1RAPL1;NEDD4;OBSL1;PTPRD;CUL7;ADGRB3;RAP2A;LZTS1;CDKL5
prerank,axonal fasciculation (GO:0007413),0.5277997464647874,1.208638982194578,0.25792811839323465,0.7367619527900854,1.0,3/12,7.10%,EPHA3;EPHA4;ARHGAP35
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4888483216090417,1.2083736449335367,0.2671081677704194,0.7362043644812412,1.0,3/18,9.40%,ROCK2;EPHA4;PICALM
prerank,regulation of axon extension (GO:0030516),-0.3815584415494355,-1.2080992206196537,0.18487394957983194,0.592354768516073,1.0,14/37,22.40%,SEMA7A;SHTN1;NRCAM;GSK3B;DNM2;RTN4;SEMA3G;DBNL;CDKL3;MT3;DBN1;L1CAM;RTN4R;SEMA3A
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5238523685266523,-1.2080534471442848,0.23954372623574144,0.5915843518117755,1.0,3/10,1.54%,LRCH1;APOD;CD200
prerank,pharyngeal system development (GO:0060037),-0.462679449716729,-1.2080385394004183,0.218436873747495,0.5907237018530765,1.0,6/15,7.46%,BMP5;TGFB2;TBX1;BMPR2;HES1;PTCH1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.37648722613695024,1.2070786441323467,0.1939799331103679,0.7386511678624457,1.0,7/61,7.12%,PRKAG2;FGFR4;PPARA;OAZ3;PSME4;PSMA2;PSMA3
prerank,regulation of protein polymerization (GO:0032271),0.4164475651772383,1.206426487773386,0.21467889908256882,0.7392280813790079,1.0,7/35,13.05%,ARHGAP28;ARHGAP40;COTL1;LATS1;ABL1;GBA2;FCHSD2
prerank,ncRNA transcription (GO:0098781),-0.4894837322578444,-1.2061292951133613,0.2277992277992278,0.5949702872090347,1.0,7/13,25.43%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;SNAPC2
prerank,epithelium development (GO:0060429),0.33835120264454743,1.205803277145533,0.15442278860569716,0.7397342818149698,1.0,10/107,7.04%,ALDH1A2;ERRFI1;OSR1;WNT4;FGFR2;LOXL3;TPP1;PTER;SALL1;KANK2
prerank,regulation of TOR signaling (GO:0032006),0.3685112447902103,1.2055220008695013,0.18877551020408162,0.7392487365372603,1.0,15/67,11.36%,NPRL3;FNIP1;DEPTOR;ARAF;RICTOR;PRKAA2;NPRL2;SLC38A9;PDCD6;UBR2;PRKAA1;EPM2A;MLST8;FLCN;AKT1S1
prerank,protein homotetramerization (GO:0051289),0.39052128101088235,1.2049120619423328,0.1986062717770035,0.7397205113312343,1.0,10/49,14.00%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;PKD2;SHMT1;CRYZ
prerank,regulation of neuron projection development (GO:0010975),-0.2837959384748953,-1.2047654807797772,0.09538461538461539,0.5978317265450075,1.0,62/163,22.40%,NTRK3;SHANK3;RAP1A;SIPA1L1;ITGA6;FBXO7;CDH2;PRAG1;ROR2;PTK2B;DAB2IP;CHN1;ROR1;SERPINI1;MBOAT1;SCARF1;KANK1;RTN4RL1;ZDHHC15;CCDC88A;DCC;PPFIA2;GSK3B;EFHC2;STMN2;RTN4IP1;MFSD2A;ABI3;PAK1;MARK1;SRCIN1;PAK2;KIF1A;RELN;NDRG4;TENM3;MARK2;RET;MT3;SPOCK1;DISC1;CAMK2B;PRKD1;KNDC1;SCN1B;TOX;NTNG1;ITM2C;NPTN;CDK5;PSEN1;PLXNB3;FKBP4;RIT2;CFL1;AKT1;DBN1;CRMP1;RTN4R;FUT9;BRSK2;SEMA3A
prerank,regulation of interleukin-10 production (GO:0032653),-0.35863154420187016,-1.2045078711515125,0.19501133786848074,0.5976272959891618,1.0,15/44,24.17%,CD34;PLCG2;TRIB2;TNFRSF21;ISG15;STAT3;HSPD1;CD47;CD274;JAK3;TYROBP;DLL1;FCGR2B;AGER;VSIR
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.47989163530540074,-1.2043310902637614,0.2350674373795761,0.5972127148441875,1.0,3/13,2.30%,CAV1;PDE4D;CALM1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3308782017215503,-1.2037248348320455,0.13917525773195877,0.5981338782209298,1.0,17/67,15.79%,B2M;IKBKB;CALR;VAMP8;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CYBB;PSMB3
prerank,actin-myosin filament sliding (GO:0033275),0.4114771202389527,1.2031234740208088,0.21080139372822299,0.7423604503686851,1.0,4/38,2.80%,TPM1;DMD;TNNC1;TNNT2
prerank,muscle filament sliding (GO:0030049),0.4114771202389527,1.2031234740208088,0.21080139372822299,0.7423604503686851,1.0,4/38,2.80%,TPM1;DMD;TNNC1;TNNT2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.358099322734403,-1.2030491895152544,0.20140515222482436,0.5989939214355816,1.0,23/46,29.75%,FBXO7;TOMM20;HK1;TOMM22;HSPD1;TIMM9;ROMO1;TIMM10B;TIMM13;BCAP31;PINK1;AKT1;TIMM22;TOMM7;MFN2;TIMM50;FIS1;TIMM44;TSPO;AIP;CHCHD4;DNLZ;TOMM34
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.48348745257586556,-1.202929895552555,0.24675324675324675,0.5984592598152657,1.0,6/13,23.87%,RUNX1;CBFB;TGFBR2;NKAP;NCKAP1L;SOCS1
prerank,positive regulation of cellular component movement (GO:0051272),-0.41317757794015875,-1.2024255858903519,0.21555555555555556,0.5989255099127875,1.0,6/24,7.87%,SPOCK2;ACTN4;CAVIN1;ETS1;RPS19;VEGFA
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.40554904707574957,1.2023488746371134,0.21981981981981982,0.7432920011400544,1.0,5/41,9.05%,IGF1;SYT11;CACTIN;NLRC3;SIRPA
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5407327647944769,1.2021437218800715,0.28118393234672306,0.741218336492606,1.0,3/10,19.27%,TULP1;CACNA2D4;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5407327647944769,1.2021437218800715,0.28118393234672306,0.741218336492606,1.0,3/10,19.27%,TULP1;CACNA2D4;GNAT1
prerank,amyloid fibril formation (GO:1990000),-0.347936583791001,-1.2012955804828276,0.17391304347826086,0.6011203988546254,1.0,12/51,9.76%,B2M;ADAM10;ITM2B;CST3;GSN;UBB;TGFBI;UBC;RPS27A;APP;H3-3A;FURIN
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5159247664281683,1.2011304868787094,0.27682403433476394,0.7427862616696091,1.0,2/12,7.98%,RBP4;MUC13
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.31542408506782077,1.2009656543057259,0.13191489361702127,0.7419437238381256,1.0,30/190,9.50%,RORA;NPRL3;C1QTNF3;ITPR1;CGNL1;PPARA;BMP7;GPD1L;BCL2;FNIP1;DEPTOR;MGRN1;VGLL4;ARHGAP12;CACTIN;UACA;PRKAA2;NPRL2;WWC1;PDCD6;WWC2;UBR2;MMP9;NLRC3;PTEN;PRKAA1;TLE1;BCL2L2;EPM2A;MDM2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.48804377071330934,-1.2009563824345626,0.22957198443579765,0.6011502816501779,1.0,4/12,16.27%,STX3;STX1A;SNAP25;STX2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.36020864085198984,-1.200895075893253,0.19954648526077098,0.6004368135274216,1.0,18/44,25.68%,PTPRJ;STK38;DAB2IP;DNAJA1;UCHL1;PDCD4;PTPN1;SPRY4;IRAK3;NF1;DUSP1;SH2B3;PRKCD;BMP4;CD300A;HYAL2;SPRY2;SORL1
prerank,sodium ion homeostasis (GO:0055078),0.4643352210127751,1.2003094018842795,0.2514177693761815,0.7425515961449302,1.0,3/21,3.07%,ATP1A2;ATP1B3;SLC8A1
prerank,cellular metal ion homeostasis (GO:0006875),0.33980240258057215,1.1987293189994304,0.17377567140600317,0.746059781634681,1.0,10/102,3.96%,ATP1A2;SLC24A3;SLC8A3;STIM1;CSRP3;SLC41A1;ATP1B3;SLC8A1;DMPK;ANK2
prerank,regulation of protein phosphorylation (GO:0001932),-0.2683707223395453,-1.1976784323774259,0.07169811320754717,0.6083983484866774,1.0,73/256,17.61%,TEK;NTRK3;FN1;SLIT2;PECAM1;LIMCH1;EFNA5;OCLN;FNIP2;PRR5L;BMPER;TFRC;KRAS;KDR;NIBAN1;RAC1;HSP90AA1;GAS6;PPP2R5C;PTK2;TARDBP;PDE8A;FYN;ENG;DAB2IP;RACK1;PPIA;SEMA4D;TBX1;HSPB1;LIMK2;CORO1C;WARS1;TGFB1;PDCL3;CAMKK2;SOD1;CCDC88A;ARRB1;CHP1;APP;FLT4;CARD14;VEGFA;PAK1;FGF7;SLCO3A1;SESN2;WWTR1;RALB;ATF4;BMP2;MEN1;XDH;GPER1;SPTBN4;CD74;IBTK;CADM4;CCN1;MT3;TERF2IP;CSF1R;FAS;CCDC88C;DNAJC10;AKAP8;DVL2;PPP2R5A;ANKRD54;KNDC1;CD40;ZC3H12A
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5407387322978965,1.197532436824484,0.2691511387163561,0.7483275010282184,1.0,4/11,8.84%,CACNG1;NOS1AP;CACNA2D1;CAMK2D
prerank,sprouting angiogenesis (GO:0002040),-0.34921070242977476,-1.1967063612191615,0.16461916461916462,0.6102246268590157,1.0,15/51,9.71%,TEK;SLIT2;BMPER;RSPO3;KDR;THBS1;ACVRL1;RAMP2;ENG;PTK2B;SEMA3E;FLT4;VEGFA;NR4A1;ESM1
prerank,leukotriene biosynthetic process (GO:0019370),-0.4630729314451272,-1.1963634131621894,0.25,0.6102771623485886,1.0,8/14,37.39%,PLA2G4A;GGT1;LTA4H;GGTA1;PLA2G5;ALOX5AP;MGST2;GGT5
prerank,negative regulation of cell communication (GO:0010648),-0.4216935924726732,-1.1962770233795479,0.225,0.6096005330141538,1.0,6/21,17.24%,HHIP;UBASH3B;SOCS5;KIF26A;PTPN1;ACVR1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.525974084550848,-1.1961997739169519,0.23138832997987926,0.6089423257751764,1.0,2/10,2.22%,RUNX1;CBFB
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.40504984008594114,-1.1960602170481833,0.22682445759368836,0.6084534119725378,1.0,8/25,20.81%,ITGA6;THBS1;APP;KCTD20;MIF;PSEN1;ANG;NCKAP1L
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.49784711928113284,-1.195764403480986,0.2591170825335892,0.6083132689498644,1.0,5/12,17.61%,ESR1;TGFB1;STAT3;LIN28B;ZC3H12A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28997545263401964,1.1952107494165665,0.09885931558935361,0.7538257226024757,1.0,48/390,8.79%,IL31RA;IGF1;EPHA7;ROCK2;EPHA3;FGFR2;FGFR4;FGFBP1;COL4A6;EFNB2;BDKRB2;KIT;ANGPT1;POLR2D;SDC2;SORBS1;FLRT2;PLCB1;PDGFRB;KL;FER;IGF2;EPHA8;MMP2;EPHA4;GRB10;GFRAL;BAIAP2;PDGFRA;DDR1;WASL;SULF1;PDGFD;IGF1R;FGF1;HNRNPH1;CLNK;FRS2;MMP9;DDR2;RYK;MTSS1;CSF1;POLR2A;ANGPT2;GTF2F1;MUSK;VEGFB
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25833969772276727,-1.1949177899537065,0.06334841628959276,0.6096802769622371,1.0,69/351,12.41%,ZBTB7C;PTPRJ;APOD;FTH1;B2M;NOS3;IGFBP6;CD200;BMP5;PLPP1;ACVRL1;TGFB2;FAP;PTPN14;CBFA2T3;TES;KLF4;PPP2R5C;ETS1;ADARB1;WNT9A;ROR2;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;P3H2;BMPR2;HES1;SFRP4;RERG;CCN3;WARS1;PINX1;GATA2;SOX4;TGFB1;IGFBP5;CTNNB1;ST18;TOB1;TBX3;ATP8A2;DDAH1;APP;ADRA1A;PTHLH;PAK1;AQP11;MAGED1;PODN;ING4;CTNNBIP1;APC;CDK6;SOX7;CDKN1B;NCK2;BTG3;BMP2;HGS;IFI35;MEN1;NDRG4;PBRM1;GPER1;REST;CDH13
prerank,muscle organ development (GO:0007517),0.37942947879675853,1.1948130603940792,0.22920203735144312,0.7536610021915099,1.0,8/54,4.90%,IGF1;VAMP5;DMD;LAMA2;LARGE1;SOX6;SPEG;SGCE
prerank,cartilage development (GO:0051216),0.38597189212931343,1.1945538593732339,0.2097902097902098,0.7531390040348593,1.0,7/49,7.27%,SOX5;OSR1;SCX;SOX6;NFIB;SULF1;WNT5B
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4657480237423032,1.1944387963401837,0.25387596899224807,0.7521631821516959,1.0,5/20,6.48%,ROCK2;FHOD1;RAB13;LLGL2;DLG1
prerank,negative regulation of ATPase activity (GO:0032780),0.49349661915039744,1.193962766254986,0.27422680412371137,0.7522003697101256,1.0,4/16,11.46%,LTF;TNNT2;THADA;OXA1L
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5181599748775995,-1.1939191183181632,0.2602996254681648,0.6115676707645873,1.0,3/10,1.84%,SLIT2;CD200;BMP5
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5277016659061426,1.1938710418848781,0.279826464208243,0.751150522287626,1.0,2/11,1.78%,IGF2BP1;NOVA1
prerank,Ras protein signal transduction (GO:0007265),0.32545858456978544,1.1935049172066867,0.15666178623718888,0.7509113944664795,1.0,17/137,7.96%,IGF1;ROCK2;ARHGAP6;KSR1;ARHGAP29;RHOD;RRAS2;PDPN;PLD1;COL1A2;ABI2;WASF1;HACD3;ARHGEF11;NTN1;EPS8L1;MYO9B
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.39411911095685564,-1.1934155292174347,0.2190082644628099,0.6120140919875162,1.0,15/27,27.55%,FBXO7;MBOAT1;HOMER1;CCDC88A;GSK3B;EFHC2;MARK1;DISC1;NTNG1;PSEN1;AKT1;BRSK2;FCGR2B;TREM2;FRMD7
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4000090981938205,-1.193156260515187,0.22494432071269488,0.6118321125650165,1.0,11/27,19.88%,UBB;UBC;RPS27A;MAP3K1;HSPD1;IRAK3;TAB3;UBA52;IRAK1;TIRAP;MYD88
prerank,oligosaccharide metabolic process (GO:0009311),-0.35105146103341683,-1.1930534820509617,0.18501170960187355,0.6112651923840141,1.0,9/46,9.51%,ST3GAL4;ST6GALNAC3;ST3GAL6;ST8SIA4;FUT8;ST6GALNAC5;ST8SIA1;ST8SIA6;MAN2B1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4402979959625167,-1.1928419760910027,0.22983870967741934,0.6109532788799562,1.0,8/18,33.25%,HHEX;ENY2;NUP133;DDX25;THOC2;ZC3H11A;NUP93;IWS1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.2848838870248904,-1.192661011696104,0.09411764705882353,0.6105563187371833,1.0,32/151,15.14%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;CEPT1;SPTLC2;PLPP1;DEGS2;GCH1;B4GALT5;KDSR;PRKD3;PPM1L;GPHN;SPNS2;SGPL1;MFSD2A;ELOVL6;FURIN;LPCAT3;GPAT4;ELOVL1;TYW1;LPCAT1;LPIN3;CSNK2B;CERS4;PLA2G4A
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2943258134798587,-1.1924483427928037,0.11581920903954802,0.6102868213436471,1.0,38/119,19.49%,PIP5K1B;EFR3B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;INPP4A;SOCS2;SYNJ1;SOCS5;PIK3C2B;ARF1;CDS1;CDIPT;PGAP4;TTC7A;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;SACM1L;PIP5K1C;SBF1;ITPKB;PI4KB;CISH;PIGZ;MTMR12;PIK3R3;INPP5F;PIP4K2A
prerank,autonomic nervous system development (GO:0048483),-0.4501976369512293,-1.1920394296787675,0.25,0.6105840689765338,1.0,7/17,22.64%,FN1;SOX4;KIF26A;NF1;SOX10;SEMA3A;SOX11
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.38636150464890734,-1.1918240227042576,0.23354564755838642,0.6102862456658186,1.0,17/28,25.95%,MAP3K5;DAB2IP;TMEM117;BAG6;ATP2A3;ATF4;SELENOK;ERO1A;BBC3;DNAJC10;TNFRSF10B;BRSK2;CEBPB;TRIB3;BAX;PPP1R15A;ERN1
prerank,apical junction assembly (GO:0043297),-0.33866882632525686,-1.1918148695313424,0.19534883720930232,0.6094265626217332,1.0,12/53,10.02%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;WDR1;MPP7;RHOA;PAK2;APC
prerank,regulation of coagulation (GO:0050818),-0.5117603967728299,-1.191655899913972,0.26968503937007876,0.6090250019850509,1.0,3/11,17.68%,CAV1;HS3ST5;PROCR
prerank,positive regulation of biosynthetic process (GO:0009891),0.407690325479148,1.1915624803277056,0.22580645161290322,0.7552120226766814,1.0,5/40,2.78%,WNT4;PPARA;SORBS1;SCX;ZBTB20
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3504761819391266,1.1913261433185534,0.1858974358974359,0.7546015077873139,1.0,12/87,8.49%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;NDNF;KL;FGF1;HNRNPH1;FRS2;POLR2A;GTF2F1
prerank,regulation of phosphatase activity (GO:0010921),-0.40646211405084276,-1.1909559360350992,0.20930232558139536,0.6101326534271828,1.0,8/24,13.76%,TIPRL;PPP1R2;HSP90B1;CHP1;BMP2;MTMR9;ZCCHC9;PPP6R1
prerank,potassium ion export across plasma membrane (GO:0097623),0.5145761485334754,1.1902903593710117,0.2604166666666667,0.7563905582559939,1.0,3/13,4.07%,KCNA5;KCNT2;KCND3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5227208825436942,-1.190201217220293,0.2589792060491493,0.6113591343528713,1.0,3/10,19.24%,SEC14L1;RNF125;GPATCH3
prerank,regulation of gene expression (GO:0010468),0.27690776626519603,1.1900712035928636,0.03969128996692393,0.7557126795994179,1.0,134/903,12.54%,IGF1;PRDM6;RORA;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;EFEMP1;SLC22A2;WNT4;AFF2;ARNT2;RBPJ;DENND4A;ZNF462;FGFR4;AFDN;WNT6;PID1;NOTCH2;BMP7;ANGPT1;IGF2BP1;PRKN;ATXN1;TULP3;NOVA1;ESRRG;RBMS3;PRDM5;MYBL1;DKK1;SCX;NR1I2;LTF;SOX6;PPARGC1B;SLC8A1;NOS1AP;NFYB;ZC3H7B;TRIM5;CTSH;IGF2;DTNBP1;PTBP2;SSBP2;CCN4;NCOA2;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;SOX1;GJA1;CACTIN;PRKAA2;PERM1;TNRC6A;FGF1;HNRNPH1;SON;METTL4;SLC2A10;EPHX2;TCF7L1;ZUP1;ZFP37;SUFU;THAP1;WWC1;IL6;WWC2;GPBP1;UBE2L3;SMAD3;ABCC2;GPBP1L1;PRKAA1;MTF2;RBL2;ZKSCAN5;ATG14;CSF1;POLR2A;WWP2;NFIA;TLE1;ATRAID;ZNF628;MUSK;YTHDF2;BRCA2;MITF;KDM6B;KAT6B;SIRPA;FUBP1;PICALM;NFYC;PARP10;NSD1;MED1;NUP107;AGO2;ABL1;PARP9;FGF9;ATOH8;ASCC2;HDAC1;ZBTB11;FLCN;TFAP2A;APLN;PCBP2;ZBTB38;MYB;BMPR1A;RNF14;SOX13;TRIM26;TRIM43;PRKAG1;SLC38A2;RNF20;PSPC1;AR;SNX12;ADNP2
prerank,cell-cell junction organization (GO:0045216),-0.31415870436505244,-1.1897294895759698,0.16756756756756758,0.6118462625778986,1.0,19/79,10.39%,CLDN5;CADM1;OCLN;TJP2;LIMS2;TGFB2;CDH11;CTNND2;PKP4;CDH1;CDH2;GJC1;CXADR;LIMS1;TGFB1;CSK;TJP1;PVR;CADM3
prerank,organelle fission (GO:0048285),-0.40889191734055375,-1.189434318823969,0.2145922746781116,0.6117621009251806,1.0,8/24,18.65%,DNM3;CORO1C;DNM2;MIEF1;DNM1;PEX11B;SEC16B;MTFR1L
prerank,glutamate receptor signaling pathway (GO:0007215),-0.37010142530126866,-1.1893055410231015,0.21100917431192662,0.6112593636612522,1.0,14/37,21.18%,GRM3;GRM7;PTK2B;KCNB1;HOMER1;GRIK4;GRIN3A;APP;GRIN1;GRM8;GRIA2;GRIK2;FMR1;GRID2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3710889986053328,-1.1887703716678972,0.20134228187919462,0.6118882094322723,1.0,17/33,27.05%,SESN3;FYN;SH3BP4;CAPN2;MTOR;SESN2;CPEB1;XBP1;LAMTOR1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;CASTOR1;GLRA1;RPTOR
prerank,skeletal muscle tissue development (GO:0007519),-0.38064328304497663,-1.1883131521830415,0.2288888888888889,0.6123654273941381,1.0,6/32,7.79%,MEF2C;CAV1;MYL6;CAV2;SIX1;LEMD2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.3661058044680161,-1.1881718267977504,0.19772727272727272,0.6119021800508705,1.0,10/39,11.93%,TEK;KDR;THBS1;GAS6;RAMP2;GATA2;ITGA4;PDCD4;SCG2;GPER1
prerank,protein kinase B signaling (GO:0043491),0.44439257199890897,1.187947376651487,0.26542056074766357,0.7608188951722938,1.0,1/23,0.03%,IGF1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4805448859748219,-1.1876880184793706,0.2509157509157509,0.6124193459297873,1.0,7/13,22.89%,AQP11;LPCAT3;CLU;NR1H2;WFS1;NR1H3;FCGR2B
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.30410466460349167,-1.1874958592499472,0.1253731343283582,0.6120557433689792,1.0,20/100,8.27%,GAB1;TEK;NTRK3;FN1;PIP5K1B;KDR;TGFB2;CBL;PPP2R5C;PTK2;ROR2;DAB2IP;PIK3IP1;SEMA4D;ROR1;PPP1R16B;CEACAM1;PDGFC;MYOC;WNT16
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.31962946091739547,-1.1869806945508963,0.1631578947368421,0.6126425462025247,1.0,19/75,14.62%,TEK;CLDN5;PTPRM;SEMA6A;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;STAB1;CTNNB1;SARS1;SERPINF1;HGS;HHEX;SYNJ2BP;COL4A2;ISM1;SPARC
prerank,negative regulation of cell activation (GO:0050866),-0.46922464466773983,-1.1864588395350886,0.2381852551984877,0.6132007810356758,1.0,4/14,12.47%,NOS3;CD200;GPER1;THBD
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5252147467209934,1.1855081619305174,0.2766393442622951,0.7666653753729379,1.0,3/11,7.27%,DAB2;DKK1;WNT5B
prerank,sphingosine metabolic process (GO:0006670),-0.4421115708705284,-1.1851356969907958,0.2396039603960396,0.6159273915907005,1.0,4/17,1.89%,ACER3;ACER2;SPTLC2;PLPP1
prerank,protein deacylation (GO:0035601),-0.4067129258507048,-1.1849322864333158,0.22153209109730848,0.615625595253303,1.0,11/23,30.77%,HDAC5;ABHD17B;LYPLA2;ABHD17A;SIRT7;HDAC7;HDAC6;LYPLA1;SIRT6;HDAC3;SIN3A
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.47750825282006637,-1.1846456561725993,0.23122529644268774,0.6155468647786521,1.0,8/13,31.20%,SOD1;ZC3H8;CAMK4;TOX;BMP4;FOXJ1;SHH;VNN1
prerank,regulation of gastrulation (GO:0010470),0.4985807905499796,1.184463918847701,0.2505399568034557,0.7684585594972969,1.0,3/14,6.08%,OSR1;SCX;PHLDB2
prerank,negative regulation of cell junction assembly (GO:1901889),0.4363003952303501,1.1844232973177569,0.24225865209471767,0.7672240519344422,1.0,5/25,7.48%,ROCK2;ARHGAP6;ACE;PHLDB2;PTEN
prerank,signal transduction by p53 class mediator (GO:0072331),-0.39050354066304305,-1.1843567457194741,0.22795698924731184,0.6154840937789187,1.0,8/30,12.41%,ACER2;PPP1R13B;DDX5;SESN2;BCL3;HINT1;PDK2;MYBBP1A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5027043614836549,1.184214779257558,0.2716049382716049,0.7665006661265982,1.0,3/16,11.64%,LEPROT;VTA1;CHMP6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.32318392334523216,1.183886870531372,0.17378497790868924,0.7661507259106292,1.0,20/150,6.43%,PRKAG2;ERRFI1;PTPN13;PID1;PRKN;DMD;PLPP3;PDPK1;GPD1L;SMAD6;PARD3;DEPTOR;DKK1;DTNBP1;PPM1E;CACTIN;LRRK2;PRKCZ;FBLN1;GNAQ
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.46944643180779144,1.1830727859359549,0.2888015717092338,0.7672925376125892,1.0,4/18,8.84%,ATP1A2;SLC43A1;MMP9;CAMK2D
prerank,axonemal dynein complex assembly (GO:0070286),0.4357179466896113,1.182569949477215,0.2365988909426987,0.7674667920711294,1.0,8/27,15.00%,ODAD3;DNAI4;SPAG1;TTC12;CCDC65;ODAD1;DNAAF3;ODAD2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4833265122744841,1.1823560312584245,0.27091633466135456,0.7668158939405942,1.0,2/16,3.14%,NPR3;NOS1AP
prerank,collagen fibril organization (GO:0030199),0.3454579454173887,1.1822815953951031,0.20418006430868169,0.7657032436186588,1.0,11/88,4.43%,COL22A1;COL26A1;COL4A5;COL4A6;PXDN;LOXL1;COL9A2;SCX;LOXL3;COL1A2;COL13A1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.5047720819592485,-1.1822692361647686,0.2774566473988439,0.6201188815298785,1.0,6/10,28.82%,RPUSD4;TSR3;RPUSD1;NHP2;RPUSD2;NOP10
prerank,lung epithelium development (GO:0060428),0.5312155156328583,1.181823576385203,0.26464646464646463,0.7657608312109762,1.0,1/10,0.35%,ERRFI1
prerank,relaxation of muscle (GO:0090075),0.5133470342457992,1.1816689548808963,0.296,0.7648934267772489,1.0,3/13,3.07%,ATP1A2;GSTM2;SLC8A1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3143637790368071,-1.1807618961348156,0.15263157894736842,0.6234773241151285,1.0,18/74,12.39%,LEF1;TIAM1;BMP5;TGFB2;PHLDB1;DAB2IP;IL17RD;TGFBR2;TGFB1;FERMT2;CTNNB1;SPRED2;MTOR;WWTR1;BMP2;GCNT2;MCRIP1;SDHAF2
prerank,motor neuron axon guidance (GO:0008045),-0.46078309673670287,-1.180325493323793,0.2583170254403131,0.6237594371930343,1.0,4/15,7.56%,SLIT2;RAC1;CHN1;TMEFF1
prerank,CENP-A containing chromatin organization (GO:0061641),0.4276583494319757,1.1801635220286786,0.24953445065176907,0.7667025016362662,1.0,9/29,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.4276583494319757,1.1801635220286786,0.24953445065176907,0.7667025016362662,1.0,9/29,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.38187271035813647,1.1788996620168317,0.24781849912739964,0.7692431485357857,1.0,8/47,9.87%,ROCK2;WNT4;C1QTNF3;SIK1;ACADL;SIRPA;APOC1;SLC27A1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.2996693899638673,-1.178787686949427,0.13243243243243244,0.62706737963376,1.0,32/107,16.39%,MEF2C;SLC12A2;GRM3;ITGB1;GRM7;CDH2;NGF;MCTP1;HOMER1;GRIK4;CLSTN2;ABR;DLGAP1;LRP8;DGKI;BCR;BTBD9;APP;SLC4A8;KCNMB4;PXK;RELN;KCTD13;DGKZ;CLSTN3;CPLX2;GRM8;NRG3;CNTNAP4;TMEM108;CX3CR1;CACNA1B
prerank,superoxide anion generation (GO:0042554),0.5080058711488155,1.178538051560458,0.28542094455852157,0.7689738323234144,1.0,4/13,13.65%,DUOX2;TAFA4;NCF2;DUOX1
prerank,carbohydrate derivative transport (GO:1901264),-0.4345195628397465,-1.1784476750093562,0.22772277227722773,0.627120207202665,1.0,5/18,8.15%,PLTP;SCARB1;LBP;SLC10A7;MFSD2A
prerank,hydrogen peroxide metabolic process (GO:0042743),0.46259016834672395,1.1783092521097378,0.25763358778625955,0.7683748912669502,1.0,5/19,14.16%,PXDN;DUOX2;DUOX1;ACOX1;MAOB
prerank,telomere capping (GO:0016233),0.48987514774423496,1.1781167108978912,0.2883435582822086,0.7676304720192104,1.0,9/16,21.86%,ACD;PRKDC;DCLRE1A;DCLRE1B;MRE11;STN1;RAD50;NBN;TERF2
prerank,positive regulation of neuron death (GO:1901216),0.38535750314506884,1.1779730757422466,0.23297491039426524,0.7667519370556928,1.0,10/46,11.33%,EPHA7;EFNB2;DKK1;PCSK9;SRPK2;NUPR1;PICALM;TFAP2A;TFAP2B;EIF2S1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3952229766364484,1.1777799025853362,0.2376599634369287,0.7660521599188836,1.0,5/41,3.29%,AFDN;BMP7;PLPP3;CXCL13;MEGF10
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4769769620049318,-1.1776836331980522,0.2709551656920078,0.6282840215052223,1.0,3/12,18.75%,ANO1;CFTR;TRPM4
prerank,muscle cell differentiation (GO:0042692),0.42247935081254595,1.1776547698532416,0.24150268336314848,0.7651277897137619,1.0,5/32,3.73%,RORA;DMD;SPEG;MEGF10;NEBL
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3735946007945824,-1.1771498629729744,0.2210065645514223,0.6288212273303927,1.0,19/33,35.68%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1;BTC;EGF;AGT;NCF1;ADAM17;CNOT9
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.38620240696467745,-1.176695463224013,0.23983739837398374,0.6291795259873048,1.0,13/29,24.76%,SLC4A10;MCTP1;APP;ZDHHC2;CAMK2B;NCDN;GRIK2;DBN1;PPFIA3;NSMF;SHISA6;RAB3A;SYP
prerank,phagolysosome assembly (GO:0001845),-0.4824489586660372,-1.1766864940083253,0.2830188679245283,0.6283293152779861,1.0,8/12,31.45%,SYT7;RAB39A;RAB7A;RAB7B;RAB14;RAB20;PLA2G5;CORO1A
prerank,regulation of epidermal cell differentiation (GO:0045604),0.44686113365660585,1.1766638089629573,0.2656826568265683,0.7667395123054721,1.0,2/21,0.39%,ERRFI1;ROCK2
prerank,cellular response to drug (GO:0035690),-0.4051230172824406,-1.1761999230903493,0.26143790849673204,0.6288254220380823,1.0,7/25,12.32%,MEF2C;ACER2;TFRC;GAS6;KCNQ1;AIM2;REST
prerank,response to retinoic acid (GO:0032526),0.3697878381078551,1.175965584111456,0.22909698996655517,0.7675164905841357,1.0,5/59,3.31%,PTK7;EPHA3;WNT6;RBP4;CTSH
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4752642006832264,-1.1754915560738197,0.25443786982248523,0.6299633028419015,1.0,9/13,32.30%,TMEM30A;CD81;SEC16B;BRSK2;INSIG1;SEC16A;SORL1;TM9SF4;TMEM30B
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.44903091943511964,1.175434515529901,0.258,0.7678076438517872,1.0,2/21,2.68%,OSBPL8;PLA2G10
prerank,regulation of cellular component organization (GO:0051128),-0.28742287451828913,-1.1750382269262718,0.1355421686746988,0.6303876772300461,1.0,32/135,15.25%,HIP1;LTBP4;RAP1A;HSPA8;TFRC;HSP90AA1;STON2;DAB2IP;SEMA4D;NET1;PACSIN2;CDK11B;STK38L;SOCS2;BCAR1;FAM107A;HJURP;GFAP;CEACAM1;HIP1R;HNRNPU;TJP1;MTOR;PTPN1;LAMTOR1;ERMN;EGLN2;CDH13;IRAK3;SPOCK1;NRG3;LAMTOR2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.348813422033701,1.1749589582302398,0.22998296422487224,0.7679866129703639,1.0,10/86,6.30%,BMP6;RBPJ;BMP7;ZEB2;DAB2;RBPMS;FOXD1;SULF1;SLC2A10;TTK
prerank,muscle contraction (GO:0006936),0.32689421841436417,1.1749149034689663,0.18376068376068377,0.7668416677119998,1.0,13/126,4.61%,ROCK2;BDKRB2;TPM1;DMD;SNTA1;SORBS1;TNNC1;MYLK;TNNT2;SLC8A1;CALD1;TLN1;CHRNE
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.31779118031773057,1.1747949719863795,0.1712121212121212,0.7658952548936472,1.0,21/140,11.34%,ADCY5;JPH1;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;CXCR6;PDGFRA;LPAR2;ADRA1D;CACNA2D1;F2RL2;PTGIR;GLP1R;ABL1;PTGER1;F2RL3;DLG4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.40416337962311893,1.1743442683204692,0.2549019607843137,0.7659643556843878,1.0,10/37,11.76%,IGF1;TPM1;MMP2;GJA1;TAFA5;MMP9;PTEN;FGF9;APLN;BMPR1A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3269982219968517,-1.1740762148611128,0.19759036144578312,0.632127620269705,1.0,17/59,13.34%,HMCN1;PECAM1;BSG;PTPRM;CADM1;CDH1;ITGB1;CDH2;PKD1;KIRREL3;ROBO4;CEACAM1;PVR;CADM3;TENM3;CDH13;CNTN6
prerank,protein O-linked glycosylation (GO:0006493),0.33805191544883373,1.173791768584868,0.21732522796352582,0.7663198632889189,1.0,11/96,6.04%,TMTC4;ST3GAL3;GALNT15;GALNT14;GALNT18;LARGE1;GXYLT2;TMTC1;B3GNT5;CRPPA;TET1
prerank,regulation of cellular response to heat (GO:1900034),-0.31626158658403086,-1.1734698552869052,0.1748768472906404,0.6329151473793363,1.0,22/77,21.48%,HSPA8;CD34;HSP90AA1;HSP90AB1;GSK3B;CHORDC1;BAG1;CRYAB;MTOR;RPA1;HSPB8;DNAJC7;NUP37;CAMK2B;DNAJB1;NUP54;NUP85;ATR;FKBP4;NUP133;POM121;MAPK3
prerank,cellular response to purine-containing compound (GO:0071415),0.5416470419635722,1.1734035460649093,0.3048245614035088,0.7662091813745062,1.0,2/10,3.07%,GSTM2;SLC8A1
prerank,visual system development (GO:0150063),0.3999511101266959,1.1727989984106373,0.25663716814159293,0.7667952309397271,1.0,7/37,8.52%,RBP4;MEIS1;SLC39A5;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.28550987342595874,-1.1725559526503295,0.13505747126436782,0.6344973071241315,1.0,45/133,20.30%,CAV1;TPT1;TRPC3;SLC35G1;CAV2;ATP1B1;SLC10A7;TRPC6;CALR;ATP2C1;ATP2A2;ATP2A3;TRPC4;RYR2;HTR2A;SLC24A2;ATP13A4;CCDC47;EDN1;SMDT1;SLC30A1;KCTD17;STIM2;RMDN3;STOML2;ATP2B1;GPER1;SELENOK;HERPUD1;MCUB;ATP13A5;SLC24A5;CXCL12;TRPC1;WFS1;ATP13A2;PLN;CD40;CCL13;NPTN;LETM1;TMEM165;PSEN1;ATP2B2;ATP2B4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4264391451581153,-1.1724645498771953,0.2620967741935484,0.6338757540376925,1.0,8/18,19.58%,ELOVL7;ELOVL5;ACSL4;ELOVL6;ELOVL1;ACSL3;TECR;ACSL5
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.27528903525531345,-1.1721004463554205,0.14329268292682926,0.6339690645823443,1.0,68/173,31.37%,SPTBN1;NSF;GAS6;CD55;MIA2;CAPZA2;ACTR10;DYNLL2;TMED5;VTI1B;COPG1;GOPC;CUL3;TMED2;BET1L;MCFD2;LMAN2;DCTN3;RAB1A;TRAPPC6B;WHAMM;SPTBN4;ARFGAP2;LMAN2L;SEC23A;TMED10;TMED3;CNIH1;DCTN4;CTSZ;ATL2;BCAP31;TRIP11;GBF1;TEX261;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;ANK3;CTSC;DCTN1;VAPA;TRAPPC4;TMEM115;TMED7;CAPZA1;RAB2A;SEC16A;COL7A1;USE1;KDELR3;SEC31A;COPA;TRAPPC1;ATL3;STX5;TRAPPC5;MPPE1;RANGRF;GRIA1;GORASP1;TMED1;SPTBN5;BCAP29;PEF1;DYNC1I1
prerank,calcium ion transport (GO:0006816),0.32798617103400046,1.171980149077206,0.2102803738317757,0.7679037297116812,1.0,10/113,4.90%,TRPM3;SLC24A3;ITPR1;SLC8A3;STIM1;NALCN;SLC8A1;ANK2;CACNA1D;CACNG7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.40939896161365275,-1.1718418618075264,0.2450199203187251,0.6337566820372905,1.0,8/23,15.52%,MYO10;MAP6;CCDC88A;KIF1A;TUBA1B;TUBA1A;HOOK1;CCDC88C
prerank,negative regulation of heart contraction (GO:0045822),0.5207564999584452,1.171818538282368,0.28775510204081634,0.7671236093945695,1.0,1/11,0.21%,ATP1A2
prerank,mammary gland epithelium development (GO:0061180),0.4942780469173728,1.1717572679317063,0.28994082840236685,0.7660469702753891,1.0,4/14,11.11%,WNT4;LATS1;EPHA2;JAK2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.32633176640383965,-1.1716026242644717,0.18575063613231552,0.631820688583688,1.0,29/61,30.99%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,vesicle coating (GO:0006901),-0.32633176640383965,-1.1716026242644717,0.18575063613231552,0.631820688583688,1.0,29/61,30.99%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,COPII vesicle coating (GO:0048208),-0.32633176640383965,-1.1716026242644717,0.18575063613231552,0.631820688583688,1.0,29/61,30.99%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,protein localization to cell surface (GO:0034394),0.426712524383851,1.1709159697143585,0.2636363636363636,0.7672724485099125,1.0,5/26,7.91%,ANGPT1;FBLN5;PIGU;ANK2;GGA2
prerank,cellular response to cytokine stimulus (GO:0071345),0.28394576913425656,1.1708237275237592,0.11055276381909548,0.7663112534403754,1.0,35/416,5.50%,IL31RA;RORA;ADAMTS12;LEPR;OXSR1;PTPN13;IL34;PID1;IL18;KIT;DAPK1;BCL2;ZEB1;DUOX2;PTPN4;DPYSL3;IL1RAPL1;FER;CNTFR;ANXA1;RIPOR2;MMP2;STAT5B;IRAK2;ITGAX;CRHBP;GRB10;NFAT5;IL13RA1;COL1A2;ZFAND6;CACTIN;NPR2;IRF8;PTPN9
prerank,chromatin assembly or disassembly (GO:0006333),0.5157077805454121,1.170798038442076,0.29850746268656714,0.7651130487957588,1.0,2/11,4.38%,HDAC8;RBBP4
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.29305225421934233,-1.17075456510916,0.1585014409221902,0.6333708958982804,1.0,36/109,23.58%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;PSMF1;MAPK8;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;CUL1;TAB3;PSME1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;PSMB4;RELA;MAPK10
prerank,cellular response to alkaloid (GO:0071312),0.47177587686999567,1.17037204948476,0.27756653992395436,0.7651264028260596,1.0,4/17,7.24%,GSTM2;SLC8A1;CRHBP;BLM
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.36414136975770983,1.1702746312912147,0.2341880341880342,0.764151384572021,1.0,13/59,14.15%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CDK1;CAMK2D;PRKDC;HIPK3;PRKD2;TBK1;MAPK1;NLK
prerank,clathrin-dependent endocytosis (GO:0072583),-0.39204947855438577,-1.1701969723292491,0.23319327731092437,0.6340129111899784,1.0,12/26,22.72%,SGIP1;FNBP1L;AP2A2;ITSN2;AP2M1;CANX;PIP5K1C;SNAP91;INPP5F;AP2B1;DLL1;AP2A1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3053422927699617,-1.1701135096424227,0.17732558139534885,0.6333866139722478,1.0,26/92,10.16%,TEK;FOXP1;NRP2;KDR;THBS1;RAC1;TGFB2;SCARB1;ETS1;DOCK1;PLCG2;PTK2B;BMPR2;IQSEC1;BCAR1;RHOB;CALR;EMC10;FLT4;VEGFA;MTOR;FGF7;GRN;EDN1;RTN4;PIK3CD
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4867271818921193,-1.1698818025154214,0.2870544090056285,0.6331618441648584,1.0,7/11,18.96%,SLIT2;RIN3;CCN3;DUSP1;MIF;GREM1;PADI2
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3023810904983705,-1.1695184111589085,0.16279069767441862,0.6333233015343204,1.0,23/87,10.85%,EFNA5;ESAM;RAC1;IQGAP1;CORO2B;F11R;PTK2B;ARHGDIB;SEMA3E;RHOB;ARHGDIA;FAM107A;CCDC88A;GPM6B;HIP1R;MTOR;ABI3;PAK1;ARHGEF19;EPS8;RHOA;ARHGEF5;CRK
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3492510091435589,-1.169375861757717,0.21608040201005024,0.6328672620234708,1.0,9/45,5.38%,GAB1;RPS6KA5;IQGAP1;CBL;PTK2;PTK2B;REPS2;BCAR1;TGFB1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4112805634040121,-1.169109582340817,0.2535211267605634,0.6327061861225357,1.0,7/21,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;VCAN;CHSY3
prerank,positive regulation of cell development (GO:0010720),-0.37633915944061064,-1.1689218426271997,0.26229508196721313,0.6323807368789265,1.0,11/31,22.91%,PDE3A;TGM2;SERPINF1;GPER1;CX3CR1;SPEN;LIG4;TYROBP;BMP4;SOX11;FAIM
prerank,inositol lipid-mediated signaling (GO:0048017),0.3792097039414518,1.1688886502370184,0.24253075571177504,0.7670516448510333,1.0,14/50,16.08%,IGF1;ADAP2;PLCB1;PDGFRB;PDGFRA;IGF1R;GPR143;PIK3R1;RPS6KB1;PLCD1;GAB2;PLCL1;PLCE1;EXOC1
prerank,chromatin remodeling (GO:0006338),0.33762805125154993,1.1688800630258869,0.20458265139116202,0.7658380730262149,1.0,37/100,20.72%,SATB1;JARID2;RBBP4;BAZ1B;HNRNPC;ARID1B;CECR2;BAZ1A;CHD4;RSF1;KDM5B;KDM6B;SMARCA5;HDAC1;NPM2;TADA2A;SMARCE1;MYB;EZH1;INO80;SMARCB1;SRCAP;KDM5C;SMARCA2;SMARCC1;INO80C;KDM6A;SMARCD3;BAZ2B;MPND;SMARCA1;KDM4D;HDAC4;BRDT;KAT2B;RUVBL2;CBX3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4359106662255705,1.1685943932716005,0.26746506986027946,0.7654438969529397,1.0,6/23,7.38%,TULP3;MGRN1;GPC3;GLI3;SUFU;HERC4
prerank,cAMP-mediated signaling (GO:0019933),0.4355781544117438,1.168593677054691,0.26806083650190116,0.7642033071685751,1.0,4/24,3.00%,ADCY1;KSR1;PDE7B;PDE7A
prerank,regulation of vasculogenesis (GO:2001212),-0.4572141665390875,-1.1685091121390463,0.2448210922787194,0.632714513455101,1.0,7/14,11.52%,RAP1A;CD34;KDR;CEACAM1;EMP2;HEY2;XDH
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4710976339654471,-1.1684070901672896,0.2730844793713163,0.6321350910963289,1.0,5/13,13.69%,CD9;ITGB1;SREBF2;CDH13;CD81
prerank,mRNA transport (GO:0051028),-0.30118632330687867,-1.1683968193683092,0.18421052631578946,0.6313087572843545,1.0,46/101,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;ZFP36L1;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;FMR1;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;KIF5C;SRSF7;ALYREF;ZFP36;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44569901819822166,-1.1681016931083168,0.24497991967871485,0.6313072655734076,1.0,9/16,19.74%,THBS1;PPP1R16B;GATA2;JCAD;PDCD10;VEGFA;APLNR;AGTR1;DLL4
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.41727541726736284,-1.1680121741396896,0.2618510158013544,0.6307440858597317,1.0,8/19,17.57%,CSGALNACT1;NDST3;HS6ST2;EXT1;EXTL3;XYLT1;HS6ST3;HS3ST5
prerank,long-term synaptic potentiation (GO:0060291),0.45461065350068575,1.1679711910312935,0.28793774319066145,0.764815234433869,1.0,4/21,6.89%,SLC8A3;TSHZ3;PRKCZ;ARC
prerank,neural tube closure (GO:0001843),0.40783929042803124,1.1677378402410954,0.26126126126126126,0.7642617387361548,1.0,9/34,11.24%,LMO4;PRICKLE1;KDM2B;MTHFR;LRP2;FOLR1;DVL3;COBL;IFT122
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.36099731326743845,-1.167375217579936,0.22632794457274827,0.6315772640251652,1.0,10/37,26.41%,ENTPD1;ENTPD7;ENTPD2;NUDT1;RNASE3;MTREX;SUPV3L1;NUDT16;RNASEH2C;HNRNPD
prerank,RNA destabilization (GO:0050779),0.46555333103171065,1.16729140016479,0.3031578947368421,0.7643242082703258,1.0,3/18,10.80%,ROCK2;YTHDF2;METTL14
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4748207563587163,1.166965041835651,0.2821576763485477,0.7640530632071616,1.0,2/14,3.19%,OXSR1;CXCL13
prerank,positive regulation of gene expression (GO:0010628),0.28470731270386135,1.1665464223295852,0.12060301507537688,0.7640621175276355,1.0,63/442,11.61%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;C1QTNF3;RBPJ;FGFR4;AFDN;WNT6;PID1;BMP7;ANGPT1;PRKN;RBMS3;PLA2R1;DKK1;SCX;NOS1AP;CTSH;DTNBP1;TFR2;PLD1;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;BAZ1B;TNRC6B;GJA1;TNRC6A;FGF1;SLC2A10;EPHX2;IL6;SMAD3;PRKAA1;CSF1;POLR2A;TLE1;MUSK;MITF;FUBP1;SAMD4A;MED1;AGO2;PRKDC;FGF9;SMARCA5;PIK3R1;TAF1A;RPS6KB1;METTL14;TFAP2A;POLR1F;FXR1;ERBB2;LARP6;POLR1A
prerank,protein modification by small protein conjugation (GO:0032446),0.28680815520899794,1.1663575991568207,0.14907651715039577,0.7633891170250147,1.0,57/361,12.61%,ASB2;PDZRN3;RNF220;EYA1;TRIM63;EPAS1;RNF43;PRKN;SPSB1;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;ATG10;RNF138;UFL1;ZNRF3;NDC1;TRPC4AP;CAND1;UBE2L3;RNF181;UBR2;RNF152;KLHL7;CUL9;RNF135;WWP2;AMFR;PIAS1;BIRC6;CRBN;USP7;TRAF7;CUL7;FBXL17;MDM2;ITCH;UBA7;NUP107;SMURF2;TRIM35;PRKDC;NEUROD2;UBA3;DTX1;FBXO4;MYCBP2;CUL4B;RNF14;CDC73;TRIM26;TRIM43;RNF20;FBXO11;RCHY1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.38463278667940565,1.1658439526315114,0.26325757575757575,0.763716590258026,1.0,9/43,10.77%,PID1;SORBS1;IGF2;GRB10;PRKCZ;PRKCB;GKAP1;TNS2;RPS6KB1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4463987038072364,-1.1657094632151352,0.27647058823529413,0.6353514324187871,1.0,3/17,7.10%,TEK;NTRK3;BAIAP2L1
prerank,defense response to tumor cell (GO:0002357),0.5374974527237871,1.1651663298753439,0.3182711198428291,0.7644621562391624,1.0,3/10,4.73%,DAPK1;RBMS3;PLK5
prerank,fatty acid biosynthetic process (GO:0006633),-0.3208492194963612,-1.165002970592378,0.208955223880597,0.6364349887008166,1.0,17/63,21.85%,ABHD2;ELOVL7;ELOVL5;GPX4;ACACA;ELOVL6;PTGS2;XBP1;ABCD3;ALOX12;ELOVL1;TECRL;TECR;SCD5;ACLY;LIAS;SCD
prerank,regulation of cell-cell adhesion (GO:0022407),-0.36225173283761486,-1.1646746421103076,0.2300469483568075,0.6365222581276867,1.0,13/39,12.09%,EFNA5;PODXL;PTPRG;JAG1;CDH1;PTK2;MINK1;TGFB1;CEACAM1;ZDHHC2;DPP4;SPINT2;TENM3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.43230683998087,-1.1646379284144137,0.26996197718631176,0.635764921802684,1.0,6/18,20.49%,ESR1;TGFB1;DDX5;ZC3H12A;MAP2K2;BMP4
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4499827332131046,-1.1640423038533732,0.28599221789883267,0.6366230968865639,1.0,8/15,29.88%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B
prerank,bicellular tight junction assembly (GO:0070830),-0.34300075385866957,-1.1639840683883655,0.21889400921658986,0.6359122787141807,1.0,10/46,10.02%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;MPP7;PAK2;APC
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5004184245575646,-1.163943008614235,0.27586206896551724,0.6351706618059094,1.0,5/10,30.16%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.43151257393978176,1.163273622231707,0.2784552845528455,0.7688493463696282,1.0,7/28,10.77%,APPL2;PID1;GRB10;PRKCZ;PRKCB;TNS2;RPS6KB1
prerank,regulation of tube diameter (GO:0035296),0.5043606858387197,1.1630665574090575,0.29958677685950413,0.7670544417425842,1.0,4/13,10.63%,ROCK2;ACE;SCPEP1;NPR1
prerank,vascular process in circulatory system (GO:0003018),0.5043606858387197,1.1630665574090575,0.29958677685950413,0.7670544417425842,1.0,4/13,10.63%,ROCK2;ACE;SCPEP1;NPR1
prerank,cellular response to metal ion (GO:0071248),-0.28633843754731053,-1.1628171169920811,0.147239263803681,0.6375160425543914,1.0,29/123,10.93%,MEF2C;SLC12A2;B2M;DLG2;CLIC4;IQGAP1;CDH1;PLCG2;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;LGMN;CPNE8;MT2A;JUN;ADCY7;CPNE2;CPNE3;MAPK8;CDKN1B;CHUK;CACNA1H;KCNA1;SYT10
prerank,RNA metabolic process (GO:0016070),0.32134867716426385,1.1620753824536165,0.2141732283464567,0.7686400845235182,1.0,21/127,11.94%,CELF2;POLR2D;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;RBPMS;HNRNPC;HNRNPH1;RBMS2;RBM5;POLR2A;GTF2F1;NOL9;TENT2;SND1;AGO2;METTL14;PCBP2;RBM39
prerank,myofibril assembly (GO:0030239),0.3954205404036165,1.161548692410159,0.25435540069686413,0.7690104028496774,1.0,6/42,4.40%,TPM1;CSRP3;TNNT2;PDGFRB;OBSL1;PDGFRA
prerank,regulation of dopamine secretion (GO:0014059),0.42929222241621257,1.1615151290671624,0.29174311926605506,0.7678758582425755,1.0,9/25,18.25%,PRKN;DTNBP1;SYT11;SYT12;GDNF;FGF20;CHRNB2;DRD2;SNCA
prerank,regulation of insulin secretion (GO:0050796),0.33053609392302835,1.1613904005803446,0.19785276073619631,0.7670283581179222,1.0,14/101,7.95%,ADCY5;TCF7L2;ITPR1;STXBP4;RBP4;PRKN;KCNA5;NLGN2;CACNA1D;IL6;PRKCA;RAPGEF4;MCU;SLC30A8
prerank,intracellular protein transmembrane transport (GO:0065002),-0.35417025720085826,-1.1610080488673737,0.21967963386727687,0.6418202437832401,1.0,19/42,29.88%,TOMM20;C2CD5;HSPA5;HSPD1;SEC62;ROMO1;SEC61G;ZFAND2B;PEX1;PEX5;PEX10;TIMM50;PEX16;SEC63;TIMM44;RTN2;CHCHD4;DNLZ;SEC61B
prerank,triglyceride biosynthetic process (GO:0019432),0.46002454773237744,1.1610078619088668,0.2926829268292683,0.7669159391038118,1.0,2/18,1.78%,AGMO;LPGAT1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.342947614854673,-1.1609367415614593,0.21176470588235294,0.6411847462557252,1.0,18/47,24.20%,KLF4;NFKBIA;TGFB1;APP;EDN1;SSH1;EIF4G1;NR1H2;EIF2A;AGTR1;NOLC1;AKT1;PUM3;NR1H3;EIF4E;PCIF1;RBM4B;DDX25
prerank,heme biosynthetic process (GO:0006783),-0.41239675995350306,-1.1609241706229645,0.26104417670682734,0.6403676565240488,1.0,11/22,28.97%,ABCG2;ABCB10;ATP5IF1;UROD;UROS;FECH;FLVCR1;HMBS;COX15;TSPO;ABCB6
prerank,negative regulation of cytokine production (GO:0001818),-0.27255194769821584,-1.160680705448165,0.14705882352941177,0.6401564336599581,1.0,56/163,24.17%,LEF1;FN1;TMSB4X;APOD;CD200;CD34;THBS1;RPS6KA5;RAC1;GAS6;KLF4;TRIB2;TRIM25;PTPRC;SARS1;TNFRSF21;ARRB1;CEACAM1;RNF125;PDCD4;ADCY7;NAV3;SRGN;NLRC5;BCL3;ISG15;ATP2B1;IRAK3;ABCD2;ASB1;NR1H4;CMKLR1;IFIH1;LAPTM5;RPS6KA4;SIGIRR;CD274;N4BP1;ZC3H12A;NPTN;GPATCH3;INHA;JAK3;TRIM27;TYROBP;NCKAP1L;SLC11A1;HDAC7;HDAC9;OTUD7B;TNFAIP3;DLL1;FCGR2B;AGER;RGCC;VSIR
prerank,icosanoid secretion (GO:0032309),0.5004068719198859,1.160555386830348,0.2874493927125506,0.7670069203334734,1.0,3/12,5.24%,BDKRB2;ANXA1;ACE
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4945736825031811,1.1605522216996995,0.2832980972515856,0.7658160473792373,1.0,3/13,11.05%,PDPK1;IGF2;APLN
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5316238110475394,1.1600789901127984,0.32819383259911894,0.7659735818705979,1.0,5/10,12.45%,GRB10;PRKCB;VTN;ARNT;PRKD2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.49535827142508954,-1.1599210367346953,0.2846441947565543,0.6413329071667163,1.0,6/10,19.76%,EMC10;EMC7;EMC1;EMC3;EMC6;EMC9
prerank,regulation of cell cycle (GO:0051726),-0.25939137100038423,-1.1598405926889892,0.10526315789473684,0.640719066880594,1.0,89/271,26.22%,MECOM;APBB2;NEK7;THBS1;ADAM10;TGFB2;FAP;IQGAP1;RPL23;HSP90AB1;TARDBP;TTC28;PPP1R13B;ADARB1;DAB2IP;NOTCH1;RACK1;FBXL3;PKD1;CDK11B;RHOB;TGFB1;CALR;PTPRC;TBX3;PLAGL1;LIN54;APBB1;HNRNPU;PDCD4;BIRC3;JUN;NR4A1;ING4;APC;CDK6;CDKN1B;STAT3;BMP2;MEN1;JUNB;BIN1;GPER1;WHAMM;MYBBP1A;TMEM8B;GADD45G;MASTL;NLRP2B;MADD;GBF1;DUSP1;MIF;CTBP1;ZBTB17;SOX2;ID2;GAS2L1;CDK5;CAMK2N1;INHA;NOP53;TFAP4;CHMP1A;L3MBTL1;BMP4;MYBL2;METTL3;GADD45A;UHMK1;CDKN1A;CDKN2D;MFN2;CCNB2;GMNC;UHRF2;SIPA1;AFAP1L2;GADD45B;RGCC;PPP1R15A;CHEK1;DTL;HRAS;NUPR2;CDKN3;HBP1;ERN1;CDC14A
prerank,regulation of apoptotic process (GO:0042981),-0.2381691413840585,-1.1593749402340274,0.020689655172413793,0.6411889330102425,1.0,147/676,15.54%,LEF1;MEF2C;UNC13B;TEK;SLIT2;HIP1;MAP3K5;ACTN4;MCF2L;PTMA;ITGA6;TIAM1;ACER2;RASSF2;TFRC;KDR;TRIO;THBS1;ADAM10;TPT1;HSP90AA1;ARHGEF3;GAS6;RNF144B;CBL;HNRNPK;PTK2;ITGB1;TARDBP;PPP1R13B;KCNMA1;SLK;PTK2B;DAB2IP;NGF;RASGRF2;UBB;NFKBIA;RPS3;RACK1;DNAJA1;PPIA;CTSD;SEMA4D;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;FLNA;ACTN1;SOCS2;RPS6;HSPB1;BCAR1;ARHGEF17;IKBKB;SOX4;ARHGEF6;RHOB;PERP;ARHGDIA;CD38;CALR;CD44;CTSB;PLK2;CTNNB1;HSP90B1;SOD1;FAF1;ABR;BCL2L1;LGALS1;UBC;RPS27A;GSK3B;TBX3;LRP8;WNK3;EGLN3;SIGMAR1;SERPINB9;APBB1;HIP1R;DNM2;RNF157;FLT4;PDCD10;BAG1;CARD14;VEGFA;TJP1;CRYAB;BIRC3;JUN;FOXO1;ARHGEF19;MAGED1;DDX20;ARHGEF26;ZBTB7A;MAPK8;ING4;RTN4;PAK2;BNIP2;HYPK;APC;XBP1;HSPA5;ARHGEF5;BCL3;ATF4;BMP2;RSL1D1;RPS6KA1;BIN1;GPER1;RYBP;EGLN2;REST;CD74;HSPD1;ARHGEF2;CLU;BNIP1;HIGD2A;RNPS1;GADD45G;NLRP2B;MT3;IAPP;DSTYK;NR1H4;PLEKHN1;NF1;CIAPIN1;FAS;CYP1B1;CASP8;UBA52;MADD;SIX4;FLT3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4716628312252873,1.1592569190079103,0.2901960784313726,0.7670887796496416,1.0,6/16,17.39%,PIGG;PIGV;PIGX;PIGC;PIGQ;PIGN
prerank,cellular response to retinoic acid (GO:0071300),0.38350211414530716,1.1586723845465186,0.26480836236933797,0.7676205616707892,1.0,3/42,1.12%,PTK7;EPHA3;WNT6
prerank,regulation of cellular metabolic process (GO:0031323),0.3749673276631415,1.1586183322057049,0.2470389170896785,0.7665686091754408,1.0,4/45,2.62%,PPARA;PID1;PRKN;DKK1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4084608664885151,-1.1572973423481874,0.2613168724279835,0.6461432220763981,1.0,5/22,17.19%,APOD;CEACAM1;GPER1;PPP2R5A;BSCL2
prerank,glucose transmembrane transport (GO:1904659),-0.4210110342987351,-1.1566920634662419,0.27607361963190186,0.6469786618959635,1.0,2/18,3.07%,SLC2A1;PPARD
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3447264333363419,-1.156355112700072,0.23094688221709006,0.6470342879971922,1.0,14/46,10.97%,TEK;FN1;TMEFF2;PARVB;RAC1;PXN;LAMA5;LAMB2;FERMT2;ITGA4;SRCIN1;PEAK1;RHOA;ITGA8
prerank,polyol metabolic process (GO:0019751),-0.3379966423312652,-1.1562168759633331,0.24,0.6465515556561313,1.0,11/46,15.42%,CALM1;PLCG2;PLCB4;INPP5D;INPP4A;SYNJ1;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,regulation of sodium ion transport (GO:0002028),0.39900679828164876,1.1562040674705882,0.27087198515769945,0.7722715655276225,1.0,7/34,6.48%,WNK4;SNTA1;GPD1L;NKAIN4;NEDD4;SIK1;DLG1
prerank,regulation of interleukin-6 production (GO:0032675),-0.29871703193591914,-1.155653752309446,0.17480719794344474,0.6472006075919532,1.0,45/96,33.97%,IL33;CD200;GAS6;PLCG2;MBP;LBP;ARRB1;APP;XBP1;STAT3;CD74;HSPD1;ARHGEF2;IRAK3;CD47;IFIH1;ZC3H12A;TIRAP;MYD88;TYROBP;NCKAP1L;TNFAIP3;HYAL2;AFAP1L2;AGER;RAB7B;SPHK2;TLR7;TREM2;FOXJ1;TLR4;LPL;C1QTNF4;IL16;TLR6;DHX9;MAVS;NOD2;PTPN22;TLR1;C5AR2;NOS2;IL1A;TSLP;SYK
prerank,dendritic spine organization (GO:0097061),-0.3913898352436349,-1.1556022628501508,0.24008350730688935,0.646504487236962,1.0,8/26,13.07%,SHANK3;CTNND2;FYN;DOCK10;LGMN;ARF1;EPHB1;PICK1
prerank,epidermis development (GO:0008544),0.3633272062290926,1.155549711003729,0.24592833876221498,0.7729697268142787,1.0,3/56,2.43%,SVEP1;FGFR2;CCN2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.463754720276699,-1.1554228341265593,0.2813102119460501,0.6461263107778797,1.0,7/13,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,nitrogen compound transport (GO:0071705),0.32040558589335916,1.155417473564062,0.21823617339312407,0.7720994491330609,1.0,16/141,8.41%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC6A12;SLC35F3;PDPN;TCN2;LRP2;NDC1;SLC43A1;ZG16;ABCC2;SLC1A5;MIA3
prerank,glycosaminoglycan metabolic process (GO:0030203),0.36785192725614296,1.1549388369752491,0.25689655172413794,0.7722468966462042,1.0,13/54,12.62%,HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;B3GALT6;NDST2;HS6ST1;UGDH;GPC4
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3144603829687294,1.1549212870923826,0.2,0.7711148523619309,1.0,12/142,4.52%,ATP1A2;ADCY5;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;CXCR6;PDGFRA;LPAR2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4261491597054977,-1.1548607339186183,0.26264591439688717,0.6467952048210375,1.0,10/17,23.02%,CAV1;KLF7;CEACAM1;APOLD1;AJAP1;MAFF;DSPP;PRKX;DLL1;CEBPB
prerank,positive regulation by host of viral transcription (GO:0043923),-0.44339641553452486,-1.1546028573130371,0.2854251012145749,0.6466108862635848,1.0,2/15,7.98%,LEF1;JUN
prerank,"phagocytosis, engulfment (GO:0006911)",-0.35521276346371444,-1.1544713308004588,0.2528216704288939,0.6461150516839387,1.0,7/36,9.80%,ELMO1;THBS1;RAC1;GSN;DOCK1;MYH9;ARHGAP25
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5048295484336482,-1.1541816695848932,0.29118773946360155,0.6461031056711137,1.0,4/10,22.56%,APC;RCC2;KNSTRN;SPAG5
prerank,nucleoside salvage (GO:0043174),-0.5028416549586125,-1.1540048516745536,0.28901734104046245,0.6457930305228481,1.0,7/10,31.88%,HPRT1;UCKL1;CDA;DCK;UCK1;UCK2;UPP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3985613233568448,-1.1539772353856164,0.28118393234672306,0.6450486601435492,1.0,11/23,29.88%,HSP90B1;DERL1;HERPUD1;AUP1;PREB;TMEM129;VCP;SEC16A;SYVN1;RANGRF;SEC61B
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5025995470195047,1.1537906617164322,0.3178947368421053,0.7731014850478481,1.0,3/12,6.76%,DOCK11;NOTCH2;IL6
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3937641392370026,1.1537137905332138,0.26094890510948904,0.7721541742346226,1.0,6/39,7.95%,TCF7L2;RBP4;NLGN2;TFR2;MCU;SLC30A8
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3534670386357315,-1.1537073016489603,0.23943661971830985,0.6449688435255783,1.0,19/37,34.04%,UBB;UBC;RPS27A;DDB1;RBX1;RPA1;UBA52;POLK;POLD3;NTHL1;POLD1;GTF2H2;XPA;ERCC5;RFC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4408495628718852,-1.1535656027611285,0.29423076923076924,0.6445230217084956,1.0,4/16,12.56%,MEF2C;MCTP1;KCNMB4;CPLX2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.29904214528562834,-1.1532207014822187,0.20466321243523317,0.6446687154320797,1.0,42/96,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,cellular response to starvation (GO:0009267),0.31801073407625896,1.1527571984179221,0.20637329286798178,0.7737559983002936,1.0,32/147,13.97%,PRKAG2;NPRL3;PPARA;PRKAG3;FNIP1;SZT2;PCSK9;SIK1;CPEB4;SESN1;PRKAA2;NPRL2;MTMR3;LRRK2;SLC38A9;WIPI1;RNF152;PRKAA1;LAMP2;ATG14;PIK3R4;ATP6V0D1;ATP6V0E1;MLST8;FLCN;EIF2S1;PRKAG1;STK24;MAPK1;RRP8;STK26;NIM1K
prerank,positive regulation of locomotion (GO:0040017),-0.3831528284886224,-1.152665026733638,0.27391304347826084,0.6453202330736464,1.0,5/27,5.38%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,negative regulation of translation (GO:0017148),0.337730850629898,1.15252625411957,0.22818791946308725,0.7732315356611602,1.0,25/87,19.33%,ROCK2;IGF2BP1;DAPK1;CPEB2;EIF4EBP1;CPEB4;TYMS;YTHDF2;SAMD4A;AGO2;METTL14;UNK;FXR1;SHMT1;CNOT8;CNOT7;LARP1;TSC1;ENC1;CNOT10;GIGYF2;DDX3X;RBM4;DHFR;LSM14A
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3647419758303977,1.1524492449179704,0.24869565217391304,0.7722384684513947,1.0,7/56,6.30%,BMP6;BMP7;DAB2;SMAD6;DKK1;RBPMS;TTK
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3363148504773494,-1.1518661364655811,0.2448512585812357,0.6458135669549473,1.0,19/51,26.70%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3363148504773494,-1.1518661364655811,0.2448512585812357,0.6458135669549473,1.0,19/51,26.70%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5011283791091472,-1.1518287788551247,0.3,0.6450815806304174,1.0,5/10,24.76%,SHANK3;APP;CAMK2B;NPTN;SYP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.33763534503672216,1.1517608547563034,0.2360655737704918,0.7730114956359948,1.0,9/86,7.87%,IGF1;EPHA7;BMP6;ANGPT1;IGF2;PRKCZ;IL6;ENPP2;VTN
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5032531438605846,1.15147131778151,0.2967479674796748,0.7727021650538501,1.0,4/11,6.00%,EFNB2;DKK1;SOX6;FRS2
prerank,cellular response to nitrogen compound (GO:1901699),0.4453484670515919,1.1512294914818428,0.29206963249516443,0.7722764238646654,1.0,3/20,12.36%,ROCK2;BLM;HSF1
prerank,regulation of oxidoreductase activity (GO:0051341),0.489697325453196,1.1508502697831726,0.3360995850622407,0.7722200689046311,1.0,4/13,11.46%,SZT2;SLAMF8;ABL1;OXA1L
prerank,positive regulation of viral life cycle (GO:1903902),-0.4120312617199787,-1.1507333985064514,0.26239669421487605,0.6472586509935061,1.0,7/22,22.29%,CHMP2B;LGALS1;DDB1;CD74;TYRO3;FMR1;CHMP3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3937946200696118,-1.150211593847735,0.28125,0.6478541093908372,1.0,11/24,15.90%,RACK1;CREB3L1;UBXN1;BCL2L1;AQP11;XBP1;LPCAT3;CLU;HERPUD1;NR1H2;WFS1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3609269925556091,-1.1501921394647034,0.25229357798165136,0.6470795101899492,1.0,8/36,5.38%,MEF2C;SLIT2;PTPRM;THBS1;ACVRL1;DAB2IP;NOTCH1;TGFB1
prerank,chromatin remodeling at centromere (GO:0031055),0.40989756404463784,1.1500369396586576,0.2843866171003718,0.7733545392082922,1.0,9/31,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.44663682537883104,1.1497185068530502,0.2992125984251969,0.7730878052135371,1.0,4/20,3.68%,ATP1A2;ATP1B3;SLC8A1;LACC1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4236407469618893,1.1495093093740845,0.28679245283018867,0.7724445072144175,1.0,5/27,6.24%,FGFR4;SMOC2;PDGFRB;NIBAN2;PARP4
prerank,negative regulation of histone acetylation (GO:0035067),-0.4852980382906365,-1.149225008055877,0.3029197080291971,0.6488024564831705,1.0,7/11,36.85%,SET;CTBP1;SPI1;NOC2L;SIN3A;THAP7;TAF7
prerank,regulation of transposition (GO:0010528),0.4876924958380874,1.14855777377029,0.3049792531120332,0.7739324460036782,1.0,2/13,7.14%,MYBL1;UBR2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.3023298412655434,-1.148132354149448,0.2111650485436893,0.6511031876766628,1.0,19/78,11.93%,SPTBN1;PRKCH;ACTB;STX3;ITGB1;STX7;TGFB1;NKD2;VTI1B;VAMP8;BCL2L1;WNK3;ABI3;ZDHHC2;ZDHHC7;AP2M1;APPL1;TMBIM1;GPER1
prerank,nucleosome assembly (GO:0006334),0.4043617269071251,1.1477782360797517,0.26806083650190116,0.7750697304220527,1.0,8/31,16.52%,RBBP4;NASP;RSF1;KAT6B;SMARCA5;NAP1L3;NAA60;NAP1L1
prerank,pulmonary valve development (GO:0003177),-0.42721879384002176,-1.147706003024662,0.27708333333333335,0.6514376799042984,1.0,11/18,11.74%,SLIT2;NOS3;TGFB2;JAG1;NOTCH1;BMPR2;STRA6;NFATC1;TNFRSF1B;HEY2;HEYL
prerank,female gonad development (GO:0008585),0.445795107818151,1.1476918332153745,0.2944550669216061,0.7741435844950115,1.0,2/19,1.24%,NR2F2;KIT
prerank,relaxation of cardiac muscle (GO:0055119),0.5019966399382012,1.147549413795154,0.316,0.7733552775006992,1.0,3/13,3.07%,ATP1A2;GSTM2;SLC8A1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3402727551901106,-1.1474084033069303,0.2585812356979405,0.6514319917029127,1.0,9/47,9.22%,SPTBN1;STXBP6;NSF;EXOC6;RAB31;EXOC4;GOPC;GOLGA7;EXOC5
prerank,peripheral nervous system development (GO:0007422),-0.393055276848259,-1.147122837948141,0.2611607142857143,0.6513625083597928,1.0,6/23,14.64%,ADGRG6;NGF;SERPINI1;SCN8A;GPC1;NF1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.338870909295669,1.1469319532025726,0.23380726698262244,0.7739094657473272,1.0,24/95,14.12%,TGFBR3;PPARA;ZEB2;DAB2;PDPK1;SNX6;DKK3;SMAD6;ITGA3;SLC2A10;SMAD3;FOLR1;NREP;LEMD3;BCL9;LATS1;SMURF2;FLCN;HTRA4;LDLRAD4;VEPH1;ADAMTSL2;CDKN1C;CREBBP
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2974751258481558,-1.1468168245880648,0.19786096256684493,0.6513201088221815,1.0,23/87,10.84%,CLDN5;ID1;ACVRL1;TGFB2;CBL;PTK2;ITGB1;F11R;ENG;UBB;PXN;TGFBR2;TGFB1;FERMT2;UBC;RPS27A;SMAD9;SMAD5;JUN;RHOA;APPL1;FURIN;GCNT2
prerank,regulation of neuron death (GO:1901214),-0.3024560814689955,-1.1462020102926174,0.21573604060913706,0.6521505019126822,1.0,33/82,23.76%,MEF2C;MAP3K5;CD200;CD34;PPARGC1A;FYN;UBB;DCC;GSK3B;EGLN3;SIGMAR1;TNFRSF1B;CHP1;DDIT4;EIF4G1;EPHB1;EGLN2;REST;CLU;CHGA;C1QA;CTSZ;NENF;ATP13A2;CDK5;TRIM2;TYROBP;AKT1;GRID2;NSMF;FCGR2B;SARM1;SNCG
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4801169780212915,-1.1457822081296398,0.3001949317738791,0.6525041575418514,1.0,4/11,11.93%,MEF2C;TGFB2;TGFB1;GPER1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.28664198975162186,-1.1457784638097703,0.20055710306406685,0.6516887536304922,1.0,28/112,9.82%,MEF2C;CLDN5;ID1;PDE3A;ACVRL1;TGFB2;CBL;PTK2;ITGB1;F11R;ENG;UBB;LIMS1;PXN;TGFBR2;TGFB1;FERMT2;UBC;RPS27A;CLEC3B;PDE2A;SMAD9;SMAD5;JUN;RHOA;APPL1;FURIN;ZFP36L1
prerank,positive regulation of histone modification (GO:0031058),-0.3614084185091597,-1.1453828020270171,0.27616926503340755,0.6518730136002912,1.0,11/33,21.48%,RPS6KA5;PPARGC1A;ARRB1;GLYR1;NOS1;APLNR;AKAP8;RPS6KA4;CTBP1;FMR1;MAPK3
prerank,second-messenger-mediated signaling (GO:0019932),0.3392951107236334,1.1453014084763933,0.24462809917355371,0.777475392243985,1.0,11/82,7.85%,RCAN2;ACKR2;CCR9;CXCR5;PDPK1;NDNF;CXCR6;SPHK1;LRRK2;PPP1R9A;MCU
prerank,actin nucleation (GO:0045010),-0.4112807079355886,-1.1452418682259389,0.2925311203319502,0.6514136846063615,1.0,10/21,21.78%,ARPC1B;ARPC3;WHAMM;ACTR2;SPIRE1;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,histone exchange (GO:0043486),0.3934441031276303,1.1451818896763795,0.27090909090909093,0.7766516820946914,1.0,12/37,16.01%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ;SRCAP;CENPX;ACTR6
prerank,regulation of translation (GO:0006417),-0.26658461231167174,-1.1450220328316385,0.14705882352941177,0.651163525924847,1.0,51/173,24.20%,THBS1;NIBAN1;EEF2;VIM;RPS3;RACK1;RPL26;HSPB1;SOX4;CALR;IGFBP5;EIF1B;TOB1;RPL5;EIF4G3;GAPDH;APP;YBX1;MTOR;PYM1;EIF4G1;EIF3D;BCL3;YTHDF3;RPS6KA1;RPS4X;SHFL;EIF4H;RPS27L;EIF3B;RPL13A;RIDA;EIF3C;EIF1;EIF2B2;EIF2A;EIF5B;NOLC1;MRPL13;MTG1;METTL3;FMR1;EIF6;EIF4B;PUM3;EIF4E;EIF5;PCIF1;PUS7;RBM4B;DDX25
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.45968631063595905,1.1448303463041387,0.292,0.7764771444566072,1.0,3/19,4.05%,ROBO1;SMOC2;CCBE1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3275690384069467,-1.1443300604849564,0.22014051522248243,0.6522208772364183,1.0,19/55,23.01%,FHL1;PINX1;PSMD13;PSMF1;RBX1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.44566993410125144,1.1440733246104124,0.3125,0.7775512510458646,1.0,7/21,17.83%,PPARA;PRKN;TFAP2A;SLC30A10;PLIN5;ABCB7;TRAP1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4956369318449194,1.1439142621928915,0.326271186440678,0.7768663049980612,1.0,3/12,8.88%,IL18;IL6;NUPR1
prerank,regulation of cell population proliferation (GO:0042127),-0.23445993038819393,-1.1437099674417013,0.008264462809917356,0.6530975239885205,1.0,131/691,12.79%,LEF1;KITLG;ZBTB7C;NTRK3;FN1;PTPRJ;FTH1;CLDN5;NOS3;ACER3;TIAM1;IGFBP6;ACER2;LIFR;CD200;TFRC;KRAS;KDR;THBS1;ADAM10;BMP5;PLPP1;ACVRL1;TGFB2;NAMPT;RUNX1;STX3;PTPN14;JAG1;CBFA2T3;TES;RPL23;KLF4;RPS9;PPP2R5C;PTK2;ETS1;ADARB1;TBC1D8;WNT9A;ROR2;ENG;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;TBX1;P3H2;BMPR2;HES1;SFRP4;LIMS1;LGMN;RPS6;RERG;RBFOX2;TGFBR2;WARS1;PINX1;TBX2;SOX4;TGFB1;CALR;TSPAN31;KDM4C;CTNNB1;JAG2;LRP5;CCDC88A;ST18;TOB1;GNL3;TNFRSF11A;TBX3;EGLN3;SIX1;ATP8A2;DDAH1;CUL3;PDGFC;APP;FLT4;PDCD10;ADRA1A;VEGFA;TJP1;JUN;ECRG4;EMP2;PTHLH;PAK1;AQP11;ELN;CNOT6L;FGF7;RHOA;PODN;EDN1;ING4;ESM1;ZFP36L1;DPP4;APC;CDK6;WWTR1;XBP1;SOX7;CDKN1B;RTKN2;NCK2;BTG3;STAT3;BMP2;GCNT2;HGS;HHEX;IFI35;MEN1;ACE2;JUNB;PBRM1;GPER1;RPS4X;TCIRG1;GLI1;REST;CDH13;ARHGEF2;CLU;LMNA
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41431480855849934,1.1436359946294974,0.30158730158730157,0.7765410698722273,1.0,6/26,5.37%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,epiboly involved in wound healing (GO:0090505),-0.4437440065679008,-1.143391074049655,0.2994011976047904,0.6531290403881479,1.0,7/16,13.57%,TMEFF2;FLNA;CD44;CEACAM1;PDCD10;RHOA;CCN1
prerank,negative regulation of neuron death (GO:1901215),-0.2952538681552059,-1.143370231595862,0.17135549872122763,0.6523591552377535,1.0,30/93,19.14%,MEF2C;CD200;CD34;FBXO7;PPARGC1A;PTK2B;NGF;LGMN;SOD1;GSK3B;FOXQ1;SIX1;TNFRSF1B;GRN;SET;EIF4G1;ATF4;MSH2;REST;CHGA;MT3;NENF;SIX4;WFS1;ATP13A2;PRKCG;CDK5;TYRO3;LIG4;PINK1
prerank,regulation of necroptotic process (GO:0060544),-0.4016966588664651,-1.1433443891101012,0.2719836400817996,0.651607955449598,1.0,10/23,23.77%,HSP90AA1;YBX3;CDC37;BIRC3;OGT;ARHGEF2;CASP8;SLC25A4;PELI1;PDCD6IP
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.45956709938652723,-1.14267245837798,0.2826510721247563,0.6525953777547127,1.0,6/14,19.43%,CARD10;CARD14;COPS8;IRAK1;TNFRSF10B;TIRAP
prerank,sarcomere organization (GO:0045214),0.4220605913763788,1.1425920464065618,0.29245283018867924,0.7783824483733256,1.0,3/27,2.80%,TPM1;CSRP3;TNNT2
prerank,triglyceride catabolic process (GO:0019433),0.4502190537023069,1.142351663907768,0.3066132264529058,0.777901173582227,1.0,4/19,16.18%,LIPH;LIPC;FABP7;FABP4
prerank,ion transport (GO:0006811),0.32402085756712395,1.1419017213749183,0.2252663622526636,0.7780689536534031,1.0,8/111,3.07%,TRPM3;SLC24A3;SLC8A3;WNK4;SLC5A5;SLC1A3;SLC20A2;SLC8A1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4228669022383339,1.1417530399535394,0.3175182481751825,0.7773199181889957,1.0,10/29,11.95%,TCF7L2;PYGO1;ASH2L;TLE3;TCF7L1;TLE1;AXIN2;BCL9;HDAC1;CDC73
prerank,cellular response to fatty acid (GO:0071398),0.49818350856959953,1.1417129857943795,0.31392931392931395,0.7762837567898333,1.0,1/12,1.17%,PID1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.456952030565243,-1.141039663987478,0.3131115459882583,0.6562985443855258,1.0,7/13,37.54%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK;CRP
prerank,response to cytokine (GO:0034097),0.3129359822465476,1.1406649012315406,0.23630672926447574,0.7781064867854027,1.0,17/141,7.89%,ALDH1A2;PTPN13;PID1;TIMP3;BCL2;PTPN4;DPYSL3;SP100;IL1RAPL1;ANXA1;IRAK2;NFAT5;SPHK1;PTPN9;SMAD3;PRKCA;TRIM56
prerank,positive regulation of macrophage differentiation (GO:0045651),0.514997133107902,1.1406523900464947,0.3226452905811623,0.7769947663575056,1.0,4/11,12.36%,IL34;PRKCA;CSF1;HSF1
prerank,neuron cell-cell adhesion (GO:0007158),0.4739473984794108,1.14000818143433,0.30462184873949577,0.7777267819238555,1.0,2/14,2.23%,CEL;NLGN2
prerank,positive regulation of cell cycle process (GO:0090068),0.32994606322953,1.1392817249598444,0.24143302180685358,0.7786457304327958,1.0,11/91,11.42%,IGF1;CXCR5;DMRT1;PDGFRB;IGF2;CDC14B;UBXN2B;PKN2;PHIP;NPM2;TGFA
prerank,cardiac atrium morphogenesis (GO:0003209),-0.43520314413061084,-1.1389379013702716,0.2938856015779093,0.6611460433802283,1.0,6/16,10.79%,TGFB2;ENG;NOTCH1;BMPR2;HEY2;BMP2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5050833100480427,1.138553330782338,0.32919254658385094,0.779640417285533,1.0,1/11,0.24%,TGFBR3
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.26435885777762036,-1.1384463622718892,0.134185303514377,0.6615814660189394,1.0,38/175,14.90%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;DAB2IP;NFKBIA;RPS3;LIMS1;IKBKB;EDA;YBX3;TNFRSF21;ST18;TNFRSF11A;TNFRSF1B;SMPD4;CARD14;BIRC3;NPNT;PSMD13;AIM2;PSMF1;COMMD7;ZFP36L1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;GPER1;ARHGEF2;PSMC3;ERBIN;GBP3;PSMD12;PSMB8;TRAF1;PSME1
prerank,carboxylic acid metabolic process (GO:0019752),-0.36272330228463523,-1.1383030410559785,0.2692307692307692,0.6611593827913017,1.0,12/33,22.48%,CSGALNACT1;ST6GAL1;SLC2A1;PTGIS;SIRT4;PLA2G4A;CYB5R3;MIF;ST3GAL1;GSTO2;LIAS;SLC2A3
prerank,inositol phosphate metabolic process (GO:0043647),-0.33336902936681134,-1.138211685392273,0.2641509433962264,0.6606052598744973,1.0,11/46,15.42%,CALM1;PLCG2;PLCB4;INPP5D;INPP4A;SYNJ1;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,potassium ion transmembrane transport (GO:0071805),0.3124942884483077,1.1381422773412206,0.22342064714946072,0.7797067264616744,1.0,10/135,4.07%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3;KCNT2;KCND3
prerank,macroautophagy (GO:0016236),0.3222283207193995,1.137962820791696,0.25379939209726443,0.7791099417967486,1.0,24/118,15.64%,PRKAG2;PRKN;PRKAG3;ATG10;PRKAA2;MTMR3;WIPI1;PRKAA1;LAMP2;ATG14;VTA1;PIK3R4;UVRAG;STAM2;FUNDC1;CHMP6;VPS37A;VPS37C;PRKAG1;STX17;TMEM74;VPS39;AMBRA1;ATG3
prerank,cellular respiration (GO:0045333),-0.34610883236778683,-1.1379506807663051,0.26222222222222225,0.6605301991400768,1.0,17/41,29.96%,PPARGC1A;ATP5F1D;NDUFA5;UQCRH;NDUFS1;COQ10B;NDUFS7;UQCRC2;UQCRC1;MTFR1L;CYCS;UQCR10;MTLN;ETFB;COX15;COX4I2;NR4A3
prerank,response to UV-B (GO:0010224),-0.4756523938319666,-1.1378446752317026,0.29549902152641877,0.6600307763980306,1.0,6/12,23.41%,CRIP1;MFAP4;MSH2;CDKN1A;HYAL2;RELA
prerank,TOR signaling (GO:0031929),0.42289014206713527,1.1375507085786443,0.27011494252873564,0.779201989156605,1.0,8/26,10.86%,NPRL3;FNIP1;EIF4EBP1;RICTOR;SYAP1;MLST8;RPS6KB1;FLCN
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.27224781450333585,-1.1373497816544669,0.16422287390029325,0.6606071482902418,1.0,41/136,19.46%,TMSB4X;ID1;ESR1;CD200;GAS6;KLF4;BHLHE40;DAB2IP;NFKBIA;HES1;PKD1;SFRP4;FLNA;FZD6;ARRB1;CHP1;PTCH1;LRRC14;PTGIS;AIM2;COMMD7;NLRC5;CTNNBIP1;CHUK;MEN1;HEYL;IRAK3;ERBIN;NLRP2B;DAP;CMKLR1;CYP1B1;WFS1;BRMS1;SIGIRR;ZC3H12A;ID2;IRAK1;SPI1;HES6;ARRB2
prerank,cardiocyte differentiation (GO:0035051),0.5139105235104524,1.1368217347439273,0.30718954248366015,0.7801649005116558,1.0,4/10,8.94%,CBY1;AKAP13;SIK1;KDM6B
prerank,transition metal ion transport (GO:0000041),-0.3573008094011949,-1.1360849308351808,0.26785714285714285,0.66331063053722,1.0,12/35,9.66%,FTH1;TFRC;TRPC3;ATOX1;IREB2;SLC30A5;TRPC6;ATP2C1;SLC31A1;SLC39A8;TRPC4;SLC30A1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3292523836856519,-1.1360459047813614,0.2529274004683841,0.6625933159416955,1.0,12/48,12.31%,LIMS2;RAC1;CARMIL1;DOCK1;LIMS1;FLNA;CALR;FERMT2;MYOC;CRK;S100A10;CDKL3
prerank,regulation of monocyte differentiation (GO:0045655),0.46994977757224876,1.1360013484087639,0.3165322580645161,0.7813216628799177,1.0,4/14,7.99%,IL34;HOXA7;ACIN1;CSF1
prerank,endothelial cell development (GO:0001885),-0.3934276937859731,-1.1358176913766451,0.2967741935483871,0.6624199434879532,1.0,9/25,7.28%,PECAM1;RAP1A;PDE4D;MSN;COL15A1;PPP1R16B;ROBO4;MET;PDE2A
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4876983744865604,-1.1357597654314753,0.3308550185873606,0.6617577157656882,1.0,6/10,30.28%,GALNT13;GALNT2;GALNT1;POGLUT3;MGAT5B;POGLUT1
prerank,negative regulation of translational initiation (GO:0045947),0.49113862947661285,1.135731332829403,0.28600405679513186,0.7809131694339749,1.0,6/13,22.87%,EIF4EBP1;AGO2;LARP1;RBM4;TPR;PAIP2B
prerank,megakaryocyte differentiation (GO:0030219),0.5117903470457531,1.1355087403606237,0.3410041841004184,0.7803729437522807,1.0,4/11,17.56%,KIT;MED1;CDKN2B;IL11
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5108418531685278,1.135262369011803,0.32563025210084034,0.7799354875577723,1.0,4/10,19.77%,SETD6;SETD7;SETD2;SETD4
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.45753925730856165,1.134825447537693,0.3199195171026157,0.7800662067430854,1.0,4/16,9.05%,APPL2;PPARA;NLRC3;SIRPA
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4860315035878521,-1.134820219952823,0.30654205607476637,0.6634924741179677,1.0,5/10,36.05%,ESR1;PSMC3;THRA;PSMC5;PSMC4
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3798173008201594,1.1347567093135014,0.2880143112701252,0.7791299136653204,1.0,6/39,6.25%,ROBO1;RBPJ;BMP2K;MAML3;ZMIZ1;MAML1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.36646620561690196,-1.1345442712430795,0.2706611570247934,0.663474932209433,1.0,10/30,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;HEXB;HEXA;IDS;VCAN;CHSY3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.46349462651598694,-1.1345345214580953,0.3111545988258317,0.6626892368666323,1.0,7/13,37.59%,GLRX5;GLRX3;ISCA2;ISCA1;CIAO2B;BOLA2;YAE1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3970145358894998,1.1342180893171112,0.30590339892665475,0.7795204975933889,1.0,5/33,4.27%,ADAMTS9;MCC;NR2F2;SP100;DUSP10
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.33231032875219707,-1.1340224121446696,0.2429245283018868,0.6632621816730302,1.0,23/47,31.76%,THBS1;PLCG2;RAB27A;TGFBR2;TGFB1;SOD1;GRIN1;XDH;ACE2;ROMO1;ZC3H12A;AGTR1;TYROBP;PRKCD;GADD45A;CDKN1A;ITGB2;DCXR;TLR4;CBR1;CD36;TLR6;AGT
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.429558681147543,-1.1334631582269552,0.2964509394572025,0.6640222317172364,1.0,11/17,30.12%,CALM1;SPRED2;DDIT4;EIF4G1;CADM4;CALM2;CALM3;DGKQ;SPRY2;SPRED3;SMAD7
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.49018629595919827,1.1334528377671687,0.34591194968553457,0.7805684513279506,1.0,3/13,11.22%,LARGE1;CHST3;RENBP
prerank,ceramide transport (GO:0035627),-0.4752487666690456,-1.1334504848833766,0.2922201138519924,0.6632428390806546,1.0,3/12,3.46%,CERT1;PLTP;PSAP
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3464017695711459,1.1332716659415054,0.2663230240549828,0.7799394872489156,1.0,13/69,12.11%,POLR2D;PHAX;CDK7;INTS8;POLR2A;CCNT2;RPRD1B;CCNT1;GTF2F1;SNAPC5;TAF8;RPRD2;ICE2
prerank,regulation of autophagosome assembly (GO:2000785),0.4002045175112266,1.1328430860739263,0.2992565055762082,0.7799976022568216,1.0,8/33,13.27%,NPRL3;NPRL2;MTMR3;LRRK2;NUPR1;TMEM39A;FEZ1;RAB3GAP1
prerank,artery morphogenesis (GO:0048844),-0.3627386630763493,-1.132705642096835,0.2851063829787234,0.6645297688476594,1.0,11/30,9.36%,TGFB2;JAG1;ENG;NOTCH1;TBX1;BMPR2;HES1;STRA6;TBX2;VEGFA;HEY2
prerank,cell-matrix adhesion (GO:0007160),0.3334296859783566,1.132628944342957,0.25041736227045075,0.7795117770893057,1.0,11/95,5.54%,ADAMTS12;NID2;ADAMTS9;FBLN5;RHOD;SORBS1;FERMT1;COL13A1;DDR1;SGCE;ITGA3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4189344411037294,1.1323536301804533,0.3089887640449438,0.7791481622491857,1.0,6/25,12.06%,ITPR1;LRRK2;GPR143;CCL4;NEUROD2;TMBIM4
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3952166987089073,1.1322042180771477,0.29577464788732394,0.7784833613214647,1.0,4/33,3.48%,STXBP4;PLCB1;UBE2E2;ANXA1
prerank,regulation of macrophage differentiation (GO:0045649),0.4704418782273199,1.1320213905662198,0.32323232323232326,0.7778593317431531,1.0,4/15,12.36%,IL34;PRKCA;CSF1;HSF1
prerank,amino acid transport (GO:0006865),0.35896704649318717,1.131834466711579,0.2849740932642487,0.777261670220799,1.0,10/49,12.29%,SLC7A11;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC43A1;SLC1A5;SLC36A2;SLC38A7;SLC38A2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4084171331237802,-1.1317871455393334,0.3097165991902834,0.6662381939218719,1.0,6/20,11.93%,THBS1;GSN;SFRP4;ITGA4;PDCD4;GPER1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4240838281991204,1.1308855925990384,0.30694980694980695,0.7788226261678136,1.0,3/24,2.58%,JPH1;DMD;GSTM2
prerank,regulation of protein transport (GO:0051223),-0.3769722728284895,-1.1306983040513099,0.2903225806451613,0.6682945310344299,1.0,15/27,30.93%,HSPA8;DNAJA1;RHBDF2;CHP1;DNAJC1;PTPN1;NDFIP2;ATP13A2;NDFIP1;DISP1;ARFIP1;SNX3;PPM1F;LCP1;STXBP5L
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.38383031606203893,1.1303285877145965,0.3019538188277087,0.7791771015850364,1.0,6/39,3.79%,OSR1;WNK4;DMD;GPD1L;NEDD4;PCSK9
prerank,positive regulation of cation channel activity (GO:2001259),-0.3437238342692338,-1.130299685989146,0.27293064876957496,0.6685645852731367,1.0,15/40,26.70%,SHANK3;TMSB4X;CALM1;RELN;ADRB2;KCNIP2;CALM2;STAC3;JPH2;ANK3;CALM3;CCR2;HAP1;CCL2;CASQ1
prerank,error-prone translesion synthesis (GO:0042276),-0.40274804267168407,-1.1302336672564062,0.3130252100840336,0.6679417099885385,1.0,7/21,16.16%,UBB;REV3L;UBC;RPS27A;RPA1;UBA52;POLK
prerank,sensory perception of smell (GO:0007608),-0.47629374061950386,-1.130079981708227,0.3268101761252446,0.6675587183844603,1.0,2/11,10.93%,ADCY3;SYT10
prerank,androgen receptor signaling pathway (GO:0030521),-0.47860477580202,-1.1299723469127891,0.30952380952380953,0.6670684336245369,1.0,4/11,8.98%,PLPP1;KDM3A;DDX5;TMF1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.26894065612956997,-1.1298542471712643,0.18211920529801323,0.6665279919816632,1.0,24/159,7.14%,HMCN1;PECAM1;BSG;ADGRL3;CLDN5;PTPRM;CADM1;TGFB2;CDH11;CDH1;CLDN11;ITGB1;CDH2;UNC5D;TENM2;LRFN5;CXADR;PKD1;KIRREL3;TGFBR2;ROBO4;ATP2C1;CEACAM1;TENM4
prerank,response to histamine (GO:0034776),-0.5016269599440777,-1.129744874834615,0.3211538461538462,0.6660536312098616,1.0,6/10,36.68%,GABRB3;GABRB1;HRH1;GABRG2;DRD3;GABRB2
prerank,RNA export from nucleus (GO:0006405),-0.2891092756545388,-1.1297007002860684,0.23746701846965698,0.6653782357310791,1.0,43/100,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;HNRNPA1;NUP35;SRSF3;NCBP2
prerank,regulation of neuron projection arborization (GO:0150011),0.4692748122639335,1.1296229454995836,0.3311827956989247,0.780056010848535,1.0,7/15,15.34%,GRIP1;MACF1;NTNG2;DVL3;DLG4;MYO9A;MOV10
prerank,excitatory postsynaptic potential (GO:0060079),-0.41473098799002317,-1.1295652865729695,0.2783300198807157,0.6649414054050888,1.0,7/19,22.77%,MEF2C;GSK3B;GRIN1;ARRB2;AKT1;GRID2;MAPK8IP2
prerank,regulation of epithelial cell migration (GO:0010632),-0.32598187770804254,-1.1294749785851048,0.2391304347826087,0.6644101586174059,1.0,13/51,9.54%,PTPRG;RHOJ;BMPER;TGFB2;PTK2;DOCK1;PLCG2;DAB2IP;BMPR2;CORO1C;CEACAM1;EMP2;RTN4
prerank,regulation of interleukin-8 production (GO:0032677),-0.3117239457027476,-1.1292826097623598,0.2125,0.6641850500355759,1.0,36/69,35.95%,TMSB4X;F3;KLF4;LBP;NOD1;PTPRC;ARRB1;BCL3;STAT3;RAB1A;CD74;TIRAP;MYD88;OTUD7B;HYAL2;AFAP1L2;RELA;HSPA1B;TLR7;TLR4;FADD;TLR6;MAVS;NOD2;PTPN22;TLR1;C5AR2;NOS2;HSPA1A;SYK;PARK7;F2R;CD33;ANXA4;TLR8;RIPK1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.41375830195497065,-1.128320600291248,0.31237322515212984,0.665850498333297,1.0,10/20,13.96%,NOTCH1;SMAD9;SMAD5;VEGFA;RUNX2;SESN2;XBP1;ATF4;BMP2;MT3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46831984271662597,1.128144353246416,0.3224489795918367,0.783132794538829,1.0,3/15,9.50%,PRKN;BCL2;MDM2
prerank,apoptotic cell clearance (GO:0043277),-0.3657158751299101,-1.12782698130263,0.28051391862955033,0.666367780523506,1.0,5/30,4.39%,THBS1;RAC1;GAS6;SCARB1;TGM2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.45713879534236523,-1.1275176294975626,0.3248031496062992,0.6664288440111887,1.0,6/13,18.61%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECRL;TECR
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.45891461272557477,1.1273393509665846,0.3392857142857143,0.7843194636790574,1.0,3/17,3.96%,SNTA1;GPD1L;ANK2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.44651821472368947,-1.1268712235572962,0.31968810916179335,0.6672903697846636,1.0,7/15,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNN2;KCNJ8;KCNIP2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3934185451359888,1.1267045154825994,0.3029197080291971,0.7850090436810034,1.0,6/33,11.42%,IGF1;IGF1R;PTEN;MYO16;PIK3R1;ERBB2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.41939866321574826,-1.1263862208162478,0.30677290836653387,0.6678708265426003,1.0,9/17,30.73%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B;HM13
prerank,acylglycerol catabolic process (GO:0046464),-0.370811113233538,-1.1259824058193049,0.26931106471816285,0.6681312189488661,1.0,4/30,10.22%,ABHD2;MGLL;LIPE;LYPLA2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.36533326244180153,-1.125875398506999,0.30869565217391304,0.667625208084894,1.0,8/33,11.93%,PRKG1;MEF2C;APOD;IGFBP5;PDCD4;CDKN1B;NDRG4;GPER1
prerank,regulation of protein autophosphorylation (GO:0031952),0.38776702591298595,1.125650089899465,0.2902621722846442,0.7868312159912303,1.0,2/36,0.35%,EPHA7;ERRFI1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2971268461745159,-1.1256114780921025,0.22704081632653061,0.6675607016070401,1.0,30/88,23.95%,TIAM1;RAC1;ROR2;FZD4;AP2A2;FZD6;ARHGEF19;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;PRICKLE2;ARRB2;PSMD5;AP2B1;AP2A1;PSMD9;PSMB4;SPEF1
prerank,neuron maturation (GO:0042551),-0.4179976061608689,-1.1254418133978772,0.32934131736526945,0.6672027216202763,1.0,11/18,27.78%,SCARF1;B4GALT5;ANKS1A;APP;PICK1;C1QA;B4GALT6;CLN5;C3;RND1;ACTL6B
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.43061351778389845,-1.1250758730487798,0.3367139959432049,0.6673299654195073,1.0,10/16,38.81%,TARDBP;ZFP36L1;PLEKHN1;ZC3H12A;RBM24;CPEB3;ZFP36;ZC3H12D;RC3H1;TRIM71
prerank,protein palmitoylation (GO:0018345),-0.35846957873436913,-1.1247628489079702,0.2975391498881432,0.6674303978070154,1.0,13/30,27.62%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;PORCN;HHAT;SELENOK;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3887257072708042,-1.1244543913326637,0.2926315789473684,0.6674591012816301,1.0,8/24,16.77%,TPT1;ACKR3;CD44;BCL2L1;CD74;CLU;CXCL12;MIF
prerank,regulation of endocytosis (GO:0030100),0.34536585479736376,1.124446227467015,0.27335640138408307,0.7891175005181945,1.0,14/61,12.63%,EPHA3;DAB2;TFR2;SYT11;SPHK1;RUFY2;GPC3;SNX33;CCL19;PICALM;ABL1;RUBCN;SNX12;PACSIN3
prerank,Rap protein signal transduction (GO:0032486),-0.4811677138027127,-1.1241302316890005,0.3448940269749518,0.6675617878142402,1.0,2/10,5.89%,RAP1A;PLK2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.37301843947502217,-1.1236941899023758,0.27816091954022987,0.6679455569093682,1.0,10/29,21.04%,HSP90AA1;HSP90AB1;PPIA;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,negative regulation of cell aging (GO:0090344),-0.44002927956073234,-1.1235599401617842,0.31237322515212984,0.667526336009566,1.0,4/16,16.77%,YBX1;CDK6;MAP3K3;MIF
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2548531978824219,-1.1233378026976617,0.172,0.6673452828387217,1.0,73/224,25.79%,UNC13B;SLC12A7;GRM3;DLG2;KCNQ3;CALM1;ATXN3;PLP1;GRM7;MBP;EXOC4;MINK1;GABRB3;SLC12A6;SLC1A1;HOMER1;SYPL1;CAMKK2;GRIK4;GABRB1;CHRM3;DLGAP1;CACNA1E;HTR2A;NRXN1;AMPH;KCNMB4;GRIN1;SLC12A4;KCNA1;SYT10;RPS6KA1;GABRG3;SYNJ2BP;GAD1;CACNB2;SNAP25;PCDHB14;BSN;PRKAR1A;HRH1;APBA3;SYN2;KCNIP2;KCNQ2;CAMK4;PTCHD1;CACNA1B;GLRA3;GRIA2;SLC6A5;CDK5;CACNB3;KCND2;GRIK2;RIT2;CAMKK1;GABRA5;HRH2;GABRE;NPTX1;SST;CHRNB1;NPY;SNCG;PNOC;CPLX1;GABRG2;HAP1;KCNC4;HTR2C;GLRA1;CNP
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.35617002504765666,-1.123327530017232,0.2835164835164835,0.6665776715194048,1.0,16/32,33.37%,APP;TMED10;NR1H4;EIF2A;TIGAR;NOLC1;PRKCD;PUM3;EIF4E;PCIF1;RBM4B;DDX25;RPL10;ATXN2;METTL18;PGAM1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3880287518042977,-1.1232791864133445,0.3105590062111801,0.6659209748853206,1.0,14/25,25.13%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;RTN4;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1
prerank,glial cell differentiation (GO:0010001),-0.3674189102797066,-1.1230668810972115,0.28863636363636364,0.6657595156237023,1.0,12/28,19.12%,ADGRG6;CDH2;SOX4;STAT3;RELN;GPC1;PICK1;EIF2B5;TPPP;SOX2;CDK5;SOX10
prerank,glycerolipid metabolic process (GO:0046486),-0.46812407683794593,-1.1227170906578485,0.31954887218045114,0.6659381073763937,1.0,6/11,29.76%,DGKB;DGKZ;DGKG;PGP;DGKQ;PLA2G15
prerank,protein transport (GO:0015031),-0.24532763374089497,-1.1223601610558946,0.14027149321266968,0.6661136605162435,1.0,128/332,28.78%,SPTBN1;TFRC;NSF;STX3;TBC1D30;TBC1D8;RAMP2;RAB31;RAB3C;STX7;MIA2;RABGAP1L;CHMP2B;STX1A;SLC10A7;TANGO6;ATP6V0A1;EHD1;VMP1;TMED5;HSP90B1;COPG1;ADPRH;ARF5;GRTP1;SCG5;STX6;SGSM1;ARF1;MYH9;TBC1D8B;TBC1D1;DNM2;RAMP1;RAB28;OLFM2;TMED2;GOLGA7;SIL1;TBC1D13;NAPB;SYNDIG1;RAB38;SCAMP1;STX12;ATP6V1A;ATP6V0C;RAB3B;SCG2;RAB1A;EVI5;TCIRG1;CD74;TBC1D10A;LMTK2;ARHGEF2;ATP6V1E1;CLU;CANX;SCAMP2;PICK1;LMAN2L;TMED10;TMED3;CALCRL;KIF13A;RABL3;TMEM167A;LAPTM5;STX2;HERC2;ATP6V0A4;RABGAP1;MTTP;YWHAH;SNX1;CHMP1B;KIF3B;ATP6V0A2;PREB;RAB1B;TBC1D10B;ABCG1;SYS1;SCAMP3;ANK3;CHMP1A;EIF2D;ARFIP2;ATP6V0D2;TVP23A;RAB8A;HDAC6;TBC1D22A;CHMP3;NECAB3;AP2A1;RAB8B;TMED7;SCFD2;RAB7A;ARL4A;RAB3A;ATP6V0E2;SNX27;ARRDC3;ZDHHC17;RAB14;ATP6V1B2;RAB5B;MCOLN1;RAB6B;VLDLR;ARFIP1;NEURL1B;ATP6V1H;CTTN;TBC1D5;SEC31A;COPA;TOM1;IL10RA;ARL6IP5;VPS33B;ARF3;STX5;VPS26B;RAB20
prerank,aortic valve development (GO:0003176),-0.35721042957408056,-1.1222889927310928,0.2924107142857143,0.6655024519963443,1.0,13/34,11.74%,SLIT2;NOS3;TIE1;JAG1;NOTCH1;BMPR2;TGFB1;NFATC1;TNFRSF1B;ELN;HEY2;BMP2;HEYL
prerank,positive regulation of hormone secretion (GO:0046887),0.46083140865470085,1.122217290085788,0.326,0.7944593111121963,1.0,2/17,3.64%,C1QTNF3;TFR2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4191913754681958,-1.122046825396389,0.3079922027290448,0.665291269543605,1.0,10/17,31.00%,SFRP4;TMEM100;BMP4;BTG1;RFX3;FGF2;FOXJ1;SFN;SULT2B1;AHI1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.34266770307553124,-1.1219185723179033,0.2807017543859649,0.6648704197175115,1.0,18/40,22.20%,HIP1;SGIP1;B2M;CBL;HNRNPK;SFRP4;ARRB1;VEGFA;CD63;CLU;PICK1;BICD1;GREM1;ARRB2;INSR;FMR1;ATAD1;C3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.307412128549383,-1.1216011451825485,0.23728813559322035,0.6648964596290254,1.0,24/65,27.49%,FHL1;PINX1;PSMD13;PSMF1;RBX1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4;INTS3;CHEK1;PSMD10;CHMP4C;AVEN
prerank,regulation of Notch signaling pathway (GO:0008593),-0.30158751247447746,-1.1215485533568623,0.24102564102564103,0.6642764961775698,1.0,19/76,12.44%,NOS3;TGFB2;JAG1;PRAG1;SREBF2;NOTCH3;NOTCH1;CCN3;GATA2;JAG2;ARRB1;PDCD10;NOTCH4;LFNG;ZBTB7A;MFNG;STAT3;SYNJ2BP;EPN2
prerank,sterol transport (GO:0015918),-0.40240917307020635,-1.1212653704209923,0.3158995815899582,0.6642355259135988,1.0,4/19,23.65%,CAV1;LCAT;OSBPL5;NPC2
prerank,snRNA transcription (GO:0009301),0.34182472700017247,1.1208143587439872,0.27692307692307694,0.7972957309714361,1.0,13/70,12.11%,POLR2D;PHAX;CDK7;INTS8;POLR2A;CCNT2;RPRD1B;CCNT1;GTF2F1;SNAPC5;TAF8;RPRD2;ICE2
prerank,sympathetic nervous system development (GO:0048485),-0.43364766704252644,-1.1208076759518233,0.3167701863354037,0.6647195580876581,1.0,6/15,22.64%,NRP2;SOX4;CTNNB1;NF1;SEMA3A;SOX11
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4267347703135488,1.120586631541386,0.3137254901960784,0.7968543176765843,1.0,2/21,2.73%,EPHA7;LTF
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.47942265918953186,1.120044220583111,0.3306122448979592,0.7973118245277939,1.0,5/15,7.50%,FGFR4;PDPN;DDR1;IL6;DDR2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4850087916389393,-1.119058222016952,0.3225806451612903,0.6686233773895357,1.0,4/10,13.07%,DGKH;PLPP1;PRKD3;PICK1
prerank,neurotrophin signaling pathway (GO:0038179),-0.4009963231821374,-1.118847851097131,0.3346456692913386,0.6684258444394257,1.0,4/21,9.32%,RAP1A;NGF;BCAR1;DDIT4
prerank,mitotic cytokinetic process (GO:1902410),-0.39885208126786,-1.1187554662079913,0.30753968253968256,0.6678973110838744,1.0,12/20,30.92%,CHMP5;CHMP2B;RHOA;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;CNTROB;VPS4B
prerank,negative regulation of MAPK cascade (GO:0043409),-0.29523086006330435,-1.1185847640700552,0.26912181303116145,0.6675626969224404,1.0,40/87,30.54%,CAV1;PTPRJ;SEMA6A;STK38;DAB2IP;PPIA;PTPRC;SPRED2;UCHL1;FOXO1;CNKSR3;PTPN1;DUSP3;GPER1;SYNJ2BP;SPRY4;IRAK3;NF1;DUSP1;WNK2;SH2B3;CAMK2N1;PRKCD;BMP4;CD300A;HYAL2;DUSP6;SPRY2;DUSP4;SORL1;EMILIN1;PSMD10;EZR;PTPRR;DUSP26;SPRED3;TLR4;ABCA7;PEBP1;DUSP7
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.373332195423818,-1.1175762191699692,0.3114406779661017,0.6695592002851516,1.0,14/28,27.76%,MAP1B;PRUNE1;STMN2;STMN1;STMN4;STMN3;GAS2L1;FKBP4;MAPRE1;MAP1A;CLASP2;CAMSAP3;CAMSAP1;SKA3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.47159360423168045,1.1173873720040364,0.3619631901840491,0.8038156145163042,1.0,4/15,7.99%,IL18;PLA2G10;MAPK9;CSF1
prerank,regulation of viral entry into host cell (GO:0046596),-0.3681009735319196,-1.1170937095033229,0.30691056910569103,0.6700427633702426,1.0,11/30,22.40%,LY6E;GSN;TRIM14;TRIM25;LGALS1;CD74;HS3ST5;MID2;TRIM27;IFITM3;CIITA
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4240939632531953,1.1170171955384296,0.3431372549019608,0.8026649230646834,1.0,9/23,17.07%,ZEB2;DAB2;SLC2A10;FLCN;CDKN1C;CREBBP;SMAD4;CDKN2B;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4240939632531953,1.1170171955384296,0.3431372549019608,0.8026649230646834,1.0,9/23,17.07%,ZEB2;DAB2;SLC2A10;FLCN;CDKN1C;CREBBP;SMAD4;CDKN2B;SDCBP
prerank,cellular response to insulin stimulus (GO:0032869),-0.2729779452706158,-1.1168417315668713,0.22,0.6699581455547342,1.0,45/124,23.23%,GAB1;GRB14;BCAR3;NAMPT;AP3S1;CAV2;RAB31;PKM;BCAR1;HDAC5;ATP6V0A1;GSK3B;CEACAM1;FOXO1;ZDHHC7;APPL1;C2CD5;CPEB1;ZFP36L1;ATP6V1A;APC;XBP1;ATP6V0C;PIK3C2A;MYO5A;PDK2;TCIRG1;ATP6V1E1;IDE;SLC39A14;LPIN3;LPIN1;ATP6V0A4;ATP6V0A2;PIK3R3;AKT1;INSR;ATP6V0D2;HDAC9;RAB8A;DENND4C;CAPN10;RAB8B;TRIB3;INSIG1
prerank,positive regulation of protein modification process (GO:0031401),-0.25533138126294497,-1.1163007311322353,0.18120805369127516,0.6706448155658721,1.0,63/203,20.96%,TEK;NTRK3;PECAM1;LIMCH1;EFNA5;TFRC;KRAS;KDR;NIBAN1;RAC1;HSP90AA1;GAS6;CALM1;PTK2;PDE8A;ENG;RACK1;PPIA;SEMA4D;TBX1;ATG7;PPP1R16B;LIMK2;TGFB1;CAMKK2;ARRB1;CHP1;APP;FLT4;CARD14;RAMP1;VEGFA;PAK1;FGF7;SLCO3A1;RALB;BMP2;GPER1;CD74;SVIP;CCN1;MT3;TERF2IP;CSF1R;FAS;SYMPK;CALM2;BRMS1;DVL2;PPP2R5A;KNDC1;CD40;NPTN;PIK3R3;PLAUR;PINK1;PTBP1;PRKCD;AKT1;BMP4;CDCA2;INSR;FMR1
prerank,negative regulation of type I interferon production (GO:0032480),0.3772468068862417,1.1162695407159469,0.3118279569892473,0.8036439894484514,1.0,13/40,14.28%,CACTIN;NLRC3;RNF135;RNF216;SIRPA;ITCH;IRF3;UBA7;PCBP2;IKBKE;CYLD;TBK1;NLRX1
prerank,iron ion homeostasis (GO:0055072),-0.31485881233675933,-1.1160472146492513,0.2506265664160401,0.6705687004198745,1.0,16/58,10.00%,ABCG2;FTH1;B2M;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;FBXL5;HMOX2;FRRS1;ATP6V1A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2964560368686995,-1.1157823123719681,0.24806201550387597,0.6705158783882765,1.0,29/85,23.01%,TIAM1;RAC1;ROR2;FZD4;AP2A2;FZD6;ARHGEF19;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;PRICKLE2;ARRB2;PSMD5;AP2B1;AP2A1;PSMD9;PSMB4
prerank,cellular senescence (GO:0090398),-0.37308742708872494,-1.1157589476720038,0.3201663201663202,0.6698153301211338,1.0,9/27,25.17%,TBX2;CALR;TBX3;ECRG4;ID2;SPI1;PRKCD;CDKN1A;HRAS
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3283256099167789,-1.1154871592084727,0.30180180180180183,0.6697827141259177,1.0,14/46,14.23%,MEF2C;SHANK3;GRM3;GRM7;CDH2;PTK2B;HOMER1;DGKI;CACNG3;NRXN1;RELN;DGKZ;GRM8;CACNG2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4218706998285462,-1.1154834261846063,0.31556503198294245,0.6690231740865354,1.0,2/17,0.54%,SLC12A2;SLC9A2
prerank,nuclear membrane reassembly (GO:0031468),-0.3203435576534336,-1.1149485611025365,0.2671232876712329,0.6696652890626925,1.0,20/54,26.70%,REEP3;CHMP2B;LEMD2;LBR;NSFL1C;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.45133873465565366,-1.1149362182899765,0.33078393881453155,0.6689433753668756,1.0,9/12,41.36%,UCKL1;CDA;DCK;UCK1;UCK2;UMPS;UPP1;TK2;CAD
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4560050486954732,1.1149234207506584,0.32595573440643866,0.8062578696862693,1.0,5/17,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,protein deubiquitination (GO:0016579),-0.24920458315388602,-1.1147651276259967,0.17562724014336917,0.6686032220151275,1.0,69/242,23.13%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;MINDY2;UBB;NFKBIA;UCHL5;TOMM20;MINDY1;EIF3F;NEDD8;RHOT1;USP29;UBC;RPS27A;USP31;UCHL1;ZRANB1;BIRC3;PSMD13;PSMF1;RHOA;PSMB10;APC;OGT;HGS;USP50;PSMB6;ENY2;PSME3;USP37;PSMB5;ADRB2;OTUD3;PSMC3;UCHL3;OTUB1;PSMD12;FOXK1;PSMB8;OTUD1;PSME1;CFTR;UBA52;IFIH1;PSMB3;RUVBL1;MYSM1;USP28;USP9X;ZC3H12A;WDR20;USP8;UBE2D1;ARRB2;RCE1;PSMD5;OTUD6B;POLB;OTUD7B;VCP;TNFAIP3;USP5;PSMD9;PSMB4;OTULIN
prerank,phospholipid translocation (GO:0045332),-0.3707250015380542,-1.1145160043750901,0.28210526315789475,0.6685530627345282,1.0,9/28,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;MFSD2A;ATP11C;ATP11B;TMEM30A;ATP11A
prerank,glutathione biosynthetic process (GO:0006750),-0.4659643044888912,-1.1143357715739763,0.3428030303030303,0.6682408541759965,1.0,5/11,32.53%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.45983614651470794,1.114311798414175,0.34274193548387094,0.806874874681468,1.0,5/16,14.12%,NAA80;AANAT;NAA35;NAA60;CREBBP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.29275264464608924,1.1143117281695198,0.25501432664756446,0.8057463783532421,1.0,29/182,11.76%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;NOTCH2;PRKN;RBMS3;PCSK9;TNRC6B;PRKAA2;TNRC6A;TET1;SLC2A10;OPTN;ABCC2;PRKAA1;RBL2;WWP2;PICALM;PARP10;AGO2;PARP9;ATOH8;HDAC1;FLCN;APLN;DLG4;BMPR1A
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2983385784815536,-1.1135087324161934,0.2606516290726817,0.6696263955724461,1.0,18/75,13.92%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC39A8;SLC24A2;SLC12A4;ATP1A3;KCNJ8;TRPV2;SLC39A14;KCNJ15
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.27746667555931526,-1.1131502116734695,0.2562674094707521,0.6697695157552418,1.0,31/104,18.41%,CAV1;BMPER;HTRA3;NOTCH1;UBB;ASPN;BMPR2;PRDM16;IL17RD;TGFBR2;CCN3;TGFB1;CD109;UBC;RPS27A;SPRED2;CRIM1;SMAD9;SMAD5;LEMD2;ZBTB7A;BMP2;STRAP;SKIL;UBA52;ACVR1;TGFB1I1;PPM1A;GREM1;TRIM33;UBE2D1
prerank,organelle fusion (GO:0048284),-0.3869479301208992,-1.1128814310973607,0.30833333333333335,0.6697398215665764,1.0,9/22,27.16%,CHCHD3;MIEF1;VPS18;MIEF2;VPS11;MFN2;BAX;SPG7;FIS1
prerank,protein modification process (GO:0036211),-0.29410719043270844,-1.112741812861507,0.23809523809523808,0.6693314015023336,1.0,22/76,19.38%,ST3GAL6;ST8SIA4;STK38;CHRM3;FBXW2;NEDD8;ADPRH;MAN2B1;RPN1;PLOD2;MMP15;CDKL3;ERO1A;UBA52;FBXL2;ST8SIA2;QPCT;DUSP12;YES1;RABGGTB;ST3GAL1;PPP4R2
prerank,negative regulation of cell death (GO:0060548),-0.2862452993334933,-1.111872888584919,0.21975308641975308,0.6708726720852045,1.0,29/88,20.49%,MECOM;CD200;CD34;PPARGC1A;PDE8A;FYN;CCN3;SOX4;NCK1;FERMT2;GSK3B;TNFRSF1B;WNT16;EIF4G1;CLU;CHGA;SRSF6;CCN1;MT3;NENF;WFS1;PRKD1;ATP13A2;DCPS;CDK5;TIGAR;PINK1;AKT1;BMP4
prerank,positive regulation of response to wounding (GO:1903036),-0.38315760339829996,-1.1118472829111572,0.32158590308370044,0.6701630623750899,1.0,7/24,8.82%,ACTG1;OCLN;PTK2;ITGB1;SCARF1;KANK1;GRN
prerank,regulation of mRNA processing (GO:0050684),-0.3561071820845677,-1.1118248178893788,0.29979035639413,0.6694550563027383,1.0,11/32,21.23%,HNRNPK;CDK11B;QKI;LARP7;ZFP36L1;KHDRBS3;SRPK1;AHCYL1;SAFB2;YTHDC1;SLTM
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.32263757423348977,-1.1117025720150557,0.2737819025522042,0.6690261008731287,1.0,14/54,14.72%,CAV1;KCNJ2;NEDD4L;KCNMA1;FHL1;FLNA;KCNAB1;KCNQ1;CD63;KCNMB4;BIN1;KCNN2;KCNJ15;KCNIP2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4558497864660653,-1.1114080891523719,0.34674329501915707,0.6689646928037248,1.0,6/12,28.50%,DAB2IP;XBP1;PTPN1;BAX;ERN1;TMEM33
prerank,regulation of tissue remodeling (GO:0034103),0.44249221595511445,1.1113563994428572,0.33992094861660077,0.8132095494149564,1.0,2/18,1.22%,LEPR;IL18
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.45911058670573807,1.1111777394407096,0.3471933471933472,0.8126014337080674,1.0,3/15,3.92%,PPARA;LPGAT1;SLC45A3
prerank,membrane assembly (GO:0071709),0.38465348475322425,1.1105752826093975,0.3185053380782918,0.8131735679439501,1.0,8/34,9.40%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;UBXN2B;PTEN;PICALM
prerank,neuronal action potential (GO:0019228),0.429087031256133,1.1101492095091705,0.33657587548638135,0.8132357827842083,1.0,1/22,0.09%,SCN7A
prerank,chemical synaptic transmission (GO:0007268),-0.24485927239762978,-1.110107459665803,0.1388888888888889,0.6716037498826081,1.0,89/284,26.59%,UNC13B;SLC12A7;GRM3;DLG2;HSPA8;KCNQ3;LIN7A;CALM1;ATXN3;PLP1;GRM7;MBP;EXOC4;PTPRN2;MINK1;GABRB3;SLC12A6;SLC1A1;HOMER1;STX1A;SYPL1;CAMKK2;GRIK4;GABRB1;CHRM3;DLGAP1;CACNA1E;SLC17A6;HTR2A;NRXN1;NAPB;AMPH;KCNMB4;GRIN1;SLC12A4;KCNA1;SYT10;RPS6KA1;GABRG3;SLC1A4;SYNJ2BP;GAD1;CACNB2;SNAP25;PCDHB14;BSN;PRKAR1A;HRH1;APBA3;SYN2;KCNIP2;KCNQ2;CAMK4;PTCHD1;CACNA1B;GLRA3;GRIA2;STAC3;SLC6A5;CDK5;CACNB3;KCND2;GRIK2;RIT2;CAMKK1;GABRA5;GRID2;PPFIA3;TSPOAP1;HRH2;GABRE;NPTX1;SHISA6;SST;CHRNB1;NPY;SNCG;RAB3A;PNOC;CPLX1;GABRG2;HAP1;KCNC4;HTR2C;GLRA1;CNP;APBA2;CHRM1;KIF1B
prerank,axon development (GO:0061564),-0.29793839942324596,-1.11000478301787,0.2538860103626943,0.67110092530621,1.0,29/78,25.06%,KLF7;ACTB;MAP1B;S100A6;PLP1;GRM7;SHTN1;RTN4RL1;NRCAM;DCC;APBB1;APP;RTN4;SLITRK5;MARK2;SPTBN4;LMTK2;NTNG1;CDK5;DSCAML1;ANK3;L1CAM;RAB8A;BRSK2;MAP1A;RAB3A;ZPR1;EPHB3;ZDHHC17
prerank,endocrine system development (GO:0035270),0.4263477527245332,1.109915917223404,0.34150943396226413,0.8127852016918817,1.0,3/21,6.81%,WNT4;DKK3;SALL1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4526051108174219,1.109403137916022,0.33849129593810445,0.8131386985169481,1.0,3/17,5.06%,ATP1A2;SLC8A1;GJA1
prerank,regulation of aerobic respiration (GO:1903715),-0.4386523879904405,-1.1089880321536065,0.3305613305613306,0.6730423934936911,1.0,6/15,21.92%,CBFA2T3;UQCC2;IDE;PINK1;NOP53;VCP
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4516340195852913,1.1089224361138632,0.32806324110671936,0.8133977033633301,1.0,2/16,1.17%,PPARA;PID1
prerank,regulation of actin filament polymerization (GO:0030833),-0.3020253766850204,-1.1087788864427082,0.24345549738219896,0.672902763335431,1.0,18/69,11.81%,SLIT2;ESAM;KANK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;KANK1;NCK1;BAIAP2L1;HIP1R;CYRIB;SSH2;SSH1;KANK4;NCK2;DBNL;BIN1
prerank,cellular protein catabolic process (GO:0044257),0.34225925870967255,1.108615637704317,0.3015075376884422,0.8131479859150038,1.0,10/59,9.50%,ADAMTS12;PRKN;CLPX;CTSH;PCSK9;ADAMTS7;BNIP3;SIAH2;YME1L1;MDM2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.39016158165183,-1.1084970705806356,0.3031578947368421,0.672907502652619,1.0,8/21,10.48%,CAV1;PDE4D;RASSF2;RACK1;NCK1;CNKSR3;DDIT4;NCK2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4510074727609699,-1.108415796543524,0.32536764705882354,0.6723691838135488,1.0,8/13,32.01%,SLC4A10;GRIK2;PPFIA3;SHISA6;RAB3A;SYP;SLC8A2;SHISA8
prerank,negative regulation of inflammatory response (GO:0050728),0.294124941157378,1.1082316411921525,0.24533715925394547,0.8131675310826734,1.0,8/182,3.61%,IGF1;RORA;ADCY5;ADCY1;C1QTNF3;PPARA;SLAMF8;ADM
prerank,negative regulation of fat cell differentiation (GO:0045599),0.38776189630562324,1.1080770410473662,0.33460076045627374,0.812520241506277,1.0,5/34,7.08%,RORA;RUNX1T1;ANKRD26;IL6;SMAD3
prerank,negative regulation of cellular senescence (GO:2000773),-0.45253394713272344,-1.1080361322197145,0.3326848249027237,0.6726357305304527,1.0,3/13,12.33%,YBX1;CDK6;MAP3K3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.45732448956189575,1.1078099561258243,0.35714285714285715,0.8121810069993304,1.0,1/15,0.51%,TCF7L2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5097427207671061,1.1075673432138193,0.3907563025210084,0.8117461213306997,1.0,1/10,0.31%,BMP6
prerank,positive regulation of neutrophil migration (GO:1902624),0.4459787096251783,1.1075386882529608,0.34063745019920316,0.8107028059711369,1.0,5/18,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,positive regulation of T cell migration (GO:2000406),0.42504925738897226,1.1073546638506202,0.3413654618473896,0.8101143133272435,1.0,2/20,3.19%,OXSR1;CXCL13
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4311228730420269,1.1071068205378392,0.3564356435643564,0.809723507479244,1.0,5/20,10.06%,EPAS1;PRKN;ZMIZ1;ITCH;WASHC1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2902098091095985,-1.1070762655168116,0.25,0.6744410395760816,1.0,30/87,23.78%,KLF4;FHL1;PINX1;FAM107A;PSMD13;PSMF1;RBX1;ZFP36L1;PSMB10;APC;CDK6;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;JADE1;CDK2AP2;PSMB3;PSMD5;SKP1;CDKN1A;CDKN2D;PSMD9;PSMB4;E2F7;RGCC
prerank,COPII-coated vesicle budding (GO:0090114),-0.3018882508725201,-1.107058932974148,0.25757575757575757,0.6737257273653116,1.0,31/68,30.99%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;VAPA;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;SEC23B;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,maturation of LSU-rRNA (GO:0000470),0.40073083500484225,1.1070368656969118,0.32375478927203066,0.8087796022084498,1.0,7/26,16.87%,NSA2;FTSJ3;DDX18;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4351497953685973,1.1066326665979127,0.35639412997903563,0.8077948217364855,1.0,3/19,8.03%,POLR2D;ACD;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4351497953685973,1.1066326665979127,0.35639412997903563,0.8077948217364855,1.0,3/19,8.03%,POLR2D;ACD;POLR2A
prerank,microtubule nucleation (GO:0007020),0.4330621212824935,1.1066132820094494,0.32879377431906615,0.806745794840901,1.0,8/19,19.48%,CCDC57;TUBGCP6;GOLGA2;TUBGCP2;RANBP9;TUBG1;AKAP9;TPX2
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.49183908331109694,1.1066054743536402,0.35051546391752575,0.8056641037058699,1.0,2/11,1.82%,PRKN;DAB2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.39913826918692447,-1.1063781671776158,0.3261802575107296,0.6747671757876785,1.0,7/21,12.73%,SLIT2;TGFB2;DAB2IP;CYRIB;ARHGAP25;CD2AP;SPRY4
prerank,oligodendrocyte differentiation (GO:0048709),0.4372759578415579,1.10633551800845,0.3397312859884837,0.8053192238506602,1.0,2/19,2.75%,SLC8A3;SOX6
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.46465287792661947,1.1061978005875592,0.35477178423236516,0.8046320495689391,1.0,3/14,11.92%,ATP1B3;ANK2;ACTN2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3009459797802905,1.1061898819643137,0.3,0.8035612791212732,1.0,18/150,6.00%,TCF7L2;OSBPL8;FGFR2;FGFR4;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;GFRAL;PDGFRA;RICTOR;IGF1R;FGF1;LRP2;FRS2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4149309957040868,-1.1060033264100733,0.3227176220806794,0.6750609722114459,1.0,8/17,11.81%,NOTCH1;SERPINE2;HES1;TGFB1;TNFRSF1B;TENM4;BMP2;BIN1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3823359930567234,-1.1059881891382763,0.3054393305439331,0.6735856673092917,1.0,9/24,17.39%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,canonical glycolysis (GO:0061621),-0.3823359930567234,-1.1059881891382763,0.3054393305439331,0.6735856673092917,1.0,9/24,17.39%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,B cell activation involved in immune response (GO:0002312),-0.4446623375900876,-1.105788273550164,0.35589941972920697,0.67334281117027,1.0,6/13,29.16%,CD180;MSH2;LIG4;RNF168;FCGR2B;RNF8
prerank,regulation of AMPA receptor activity (GO:2000311),-0.37781615125698015,-1.1057135139099998,0.2874743326488706,0.6728056646495605,1.0,11/25,23.72%,MEF2C;SHANK3;MINK1;CACNG3;RELN;ADRB2;CACNG2;CNIH3;SHISA6;MAPK8IP2;SHANK1
prerank,peptidyl-threonine modification (GO:0018210),0.33868783349186155,1.1056862042310178,0.2907563025210084,0.803905247666942,1.0,15/66,14.33%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CDK1;CAMK2D;GALNT16;PRKDC;HIPK3;PRKD2;TBK1;MAPK1;NLK;GALNTL6
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2969315537591399,-1.1056242284355688,0.26756756756756755,0.6722956933250301,1.0,25/76,19.46%,TMSB4X;CD200;KLF4;DAB2IP;NFKBIA;FAF1;ARRB1;CHP1;LRRC14;PTGIS;AIM2;COMMD7;NLRC5;CHUK;IRAK3;ERBIN;NLRP2B;DAP;CMKLR1;CYP1B1;BRMS1;ZC3H12A;IRAK1;SPI1;ARRB2
prerank,regulation of feeding behavior (GO:0060259),0.5014296657648676,1.1051894807396507,0.35294117647058826,0.8041935436908983,1.0,1/11,0.34%,LEPR
prerank,actin filament organization (GO:0007015),0.30090211424127444,1.105133599170533,0.2805232558139535,0.8032504016553336,1.0,23/151,8.13%,SHROOM3;CGNL1;TPM1;MYO5C;RHOD;FHOD1;DPYSL3;SHROOM2;AVIL;MYO1H;NEBL;ABI2;BAIAP2;ARHGAP12;WASL;FAT1;BAIAP2L2;DLG1;PPP1R9A;RHOBTB2;SPIRE2;MCU;CORO7
prerank,cellular response to hormone stimulus (GO:0032870),0.3373362936368662,1.1050354736089538,0.3204903677758319,0.8024541760777302,1.0,10/69,6.98%,ATP1A2;TFPI;SLC5A5;BRD8;CTSH;NCOA2;STAT5B;CRHBP;NCOA3;UBE2L3
prerank,glycolipid biosynthetic process (GO:0009247),0.3776935840735821,1.1050140333409206,0.32451499118165783,0.8014298904372155,1.0,10/38,12.88%,LARGE1;B3GNT5;PIGU;A4GALT;ST3GAL5;PIGG;PIGV;GBGT1;PIGC;PIGQ
prerank,negative regulation of wound healing (GO:0061045),-0.37194722716964423,-1.104481557133482,0.31385281385281383,0.6746841188476033,1.0,9/28,12.47%,SLC12A2;CD34;SERPINE2;CD109;AJAP1;EDN1;CRK;CASK;THBD
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.37830028369102764,-1.1044169060524722,0.3163716814159292,0.6741089960357716,1.0,4/25,3.90%,B2M;SLC7A5;PLCG2;CD55
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.48874842952606423,-1.1042673382486459,0.3491773308957952,0.6737719378569099,1.0,8/10,43.98%,DNAJB1;HSPA1B;SORL1;DNAJB6;HSPA1A;DNAJB2;DNAJA4;DNAJB8
prerank,organophosphate ester transport (GO:0015748),-0.38403220287363926,-1.1041100277036169,0.3158995815899582,0.6734072881168587,1.0,11/24,23.65%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB;OSBPL5;NPC2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3754435819999608,-1.1037449450347494,0.3138075313807531,0.6736648900229558,1.0,9/25,25.74%,MEF2C;GSK3B;GRIN1;INSYN2A;ARRB2;AKT1;GRID2;MAPK8IP2;GLRA1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3798178214315152,-1.1037043680978014,0.29347826086956524,0.6730454790172057,1.0,13/24,37.72%,ISCU;CIAPIN1;GLRX5;GLRX3;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;BOLA2;NFS1;NUBP1;NUBP2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3654538620088907,-1.1035793268105782,0.28964059196617337,0.6726423094743645,1.0,4/27,2.60%,UTRN;FXYD5;SLMAP;NEDD4L
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.39519031564627777,-1.1034330067904294,0.30515463917525776,0.6722792742795586,1.0,10/21,11.33%,LIMCH1;EFNA5;ACTG1;PTK2;SLK;CORO1C;GPM6B;PEAK1;RHOA;DUSP3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.28087291949455745,-1.1031125559506443,0.23118279569892472,0.6723568797409792,1.0,38/100,23.48%,RPL11;RNF144B;CBFA2T3;HSP90AB1;RNF144A;RACK1;TRIB2;UCHL5;UBXN1;NKD2;SOCS5;BAG6;GSK3B;GNA12;ZYG11B;RBX1;OGT;FOXF2;CAMLG;UBQLN4;RYBP;CLU;HERPUD1;ELOB;ARIH2;COP1;RNF19B;N4BP1;TLK2;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;MAP1A;HSPA1B
prerank,protein ubiquitination (GO:0016567),0.2659086230161075,1.1030291610143643,0.229404309252218,0.8060093001711649,1.0,73/471,12.61%,ASB2;PDZRN3;RNF220;SASH1;TRIM63;EPAS1;RNF43;PRKN;PELI2;BCL2;SPSB1;UBE2E2;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;FBXW4;RNF138;DDB2;RNF217;ZNRF3;PSME4;PSMA2;FBXO44;SH3RF1;TRPC4AP;CAND1;UBE2L3;RNF181;PSMA3;NPEPPS;UBR2;RNF152;SPOP;KLHL7;CUL9;RNF135;SIAH2;WWP2;AMFR;BIRC6;CRBN;USP7;TRAF7;CUL7;RC3H2;UBE4A;FBXL17;NHLRC1;FBXO6;MDM2;PSMD8;ITCH;SMURF2;TRIM35;PRKDC;NEUROD2;DTX1;PSMD3;SH3RF2;RBBP6;FBXO4;MYCBP2;KLHL22;CUL4B;RNF14;CDC73;TRIM26;TRIM43;RNF20;FBXO11;RCHY1
prerank,synaptic vesicle localization (GO:0097479),-0.44616486243349385,-1.1028490147511991,0.34345351043643263,0.672316825435865,1.0,8/13,31.89%,RAB27A;SYNJ1;DNM2;SYNDIG1;CDK5;KIF5C;SNAPIN;KIF5B
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.375702056582064,-1.102817934217285,0.2976939203354298,0.6716570448289336,1.0,9/25,17.39%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,positive regulation of multicellular organismal process (GO:0051240),0.27439316200522235,1.1028118635578852,0.22620689655172413,0.8055327887829238,1.0,33/308,7.08%,SOX5;LEPR;C1QTNF3;APPL2;EPAS1;IL18;DAB2;ACSL1;ESRRG;GNAS;PLA2R1;SCX;SOX6;PLCB1;ALMS1;PPARGC1B;PDPN;ITGAX;GRB10;ABCA1;FOXD1;GLIPR2;GJA1;ACADL;IGF1R;CPT2;PTN;NIBAN2;ADRA1D;IL6;PTH2R;NCOA3;SMAD3
prerank,secondary alcohol metabolic process (GO:1902652),0.3715555293869739,1.1026554796338741,0.3469750889679715,0.8048874068030635,1.0,8/42,12.24%,CYP27A1;ABCA1;ABCA5;IDH2;SOAT2;RXRA;IDH3G;GBA2
prerank,nuclear body organization (GO:0030575),0.4828635831542045,1.1024484730323085,0.35330578512396693,0.8043835453628253,1.0,2/12,3.90%,AFF2;SRPK2
prerank,actin cytoskeleton reorganization (GO:0031532),0.3389459503079332,1.1021309424289922,0.2864493996569468,0.8041758880559414,1.0,9/63,5.14%,AUTS2;PTK7;NRK;KIT;ANTXR1;FER;ANXA1;DTNBP1;RICTOR
prerank,peptidyl-arginine modification (GO:0018195),-0.4262340754869117,-1.1019793726412663,0.3313373253493014,0.6730185325254405,1.0,3/15,8.10%,ART3;KRTCAP2;PRMT8
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.44377458459772956,1.1017241826633266,0.3380281690140845,0.8042307974327652,1.0,5/19,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,gliogenesis (GO:0042063),-0.4320102100917054,-1.1016835881254419,0.3387096774193548,0.6730840134566108,1.0,5/15,10.65%,TGFB2;CD9;CDH2;CDK6;RELN
prerank,hemopoiesis (GO:0030097),-0.2846268056268067,-1.101409385211192,0.264,0.6730847703714832,1.0,33/87,22.87%,MECOM;KITLG;TEK;MFAP5;CD34;KDR;TGFB2;RUNX1;JAG1;KIRREL3;TGFBR2;TGFB1;PTPRC;FLT4;NOTCH4;RUNX2;RTKN2;ATF4;TAL1;ARIH2;GLRX5;CSF1R;FLT3;RRAS;TOX;SH2B3;TIRAP;L3MBTL1;BMP4;MKNK2;PRKX;DLL1;CEBPA
prerank,negative regulation of cell cycle process (GO:0010948),0.3405096572341363,1.1013542670426715,0.288961038961039,0.8041787347289144,1.0,8/61,6.57%,BMP7;DMRT1;RBBP4;L3MBTL2;MGA;TOM1L2;RNF2;RBBP7
prerank,cilium organization (GO:0044782),0.2890459432963647,1.1012976593916355,0.2669376693766938,0.8032637538650015,1.0,62/209,19.76%,DCDC2;ASAP1;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;ARL6;CEP19;IQCB1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;IFT122;CFAP126;TTC39C;PKD2;EXOC3;ARMC2;IFT140;CFAP298;CCDC65;WDR90;CEP164;CFAP70;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;PDE6D;RAB11FIP3;ARF4;RP2;TMEM237;BBS1;RTTN;TRAF3IP1;IFT81;IFT46;BBS2;CEP78;TTC17
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2582971176916036,-1.1011856409225873,0.21630094043887146,0.6729260742889694,1.0,44/172,16.57%,PIP5K1B;DGKH;PITPNM2;CEPT1;PLCG2;INPP5D;BMX;CRLS1;PIK3R6;INPP4A;SYNJ1;DGKB;PIK3C2B;ARF1;CDS1;FAR1;MFSD2A;CDIPT;CPNE3;PLEKHA1;PIK3CD;LPCAT3;PIK3C2A;GPAT4;MTM1;GPAT3;DGKZ;MTMR6;DGKG;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;LPCAT1;SACM1L;LPIN3;CSNK2B;PIP5K1C;SBF1;PLA2G4A;PI4KB;ETNK1;LPIN1
prerank,regulation of actin filament depolymerization (GO:0030834),0.4791480001330021,1.1010777300388261,0.365702479338843,0.8028001174645555,1.0,2/12,7.18%,PLEKHH2;LIMA1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.43390481495493255,-1.1009337426759485,0.3458646616541353,0.6728990366042567,1.0,8/15,34.32%,SIX1;VEGFA;SIX4;BMP4;PAX8;AGT;NOG;PAX2
prerank,cellular response to osmotic stress (GO:0071470),0.4231854882130751,1.1007437160918172,0.34368932038834954,0.8026485441247488,1.0,4/21,7.82%,OXSR1;MYLK;LRRC8E;RCSD1
prerank,DNA biosynthetic process (GO:0071897),-0.41806963549268517,-1.1005166288727557,0.3365570599613153,0.673298361170049,1.0,8/16,26.39%,PPIA;WRNIP1;POLA1;POLE;POLD3;CDKN2D;POLD1;POLL
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.47589583379721545,-1.0995251882721626,0.3570057581573896,0.6751369120157521,1.0,6/10,28.70%,ST6GAL1;ST3GAL1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4404584356231623,1.0990170538794655,0.3522504892367906,0.8063847785994454,1.0,4/16,10.08%,LHPP;AMPD3;ADSL;GMPS
prerank,proteolysis (GO:0006508),0.28297260467971497,1.098755124343557,0.2786206896551724,0.8060702777510506,1.0,23/252,9.50%,ADAMTS12;ADAMTS9;CPQ;ADGRV1;AEBP1;TRABD2B;CLPX;CAPN9;CTSH;MMP2;ACE;TPP1;ADAMTS7;MMP19;SUFU;NPEPPS;MMP9;CPXM1;USP25;CUL7;YME1L1;FBXO6;MDM2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3796365205220972,-1.0984875297033239,0.3319327731092437,0.6771629557084536,1.0,4/22,13.11%,ESR1;MED17;PSMC3;MED14
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.44903880578478833,-1.09848065511713,0.35283363802559414,0.6764401966986047,1.0,6/12,18.13%,HSP90AA1;HSP90AB1;B4GALT5;EPHB1;SPTBN4;B4GALT6
prerank,Golgi to endosome transport (GO:0006895),-0.42195160661116693,-1.0981385530147971,0.3510436432637571,0.6766054058527823,1.0,8/16,25.06%,MON2;VPS13A;VPS13C;AP1AR;GBF1;SYS1;AP2A1;RAB14
prerank,neural tube development (GO:0021915),0.45076949977255715,1.0980498698431544,0.3489278752436647,0.8068640177322836,1.0,1/15,0.23%,ALDH1A2
prerank,anion transport (GO:0006820),-0.35103950999281885,-1.098018575288326,0.3150684931506849,0.6761807661302903,1.0,6/33,2.70%,ABCG2;SLC26A7;LRRC8C;LRRC8D;LRRC8B;SLCO2B1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.499047542879254,1.0976583162512434,0.3651804670912951,0.8069029039034462,1.0,5/10,13.93%,ACD;DCLRE1A;DCLRE1B;RTEL1;APEX1
prerank,cellular response to heat (GO:0034605),-0.3466506412437902,-1.097530391525081,0.30275229357798167,0.6767091063602187,1.0,5/35,2.39%,ANO1;THBS1;HSP90AA1;HSP90AB1;ATXN3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.34845530435884314,1.0974210138512523,0.32160804020100503,0.806446449800837,1.0,8/55,5.38%,CEMIP;FMOD;SDC2;OGN;GPC6;OMD;PRELP;GPC3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3119463618991005,1.097413382259557,0.28885400313971743,0.8054052870100459,1.0,9/101,5.51%,ROBO1;IL34;CEMIP;KIT;LTF;PDGFRB;PDGFD;LRRK2;FGF1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.42972268034497973,-1.0973965370581151,0.3562992125984252,0.6763334856710661,1.0,5/14,8.57%,LIMS2;LIMS1;FLNA;EMP2;CD63
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.28769206927967184,-1.0972541806849234,0.2647058823529412,0.6760020210162342,1.0,34/86,26.33%,KLF2;UBB;UBC;RPS27A;EGLN3;VEGFA;PSMD13;PSMF1;RBX1;PSMB10;LIMD1;ATF4;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;PSMD12;PSMB8;ELOB;PSME1;UBA52;PSMB3;DNAJB1;PSMD5;ATF3;HIGD1A;PSMD9;PSMB4;VHL;CUL2;CHEK1;PSMD10;EPO
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4466308986912565,1.0968069912397072,0.35192307692307695,0.8060370020703419,1.0,2/17,1.19%,ROBO1;EFNB2
prerank,positive regulation of cellular component organization (GO:0051130),0.3128944506733718,1.0965372655326955,0.29555895865237364,0.8056982302745515,1.0,15/107,7.56%,FRMPD4;TRABD2B;ASAP1;BMP7;ADGRL1;LRP4;DAB2;FNIP1;TFR2;CRB3;GPC3;IGF1R;BNIP3;SLF1;CCL19
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.27914182411882393,-1.0964930676561329,0.2535211267605634,0.6772817837339727,1.0,29/108,16.12%,HIP1;MAP3K5;ACER2;GSN;F3;NGF;RPS3;RACK1;CTSD;TNFSF10;NOD1;ST18;EGLN3;ATP2A3;HIP1R;SOX7;NDUFA13;XDH;GPER1;REST;HSPD1;CASP8AP2;RPS27L;BBC3;DAP;FAS;BCAP31;CASP8;LAPTM5
prerank,ventricular septum morphogenesis (GO:0060412),0.39397861889550345,1.095409458051909,0.32774674115456237,0.807806998232937,1.0,2/27,0.29%,TGFBR3;ROBO1
prerank,positive regulation of secretion by cell (GO:1903532),0.3380346914702264,1.0952405674033048,0.3411371237458194,0.8072131295361558,1.0,5/70,3.51%,IGF1;BMP6;FRMD4A;PLA2G10;DTNBP1
prerank,positive regulation of cell killing (GO:0031343),-0.4413854480880638,-1.095110993156686,0.3596153846153846,0.6800678534566185,1.0,3/13,16.37%,RAC1;MAPK8;DVL2
prerank,neural crest cell differentiation (GO:0014033),-0.414937937732728,-1.0951104037173487,0.35051546391752575,0.679344584290441,1.0,2/18,2.75%,MEF2C;CDH2
prerank,negative regulation of insulin secretion (GO:0046676),-0.4104474459049846,-1.0951032743720217,0.36270491803278687,0.6786264639098908,1.0,6/17,14.02%,KLF7;KCNB1;CCN3;REST;CHGA;SIRT4
prerank,protein autophosphorylation (GO:0046777),0.29412446625745897,1.0948287374700882,0.2817919075144509,0.807349000824535,1.0,27/157,12.59%,OXSR1;FGFR2;FGFR4;KIT;DAPK1;PDPK1;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;DDR1;SIK1;IGF1R;LRRK2;STK17B;DDR2;GRK5;MUSK;CAMK2D;VRK2;ABL1;JAK2;ERBB2;MAPKAPK2;PRKD2;STK24
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.42167018550094176,1.0946997482850138,0.3548387096774194,0.8066419616012891,1.0,2/22,3.71%,ROCK2;EPHA4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4215096113558139,1.0944110454255926,0.35283018867924526,0.8064209578253354,1.0,2/20,0.85%,TGFBR3;RBPJ
prerank,cilium assembly (GO:0060271),0.27819924639349614,1.0939303802653382,0.2664941785252264,0.8066793937064003,1.0,82/296,19.71%,DCDC2;ASAP1;NINL;INTU;ALMS1;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;HAUS4;CEP152;CC2D2A;ARMC9;WDR19;SDCCAG8;UBXN10;TTC8;WDPCP;TBC1D32;KIF27;WDR35;ARL6;CEP19;IQCB1;ARL13A;CDK1;RPGRIP1L;PAFAH1B1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;HAUS1;IFT27;IFT122;SFI1;TTC39C;CEP57;CFAP74;EXOC3;KIF3C;TNPO1;IFT140;CFAP298;CCDC65;WDR90;CEP63;CEP164;CFAP70;DNAAF3;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;TUBG1;IFT22;PDE6D;RAB11FIP3;CEP97;ARF4;RP2;TMEM237;BBS1;AKAP9;TRAF3IP1;IFT81;IFT46;BBS2;CNTRL;GAS8;CEP78
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2837435501855126,-1.0938188927378776,0.2699724517906336,0.6813997387315803,1.0,32/88,23.79%,FNIP2;TFRC;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;MPP7;FAF1;GSK3B;VEGFA;SPIDR;HGS;PIH1D1;TAL1;CLU;CHGA;TPPP;ATP13A2;CDC42EP2;TIRAP;MMP1;SDC4;BIK;VCP;BMF;MTLN;RAB7A;PDCD6IP;RGCC;BAX
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4342221960174365,-1.0937480896931673,0.35671342685370744,0.6808627985792945,1.0,5/13,10.65%,SHANK3;LGMN;APP;ZDHHC2;RELN
prerank,regulation of axonogenesis (GO:0050770),0.35009003015747603,1.0934082472637627,0.32945091514143093,0.807063749480408,1.0,8/51,7.48%,PLXNA2;ROBO1;LRP4;KIF13B;EPHA4;PLXNC1;ARHGAP35;PTEN
prerank,cellular response to interleukin-1 (GO:0071347),-0.26061592423379776,-1.0932760931921035,0.2543859649122807,0.6813619247765967,1.0,49/143,23.41%,RPS6KA5;DAB2IP;UBB;NFKBIA;NOD1;IKBKB;ST18;IL1R1;UBC;RPS27A;IL1RAP;PTGIS;PSMD13;PSMF1;RBX1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;MAP3K3;PSMC3;IRAK3;GBP3;PSMD12;PSMB8;CUL1;MAP3K8;TAB3;CD47;PSME1;UBA52;PSMB3;RPS6KA4;CD40;ZC3H12A;CCL13;IRAK1;PSMD5;MYD88;SKP1;MAPK3;MAPK11;PSMD9;HYAL2;PELI1;PSMB4;RELA
prerank,myelin assembly (GO:0032288),-0.4722159664234169,-1.0930442582404816,0.350293542074364,0.6812213129970361,1.0,7/10,24.20%,CD9;TENM4;GPC1;TPPP;ABCA2;NCMAP;EPB41L3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.38173938636396065,1.0922014952551888,0.35315985130111527,0.8093517242986035,1.0,3/32,2.58%,CEMIP;PDPK1;GSTM2
prerank,positive regulation of endocytosis (GO:0045807),-0.32666791398379047,-1.0914884849541087,0.3062645011600928,0.6845941193161545,1.0,7/45,3.38%,HIP1;SGIP1;B2M;CBL;HNRNPK;NEDD4L;RAB31
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2777530542677103,-1.091484682399648,0.2681564245810056,0.6838797608692446,1.0,33/103,18.23%,ARHGAP31;RAPGEF5;TIAM1;RASGRP3;KRAS;RAC1;SHTN1;RERG;NRAS;G3BP1;PLK2;CCDC88A;ABR;BCR;MRAS;CHP1;JUN;NUCB1;RAB38;RALB;USP50;KSR2;RHEB;GRAP;RUNDC3A;NF1;CCDC88C;PRKD1;USP28;RRAS;USP8;CDK2;RGS19
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.46185048832555414,1.091354306578122,0.3642105263157895,0.8106435185056525,1.0,4/14,8.91%,TPP1;ACD;XRCC5;BRCA2
prerank,blood circulation (GO:0008015),-0.317596706034982,-1.09113541894514,0.30855855855855857,0.6840701069746926,1.0,17/49,19.74%,SGCD;NOS3;ACVRL1;MEOX2;TBC1D8;GUCY1B1;GCLM;GUCY1A1;SOD1;ELN;ACE2;CXCL12;CYB5R3;PLN;SGCZ;AGTR1;DLL4
prerank,artery development (GO:0060840),-0.37619329625525944,-1.091082995241398,0.3388773388773389,0.6834897714368483,1.0,8/23,7.87%,ACVRL1;ENG;TBX1;BMPR2;HES1;STRA6;PDE2A;VEGFA
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.36257113744690433,1.0910275237568046,0.3268892794376098,0.810505159944661,1.0,1/41,0.08%,PRKAG2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5001286203298482,1.09069171680111,0.3655030800821355,0.8103624954928974,1.0,3/10,16.13%,KIT;BTLA;LYN
prerank,transition metal ion homeostasis (GO:0055076),0.39957078620872954,1.090430642969841,0.3383742911153119,0.8100816157774434,1.0,6/28,9.40%,CP;HEPH;PRKN;TFR2;NEO1;PICALM
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.43598047198086354,-1.0897567009371738,0.35192307692307695,0.6862687363924395,1.0,5/13,15.32%,BMP5;SOD1;BMP2;REST;ERLIN2
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.32318097909557597,-1.0896243049587906,0.3236607142857143,0.6858415017068292,1.0,17/45,25.95%,TGFB1;DDX5;BUD23;GRSF1;LIN28B;MAP2K2;UTP15;SUPV3L1;HNRNPLL;BMP4;RBM22;SIRT7;RBM20;RELA;ZPR1;HRAS;ERN1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.43748606578243227,1.0896053482981656,0.3629191321499014,0.8112180811399978,1.0,2/18,5.86%,PRKAG2;PRKCB
prerank,erythrocyte differentiation (GO:0030218),0.3624574156813275,1.0893797967151868,0.3274336283185841,0.8107649100390768,1.0,9/44,12.76%,TGFBR3;KIT;ACIN1;UFL1;LYAR;CEBPG;MED1;JAK2;SLC25A38
prerank,zinc ion transmembrane transport (GO:0071577),-0.3864974114324786,-1.0893611121244289,0.3292929292929293,0.6858180448808165,1.0,6/22,13.34%,SLC39A10;SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4880858886284769,1.089164317892157,0.38253638253638256,0.8103198673394428,1.0,2/12,8.41%,PPARA;MIA3
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.38717339137884904,-1.0889552235375755,0.35918367346938773,0.6861319813297506,1.0,8/21,9.36%,NOS3;GAS6;PTK2B;NOTCH1;ASPN;TGFB1;SRGN;HEY2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.47123326749657857,1.0887651399073588,0.36363636363636365,0.810395013755329,1.0,2/12,9.75%,IL18;IL17D
prerank,regulation of interleukin-1 production (GO:0032652),-0.42749741663919716,-1.0886474468269305,0.3575638506876228,0.6861815761277904,1.0,4/15,13.99%,FOXP1;GAS6;CEACAM1;TMED10
prerank,spliceosomal complex assembly (GO:0000245),0.3594928500613051,1.0884850985005816,0.323943661971831,0.8101251541040274,1.0,10/46,13.76%,CELF2;SRPK2;NOL3;RBM5;SF3A3;DDX23;SMN1;SNRNP200;SCAF11;CRNKL1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3842071290179896,1.0883847867614072,0.34823091247672255,0.8093486767476394,1.0,4/31,6.47%,RANBP3L;SMAD6;TMEM64;SUFU
prerank,fatty acid oxidation (GO:0019395),0.33894654932840396,1.088352004376536,0.3048780487804878,0.8083976094889371,1.0,15/57,14.65%,EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,acute inflammatory response (GO:0002526),-0.3819521403579017,-1.0878822660200667,0.3373253493013972,0.6875516020846708,1.0,11/23,37.54%,F3;LBP;CTNNBIP1;SIGIRR;CEBPB;AHSG;VNN1;MYLK3;HPR;HP;CRP
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.35872897201646015,-1.0876672344117984,0.319672131147541,0.6874190665407316,1.0,4/29,5.63%,JAM2;GAS6;LGMN;CALR
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.35913953544306526,1.0871091972450386,0.34229390681003585,0.8109138303609738,1.0,5/45,6.30%,BMP6;BMP7;DAB2;RBPMS;TTK
prerank,N-glycan processing (GO:0006491),-0.39811535485090743,-1.0868488262169034,0.3381742738589212,0.6888709394925909,1.0,7/18,15.97%,ST8SIA4;FUT8;ST8SIA1;ST8SIA6;MAN1A2;MAN2A2;ST8SIA2
prerank,aggrephagy (GO:0035973),-0.3581744966673128,-1.086754177100396,0.3242630385487528,0.6883887751319139,1.0,8/27,15.45%,VIM;UBB;DYNLL2;UBC;RPS27A;WDFY3;CFTR;UBA52
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.47328638810673046,-1.086433597680936,0.403921568627451,0.6885345329495756,1.0,6/10,26.47%,SVIP;ERLEC1;INSIG1;UBE2J1;YOD1;UBAC2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4437374364597052,-1.0862755718615746,0.3727087576374745,0.6881900304434432,1.0,3/12,6.03%,RUNX1;CBFB;PTPRC
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.47228345631801094,1.0859193148414994,0.37136929460580914,0.8130702062010671,1.0,3/12,8.39%,PPARA;ABCA1;ABCA5
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3835527394736795,1.0858675250412795,0.3486238532110092,0.8121651677246134,1.0,7/30,7.35%,SNTA1;KCNA5;GPD1L;ANK2;CACNA1D;GJA1;CACNA2D1
prerank,protein localization to phagophore assembly site (GO:0034497),0.49919093081797816,1.0858294387151977,0.3741794310722101,0.8112291392062827,1.0,4/11,13.39%,WIPI1;TRAPPC8;ATG9A;STX17
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4315087913617656,-1.0857266583958982,0.3701550387596899,0.6888896842649672,1.0,3/13,9.24%,MSN;ZDHHC7;RHOA
prerank,negative regulation of programmed cell death (GO:0043069),0.2671553766078117,1.0854601468285514,0.2609254498714653,0.8112381422459092,1.0,53/355,11.31%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;DAB2;BCL2;SMAD6;DKK1;SCX;LTF;IFIT3;CTSH;ANXA1;PDPN;ARAF;SPHK1;ZFAND6;PRKAA2;IGF1R;LRP2;SON;NIBAN2;KRT18;MYO18A;BNIP3;SH3RF1;IL6;NOL3;KANK2;MMP9;PRKAA1;BIRC5;SIAH2;GRK5;BIRC6;CDK1;NUPR1;BCL2L2;YME1L1;ITCH;MED1;NAA35;AXL;PHIP;PRKDC;HDAC1;PIK3R1;RPS6KB1;TFAP2A;TFAP2B;SH3RF2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3987186060283081,1.0852504457360876,0.36608863198458574,0.810759218940687,1.0,4/26,8.62%,FBN1;HOXA7;LRRC17;FSTL3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.43543621970249685,1.0848659130368525,0.33867735470941884,0.8107470629033078,1.0,5/17,15.34%,LPGAT1;PLA2G10;PLA2G4B;SERAC1;PLA2G12A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3720540438777162,1.0847410350355562,0.35125448028673834,0.8100403546613605,1.0,14/37,19.12%,DYNC2H1;IFT80;WDR19;WDR35;IFT27;IFT122;KIF3C;TNPO1;IFT140;DYNC2I1;IFT22;TRAF3IP1;IFT81;IFT46
prerank,positive regulation of transferase activity (GO:0051347),0.29991099793710924,1.0843518922535322,0.3034379671150972,0.8100348453379882,1.0,19/142,8.66%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;IGF2;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;ACD;UBE2L3;XRCC5;DDR2;RYK;MUSK
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40676009825957476,-1.0841622205301662,0.35070140280561124,0.6922646492359278,1.0,5/17,11.93%,PRKG1;MEF2C;PDCD4;CDKN1B;GPER1
prerank,centromere complex assembly (GO:0034508),0.38379274768429616,1.083961765843043,0.34615384615384615,0.8100669539300956,1.0,11/36,15.71%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ;CENPX;MIS12
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3763437354752207,-1.0839353904719797,0.3551020408163265,0.6921995923877252,1.0,4/23,9.41%,CADM1;PIK3R6;LAMP1;PVR
prerank,negative regulation of defense response (GO:0031348),0.32184091993668174,1.083597894792216,0.31280388978930307,0.8099840359061095,1.0,15/77,16.16%,RORA;C1QTNF3;PPARA;CACTIN;NLRC3;LYAR;SIRPA;ITCH;ENPP3;PCBP2;MAPKBP1;NLRP12;PTGER4;CDH5;TRAFD1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.31684297728266864,1.0835278269752069,0.3264984227129338,0.8091727432005466,1.0,19/94,12.44%,NINL;ALMS1;RAB3IP;HAUS4;CEP152;CC2D2A;SDCCAG8;IQCB1;CDK1;RPGRIP1L;PAFAH1B1;TCTN1;SCLT1;CEP89;FBF1;OFD1;HAUS1;SFI1;CEP57
prerank,positive regulation of wound healing (GO:0090303),-0.3430090124043045,-1.0833986770309323,0.32235294117647056,0.6929700716896562,1.0,10/36,10.15%,ST3GAL4;ACTG1;OCLN;THBS1;PTK2;ITGB1;KANK1;FERMT2;MTOR;XBP1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2924717766366545,-1.0832884944513472,0.2905759162303665,0.692539746205984,1.0,18/75,17.58%,GPCPD1;DGKH;SERINC1;SERINC5;CRLS1;SYNJ1;SMPD4;FAR1;GDPD1;CPNE3;PLCB3;GDPD3;PNPLA6;CSF1R;PLA2G4A;ABCA3;PGP;PIGZ
prerank,reticulophagy (GO:0061709),0.4873496737224865,1.0832519966125747,0.3774703557312253,0.8088822845284848,1.0,3/12,10.75%,UFL1;RETREG1;TEX264
prerank,regulation of adenylate cyclase activity (GO:0045761),0.41901019180451426,1.0828344671954684,0.3820662768031189,0.8090574046462523,1.0,3/22,4.74%,ADGRV1;STIM1;CACNA1D
prerank,vasculature development (GO:0001944),0.44062116534189943,1.0828038812841094,0.3860369609856263,0.8081314425173345,1.0,3/16,4.40%,ERRFI1;PDGFRB;PDGFRA
prerank,regulation of histone acetylation (GO:0035065),-0.34196088029025534,-1.0825917521118478,0.34549356223175964,0.6936153341178872,1.0,12/33,21.48%,RPS6KA5;PPARGC1A;HDAC5;ARRB1;SET;GLYR1;NOS1;RPS6KA4;CTBP1;SPI1;NOC2L;MAPK3
prerank,cellular response to UV-A (GO:0071492),0.4789661810896693,1.0824529554418807,0.37678207739307534,0.8080141563613764,1.0,3/11,9.41%,MMP2;MMP9;CERS1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3141509068432441,-1.0824520960259414,0.3356009070294785,0.6933170325873197,1.0,11/48,13.61%,FNIP2;CRIP1;BCL2L1;BAG6;TNFRSF1B;CHEK2;DDIT4;BCL3;MSH2;AEN;RPS27L
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4747753546961867,1.0823308653241317,0.3941908713692946,0.8073301525644908,1.0,1/12,1.22%,IL18
prerank,response to estrogen (GO:0043627),-0.35069797213282394,-1.0820518755581212,0.34347826086956523,0.693629890550124,1.0,8/31,14.67%,CAV1;ESR1;TRIM25;SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,regulation of microtubule nucleation (GO:0010968),-0.4768823847870547,-1.0819693171007216,0.37258687258687256,0.6931285068710079,1.0,7/10,33.16%,PAK1;GIT1;CKAP5;DCTN1;HSPA1B;RANGRF;HSPA1A
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4099510518996562,-1.0819127397972312,0.35645472061657035,0.6925351488291674,1.0,6/16,19.83%,CAV1;TRIM14;TRIM25;FUCA2;HS3ST5;TRIM27
prerank,positive regulation of isotype switching (GO:0045830),-0.4208505272944798,-1.0818969099917242,0.35355648535564854,0.6918686874735378,1.0,8/15,31.51%,TFRC;TGFB1;CD40;KMT5C;CLCF1;SHLD3;RIF1;SHLD2
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4344153555502397,-1.0818216142068309,0.38519924098671726,0.6913509693723058,1.0,5/12,20.13%,TARDBP;JUN;REST;PSMC3;TFAP4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.47043751354074653,-1.0814820298387922,0.35946462715105165,0.6915448563611558,1.0,5/10,26.09%,ACER2;NEXMIF;CYP1B1;JAM3;SNAI2
prerank,mesenchymal cell development (GO:0014031),-0.3892339132544791,-1.0814733774997785,0.35546875,0.6908467560187994,1.0,10/18,33.49%,CDH2;NOTCH1;HEY2;HEYL;NOLC1;SOX11;SNAI2;PEF1;TBX20;KBTBD8
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.40165810951485315,1.0814376050045136,0.35239852398523985,0.8087359585330216,1.0,2/26,1.91%,ERRFI1;SNX6
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4712748188336314,-1.081229227873205,0.3816793893129771,0.6907666245598645,1.0,7/10,42.61%,TMEM30A;ABCA3;DBI;ABCA7;PRELID1;ABCB4;TRIAP1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3800320040687267,-1.0812127397169065,0.352112676056338,0.6900950385314629,1.0,10/23,24.36%,HSP90AB1;CDC37;NLRC5;IFNGR1;NR1H2;JAK1;TXK;NR1H3;SOCS1;STAT1
prerank,myelin maintenance (GO:0043217),-0.4648478758824369,-1.0807419084001197,0.3767258382642998,0.6906149385274521,1.0,6/10,26.51%,SOD1;CLU;ABCD2;EPB41L3;PRX;MYRF
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3564498849718453,-1.0806776054172984,0.3368869936034115,0.690064820019181,1.0,5/29,9.41%,CADM1;STX7;LAMP1;CYRIB;PVR
prerank,axon extension (GO:0048675),0.4013566740454847,1.0803826288407745,0.35384615384615387,0.8106024371701909,1.0,2/23,0.61%,ALCAM;AUTS2
prerank,regulation of cell motility (GO:2000145),-0.2623451542742489,-1.0802805868025038,0.259375,0.6903924580552759,1.0,27/121,10.85%,FRMD5;TMSB4X;SPOCK2;RAC1;CAVIN1;PLXND1;PRAG1;SLK;SERPINE2;DOCK10;TMSB10;CCDC125;MINK1;PLXNA4;FLNA;SPATA13;RHOB;TGFB1;ROBO4;CEACAM1;ABI3;CYRIB;FGF7;SRCIN1;RHOA;CDK6;CRK
prerank,regulation of cytoskeleton organization (GO:0051493),-0.27386287641218643,-1.0801362426972458,0.29080118694362017,0.6900888111622921,1.0,26/108,12.26%,EFNA5;CLIC4;RAC1;IQGAP1;PTK2;CORO2B;PHLDB1;F11R;MAP6;RHOB;FAM107A;CAPN2;CCDC88A;GSK3B;GPM6B;HIP1R;TJP1;MTOR;PAK1;ARHGEF19;RHOA;PAK2;ARHGEF5;CRK;SORBS3;MARK2
prerank,protein targeting to lysosome (GO:0006622),-0.39701067725464584,-1.079753683937798,0.350210970464135,0.6904134512349471,1.0,11/20,25.68%,HSPA8;SNX16;HGS;CLU;NCOA4;M6PR;LAPTM5;GNPTAB;RAB7A;SCARB2;SORL1
prerank,aortic valve morphogenesis (GO:0003180),0.38386842963773143,1.079486496600835,0.3442028985507246,0.8120524006995122,1.0,3/30,2.28%,ROBO1;ROCK2;SMAD6
prerank,cell part morphogenesis (GO:0032990),0.46110606464114423,1.0793771767791562,0.3798767967145791,0.811342046109195,1.0,2/13,4.45%,PID1;WASF1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4706586320977736,1.0793499174711512,0.3784860557768924,0.8103999904461744,1.0,1/12,0.19%,ADAMTS12
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.24309464799954641,-1.078802225330336,0.22,0.6922475476084058,1.0,55/234,16.37%,PRKCH;CAV1;ESR1;CD200;TFRC;RPS6KA5;PPARGC1A;PLCG2;UBB;NFKBIA;RPS3;PPIA;NOD1;ROR1;FZD4;TRIM14;IKBKB;HDAC5;EDA;TRIM25;CTNNB1;UBC;RPS27A;TNFRSF11A;LRP8;APP;CARD14;VEGFA;IL1RAP;AIM2;SLCO3A1;ZBTB7A;EDN1;ARHGEF5;CHUK;RTKN2;STAT3;RELN;ARHGEF2;CLU;IRAK3;STK36;PPRC1;TAB3;JUP;TERF2IP;TRIM13;TRAF1;UBA52;CX3CR1;TCF3;CARD16;PRKD1;RPS6KA4;DVL2
prerank,retinol metabolic process (GO:0042572),0.4630932863251702,1.0781051541486435,0.384765625,0.8126452303423123,1.0,3/14,15.98%,RBP4;DHRS3;RDH11
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.29727662238540353,-1.0779313655038483,0.324582338902148,0.6936878285352772,1.0,28/62,28.21%,TPT1;ACKR3;DNAJA1;PPIA;CREB3L1;HSPB1;YBX3;BCL2L1;XBP1;RTKN2;NDUFA13;ARHGEF2;CLU;HERPUD1;CXCL12;PLAUR;PINK1;TMBIM6;AKT1;NOC2L;CDKN2D;PTTG1IP;CREB3;URI1;SNAI2;EPO;SYVN1;TMEM161A
prerank,regulation of DNA binding (GO:0051101),0.35695069402297946,1.0779295756573783,0.3407917383820998,0.8120957823868857,1.0,6/44,8.99%,IGF1;PRKN;SP100;MMP9;RSF1;CEBPG
prerank,inner dynein arm assembly (GO:0036159),-0.47110380678953334,-1.077718149815964,0.3768939393939394,0.6935115485916543,1.0,8/10,47.14%,CFAP100;CCDC40;DNAAF4;CCDC39;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,regulation of vasoconstriction (GO:0019229),-0.36514463354216453,-1.0776996600350794,0.36401673640167365,0.6928525018698279,1.0,9/27,11.79%,CAV1;BMPR2;ADRA1B;CHRM3;ADRA1A;KCNMB4;ECE1;ACE2;ATP2B1
prerank,regulation of isotype switching (GO:0045191),-0.4217493551475084,-1.0776710726729686,0.3816046966731898,0.6922062410842204,1.0,10/14,46.31%,TFRC;KMT5C;SHLD3;SLC15A4;RIF1;SHLD2;KMT5B;IL4;MAD2L2;PARP3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4653776894841754,-1.0774502989376007,0.35589941972920697,0.6920617221012427,1.0,5/11,19.11%,GSN;ST18;PIH1D1;FAS;PLAUR
prerank,Wnt signaling pathway (GO:0016055),0.3142331011930369,1.0768706822845013,0.31993299832495814,0.8140101542664047,1.0,15/92,10.14%,WLS;TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;ARL6;WNT5B;PTEN;RYK;USP34;BCL9;DVL3
prerank,regulation of nervous system development (GO:0051960),-0.33828227299516456,-1.0768666624245586,0.35091743119266056,0.6928853588029336,1.0,15/37,25.82%,BHLHE40;HES1;CTNNB1;TNFRSF1B;PRUNE1;TENM4;HEY2;HEYL;CX3CR1;HES6;DLL1;HEY1;GBX1;ZPR1;KIF14
prerank,L-glutamate transmembrane transport (GO:0015813),0.4912074966499134,1.0767426605204597,0.3648068669527897,0.8133296997063247,1.0,3/10,9.27%,SLC1A3;SLC25A18;SLC25A22
prerank,negative regulation of protein modification process (GO:0031400),0.32369501639788195,1.0764552345040823,0.3370967741935484,0.8130904422859091,1.0,15/79,9.05%,PTPN13;PID1;PRKN;DMD;SNTA1;PLPP3;PTPA;CACTIN;PRKAA2;LRRK2;FBLN1;PTEN;PRKAA1;ATG14;SIRPA
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4415507407266813,-1.0757881098251472,0.3784313725490196,0.6950287834985512,1.0,3/13,1.89%,ABHD2;ESR1;PLPP1
prerank,Fc receptor signaling pathway (GO:0038093),-0.26693366307768507,-1.0757746485368511,0.3031161473087819,0.6943556029601737,1.0,36/110,23.58%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;PSMF1;MAPK8;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;CUL1;TAB3;PSME1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;PSMB4;RELA;MAPK10
prerank,negative regulation of catalytic activity (GO:0043086),-0.37663117392834344,-1.0757652020318222,0.352549889135255,0.6936735527389644,1.0,8/24,16.80%,NOTCH1;NOS1;TMBIM1;NES;APBA3;MT3;ATP5IF1;PLN
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3876746865856154,-1.0754757184241577,0.376984126984127,0.6937078748443737,1.0,4/19,3.66%,CYTH3;MSN;CYTH1;SIPA1L3
prerank,anterograde axonal transport (GO:0008089),-0.33378912345074885,-1.0747426919862715,0.3326226012793177,0.6948810791752557,1.0,18/37,32.77%,DLG2;AP3S1;HSPB1;BLOC1S2;SOD1;AP3M2;KIF1A;KIF3B;NEFL;MAP1A;KIF4A;HAP1;KIF1B;KIF5C;SNAPIN;MAPK8IP3;KIF5B;AP3B2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.43114755254185566,1.0745693548471855,0.35714285714285715,0.8172704125411324,1.0,5/19,8.85%,CUX1;IL1RAPL1;OBSL1;PTPRD;CUL7
prerank,negative regulation of kinase activity (GO:0033673),0.33511944061937105,1.0741519762598601,0.3628620102214651,0.8173851815956655,1.0,7/62,6.43%,PRKAG2;PDPK1;DEPTOR;DTNBP1;PPM1E;NPRL2;GNAQ
prerank,mitotic cytokinesis (GO:0000281),0.35228698806137704,1.0740627690607074,0.3674496644295302,0.8166305696550256,1.0,7/47,5.85%,ROCK2;KLHDC8B;ARL3;SNX18;SNX9;SNX33;SON
prerank,response to interferon-alpha (GO:0035455),-0.4168841989039595,-1.0738937318434802,0.3799621928166352,0.6963491122034772,1.0,6/16,22.88%,GAS6;ADAR;BST2;IFITM3;RO60;IFNAR1
prerank,protein localization to chromatin (GO:0071168),-0.399613675089579,-1.0738403120136153,0.35908141962421714,0.6957697988867502,1.0,10/18,32.08%,ESR1;LEMD2;PIH1D1;TASOR;MSH2;MCM8;CHMP7;SGF29;PPHLN1;PLK1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3110581795647705,1.073709608903592,0.3161094224924012,0.8165649133880596,1.0,10/102,4.51%,ADCY5;ADCY1;PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CRHBP;CPEB2
prerank,signal peptide processing (GO:0006465),-0.45579378159304096,-1.0728188793997795,0.3881453154875717,0.6976924547589782,1.0,6/11,31.39%,FURIN;PCSK5;CLN5;SEC11A;HM13;SPCS3
prerank,embryonic organ development (GO:0048568),0.332227275447764,1.0728084336812436,0.337248322147651,0.8180016269028771,1.0,11/61,8.09%,RBPJ;FGFR2;KIT;RBP4;KMT2A;COL13A1;TEAD1;GLI3;SALL1;PBX4;TEAD3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3730951565913587,-1.0727594499473387,0.375,0.6971367043908204,1.0,9/21,17.57%,NDST3;HS3ST4;HS6ST2;EXT1;EXTL3;XYLT1;GPC1;HS6ST3;HS3ST5
prerank,response to muscle stretch (GO:0035994),0.4413083717760572,1.0723610562597112,0.38697318007662834,0.8182334105241541,1.0,3/15,3.07%,DMD;CSRP3;SLC8A1
prerank,canonical Wnt signaling pathway (GO:0060070),0.327150706357285,1.0720731112879998,0.33220910623946037,0.8179758094680285,1.0,12/68,10.14%,TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;WNT5B;PTEN;RYK;BCL9;DVL3
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.39275837857070645,-1.0719062803123178,0.3702970297029703,0.6987388746256356,1.0,4/18,6.19%,MSN;HSP90AA1;DAB2IP;FAF1
prerank,telomere organization (GO:0032200),0.36010799905323404,1.0716801851741746,0.36042402826855124,0.8180778224817656,1.0,12/43,15.56%,SP100;HUS1B;ACD;XRCC5;BLM;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1
prerank,homotypic cell-cell adhesion (GO:0034109),0.3636608937164003,1.071521942995502,0.3709090909090909,0.817509939344642,1.0,6/39,4.40%,MEGF11;PLPP3;GNAS;MEGF10;TLN1;PDGFRA
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4071477577556709,-1.0714986320533544,0.37573385518590996,0.6991199804988499,1.0,9/17,24.26%,CALM1;HSP90AB1;PTPRC;MTOR;CALM2;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,positive regulation of protein transport (GO:0051222),0.32750130642000047,1.0710044034901411,0.3284789644012945,0.817991311252763,1.0,3/67,1.88%,IGF1;BMP6;FRMD4A
prerank,central nervous system neuron development (GO:0021954),-0.4264528704987045,-1.070615086955649,0.3772819472616633,0.7007563793565404,1.0,4/15,9.45%,HSP90AA1;HSP90AB1;B4GALT5;LHX6
prerank,positive regulation of heart rate (GO:0010460),-0.4107292626669144,-1.0703803201565913,0.3709016393442623,0.700632314170408,1.0,7/17,9.30%,PDE4D;ADRA1B;ATP2A2;KCNQ1;ADRA1A;RYR2;EDN1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.28600372828671816,1.070171601069265,0.32305433186490456,0.8193475112182891,1.0,27/166,12.46%,IGF1;FGFR4;SMOC2;ZEB2;SLC6A9;LPGAT1;SORBS1;PDGFRB;NOS1AP;IGF2;PLD1;SLC45A3;IL6;SMAD3;CCL19;ARNT;SLC27A1;SAMD4A;PRKDC;RPS6KB1;METTL14;NPM2;FXR1;ERBB2;LARP6;PRKD2;PKD2
prerank,cortical cytoskeleton organization (GO:0030865),0.35788594203897023,1.07005334999027,0.3476027397260274,0.8186449606429979,1.0,7/41,7.67%,ROCK2;RHOD;FHOD1;RAB13;LLGL2;DLG1;RHOBTB2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4337814733720009,-1.0699718042804154,0.3664717348927875,0.7010024851055217,1.0,7/13,27.87%,CD44;CD74;MIF;PTTG1IP;SNAI2;PSMD10;YJU2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4497903917941694,-1.0699484082200423,0.38476190476190475,0.7003658226195768,1.0,5/11,22.08%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,RNA processing (GO:0006396),0.283888229579653,1.0695488823789892,0.3226744186046512,0.8190287743435863,1.0,53/176,19.91%,CELF2;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;SRPK2;RBPMS;HNRNPC;HNRNPH1;SON;RBMS2;TSEN34;NOL3;RBM5;SLU7;SF3A3;DDX23;RP9;NOL9;PRPF3;TENT2;AKAP8L;PDCD7;TUT1;RBM39;SCAF11;NONO;DICER1;TSEN2;SRRM4;LSM5;SNRNP40;DHX8;CSTF3;HNRNPH3;SNRPA1;DHX15;RNGTT;HNRNPR;U2AF1;TUT4;NUDT21;PRPF6;HNRNPA2B1;RSRC1;LSM3;RBM4;LSM1;SRSF11;LSM4;SNRPF;PPIG
prerank,negative regulation of hippo signaling (GO:0035331),0.479642688499997,1.069433826158262,0.3987730061349693,0.818331612911564,1.0,3/12,6.78%,VGLL4;WWC1;WWC2
prerank,sulfur compound transport (GO:0072348),0.38648461303318,1.069334680966439,0.37681159420289856,0.8175967222090833,1.0,7/27,10.43%,SLC6A13;SLC13A4;SLC35F3;SLC25A11;SLC27A1;SLC19A2;SLC13A1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28566875432192823,-1.0690401761832073,0.30788804071246817,0.7019449792571503,1.0,17/76,18.48%,ANO1;ESR1;GPR4;TGM2;HOMER1;ADRA1B;GNA14;ADRA1A;HTR2A;GNA11;LPAR6;HRH1;PTGER3;CMKLR1;CX3CR1;AGTR1;CCKBR
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.339144838241778,-1.0690371406553412,0.34408602150537637,0.7012480682703153,1.0,16/35,24.26%,CALM1;HSP90AB1;TIPRL;PPP1R2;HSP90B1;GSK3B;MTOR;MASTL;PPP6R1;CSNK2B;CALM2;BOD1;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3955490723420356,-1.0688788821450919,0.37058823529411766,0.7009840397531812,1.0,8/18,12.33%,RHOJ;KDR;GATA2;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,regulation of astrocyte differentiation (GO:0048710),-0.43811157952570234,-1.0686710766683472,0.3840304182509506,0.7008235450100562,1.0,6/12,17.66%,NOTCH1;SERPINE2;HES1;BMP2;BIN1;ID2
prerank,regulation of cell adhesion (GO:0030155),0.29554948685810645,1.0685206593324756,0.3323216995447648,0.8187537432612556,1.0,11/129,4.57%,EPHA7;PLXNA2;ROCK2;IL18;ANGPT1;TPM1;RHOD;EPHA8;RIPOR2;EPHA4;PLXNC1
prerank,protein stabilization (GO:0050821),-0.25008000623494725,-1.0684803307109456,0.30363036303630364,0.7006063283266428,1.0,39/168,13.96%,HIP1;RASSF2;RPL11;HSP90AA1;RPL23;HSP90AB1;PPARGC1A;RPS7;ATP1B1;SOX17;FLNA;SOX4;PDCL3;CALR;BAG6;CDC37;RPL5;CHP1;GAPDH;HIP1R;PDCD10;BAG1;CRYAB;GOLGA7;LAMP1;CHEK2;GRN;UBE2B;PPIB;RTN4;HYPK;STX12;CAMLG;HSPD1;CLU;OTUD3;CDC37L1;MTMR9;MT3
prerank,ephrin receptor signaling pathway (GO:0048013),0.3154642575606648,1.0683531687720342,0.34731543624161076,0.8181818132973381,1.0,9/82,5.21%,EPHA7;ROCK2;EPHA3;EFNB2;SDC2;EPHA8;MMP2;EPHA4;WASL
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3146602937966687,-1.0682575534643233,0.3294930875576037,0.7004621755571694,1.0,17/50,22.02%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;PAK2;PIH1D1;RPS6KA1;RNF34;MT3;CARD16;RAF1;ARL6IP1;PLAUR;AKT1;CDKN2D
prerank,positive regulation of cell adhesion (GO:0045785),-0.2899537477908562,-1.0680515191095448,0.34739454094292804,0.7002680790888447,1.0,13/74,8.32%,FRMD5;PTPRJ;ZFHX3;RAC1;TGFB2;VIT;STX3;LIMS1;TGM2;FBLN2;VEGFA;ECM2;NPNT
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.44989550316971455,-1.0678748813209211,0.390495867768595,0.7000509519656578,1.0,2/12,5.38%,ESR1;TGFB1
prerank,hippo signaling (GO:0035329),0.3972979988668961,1.0677650273107895,0.36704119850187267,0.8187340849445436,1.0,6/26,10.14%,AMOTL2;FAT4;TEAD1;WWC1;TEAD3;LATS1
prerank,Notch signaling involved in heart development (GO:0061314),0.48888941591465246,1.0677170541529681,0.4150537634408602,0.8178747533164452,1.0,2/11,1.17%,RBPJ;NOTCH2
prerank,O-glycan processing (GO:0016266),0.3474608183652491,1.0677039874492418,0.3531468531468531,0.816920620505159,1.0,5/54,2.72%,ST3GAL3;GALNT15;GALNT14;GXYLT2;B3GNT5
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3288830960185455,-1.067692766570565,0.3468950749464668,0.6998242314871658,1.0,13/36,22.77%,SGMS1;DAB2IP;RPS3;PPIA;TPD52L1;TRAF1;FAS;MADD;CX3CR1;NR4A2;TMBIM6;MAZ;MAPK8IP2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3454934701181711,1.0676559382988775,0.36769759450171824,0.8160764269080875,1.0,5/48,5.98%,ADCY5;ADCY1;AMPD3;NPR2;ADSL
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3277573838705863,-1.0674528645615442,0.36384976525821594,0.6997582238322215,1.0,6/39,4.63%,PTPRJ;SH3KBP1;CBL;DAB2IP;PTPN12;LGMN
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4703726098691444,1.0672793020566704,0.38626609442060084,0.816139915696477,1.0,2/11,7.52%,PLA2G10;LIPC
prerank,T cell differentiation (GO:0030217),0.3626863188901086,1.0669564834832572,0.36221837088388215,0.816035138836079,1.0,7/40,12.17%,LEPR;KIT;ANXA1;GLI3;NHEJ1;MR1;SOX13
prerank,pyruvate metabolic process (GO:0006090),-0.3090733998162145,-1.0669275108035519,0.36027713625866054,0.7004450480080192,1.0,12/52,17.39%,BSG;PKM;SLC16A1;ME1;HK1;GAPDH;PDHA1;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3923233006308044,1.0668739674476195,0.35551330798479086,0.815287138306895,1.0,9/26,12.36%,SMOC2;SPHK1;CCDC57;EIF4EBP1;PRKCA;PKN2;MDM2;RPS6KB1;HSF1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.26852813876129267,-1.066873196857075,0.29512893982808025,0.6998687374984824,1.0,30/101,24.31%,MEF2C;LBP;DAB2IP;VIM;CHMP5;TGFB1;SBNO2;TNFRSF1B;DEFA6;PDCD4;RHOA;MAPK8;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;PRKCE;ZC3H12A;ADAM9;IRAK1;MYD88;NR1H3;CASP1;TNFAIP3;PLAA;RELA;CD80;CD68
prerank,negative regulation of viral life cycle (GO:1903901),-0.4211357576251431,-1.0668579697875173,0.4,0.6992014740209319,1.0,7/15,22.40%,LY6E;GSN;PPIA;BST2;MID2;IFITM3;CIITA
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4944917614901731,1.0665105958200052,0.3877551020408163,0.8152604596211032,1.0,6/10,20.02%,MTHFR;TYMS;SHMT1;MTHFS;DHFR;MTHFD2
prerank,cardiac muscle cell contraction (GO:0086003),-0.39221375586118445,-1.0664440439997005,0.36328125,0.6995819665554875,1.0,7/19,17.92%,KCNJ2;ATP1A1;GSN;CACNA1G;CACNA1C;SCN1A;SCN1B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42348737685835924,1.0663914520673805,0.42276422764227645,0.8146038017193257,1.0,3/18,6.51%,BCL2;SLC25A31;BNIP3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.46518266878139625,1.0663206357926347,0.39156626506024095,0.8138267467974809,1.0,3/12,13.96%,NINL;CEP19;BICD2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4486165571226723,-1.0662236191259957,0.37258687258687256,0.699453403732681,1.0,4/11,18.62%,WDR1;STMN2;NES;CFL2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.45514013308795565,1.0661024420366454,0.3804780876494024,0.8134073271518841,1.0,2/13,4.57%,PLXNA2;PLXNC1
prerank,response to molecule of bacterial origin (GO:0002237),-0.29452965255615404,-1.0659027028779562,0.3477157360406091,0.6995496771280513,1.0,20/69,22.89%,FOXP1;NOS3;LBP;GCH1;TNFRSF11A;CYRIB;NOS1;IRAK3;ERBIN;HNRNPA0;IRAK1;IRF5;TIRAP;SLC11A1;LIAS;TNFAIP3;GGT1;PELI1;IFNAR1;FCGR2B
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2875076598383803,-1.0656943557805014,0.3448275862068966,0.6993937700910687,1.0,16/69,11.55%,TFRC;STX3;HSP90AB1;FYN;LIMK2;TGFB1;FERMT2;CCDC88A;GNL3;GSK3B;CARD10;RTN4;SESN2;APC;WWTR1;GPR137B
prerank,regulation of cilium assembly (GO:1902017),0.33221506754292457,1.065441412679513,0.35858585858585856,0.8142283233972856,1.0,17/62,18.86%,DCDC2;ODAD3;TBC1D9B;SDCCAG8;ARHGAP35;CROCC;CYLD;TBC1D19;IFT140;CDKL5;TBC1D17;ATG3;CEP120;USP6NL;TBC1D15;CEP97;TBC1D7
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.30275574813440725,-1.064990745052089,0.32779097387173395,0.7005366246392016,1.0,19/57,23.79%,KDR;FBXO7;PPARGC1A;TNFSF10;CAMKK2;GSK3B;HIP1R;MIEF1;GPER1;BBC3;MIEF2;SPIRE1;PLAUR;PINK1;DCN;BIK;BMF;CHCHD10;BAX
prerank,cellular protein modification process (GO:0006464),0.24641371577310156,1.0643800326416648,0.26421404682274247,0.8160422204694657,1.0,152/982,12.60%,PRKAG2;ASB2;ROCK2;OXSR1;PTPN13;B3GALT1;CP;FBN1;APLP2;NRK;EPAS1;WNK4;CDK8;ST3GAL3;DAPK1;PRKAG3;GALNTL5;LARGE1;UST;PDPK1;PDK1;ITIH2;SDC2;LHPP;CEL;BMP2K;TNC;LOXL1;SERPIND1;PPM1M;SPSB1;B3GNT5;PTPN4;UBE2E2;RNASEL;HIF3A;DMPK;FER;MAP4K5;CDK7;PIGU;ANXA1;RAB13;PRKCSH;NAA80;FAM20A;PCSK9;IGFBP4;SRPK2;ST3GAL5;OBSL1;NEURL2;DUSP10;ARAF;PPM1E;MAPK9;FBXW4;ATG10;DDB2;CDC14B;PTPRA;DCAF4;SIK1;PRKAA2;UFL1;GPC3;MTMR3;MSRA;LRRK2;PRKCZ;PTPN9;WIPI1;PSME4;PRKCB;PARP4;MAML1;STK17B;PSMA2;RBBP7;FBXO44;IL6;CAND1;F5;CCDC8;UBE2L3;PTPRD;PSMA3;PRKCA;GRK3;PTEN;PRKAA1;NEK4;NRBP1;CUL9;RYK;CSF1;BIRC5;WWP2;GRK5;USP25;BIRC6;CCNT1;DCAF10;MIA3;CHRDL1;PKN2;FSTL3;CDK1;TGM5;CAMK2D;CUL7;PIK3R4;KLHL11;NEK10;GRK4;FEM1B;FBXO6;ASB3;PSMD8;GOLGA2;VRK2;PARP10;IGFBP7;KBTBD7;UBA7;LATS1;FRK;PMM2;ABL1;PRKDC;PARP9;UBA3;PSMD3;JAK2;COQ8B;ERBB2;SLC35A1;IKBKE;FBXO4;KLHL22;BMPR1A;MAPKAPK2;CUL4B;PTPN3;PRKAG1;HIPK3;CCNE1;PRKD2;FBXO11;SENP8;STK24;SERP1
prerank,vesicle transport along actin filament (GO:0030050),-0.38571667083788036,-1.0643030128403441,0.37636761487964987,0.7015856707283958,1.0,3/19,2.00%,MYO1D;ACTN4;FNBP1L
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.33440099864531486,-1.0641332461016353,0.3691275167785235,0.7013070026449124,1.0,12/35,13.76%,HEG1;TGFB2;RASIP1;DAB2IP;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;SPRY4;STMN1
prerank,mitochondrial fission (GO:0000266),-0.3975670483504051,-1.064105664458664,0.3920792079207921,0.7006788090143061,1.0,4/16,11.96%,DNM3;DNM2;MIEF1;DNM1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.45716266906002656,1.0638518223875277,0.38054968287526425,0.8155121855781122,1.0,1/12,1.02%,FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.45716266906002656,1.0638518223875277,0.38054968287526425,0.8155121855781122,1.0,1/12,1.02%,FHL2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3911475455747026,1.063673679933142,0.3953068592057762,0.8150075211271466,1.0,4/27,4.85%,JPH1;DMD;ANK2;CACNB4
prerank,intermediate filament organization (GO:0045109),-0.4057493798936873,-1.0634374068003518,0.38779527559055116,0.7017477129641947,1.0,6/17,25.93%,VIM;GFAP;MTM1;DSP;NEFL;DNAJB6
prerank,multivesicular body organization (GO:0036257),-0.33490351219446535,-1.063132526338536,0.3642241379310345,0.7018443638491162,1.0,14/31,30.92%,RAB27A;CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3273161533610892,-1.0630581853915955,0.3433874709976798,0.7013590865291287,1.0,10/39,15.46%,MYO1D;ACTN4;FNBP1L;PPFIA2;KIF1A;RAB1A;MYO5A;SYT4;NDE1;BICDL1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.45939688798462,-1.0628422433430822,0.4003831417624521,0.7012508756828818,1.0,6/10,36.68%,GABRG3;GABRA5;GABRE;GABRG2;GABRG1;GABRB2
prerank,positive regulation of exocytosis (GO:0045921),-0.33578276727414474,-1.062518336745797,0.3619489559164733,0.7013937390215712,1.0,14/35,31.09%,RAB27A;HGS;CFTR;ATP13A2;SDC4;CLASP2;RAB7A;PDCD6IP;RAB3A;SYTL4;UNC13D;ATP6AP1;VPS4B;RAB15
prerank,renal filtration (GO:0097205),-0.4634399500326893,-1.0624811123931477,0.39558232931726905,0.7007866623854746,1.0,3/10,7.33%,CD34;MCAM;TBC1D8B
prerank,positive regulation of catabolic process (GO:0009896),-0.2960342145331732,-1.0623221378482521,0.35391923990498814,0.7005153307594351,1.0,15/65,13.03%,WWP1;NSF;NEDD4L;DAB2IP;ATG7;PLK2;GSK3B;FOXO1;DDB1;OAZ1;APC;CDKN1B;NDUFA13;EGLN2;IDE
prerank,positive regulation of lipid catabolic process (GO:0050996),0.41086648667979736,1.061833712806063,0.40152963671128106,0.8190533063511217,1.0,2/19,7.58%,PPARA;DAGLB
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3652422532125676,1.0617866197794683,0.3585951940850277,0.8182013718192789,1.0,9/38,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,regulation of phagocytosis (GO:0050764),-0.3023189500361106,-1.061648740232967,0.3261904761904762,0.7015377592373141,1.0,11/53,10.49%,GAS6;SCARB1;RACK1;RAB27A;TGM2;GATA2;CALR;DOCK2;PTPRC;DYSF;LMAN2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.273206069583996,-1.0615892554500728,0.3035230352303523,0.7010065212927589,1.0,17/93,8.27%,MAP3K5;RASSF2;TGFB2;ANKRD6;PTK2B;DAB2IP;MID1;MINK1;SH3RF3;TPD52L1;EMC10;APP;FLT4;PDCD10;VEGFA;STK25;WNT16
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3408649651372817,-1.061388183049686,0.3724137931034483,0.7008469619122212,1.0,8/34,11.33%,PTPRB;PTPRJ;DUSP16;PTPN12;UBASH3B;PTPN1;DUSP8;DUSP3
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3369300187399646,-1.0611117408497202,0.3522727272727273,0.700889189855503,1.0,13/33,18.95%,DNM3;STON2;SYNJ1;STX1A;ITSN2;DNM2;AMPH;DNM1;CANX;PIP5K1C;SYT2;CDK5;SNAP91
prerank,phagosome maturation (GO:0090382),-0.3394983681390104,-1.0609042373590083,0.3778280542986425,0.7007387594556782,1.0,18/35,26.57%,RAB31;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;RAB39A;MREG;ATP6V0D2;RAB7A;ATP6V0E2;RAB14;ATP6V1B2;MCOLN1;ATP6V1H
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35508720200914273,1.0606812001679715,0.3758620689655172,0.8201802517375484,1.0,6/44,4.50%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,organelle organization (GO:0006996),-0.22472739896307647,-1.0603722145463546,0.21658986175115208,0.701440784439292,1.0,119/388,25.58%,FMNL2;FGD5;CAV1;ATP8B1;SYNE1;FGD6;NOS3;SEMA6A;MICAL2;SH3KBP1;FNBP1L;PPARGC1A;ARAP3;CAV2;RAB31;STX7;PPIA;SIPA1L3;CXADR;PACSIN2;REEP5;CHMP5;LYSMD3;CHMP2B;CHCHD2;VPS13C;VMP1;TMED5;TFB2M;RHOT1;ZRANB1;SMPD4;TMED2;MICAL1;MARK1;TOR1B;RAB38;LIMD1;LMAN2;SPRYD3;YTHDF3;RAB1A;NSFL1C;PCLO;STOML2;ABCD3;BIN1;CHGA;VPS18;BNIP1;MAST3;LMAN2L;PPRC1;ABCD2;TMED10;MIEF2;SIRT4;TMED3;NEDD9;MTX3;FMNL3;MSTO1;BRWD3;ODF2;ATL2;DIAPH3;PRKD1;TRIP11;GBF1;VPS11;PEX1;ABCA3;PEX11B;BSCL2;AUP1;SEC16B;CCL13;CHMP1B;ABCD4;VPS51;ATP5F1B;PITPNB;LIG4;VPS13D;PINK1;SPTSSB;IRAG2;THY1;MREG;CFL1;CHMP1A;NUMA1;PAK5;ARHGAP10;CYCS;VAPA;MAST1;CHMP3;TNFAIP3;BCS1L;PEX10;SIPA1;CHMP7;CLASP2;TMED7;RAB7A;CHCHD10;PDCD6IP;GEM;HUWE1;RAB2A;KIF4A;PEX16;CDC42BPB;RAB14;CAMSAP1;TMEM135;SEC16A;MCOLN1
prerank,pre-replicative complex assembly (GO:0036388),-0.29222457744020086,-1.0602321753216741,0.34096692111959287,0.7011217980525521,1.0,17/64,17.27%,UBB;UBC;RPS27A;PSMD13;PSMF1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;PSME1;UBA52;PSMB3;MCM8
prerank,striated muscle cell development (GO:0055002),-0.41520348920262184,-1.0601212474427804,0.41188524590163933,0.7007535287998512,1.0,1/14,0.29%,PGM5
prerank,regulation of neurogenesis (GO:0050767),-0.30727099487456777,-1.059896293680203,0.3526570048309179,0.70069051596801,1.0,20/55,23.11%,B2M;BHLHE40;NOTCH1;HES1;TGM2;CTNNB1;PRUNE1;SERPINF1;HEY2;HEYL;GPER1;REST;CX3CR1;SPEN;LIG4;HES6;DLL1;SOX11;FAIM;HEY1
prerank,T cell activation (GO:0042110),0.31919776081717816,1.0598888661138401,0.343801652892562,0.821376885957659,1.0,5/69,2.65%,LEPR;KIT;JAML;KIF13B;CTPS1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.37606621205268115,-1.0597941569341724,0.4025157232704403,0.7002811518822142,1.0,5/21,11.40%,RPL11;RPL23;RPS7;RPL5;RAB1A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.23508909770263886,-1.0597929422730656,0.27165354330708663,0.6996064868076647,1.0,102/314,26.17%,WWP1;ATXN3;PPP2R5C;NEDD4L;UBB;FBXL3;STT3B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;HSP90B1;FAF1;ARRB1;BAG6;UBC;RPS27A;RMND5B;UCHL1;CUL3;ECRG4;DERL1;FBXL5;PSMD13;PSMF1;DDB1;UBE2B;RBX1;PSMB10;FBXO31;HSPA5;KCTD17;KCTD13;FBXL20;FEM1A;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;HERPUD1;PSMD12;PSMB8;RNF34;CUL1;KLHL42;PTTG1;TRIM13;PSME1;ANAPC16;ERLIN2;UBE2G1;UBA52;ZFAND2B;DNAJC10;PSMB3;WFS1;FBXL2;COP1;SPSB3;SPOPL;AUP1;CCNF;FBXL14;CDK2;DCAF12;BUB1B;UBE2D1;RNF5;DNAJB9;ARRB2;TRIM2;SHARPIN;PSMD5;FBXO17;ZSWIM8;SKP1;KCTD5;TMEM129;VCP;RBCK1;RNF103-CHMP3;FBXO9;ANAPC7;PLAA;PSMD9;PELI1;PSMB4;PCNP;HUWE1;CUL2;SPSB4;UBE2J1;BFAR;DMAC2;KIF14;DCAF11;YOD1;PSMD10
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3636011419445641,-1.059646309938571,0.3739669421487603,0.6992789299051598,1.0,5/24,5.27%,TEK;KDR;GAS6;RAMP2;GATA2
prerank,response to steroid hormone (GO:0048545),-0.3441936030197076,-1.059587146302062,0.3793103448275862,0.6987641571390739,1.0,7/31,5.38%,ABHD2;CAV1;ATP1A1;THBS1;TGFB2;UBE3A;TGFB1
prerank,positive regulation of filopodium assembly (GO:0051491),0.3948709878861685,1.0586245388176085,0.39889705882352944,0.8239215448789299,1.0,4/24,5.21%,DOCK11;DPYSL3;RIPOR2;WASL
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.42321462307803104,1.0586040605189462,0.36088709677419356,0.8230008466107198,1.0,1/18,0.06%,UNC13C
prerank,regulation of organelle organization (GO:0033043),-0.2800462950986621,-1.0582011524290968,0.34316353887399464,0.7016952632178118,1.0,28/80,24.32%,MSN;CLIC4;PTK2;F11R;PDE4DIP;CAPN2;RHOT1;PDE2A;PDCD10;TJP1;PAK2;ARHGEF5;MTM1;MYO5A;MARK2;EHD3;MIEF2;ATP13A2;VPS11;ARL6IP1;PREB;STMN3;PINK1;SIRT7;MAPK3;SPEF1;CAMSAP3;SCARB2
prerank,regulation of autophagy (GO:0010506),0.27649285566649545,1.0578687494938315,0.33047210300429186,0.8240825666234167,1.0,31/216,11.14%,PRKAG2;LEPR;ITPR1;DAPK1;PRKN;PRKAG3;SNX6;BCL2;TRIM5;NEDD4;PRKAA2;UFL1;NPRL2;MTMR3;LRRK2;SLC38A9;BNIP3;OPTN;RNF152;PRKAA1;KAT8;NUPR1;ATP6V0D1;ATP6V0E1;PLEKHF1;GOLGA2;WASHC1;ABL1;MLST8;FLCN;RUBCN
prerank,telomere maintenance via recombination (GO:0000722),0.4750551801124927,1.057299692787496,0.4057377049180328,0.8246787184630222,1.0,7/11,28.25%,TEP1;RAD51;TPRKB;RAD50;ERCC4;SMC5;SMC6
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3276001230689076,1.0571108647300174,0.3622950819672131,0.8242364677740582,1.0,3/57,1.83%,ADCY5;ADCY1;LPAR1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3320230428477401,-1.0570735715042412,0.3640552995391705,0.7039106379489052,1.0,7/33,9.17%,ESR1;RUNX1;CBFB;CALR;KDM4C;DDX5;H3-3A
prerank,positive regulation of developmental process (GO:0051094),0.279140175446421,1.0567012271553429,0.33681073025335323,0.8244349407155113,1.0,29/164,12.83%,SOX5;BMP7;PRKN;ADGRL1;CCN2;SCX;SOX6;PLCB1;GRIP1;FOXD1;GJA1;PTN;PHLDB2;NIBAN2;BNIP3;ENPP2;NCOA3;MCU;DVL3;AGO2;SMURF2;COBL;NEUROD2;DLG4;BMPR1A;RBM19;AR;RAPGEF3;GDNF
prerank,cellular iron ion homeostasis (GO:0006879),-0.30288024395266044,-1.0563730338495132,0.3316582914572864,0.7050592675185815,1.0,15/55,10.00%,ABCG2;FTH1;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;FBXL5;HMOX2;FRRS1;ATP6V1A
prerank,positive regulation of monooxygenase activity (GO:0032770),0.39321886910545845,1.0560796662733487,0.4027504911591356,0.8251163770615146,1.0,2/26,3.14%,NPR3;NOS1AP
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.4221196241816769,-1.055685314199689,0.39087301587301587,0.7060572760745145,1.0,6/13,24.10%,NOTCH1;TGFB1;TBX3;BMP4;DLL1;EID2B
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4800925829169082,1.055556206190502,0.3995859213250518,0.8255214999279958,1.0,1/10,1.49%,ZEB2
prerank,negative regulation of RNA splicing (GO:0033119),-0.38727719376012143,-1.0540013551031706,0.3889943074003795,0.7097844917089213,1.0,7/19,20.16%,SRSF9;RNPS1;SRSF6;RPS26;TMBIM6;PCBP4;PTBP1
prerank,phagosome acidification (GO:0090383),-0.3612010299937234,-1.053852674446832,0.38865546218487396,0.709436479834203,1.0,15/26,28.78%,ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;RAB39A;ATP6V0D2;RAB7A;ATP6V0E2;ATP6V1B2;ATP6V1H;RAB20
prerank,cellular response to hypoxia (GO:0071456),0.296179409432273,1.053629199957627,0.39006024096385544,0.8296658443245692,1.0,16/126,9.55%,RORA;SLC8A3;EPAS1;BMP7;HIF3A;NDNF;CPEB2;PSME4;PSMA2;BNIP3;PSMA3;NPEPPS;ARNT;ACAA2;MDM2;PSMD8
prerank,ESCRT III complex disassembly (GO:1904903),-0.459354008731871,-1.0535902270960966,0.41505791505791506,0.7087649555865464,1.0,7/10,35.03%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,ESCRT complex disassembly (GO:1904896),-0.459354008731871,-1.0535902270960966,0.41505791505791506,0.7087649555865464,1.0,7/10,35.03%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.38656271532302755,1.0533973429594272,0.39552238805970147,0.8293352419884448,1.0,6/26,8.16%,ATP1B3;NEDD4;ANK2;CACNA1D;DLG1;WWP2
prerank,receptor catabolic process (GO:0032801),0.3922755528052296,1.0532964549091306,0.39147286821705424,0.8286200572846809,1.0,6/24,9.09%,RNF43;NEDD4;PCSK9;ZNRF3;PIK3R4;UVRAG
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.44830925636642494,1.0530982566957667,0.40980392156862744,0.8281610439473632,1.0,3/14,7.32%,OSR1;ZEB1;MMP9
prerank,hydrogen peroxide catabolic process (GO:0042744),0.47142687247073484,1.0524594477808291,0.42424242424242425,0.8289751692847548,1.0,1/11,2.38%,PXDN
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3417869679073429,1.0523146279301612,0.38898163606010017,0.8283825140373475,1.0,6/51,4.50%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,phagosome-lysosome fusion (GO:0090385),-0.4486977708264147,-1.052137970940154,0.3966789667896679,0.7118309860966047,1.0,7/10,38.02%,SYT7;RAB39A;RAB7A;RAB7B;RAB20;PLA2G5;CLN3
prerank,neutrophil migration (GO:1990266),-0.2961771070823922,-1.0519472663620788,0.3556085918854415,0.7116363213864763,1.0,8/58,10.16%,PECAM1;BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.45163944865962735,-1.0517701131384525,0.41682242990654206,0.7114313465073022,1.0,6/11,22.86%,YBX3;BIRC3;ARHGEF2;CASP8;SLC25A4;PELI1
prerank,extracellular matrix assembly (GO:0085029),-0.3698659508189796,-1.0517132238360845,0.4133611691022965,0.7108809847355939,1.0,9/23,12.91%,GAS6;RAMP2;TNXB;MYH11;TGFB1;LAMB2;GPM6B;MFAP4;NTN4
prerank,regulation of membrane depolarization (GO:0003254),0.4130892225153116,1.0513523646376532,0.3996101364522417,0.8300423031519241,1.0,6/18,12.39%,GPD1L;LRRK2;CAMK2D;SCN3B;PTPN3;SCN2B
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.30253072678943016,-1.0512556819068397,0.37557603686635943,0.7113946737442997,1.0,8/52,6.77%,SPTBN1;PRKCH;EPB41;STX3;ITGB1;NKD2;GNAI1;WNK3
prerank,negative regulation of histone modification (GO:0031057),0.44598704688343294,1.0511486194178368,0.4133611691022965,0.8296015659574818,1.0,2/14,3.15%,AASS;JARID2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.25279988649051593,1.0509008610857602,0.3409090909090909,0.829272680553437,1.0,47/509,6.76%,IGF1;ROCK2;SASH1;WLS;ADGRV1;TCF7L2;OSBPL8;KSR1;FGFR2;FGFR4;IL18;KIT;ANGPT1;PRKN;PELI2;LPAR1;PDPK1;BCL2;FNIP1;LTF;PDGFRB;KL;ECM1;NOS1AP;TRIM5;IGF2;NEDD4;EPHA8;NFAT5;GFRAL;PDGFRA;SPHK1;AKAP13;GJA1;RICTOR;PDGFD;IGF1R;FGF1;SLC38A9;DDX60;LRP2;PRKCB;FRS2;CXXC5;WWC1;ADRA1D;IL6
prerank,spinal cord development (GO:0021510),-0.42346491398181313,-1.0507569479057925,0.41140529531568226,0.71202987937242,1.0,8/12,24.56%,VIT;PKD1;SOX4;RELN;NF1;DLL1;SOX11;ZPR1
prerank,positive regulation of type 2 immune response (GO:0002830),0.44201416336799726,1.0507538155561216,0.41140529531568226,0.8286678096249722,1.0,3/14,6.76%,IL18;PRKCZ;IL6
prerank,regulation of macroautophagy (GO:0016241),0.3017334965264752,1.050678044440406,0.36570561456752654,0.8279381224528478,1.0,28/105,17.32%,PRKAG2;PRKAG3;SNX6;NEDD4;SESN1;PRKAA2;LRRK2;SLC38A9;BNIP3;PRKAA1;ATP6V0D1;EPM2A;ATP6V0E1;MLST8;GPSM1;PRKAG1;LZTS1;TBK1;MAP3K7;ATP6V1D;RUFY4;EXOC7;EXOC1;LARP1;VPS26A;ATP6V1G2;VPS35;TSC1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4226323287455138,1.0506020166409926,0.40077821011673154,0.8271621961941132,1.0,3/16,5.24%,KLK2;ADM;ACE
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3539896497506827,-1.049959874252506,0.3559670781893004,0.7134737070955522,1.0,7/26,11.33%,EEF1A1;IQGAP1;PDE8A;DAB2IP;PTPN12;ZFP36L1;DUSP3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4133117963549247,-1.0496967500610883,0.4086444007858546,0.7135156744067933,1.0,4/15,7.18%,KDR;PTK2B;BMX;AATK
prerank,central nervous system neuron differentiation (GO:0021953),-0.33281281554198155,-1.049683630119278,0.3726315789473684,0.712874602645805,1.0,13/33,30.77%,SOX4;CTNNB1;MDGA2;SPOCK1;NR4A2;KNDC1;TOX;GRID2;NPY;AGTPBP1;LMX1A;FAIM2;SIN3A
prerank,calcium ion import (GO:0070509),-0.34189209869143167,-1.0495900823386655,0.3769063180827887,0.7124639539563741,1.0,11/28,16.39%,CACNA1G;CACNA1E;ATP2A2;TRPC4;SMDT1;CACNA1H;CACNA1C;CACNB2;MCUB;CACNA1I;CACNA1B
prerank,regulation of lymphocyte migration (GO:2000401),-0.4469068205232218,-1.0495666754151747,0.4,0.7118420585615715,1.0,2/10,1.66%,MSN;JAM2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2845105087057778,-1.0494300546596793,0.3621621621621622,0.7115295474212074,1.0,22/79,14.11%,SLIT2;BMPER;THBS1;HTRA3;DAB2IP;NOTCH1;BMPR2;CREB3L1;CRIM1;SMAD9;SMAD5;LEMD2;PTPN1;BMP2;HGS;HHEX;GPC1;EPN2;CASK;SPRY4;CADM4;SKIL
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.42614781905165566,-1.0487535465981956,0.4116504854368932,0.7125667334571123,1.0,3/13,6.69%,PDE8A;RACK1;MET
prerank,response to reactive oxygen species (GO:0000302),-0.2996196832116695,-1.0485697101353748,0.37777777777777777,0.7123778111648247,1.0,14/54,13.74%,APOD;FYN;RPS3;PXN;CAMKK2;SOD1;PDCD10;JUN;STK25;MAPK8;CHUK;PDK2;AGAP3;ROMO1
prerank,positive regulation of heart contraction (GO:0045823),0.42153647529005683,1.0484816654173055,0.4260355029585799,0.8317071449041412,1.0,4/19,11.05%,ATP1A2;ADM;SCN3B;APLN
prerank,mitochondrion organization (GO:0007005),-0.24722297003711746,-1.0482072600352887,0.33663366336633666,0.7126211997268698,1.0,55/165,25.13%,DNM3;NOS3;FBXO7;PPARGC1A;CAV2;CXADR;TOMM20;CHCHD2;VPS13C;ATP5F1D;TFB2M;RHOT1;BCL2L1;DNM2;CHCHD3;RAB38;MIEF1;MTM1;STOML2;TOMM22;NDUFS1;DNM1;HSPD1;HIGD2A;PPRC1;TIMM9;MIEF2;SIRT4;MTX3;TIMM10B;TIMM13;MSTO1;BCAP31;ATP5F1B;MTFR1L;VPS13D;PINK1;SUPV3L1;TIMM22;MYH14;SLC25A4;HIGD1A;CYCS;BIK;TOMM7;MFN2;BCS1L;HIGD1B;TIMM50;CHCHD10;BAX;ATCAY;SPG7;RAB5IF;HAP1
prerank,regulation of superoxide anion generation (GO:0032928),-0.41597471384171325,-1.0480053952528883,0.41832669322709165,0.7124579057795263,1.0,7/14,37.54%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK;CRP
prerank,outflow tract septum morphogenesis (GO:0003148),0.39037962947417076,1.0479975262843921,0.37523809523809526,0.8320762781307125,1.0,4/24,5.73%,ROBO1;FGFR2;SMAD6;LRP2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4422531461031788,-1.047738553092981,0.4028056112224449,0.7125310448055001,1.0,9/11,50.08%,CAMK4;SPI1;TYROBP;ITGB2;MAVS;TICAM1;STAP1;F2RL1;CD177
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.42415165607742356,-1.0477223106948357,0.42248062015503873,0.7119026578090693,1.0,5/14,28.55%,GAS6;NLRP2B;CARD16;TRAIP;GPS2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.40216548024567245,1.0477010880195252,0.384180790960452,0.8318973695999933,1.0,4/22,9.48%,DMD;NOS1AP;CACNB4;GNB5
prerank,regulation of intracellular signal transduction (GO:1902531),0.25605696723377636,1.046809622290273,0.34099616858237547,0.8332154308767491,1.0,47/420,8.73%,ARHGAP28;PRKAG2;ARHGAP24;ARHGAP6;GMIP;PTPN13;ARHGAP29;NRK;FGD4;PRKAG3;PDPK1;RHOD;ARHGAP20;AKAP7;SYDE2;ATRIP;ARAF;MAP2K6;RBBP4;ARHGAP26;SOS2;AKAP13;ARHGAP12;ZFAND6;RICTOR;PRKAA2;UFL1;ARHGAP40;LRRK2;FGF1;ARHGEF11;DLG1;WWC1;RBBP7;WWC2;BANP;OPTN;ARHGAP35;BLM;CHD4;PTEN;PRKAA1;ARHGAP9;MYO9B;GPR143;USP7;CDK1
prerank,sulfur compound biosynthetic process (GO:0044272),0.2992968667781596,1.0466348928128426,0.35545023696682465,0.8327196670220699,1.0,13/104,5.86%,ANGPT1;ST3GAL3;FMOD;UST;CBS;OGN;GSTM2;OMD;B4GALT1;GSTT1;PRELP;CHSY1;CHST3
prerank,regulation of hormone secretion (GO:0046883),0.4379567594454268,1.046084935219057,0.3941747572815534,0.8331904471234938,1.0,2/15,3.48%,SNX6;ANXA1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.42325845671117013,-1.046078517558816,0.4060721062618596,0.7156113384607876,1.0,3/13,9.41%,STX7;CYRIB;PVR
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4450540952549094,1.0459558486748022,0.42943548387096775,0.8325490871851622,1.0,4/14,13.59%,MRNIP;WDR48;ARID2;FANCB
prerank,epithelial structure maintenance (GO:0010669),0.4625985406699075,1.045935723523084,0.41555555555555557,0.8316573028972977,1.0,2/11,7.98%,RBP4;MUC13
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.29752112412983595,-1.045327838708279,0.3640897755610973,0.7168817223175056,1.0,13/53,14.90%,HSP90AB1;DAB2IP;UBB;PKD1;UCHL5;GNA12;TMF1;PSMF1;FOXF2;PSME3;UBQLN4;PSMC3;PSME1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4275651669350882,1.045233867273498,0.418,0.8326174904655782,1.0,3/16,9.15%,APPL2;ACADL;APOC1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.4292132263578253,-1.044835914290568,0.4,0.7174104013705086,1.0,8/13,33.90%,GAS6;CD74;IFIH1;TRIM44;DHX9;MAVS;TSLP;IL7
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3980055450183345,1.0447613593747311,0.38943248532289626,0.8328421239043906,1.0,4/23,7.43%,C1QTNF3;BMP7;UACA;NLRC3
prerank,lymphocyte proliferation (GO:0046651),-0.36956977984330175,-1.044528772154556,0.40794979079497906,0.7174963828489617,1.0,8/22,17.60%,MEF2C;MSN;PTPRC;LMBR1L;HSPD1;FLT3;CR2;CD40
prerank,icosanoid biosynthetic process (GO:0046456),-0.45059021650930214,-1.044427465304565,0.436,0.7170727798974714,1.0,7/10,44.77%,PLA2G4A;LTA4H;PLA2G5;ALOX5AP;MGST2;FADS1;LTC4S
prerank,DNA replication initiation (GO:0006270),-0.3282414525361512,-1.044002665903325,0.3675799086757991,0.7175118275248212,1.0,20/37,36.86%,RPA1;MCM4;TOPBP1;PRIM1;MCM8;POLA1;CDK2;POLE4;POLE;MCM5;MCM10;POLE3;ORC1;RPA3;MCM6;GMNN;CDC6;RPA2;CDC7;CDC34
prerank,negative regulation of gene expression (GO:0010629),0.25986714633193747,1.0437114897719058,0.3569553805774278,0.8346125581213943,1.0,37/302,11.28%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;LGR4;NOTCH2;IGF2BP1;DAPK1;PRKN;RBMS3;JARID2;PTBP2;SYT11;RBBP4;TNRC6B;PRKAA2;TNRC6A;SLC2A10;RBBP7;TYMS;ABCC2;PRKAA1;MTF2;RBL2;WWP2;YTHDF2;PICALM;PARP10;SAMD4A;AGO2;PARP9;ATOH8;HDAC1;FLCN;APLN;FXR1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4220531377763792,-1.0436881715902342,0.42105263157894735,0.7176843098358767,1.0,5/13,12.48%,NOS3;GLS;DDAH1;NOS1;GAD1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.31211597896589127,-1.0436150455780793,0.3656387665198238,0.717197959370627,1.0,17/46,26.17%,MSN;PPIA;SOD1;ARF1;PDCD4;PAK2;RPLP0;TALDO1;HNRNPDL;MIF;PITPNA;JAK1;HSPA9;CFL1;CAPZA1;HNRNPF;IL12RB2
prerank,RNA 3'-end processing (GO:0031123),-0.28892086004958845,-1.0434505008972248,0.38366336633663367,0.7169224176926627,1.0,35/69,35.96%,SRSF2;SRSF1;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;RBM8A;RNPS1;SRSF6;SYMPK;CLP1;LIN28B;CPSF2;CSTF2T;PCF11;CSTF2;THOC3;SUPV3L1;MAGOH;THOC6;THOC2;EIF4A3;SRSF7;ALYREF;CSTF1;TENT4B;CPSF1;ZC3H11A;MTPAP;DHX38;U2AF1L4;CHTOP;SRSF3;NCBP2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4091384068710881,-1.0433184793444854,0.4064885496183206,0.7166035718738389,1.0,5/14,10.69%,PTK2;SOCS2;PXN;STAT3;PTPN1
prerank,cellular response to interleukin-12 (GO:0071349),-0.3084210638676848,-1.0431841899019676,0.36607142857142855,0.7162644743378076,1.0,15/48,20.20%,MSN;PPIA;SOD1;ARF1;PDCD4;PAK2;RPLP0;TALDO1;HNRNPDL;CD47;MIF;PITPNA;JAK1;HSPA9;CFL1
prerank,cellular response to leucine starvation (GO:1990253),-0.44490024872726935,-1.0431254854391043,0.4266409266409266,0.7157562675802728,1.0,4/10,18.47%,SESN3;MTOR;SESN2;RRAGB
prerank,nervous system development (GO:0007399),0.254409476837305,1.0430161450245898,0.3623011015911873,0.835559917932682,1.0,38/429,5.47%,ALDH1A2;ROBO1;ADGRV1;SDK1;ARNT2;ZIC1;NOTCH2;IGF2BP1;PRKN;ATXN1;ZEB2;LPAR1;NLGN2;IGSF8;ZIC2;SZT2;PCDHA3;B3GNT5;SOX6;FAT4;INTU;AVIL;JARID2;ZIC5;CNTFR;PCSK9;ARTN;OBSL1;GFRAL;PAFAH1B3;ARHGAP26;TEAD1;IGFN1;NRSN2;NDP;DPF2;PMP22;TPP1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.33536404607488296,-1.042970116824211,0.3764172335600907,0.7154872560373169,1.0,10/31,18.00%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;REST;SYT4;CACNA1I;SYT2;SYT7
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.40426080952440435,-1.0427706726559465,0.4003831417624521,0.7153476330752793,1.0,4/14,12.73%,THBS1;CREB3L1;GPC1;SPRY4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4135894108202813,1.0427420867624226,0.3912175648702595,0.835344177126847,1.0,4/18,5.91%,IL34;SLC45A3;SOX1;PTN
prerank,regulation of inflammatory response (GO:0050727),0.273792249431324,1.0427078562482994,0.36637931034482757,0.8344819614460116,1.0,19/190,7.58%,RORA;ADAMTS12;C1QTNF3;PPARA;IL18;SNX6;ANXA1;CCN4;LACC1;SPHK1;UFL1;GPSM3;CASP12;SETD6;NAPEPLD;IL6;MMP9;NLRC3;DAGLB
prerank,negative regulation of centrosome duplication (GO:0010826),-0.440752324962461,-1.0418021228602754,0.4151291512915129,0.7172207937039758,1.0,7/11,41.68%,MDM1;RBM14;CCNF;NPM1;TMEM67;KAT2A;CENATAC
prerank,protein neddylation (GO:0045116),-0.427290644900841,-1.04158490535343,0.4168260038240918,0.7171420698187345,1.0,4/13,14.54%,NEDD8;RBX1;DCUN1D1;DCUN1D2
prerank,regulation of response to external stimulus (GO:0032101),0.2913958201313602,1.0415353599830663,0.3782542113323124,0.8366572488898336,1.0,15/121,7.98%,ADAMTS12;APPL2;EFNB2;NMT2;TRIM5;ANXA1;LACC1;PDGFRA;UFL1;CASP12;PDE6G;SETD6;CAMKMT;DAGLB;RNF135
prerank,organelle transport along microtubule (GO:0072384),-0.331865398580965,-1.0410965632496245,0.40898876404494383,0.7176667509827109,1.0,7/31,16.43%,UBB;COPG1;RHOT1;RAB1A;NDE1;BICDL1;BICD1
prerank,keratan sulfate metabolic process (GO:0042339),0.37095231457766237,1.0409909197518765,0.41312741312741313,0.8371949276640731,1.0,6/31,5.37%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,synaptic vesicle membrane organization (GO:0048499),-0.39405104017894904,-1.0408904129394827,0.42292490118577075,0.7175660128077417,1.0,6/17,26.09%,STX3;STX1A;SNAP25;STX2;SYP;SYNGR2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.3139916900132978,-1.0406842155855036,0.36492890995260663,0.7175006378564509,1.0,14/42,29.62%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.38282369167556607,-1.0406821983208787,0.3972602739726027,0.7168379336369944,1.0,6/18,20.09%,SEC14L1;RNF125;PUM2;BIRC3;GPATCH3;NOP53
prerank,glutamate metabolic process (GO:0006536),-0.37864195542844686,-1.0406607901162856,0.39914163090128757,0.7162301545496061,1.0,4/19,12.48%,GLS;GCLM;ALDH18A1;GAD1
prerank,nuclear membrane organization (GO:0071763),-0.38377926143619934,-1.0403197850067882,0.39789473684210525,0.716476748524444,1.0,5/19,11.93%,TARDBP;TOR1B;TMEM43;NSFL1C;GPER1
prerank,cGMP metabolic process (GO:0046068),-0.4318845725797368,-1.0402128814746423,0.43151969981238275,0.7160693665143236,1.0,3/12,7.28%,GUCY1B1;GUCY1A1;PDE2A
prerank,regulation of calcium ion import (GO:0090279),-0.37596174286629086,-1.0399110531481508,0.42073170731707316,0.7161385216142513,1.0,9/21,26.34%,FYN;CTNNB1;WNK3;SLC30A1;CXCL12;PLN;TRIM27;SPHK2;CCL2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.44433259345738385,-1.0396972677056695,0.4264432029795158,0.7160388110819791,1.0,6/10,31.25%,OGT;PDK2;ZNF692;SIRT7;DGKQ;GNMT
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2186772520955399,-1.0395623837971868,0.2732919254658385,0.7157511700058572,1.0,139/532,20.46%,FN1;PTPRJ;TMSB4X;ADIPOR2;B2M;ACTN4;MSN;IL33;HSPA8;LIFR;RPS6KA5;MAOA;TNFRSF11B;STX3;HSP90AA1;CBL;F3;ITGB1;LBP;FYN;PTK2B;MID1;VIM;INPP5D;ACKR3;UBB;NFKBIA;S1PR1;PPIA;NOD1;LIMS1;SOCS2;STX1A;LAMA5;IKBKB;TGFB1;EDA;TRIM25;CD44;HSP90B1;SOD1;ST18;BCL2L1;SOCS5;IL1R1;UBC;RPS27A;TNFRSF11A;LRP8;MT2A;CEACAM1;CSK;TNFRSF1B;ARF1;PDCD4;CARD14;VEGFA;BIRC3;IL1RAP;FOXO1;PSMD13;AIM2;PSMF1;PTGS2;APPL1;COMMD7;PAK2;RBX1;RPLP0;TALDO1;ADAR;PSMB10;PIK3CD;CDKN1B;CHUK;ISG15;STAT3;CRK;IFI35;PSMB6;TOLLIP;IL1RL2;PSME3;JUNB;PSMB5;MAP3K3;OAS2;RSAD2;CANX;PSMC3;IRAK3;PSMD12;PSMB8;CUL1;MAP3K8;IL17RE;HNRNPDL;TAB3;MT3;INPPL1;IFNGR1;CSNK2B;TRAF1;CSF1R;PSME1;CAMK2B;CXCL12;UBA52;IL20RB;FLT3;PSMB3;CISH;RPS6KA4;MIF;IL18BP;SOX2;CD40;CCL13;IL15;EIF5A;IRAK1;IL4R;IRF5;SH2B3;PITPNA;BST2;SPI1;JAK3;PSMD5;MYD88;SLA;JAK1;HSPA9;IFITM3;PRKCD;CFL1;AKT1;SKP1;CSF3R
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4405045303626283,-1.039462163394089,0.4397705544933078,0.7153428716140148,1.0,4/11,28.41%,ATG7;TTL;ICMT;AGTPBP1
prerank,regulation of secretion by cell (GO:1903530),-0.29691117804357064,-1.039423611073956,0.37971698113207547,0.7147762841680237,1.0,25/54,31.09%,MEF2C;NSF;RAB3C;MCTP1;VAMP8;SCG5;RHBDF2;DNAJC1;KCNMB4;RAB3B;CPLX2;FMR1;RAB8A;RAB8B;RAB3A;LGI3;DISP1;CPLX1;HAP1;ARFIP1;VAMP3;RIMS2;SYT1;STXBP5L;RAB15
prerank,fatty acid elongation (GO:0030497),-0.4176155323135733,-1.0392941970856613,0.4400785854616896,0.71446086467726,1.0,5/13,18.61%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECR
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4081212196445569,-1.0391290477274484,0.4367816091954023,0.7142084981773833,1.0,8/15,30.44%,PRKCH;SFRP4;BMP4;NUMA1;ETV4;NME2;SFN;SULT2B1
prerank,neuron projection development (GO:0031175),-0.24443691059776343,-1.0391268217668634,0.3516819571865443,0.7135595772844746,1.0,25/168,8.40%,FRY;SHANK3;PTPRM;TRIO;STX3;CTNND2;PLP1;GRM7;MAP4;DAB2IP;NGF;UBB;DOCK10;MINK1;SHTN1;NCKAP1;BLOC1S2;EHD1;GSK3B;GPM6B;STMN2;DNM2;APP;MYOC;PAK1
prerank,mRNA splice site selection (GO:0006376),0.3706304905794714,1.0382930665816539,0.3717948717948718,0.8435495822410382,1.0,4/30,8.29%,CELF2;NOL3;SLU7;SF3A3
prerank,phosphorylation (GO:0016310),0.2543716825864516,1.038282159939455,0.38257575757575757,0.84262277576433,1.0,71/384,14.24%,PRKAG2;EPHA7;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;BMP2K;RNASEL;DMPK;FER;MAP4K5;CDK7;FAM20A;SRPK2;SPHK1;MAPK9;SIK1;PRKAA2;LRRK2;PRKCZ;PRKCB;MAML1;STK17B;PRKCA;GRK3;PRKAA1;NEK4;NRBP1;RYK;BIRC5;GRK5;BIRC6;CCNT1;PKN2;CDK1;CAMK2D;PIK3R4;NEK10;GRK4;VRK2;LATS1;FRK;ABL1;PRKDC;JAK2;COQ8B;ERBB2;IKBKE;BMPR1A;MAPKAPK2;PRKAG1;HIPK3;CCNE1;PRKD2;STK24;TBK1;ROS1;MAPK1;DCLK1;PRKACB;MORC3;STK26;NIM1K;CDKL5;NLK;CDK15
prerank,positive regulation of catalytic activity (GO:0043085),0.3557341702713098,1.0379816879231236,0.40319715808170514,0.8424677890424904,1.0,11/37,15.10%,FGFR4;IGF2;AZIN2;XRCC5;XRCC4;SSBP1;NHEJ1;ABL1;PSENEN;CIB1;WRN
prerank,response to UV (GO:0009411),-0.2653996014129553,-1.0379419034441557,0.36813186813186816,0.7159715951637765,1.0,33/95,28.21%,RPL26;UVSSA;MAPK8;UBE2B;BCL3;MAP2K7;ATF4;MFAP4;MEN1;MSH2;ERCC8;SDF4;COPS9;POLK;USP28;N4BP1;SPRTN;ATR;PRKCD;AKT1;NOC2L;METTL3;FMR1;CDKN2D;BMF;POLD1;RELA;GTF2H2;DTL;XPA;ERCC5;CAT;TMEM161A
prerank,cardiac muscle cell development (GO:0055013),0.41014835382336856,1.0371126889030133,0.4186046511627907,0.8439221366742677,1.0,5/20,4.40%,CSRP3;PDGFRB;SLC8A1;OBSL1;PDGFRA
prerank,lysosome localization (GO:0032418),-0.32455610019254133,-1.036977935869553,0.4121951219512195,0.7177960023591856,1.0,20/37,31.89%,MAP6;BLOC1S2;MYH9;PIK3CD;LAMTOR1;CHGA;PLEKHM1;SPAG9;HDAC6;S100A13;RAB3A;SYTL4;MILR1;BORCS6;KLC2;SNAPIN;VPS33B;HPS6;NR4A3;KIF5B
prerank,positive regulation of vasculature development (GO:1904018),0.3023965445622465,1.0366300662826158,0.40096618357487923,0.8442827662709159,1.0,15/94,7.40%,SASH1;ADAM12;STIM1;SMOC2;PDPK1;HK2;ECM1;CTSH;ANXA3;ITGAX;SPHK1;FGF1;PRKCB;PDCD6;PRKCA
prerank,response to laminar fluid shear stress (GO:0034616),-0.44615698302871404,-1.0362751234038905,0.4277227722772277,0.7189415491531214,1.0,3/10,3.12%,KLF2;KLF4;SREBF2
prerank,positive regulation of viral transcription (GO:0050434),0.38220716732146365,1.0351873491807309,0.4180327868852459,0.8471369731931753,1.0,5/25,8.49%,POLR2D;POLR2A;RSF1;CCNT1;GTF2F1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.30525951998460477,-1.0351274150599303,0.3949771689497717,0.7211962651320878,1.0,23/51,33.86%,HSPB1;APP;AIM2;STAT3;GBP5;USP50;PANX1;TMED10;CASP8;MYD88;TYROBP;S100A13;CASP1;AGER;NLRC4;TLR4;LPL;CD36;IL16;TLR6;NOD2;P2RX7;NLRP3
prerank,nucleosome organization (GO:0034728),0.32560286298882324,1.0351068649349158,0.41480206540447506,0.8463879392758112,1.0,20/55,22.11%,NASP;RSF1;ARID2;KAT6B;SMARCA5;SMARCE1;NAP1L3;INO80;SMARCB1;NAA60;SRCAP;SMARCC1;ACTR6;SMARCD3;NAP1L1;SETD2;BRDT;PAF1;ANP32B;SOX9
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.43348190477494686,-1.034536960610797,0.42338709677419356,0.7220901286995712,1.0,5/11,22.43%,ITM2B;ITM2A;ITM2C;ABCA2;NECAB3
prerank,regulation of microglial cell activation (GO:1903978),0.41902321201626735,1.0345246243522743,0.42736842105263156,0.8470314669502261,1.0,5/15,15.39%,SYT11;SPHK1;IL6;CST7;CX3CL1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.30262083582951466,-1.0343266670174036,0.39351851851851855,0.7219779463151208,1.0,12/48,18.97%,HSP90AB1;FLNA;CRYAB;EDN1;AZIN1;CLU;IRAK3;CYP51A1;IAPP;PFDN6;PRKCG;PFDN5
prerank,protein modification by small protein removal (GO:0070646),-0.2314747361365906,-1.0342841925366744,0.3225806451612903,0.7214287779582969,1.0,56/252,17.81%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;UBB;NFKBIA;UCHL5;TOMM20;EIF3F;COPS7A;NEDD8;RHOT1;USP29;UBC;RPS27A;USP31;UCHL1;ZRANB1;BIRC3;PSMD13;PSMF1;RHOA;PSMB10;APC;OGT;HGS;USP50;PSMB6;PSME3;USP37;PSMB5;ADRB2;OTUD3;PSMC3;UCHL3;OTUB1;PSMD12;FOXK1;PSMB8;OTUD1;PSME1;CFTR;UBA52;COPS8;IFIH1;PSMB3;RUVBL1;MYSM1;USP28;USP9X;ZC3H12A;COPS6;WDR20;USP8
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.44156697072682327,-1.034025585766392,0.4397590361445783,0.7214260910413918,1.0,8/10,34.20%,MYD88;AKT1;CD68;TREM2;TLR4;CD36;TLR6;TICAM1
prerank,response to nutrient levels (GO:0031667),-0.3850286092683876,-1.0332164124899499,0.4185606060606061,0.7228310396845264,1.0,5/17,10.68%,KCNB1;FAM107A;MTOR;EIF4G1;ATF4
prerank,positive regulation of innate immune response (GO:0045089),-0.33075432867206517,-1.0331332885084028,0.41561181434599154,0.7223768898737568,1.0,15/30,35.90%,LBP;RPS19;NLRC5;GBP5;IFI35;SPI1;POLR3D;POLR3F;SLC15A4;FADD;PLA2G5;DHX9;MAVS;CCL5;TLR8
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.45876473460790507,-1.0329791076365904,0.4330097087378641,0.7221170530592197,1.0,6/10,49.81%,NCKAP1L;VSIR;TLR4;IL12A;FOXP3;IL12B
prerank,negative regulation of apoptotic process (GO:0043066),0.2488857261990008,1.0327634655600886,0.3635220125786163,0.8507367122264754,1.0,75/444,13.69%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;PRKN;DAB2;SNX6;BCL2;FNIP1;SMAD6;DKK1;SCX;LTF;IFIT3;NDNF;CTSH;ANXA1;PDPN;RNF213;ARAF;SPHK1;KDM2B;ZFAND6;CPEB4;PRKAA2;IGF1R;LRP2;SON;NIBAN2;KRT18;MYO18A;BNIP3;SH3RF1;IL6;NOL3;MMP9;PRKCA;PRKAA1;BIRC5;SIAH2;GRK5;BIRC6;TLE1;CDK1;NUPR1;BCL2L2;RETREG1;YME1L1;ITCH;MED1;NAA35;AXL;PHIP;PRKDC;HDAC1;PIK3R1;RPS6KB1;TFAP2A;TFAP2B;SH3RF2;TMBIM4;APOH;CFLAR;HIPK3;GDNF;FSTL1;NFATC4;MAPK1;MRE11;ANXA5;NTSR1;CIB1;SLC30A10
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.30353372996227984,1.032386901148759,0.38461538461538464,0.8508206285644785,1.0,3/84,1.37%,IGF1;IGF2BP1;DAPK1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3729361529848659,-1.032341424095103,0.4178498985801217,0.7231319416464044,1.0,8/20,32.53%,GATM;GCLM;PLOD2;GGT1;GAMT;CHAC2;MGST2;OPLAH
prerank,peptidyl-proline modification (GO:0018208),-0.3539810198783244,-1.0322553641955077,0.42998027613412226,0.7226918981194221,1.0,6/25,11.70%,PPIA;P3H2;PPWD1;PPIE;PPIB;NKTR
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.43253909290140036,-1.0319810847498154,0.44954128440366975,0.7227426391763393,1.0,7/12,34.32%,SIX1;VEGFA;SIX4;PAX8;AGT;NOG;PAX2
prerank,cellular potassium ion homeostasis (GO:0030007),0.4410222761338495,1.031915473952061,0.42462845010615713,0.8511347148921583,1.0,2/13,2.26%,ATP1A2;ATP1B3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3785688742801667,1.0317670580934473,0.4342857142857143,0.8505721018546022,1.0,8/26,21.65%,KMT2A;SETD1A;SETD2;CTR9;WDR82;SETD4;BEND3;TET3
prerank,regulation of nuclear division (GO:0051783),0.4040650388373611,1.0317333602184178,0.42964352720450283,0.8497083246135028,1.0,4/20,8.85%,OBSL1;CCDC8;CUL9;CUL7
prerank,dendritic spine morphogenesis (GO:0060997),-0.40821371039627286,-1.0314284556328144,0.4171656686626746,0.7235624312770946,1.0,3/15,3.75%,SHANK3;CTNND2;DOCK10
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2864121578647574,1.0312723549881389,0.4205748865355522,0.8499611770002437,1.0,21/122,12.49%,IGF1;FGFR4;SMOC2;SLC6A9;SORBS1;PDGFRB;IGF2;PLD1;IL6;CCL19;SAMD4A;PRKDC;RPS6KB1;METTL14;NPM2;JAK2;FXR1;ERBB2;LARP6;PRKD2;AR
prerank,positive regulation of cell division (GO:0051781),0.3423285273878666,1.0311724619346336,0.43447037701974867,0.8492911199348256,1.0,5/38,8.59%,FGFR2;CXCR5;CDC14B;FGF1;PKN2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3109346638324689,1.0306193629422296,0.38950715421303655,0.8497699323045851,1.0,8/72,5.40%,IGF1;IL18;KIT;PDGFRB;NEDD4;PDGFRA;PDGFD;IGF1R
prerank,protein acetylation (GO:0006473),0.3704646820325192,1.0304988440641312,0.42,0.8490925501700827,1.0,12/30,21.84%,NAA80;SPHK1;AANAT;NAA35;NAA60;ESCO1;CLOCK;CREBBP;DSCC1;KAT2B;KAT5;NAA50
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3571015535719188,-1.0303933144037036,0.4231578947368421,0.7255727464695529,1.0,8/24,13.96%,KLF2;NOTCH1;CREB3L1;VEGFA;SESN2;HSPA5;ATF4;MT3
prerank,receptor recycling (GO:0001881),0.46792338314924187,1.0302097444172933,0.42592592592592593,0.8489229229854671,1.0,5/10,14.67%,PLEKHJ1;REP15;ARFGEF2;PHETA1;RAB11B
prerank,cellular response to amino acid starvation (GO:0034198),-0.28193202116520094,-1.0300687112192202,0.3838383838383838,0.7257184852370442,1.0,33/71,27.05%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;ATP6V0C;WDR59;ATF4;LAMTOR1;RHEB;TCIRG1;ATP6V1E1;DAP;FAS;LAMTOR2;PRKD1;ITFG2;RRAGB;ATP6V0D2;MAPK3;CDKN1A;LAMTOR4;DEPDC5;CEBPB;ATP6V0E2;CASTOR1;ATP6V1B2;WDR24;ATP6V1H;RPTOR
prerank,establishment of protein localization to membrane (GO:0090150),0.3146458820776038,1.0300063598472269,0.43527508090614886,0.8485233620171948,1.0,19/66,17.78%,AFDN;PARD3;RAB3IP;SYNE3;ZDHHC1;ARL6;ZDHHC3;MICALL1;OXA1L;VPS37A;VPS37C;RAB3GAP1;PRKCI;RAB11B;ATG3;GRIN3B;VPS37D;SDCBP;TAOK2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.38958514549449746,-1.0299839502650745,0.4409937888198758,0.7252811136054826,1.0,11/18,28.70%,MSN;HSP90AA1;FAF1;CD81;ATP5IF1;VPS11;ABCA2;CTSC;PTTG1IP;EZR;RNF128
prerank,protein import into peroxisome matrix (GO:0016558),-0.4259092235432947,-1.0299657547554981,0.42962962962962964,0.7246795880377319,1.0,6/12,29.55%,PEX5L;PEX1;PEX5;PEX10;PEX16;PEX13
prerank,negative regulation of defense response to virus (GO:0050687),0.4579302612885224,1.0298725482061857,0.41935483870967744,0.8479556483647303,1.0,4/10,19.05%,ITCH;PCBP2;TRAF3IP1;ILRUN
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.43195333434094063,1.0294952979600513,0.42071881606765327,0.8480576129195316,1.0,2/14,9.75%,IL18;IL17D
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.38444614616915174,-1.029253024802892,0.41141732283464566,0.725777315658865,1.0,8/17,26.32%,PODXL;TGFB2;PIEZO1;RET;ADAM9;NCKAP1L;P2RY12;SKAP1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4090003653383344,1.0287210603616896,0.41005802707930367,0.8491743401636295,1.0,7/19,20.02%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4568889868111912,-1.028643310262093,0.4606741573033708,0.726645178096767,1.0,6/10,27.38%,CORO2B;DNAJA1;NDFIP2;NDFIP1;SNX3;PPM1F
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.45277540744956224,1.028551608769213,0.4492753623188406,0.8486985111589636,1.0,2/11,6.22%,RBBP4;NASP
prerank,regulation of protein ubiquitination (GO:0031396),-0.2575586569037223,-1.0284561982388696,0.40168539325842695,0.7264492725185945,1.0,43/108,25.33%,CAV1;HSP90AA1;HSP90AB1;UBE3A;UBB;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;FAM107A;ARRB1;CHP1;CUL3;BIRC3;DERL1;OGT;ISG15;NDFIP2;FOXF2;CAMLG;DCUN1D1;NXN;WFS1;LAPTM5;PRMT3;SPOPL;N4BP1;SPRTN;PRKCG;UBE2D1;PINK1;ARRB2;AKT1;SIRT7;TNFAIP3;NDFIP1;HSPA1B;SPRY2;HUWE1;PTTG1IP;TSPYL5
prerank,positive regulation of immune system process (GO:0002684),-0.3919921696513703,-1.0281087465637568,0.4352226720647773,0.7266525666781701,1.0,6/16,20.81%,TGFB2;VEGFA;PIK3CD;RSAD2;IL15;NCKAP1L
prerank,negative regulation of response to wounding (GO:1903035),-0.3756467239838894,-1.0277418251509551,0.41995841995842,0.7269315902598965,1.0,8/19,21.36%,RTN4RL1;CD109;AJAP1;CRK;GIT1;CASK;INPP5F;RTN4R
prerank,central nervous system development (GO:0007417),0.26537018372463045,1.0275169524661953,0.41216216216216217,0.8504623255994361,1.0,26/250,7.48%,EPHA7;AFF2;ARNT2;SLC8A3;ZIC1;PRKN;ATXN1;MEIS1;ZIC2;SZT2;B3GNT5;SOX6;SHROOM2;LOXL3;JARID2;ZIC5;PAFAH1B3;NFIB;ZFHX2;TPP1;SYNJ2;PHF8;SETD1A;AMIGO3;PBX4;PTEN
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3936884319835002,-1.0274078333998895,0.4400785854616896,0.7271160825526,1.0,3/15,4.46%,CSGALNACT1;CSPG4;BGN
prerank,negative regulation of cellular component movement (GO:0051271),0.4142616450325287,1.0273825672838417,0.4317718940936864,0.8498906324151294,1.0,3/15,6.36%,TGFBR3;SP100;FBLN1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.3886861689525587,-1.0272930546140673,0.4691848906560636,0.7261130697664366,1.0,5/16,5.59%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.3886861689525587,-1.0272930546140673,0.4691848906560636,0.7261130697664366,1.0,5/16,5.59%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,protein homooligomerization (GO:0051260),0.289732786438681,1.0269219103917917,0.41274658573596357,0.8501677557920938,1.0,17/114,10.46%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CBY1;IKZF4;HSD17B10;ARC;BLM;SLC1A5;RNF135;SSBP1;GOLGA2;GSDMD;CLYBL;MICU1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.30488699834724364,1.026765786442363,0.40663176265270506,0.8496562067223893,1.0,7/75,5.00%,DCDC2;FGFR2;LRP4;SDC2;PARD3;BAIAP2;NTNG2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.39431142004168185,1.0264258953562073,0.4362549800796813,0.8496206782007938,1.0,3/20,4.55%,B3GALT1;ST3GAL3;B4GALT1
prerank,negative regulation of signaling (GO:0023057),-0.34847319906982277,-1.0262072322795552,0.41409691629955947,0.728221282751175,1.0,6/25,10.69%,HHIP;AP1AR;UBASH3B;SOCS5;KIF26A;PTPN1
prerank,negative regulation of blood pressure (GO:0045776),-0.4155754338482629,-1.0254994382204823,0.44356435643564357,0.7293279699314562,1.0,4/13,17.59%,NOS3;BMPR2;NOS1;PRCP
prerank,dicarboxylic acid metabolic process (GO:0043648),0.337464801878779,1.0254200375949458,0.4209650582362729,0.8513084139741498,1.0,12/52,15.15%,ADHFE1;ACOT4;MTHFR;HOGA1;FOLR2;IDH2;PHYH;SLC19A1;SHMT1;AADAT;ME3;MTHFS
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.46997776610949243,1.0253207735964236,0.4168466522678186,0.8506597923080734,1.0,1/10,0.35%,ERRFI1
prerank,negative regulation of peptidase activity (GO:0010466),-0.29708588392577484,-1.025233967455201,0.38534278959810875,0.7293421965254063,1.0,8/47,7.50%,SPOCK2;CST3;SERPINE2;SERPINI1;UBXN1;SERPINF1;SERPINB9;GAPDH
prerank,protein homotrimerization (GO:0070207),-0.3959198341752477,-1.0251830292805033,0.42338709677419356,0.7281677039171771,1.0,9/14,34.36%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,protein trimerization (GO:0070206),-0.3959198341752477,-1.0251830292805033,0.42338709677419356,0.7281677039171771,1.0,9/14,34.36%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,positive regulation of vascular permeability (GO:0043117),0.4430906144001646,1.0250843180618086,0.42857142857142855,0.850342640953691,1.0,2/12,1.29%,BMP6;ANGPT1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.41049272675226317,-1.024902752411285,0.46296296296296297,0.7282991310900289,1.0,2/13,6.40%,UBB;RHOT1
prerank,regulation of protein localization (GO:0032880),-0.2895822211842048,-1.0248490275929307,0.43828715365239296,0.7277862951337034,1.0,12/58,10.92%,HSP90AA1;HSP90AB1;RACK1;CTSD;RABGAP1L;TRIM14;TRIM25;STX6;MMD2;ZDHHC7;MAPK8;RSL1D1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4193882710263825,-1.0246227984411829,0.4387755102040816,0.7277453132753452,1.0,8/13,34.18%,RPS21;BMS1;TBL3;KRI1;TSR1;ABT1;UTP20;RPP40
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4022328886623833,1.0242365309175996,0.41304347826086957,0.851698297214003,1.0,2/20,1.82%,PID1;DAB2
prerank,inorganic anion transport (GO:0015698),-0.2922700000971788,-1.0241140689323407,0.39650872817955113,0.7283482824537323,1.0,7/53,6.11%,SLC4A10;SLC26A7;ANO1;ANO4;CLIC4;CLIC5;TTYH3
prerank,base conversion or substitution editing (GO:0016553),-0.43322112559891723,-1.0239362890967523,0.4437984496124031,0.7281861314441286,1.0,5/11,25.11%,ADARB1;ADARB2;ADAR;METTL3;NUDT16
prerank,MAPK cascade (GO:0000165),0.2572464973630301,1.023784993121998,0.40433673469387754,0.8519032820956765,1.0,23/295,6.48%,IL31RA;IGF1;KSR1;FGFR2;FGFR4;NRK;IL18;KIT;ANGPT1;NCAM1;PDGFRB;KL;CTSH;ARTN;ARAF;PDGFRA;PTPRA;LRRK2;FGF1;PSME4;FRS2;PSMA2;DLG1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.34082796374432495,-1.0234262990980536,0.40162271805273836,0.728827196470695,1.0,10/27,19.62%,VPS13A;VPS13C;ZDHHC15;GBP5;RIPOR1;TMED10;GBF1;VPS13D;SYS1;IFT20
prerank,ventricular septum development (GO:0003281),0.34169112699802984,1.0230000130209045,0.4186046511627907,0.853018868744025,1.0,2/37,0.29%,TGFBR3;ROBO1
prerank,sensory perception (GO:0007600),0.33188896443684907,1.0229173910963847,0.41337907375643224,0.8523276491813198,1.0,5/45,9.33%,ADGRV1;GNAS;TTC8;WHRN;RETREG1
prerank,regulation of cell development (GO:0060284),-0.31844344069255615,-1.022713366326639,0.4088785046728972,0.7300223583431936,1.0,17/36,23.11%,BHLHE40;RPS19;HES1;CTNNB1;PRUNE1;FOXO1;GRN;HEY2;RHEB;HEYL;CX3CR1;HES6;ADGRA2;AKT1;HDAC9;DLL1;HEY1
prerank,skeletal muscle organ development (GO:0060538),-0.3470541790562807,-1.0225888881246337,0.43451143451143454,0.7296953026140861,1.0,5/26,6.87%,MEF2C;CAV1;MYL6;STRA6;SIX1
prerank,positive regulation of binding (GO:0051099),-0.2727698224012584,-1.0225854969597115,0.39949748743718594,0.7290601402901706,1.0,18/84,11.31%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;NGF;HES1;PKD1;GSK3B;MET;ADD2;HIP1R;APP;DERL1;RALB;BMP2;MEN1
prerank,negative regulation of endocytosis (GO:0045806),0.37498909813925446,1.0225311082452644,0.4227005870841487,0.8523848431019315,1.0,7/24,12.63%,EPHA3;SYT11;SNX33;APOC1;PICALM;RUBCN;PACSIN3
prerank,T cell proliferation (GO:0042098),-0.4158125763083922,-1.022511764943209,0.437847866419295,0.7286044448918535,1.0,3/13,9.62%,CADM1;MSN;LMBR1L
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3794473707326635,-1.0221286614096925,0.42658730158730157,0.7289715872662293,1.0,7/18,20.16%,ESR1;TGFB1;RPS26;ZC3H12A;NRDE2;TMBIM6;PTBP1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.38355028498509425,1.0220749213278084,0.43263757115749524,0.852634324903954,1.0,12/25,24.84%,SLU7;SF3A3;DDX23;PRPF3;SCAF11;DBR1;SNRNP40;PRPF6;LSM1;SF3B3;KHSRP;SRRM1
prerank,oxoacid metabolic process (GO:0043436),0.37423617465083436,1.0220507866497477,0.4269230769230769,0.8517702507691618,1.0,2/27,2.99%,DDO;TPST1
prerank,synaptic vesicle transport (GO:0048489),-0.43488476168127566,-1.0219430781986885,0.4389312977099237,0.7287666080707011,1.0,7/11,31.89%,RAB27A;SYNJ1;DNM2;CDK5;KIF5C;SNAPIN;KIF5B
prerank,positive regulation of response to external stimulus (GO:0032103),0.2811876086822709,1.0219340058551254,0.4222560975609756,0.8511617632980591,1.0,13/128,7.68%,BMP6;SASH1;IL18;PDGFRB;CCN4;GPSM3;DDX60;PTN;NAPEPLD;OPTN;PRKCA;CCL19;POLR3G
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3750907281759379,1.0218991476322723,0.4159132007233273,0.8503295445759408,1.0,3/26,3.48%,PLCB1;UBE2E2;ANXA1
prerank,regulation of RNA metabolic process (GO:0051252),0.32028058633485756,1.0218589962342837,0.44221105527638194,0.8495294334972835,1.0,12/59,11.47%,AFF2;IGF2BP1;NOVA1;PTBP2;HNRNPH1;SON;METTL4;YTHDF2;MITF;RC3H2;MED1;PCBP2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.43234567650532973,-1.021605360047167,0.43953934740882916,0.7290120848578256,1.0,6/11,31.96%,PUM2;LIMD1;STAT3;FMR1;ZFP36;DHX9
prerank,regulation of myoblast differentiation (GO:0045661),0.36119662802178865,1.0215107974769426,0.43674176776429807,0.8494779836059877,1.0,3/32,3.63%,RANBP3L;PLCB1;RIPOR2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4125830904678738,-1.02151069212032,0.44656488549618323,0.7286277467330975,1.0,6/13,27.20%,STAT3;OAS2;CANX;JAK1;STAT1;OASL
prerank,negative regulation of transport (GO:0051051),0.3281743332845413,1.0213576199644274,0.43617021276595747,0.8489389874525581,1.0,10/51,12.63%,EPHA3;PRKN;SYT11;SNX33;PTEN;WWP2;SIRPA;RUBCN;SNX12;PACSIN3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3901617061988129,1.0208499341805413,0.45048543689320386,0.8493296276956614,1.0,2/23,1.91%,ERRFI1;SNX6
prerank,regulation of cellular component movement (GO:0051270),0.334390732259779,1.0208194285339633,0.42614601018675724,0.8484990221067492,1.0,4/49,3.58%,TGFBR3;ROCK2;SP100;PDPN
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.29282448685592194,-1.0204853128342342,0.42997542997543,0.7305710521806779,1.0,17/52,20.30%,SPTBN1;PRKCH;STX3;ITGB1;RACK1;NKD2;ATP2C1;WNK3;ZDHHC2;GPER1;RHOG;PRKCE;STAC3;ACSL3;ZDHHC8;AKT1;ATP2B4
prerank,regulation of neuron differentiation (GO:0045664),-0.27218738179219926,-1.020397386029144,0.3932291666666667,0.7301664177194958,1.0,23/76,18.05%,MEF2C;ZFHX3;TIAM1;NGF;HES1;NRCAM;CALR;SIX1;MMD2;RHOA;YWHAG;BMP2;HEYL;BIN1;REST;ARHGEF2;BRINP2;TCF3;DISP3;YWHAH;SOX2;ID2;CASZ1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.38147281793553445,-1.020145147207812,0.4437869822485207,0.7301816311672367,1.0,4/17,8.54%,PPIA;HSPB1;SOD1;SFPQ
prerank,negative regulation of B cell activation (GO:0050869),-0.35596653524454347,-1.0200190312201425,0.4087912087912088,0.7298905667600993,1.0,9/21,22.89%,TNFRSF21;SAMSN1;LAPTM5;ID2;INHA;TYROBP;CD300A;TNFAIP3;FCGR2B
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3967647051133839,-1.019203866788509,0.46322067594433397,0.7313254444969105,1.0,6/15,30.92%,HGS;ATP13A2;SDC4;RAB7A;PDCD6IP;VPS4B
prerank,estrogen metabolic process (GO:0008210),0.42559791513350453,1.0191295159376217,0.4247967479674797,0.852128516627903,1.0,2/15,5.65%,HSD17B1;HSD17B10
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.28111906876475606,-1.0187871721252566,0.4319371727748691,0.7317088080292914,1.0,18/73,15.86%,KITLG;LMO2;RUNX1;CBFB;GATA2;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,positive regulation of autophagy (GO:0010508),0.3053594727611979,1.018696310938468,0.40938511326860844,0.8522842996011273,1.0,22/81,16.63%,DAPK1;PRKN;TRIM5;SESN1;PRKAA2;UFL1;NPRL2;LRRK2;BNIP3;OPTN;RNF152;PRKAA1;EPM2A;PLEKHF1;FLCN;GPSM1;TBK1;MAP3K7;MTDH;RUFY4;LARP1;IRGM
prerank,response to calcium ion (GO:0051592),-0.2574130795902122,-1.0186067050433956,0.3783783783783784,0.7314923148155366,1.0,29/102,18.00%,MEF2C;CAV1;CLIC4;THBS1;TRPC3;IQGAP1;CALM1;PLCG2;KCNMA1;LGMN;HOMER1;CPNE8;RYR2;CPNE2;CPNE3;KCNMB4;SYT10;SYT4;PPP3CA;ITPR3;KCNIP2;ITPKB;AHCYL1;CALM2;TRPC1;CPNE9;SYT2;ADAM9;SYT7
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.3389945651699899,-1.0185958013919987,0.4340425531914894,0.7308754648774187,1.0,10/28,23.11%,NOTCH3;GATA2;ARRB1;LFNG;ZBTB7A;DLL4;AKT1;METTL3;DLL1;HEY1
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3272445763244618,-1.0185817616771566,0.41541755888650966,0.7302635872203584,1.0,8/33,15.48%,KCNJ2;NEDD4L;CHRM3;WNK3;KCNQ1;KCNJ8;KCNJ15;AHCYL1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.25967575433317913,-1.0185473731275558,0.42118863049095606,0.7296956018340117,1.0,32/98,20.30%,SPTBN1;PRKCH;STX3;ITGB1;PPP1R13B;FYN;KCNB1;NKD2;NMT1;YWHAB;WNK3;CHP1;MAPK8;C2CD5;YWHAG;MIEF1;GPER1;BBC3;CD81;MIEF2;MTCL1;CASP8;RHOG;YWHAQ;PRKCE;STAC3;YWHAH;PPP3R1;ANK3;ZDHHC8;AKT1;ATP2B4
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.38647034539519276,-1.0184148943134692,0.44190871369294604,0.7293833942077292,1.0,2/15,2.50%,PLTP;SCARB1
prerank,negative chemotaxis (GO:0050919),0.35958463896176823,1.0183006135837054,0.4430379746835443,0.8524242258662291,1.0,3/33,2.39%,EPHA7;ROBO1;SEMA3B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3659476532579091,-1.0182009137072698,0.43710021321961623,0.7293272687270278,1.0,10/18,46.35%,BCAR1;BAG6;CMKLR1;LAX1;C5AR2;FPR3;BLK;C5AR1;SLA2;GPLD1
prerank,neuron projection extension (GO:1990138),0.3544842562783411,1.017826425354285,0.4103942652329749,0.8527411808847987,1.0,2/32,0.61%,ALCAM;AUTS2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.37099671343735596,-1.017785456905844,0.44668008048289737,0.7297148907426096,1.0,7/19,19.75%,NFATC2;NFATC1;EDN1;PPP3CA;HRH1;PPP3R1;NFATC3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.42955401092463197,-1.0177215993013615,0.43564356435643564,0.7292444084354252,1.0,2/11,10.16%,MEF2C;PIK3CD
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3923222802844205,1.017551639511423,0.421455938697318,0.8516335327340246,1.0,2/20,5.01%,GSTM2;GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),0.3923222802844205,1.017551639511423,0.421455938697318,0.8516335327340246,1.0,2/20,5.01%,GSTM2;GSTT1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4371658409092801,-1.0174600229767192,0.4669187145557656,0.7293058110845961,1.0,4/10,16.43%,GSK3B;APC;NSFL1C;BICD1
prerank,regulation of immune response (GO:0050776),-0.24888463719193346,-1.0173913181170173,0.40963855421686746,0.728851990883356,1.0,31/135,19.89%,FOXP1;B2M;CLEC2D;CD200;CD34;TGFB2;ITGB1;CXADR;DENND1B;ITGA4;LRP8;CSK;AHR;BIRC3;ADCY7;APPL1;PVR;NPDC1;RSAD2;ICAM2;CD81;COL1A1;COL3A1;CASP8;ULBP1;N4BP1;CD40;IL15;PIANP;TIRAP;TYROBP
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3497538819944205,-1.0172538902988881,0.42857142857142855,0.7285905067963968,1.0,11/22,31.82%,UBB;UBC;RPS27A;DDB1;RBX1;UBA52;CETN2;GTF2H2;XPA;ERCC3;GTF2H5
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3811637192432283,1.0172408652603584,0.4291044776119403,0.8515465708606419,1.0,3/24,4.29%,AUTS2;AVIL;ABI2
prerank,regulation of dendrite development (GO:0050773),-0.3174762076722305,-1.016287099822773,0.4304635761589404,0.7303341802239461,1.0,11/37,8.57%,BMP5;NEDD4L;DAB2IP;SEMA4D;ZDHHC15;DCC;GSK3B;LRP8;RTN4IP1;MFSD2A;MARK1
prerank,plasma membrane invagination (GO:0099024),0.3651403716587878,1.0162373150686308,0.4500907441016334,0.8532727710049873,1.0,6/29,7.84%,GULP1;ARHGAP12;SNX18;SNX9;SNX33;SPIRE2
prerank,organic substance transport (GO:0071702),0.2875925213973836,1.0160848715452817,0.44242424242424244,0.8527611193820449,1.0,19/120,11.16%,SLC22A4;SLC22A2;ABCA4;SLC35F3;ABCA9;TCN2;ABCA1;ABCA13;SLCO1B1;LRP2;NDC1;ZG16;ABCA5;MIA3;SLC22A6;SLC19A2;SLC19A1;MFSD2B;PLEKHA8
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3920327189524382,-1.0160562244352063,0.42588726513569936,0.7302650177477683,1.0,3/16,9.41%,CADM1;LAMP1;PVR
prerank,negative regulation of organelle assembly (GO:1902116),-0.3181949643810974,-1.015751913322183,0.4166666666666667,0.7303937831929326,1.0,9/35,19.14%,TBC1D30;LIMK2;MDM1;RBM14;MTM1;ODF2L;FEZ2;SMCR8;PINK1
prerank,gas transport (GO:0015669),-0.43298025567458226,-1.0156610480767354,0.463265306122449,0.7299862941653209,1.0,2/10,11.41%,CA2;CYGB
prerank,ion homeostasis (GO:0050801),-0.33389028969595336,-1.0152857600496306,0.4264705882352941,0.7303009862321775,1.0,6/30,11.06%,SLC4A10;NEDD4L;FHL1;WNK3;SLC4A8;SLC4A2
prerank,regulation of G0 to G1 transition (GO:0070316),0.3456718725723711,1.0148362148186765,0.43087971274685816,0.8551148864720991,1.0,11/38,16.36%,RBBP4;L3MBTL2;MGA;RNF2;RBBP7;E2F6;TFDP2;APAF1;UXT;RAD51;CDKN2B
prerank,embryonic digestive tract development (GO:0048566),0.40605082235598483,1.014760907869019,0.43822393822393824,0.8543898090026792,1.0,4/18,6.81%,FGFR2;PDGFRA;GLI3;SALL1
prerank,tRNA aminoacylation (GO:0043039),-0.3131069040863613,-1.0146788350756,0.4321266968325792,0.7311733432929226,1.0,13/37,29.62%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;CARS1;KARS1;MARS2;GARS1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.31429436352453755,-1.0144651958849904,0.44298245614035087,0.7311037562464453,1.0,11/38,14.86%,CAV1;GAS6;PTPRC;LRP8;APP;SRCIN1;NCK2;RELN;PTPN1;NEDD9;CSF1R
prerank,plasma membrane repair (GO:0001778),-0.41187256603128775,-1.0137473126013443,0.4528301886792453,0.7321939394145048,1.0,6/13,24.52%,AHNAK2;MYH9;DYSF;SYT7;RAB3A;SYTL4
prerank,cholesterol metabolic process (GO:0008203),0.3132455244142502,1.0134976695101767,0.4400656814449918,0.8566205639433888,1.0,12/68,12.24%,CYP27A1;CEL;INSIG2;ABCA1;ABCA5;PMVK;ACAA2;SOAT2;ACAT2;FDPS;RXRA;GBA2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.26852996660106576,-1.0134827944294749,0.43041237113402064,0.7322301490890395,1.0,27/80,23.62%,THBS1;NIBAN1;EEF2;VIM;RACK1;RPL26;SOX4;LRRTM3;RPL5;MTOR;PYM1;EIF3D;BCL3;YTHDF3;RPS4X;CLU;RPS27L;IFNGR1;EIF3C;ABCA2;ABCG1;PRKCD;METTL3;FMR1;EIF6;RELA;PCIF1
prerank,myeloid leukocyte differentiation (GO:0002573),0.31484132685004457,1.0133011152053717,0.43079584775086505,0.8562198122233149,1.0,9/65,11.41%,IL31RA;KIT;MMP9;CCL19;OSTM1;CSF1;BATF2;EPHA2;RXRA
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2766370375592303,-1.0133008132540469,0.4444444444444444,0.7320504942487288,1.0,17/63,20.81%,MEF2C;TFRC;SLC7A1;NCK1;NFATC2;CD38;PTPRC;NCK2;CD74;CD81;MIF;CD274;CD40;IL15;JAK3;TIRAP;NCKAP1L
prerank,protein secretion (GO:0009306),0.3206657937221417,1.0132500077446054,0.426056338028169,0.8554699897797432,1.0,9/56,10.02%,WLS;TANGO2;ANXA1;RAB13;ARFGAP3;ABCA1;SLC30A8;MIA3;STEAP3
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.43435952159616764,-1.0128811978973729,0.44731977818853974,0.7324720010319654,1.0,2/10,5.02%,CARMIL1;WDR1
prerank,carbohydrate catabolic process (GO:0016052),-0.3144274732700847,-1.0124405065799496,0.4400871459694989,0.7329148074285613,1.0,13/38,23.11%,PKM;HK1;GAPDH;MAN2B1;MAN2C1;PFKM;TPI1;ALDOA;LDHA;ALDOC;MAN2B2;MANBA;PFKFB2
prerank,regulation of protein kinase B signaling (GO:0051896),0.26630704802233895,1.012117720080344,0.4556786703601108,0.8574980677692928,1.0,22/193,7.56%,TCF7L2;OSBPL8;FGFR2;FGFR4;PPARA;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;GFRAL;PDGFRA;RICTOR;IGF1R;FGF1;LRP2;FRS2;PDCD6;PTEN;CCL19
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3044456557100097,-1.0114137022504346,0.4412470023980815,0.7348205424400867,1.0,11/43,12.32%,TGFB2;KLF4;ETS1;PPARD;GATA2;TGFB1;GNL3;JUN;DDX5;STAT3;REST
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.38101517096980764,-1.011214816088358,0.4321503131524008,0.7347081068837391,1.0,3/17,9.41%,CADM1;LAMP1;PVR
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3559278243123303,1.011182982549266,0.4450651769087523,0.8590061960378115,1.0,4/30,9.38%,LEPROT;UBE2L3;NPEPPS;HSPA1L
prerank,response to amino acid starvation (GO:1990928),-0.27663237874889024,-1.0106700401066013,0.42025316455696204,0.7354391486182327,1.0,33/72,27.05%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;ATP6V0C;WDR59;ATF4;LAMTOR1;RHEB;TCIRG1;ATP6V1E1;DAP;FAS;LAMTOR2;PRKD1;ITFG2;RRAGB;ATP6V0D2;MAPK3;CDKN1A;LAMTOR4;DEPDC5;CEBPB;ATP6V0E2;CASTOR1;ATP6V1B2;WDR24;ATP6V1H;RPTOR
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.2772053643427878,-1.0105720513460075,0.4297082228116711,0.7350467941157219,1.0,18/66,20.49%,TFRC;CDH1;FLNA;LIMK2;PINX1;TGFB1;FERMT2;CARD10;LARP7;SESN2;WWTR1;MEPCE;JUP;ZC3H12A;PSEN1;PRKCD;AKT1;RBM22
prerank,DNA repair (GO:0006281),0.2551738129679623,1.0102133222414962,0.4308510638297872,0.8606124205490115,1.0,72/284,17.88%,EYA1;FANCA;APEX2;RAD51B;ATRIP;BAZ1B;RAD51AP2;DDB2;HUS1B;RAD51C;TDP2;INIP;PDS5B;PSME4;PARP4;XRCC5;BLM;XRCC4;WDR48;FANCI;CDK1;BRCA2;MGME1;UVRAG;FBXO6;MBD4;MDC1;PDS5A;ABL1;PRKDC;DCLRE1A;PARP9;SMARCA5;ASCC2;TEX264;DCLRE1B;CUL4B;MPG;LIG1;INO80;PRIMPOL;MRE11;USP45;WDR33;FANCB;CIB1;FANCF;APEX1;UBE2V1;MNAT1;RAD23B;FANCE;FAAP100;UBE2A;CENPX;MLH1;BABAM2;WRN;FANCC;RAD18;RAD51;REXO4;BRIP1;BACH1;RNASEH2A;RPAIN;SETD2;TRRAP;XPC;ERCC6L2;DTX3L;FAAP24
prerank,regulation of Ras protein signal transduction (GO:0046578),0.29944205895621656,1.0094348390146737,0.42586750788643535,0.8616892372395043,1.0,13/85,11.11%,IGF1;DENND4A;NOTCH2;AKAP13;KANK2;EPS8L1;RALGPS1;MYO9B;ARHGEF18;KBTBD7;DENND4B;FLCN;JAK2
prerank,purine-containing compound catabolic process (GO:0072523),0.4439680830012179,1.0092338982824998,0.4393638170974155,0.8612713590300578,1.0,1/13,0.43%,DPYD
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3676580366305813,1.0090793759098757,0.45614035087719296,0.8607552938065102,1.0,13/27,22.27%,BRD8;KAT8;KAT6B;CREBBP;NAT8;TRRAP;KAT2B;RUVBL2;KAT5;PHF20;MSL3;NAA50;TAF6L
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.31997040322081827,-1.0089847934603768,0.4461538461538462,0.7384314989284623,1.0,13/33,26.09%,ACER2;TGFB2;PTK2;NEXMIF;DPP4;RET;CYP1B1;ADAM9;JAM3;NCKAP1L;ADA;P2RY12;SNAI2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3782498712811085,-1.0089644903534476,0.44402985074626866,0.7378496040710725,1.0,7/17,22.06%,SREBF2;SOD1;LPCAT3;ERLIN2;ABCA2;ABCG1;MBTPS1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4485498997241726,1.0087599792571016,0.44664031620553357,0.860666637660983,1.0,1/11,0.34%,LEPROT
prerank,actin filament-based transport (GO:0099515),0.39435345361122576,1.0083715197862386,0.4419889502762431,0.8607777943076188,1.0,4/21,5.21%,MYO5C;SYNE2;MYO1H;WASL
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.399801774774723,-1.0080222174521016,0.45849802371541504,0.7395843541169205,1.0,7/14,28.50%,DAB2IP;HSPA5;PTPN1;DNAJB9;BAX;BFAR;TMEM33
prerank,positive regulation of protein kinase activity (GO:0045860),-0.24244370455347145,-1.0079981438544554,0.4556213017751479,0.7390072233596562,1.0,32/148,12.75%,RAP1A;RASSF2;TGFB2;HSP90AA1;IQGAP1;GAS6;CALM1;HSP90AB1;PTK2;PTK2B;DAB2IP;MINK1;TGFBR2;MTCP1;PTPRC;CCDC88A;LRP8;PDCD10;VEGFA;EMP2;MMD2;PAK1;SRCIN1;RHOA;PAK2;RALB;RELN;PTPN1;PIH1D1;MARK2;CLU;ADRB2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.36875556113688723,1.0079595709061295,0.43503937007874016,0.8609665832486249,1.0,2/26,1.27%,ADCY5;STXBP4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.35068304178864407,1.0078873834993864,0.44485981308411215,0.8602538095264347,1.0,14/32,21.10%,CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;NBN
prerank,aerobic respiration (GO:0009060),-0.3580264436648877,-1.0078369396703022,0.4453125,0.7387750284862998,1.0,7/20,22.97%,ATP5F1D;UQCRH;NDUFS7;UQCRC2;UQCRC1;MTFR1L;UQCR10
prerank,positive regulation of neurogenesis (GO:0050769),0.31151208618733794,1.0078211321689803,0.45203252032520325,0.8594875758125344,1.0,8/68,7.00%,PLXNA2;ROBO1;CUX1;IL1RAPL1;OBSL1;PLXNC1;LRP2;PTPRD
prerank,Golgi ribbon formation (GO:0090161),0.4260917824949255,1.0077662321041245,0.45588235294117646,0.858702128335269,1.0,5/13,11.12%,MYO18A;OPTN;STX16;GOLGA2;VTI1A
prerank,acylglycerol biosynthetic process (GO:0046463),0.37632588489982577,1.0076139459930216,0.44646464646464645,0.85821619661198,1.0,2/23,1.78%,AGMO;LPGAT1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.34463115083514095,-1.00738846866999,0.4197802197802198,0.7392457419321086,1.0,10/24,18.67%,UBB;NOD1;UBC;RPS27A;RNF34;TAB3;AAMP;CASP8;UBA52;IRAK1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.4304304626564963,-1.0073049333876403,0.4775828460038986,0.7388392079860197,1.0,4/12,18.75%,ABCC9;CACNA1H;KCNJ8;TRPM4
prerank,positive regulation of axonogenesis (GO:0050772),0.3316334185312326,1.00713196510553,0.44646098003629764,0.8585427072588764,1.0,4/43,4.57%,PLXNA2;ROBO1;MACF1;PLXNC1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.32637464462447646,1.0070661270711099,0.41872791519434627,0.8578371536213825,1.0,6/46,9.87%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.36673813183008874,1.0068953265182325,0.4628252788104089,0.8573574246569224,1.0,7/27,8.90%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.39736133586552563,1.0068092854778976,0.4609375,0.8567016693456316,1.0,4/17,6.52%,RBPJ;MAML3;MAML1;WWC1
prerank,regulation of chromatin organization (GO:1902275),0.426555015712009,1.0061587920467256,0.453027139874739,0.8575194248627463,1.0,3/14,6.28%,IGF2;METTL4;SETD1A
prerank,telomere maintenance via telomerase (GO:0007004),-0.3366738839993454,-1.0060655644872258,0.43577981651376146,0.7413514320499511,1.0,9/28,21.04%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,positive regulation of protein acetylation (GO:1901985),0.4362939210724413,1.0056490460732501,0.47186147186147187,0.8579689968424653,1.0,5/12,20.52%,PRKAA2;PRKAA1;RAPGEF3;DDX3X;KAT5
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.25101416690352224,-1.0049689738126497,0.4332344213649852,0.7434787325112915,1.0,36/124,25.95%,FRY;PTPRM;RAC1;CARMIL1;STX3;PLP1;MAP4;BLOC1S2;EHD1;GSK3B;GPM6B;STMN2;APP;MYOC;PLEKHA1;STMN1;CSF1R;ODF2;BICDL1;TMEM108;STMN4;NCDN;STMN3;CDK5;SH3GL2;GPM6A;ARFIP2;L1CAM;UHMK1;VAPA;NPY;AGER;ATCAY;CAMSAP1;ADCYAP1;MICALL2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.46044129686698526,1.0040834341669729,0.4610526315789474,0.8611135863205179,1.0,4/10,23.37%,ALDH7A1;LRTOMT;SMOX;COMT
prerank,stress fiber assembly (GO:0043149),-0.3870651070715834,-1.00400353413361,0.45542635658914726,0.7445925569487732,1.0,6/15,10.75%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3870651070715834,-1.00400353413361,0.45542635658914726,0.7445925569487732,1.0,6/15,10.75%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,mRNA destabilization (GO:0061157),0.3366327061302151,1.0039520449453077,0.4614003590664273,0.8605654267787264,1.0,5/38,10.80%,ROCK2;POLR2D;YTHDF2;RC3H2;METTL14
prerank,triglyceride metabolic process (GO:0006641),0.32633313979208206,1.0038914245477386,0.4537205081669691,0.8598310581622115,1.0,10/48,16.79%,AGMO;LPGAT1;LIPH;LIPC;APOC1;APOH;FABP7;LMF1;FABP4;GK
prerank,membrane raft organization (GO:0031579),-0.3850483419670176,-1.0036123536553678,0.4782608695652174,0.7449341212875156,1.0,3/15,12.24%,RFTN1;EMP2;S100A10
prerank,B cell proliferation (GO:0042100),-0.37709022174879814,-1.0035961521360532,0.4649298597194389,0.7443540279287072,1.0,6/17,17.60%,MEF2C;PTPRC;CD180;HSPD1;CR2;CD40
prerank,folic acid metabolic process (GO:0046655),0.4070725836648236,1.0033084148132567,0.4280155642023346,0.8603886509555657,1.0,7/18,20.02%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.438371628848336,-1.00264843316767,0.4793713163064833,0.7460360690269092,1.0,4/10,6.94%,RAP1A;CD34;KDR;CEACAM1
prerank,actin filament depolymerization (GO:0030042),0.4319884515328515,1.0019922365447402,0.45252525252525255,0.8627642141939573,1.0,1/11,0.33%,MICAL3
prerank,stress granule assembly (GO:0034063),-0.3616477609471046,-1.0019295090676654,0.4624505928853755,0.7471565853187461,1.0,5/20,16.43%,RPS23;G3BP1;ATXN2L;YTHDF3;BICD1
prerank,positive regulation of macroautophagy (GO:0016239),-0.29691886810886947,-1.0014758665425454,0.44730679156908665,0.7477235854063987,1.0,17/48,23.70%,KDR;SPTLC2;SESN3;SH3GLB1;SESN2;RALB;HSPB8;ADRB2;TRIM13;SMCR8;VPS13D;PINK1;DCN;PIP4K2A;SLC25A4;SPTLC1;SCOC
prerank,tube closure (GO:0060606),0.36047502354414895,1.0012982128219097,0.45555555555555555,0.8636360449358583,1.0,7/31,11.24%,LMO4;PRICKLE1;MTHFR;LRP2;FOLR1;COBL;IFT122
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.32408179765417544,1.0000786732920044,0.4528301886792453,0.8658643224393511,1.0,1/48,0.08%,PRKAG2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4336355170863068,0.9993737577743985,0.4697286012526096,0.86671716041446,1.0,1/12,0.45%,COLEC12
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3528105238441082,-0.9993040553133881,0.4625267665952891,0.7518976726369135,1.0,8/22,22.71%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3528105238441082,-0.9993040553133881,0.4625267665952891,0.7518976726369135,1.0,8/22,22.71%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.32439518041814397,0.9990655837615121,0.46785714285714286,0.8666028527072578,1.0,9/51,9.11%,NRK;BMP7;GAS7;ALS2;DTNBP1;WASF1;LRRK2;NBL1;MYO16
prerank,positive regulation of cell cycle (GO:0045787),0.30619800707189027,0.9990467189641503,0.4699828473413379,0.8657457308182813,1.0,13/62,12.46%,FGFR2;SMOC2;SRPK2;SPHK1;CCDC57;EIF4EBP1;PRKCA;PKN2;NUPR1;MDM2;RPS6KB1;HSF1;PKD2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2642098730855299,-0.9987521141292844,0.4429347826086957,0.7526648940633219,1.0,27/84,22.30%,MBNL1;NOVA2;HNRNPK;RBFOX1;QKI;RBFOX3;RBFOX2;HNRNPU;LARP7;DDX5;ZBTB7A;SRSF9;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;SRPK1;RBMXL1;DDX17;YTHDC1;PCBP4;PTBP1;MAGOH;FMR1;TRA2B;RBM24
prerank,barbed-end actin filament capping (GO:0051016),-0.37048071058963383,-0.9986095045182029,0.463768115942029,0.7517704303260611,1.0,5/18,8.65%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,actin filament capping (GO:0051693),-0.37048071058963383,-0.9986095045182029,0.463768115942029,0.7517704303260611,1.0,5/18,8.65%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,positive regulation of JNK cascade (GO:0046330),-0.2737832383381172,-0.998502983885453,0.45185185185185184,0.7514175158670822,1.0,11/70,8.27%,MAP3K5;RASSF2;ANKRD6;PTK2B;DAB2IP;MINK1;SH3RF3;TPD52L1;APP;FLT4;WNT16
prerank,myelination in peripheral nervous system (GO:0022011),-0.4090971772254198,-0.9983671577766775,0.48041237113402063,0.7511007539547009,1.0,6/13,19.91%,ADGRG6;SOD1;MYOC;ARHGEF10;NF1;NCMAP
prerank,regulation of protein secretion (GO:0050708),0.2810602180019142,0.9973556729758372,0.44773790951638065,0.8692753320513373,1.0,11/119,7.58%,IGF1;BMP6;ITPR1;FRMD4A;KCNA5;LLGL2;CACNA1D;MYO18A;IL6;PRKCA;RAPGEF4
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.43837810265686206,0.9972783357531283,0.4596774193548387,0.8685991216464112,1.0,4/12,16.13%,IL34;CSF1;MAPK1;LYN
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.37655306834019,0.9971380792991824,0.452755905511811,0.8680337021089896,1.0,7/24,16.68%,LPGAT1;PLA2G10;SLC27A1;PLA2G4B;SERAC1;PLA2G12A;CDS2
prerank,positive regulation of lipid transport (GO:0032370),-0.41860037071816064,-0.997112399188993,0.4681647940074906,0.7535634705786853,1.0,11/12,56.68%,SPP1;ABCA3;DBI;PRELID1;LRP1;ABCB4;TRIAP1;ABCA12;CYP19A1;PRAP1;ADIPOQ
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3827583046956703,0.9970601059571682,0.4689265536723164,0.867337932920077,1.0,3/22,5.48%,APPL2;KDM2B;LRRK2
prerank,secondary palate development (GO:0062009),0.4161872995081574,0.9964136644169546,0.46473029045643155,0.8680924516106492,1.0,1/14,0.24%,TGFBR3
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.405702498261472,-0.9963987087946283,0.4951644100580271,0.7547113002152072,1.0,8/12,34.93%,PTK2B;UBASH3B;RYR2;MTLN;CASQ1;TRDN;CASQ2;FKBP1B
prerank,I-kappaB phosphorylation (GO:0007252),-0.44254170284826333,-0.9963293226601616,0.4953789279112754,0.7542488244358767,1.0,4/10,28.94%,DAB2IP;CHUK;TLR7;TLR4
prerank,T cell activation involved in immune response (GO:0002286),-0.4153537128868244,-0.9961974481417745,0.462,0.7539867188978969,1.0,12/12,58.50%,CD74;SLC11A1;LCP1;MDK;ICAM1;ITGAL;F2RL1;IFNK;TNFSF18;EIF2AK4;LILRB1;FCER1G
prerank,skin development (GO:0043588),-0.2737660037284578,-0.996031539908388,0.4793187347931874,0.7537371655760894,1.0,18/65,18.18%,ITGA6;CLIC4;JAG1;LSR;ITGB4;COL5A2;PKD1;MET;BCR;WNT16;HRNR;ALOX12;STMN1;COL1A1;COL3A1;COL5A3;ADAM9;DSP
prerank,negative regulation of phosphorylation (GO:0042326),0.29504984033710396,0.9958486401591781,0.4413145539906103,0.8687215719356063,1.0,14/85,9.05%,PTPN13;PPARA;PID1;BMP7;PRKN;PLPP3;CACTIN;NPRL2;LRRK2;FBLN1;PTEN;ATG14;NUPR1;SIRPA
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4203205261009002,0.9954633782936391,0.4742063492063492,0.8679412350671104,1.0,2/13,3.68%,PLCB1;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),0.4203205261009002,0.9954633782936391,0.4742063492063492,0.8679412350671104,1.0,2/13,3.68%,PLCB1;STAT5B
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3870502548325153,0.9952919866073976,0.4572564612326044,0.8674730235542022,1.0,5/20,9.87%,WNT4;SIK1;ACADL;APOC1;SLC27A1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.36146771202207906,-0.9952678777502547,0.47834645669291337,0.754992762030412,1.0,10/20,35.47%,ADAM10;TGFB1;ADAM9;PSEN1;MBTPS1;RELA;HM13;NGFR;SPPL2B;ADAM17
prerank,regulation of transport (GO:0051049),-0.31475416350191865,-0.9951434073518799,0.4419134396355353,0.7546683568631215,1.0,6/36,4.23%,ACTB;EPB41;ACTG1;ICA1;DNAJA1;REEP5
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4121383808724013,0.9946221601078393,0.47334754797441364,0.86832387750209,1.0,4/16,12.17%,BMP7;NAPEPLD;FLCN;SOX13
prerank,cilium movement (GO:0003341),0.3314332417368521,0.9940761977349352,0.4473684210526316,0.8687996655818694,1.0,9/47,15.00%,ODAD3;DNAI4;DNAH11;TEKT2;SPA17;DNHD1;ODAD1;CFAP70;ODAD2
prerank,phosphatidic acid metabolic process (GO:0046473),0.32049668868931,0.9938382979756505,0.4575971731448763,0.8685322635949888,1.0,6/48,9.87%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1
prerank,negative regulation of neuron projection development (GO:0010977),0.3147964214913385,0.9936359471152236,0.48299319727891155,0.8682002535080184,1.0,7/56,7.48%,EFNB2;LRP4;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.21641128116830952,-0.9935603250913143,0.48091603053435117,0.7580349949640685,1.0,98/341,23.01%,WWP1;RNF144B;CBL;ATXN3;PPP2R5C;FBXO7;NEDD4L;OTUD7A;RNF144A;MVB12B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;UBAP1;FAF1;NEDD8;ARRB1;UBE3C;BAG6;RMND5B;UCHL1;RNF125;CUL3;ZRANB1;PSMD13;PSMF1;DDB1;UBE2B;RBX1;PSMB10;XBP1;RNF215;KCTD17;KCTD13;NDFIP2;FEM1A;PSMB6;TOLLIP;NSFL1C;PSME3;RNF150;PSMB5;UBQLN4;PTPN23;ERCC8;PSMC3;AGAP3;HERPUD1;MVB12A;PSMD12;PSMB8;RNF34;KLHL42;PTTG1;ARIH2;TRIM13;PSME1;KCTD21;ANAPC16;UBE2G1;ZFAND2B;PSMB3;COP1;SPSB3;SPOPL;USP9X;UBAP1L;RNF19B;TGFB1I1;FBXL14;BUB1B;UBE2D1;RNF5;PINK1;ARRB2;TRIM2;SHARPIN;PSMD5;ZSWIM8;RNF11;RNF168;KCTD5;UBA1;ARIH1;OTUD7B;VCP;RBCK1;TNFAIP3;RNF19A;ANAPC7;PLAA;UBL7;NDFIP1;PSMD9;PELI1;PSMB4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.309587872772706,0.9932462897268299,0.43717728055077454,0.8682796088767852,1.0,17/62,20.96%,POLR2D;CDK7;ELOA;POLR2A;CCNT2;CCNT1;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;CTR9;ELL;CDK9;ELP2;PAF1
prerank,UV protection (GO:0009650),-0.42604639244903075,-0.993163994326361,0.4915572232645403,0.7583987173189591,1.0,6/10,33.41%,MFAP4;SDF4;XPA;ERCC5;CAT;FEN1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.37576645139878956,0.9931543202117812,0.4618320610687023,0.8676344172216315,1.0,4/23,9.26%,NMT2;PDE6G;CAMKMT;GRK4
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.3487738826651993,-0.9930010701707783,0.46637744034707157,0.7581632408637825,1.0,11/22,37.72%,ISCU;CIAPIN1;GLRX5;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;NFS1;NUBP1;NUBP2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4386955874238249,0.9925037808322664,0.4957081545064378,0.8683710514082481,1.0,3/11,12.86%,ARID1B;ZMIZ1;ZMIZ2
prerank,innate immune response (GO:0045087),-0.22858635234667712,-0.9924134452156322,0.46488294314381273,0.7589138576073102,1.0,56/217,23.69%,B2M;SERINC5;PTK2;ADAM15;PLCG2;LBP;FYN;PTK2B;GCH1;TRIM14;IKBKB;CAPZA2;PGLYRP1;TRIM25;DEFA6;APP;ANKHD1;NLRC5;ADAR;PIK3CD;CHUK;ISG15;MFAP4;NRROS;CD74;CHGA;SHFL;SRPK1;TRIM13;CYBB;IFIH1;CX3CR1;AKAP1;CR2;RNASE3;STYK1;CD40;YES1;IRAK1;IRF5;BST2;MID2;SERINC3;TRIM27;MYD88;TYROBP;SLA;IFITM3;ANG;SLC11A1;C3;CIITA;OTULIN;RELA;CAPZA1;AGER
prerank,prostaglandin metabolic process (GO:0006693),-0.33796035910082856,-0.9923239880129651,0.4784394250513347,0.7585124983966524,1.0,10/26,27.00%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF;PLAA;HPGDS;PRXL2B
prerank,cellular response to unfolded protein (GO:0034620),-0.3310543683347363,-0.9921419956711368,0.45643153526970953,0.7583654589154502,1.0,13/26,25.95%,HSPA8;DAB2IP;ABCB10;HSPA14;HSPA5;PTPN1;HSPB8;HSPD1;TMBIM6;HSPA9;HSPA1B;BAX;ERN1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.43113809693225763,0.9918288852017986,0.4594017094017094,0.8692240862256846,1.0,1/13,0.48%,ADGRV1
prerank,DNA geometric change (GO:0032392),0.372908282614314,0.9912197142559854,0.4867924528301887,0.8698964431072895,1.0,9/24,21.10%,ANXA1;BLM;RTEL1;MRE11;WRN;HNRNPA2B1;RECQL5;RAD50;NBN
prerank,retinal metabolic process (GO:0042574),0.44031857821258874,0.9903525629981024,0.4948453608247423,0.8711539005993226,1.0,4/12,19.50%,ABCA4;RDH11;RDH13;BCO2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4352125159686502,-0.9898399843786256,0.4969939879759519,0.763609450100489,1.0,8/10,45.29%,SH2B3;INPP5F;SOCS1;PPP2CA;NF2;PPP2R1A;PIBF1;PTPN2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.3061027935216017,-0.989137770463421,0.46357615894039733,0.7647172196262542,1.0,13/35,24.36%,ETS1;ABCB10;ZFP36L1;CDK6;STAT3;TAL1;ANKRD54;SPI1;HSPA9;NCKAP1L;MAPK11;HSPA1B;STAT1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.4128682261545117,-0.9890851176742647,0.48872180451127817,0.762968175974849,1.0,6/12,36.34%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.4128682261545117,-0.9890851176742647,0.48872180451127817,0.762968175974849,1.0,6/12,36.34%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.4128682261545117,-0.9890851176742647,0.48872180451127817,0.762968175974849,1.0,6/12,36.34%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,purine nucleotide metabolic process (GO:0006163),-0.3372375356097612,-0.9889721965226321,0.4717391304347826,0.7626440898137908,1.0,8/24,15.56%,PRPS2;NT5C2;HPRT1;GDA;NT5C;XDH;GUK1;NT5E
prerank,regulation of peptidase activity (GO:0052547),0.39151379267113384,0.9885124433803187,0.4666666666666667,0.8751313288292251,1.0,7/19,10.71%,ECM1;CTSH;A2ML1;NRDC;PSMA3;CST7;HDAC1
prerank,bile acid metabolic process (GO:0008206),0.3679197362601157,0.9883493126685928,0.4781746031746032,0.8747125010893834,1.0,4/27,12.28%,CYP27A1;HSD17B10;GBA2;AMACR
prerank,regulation of store-operated calcium entry (GO:2001256),0.4478058027276718,0.9883174463238842,0.48237885462555063,0.8739080630169227,1.0,1/10,1.35%,STIM1
prerank,regulation of ion transport (GO:0043269),0.29362139975933604,0.9881416049784166,0.4453507340946166,0.8734676967302656,1.0,9/76,4.99%,PRKN;SNX6;KCNA5;NKAIN4;DTNBP1;NEDD4;SYT11;SYT12;SIK1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.4046029888996482,-0.9881293957262084,0.4931506849315068,0.764190808819704,1.0,7/13,26.47%,SVIP;ERLEC1;BCAP31;BRSK2;UBE2J1;YOD1;UBAC2
prerank,negative regulation of proteolysis (GO:0045861),0.34673605463505164,0.9880726041722847,0.4616724738675958,0.8727695876167193,1.0,8/34,12.57%,TIMP3;ECM1;EPHA4;LRRK2;CST7;PTPN3;SNX12;GAS1
prerank,cellular amide metabolic process (GO:0043603),0.2806285646618112,0.9880134736060776,0.48253968253968255,0.8720493139483301,1.0,10/102,8.19%,AEBP1;PCCA;PLPP3;MCCC2;PM20D1;ACOT4;MTHFR;NAPEPLD;FOLR2;CPXM1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.24402204543200443,0.9878507949304731,0.4749034749034749,0.8715804489503524,1.0,48/348,11.76%,IGF1;PRKAG2;BMP6;LEPR;ROCK2;IL34;CEMIP;BMP7;ANGPT1;PELI2;DAB2;FNIP1;ALS2;IGF2;FAM20A;RBPMS;ARAF;SPHK1;MRNIP;PDGFD;LRRK2;FGF1;SNX9;TTK;IL6;ENPP2;XRCC5;MMP9;DDR2;CCL19;VTN;ATG14;CSF1;MUSK;VEGFB;NEK10;GDF1;AXIN2;DVL3;LATS1;ABL1;FGF9;FLCN;JAK2;FXR1;ERBB2;RAP2A;BMPR1A
prerank,B cell mediated immunity (GO:0019724),-0.4299198188201802,-0.9876635102415985,0.49411764705882355,0.7646856593760468,1.0,8/10,54.01%,MSH2;CD74;FCGR2B;TLR8;CARD9;SLA2;CD27;CD19
prerank,cellular response to reactive oxygen species (GO:0034614),0.31667140972165875,0.9875811650434043,0.472636815920398,0.8713911862834608,1.0,10/59,10.44%,OSER1;TPM1;FER;ANXA1;PDGFRA;MAPK9;IL6;MMP9;SIRPA;ABL1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2779480217807353,0.9873706234907572,0.4660347551342812,0.8710161143678186,1.0,11/110,6.53%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;GNAQ;ADRA1D
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.36153721998734134,0.987255109082756,0.4744094488188976,0.8704296074842298,1.0,5/26,7.48%,SLC8A3;NLGN2;LRRK2;PRKCZ;PTEN
prerank,peptide cross-linking (GO:0018149),-0.3261711202424203,-0.9869097970198558,0.46555323590814196,0.7659754593200933,1.0,3/25,4.39%,FN1;THBS1;TGM2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4128442163725566,-0.9867151409372837,0.5047984644913628,0.7658620576795692,1.0,4/12,20.79%,SMCHD1;HNRNPU;YTHDC1;METTL3
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23824939364746966,-0.9862471031013424,0.49244712990936557,0.7663992691998341,1.0,60/144,28.73%,PRR5L;GAS6;CDH1;PPP1R13B;SREBF2;FYN;SH3GLB1;KCNB1;FLNA;TGFB1;NMT1;YWHAB;GSK3B;CHP1;PDCD10;ZDHHC2;MAPK8;C2CD5;TMEM30A;OAZ1;YWHAG;MIEF1;RIPOR1;BBC3;CD81;JUP;MIEF2;MTCL1;ARIH2;CASP8;VPS11;YWHAQ;YWHAH;ZC3H12A;SEC16B;PINK1;PSEN1;PPP3R1;ANK3;PRKCD;RBM22;TOMM7;HYAL2;ZPR1;HUWE1;HRAS;SEC16A;SORL1;MICALL2;YWHAZ;PCM1;RNF31;PPP3CC;FIS1;ITGB2;ABLIM3;HDAC3;BID;TM9SF4;SFN
prerank,pulmonary valve morphogenesis (GO:0003184),0.4056504172783351,0.9862086127200075,0.49224806201550386,0.872313105361864,1.0,3/17,2.28%,ROBO1;NOTCH2;SMAD6
prerank,linoleic acid metabolic process (GO:0043651),0.39323720244761906,0.9860153752681909,0.4678362573099415,0.8719481492368752,1.0,2/17,2.58%,ACSL1;GSTM2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22926626157963528,-0.9856623181322022,0.5105633802816901,0.7672646708636992,1.0,55/198,20.26%,PTPRB;PLPP1;DUSP16;CALM1;PLCG2;PLCB4;INPP5D;TNFAIP8L3;INPP4A;LIMK2;SYNJ1;TGFB1;GPX4;NUDT3;PTPRC;NADK;PGM2L1;HK1;ALPL;MTOR;PAK1;PLCB3;PAK2;CERK;NT5C;PIK3CD;LIMD1;PPP1CA;NUDT4;STAT3;DUSP8;GPD2;DUSP3;TOLLIP;PFKM;PPP3CA;ALDOA;PFKP;INPPL1;PLA2G4A;ITPKB;DUSP12;PGP;ALDOC;CLN8;PPM1A;PRKCG;CDK5;TIGAR;PIP4K2A;PANK2;ACP2;PFKFB3;LCAT;AKT1
prerank,DNA metabolic process (GO:0006259),0.2523628617573699,0.9853418845245038,0.5079155672823219,0.8727407008404476,1.0,59/270,17.60%,TCF7L2;CBS;FANCA;SP100;RAD51B;SRPK2;TOP2B;ATRIP;DDB2;HUS1B;RAD51C;INIP;ACD;DMC1;PDS5B;PSME4;PARP4;TYMS;XRCC5;BLM;DDX23;USP7;CDK1;UVRAG;FBXO6;AXIN2;MBD4;PDS5A;PRKDC;RFC1;DCLRE1B;RTEL1;ORC2;MPG;LIG1;INO80;SMARCB1;PRIMPOL;MRE11;USP45;APEX1;TOP1MT;MNAT1;UBE2A;WRN;ORC3;FANCC;STN1;MCM2;RAD18;RAD51;REXO4;BACH1;RNASEH2A;RPAIN;ORC6;TRRAP;XPC;PURA
prerank,regulation of potassium ion transport (GO:0043266),0.34917255310837986,0.9850616547330866,0.4573055028462998,0.8725631046417924,1.0,5/31,6.48%,KCNIP3;KCNA5;ANK2;CACNA1D;DLG1
prerank,proteasomal protein catabolic process (GO:0010498),-0.23104787597808926,-0.9850190364279604,0.5,0.7681808591376068,1.0,66/201,26.17%,WWP1;ATXN3;PPP2R5C;NEDD4L;UBXN1;ZNRF1;CTNNB1;FAF1;ARRB1;BAG6;RMND5B;UCHL1;CUL3;DERL1;PSMD13;CCDC47;PSMF1;DDB1;UBE2B;RBX1;PSMB10;UBXN6;KCTD17;KCTD13;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;PSMD12;ERLEC1;PSMB8;RNF34;KLHL42;TRIM13;PSME1;UBE2G1;ZFAND2B;PSMB3;COP1;SPSB3;SPOPL;RNF5;ARRB2;TRIM2;SHARPIN;PSMD5;ZSWIM8;KCTD5;VCP;RBCK1;BRSK2;PLAA;PSMD9;PELI1;PSMB4;PCNP;HUWE1;ATE1;SPSB4;BFAR;KIF14;DCAF11;PSMD10
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.29423676397239473,0.9849716012814647,0.49291338582677163,0.8719357548268354,1.0,12/75,10.51%,ROCK2;TULP3;NMT2;PLCB1;MGRN1;PDE6G;CAMKMT;ZDHHC3;GRK5;RPGRIP1L;GRK4;GNG7
prerank,positive regulation of calcium ion transport (GO:0051928),-0.31260284211669775,-0.9847815076702896,0.4734607218683652,0.7681538754845258,1.0,11/36,17.04%,CAV1;TRPC3;TRPC6;WNK3;STIM2;GRIN1;ATP2B1;CACNB2;CXCL12;WFS1;ORAI1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.39212666031225163,-0.9844279642053833,0.4940944881889764,0.768412223643276,1.0,3/13,9.21%,NAMPT;PTGIS;PTGS2
prerank,epithelial cell differentiation (GO:0030855),0.29152806301122525,0.984399371161164,0.47425897035881437,0.8725976023656781,1.0,17/88,16.63%,MAF;FGFR2;DAB2;ANXA1;TPP1;PTER;CDK1;KDM6B;LATS1;HDAC1;UPK1A;CNN3;FSTL1;BDH2;FZD7;HNRNPH3;ASCL1
prerank,cellular response to peptide (GO:1901653),0.30900245523731723,0.9842639896641039,0.4565587734241908,0.8720745803045502,1.0,6/56,7.35%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,error-free translesion synthesis (GO:0070987),-0.3448240154777843,-0.9837442372354637,0.5061728395061729,0.7694686670377056,1.0,8/22,22.50%,UBB;UBC;RPS27A;RPA1;UBA52;SPRTN;VCP;POLD1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.33689967583147346,0.9837130508259104,0.47686832740213525,0.8725818014845234,1.0,10/36,16.11%,RBBP4;L3MBTL2;MGA;RNF2;RBBP7;E2F6;TFDP2;APAF1;UXT;RAD51
prerank,tRNA 5'-leader removal (GO:0001682),-0.40081053216669177,-0.9832820891845938,0.50293542074364,0.7699939083661004,1.0,7/13,28.41%,SSB;POP5;POP4;RPP21;RPP30;PRORP;POP7
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3900620187505347,-0.9832296908112402,0.4939516129032258,0.7695012513935617,1.0,3/15,9.32%,NGF;BCAR1;DDIT4
prerank,negative regulation of cyclase activity (GO:0031280),0.42607806762418765,0.9829479672831082,0.5063559322033898,0.8736499782618163,1.0,1/14,0.48%,ADGRV1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3203568316756147,-0.982844806549837,0.5011441647597255,0.7697831768581305,1.0,6/29,12.72%,ESR1;RUNX1;CBFB;PAK1;WBP2;VPS18
prerank,regulation of cholesterol esterification (GO:0010872),-0.4198461544533881,-0.9828290854797231,0.504725897920605,0.7692004289182185,1.0,6/10,31.98%,LAMTOR1;AGTR1;ABCA2;ABCG1;AGT;STARD4
prerank,mRNA export from nucleus (GO:0006406),-0.25244874681937074,-0.9827465474396555,0.46875,0.7687578471993022,1.0,44/102,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;ENY2;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;IWS1;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,positive regulation of synaptic transmission (GO:0050806),0.2956360851602379,0.9823725163933514,0.4812398042414356,0.8742583267891787,1.0,9/72,8.02%,ADCY1;SLC8A3;NLGN2;TSHZ3;DTNBP1;CACNG7;PRKCZ;ARC;ZDHHC3
prerank,negative regulation of viral release from host cell (GO:1902187),0.4215427729880007,0.9823342689061755,0.48846960167714887,0.8735035340454715,1.0,4/13,16.21%,TRIM5;TRIM35;TRIM26;PML
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4200103068137747,0.9822961337984929,0.498,0.8727475608626061,1.0,2/14,1.48%,WNK4;DMD
prerank,carbohydrate biosynthetic process (GO:0016051),0.37562126442736915,0.9821503469225332,0.49498997995991983,0.8722417582401527,1.0,3/21,4.55%,B3GALT1;ST3GAL3;B4GALT1
prerank,neuron migration (GO:0001764),0.3219265610788057,0.982077927550019,0.4797979797979798,0.8715517485314047,1.0,8/48,9.85%,DCDC2;AUTS2;NDNF;SOX1;SDCCAG8;SH3RF1;PAFAH1B1;TUBGCP2
prerank,cytoskeleton organization (GO:0007010),0.27829754763303205,0.9820725648636919,0.4704968944099379,0.8707065431391705,1.0,15/114,7.74%,MICAL3;SH3D19;FGD4;TPM1;RHOD;OBSL1;ABI2;SYNE3;CNN2;CECR2;CAPZB;ARC;WDPCP;RHOBTB2;WASF3
prerank,cellular protein-containing complex assembly (GO:0034622),-0.23316101259608926,-0.982064478838925,0.4850498338870432,0.769860674795243,1.0,27/159,13.36%,STXBP6;HIP1;SGIP1;TIAM1;HSP90AA1;HSP90AB1;RPL38;PDE4DIP;PXN;TGFB1;NCK1;GPX4;VAMP8;HIP1R;PSMD13;AP2M1;POMP;RTN4;NCK2;PIK3C2A;NSG2;BIN1;HSPD1;CLU;ADRB2;HIGD2A;EIF4H
prerank,regulation of cell death (GO:0010941),-0.25376387737454364,-0.9820462810036373,0.47513812154696133,0.7692792851853167,1.0,25/94,16.17%,ACER3;ACER2;PDE8A;UBB;CCN3;SOX4;NCK1;FERMT2;FAF1;DCC;TNFRSF1B;CHP1;CRYAB;WNT16;EIF4G1;APC;CDKN1B;EPHB1;CLU;SRSF6;CCN1;MT3;TRIM13;CTSZ;PRKD1
prerank,regulation of exocytosis (GO:0017157),-0.29314890772936025,-0.9819908019935061,0.4900497512437811,0.768798686970908,1.0,22/46,31.09%,STXBP6;NSF;RAB3C;RAB27A;RAB3B;CPLX2;CFTR;RAB8A;CHMP3;RAB8B;CLASP2;RAB3A;LGI3;SYTL4;CPLX1;HAP1;RIMS2;SYT1;UNC13D;ATP6AP1;STXBP5L;RAB15
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27048349652166326,-0.9816803953251182,0.504,0.7689346958378815,1.0,27/70,31.44%,CEPT1;MBOAT1;MFSD2A;LPCAT3;GPAT4;TMEM86B;LPCAT1;LPIN3;CSNK2B;NR1H2;PLA2G4A;LPIN1;ABCA3;LCAT;NR1H3;SLC44A5;PLA2G4F;SLC44A2;DBI;PLAAT1;PEMT;PLA2G15;CHPT1;PLA2G5;MBOAT2;LPCAT4;STARD10
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.33008880893580017,-0.9814854726370834,0.4806378132118451,0.7687877415868621,1.0,10/26,18.67%,UBB;NOD1;UBC;RPS27A;TAB3;AAMP;CASP8;UBA52;IFIH1;IRAK1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.38899725292005394,0.9814005087671835,0.4896265560165975,0.8715354713088082,1.0,3/18,3.98%,ROCK2;RIPOR2;LLGL2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3076035266221061,-0.981228742210305,0.5045045045045045,0.7687831876911928,1.0,18/37,24.19%,EFNA5;PHLDB1;MAP6;FAM107A;GSK3B;STMN2;MARK2;STMN1;CDK2AP2;TPPP;STMN4;BICD1;STMN3;GAS2L1;MAPRE1;TRIM36;CLASP2;CAMSAP3
prerank,protein depolymerization (GO:0051261),0.3486168529446977,0.98117586430592,0.46938775510204084,0.8712095289661743,1.0,2/27,1.98%,MICAL3;KIF2A
prerank,calcium ion transport into cytosol (GO:0060402),0.3764831109937366,0.9811249301700213,0.4912959381044487,0.8704877789816929,1.0,3/21,7.35%,JPH1;SLC8A1;CACNA2D1
prerank,negative regulation of lyase activity (GO:0051350),0.4088173150561218,0.9810380308067549,0.4979919678714859,0.8698365608510767,1.0,1/16,0.48%,ADGRV1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4446047953668423,0.9800331586531225,0.4904051172707889,0.8714969127468747,1.0,1/10,0.98%,APPL2
prerank,response to nitric oxide (GO:0071731),-0.39919397502953147,-0.9799011122500803,0.5009242144177449,0.7713825358459269,1.0,5/13,21.70%,GUCY1B1;FOXO1;MT3;CDK2;KCNC2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.3779687728255069,-0.9798027717485326,0.4836852207293666,0.7710160874657102,1.0,3/15,4.22%,TIAM1;RSPO3;SFRP4
prerank,protein export from nucleus (GO:0006611),0.3535886883708867,0.9794908948850258,0.4888475836431227,0.8720406704394139,1.0,1/27,0.13%,RANBP3L
prerank,calcium ion homeostasis (GO:0055074),0.28388375942899946,0.9791843299527507,0.48450244698205547,0.8719676094799301,1.0,8/95,3.96%,SLC24A3;SLC8A3;STIM1;CSRP3;SLC8A1;DMPK;FAM20A;ANK2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.42512231168059295,0.978887434699764,0.4871244635193133,0.8718682148301866,1.0,7/12,23.69%,IGF1R;BNIP3;UVRAG;IRGM;SETX;JMJD4;FYCO1
prerank,negative regulation of chemokine production (GO:0032682),0.40575761482796946,0.9788186753346052,0.4793388429752066,0.8711597598429989,1.0,3/14,9.05%,C1QTNF3;IL6;SIRPA
prerank,regulation of actin filament-based process (GO:0032970),0.29619026527525905,0.9784940524283543,0.4797297297297297,0.8711071537268253,1.0,9/70,7.67%,ROCK2;EPHA3;RHOD;PDGFRB;BAIAP2;CNN2;RICTOR;ARHGAP35;RHOBTB2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3745028197112461,0.97835177832294,0.4737903225806452,0.8705970625554326,1.0,9/22,18.67%,FTSJ3;ERI3;ERI2;EXOSC8;NOL9;ERI1;NOP9;EXOSC3;NOP14
prerank,negative regulation of binding (GO:0051100),0.28615855100604964,0.978168895682248,0.45840407470288624,0.8702048902677036,1.0,10/81,9.66%,ARHGAP28;DAB2;DKK1;SP100;IFIT2;LRRK2;PSME3IP1;RSF1;GTF2F1;GOLGA2
prerank,transferrin transport (GO:0033572),-0.31165935512074006,-0.9780572753704492,0.4893162393162393,0.7747385473295552,1.0,15/33,26.57%,TFRC;ATP6V0A1;DNM2;ATP6V1A;ATP6V0C;TCIRG1;LMTK2;ATP6V1E1;ATP6V0A4;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2;MCOLN1;ATP6V1H
prerank,positive regulation of insulin secretion (GO:0032024),0.3346028401122047,0.977909704321789,0.4863883847549909,0.870008456849103,1.0,5/36,7.95%,TCF7L2;RBP4;NLGN2;MCU;SLC30A8
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.25477452747182694,0.9777783150345761,0.5122302158273381,0.8694886443751755,1.0,37/208,15.55%,RORA;WLS;PRKN;PELI2;LPAR1;PDPK1;LTF;ECM1;TRIM5;AKAP13;ZFAND6;GJA1;CACTIN;UFL1;PRKCB;CXXC5;OPTN;NLRC3;CCL19;TLE1;SLC20A1;GOLT1B;IKBKE;CFLAR;GPRC5B;TBK1;MAP3K7;UNC5CL;MAPKBP1;UBE2V1;MTDH;NLRP12;NLRX1;BIRC2;TRIM62;CX3CL1;TMEM9B
prerank,negative regulation of DNA binding (GO:0043392),-0.32059562496684674,-0.9777134086774141,0.48695652173913045,0.7749719915936196,1.0,8/28,23.11%,LEF1;NFKBIA;JUN;HEY2;SUMO3;TFAP4;SOX11;HEY1
prerank,post-translational protein modification (GO:0043687),0.24247645528104464,0.9776581775876327,0.5026246719160105,0.8689549428550525,1.0,55/332,13.28%,ASB2;CP;FBN1;APLP2;EPAS1;ITIH2;SDC2;TNC;SERPIND1;SPSB1;HIF3A;RAB13;PRKCSH;PCSK9;IGFBP4;OBSL1;NEURL2;FBXW4;DDB2;DCAF4;GPC3;PSME4;PSMA2;RBBP7;FBXO44;IL6;CAND1;F5;CCDC8;PSMA3;CUL9;CSF1;DCAF10;MIA3;CHRDL1;FSTL3;CUL7;KLHL11;FEM1B;FBXO6;ASB3;PSMD8;IGFBP7;KBTBD7;UBA3;PSMD3;FBXO4;KLHL22;CUL4B;FBXO11;SENP8;ASB5;FSTL1;ESCO1;P4HB
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3744069518075695,0.9775521855485042,0.47912524850894633,0.8683776191334386,1.0,4/21,10.46%,SLC8A3;MAIP1;MCU;MICU1
prerank,regulation of cilium movement (GO:0003352),0.43644332567135946,0.977472575334508,0.4808080808080808,0.867749801623365,1.0,4/10,15.00%,DNAH11;CFAP298;CCDC65;ODAD2
prerank,response to interleukin-1 (GO:0070555),0.29812829494223414,0.9772309772638087,0.5274542429284526,0.8674902816266848,1.0,9/73,10.07%,ADAMTS12;ANXA1;IRAK2;CACTIN;ADAMTS7;PRKCA;CCL19;SIRPA;CCL4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.39902658785145295,0.9770328236040547,0.5153256704980843,0.8671247409352021,1.0,1/16,0.34%,LEPROT
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4218007817405738,-0.976768867491212,0.494949494949495,0.7767462992654608,1.0,7/11,38.07%,TIRAP;TNFAIP3;TREM2;TLR6;MFHAS1;TLR1;PJA2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2969462134213513,0.9765195187171207,0.4941569282136895,0.8675249179649531,1.0,12/69,12.01%,IGF1;PLCB1;PDGFRB;PDGFRA;IGF1R;PTEN;GPR143;MYO16;PIK3R1;RPS6KB1;ERBB2;PLCD1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.35854599121567493,-0.9763195043385778,0.4702258726899384,0.7772183442700078,1.0,9/19,27.36%,PTPRJ;KDR;PTPRC;RYR2;BCAP31;PTGFR;TRPM2;FIS1;SELP
prerank,regulation of vasculature development (GO:1901342),-0.3286900205605595,-0.975995881235398,0.5201793721973094,0.7774276167623452,1.0,6/26,8.12%,BMPER;PLXND1;ETS1;WARS1;CTNNB1;EMP2
prerank,tRNA metabolic process (GO:0006399),-0.37163625931930133,-0.975896873896979,0.49075975359342916,0.7770454762216019,1.0,8/17,28.41%,SARS1;SSB;POP5;RPP21;RPP30;ADAT1;KARS1;POP7
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.31246170978831284,-0.975801743049985,0.4864864864864865,0.7766657484196596,1.0,8/32,12.72%,MEF2C;MCTP1;GSK3B;KCNMB4;SLC30A1;GPER1;CPLX2;VPS18
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4450504595193846,0.9757338088179055,0.46511627906976744,0.8686720312435722,1.0,2/10,11.50%,JARID2;MYB
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.25208370174429023,0.9755892974504842,0.5143266475644699,0.8681897457761992,1.0,21/214,7.56%,EPHA7;TGFBR3;FGFR2;FGFR4;NOTCH2;TIMP3;ANGPT1;MTURN;CCN2;PDGFRB;DUSP10;PDGFRA;GLIPR2;PDGFD;PRKCZ;FBLN1;DLG1;LMO3;PRKCA;PTEN;CCL19
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36632253484687133,0.9750321387271097,0.49609375,0.8687442932213835,1.0,2/24,1.82%,PID1;DAB2
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.42149102185858645,-0.9749588050209621,0.502970297029703,0.7781692849745777,1.0,4/10,15.75%,CTNNB1;VEGFA;DISC1;CX3CR1
prerank,regulation of fibroblast proliferation (GO:0048145),0.3170241341879327,0.9744888080645069,0.4666666666666667,0.8692378136273269,1.0,5/45,7.50%,IGF1;PDGFRA;SPHK1;NLRC3;DDR2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.36680357741915853,-0.9743809294009979,0.5101626016260162,0.7789533106894568,1.0,6/17,16.99%,JAG1;CD55;STAT3;MSH2;IL18BP;BTN3A3
prerank,response to fatty acid (GO:0070542),0.3929737918766224,0.9742082514582625,0.49404761904761907,0.8690610797125384,1.0,1/17,1.17%,PID1
prerank,positive regulation of nervous system development (GO:0051962),-0.2948628995693826,-0.9739476836456346,0.48008849557522126,0.779399788823673,1.0,17/42,24.83%,TGM2;CLSTN2;SERPINF1;IL1RAP;NRXN1;SYNDIG1;EPHB1;GPER1;CLSTN3;CX3CR1;SPEN;LIG4;GRID2;SOX11;LRRC4B;FAIM;EPHB3
prerank,negative regulation of response to external stimulus (GO:0032102),0.2761235535189638,0.9737651498673643,0.4899536321483771,0.8693746883994137,1.0,21/105,17.25%,RORA;C1QTNF3;PPARA;LTF;EPHA4;CACTIN;NLRC3;PTEN;LYAR;SIRPA;ITCH;ENPP3;PCBP2;SERPINE1;MAPKBP1;NLRP12;PTGER4;CDH5;TRAFD1;DRD2;VPS35
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3051585178478877,0.9734703242344295,0.49125874125874125,0.8692917369125365,1.0,10/59,10.45%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MITF;MED1;MED13
prerank,regulation of cell cycle phase transition (GO:1901987),-0.25580767199239607,-0.9734423231573384,0.5234159779614325,0.7801161585250432,1.0,27/91,23.55%,BUB3;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;ANAPC16;PSMB3;BUB1B;UBE2D1;PSMD5;TFAP4;ATP2B4;SKP1;CDKN1A;ANAPC7;PSMD9;PSMB4;NEK11
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3964871157423724,-0.9728493665477217,0.51171875,0.7809003209032249,1.0,8/13,32.30%,TMEM30A;CD81;BCAP31;SEC16B;SEC16A;SORL1;TM9SF4;TMEM30B
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.35277679189473976,-0.9726711210824657,0.5148514851485149,0.7807215143496414,1.0,11/20,23.79%,TGM2;ATP2A2;CCDC47;KCTD17;SELENOK;HERPUD1;BCAP31;WFS1;PSEN1;RAP1GDS1;BAX
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3654521984270601,-0.9724838466559003,0.4970414201183432,0.7805564024060342,1.0,10/16,48.33%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;CELF3;SF3B4;RBM3;TRA2A;NCBP1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2636583926036788,0.9724495679706606,0.5137614678899083,0.8709609041667069,1.0,21/148,12.39%,PRKAG2;PRKAG3;PDPK1;ATRIP;MAP2K6;RBBP4;RICTOR;PRKAA2;RBBP7;BANP;BLM;CHD4;PRKAA1;USP7;CDK1;MDM2;MLST8;HDAC1;TAF3;PRKAG1;TTC5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2600537454040943,-0.9723371767941005,0.5166240409207161,0.7803218858638652,1.0,26/75,22.87%,PTPRJ;HEG1;STK38;RASIP1;DAB2IP;LRP5;UCHL1;APC;CDKN1B;PTPN1;HHEX;MEN1;SPRY4;IRAK3;PRKAR1A;NF1;DUSP1;SH2B3;TFAP4;PRKCD;AKT1;BMP4;CD300A;GADD45A;HYAL2;CEBPA
prerank,neuron projection regeneration (GO:0031102),0.44738780287257907,0.9719955136329765,0.48638132295719844,0.8712467060137173,1.0,3/10,8.35%,PTN;FOLR1;NREP
prerank,macrophage chemotaxis (GO:0048246),0.4427764513898356,0.9715347287971275,0.5138004246284501,0.8715466461253123,1.0,3/10,17.66%,TAFA4;CKLF;EDNRB
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.35684559096911184,0.9714216600598857,0.5205479452054794,0.871016569316573,1.0,5/26,6.69%,LARGE1;B3GNT5;GAL3ST2;ALG6;ALG2
prerank,regulation of cell morphogenesis (GO:0022604),0.3514570480866749,0.9713747040230378,0.4990476190476191,0.8702952204208003,1.0,8/30,10.48%,SH3D19;PDPN;MACF1;NTNG2;CAPZB;ARC;PHIP;ZMYM4
prerank,cellular response to organic substance (GO:0071310),0.27267024913532767,0.9713351787269531,0.5054773082942097,0.8695692219407168,1.0,16/116,7.08%,PTPN13;PID1;IL18;PTPN4;DPYSL3;IL1RAPL1;NCOA2;STAT5B;NFAT5;SPHK1;PLK5;LRRK2;PTPN9;LRP2;NCOA3;SMAD3
prerank,cellular response to dsRNA (GO:0071359),0.401769986140984,0.9713285714981827,0.5194274028629857,0.8687516638501344,1.0,1/15,0.45%,COLEC12
prerank,protein localization to mitochondrion (GO:0070585),0.4313373129386925,0.9705791103754954,0.48148148148148145,0.8697618940344739,1.0,3/11,6.59%,HK2;LRRK2;MAIP1
prerank,regulation of cell size (GO:0008361),-0.3342786710425726,-0.970481302657854,0.4989517819706499,0.7841877664819791,1.0,5/23,9.30%,MSN;RAC1;MTOR;RHOA;EDN1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.30911224063010145,-0.9704345317652775,0.5135135135135135,0.7836831978103188,1.0,9/31,14.11%,DLG2;MSN;LIN7A;WDR1;RHOA;MARK2;SYNJ2BP;ERBIN;MTCL1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2588607630222939,-0.970343073639162,0.4897959183673469,0.7832774493667333,1.0,20/84,13.03%,WWP1;MSN;NSF;HSP90AA1;NEDD4L;DAB2IP;ATG7;PLK2;FAF1;GSK3B;TNFRSF1B;FOXO1;DDB1;FURIN;OAZ1;APC;CDKN1B;NDUFA13;EGLN2;IDE
prerank,sulfation (GO:0051923),0.4336018037939042,0.9702572662643404,0.4809322033898305,0.869735119466215,1.0,2/11,11.32%,UST;SULT4A1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.36228023827411754,0.9700846201025354,0.4887640449438202,0.8692904690733586,1.0,7/24,8.42%,NEDD4;GRB10;PRKCB;NIBAN2;PDCD6;VTN;ARNT
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3903123071192809,-0.9700369769506465,0.503921568627451,0.7834047708180965,1.0,5/12,17.36%,VEGFA;APLNR;AKAP8;PRKD1;CTBP1
prerank,regulation of fat cell differentiation (GO:0045598),0.29054152850035636,0.969630863605302,0.502454991816694,0.8695736973832943,1.0,11/74,10.39%,RORA;MEDAG;RUNX1T1;ANKRD26;TMEM64;IL6;SMAD3;LMO3;SYAP1;TAF8;ASXL2
prerank,regulation of lamellipodium assembly (GO:0010591),0.3355409350134745,0.9688738485992329,0.4991119005328597,0.8707017848105003,1.0,7/34,11.05%,AUTS2;AVIL;FER;ABI2;CAPZB;PIK3R1;EPHA2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3268417798466685,-0.9686038012155513,0.5144628099173554,0.7862417057682021,1.0,7/26,12.32%,FBXO7;PDE8A;FYN;PPIA;HSPB1;ATF4;REST
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3371569300490038,-0.9684592240475888,0.4909819639278557,0.7859780069458333,1.0,8/24,14.44%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;IBTK;ERO1A;ITPR3
prerank,regulation of JUN kinase activity (GO:0043506),-0.3089631286064616,-0.9684245831907722,0.48414376321353064,0.7854358273107817,1.0,9/33,10.23%,MAP3K5;DAB2IP;RPS3;DNAJA1;TNFRSF11A;PDCD4;PAK1;EDN1;ARHGEF5
prerank,melanosome organization (GO:0032438),0.3539413345868188,0.9682115375921888,0.5018656716417911,0.8715179573716796,1.0,7/26,15.12%,SHROOM2;DTNBP1;GPR143;RAB32;BLOC1S4;AP1M1;AP3B1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.44222185937736513,0.968008442028174,0.5042735042735043,0.8703502031997173,1.0,5/10,18.58%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.44222185937736513,0.968008442028174,0.5042735042735043,0.8703502031997173,1.0,5/10,18.58%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.32014837210088193,-0.9677367640410386,0.5133470225872689,0.7864796039982854,1.0,9/27,20.96%,TGFB1;PUM2;DDX5;EIF4G1;LIMD1;STAT3;MAP2K2;BMP4;FMR1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.41204222973466254,-0.9675577171314532,0.4888888888888889,0.7863041380997526,1.0,4/11,20.49%,TGFB1;DDX5;MAP2K2;BMP4
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.31141317707979677,-0.9674318915004628,0.4978540772532189,0.7860022376845948,1.0,6/30,16.96%,CD34;PLCG2;ISG15;STAT3;HSPD1;CD274
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2977439380665224,-0.9669126740902625,0.5179372197309418,0.7866517368694564,1.0,10/40,20.17%,LBP;PGLYRP1;GBP4;DEFA6;CHGA;ROMO1;RNASE3;TIRAP;MYD88;ANG
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.34823313404548223,0.9668798203761362,0.5176908752327747,0.8722412344411345,1.0,5/30,8.62%,KIT;HOXB4;ACE;UFL1;FSTL3
prerank,regulation of response to interferon-gamma (GO:0060330),-0.38187767640728976,-0.9668211576512216,0.5018867924528302,0.7862553763618766,1.0,6/14,24.36%,HSP90AB1;CDC37;IFNGR1;JAK1;SOCS1;STAT1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4065782137646523,0.9667639040065813,0.4717741935483871,0.8716846313015413,1.0,3/15,11.22%,LARGE1;CHST3;RENBP
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3983688666091554,-0.966584106348649,0.5040160642570282,0.7862282712129263,1.0,6/13,13.40%,DAB2IP;PTPN1;HGS;HHEX;EPN2;CADM4
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.29827795046988753,0.9665281695983878,0.48299319727891155,0.871467194706382,1.0,17/64,20.96%,POLR2D;CDK7;ELOA;POLR2A;CCNT2;CCNT1;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;CTR9;ELL;CDK9;ELP2;PAF1
prerank,negative regulation of blood coagulation (GO:0030195),-0.29433512297535663,-0.965788171079208,0.5265486725663717,0.7875924090627255,1.0,7/38,12.47%,NOS3;CD34;F3;SERPINE2;A2M;EDN1;THBD
prerank,apoptotic mitochondrial changes (GO:0008637),0.3358429816501365,0.9657290781038682,0.5055350553505535,0.8725443362894603,1.0,4/32,6.51%,HK2;BCL2;IFIT2;BNIP3
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3385969564445786,0.9655911785614125,0.5062388591800356,0.8720663794026732,1.0,6/33,12.90%,APPL2;STXBP4;PLK5;PTEN;CDC73;INO80
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3729716874109995,-0.965486164816266,0.5279503105590062,0.7876922682013792,1.0,5/16,9.43%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4234776650487062,-0.9649788058924547,0.5337301587301587,0.7883308151057085,1.0,3/10,9.97%,PODXL;PIEZO1;DPP4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.257617266884247,-0.9646791602058932,0.515,0.7884537271185996,1.0,27/78,23.56%,CAV1;RNF144B;CBFA2T3;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;HERPUD1;ELOB;ARIH2;BCAP31;COP1;RNF19B;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B;SIRT6
prerank,negative regulation of protein kinase activity (GO:0006469),0.28126849484632055,0.9643925377295731,0.4959083469721768,0.874226278377311,1.0,8/88,4.50%,PRKAG2;SLC8A3;PDPK1;DEPTOR;SLC8A1;DTNBP1;DUSP10;PPM1E
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.35891505286414926,-0.9642538362316536,0.5099206349206349,0.7888872680710638,1.0,5/18,10.65%,SHANK3;PTK2B;NRXN1;GRIN1;RELN
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3418646279288852,-0.9640172374841498,0.5136268343815513,0.7887975107584242,1.0,12/21,33.29%,DUSP3;SAMSN1;LAPTM5;JAK3;TNFAIP3;SOX11;FCGR2B;FOXJ1;LAX1;IL4I1;PTPN22;GPNMB
prerank,phospholipid biosynthetic process (GO:0008654),-0.30112391034557134,-0.9638380890060172,0.5448275862068965,0.788628772815137,1.0,6/36,8.81%,SGMS1;SGMS2;MBOAT1;CRLS1;FAR1;CPNE3
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.3944380880039392,-0.9637689704596113,0.5235294117647059,0.7882046739270726,1.0,2/12,1.98%,CSGALNACT1;FUT8
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.4439751671968609,0.9637471400799106,0.5109649122807017,0.8750059035786398,1.0,2/10,3.92%,LPGAT1;SLC45A3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3001925429058618,0.963663867326989,0.5160744500846024,0.8743947438446353,1.0,16/60,17.76%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MED1;MED13;SRF;CDK4;ATF7IP;MOV10;MED10;MED15;MED26
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.37319369610048986,-0.9635347134425849,0.5098425196850394,0.7881621851353794,1.0,8/15,31.10%,GBP5;USP50;NLRP2B;MYD88;TREM2;TLR4;CD36;TLR6
prerank,regulation of establishment of cell polarity (GO:2000114),0.3923570073976672,0.9633173946917778,0.5111111111111111,0.8744444408734251,1.0,2/16,3.63%,ROCK2;RIPOR2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.2959062033448085,0.9632655369718975,0.492776886035313,0.8737427362300514,1.0,14/65,13.86%,FBN1;PPARA;FBN2;PDPK1;SNX6;SMAD6;SLC2A10;SMAD3;LEMD3;SMURF2;HTRA4;LDLRAD4;VEPH1;ADAMTSL2
prerank,lipid biosynthetic process (GO:0008610),0.288870513810903,0.9632453515979982,0.5094339622641509,0.8729738821943118,1.0,8/77,7.55%,AGPAT4;ACSL1;HSD17B1;FDXR;PRKAA2;LIPH;LIPC;PRKAA1
prerank,positive regulation of cytokine production (GO:0001819),-0.21180548096267796,-0.9626841793015373,0.5968379446640316,0.789601120280784,1.0,78/292,24.19%,SPTBN1;FOXP1;CADM1;PDE4D;LRRFIP1;IL33;CD200;SLC7A5;CD34;RUNX1;F3;PLCG2;MBP;LBP;RPS3;NOD1;RFTN1;G3BP1;TGFB1;CTNNB1;PTPRC;SOD1;IL1R1;GAPDH;APP;FLT4;CYRIB;PTGS2;APPL1;PAEP;XBP1;PIK3CD;ISG15;STAT3;ATF4;GBP5;CRCP;RAB1A;STOML2;CD74;HSPD1;ARHGEF2;TMED10;NR1H4;CSF1R;CYP1B1;IFIH1;LAPTM5;MIF;CD274;CD40;IL15;IRAK1;IRF5;TIRAP;TRIM27;MYD88;TYROBP;TXK;SLC11A1;POLR3D;HPSE;C3;S100A13;MAPK11;HYAL2;CEBPB;NFKB2;AFAP1L2;RELA;HSPA1B;AGER;RGCC;CD80;CRLF2;CCR2;POLR2L;POLR3F
prerank,cellular response to nutrient levels (GO:0031669),-0.2665160516864814,-0.9625082462666211,0.5357142857142857,0.7894165067006461,1.0,15/62,12.16%,HSPA8;SREBF2;BMPR2;ATG7;KCNB1;FAM107A;MAP1LC3B;MTOR;MFSD2A;FOXO1;EIF4G1;XBP1;RALB;RIPOR1;PDK2
prerank,regulation of B cell activation (GO:0050864),-0.32825440093404684,-0.9621673720629309,0.5094339622641509,0.7896595177441534,1.0,12/25,34.84%,SH3KBP1;AHR;ZFP36L1;SAMSN1;LAPTM5;TNFAIP3;FCGR2B;FOXJ1;IL4I1;NOD2;IKZF3;THEMIS2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3144724168548471,-0.9621158578451802,0.4988610478359909,0.7891671471224941,1.0,5/29,12.39%,BMP5;DAB2IP;IL17RD;SPRED2;SDHAF2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3433707638321406,-0.9611986910847898,0.5251509054325956,0.7907905189070876,1.0,4/21,3.28%,MTUS1;THBS1;PTK2;PTK2B
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.33316119794045096,0.9610697478066974,0.5135623869801085,0.8775199418875598,1.0,4/35,6.76%,LEPROT;KIT;PIGU;IL6
prerank,cellular response to chemical stress (GO:0062197),-0.24907262715921202,-0.9609669360765212,0.5657142857142857,0.790710388712875,1.0,35/96,28.21%,CAV1;PRR5L;LRRC8D;PPARGC1A;PPIA;ATG7;CHCHD2;SOD1;FOXO1;SESN2;ATF4;VKORC1L1;GSR;ERO1A;MT3;FAS;CYBB;PRKD1;ATP13A2;STX2;ZC3H12A;GPX7;PINK1;PYROXD1;CYCS;HSPA1B;PYCR2;PRDX6;KEAP1;PRDX1;GPX8;GPX3;TRPV4;CAT;TMEM161A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.40750845863866086,0.9606186958599255,0.5266393442622951,0.8777951633811076,1.0,5/15,17.12%,WNT6;ANKRD11;HDAC1;GLI2;MSX1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4110594203532391,-0.9604356575964621,0.5169660678642715,0.7913881047453787,1.0,3/11,5.79%,KANK1;CORO1C;CD44
prerank,positive chemotaxis (GO:0050918),-0.36887582533474256,-0.9603049771772423,0.5345911949685535,0.7911192230474364,1.0,5/17,11.30%,PTPRJ;MET;VEGFA;FGF7;SCG2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4080811129614721,0.9602336784768043,0.5271966527196653,0.8779223621425456,1.0,2/13,1.17%,PPARA;PID1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.41198157695736587,0.9602043543790785,0.498,0.877181106929081,1.0,4/13,13.89%,PPARA;NFIB;NFATC4;SRF
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3105088266188275,-0.9601541575766185,0.498960498960499,0.7908943402532431,1.0,13/31,22.51%,MEF2C;CDH2;CDON;CTNNB1;BNIP2;BOC;TCF3;ID2;CTNNA1;PTBP1;HDAC9;SPAG9;MAPK11
prerank,spermatid development (GO:0007286),0.3339351754537938,0.9601088949898932,0.4962121212121212,0.8765926754785425,1.0,6/32,14.09%,GALNTL5;ZMYND15;NME5;CEP57;CIB1;NECTIN2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.293057394330838,-0.9599437724587382,0.5062761506276151,0.790802186229484,1.0,13/38,18.75%,CAV1;KCNJ2;CACNA1G;KCNQ1;CTNNA3;CACNA1C;BIN1;CACNB2;JUP;DSG2;SCN1B;DSP;TRPM4
prerank,regulation of catecholamine secretion (GO:0050433),0.3462081124205965,0.9595960648088043,0.5252707581227437,0.8770434073046045,1.0,4/29,4.13%,PRKN;DTNBP1;SYT11;SYT12
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3307677683205692,-0.9594886430241342,0.5160599571734475,0.7913732917818078,1.0,9/22,23.11%,B2M;HES1;CALR;GSK3B;REST;DISP3;SOX2;DLL1;HEY1
prerank,cochlea morphogenesis (GO:0090103),-0.4245320861788687,-0.9588987284623187,0.5239043824701195,0.7922713302339138,1.0,8/10,49.88%,TBX1;MYO3B;MYO3A;PAX2;TIFAB;HOXA1;HPN;POU3F4
prerank,phosphate ion transport (GO:0006817),0.3997709749164458,0.9588864556627842,0.5313725490196078,0.8779870735165183,1.0,4/16,9.59%,SLC20A2;SLC34A3;SLC25A11;SLC20A1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.37287394363659,0.9587385458127411,0.5159362549800797,0.877521186965035,1.0,2/20,1.82%,PID1;DAB2
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.37867159523942917,-0.958593928883119,0.5245901639344263,0.7924198684135909,1.0,5/14,27.85%,MSN;RHOA;CAMSAP3;EZR;FOXJ1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3294635442221077,-0.9583502745680528,0.5094736842105263,0.7924292633638728,1.0,5/26,12.46%,CAV1;LBP;RTN4;IFI35;RSAD2
prerank,response to hexose (GO:0009746),0.35801427027301386,0.9582509491060409,0.5214953271028038,0.8779530314252182,1.0,1/25,0.51%,TCF7L2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3412093750993279,0.9581285141141098,0.5018796992481203,0.8766240093075189,1.0,4/31,8.49%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,7-methylguanosine RNA capping (GO:0009452),0.3412093750993279,0.9581285141141098,0.5018796992481203,0.8766240093075189,1.0,4/31,8.49%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,positive regulation of cilium assembly (GO:0045724),-0.3519706540721912,-0.9581009443314864,0.5108055009823183,0.792416087986414,1.0,5/18,17.71%,CCDC88A;SEPTIN9;KCTD17;WRAP73;ENTR1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4233052179333704,0.958034245204916,0.48936170212765956,0.8760382479455378,1.0,4/11,13.29%,CTPS2;SLC19A2;ENPP3;THTPA
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4041746898187625,-0.9580084522488292,0.5335820895522388,0.7920180492494586,1.0,6/11,12.44%,SEMA6A;KLF2;THBS1;CREB3L1;SYNJ2BP;EPN2
prerank,regulation of phospholipase C activity (GO:1900274),0.40018719546631726,0.9578058580263993,0.54,0.8757876053242891,1.0,3/15,4.40%,KIT;PDGFRB;PDGFRA
prerank,regulation of cellular catabolic process (GO:0031329),0.30000396715431943,0.9575201006835422,0.518581081081081,0.8756759220861299,1.0,8/62,10.44%,ITPR1;DAPK1;PRKN;MTMR3;LRRK2;KAT8;NUPR1;ABL1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3235715011246995,-0.9573137346309951,0.4959016393442623,0.7930437670016813,1.0,8/26,14.44%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;IBTK;ERO1A;ITPR3
prerank,stem cell development (GO:0048864),-0.36139535378877363,-0.956917686440255,0.5138888888888888,0.7934196268708423,1.0,9/16,33.49%,CDH2;PTPRC;NOLC1;SOX11;SNAI2;SHH;PEF1;WNT7A;KBTBD8
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.31439516158761416,0.9566289598119712,0.5293072824156305,0.877111483878232,1.0,14/43,17.78%,HUS1B;CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;CHFR;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2
prerank,cellular macromolecule catabolic process (GO:0044265),0.313927161071418,0.9564340414011022,0.5223367697594502,0.876797254079159,1.0,9/49,14.75%,ADAMTS9;PRKN;FBXO44;SIAH2;FBXO6;SND1;NGLY1;RAB12;HTRA2
prerank,digestive tract development (GO:0048565),0.343085031788927,0.9561360812415637,0.5065176908752328,0.8767240510280001,1.0,6/32,10.55%,FGFR2;KIT;GLI3;SALL1;BBS7;COBL
prerank,cellular protein localization (GO:0034613),-0.2098617573200968,-0.9560301265485901,0.6293103448275862,0.7949710908337946,1.0,64/285,17.29%,ESAM;OCLN;ID1;NSF;STX3;TBC1D30;TBC1D8;REEP1;RAB31;STX7;RABGAP1L;FLNA;STX1A;ZDHHC15;FERMT2;EHD1;CTNNB1;TMED5;ADPRH;ARF5;GRTP1;SCG5;STX6;SGSM1;ARF1;TBC1D8B;TBC1D1;RAB28;TMED2;EMP2;CD63;SIL1;FGF7;TBC1D13;SEPTIN9;NAPB;SYNDIG1;HEY2;RAB38;STX12;ABHD17A;LAMTOR1;HGS;HHEX;RAB1A;CEP68;EVI5;MESD;TM9SF3;CD74;TBC1D10A;ARHGEF2;PICK1;TMED10;TMED3;KIF13A;RABL3;LAMTOR2;LAPTM5;STX2;BICD1;HERC2;RABGAP1;YWHAH
prerank,glycine transport (GO:0015816),0.43575150568457666,0.955816734564508,0.5161987041036717,0.8766734262256759,1.0,3/10,12.76%,SLC6A9;SLC36A2;SLC25A38
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.28548695104385474,0.955756221785485,0.5289514866979655,0.8760116779240886,1.0,15/67,15.64%,DCDC2;ODAD3;FER;PLD1;TBC1D9B;SDCCAG8;CAPZB;EPHA2;FXR1;CYLD;TBC1D19;IFT140;CDKL5;TBC1D17;ATG3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.25852799917816194,-0.9556811226191074,0.5150753768844221,0.7951841424309739,1.0,22/74,15.79%,NOTCH1;UBB;UBC;RPS27A;EGLN3;VEGFA;PSMD13;PSMF1;RBX1;PSMB10;LIMD1;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;PSMD12;PSMB8;ELOB;PSME1;UBA52;PSMB3
prerank,regulation of Golgi organization (GO:1903358),-0.36455152786928635,-0.9549462370284204,0.5509355509355509,0.7963769439240391,1.0,8/17,28.53%,PDE4DIP;PDCD10;MYO5A;EHD3;MAP2K2;MAPK3;CAMSAP3;STX5
prerank,protein auto-ADP-ribosylation (GO:0070213),0.41307270238864097,0.9547522435689425,0.51440329218107,0.8775962969334264,1.0,6/12,28.04%,PARP10;PARP12;TIPARP;TNKS2;PARP2;TNKS
prerank,L-amino acid transport (GO:0015807),-0.3148392864630173,-0.9547209892750921,0.5218295218295218,0.796310746695521,1.0,8/28,12.14%,SLC7A5;SLC7A1;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC36A1;SLC1A4
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2405995448298215,-0.9546925081171431,0.5510204081632653,0.7957747671631964,1.0,29/109,15.50%,PIP5K1B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;INPP4A;SYNJ1;PIK3C2B;ARF1;CDS1;CDIPT;PLCB3;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;SACM1L;PIP5K1C;CSF1R;SBF1;PLA2G4A;PI4KB
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.332661389755902,0.9546794383442758,0.5227686703096539,0.87696061431147,1.0,10/34,11.14%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4;WASHC1;PIK3R1;RUBCN
prerank,rRNA modification (GO:0000154),-0.34385516744952377,-0.954672182103232,0.5166666666666667,0.795210322830441,1.0,8/21,21.04%,TFB2M;BUD23;FBL;TSR3;NSUN4;MRM2;THUMPD1;NHP2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4075808220126473,0.9544237036519164,0.48846960167714887,0.8767567475027289,1.0,3/12,10.05%,BRD8;CTSH;MED1
prerank,steroid hormone biosynthetic process (GO:0120178),0.33802764467737156,0.9543910155525446,0.526508226691042,0.8760460564323574,1.0,5/29,15.05%,HSD17B1;FDXR;MED1;AKR1B1;HSD17B14
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2501030988178563,-0.9543702560616549,0.5613577023498695,0.7952846342505365,1.0,28/85,23.48%,RNF144B;CBFA2T3;ATXN3;RNF144A;DAB2IP;RACK1;TRIB2;NKD2;SOCS5;BAG6;GSK3B;ZYG11B;RBX1;CLU;PSMC3;ELOB;ARIH2;COP1;RNF19B;NOP53;FMR1;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B
prerank,sulfur amino acid catabolic process (GO:0000098),0.4263605923294011,0.9543254803187262,0.47974413646055436,0.875410241967948,1.0,1/10,2.11%,CBS
prerank,negative regulation of axonogenesis (GO:0050771),-0.32397644935616665,-0.9539230254102609,0.5342163355408388,0.7957803205151425,1.0,11/27,21.36%,ARHGDIA;DCC;RHOA;RTN4;SEMA3G;EFNB3;CDKL3;MT3;GDI1;THY1;RTN4R
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2566013918922375,-0.9536647645240034,0.5644329896907216,0.7957586723769213,1.0,26/72,27.55%,UBB;UVSSA;COPS7A;UBC;RPS27A;PPIE;DDB1;RBX1;RPA1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;COPS6;POLD3;POLD1;GTF2H2;POLR2L;HMGN1;XPA;ERCC5;LIG3;RFC5
prerank,pyroptosis (GO:0070269),0.39111775207590216,0.9536500898172123,0.5366876310272537,0.8762275024646279,1.0,4/15,13.36%,GSDMA;GSDMD;GSDME;ZBP1
prerank,regulation of biomineral tissue development (GO:0070167),0.35235764603747316,0.9535230946899869,0.49272727272727274,0.8757255330882208,1.0,3/26,3.12%,ROCK2;BMP2K;ECM1
prerank,response to thyroid hormone (GO:0097066),0.3976159139138423,0.9533741730806207,0.4959016393442623,0.8752830136100872,1.0,3/13,10.05%,BRD8;CTSH;MED1
prerank,adipose tissue development (GO:0060612),-0.4044958992968783,-0.9529839547982225,0.5439560439560439,0.7967968905342754,1.0,4/11,10.15%,SPTLC2;NAMPT;LRP5;XBP1
prerank,regulation of protein export from nucleus (GO:0046825),0.36228088412493803,0.9526378715802154,0.5430861723446894,0.8762554586822159,1.0,2/23,2.89%,TCF7L2;SP100
prerank,isotype switching (GO:0045190),-0.41198338290305725,-0.952141901978858,0.5463510848126233,0.7982051145610342,1.0,5/10,29.16%,MSH2;HSPD1;LIG4;RNF168;RNF8
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3724887087157047,-0.9521023714991266,0.5422396856581533,0.7976757058257976,1.0,3/16,9.24%,ST3GAL4;ETS1;RHOA
prerank,atrial septum development (GO:0003283),0.4045096268191115,0.9520937511871448,0.5112474437627812,0.8767686120751429,1.0,2/13,3.96%,NOTCH2;ANK2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.33610625352913825,0.9510280326772482,0.5330948121645797,0.8785098905013241,1.0,7/29,8.90%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,protein tetramerization (GO:0051262),0.29323616064571406,0.9509115517706909,0.504302925989673,0.8780007363740505,1.0,11/67,14.00%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;OXA1L;PKD2;SHMT1;CRYZ
prerank,protein insertion into membrane (GO:0051205),-0.3013185330335626,-0.950868248542129,0.5542725173210161,0.8000313803225692,1.0,13/32,32.25%,REEP1;STX1A;APP;CCDC47;SEC61G;GET4;VAPA;OTOF;RTP4;WDR83OS;STX5;SEC61B;UBE2J2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.29107881038846434,-0.9507865447255879,0.5289079229122056,0.7996024183255434,1.0,16/41,29.67%,KCNJ2;KCNMA1;FLNA;KCNQ1;KCNMB4;NOS1;ACE2;KCNN2;KCNJ15;ANK3;KCNH2;KCNJ6;GABBR1;GNB1;KCNJ16;KCNJ10
prerank,positive regulation of protein maturation (GO:1903319),0.4165687553155582,0.9506119654303863,0.5070422535211268,0.877913486730441,1.0,2/11,4.05%,TFR2;CCBE1
prerank,"wound healing, spreading of cells (GO:0044319)",0.3657592574015003,0.9504678761687557,0.536779324055666,0.8775000881359212,1.0,4/24,7.10%,ARHGAP24;PDPN;DDR1;ARHGAP35
prerank,positive regulation of synapse assembly (GO:0051965),-0.3209030077878996,-0.9502696482522467,0.5377969762419006,0.8002692449984823,1.0,8/27,12.02%,AGRN;SEMA4D;CLSTN2;IL1RAP;NRXN1;SYNDIG1;EPHB1;CLSTN3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4141962881169266,-0.9500570615685923,0.5581818181818182,0.8001818693307412,1.0,1/10,0.19%,PRKCH
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2895979627334898,0.9499694408464905,0.5261382799325464,0.8778385776688788,1.0,15/66,15.04%,APPL2;PLCB1;UBE2E2;ANXA1;PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;CDC73;PKD2;INO80;CDK4;HYAL1
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3017791203554128,-0.9496511763752149,0.5229759299781181,0.8005875372895297,1.0,12/33,16.39%,NGF;GRIK4;ABR;LRP8;BCR;BTBD9;SLC4A8;PXK;RELN;NRG3;CX3CR1;CACNA1B
prerank,positive regulation of interleukin-17 production (GO:0032740),0.36228988910056514,0.9496191192709866,0.5377358490566038,0.8778711966368674,1.0,4/22,8.61%,IL18;SPHK1;IL6;SLAMF6
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2659061397055059,-0.9494906119556605,0.5555555555555556,0.8003506700632009,1.0,20/57,23.72%,MEF2C;DLG2;PTK2B;MINK1;DLGAP1;APP;CACNG3;GRIN1;RELN;CACNG2;LYNX1;CAMK2B;GRIA2;CNIH3;NPTXR;NEFL;NPTX1;SHISA6;MAPK8IP2;SHANK1
prerank,vesicle organization (GO:0016050),-0.28225591109740883,-0.9489572424867319,0.5448275862068965,0.8009816240286792,1.0,14/46,17.81%,CAV1;CD34;FNBP1L;CAV2;CHMP2B;ALS2CL;SRGN;LAMTOR1;USP50;DNM1;VPS18;HOOK1;VPS11;USP8
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.27800306953286497,-0.9489266271299919,0.5465393794749404,0.8004431002979613,1.0,20/52,22.30%,MBNL1;NOVA2;RBFOX1;RBFOX3;RBFOX2;HNRNPU;DDX5;ZBTB7A;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;DDX17;YTHDC1;PTBP1;MAGOH;FMR1;TRA2B;RBM24
prerank,regulation of synapse assembly (GO:0051963),-0.2817203385642376,-0.9484413914221169,0.5423340961098398,0.8009904110692984,1.0,10/46,12.02%,MEF2C;LRFN5;CLSTN2;APP;IL1RAP;NRXN1;SYNDIG1;EIF4G1;EPHB1;CLSTN3
prerank,positive regulation of intracellular transport (GO:0032388),-0.2990928979182942,-0.9483868883970671,0.5408388520971302,0.8005080166158035,1.0,21/38,39.03%,PRR5L;EHD1;PDCD10;OAZ1;RIPOR1;NUMA1;MLC1;SPAG5;CAPN10;SORL1;PCM1;CEP131;PGAP1;DYNC1H1;ATP2A1;STK11;PCNT;PLK3;OAZ2;EIPR1;EHD2
prerank,cellular response to ionizing radiation (GO:0071479),-0.2815486339385933,-0.9483392714455667,0.5450346420323325,0.8000033966067938,1.0,16/47,25.33%,NET1;RPL26;RHOB;EEF1D;CRYAB;SPIDR;TNKS1BP1;RAD9A;ATR;LIG4;TLK2;GADD45A;CDKN1A;TMEM109;HRAS;TSPYL5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3786655458813045,0.9482494094415407,0.5194274028629857,0.8802928859925933,1.0,4/18,14.83%,RAD51B;RAD51C;CDK1;CDK4
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2391857503287067,-0.9479649587043233,0.5363128491620112,0.8003203697985433,1.0,26/110,13.03%,WWP1;KLF2;NSF;KLF4;NEDD4L;DAB2IP;NFKBIA;ATG7;TGFB1;PLK2;GSK3B;APP;ABCB10;FOXO1;DDB1;MAPK8;PAEP;EIF4G1;OAZ1;APC;CDKN1B;NDUFA13;RAB1A;EGLN2;CLU;IDE
prerank,immunoglobulin mediated immune response (GO:0016064),-0.41652903415791065,-0.9477792553179255,0.541501976284585,0.8001605327831791,1.0,3/10,22.89%,CD74;CD81;FCGR2B
prerank,skeletal muscle contraction (GO:0003009),0.36802646187333543,0.9477142725418028,0.5107212475633528,0.8807970166206811,1.0,3/19,13.74%,TNNC1;RCSD1;CCDC78
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.20997517967964704,-0.9476984453662762,0.6654411764705882,0.7997481076433033,1.0,58/241,20.79%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;SRSF5;DDX39B;CPSF3;HNRNPH2;SRSF9;CWC15;RALY;USP39;RBM8A;POLR2C;XAB2;RNPS1;SNRPC;SRSF6;PRPF40B;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;MTREX;HNRNPUL1;YTHDC1;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.34238183245661136,-0.9474869537291273,0.5326315789473685,0.7996160763852688,1.0,6/20,13.69%,B2M;CD55;DENND1B;IL1R1;RSAD2;CD81
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.33903559118087,0.9473265114046264,0.5430210325047801,0.8809280676039714,1.0,4/29,8.72%,TERB2;HORMAD1;TEX11;MAJIN
prerank,regulation of cell communication (GO:0010646),0.3322532519185651,0.9471724040268878,0.5352112676056338,0.8805117389026537,1.0,10/35,13.12%,SLC8A1;ANXA1;ANK2;GRK3;GRK5;CAMK2D;GRK4;IGFBP7;TSPYL2;VEPH1
prerank,mitochondrion localization (GO:0051646),-0.34492942917270253,-0.947021019037989,0.554140127388535,0.800110281205932,1.0,10/19,28.06%,MARK1;MTM1;MARK2;MSTO1;MFN2;TLE6;ATCAY;HAP1;ZBED3;MEF2A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3112108153736897,-0.9456984074475762,0.5355648535564853,0.8026979719043509,1.0,14/27,30.82%,CD44;SPRED2;DDX5;CD74;MIF;EEF1E1;ATR;PTTG1IP;SNAI2;PSMD10;YJU2;SPRED3;PMAIP1;KMT5A
prerank,methylguanosine-cap decapping (GO:0110156),-0.40531058291239364,-0.9456091470545237,0.544921875,0.8023077128737044,1.0,7/10,35.40%,PATL1;DCPS;EDC3;EDC4;PNRC2;PATL2;DCP1A
prerank,chromatin organization (GO:0006325),0.2617720022932819,0.9453748052377527,0.5533536585365854,0.8841084395585888,1.0,42/132,20.84%,SATB1;JARID2;HDAC8;RBBP4;BAZ1B;SOX1;SETD7;TCF7L1;BAZ1A;MTF2;RSF1;KDM5B;KDM6B;SMARCA5;HDAC1;NPM2;TADA2A;SMARCE1;MYB;EZH1;INO80;SMARCB1;SNAI1;KDM5C;SMARCA2;SMARCC1;INO80C;KDM6A;PHF1;SMARCD3;BAZ2B;SETD2;MPND;SMARCA1;HMGN3;KDM4D;HDAC4;BRDT;KAT2B;RUVBL2;CBX3;BRWD1
prerank,hexose biosynthetic process (GO:0019319),0.3098705077354577,0.9453488286869908,0.5256410256410257,0.8833692963028944,1.0,9/42,14.14%,RBP4;SORD;SLC25A11;CHST15;CRY1;AKR1B1;ENO2;PFKFB1;GPI
prerank,regulation of translational initiation (GO:0006446),-0.26417506760309045,-0.9452769152269997,0.5443037974683544,0.8025156125354731,1.0,22/63,24.26%,HSPB1;NCK1;EIF1B;EIF4G3;EIF4G1;NCK2;ATF4;YTHDF3;EIF4H;EIF3B;EIF2B5;EIF1;POLR2G;EIF2B2;EIF5B;ATF3;FMR1;UHMK1;EIF4B;CEBPB;EIF5;PPP1R15B
prerank,cellular response to misfolded protein (GO:0071218),-0.3393256460172031,-0.9448628135334086,0.5667351129363449,0.8028811339881735,1.0,7/20,21.92%,ATXN3;BAG6;CUL3;DERL1;AUP1;RNF5;VCP
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.37119097336548973,0.9446745543038497,0.5564853556485355,0.8841489260505526,1.0,8/21,19.40%,HK2;RPE;H6PD;RBKS;DERA;GPI;GCK;SHPK
prerank,integrated stress response signaling (GO:0140467),-0.36576576146906675,-0.9446606501377808,0.5459770114942529,0.8027819362669937,1.0,5/14,30.16%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,natural killer cell activation (GO:0030101),-0.32920319014346755,-0.9444901649933497,0.5714285714285714,0.8025555495082197,1.0,10/23,29.89%,PTPRC;BAG6;PIK3CD;RABL3;CASP8;ULBP1;TOX;SNX27;PRDX1;RASGRP1
prerank,multivesicular body assembly (GO:0036258),-0.30173675380933784,-0.9444818971722491,0.535031847133758,0.8019654720042434,1.0,13/30,30.92%,CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.32198743288689313,-0.9444613072076875,0.5225806451612903,0.8014133332542029,1.0,15/27,32.23%,ETS1;CD44;CYRIB;RHOA;HSPD1;CD47;IRAK1;THY1;RELA;CCR2;SKAP1;CCL2;ITGB2;NR4A3;MDK
prerank,peptidyl-serine modification (GO:0018209),-0.22416488940439808,-0.9441751748475686,0.6118421052631579,0.8015528138460081,1.0,50/166,22.18%,PRKCH;STK38;RPS6KA5;GAS6;GALNT13;PKD1;STK38L;TGFBR2;IKBKB;PLK2;GSK3B;GALNT2;MTOR;MARK1;MAPK8;PAK2;CHUK;RPS6KA1;MARK2;LMTK2;STK32B;STK32A;MAST3;MAP3K12;MASTL;PKN3;GALNT1;VRK3;VRK1;CAMK4;PRKD1;RPS6KA4;POGLUT3;SGK1;PRKCE;CDK2;PRKCG;ATR;CDK5;PINK1;TLK2;PRKCD;AKT1;MKNK2;TTBK2;SBK1;UHMK1;DCLK3;PRKX;MAST1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.30053921029835945,0.9440718093949604,0.5475792988313857,0.884738655601667,1.0,9/56,8.85%,ROCK2;ARL3;SNX18;CECR2;SNX9;SNX33;SON;SPIRE2;CUL7
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2813196797191854,0.9440158268142606,0.5673076923076923,0.884069941192391,1.0,10/80,7.56%,AUTS2;DOCK11;DPYSL3;AVIL;RIPOR2;ABI2;WASL;ARHGAP35;EPS8L1;CCL19
prerank,cellular response to oxidative stress (GO:0034599),0.2667876044635275,0.9439336986844261,0.5464231354642314,0.8834567690481446,1.0,23/118,12.54%,TPM1;DAPK1;SOD3;PLA2R1;FER;PDGFRA;CPEB2;MAPK9;PRKAA2;MSRA;LRRK2;MMP9;PRKAA1;ARNT;TXNRD1;TXNRD2;VRK2;CCS;ABL1;EIF2S1;NCF2;PKD2;ADNP2
prerank,histone H3-K9 demethylation (GO:0033169),0.42280798292777344,0.9439011221630738,0.5655913978494623,0.8827312621391491,1.0,3/11,9.01%,KDM7A;PHF8;KDM3B
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.41090316115027214,-0.9436873210202759,0.5528756957328386,0.8020914478880111,1.0,5/10,36.85%,SET;CTBP1;NOC2L;THAP7;TAF7
prerank,bile acid biosynthetic process (GO:0006699),0.35936780287363024,0.9436020461612444,0.54,0.8827202709545651,1.0,2/24,5.65%,CYP27A1;HSD17B10
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2618892860009991,0.943277469396279,0.5607476635514018,0.8827165788968138,1.0,29/128,16.32%,TGFBR3;BMP6;APPL2;BMP7;SMAD6;PARD3;SLC39A5;SCX;COL1A2;PRKCZ;ZMIZ1;SMAD3;RGMB;GDF1;ARHGEF18;SMURF2;ZFYVE9;BMPR1A;HIVEP1;ZMIZ2;ITGB5;MAP3K7;NLK;FAM83G;CDH5;SKI;SMAD4;CGN;SLC33A1
prerank,regulation of osteoclast differentiation (GO:0045670),0.3271691606004034,0.943131670240333,0.5577299412915852,0.8822345020940286,1.0,4/33,8.62%,FBN1;LRRC17;CSF1;FSTL3
prerank,positive regulation of neuron projection development (GO:0010976),0.2744428617331793,0.9429541974158085,0.5467741935483871,0.8818752026900999,1.0,10/85,7.10%,PTK7;EPHA3;BMP7;CAMK1D;DPYSL3;AVIL;NDNF;PLK5;PTN;ARHGAP35
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.36255503368258923,-0.9426493023594509,0.5755693581780539,0.8039373587238491,1.0,7/15,13.25%,MVB12B;PTPN12;LGMN;CEACAM1;RHBDF2;CDH13;MVB12A
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2341085766052572,-0.9425983284722367,0.5859154929577465,0.8034466814026948,1.0,37/124,20.30%,LEF1;TIAM1;RAC1;CALM1;ROR2;SFRP4;FZD4;AP2A2;FZD6;NFATC1;CTNNB1;ARHGEF19;PLCB3;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;PSME1;CCDC88C;TNRC6C;PSMB3;DVL2;PRICKLE2;PPP3R1;ARRB2;PSMD5;AP2B1;AGO3
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32949868763339996,-0.942362476225324,0.5343035343035343,0.803382887474737,1.0,7/22,25.12%,SLC7A5;TNFRSF1B;LAPTM5;TRPM4;TRIL;CCR2;SPHK2
prerank,regulation of neuron apoptotic process (GO:0043523),0.268713320539246,0.9423074095489793,0.5601317957166392,0.8826926360976647,1.0,9/96,5.04%,EPHA7;PRKN;SNX6;BCL2;NDNF;PCSK9;SRPK2;KDM2B;CPEB4
prerank,negative regulation of hemostasis (GO:1900047),0.4215277614510938,0.9422084333579555,0.5472103004291845,0.8821401483114015,1.0,4/12,12.56%,TFPI;VTN;APOH;SERPINE1
prerank,C4-dicarboxylate transport (GO:0015740),0.4039795751454813,0.9420344457676426,0.5354330708661418,0.8817665985892301,1.0,5/14,9.27%,SLC25A18;SLC13A5;LRRC8E;SLC25A11;SLC25A22
prerank,double-strand break repair (GO:0006302),0.25343370584841207,0.9417914977584867,0.5458579881656804,0.881515193411798,1.0,25/158,11.35%,EYA1;RAD51B;BAZ1B;RAD51AP2;RNF138;HUS1B;RAD51C;TDP2;XRCC5;BLM;XRCC4;HELQ;KDM2A;AUNIP;BRCA2;POLM;ZSWIM7;MDC1;NHEJ1;PRKDC;DCLRE1A;PARP9;SMARCA5;DCLRE1B;ZFYVE26
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.31804342652777134,-0.9417804725369427,0.5327510917030568,0.8041046220424537,1.0,9/25,19.90%,TMTC2;CAV1;GRIN1;KCNA1;MT3;WFS1;ATP13A2;JPH2;ANK3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.308879590093631,-0.9412953797761248,0.559652928416486,0.8046284353389385,1.0,6/30,11.31%,ACVRL1;DACH1;BMPR2;PINX1;HNRNPU;MEN1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2324178281907258,-0.9412423153863256,0.5945945945945946,0.8041579612350324,1.0,36/121,23.01%,PRR5L;HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;UBC;RPS27A;PUM2;PSMD13;SET;PSMF1;EIF4G1;ZFP36L1;PSMB10;YTHDF3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;UBA52;PSMB3;SERBP1;ZC3H12A;PSMD5;PCBP4;PRKCD;AKT1;FMR1;RBM24;PSMD9;PSMB4
prerank,action potential (GO:0001508),0.3117323021517321,0.9411789127129749,0.5212765957446809,0.8821154237393548,1.0,2/44,1.48%,SCN7A;DMD
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.416839492788068,-0.9410186623236866,0.5619389587073609,0.8040461534061013,1.0,3/10,12.65%,HSP90AA1;HSP90AB1;CLU
prerank,protein monoubiquitination (GO:0006513),0.3283696797868231,0.94077926913044,0.5396825396825397,0.8822255272817832,1.0,12/36,20.96%,PRKN;MGRN1;KLHL22;CDC73;RNF20;RAD18;OBI1;CTR9;UBE2E1;DTX3L;KLHL12;PAF1
prerank,regulation of protein import into nucleus (GO:0042306),-0.29210276228783205,-0.9403873448698383,0.5540229885057472,0.8049139933103221,1.0,14/36,24.56%,APOD;CDH1;FLNA;TGFB1;CHP1;JUP;MDFIC;ZC3H12A;PSEN1;PRKCD;BMP4;RBM22;HYAL2;ZPR1
prerank,cellular component disassembly (GO:0022411),-0.27270884951718843,-0.9401837326355202,0.5756097560975609,0.8048151493151503,1.0,11/53,12.11%,BSG;TLL1;ADAM10;GSN;ADAM15;CD44;CAPN2;A2M;FURIN;ADAMTS4;MMP15
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.24486926110480697,-0.9394839970423372,0.5940860215053764,0.8058121329492309,1.0,23/94,15.67%,MAP3K5;FNIP2;PPP1R13B;DAB2IP;TMEM117;CRIP1;BCL2L1;BAG6;TNFRSF1B;ATP2A3;CUL3;CHEK2;DDX5;ATF4;HINT1;PDK2;MYBBP1A;SELENOK;ERO1A;BBC3;CUL1;CYP1B1;DNAJC10
prerank,negative regulation of cellular catabolic process (GO:0031330),0.28722983615951947,0.9392841312543976,0.5346869712351946,0.8849510359963763,1.0,14/63,14.04%,LEPR;TIMP3;BCL2;ATRAID;NUPR1;APOC1;GOLGA2;RIC1;WASHC1;RUBCN;KLHL22;PTPN3;FOXK2;PLIN5
prerank,glycolytic process (GO:0006096),-0.31270142431837067,-0.9392567484002305,0.5300207039337475,0.8057436191655867,1.0,8/28,17.39%,PKM;HK1;GAPDH;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,positive regulation of neuron differentiation (GO:0045666),-0.28515862699090766,-0.938742123417251,0.527027027027027,0.8063034715282635,1.0,11/40,15.86%,MEF2C;NGF;NRCAM;MMD2;RHOA;BMP2;HEYL;REST;ARHGEF2;BRINP2;TCF3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.25188754664719637,-0.9383356513375156,0.5670391061452514,0.8067076221347351,1.0,30/88,26.17%,FBXL3;FBXL5;PSMD13;PSMF1;RBX1;PSMB10;FBXO31;FBXL20;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;FBXL2;CCNF;FBXL14;PSMD5;FBXO17;SKP1;FBXO9;PSMD9;PSMB4;CUL2;DMAC2;KIF14;PSMD10
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3032647130953866,0.937946406625016,0.563573883161512,0.8873758939584926,1.0,24/52,24.98%,POLR2D;EXOSC8;RC3H2;SAMD4A;CNOT2;DCP2;LSM5;PARN;CNOT8;CNOT7;CNOT10;EXOSC3;TUT4;LSM3;LSM1;LSM4;DDX6;PDE12;TUT7;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,mitochondrial translation (GO:0032543),-0.23813981527526834,-0.9376385600260951,0.5982658959537572,0.8078233632766537,1.0,30/104,26.84%,LARS2;MRRF;GFM1;NDUFA7;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.40785893226171777,-0.9374041875023407,0.553639846743295,0.8077494000448592,1.0,2/10,9.24%,MSN;RHOA
prerank,extracellular matrix disassembly (GO:0022617),-0.2721901150111912,-0.9370276399489905,0.5660847880299252,0.8080477287492036,1.0,11/53,12.11%,BSG;TLL1;ADAM10;GSN;ADAM15;CD44;CAPN2;A2M;FURIN;ADAMTS4;MMP15
prerank,global genome nucleotide-excision repair (GO:0070911),-0.31011049495339116,-0.9365389286023602,0.5555555555555556,0.8086096006252329,1.0,7/26,17.98%,UBB;UBC;RPS27A;DDB1;RBX1;UBA52;CETN2
prerank,regulation of defense response (GO:0031347),0.281125999334664,0.9363227070554282,0.5544715447154471,0.8905084409645586,1.0,9/76,7.98%,ADAMTS12;APPL2;ANXA1;LACC1;UFL1;CASP12;SETD6;DAGLB;RNF135
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23453627132828106,0.9358790211717425,0.6204663212435233,0.890795536960926,1.0,25/291,7.32%,RORA;ROCK2;PTK7;EPHA3;WNT6;PID1;SLC5A5;TPM1;DAPK1;CXCL13;FER;CRHBP;PDGFRA;MAPK9;CPEB4;CACTIN;AANAT;SSTR2;SLC38A9;IL6;NCOA3;PDCD1LG2;WNT5B;FOLR1;MMP9
prerank,oogenesis (GO:0048477),0.38606569581907024,0.9355504321598558,0.5443548387096774,0.890757533517706,1.0,2/15,5.91%,HORMAD1;PTN
prerank,lipoprotein localization (GO:0044872),0.403453656213445,0.9352132744944524,0.5326530612244897,0.8907643287559914,1.0,3/11,8.41%,PRKCB;ZDHHC3;MIA3
prerank,positive regulation of phagocytosis (GO:0050766),-0.2759248924956643,-0.9351752918298554,0.580335731414868,0.811226213058815,1.0,8/47,6.03%,PTPRJ;GAS6;RAB31;RAB27A;GATA2;CALR;DOCK2;PTPRC
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.20648610569940232,-0.9349681514549892,0.7165354330708661,0.8111076702983192,1.0,64/264,20.79%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;DDX20;SRSF5;DDX39B;CPSF3;HNRNPH2;SRSF9;CLNS1A;CWC15;RALY;USP39;RBM8A;POLR2C;STRAP;XAB2;RNPS1;SNRPC;SRSF6;PRPF40B;SRPK1;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;DCPS;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;DDX17;MTREX;HNRNPUL1;YTHDC1;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.37108868570871184,-0.9348851727123609,0.562992125984252,0.8107118228057351,1.0,5/14,14.67%,SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,establishment of vesicle localization (GO:0051650),-0.34813779554757146,-0.9345575480557372,0.5676767676767677,0.8108529025334983,1.0,4/18,7.68%,RAB27A;LIMK2;SYNJ1;DNM2
prerank,embryonic hemopoiesis (GO:0035162),-0.38167982776938697,-0.9343624609066254,0.5493230174081238,0.8107167037056999,1.0,5/12,11.47%,KITLG;KDR;TGFBR2;ATF4;TAL1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23155627693079603,0.9343052986267321,0.6348993288590604,0.8920663698287219,1.0,64/327,16.72%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;IGF2;SSBP2;NCOA2;SOX1;PERM1;TCF7L1;ZMIZ1;ZFP37;SUFU;THAP1;WWC1;WWC2;GPBP1;UBE2L3;GPBP1L1;MTF2;ZKSCAN5;POLR2A;NFIA;ZNF628;BRCA2;MITF;KAT6B;NFYC;NSD1;NUP107;ABL1;ASCC2;ZBTB11;ZBTB38;MYB;RNF14;SOX13;RNF20;PSPC1;NONO;FOXK2;CLOCK;UBE2V1;CREBBP;NLK;PCGF1;SOX12;SMARCA2;PATZ1;ZNHIT3;FZD7;PML;PHF1;IGSF1;REXO4;BACH1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4076267856434612,0.934180327608617,0.544468546637744,0.8915656719638652,1.0,3/12,10.08%,LHPP;ADSL;GMPS
prerank,female gamete generation (GO:0007292),0.3351256409874343,0.934081641927235,0.5286738351254481,0.8910069080786275,1.0,4/29,5.91%,DIAPH2;HORMAD1;DMC1;PTN
prerank,long-chain fatty acid metabolic process (GO:0001676),0.28838394643558646,0.9339610826561829,0.5421487603305785,0.8905271350999485,1.0,13/64,14.65%,ACSL1;GSTM2;PLA2G10;ACOT4;ACADL;CPT2;EPHX2;DAGLB;ACOT1;PLA2G4B;PLA2G4C;ACOX1;HACL1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3873163293883291,-0.9339383542228641,0.5700757575757576,0.8110922863335508,1.0,8/12,44.95%,PLK2;BUB1B;ZWINT;BUB1;WEE2;NABP1;ZW10;PRCC
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.3787196198753181,0.9338125279645387,0.5397489539748954,0.8900736575844674,1.0,4/16,5.26%,PDGFRB;FER;PDGFRA;PDGFD
prerank,male gonad development (GO:0008584),0.32914974777741046,0.9335389159963011,0.5415896487985212,0.8899141665938174,1.0,3/34,5.73%,WNT4;KIT;LRP2
prerank,response to UV-A (GO:0070141),0.3960616460419376,0.9333731604174833,0.532803180914513,0.8895056906784314,1.0,3/14,9.41%,MMP2;MMP9;CERS1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3714501298409252,0.9329041224104825,0.5611650485436893,0.8898585577472893,1.0,2/19,2.20%,IL34;CAMK1D
prerank,translational termination (GO:0006415),-0.2406564857788926,-0.9323233069787982,0.5828571428571429,0.814283466243942,1.0,31/95,29.09%,MRRF;MRPL32;MRPL33;APEH;MRPS14;GSPT2;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;ETF1;AURKAIP1;CHCHD1
prerank,blood vessel endothelial cell migration (GO:0043534),0.3537893511748992,0.9322374367431457,0.55893536121673,0.8906529872326645,1.0,2/22,1.19%,ROBO1;EFNB2
prerank,regulation of primary metabolic process (GO:0080090),0.26020260419899466,0.9321745845878622,0.5898959881129272,0.8900232501662295,1.0,18/126,11.41%,ROCK2;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;OAZ3;PSME4;PSMA2;PSMA3;CHD9;PMVK;PSMD8;NFYC;MED1;PSMD3;FDPS;RXRA
prerank,blood vessel diameter maintenance (GO:0097746),0.32963212656683866,0.9321253352835173,0.5472727272727272,0.889366142002213,1.0,4/34,6.13%,ROCK2;BDKRB2;ACE;SCPEP1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4013319819416465,0.9316931584841608,0.5405982905982906,0.8896017099482261,1.0,3/13,12.17%,BMP7;NAPEPLD;SOX13
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2977345592677543,-0.9316303862745078,0.5647321428571429,0.8153226547688107,1.0,13/31,25.95%,HSPA8;ATXN3;DAB2IP;HSPA14;HSPA5;PTPN1;HSPB8;TMBIM6;HSPA9;HDAC6;HSPA1B;BAX;ERN1
prerank,actomyosin structure organization (GO:0031032),0.2823372229201014,0.9312950546881481,0.5532258064516129,0.889754739630523,1.0,9/75,6.42%,ROCK2;TPM1;SORBS1;CSRP3;FRMD6;TNNT2;EPB41L5;FAM171A1;MYO18A
prerank,brain morphogenesis (GO:0048854),-0.3856891733822059,-0.9312415333512803,0.5572232645403377,0.8156593720703418,1.0,1/12,0.48%,SHANK3
prerank,cellular response to interleukin-6 (GO:0071354),-0.30891494181238466,-0.9311645887795824,0.5607675906183369,0.8152333704839737,1.0,13/26,24.71%,ST3GAL6;CBL;SBNO2;ST18;PTGIS;STAT3;SPI1;JAK1;CEBPA;RELA;STAT1;SELPLG;PTPRT
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2810602599164015,0.9306269396449958,0.5609348914858097,0.8906238869725475,1.0,9/76,7.56%,SASH1;C1QTNF3;BMP7;NFAT5;SPHK1;UACA;DLG1;NLRC3;CCL19
prerank,in utero embryonic development (GO:0001701),0.35218460473146906,0.930386165317756,0.5391969407265774,0.8903958024302114,1.0,3/25,3.44%,ARNT2;FGFR2;IGF2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3146849784299157,0.9302953215670943,0.5444839857651246,0.8898341785182448,1.0,9/41,13.78%,ACSL1;GSTM2;PLA2G10;PTGR1;DAGLB;FADS3;PLA2G4B;PLA2G4C;ACOX1
prerank,regulation of stem cell differentiation (GO:2000736),-0.24364795075442658,-0.9297748242169296,0.612987012987013,0.8178447579862088,1.0,21/89,15.86%,LMO2;RUNX1;JAG1;CBFB;NOTCH1;HES1;GATA2;HNRNPU;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3694480923249572,0.9295805800042599,0.5444234404536862,0.8907474044222051,1.0,3/19,6.48%,PARD3B;PARD3;DLG1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.37170032846822115,0.9294092797820522,0.5305343511450382,0.8903429112259809,1.0,5/18,12.80%,ADCY1;CAMK1D;PRKD2;CRTC1;CRTC3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2727506198756745,-0.9293878441611189,0.5754716981132075,0.8180834282011935,1.0,18/54,23.48%,GAS6;RACK1;IKBKB;BIRC3;CHUK;NLRP2B;TRAF1;CASP8;MADD;CARD16;LAPTM5;SHARPIN;CASP1;RBCK1;TNFAIP3;TRAIP;OTULIN;HSPA1B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3260228465283409,-0.9286056384611763,0.574468085106383,0.8193708807797204,1.0,8/21,19.74%,CTNNB1;VEGFA;NES;DISC1;CX3CR1;DISP3;TOX;DLL4
prerank,neutral amino acid transport (GO:0015804),0.3351956415967133,0.9268273807191768,0.552434456928839,0.8956239971064719,1.0,7/28,12.29%,SLC38A3;SLC6A9;LLGL2;SLC43A1;SLC1A5;SLC36A2;SLC38A2
prerank,glucose metabolic process (GO:0006006),-0.26070956119243127,-0.9265425933036946,0.6132723112128147,0.8236240609034422,1.0,10/58,14.04%,APOD;PPARGC1A;PPARD;LRP5;HECTD4;GAPDH;ATF4;SLC39A14;TPI1;ALDOA
prerank,mitotic metaphase plate congression (GO:0007080),-0.2694209780509017,-0.9265137505105104,0.6086956521739131,0.8230911476646667,1.0,18/51,26.80%,CHMP5;CHMP2B;PINX1;CUL3;RMDN1;BOD1;CHMP1B;CHMP1A;CHMP3;KIFC1;CHMP7;PDCD6IP;NDC80;KIF14;SPDL1;CHMP4C;CDCA8;CEP55
prerank,fluid transport (GO:0042044),-0.38021064711261365,-0.9264539612604248,0.5757575757575758,0.8226344932187724,1.0,3/12,11.74%,AQP4;AQP11;SLC26A6
prerank,autophagy of mitochondrion (GO:0000422),0.31537694193554305,0.926147842376018,0.5588752196836555,0.8964960383610187,1.0,9/38,15.64%,PRKN;WIPI1;BNIP3;ATG14;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4024472658075676,-0.9260803822119089,0.5797373358348968,0.8229064842249575,1.0,7/11,39.30%,STAT3;CANX;JAK1;STAT1;IL12RB2;IL6ST;IL12A
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.3998915225666386,0.9256445182656888,0.5450901803607214,0.8969227255638185,1.0,5/12,8.41%,PLCB1;SLAMF8;WASL;NBL1;MIA3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.25062899061171606,-0.9255038499239356,0.6150234741784038,0.823663856723914,1.0,13/70,15.40%,TGFB2;DAB2IP;NGF;BLOC1S2;TGFB1;DCC;BCL2L1;GSK3B;TNFRSF1B;APPL1;CASP8AP2;FAS;CASP8
prerank,negative regulation of cell projection organization (GO:0031345),0.3010904365028085,0.9254704930343133,0.5746527777777778,0.8965283686106175,1.0,6/48,7.48%,EFNB2;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,mRNA metabolic process (GO:0016071),-0.24009996207380055,-0.9249947780420011,0.5961538461538461,0.8242760475152825,1.0,30/90,28.92%,PPARGC1A;SRSF2;SRSF1;SF3B2;SFPQ;DDX5;SRSF5;SSB;CPSF3;KIN;SRSF9;CPSF6;USP39;PRPF18;HNRNPA0;RIDA;RNASE4;PCF11;PTBP1;AGO3;METTL3;SNRPG;HSPA1B;NUDT16;ERN1;RNH1;DIS3L2;AURKAIP1;LSM11;SRSF7
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3870819837565952,0.9248773289025816,0.5387755102040817,0.8971351116720442,1.0,4/14,13.78%,EHHADH;ECI2;AMACR;ACOX1
prerank,positive regulation of cellular process (GO:0048522),0.22083809191840714,0.9247693367942708,0.6906729634002361,0.8966161167830342,1.0,77/565,12.90%,IL31RA;IGF1;BMP6;COLEC12;IL34;FGFR2;FGFR4;EFNB2;TPM1;MEIS1;RHOD;BCL2;CAMK1D;CCN2;PARD3;DKK1;SCX;PDGFRB;FER;CTSH;IGF2;PDPN;EPHA4;SRPK2;ITGAX;IL13RA1;TULP1;ASH2L;PDGFRA;SPHK1;PRKAA2;PDGFD;UFL1;IGF1R;FGF1;PTN;TET1;TTK;ECHDC3;ADRA1D;CDC123;IL6;FOLR2;PRKCA;PTEN;PRKAA1;CSF1;BIRC5;LYAR;GRK5;RPRD1B;COX17;NUPR1;SIRPA;MDM2;IER5;AXIN2;CST7;PHIP;FGF9;TNFSF13;HDAC1;FLCN;TFAP2B;FXR1;ERBB2;TGFA;KLHL22;PRODH;HSF1;PRKD2;AREG;AR;ADNP2;S100A9;GDNF;INO80
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.25150345814252095,-0.9242675968829795,0.5882352941176471,0.8253863169004877,1.0,20/72,23.79%,ACER2;RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;ING4;SESN2;CDKN1B;BCL3;RPS27L;TNKS1BP1;PCBP4;TFAP4;GADD45A;CDKN1A;E2F7;RGCC;BAX
prerank,peroxisome organization (GO:0007031),-0.3210145544800959,-0.9240062582306519,0.5765199161425576,0.8253555156544498,1.0,10/25,27.16%,ABCD3;ABCD2;PEX1;PEX11B;SEC16B;ABCD4;PEX10;PEX16;TMEM135;FIS1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.25282591592561043,-0.9239306199863275,0.6127450980392157,0.8249294302829568,1.0,17/70,15.86%,LMO2;RUNX1;CBFB;GATA2;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,response to estradiol (GO:0032355),0.33392691304428784,0.9237010251392345,0.5822550831792976,0.8983415304864201,1.0,6/31,7.77%,ANXA1;STAT5B;CRHBP;SSTR2;NCOA3;STRN3
prerank,myeloid dendritic cell activation (GO:0001773),-0.3901377005932481,-0.9236572961449733,0.5875706214689266,0.8249275747425117,1.0,3/12,15.69%,TGFBR2;DOCK2;CAMK4
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.30975276938018814,0.9234347136338636,0.569060773480663,0.8982018388445075,1.0,5/41,7.56%,ITPR1;SLC8A3;SLC8A1;CACNA2D1;CCL19
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3383168948322191,0.9233346500162406,0.5495327102803739,0.8976661069547233,1.0,4/27,4.96%,SLC22A2;SLC6A9;SLC1A3;SLC25A18
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.33121367218573095,-0.9233334513299669,0.572938689217759,0.8250358283665544,1.0,7/20,22.25%,ENTPD1;HSP90AB1;APP;PSTPIP1;NT5E;C3;CASP1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.34515640318480173,0.9232101968484105,0.5766871165644172,0.8971726113613467,1.0,6/27,10.77%,PID1;GRB10;PRKCZ;PRKCB;TNS2;RPS6KB1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.29967638767514165,-0.9231774082328764,0.5620915032679739,0.8248268857731916,1.0,8/29,22.30%,PABPC1;HNRNPU;YBX1;FUS;TENT5A;FMR1;SLC11A1;RBM24
prerank,glycoprotein metabolic process (GO:0009100),0.2908447672175389,0.9226808464821545,0.5745393634840871,0.8976066627130823,1.0,7/53,7.36%,ADAMTS9;LARGE1;PRKCSH;GAL3ST2;MAN1C1;FBXO44;GANC
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.38518523367284213,0.9221251502111903,0.5470588235294118,0.8980936499464597,1.0,2/15,4.40%,FGFR2;PDGFRA
prerank,polyamine metabolic process (GO:0006595),-0.37931755506475767,-0.9213037032711808,0.5702479338842975,0.8285298803600291,1.0,8/13,37.43%,AMD1;HDAC6;SRM;DHPS;SMS;ODC1;HDAC10;OAZ2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4151071062982528,0.9209074210970705,0.5588235294117647,0.9001423475308353,1.0,1/10,1.37%,PRKN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2539246899771229,-0.9208629085363387,0.6119791666666666,0.8289372014721197,1.0,19/73,16.12%,HIP1;ACER2;F3;NGF;RACK1;TNFSF10;NOD1;EGLN3;ATP2A3;HIP1R;XDH;HSPD1;CASP8AP2;RPS27L;BBC3;DAP;FAS;CASP8;LAPTM5
prerank,mitochondrial translational elongation (GO:0070125),-0.24045568835574505,-0.9206222890954953,0.6124661246612466,0.8289145447823154,1.0,28/88,29.09%,GFM1;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;AURKAIP1;CHCHD1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.32244310053779035,-0.9204499983145912,0.6016260162601627,0.8287432083769842,1.0,8/22,18.52%,UBB;EDEM3;UBC;RPS27A;TRIM13;MAN1A2;UBA52;RNF5
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.33037978975664123,0.9199965385392647,0.5480943738656987,0.9014224425684978,1.0,5/30,8.30%,ROBO1;LPAR1;AKAP13;ABRA;F2RL2
prerank,glucose import (GO:0046323),-0.3598841884891757,-0.919825003699848,0.5524193548387096,0.8296659482693366,1.0,2/13,9.10%,SLC2A1;ZDHHC7
prerank,positive regulation of translational initiation (GO:0045948),0.369161924624481,0.9197755863085233,0.5526838966202783,0.9011257282451356,1.0,6/18,16.41%,POLR2D;CDC123;YTHDF2;RPS6KB1;BOLL;LARP1
prerank,protein localization to cell junction (GO:1902414),-0.3253301584800203,-0.9191113096038582,0.5932539682539683,0.830718804017416,1.0,10/22,20.76%,HEG1;TJP2;FERMT2;TJP1;PAK2;PCLO;BSN;DSP;JAK1;JAM3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3049383011598977,0.9190437130524587,0.582010582010582,0.9021034744251039,1.0,3/46,3.54%,TCF7L2;ZIC1;NEDD4
prerank,protein-containing complex assembly (GO:0065003),0.23542016769726898,0.9188999571661817,0.654421768707483,0.9016393467606968,1.0,45/259,12.49%,TCF7L2;PLEKHA7;AFDN;DMD;KMT2A;FANCA;PARD3;PYGO1;ASH2L;SH3PXD2B;TEAD1;WASF1;TLE3;WASL;LRRK2;SNX9;TCF7L1;WDR19;PDCD6;CDC123;CAND1;F5;NOL3;BLM;FOLR1;WASF3;MCU;TLE1;MITF;PICALM;MDM2;GOLGA2;AXIN2;TUBGCP2;GSDMD;BCL9;HDAC1;LLGL1;DLG4;TGFA;CDC73;SAR1B;DNAJB12;HSF1;AREG
prerank,response to insulin (GO:0032868),0.27619985067547864,0.918816718371984,0.5691056910569106,0.9010537178889065,1.0,13/80,10.77%,PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CPEB2;SYAP1;TBC1D4;SLC27A1;PRKDC;PIK3R1;RPS6KB1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.37557636753627927,0.9186630282938376,0.5653923541247485,0.9006392392075168,1.0,2/17,1.17%,RBPJ;NOTCH2
prerank,regulation of telomere maintenance (GO:0032204),0.3378981254848133,0.9185969393132829,0.5423728813559322,0.9000230200223523,1.0,11/26,22.12%,HDAC8;YLPM1;XRCC5;USP7;RTEL1;MRE11;PML;RAD50;NBN;TERF2;SMG1
prerank,regulation of protein kinase activity (GO:0045859),0.2644145816607393,0.9182613806121669,0.6142857142857143,0.9000262739196422,1.0,14/106,9.09%,PRKAG2;PDPK1;DEPTOR;ALS2;DTNBP1;PPM1E;MRNIP;SNX9;GNAQ;XRCC5;DDR2;CCL19;CSF1;UVRAG
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.40024463775427377,-0.9181288473814663,0.5769230769230769,0.8324553154519654,1.0,4/11,11.40%,TJP2;F11R;TJP1;RAB1A
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.24646243717916072,0.9181268990385515,0.6231884057971014,0.8995674575416333,1.0,20/152,11.66%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;CACNA1D;GNAQ;ADRA1D;PTH2R;GRK5;PTGIR;GLP1R;PTGER1;ADRB3;AKAP12;ADGRB3
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3103600834238279,-0.9178756961072476,0.6115702479338843,0.8324682728816729,1.0,6/27,15.14%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,positive regulation of inflammatory response (GO:0050729),-0.2435026551967666,-0.9177795432731228,0.6071428571428571,0.8320812230887604,1.0,16/86,14.36%,IL33;ETS1;LBP;NFKBIA;RPS19;GPR4;VAMP8;PDE2A;PDCD4;APP;GRN;FEM1A;IFI35;CD81;NFKBIZ;CD47
prerank,regulation of protein processing (GO:0070613),-0.32046771275005514,-0.9177399173346026,0.5717213114754098,0.8315774133313845,1.0,3/21,5.68%,RUNX1;SERPINE2;NKD2
prerank,dendrite self-avoidance (GO:0070593),-0.3506320000486515,-0.9177053654347194,0.573170731707317,0.831058970769128,1.0,8/16,27.65%,BSG;ROBO4;CNTN6;NPTN;DSCAML1;VSTM2L;CNTN2;EMB
prerank,regulation of ATP metabolic process (GO:1903578),0.2947775518119931,0.9173421740763882,0.5869191049913941,0.9006354782421303,1.0,1/54,0.08%,PRKAG2
prerank,response to cholesterol (GO:0070723),-0.3385777352942484,-0.9173191464231181,0.5781893004115226,0.8312942750607268,1.0,4/17,9.08%,TGFBR2;TGFB1;PTCH1;GRAMD1A
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3182423692081021,-0.9171114423477258,0.5731958762886598,0.8311578569132242,1.0,7/23,24.17%,GAS6;NR1H4;LAPTM5;CD274;ZC3H12A;INHA;VSIR
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3161665383803429,0.9169872393156611,0.5683836589698046,0.9006666926008986,1.0,6/36,8.45%,AFDN;VAMP5;MACF1;OPTN;GGA2;BLZF1
prerank,cellular response to calcium ion (GO:0071277),0.28361492521561554,0.9166712647187963,0.5884297520661157,0.9006270673707196,1.0,10/67,10.68%,ADGRV1;ADCY1;CRHBP;SYT11;SYT12;PRKAA2;PRKAA1;CAMK2D;CPNE4;NEUROD2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.23474102227835955,0.91632182408432,0.6437086092715232,0.9006282540184503,1.0,71/259,19.12%,DCDC2;ASAP1;KIT;FGD4;RHOD;MYLK;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;PMP22;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;NTN1;ARL6;CEP19;IQCB1;MTSS1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;IFT122;RAP2A;ACTN2;TTC39C;EXOC3;IFT140;CFAP298;STK26;CCDC65;WDR90;CEP164;CFAP70;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;SDCBP;SRGAP2;PDE6D;RAB11FIP3;RAP1B;ANO6;ARF4;RP2;TMEM237;BBS1;TRAF3IP1;MAP4K4;IFT81;TNIK;IFT46
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.384209828722748,0.9159818026096217,0.5774378585086042,0.9006440325898111,1.0,2/16,2.67%,WNT4;SCX
prerank,inflammatory response (GO:0006954),0.2420778433796988,0.9154509436701146,0.614406779661017,0.9010826479631852,1.0,27/195,13.76%,ADCY1;BDKRB2;IL18;KIT;LOXL3;TPST1;CXCL13;ANXA1;ADM;CRHBP;PARP4;IL6;FOLR2;CCL19;PTGIR;IL17D;ITCH;CCL4;PTGER1;CDO1;MAPKAPK2;S100A9;NFATC4;TBK1;PLA2G4B;ADORA1;PLA2G4C
prerank,primary neural tube formation (GO:0014020),0.3296876713353846,0.9154000585694791,0.5424354243542435,0.9004316685887008,1.0,6/30,11.24%,LMO4;PRICKLE1;MTHFR;LRP2;COBL;IFT122
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4193363890311318,0.9150786032383452,0.5738758029978587,0.9004514048883278,1.0,2/10,8.47%,HK2;GFPT2
prerank,protein autoprocessing (GO:0016540),0.36397674245490036,0.9150130282611048,0.5576923076923077,0.8998242686019458,1.0,4/17,14.92%,PCSK9;MYRFL;HTRA2;OMA1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.38469176738354743,-0.9149926236868295,0.5851272015655578,0.8354604849914695,1.0,4/12,14.61%,PROM1;VEGFA;STAT3;RORB
prerank,negative regulation of phagocytosis (GO:0050765),-0.35014655261831246,-0.9148307584487188,0.5968688845401174,0.8352051666942403,1.0,8/17,26.99%,RACK1;DYSF;APPL1;CD47;PIP4P2;CD300A;FCGR2B;SNX3
prerank,positive regulation of viral process (GO:0048524),0.28642028842477585,0.913899437797484,0.5901060070671378,0.9015906162106335,1.0,10/60,10.30%,PPARA;POLR2D;SRPK2;HACD3;POLR2A;RSF1;CCNT1;GTF2F1;PKN2;AXL
prerank,ovarian follicle development (GO:0001541),-0.3651413690382479,-0.913874111327581,0.56312625250501,0.836828891601219,1.0,8/13,23.02%,SOD1;VEGFA;EIF2B5;EIF2B2;INHA;FOXL2;ANG;CEBPB
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.2762159222511448,-0.9137174370688236,0.5827664399092971,0.8365930809737229,1.0,20/45,33.86%,HSPB1;APP;AIM2;STAT3;GBP5;USP50;PANX1;CASP8;MYD88;TYROBP;CASP1;AGER;NLRC4;TLR4;LPL;CD36;TLR6;NOD2;P2RX7;NLRP3
prerank,negative regulation of cation channel activity (GO:2001258),0.33160525057527684,0.9121811474959608,0.560077519379845,0.9047386777906385,1.0,8/26,19.44%,SLC6A9;GSTM2;MMP9;GNB5;PKD2;DRD2;GPR35;EPHB2
prerank,regulation of JNK cascade (GO:0046328),0.262581754071187,0.9120108480185027,0.6383647798742138,0.9043767406609736,1.0,15/101,12.05%,TGFBR3;PRKN;MTURN;CCN2;PLCB1;MBIP;DUSP10;IGF1R;SH3RF1;CCL19;SIRPA;ITCH;SH3RF2;RAP2A;CYLD
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3262735743403882,-0.9118314543614268,0.5780590717299579,0.8403098570819831,1.0,5/21,10.79%,MEF2C;CXADR;MYH11;VEGFA;BMP2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3622186492539019,-0.9116312381371302,0.5893223819301848,0.840124936751589,1.0,2/15,1.93%,STOX2;TGFB2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3319354458785578,0.9112933041085327,0.5620437956204379,0.9052772454534892,1.0,7/27,15.07%,PLA2G10;ETNK2;NAPEPLD;SLC27A1;PISD;CHKA;NAAA
prerank,sphingoid metabolic process (GO:0046519),0.40442290746815435,0.9109249593845287,0.5588865096359743,0.9053705279492912,1.0,5/12,15.07%,PLPP3;SPHK1;SGPP1;PLPP2;NAAA
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2596769613927739,-0.9109124834398595,0.6080760095011877,0.8411701195501066,1.0,12/55,15.39%,CAV1;DAB2IP;RPS3;RACK1;TNFSF10;TPD52L1;BCL2L1;PAK2;GPER1;BBC3;FAS;BCAP31
prerank,inhibitory synapse assembly (GO:1904862),-0.3827409895017214,-0.9107272247614235,0.5970695970695971,0.8409864523313797,1.0,6/11,43.50%,GABRB3;GABRG2;FGF13;GABRB2;LGI2;NPAS4
prerank,B cell homeostasis (GO:0001782),-0.4006275821652291,-0.9105744466090546,0.6104166666666667,0.840732460770591,1.0,6/10,22.30%,MEF2C;DOCK10;CAMLG;PPP2R3C;NCKAP1L;TNFAIP3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.26801057388819205,-0.9100678748843739,0.6031390134529148,0.841305243444146,1.0,17/49,28.42%,CAV1;SGMS1;RACK1;BCL2L1;RTKN2;NDUFA13;HERPUD1;BBC3;BCAP31;PLAUR;PINK1;NOC2L;BMF;BAX;URI1;FIS1;BID
prerank,epithelial cell migration (GO:0010631),-0.278941637462527,-0.909799766381555,0.6177777777777778,0.8412948875003943,1.0,16/37,24.36%,NOS3;FAP;PLXND1;PXN;KANK1;RHOA;DPP4;SCG2;CDH13;PKN3;CYP1B1;ADGRA2;PLEKHG5;PRKX;PTP4A3;STAT1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.34600795165482023,-0.9097973749746322,0.5705263157894737,0.8406970432111712,1.0,7/16,28.31%,IKBKB;RAD17;SMG5;TIGAR;PSEN1;SMG6;BARD1
prerank,regulation of glycogen metabolic process (GO:0070873),0.39666648392483744,0.909571043587676,0.5746421267893661,0.9077317100026341,1.0,2/12,10.37%,PPP1R3G;PPP1R3F
prerank,negative regulation of interleukin-6 production (GO:0032715),0.33344795156587653,0.9090120442742295,0.5742574257425742,0.9082565074639085,1.0,7/27,15.72%,C1QTNF3;SYT11;NLRC3;SIRPA;NLRP12;CX3CL1;CD200R1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.367534759893982,0.9088648324400783,0.591715976331361,0.9078581530291757,1.0,1/17,0.39%,ROCK2
prerank,pentose-phosphate shunt (GO:0006098),0.397936302825708,0.9087662457237162,0.5714285714285714,0.9073282872781243,1.0,4/11,11.21%,RPE;H6PD;RBKS;DERA
prerank,negative regulation of bone remodeling (GO:0046851),-0.3832042526833451,-0.9085097671379728,0.5932203389830508,0.8430482654397662,1.0,8/11,37.13%,UBASH3B;GPR137B;GPR137;GREM1;TNFAIP3;CALCA;P2RX7;TMEM119
prerank,cellular response to type I interferon (GO:0071357),0.3040657173674595,0.9081416827294985,0.6119133574007221,0.9072670082312897,1.0,5/41,5.33%,SP100;IFIT3;IFIT2;RNASEL;IRF8
prerank,type I interferon signaling pathway (GO:0060337),0.3040657173674595,0.9081416827294985,0.6119133574007221,0.9072670082312897,1.0,5/41,5.33%,SP100;IFIT3;IFIT2;RNASEL;IRF8
prerank,response to hydrogen peroxide (GO:0042542),-0.27466549017049946,-0.9079585926251417,0.6203703703703703,0.8437152634300519,1.0,9/45,10.10%,MAP3K5;FYN;RPS3;NET1;RHOB;SOD1;PDCD10;STK25;PLEKHA1
prerank,engulfment of apoptotic cell (GO:0043652),-0.3509816074435944,-0.907934872472256,0.6004098360655737,0.8431792694150433,1.0,2/15,1.92%,THBS1;RAC1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2890220593534799,0.9077751984410483,0.6017699115044248,0.9073421532856463,1.0,5/56,4.81%,PLCB1;UBE2E2;ANXA1;RAD51B;RAD51C
prerank,regulation of receptor recycling (GO:0001919),-0.3445935078794633,-0.9077534308788585,0.5906313645621182,0.8430008034993555,1.0,4/16,10.74%,NSF;AP1AR;ECE1;LAMTOR1
prerank,presynapse organization (GO:0099172),0.41302606147734766,0.9071252362068924,0.5740318906605922,0.9080713239970495,1.0,1/10,2.23%,NLGN2
prerank,regulation of ruffle assembly (GO:1900027),0.34683301020818885,0.9071199883740245,0.5816135084427767,0.9073210990822546,1.0,1/23,0.20%,ARHGAP24
prerank,rRNA transcription (GO:0009303),-0.3421520879100312,-0.9070669501603013,0.5967741935483871,0.8439272080735697,1.0,8/17,23.04%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;GTF3C2;GTF3C4
prerank,regulation of exit from mitosis (GO:0007096),-0.2740780395185026,-0.9066903496094779,0.6359550561797753,0.8441573179078027,1.0,13/38,28.26%,UBB;BUB3;UBC;RPS27A;ANAPC16;UBA52;BUB1B;UBE2D1;ANAPC7;RGCC;KNTC1;CDC14A;MAD2L1BP
prerank,nucleotide-excision repair (GO:0006289),-0.22938191344325692,-0.9066623893972016,0.6759002770083102,0.8436225369516552,1.0,34/101,27.55%,ATXN3;UBB;UVSSA;COPS7A;UBC;RPS27A;PPIE;DDB1;RBX1;RPA1;OGG1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;POLA1;COPS6;CETN2;LIG4;POLE;POLD3;POLB;POLD1;GTF2H2;POLR2L;HMGN1;XPA;POLL;ERCC5;LIG3;RFC5
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2228564903797408,0.906536881998341,0.6880503144654088,0.9079424882895907,1.0,68/417,14.06%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;PRDM5;ZEB1;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;VGLL4;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;IKZF4;DPF2;GLI3;SFMBT1;NIBAN2;BCOR;SALL1;XRCC5;BIRC5;WWP2;RSF1;ZMYND15;TLE1;KAT8;KAT6B;MDM2;MBTD1;SMURF2;SCMH1;L3MBTL3;ATOH8;HDAC1;TFAP2A;SMARCE1;TFAP2B;ZNF568;ZBTB38;MYB;CRY1;SOX13;CBFA2T2;PSPC1;NONO;FOXK2;SCML4;TFDP2;CLOCK;ZNF148;KDM5C;CDKN1C
prerank,positive regulation of integrin activation (GO:0033625),0.40175056249846797,0.906438377737403,0.5770020533880903,0.9074028247613632,1.0,3/11,6.16%,CXCL13;FERMT1;CDH17
prerank,protein localization to vacuole (GO:0072665),-0.3591549621573108,-0.9064322249493738,0.5881147540983607,0.8435477245667883,1.0,5/13,16.20%,SH3BP4;SH3GLB1;RTN4;CD81;ATP13A2
prerank,regulation of centriole replication (GO:0046599),0.3750245233140188,0.9056545911390366,0.5808383233532934,0.9083754934834153,1.0,2/17,2.87%,SPICE1;ALMS1
prerank,negative regulation of cell cycle (GO:0045786),-0.2430597557359953,-0.9054884737830656,0.6747967479674797,0.8450810866722478,1.0,26/73,22.87%,PPP1R13B;RHOB;TGFB1;PDCD4;NR4A1;APC;CDK6;CDKN1B;BTG3;BMP2;HHEX;MEN1;GPER1;NLRP2B;BRINP2;DUSP1;ZBTB17;CAMK2N1;INHA;TFAP4;CHMP1A;BMP4;BTG1;GMNC;SIPA1;CEBPA
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3879383609387946,-0.9053140928927564,0.6014625228519196,0.8442665879107996,1.0,5/10,19.75%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.3879383609387946,-0.9053140928927564,0.6014625228519196,0.8442665879107996,1.0,5/10,19.75%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,protein localization to lysosome (GO:0061462),-0.30436121289662893,-0.9052676909214729,0.6073903002309469,0.8437741015871892,1.0,15/28,30.21%,SH3BP4;SNX16;RTN4;HGS;CD81;NCOA4;M6PR;LAPTM5;ATP13A2;LAMTOR4;RAB7A;SCARB2;SORL1;RNF128;ZFYVE16
prerank,regulation of stem cell proliferation (GO:0072091),0.365482204059416,0.9048383981223118,0.586,0.9094709346807333,1.0,3/17,6.36%,GJA1;ACE;FBLN1
prerank,histone mRNA catabolic process (GO:0071044),0.3760338479420218,0.9048036087643365,0.587737843551797,0.9087934895455533,1.0,9/15,23.35%,TENT2;TUT1;DCP2;ERI1;TUT4;LSM1;XRN1;TUT7;EXOSC4
prerank,cellular response to cAMP (GO:0071320),-0.2965248763075283,-0.9047284531017681,0.6147540983606558,0.8443592465114961,1.0,10/30,17.87%,RAP1A;IGFBP5;AHR;PDE2A;KCNQ1;ZFP36L1;SLC26A6;HCN1;CFTR;HCN2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.38784710668845035,-0.904683950961971,0.6273408239700374,0.8438570909807452,1.0,4/10,21.48%,FAS;MAP2K2;GREM1;MAPK3
prerank,cytosolic calcium ion transport (GO:0060401),0.32507491380060266,0.9046637850407638,0.5703422053231939,0.908324166772516,1.0,6/28,10.46%,JPH1;SLC8A1;MAIP1;CACNA2D1;MCU;MICU1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3563600099621391,0.9045068428488446,0.54510556621881,0.9079135368089234,1.0,5/20,14.06%,NR2F2;PTEN;CDK5RAP1;LATS1;CDKN1C
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3499763990376775,-0.9040709402716351,0.595703125,0.8445759713741324,1.0,10/15,44.58%,RYR2;SRPRB;SEC61G;ZFAND2B;SRP14;SPCS3;RAB10;SEC61A1;SPCS1;SRPRA
prerank,GPI anchor biosynthetic process (GO:0006506),0.32038373215875354,0.9038277588188356,0.578853046594982,0.9086773300201973,1.0,6/30,12.88%,PIGU;PIGG;PIGV;PIGX;PIGC;PIGQ
prerank,cellular response to interleukin-7 (GO:0098761),-0.33760446247412795,-0.9037517348343248,0.594488188976378,0.8440922396112411,1.0,11/17,34.94%,SOCS2;STAT3;CISH;JAK3;JAK1;SOCS1;CRLF2;IL2RG;TSLP;IL7;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.33760446247412795,-0.9037517348343248,0.594488188976378,0.8440922396112411,1.0,11/17,34.94%,SOCS2;STAT3;CISH;JAK3;JAK1;SOCS1;CRLF2;IL2RG;TSLP;IL7;IL7R
prerank,regulation of cellular protein localization (GO:1903827),-0.26419134151667417,-0.9036124362925557,0.6056338028169014,0.84381532680586,1.0,20/45,30.79%,HSP90AA1;HSP90AB1;CTNNB1;SPIDR;RALB;PTPN1;GPC1;RAB11FIP5;CCDC66;ATP13A2;GBF1;SUMO3;ABCA2;VCP;MAP1A;PPM1F;TRIM67;LCP1;EGF;SHH
prerank,establishment of melanosome localization (GO:0032401),0.35944805043594497,0.9035164830150729,0.5752380952380952,0.9086162151770638,1.0,5/19,14.67%,SHROOM2;ARL6;GPR143;BBS7;RAB11B
prerank,phospholipid dephosphorylation (GO:0046839),0.3031875642960315,0.9029495901206082,0.5921985815602837,0.9091763513696323,1.0,6/37,7.48%,PLPP3;MTMR3;SYNJ2;EPHX2;SGPP1;PTEN
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.41628994501760613,0.9025701265099093,0.5702127659574469,0.9092708303465029,1.0,4/10,15.68%,KMT2A;RAPGEF3;SMARCB1;SMAD4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4009543401481286,0.9025447451469654,0.5689655172413793,0.9085675395975974,1.0,1/11,3.14%,NOS1AP
prerank,positive regulation of immune effector process (GO:0002699),-0.3116978035006794,-0.9023357856352058,0.6106382978723405,0.8461857640145708,1.0,6/27,13.69%,PTPRJ;LBP;RPS19;PTPRC;XBP1;CD81
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.30724299074495104,0.9023332082202336,0.6061151079136691,0.9082844713368029,1.0,6/37,9.75%,APPL2;PPARA;IL6;NLRC3;SIRPA;IL17D
prerank,positive regulation of dendrite development (GO:1900006),-0.39957011100987483,-0.9017452033958646,0.6037383177570094,0.8469746375772196,1.0,4/10,6.74%,BMP5;DAB2IP;ZDHHC15;LRP8
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3420839133723725,0.9017383954984202,0.5798816568047337,0.9088370406435529,1.0,4/22,12.24%,AEBP1;AKAP13;ABL1;GBA2
prerank,protein polyubiquitination (GO:0000209),0.22694628920558987,0.9010327268372202,0.7214673913043478,0.9096979787203979,1.0,66/297,17.96%,SASH1;PRKN;PELI2;BCL2;SPSB1;UBE2E2;TRIM5;NEDD4;RNF213;FBXW4;DDB2;ANAPC13;RNF217;PSME4;PSMA2;FBXO44;UBE2L3;PSMA3;NPEPPS;UBR2;RNF152;SPOP;TTC3;TRIM56;RNF135;SIAH2;WWP2;AMFR;RNF216;RC3H2;UBE4A;FBXL17;NHLRC1;FBXO6;MDM2;PSMD8;ITCH;KBTBD7;SMURF2;PSMD3;RBBP6;FBXO4;FBXO38;RNF14;RNF20;FBXO11;CDC26;IFI27;UBE2V1;UBE2A;CHFR;BIRC2;TRIM62;PPIL2;SKP2;UBE2H;HECTD1;HERC6;TRIM69;ANAPC2;UBE2E1;NHLRC3;PELI3;DTX3L;UBE4B;FBXW10
prerank,regulation of myotube differentiation (GO:0010830),-0.31214365533529553,-0.9009332303062159,0.5995670995670995,0.8482221228722502,1.0,7/24,13.45%,NOTCH1;CCN3;HDAC5;PIEZO1;XBP1;ATP11A;SMYD1
prerank,response to organonitrogen compound (GO:0010243),-0.2827733642947099,-0.9007556915015116,0.6191536748329621,0.8480431540719708,1.0,16/38,27.15%,MTOR;DERL1;CCDC47;UBXN6;IRAK3;ERLEC1;NR1H4;GLRA3;RNF5;IRF5;VCP;BRSK2;GLRA1;MEAK7;TRPM2;SYVN1
prerank,histone H4-K8 acetylation (GO:0043982),-0.35205847932664613,-0.8997404324525985,0.5976095617529881,0.8491480049084343,1.0,5/15,17.31%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,histone H4-K5 acetylation (GO:0043981),-0.35205847932664613,-0.8997404324525985,0.5976095617529881,0.8491480049084343,1.0,5/15,17.31%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.26278989437650563,-0.8991488102087906,0.642691415313225,0.8498588892840611,1.0,13/50,15.79%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.34005619721344793,-0.8990401775459812,0.5842911877394636,0.8495331181326479,1.0,4/17,10.40%,TMSB4X;KLF4;ARRB1;BCL3
prerank,purine-containing compound biosynthetic process (GO:0072522),0.33408289176803124,0.8985190655830083,0.590339892665474,0.9146607132916886,1.0,8/25,18.21%,PRPSAP2;AMPD3;ADSL;GMPS;SHMT1;ADK;APRT;GMPR2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.35228665365086087,-0.8973345655548658,0.6053639846743295,0.8527350401212372,1.0,8/14,31.31%,CPSF7;CPSF6;CPSF2;CSTF2T;CSTF2;ERN1;CPSF4L;CPSF1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.391561745567751,0.897311603351005,0.5851703406813628,0.9165782069074193,1.0,4/13,10.82%,KCNA5;ANK2;GJA1;SCN3B
prerank,vesicle transport along microtubule (GO:0047496),-0.3111283378937649,-0.8971938039262725,0.6224489795918368,0.8524508638474902,1.0,10/23,32.71%,KIF1A;RAB1A;KIF13A;NDE1;BICDL1;KIF3B;HAP1;DYNC1I1;KIF5B;DYNC1H1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.37091488905550557,0.8970777721221965,0.6022727272727273,0.9163351368768908,1.0,2/17,2.67%,WNT4;SCX
prerank,negative regulation of cellular component organization (GO:0051129),0.2741626610336766,0.8964764777113733,0.6644518272425249,0.9169078012371603,1.0,13/74,12.83%,BMP6;EPHA3;SYT11;WASL;PRKCZ;SNX33;XRCC5;RUBCN;RTEL1;HSF1;AR;PACSIN3;RAPGEF3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.30372560529570425,0.8964266827305385,0.5872420262664165,0.9162571593623552,1.0,7/38,14.28%,RORA;CACTIN;NLRC3;TLE1;MAPKBP1;NLRP12;NLRX1
prerank,atrial septum morphogenesis (GO:0060413),-0.39150215690912504,-0.8963993660739926,0.5878003696857671,0.8536279093305421,1.0,4/10,9.36%,TGFB2;BMPR2;SOX4;HEY2
prerank,regulation of RNA splicing (GO:0043484),-0.24124399222845175,-0.8961555572204005,0.6556122448979592,0.8535378318549302,1.0,26/69,25.95%,MBNL1;AHNAK2;HNRNPK;AHNAK;QKI;LARP7;HNRNPH2;KHDRBS3;SRPK1;GRSF1;FUS;RPS26;TMBIM6;YTHDC1;HNRNPLL;PTBP1;RBM22;TRA2B;RBM20;FAM50A;FASTK;HNRNPF;MBNL2;ZPR1;PRX;ERN1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.23133641362022045,-0.8957324121281487,0.7239583333333334,0.8538354779840356,1.0,13/88,9.46%,CST3;DAB2IP;SERPINE2;RPS3;RACK1;CALR;IGFBP5;TOB1;BAG6;GAPDH;YBX1;EDN1;DNAJC1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3373323816599887,-0.8957093340212192,0.618860510805501,0.8532829376242456,1.0,3/17,7.65%,FERMT2;PTPRC;HNRNPU
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24207991333639622,-0.8955888959426741,0.6738544474393531,0.8529555842286722,1.0,27/80,22.25%,MAP3K5;THBS1;GAS6;KLF4;NGF;CTSD;TNFSF10;NOD1;CD44;VEGFA;SOX7;NDUFA13;RPS6KA1;GPER1;REST;MT3;BCAP31;CARD16;RAF1;ARL6IP1;SOX2;FOXL2;AKT1;ACVR1C;CYCS;CDKN2D;CASP1
prerank,negative regulation of immune system process (GO:0002683),0.3690629720809329,0.895145379789061,0.5745098039215686,0.9184286659274481,1.0,4/16,9.75%,HOXA7;FCRLB;PDCD1;IL17D
prerank,focal adhesion assembly (GO:0048041),-0.31539067005094135,-0.8949609053625214,0.6198019801980198,0.8537124658572677,1.0,7/21,15.08%,THSD1;ACTN1;FERMT2;BCR;PEAK1;WHAMM;RCC2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3773903441369959,0.8947194521050752,0.6072961373390557,0.9186060120736511,1.0,5/14,16.89%,LHPP;ADSL;GMPS;ADK;PFAS
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3286473876368467,-0.8946299749527794,0.6167664670658682,0.8538779774710799,1.0,5/20,11.70%,PPIA;PPWD1;PPIE;PPIB;NKTR
prerank,RNA transport (GO:0050658),-0.24505842838061184,-0.8945189130516067,0.6936708860759494,0.85351344037605,1.0,36/71,35.96%,RBFOX1;SRSF2;RFTN1;TGFBR2;SRSF1;YBX1;SRSF5;DDX39B;ZFP36L1;SRSF9;RBM8A;RNPS1;SRSF6;RTRAF;CKAP5;THOC3;MAGOH;FMR1;POM121;THOC6;EIF4E;THOC2;NUP153;EIF4A3;KIF5C;SRSF7;ALYREF;ATXN2;ZFP36;ZC3H11A;DHX38;U2AF1L4;CHTOP;HNRNPA1;SRSF3;NCBP2
prerank,negative regulation of protein transport (GO:0051224),-0.3042126667539109,-0.8935728565942349,0.6234817813765182,0.8549178769431857,1.0,11/25,35.14%,CSK;RHBDF2;NDFIP2;RSAD2;CYP51A1;NDFIP1;SNX3;PPM1F;HMGCR;PKDCC;DRD3
prerank,steroid catabolic process (GO:0006706),-0.3912184294902885,-0.8933493530350034,0.6039783001808319,0.8547814294754986,1.0,3/10,17.70%,SPP1;YWHAH;HSD11B1
prerank,regulation of receptor internalization (GO:0002090),-0.2791751208102819,-0.8929438588047833,0.6462882096069869,0.8550298300547048,1.0,15/35,21.02%,SFRP4;RIN3;ARRB1;ARF1;VEGFA;CD63;ANKRD13A;PICK1;MKLN1;GREM1;ANKRD13B;ARRB2;INSR;FMR1;ATAD1
prerank,nuclear export (GO:0051168),0.2639451369503563,0.8927840909669033,0.6451612903225806,0.9222184333188054,1.0,3/80,1.72%,RANBP3L;ATXN1;PHAX
prerank,cellular response to virus (GO:0098586),-0.28780813543095257,-0.8925902982592042,0.640495867768595,0.8552420912704904,1.0,12/30,26.71%,HSP90AA1;ARF1;CHUK;IFIH1;GBF1;ZC3H12A;EIF5A;FMR1;MAPK11;BAX;VWCE;CXCL10
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.4003921133967644,0.8924310588419943,0.5806451612903226,0.922259631887259,1.0,1/12,1.28%,BMP7
prerank,negative regulation of ion transport (GO:0043271),0.3321062735311897,0.8920326213023093,0.5965583173996176,0.9223770772634557,1.0,3/24,4.13%,WNK4;NEDD4;SYT11
prerank,phosphatidylserine metabolic process (GO:0006658),0.31144730168535284,0.891851232808369,0.5992438563327032,0.9220086865232042,1.0,8/32,18.18%,OSBPL8;PLA2G10;SLC27A1;PLA2G4B;PLA2G12A;OSBPL10;ABHD12;ABHD16A
prerank,lysosome organization (GO:0007040),0.30566081714629356,0.8916598987594937,0.6226765799256505,0.9216875023581761,1.0,6/36,6.91%,HOOK2;ABCA1;TPP1;LRRK2;ACP3;ATP10B
prerank,cellular response to alcohol (GO:0097306),0.3016677945823986,0.8914243113543332,0.6179001721170396,0.9214703187155246,1.0,3/42,3.74%,ADCY5;ADCY1;GRAMD1C
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3644300759502835,-0.8910918138515751,0.639763779527559,0.8579236382455232,1.0,4/13,21.23%,MGLL;DGAT1;PLA2G4A;ABHD6
prerank,positive regulation of lipid localization (GO:1905954),0.4080421054491504,0.8910861314577708,0.5948827292110874,0.9215008846988832,1.0,5/11,22.08%,PLA2G10;IKBKE;PLIN5;HILPDA;NFKB1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.34047933995484414,-0.8910505290310949,0.6279527559055118,0.8574101720845664,1.0,9/16,33.54%,SMCHD1;UBQLN4;POLQ;SHLD3;RMI2;CGAS;RIF1;SHLD2;HELB
prerank,response to purine-containing compound (GO:0014074),-0.34026166756553344,-0.8910300223728371,0.6312625250501002,0.856861700786437,1.0,10/17,34.89%,ABCC9;TRPC3;RYR2;VGF;DGKQ;STAT1;TRPM2;P2RY1;P2RX7;RYR1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.29892031533586283,0.8910146145594858,0.631484794275492,0.9209145311128001,1.0,4/40,5.48%,PID1;BCL2;SPART;LRRK2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3334899284088492,-0.8907217410731081,0.6020833333333333,0.8569145811895088,1.0,6/18,14.23%,SHANK3;PTK2B;CACNG3;NRXN1;RELN;CACNG2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.35625582140719075,0.8903799656802585,0.6,0.9215714510756681,1.0,3/19,6.76%,WNT4;SCX;IL6
prerank,synaptic vesicle exocytosis (GO:0016079),0.30065234447137246,0.8903313708753501,0.6079447322970639,0.9209189620285736,1.0,1/40,0.06%,UNC13C
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3135984350740568,0.8900965797268823,0.6283662477558348,0.9207143357870136,1.0,4/32,6.79%,AUTS2;AVIL;ABI2;ENPP2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.37216209147655704,0.8899963558191564,0.6029411764705882,0.920193056008292,1.0,3/13,12.86%,ARID1B;ZMIZ1;ZMIZ2
prerank,regulation of humoral immune response (GO:0002920),0.2968704011690458,0.8898885931868282,0.6171735241502684,0.9196763016504315,1.0,7/44,11.25%,PROS1;CXCL13;C2;CFH;VTN;C8B;C8G
prerank,regulation of actin filament-based movement (GO:1903115),0.40713467724795904,0.889802464830722,0.5831578947368421,0.9191207396530479,1.0,2/10,3.96%,PDPN;ANK2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3692214840280358,-0.8890028079675696,0.6140350877192983,0.8601140324324213,1.0,5/12,32.53%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,positive regulation of telomere maintenance (GO:0032206),-0.28634997902028864,-0.8888952444620664,0.6318181818181818,0.8597639712216477,1.0,4/31,10.52%,NEK7;GNL3;PPP1R10;MAP2K7
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3053955680418631,-0.8885770401721732,0.6443514644351465,0.8598898416599954,1.0,10/22,26.70%,CALM1;ATP1B1;VMP1;RYR2;CALM2;STAC3;JPH2;CALM3;HAP1;CASQ1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.3953520596081824,0.8885712912185237,0.5795918367346938,0.921179424784015,1.0,1/11,1.07%,PPARA
prerank,negative regulation of protein processing (GO:0010955),-0.3709413885644072,-0.8883055493017901,0.6254901960784314,0.8598553598115796,1.0,2/12,3.49%,THBS1;SERPINE2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.36110426156910447,-0.8880979212610092,0.6254826254826255,0.8597064815779141,1.0,5/13,25.17%,EPS8L2;EPS8;PLEKHM1;P2RY12;HRAS
prerank,replication fork processing (GO:0031297),0.3004242106683505,0.8880883253716537,0.6140035906642729,0.9215545489219579,1.0,15/38,23.30%,BLM;BRCA2;ZGRF1;RTEL1;BOD1L1;PRIMPOL;MRE11;CENPX;WRN;RAD51;CDK9;SAMHD1;ETAA1;SMARCAL1;THOC1
prerank,protein catabolic process (GO:0030163),0.28036766713173045,0.8875311476639173,0.6215277777777778,0.9220220873878551,1.0,13/59,14.75%,ADAMTS9;PRKN;CLPX;TPP1;FBXO44;LAMP2;SIAH2;FBXO6;CUL4B;NGLY1;RAB12;TRIM24;HTRA2
prerank,dephosphorylation (GO:0016311),0.2424382589977633,0.8874663185773429,0.6731927710843374,0.9214232438510274,1.0,17/147,7.48%,PTPN13;PXYLP1;PLPP3;LHPP;PPM1M;PTPN4;DUSP10;PPM1E;CDC14B;PTPRA;MTMR3;PTPN9;EPHX2;SGPP1;ACP3;PTPRD;PTEN
prerank,positive regulation of lyase activity (GO:0051349),-0.3488665833105724,-0.8873817505714716,0.622680412371134,0.8606720949407692,1.0,6/14,17.04%,NOS3;ISCU;CACNA1C;NOS1;NF1;ORAI1
prerank,actin crosslink formation (GO:0051764),0.38297991698482975,0.8872320475099812,0.58004158004158,0.9212210003556159,1.0,3/12,6.45%,DPYSL3;BAIAP2;BAIAP2L2
prerank,hyaluronan catabolic process (GO:0030214),-0.334717430971879,-0.8871900278962794,0.6283924843423799,0.8605328966777003,1.0,6/18,8.91%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,pinocytosis (GO:0006907),-0.38307224136183193,-0.8870864362598023,0.6305970149253731,0.8601585316509187,1.0,2/10,5.70%,CARMIL1;DOCK2
prerank,positive regulation of myelination (GO:0031643),0.3933321504686893,0.887062033192099,0.5882352941176471,0.9208554095049377,1.0,4/11,13.79%,PARD3;ITGAX;CST7;DICER1
prerank,endomembrane system organization (GO:0010256),-0.2054324263875117,-0.8865521421790434,0.778125,0.8606884551911624,1.0,61/178,28.37%,SPTBN1;ATP8B1;SYNE1;REEP3;CAV2;REEP5;LYSMD3;CHMP2B;VMP1;TMED5;ALS2CL;SMPD4;LEMD2;TMED2;SRGN;DYSF;TOR1B;LMAN2;LAMTOR1;USP50;RAB1A;NSFL1C;DNM1;VPS18;BNIP1;LMAN2L;TMED10;TMED3;HOOK1;ATL2;TLCD2;PRKD1;TRIP11;GBF1;VPS11;SEC16B;USP8;VPS51;SUN1;SPTSSB;ANK3;CTDNEP1;VAPA;EXOC8;CLASP2;TMED7;HUWE1;OTOF;SYP;RAB2A;SEC16A;SYNGR2;ANXA8L1;ANXA8;PI4K2B;RNF112;FBXW8;SEC31A;ATL3;RNF26;VPS33B
prerank,regulation of T cell proliferation (GO:0042129),-0.2527122124965307,-0.8865380957627601,0.6903073286052009,0.8601233893152345,1.0,14/61,23.85%,TFRC;SLC7A1;NCK1;PTPRC;TNFRSF21;TNFRSF1B;NCK2;CD274;IL15;JAK3;NCKAP1L;SDC4;CEBPB;CD80
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.27212567503804064,-0.8864005661196857,0.6506849315068494,0.8598078360384585,1.0,13/38,23.23%,PTPRJ;PPP2R5C;RACK1;PLEKHA1;XDH;GPER1;OTUD3;SH2B3;ARRB2;NOP53;AKT1;HYAL2;TRIB3
prerank,hexose metabolic process (GO:0019318),-0.2793138788408658,-0.886082341007892,0.6484018264840182,0.8599028838961548,1.0,15/39,30.91%,APOD;PPARD;HECTD4;HK1;FUCA2;ALDOA;ALDOC;GALT;AKR1A1;FUOM;SLC37A4;GALM;DCXR;GDPGP1;PMM1
prerank,osteoclast differentiation (GO:0030316),-0.3095184460771402,-0.8859887245892789,0.6340996168582376,0.8595340857799281,1.0,3/22,6.65%,FOXP1;SBNO2;TNFRSF11A
prerank,signal transduction in response to DNA damage (GO:0042770),-0.25906676111140853,-0.8856496869448945,0.6705069124423964,0.8596453293485263,1.0,17/49,30.01%,ACER2;TIPRL;CHEK2;SESN2;BCL3;DONSON;RAD17;USP28;RAD9A;ATR;GADD45A;DOT1L;E2F7;CHEK1;BID;USP10;NDRG1
prerank,regulation of cation transmembrane transport (GO:1904062),0.31835235502791437,0.885177764487189,0.6223091976516634,0.9242402173421344,1.0,4/29,6.48%,KCNIP3;SNTA1;CACNA1D;DLG1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.32939765962224843,0.8841876917875827,0.6017857142857143,0.9256425652796368,1.0,4/24,7.80%,JARID2;RBBP4;RBBP7;MTF2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.34856726145068573,-0.8841352044434613,0.6284046692607004,0.8623444332170751,1.0,7/14,38.65%,TFRC;KMT5C;SHLD3;RIF1;SHLD2;KMT5B;CD226
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.40322685875496833,0.8839727833418386,0.5948103792415169,0.9253960119293135,1.0,2/10,4.71%,BMP7;ARHGAP12
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.27144172772327163,-0.8839282993379025,0.6440677966101694,0.8621688776358424,1.0,16/39,23.90%,RAB3C;MIA2;TANGO6;COPG1;OLFM2;RAB3B;SCG2;CANX;TMEM167A;MTTP;PREB;TVP23A;RAB8A;NECAB3;RAB8B;RAB3A
prerank,camera-type eye morphogenesis (GO:0048593),0.396044691422604,0.883900780110673,0.6052060737527115,0.9247958890270169,1.0,4/10,15.57%,SHROOM2;KDM2B;IFT122;SKI
prerank,defense response to bacterium (GO:0042742),0.25111704921698785,0.8837723727972777,0.6511254019292605,0.9243160860135777,1.0,13/105,12.82%,COLEC12;GSDMA;LTF;CXCL13;SLAMF8;ANXA3;IL6;OPTN;GSDMD;PGLYRP3;MR1;SERPINE1;S100A9
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.28146288841851586,-0.883696717228542,0.6616379310344828,0.8621016962585736,1.0,20/35,40.80%,SMUG1;RPA1;OGG1;NEIL1;POLE;POLD3;POLB;NTHL1;POLD1;POLL;LIG3;RFC5;RPA3;FEN1;RPA2;XRCC1;RFC2;POLG;UNG;PCNA
prerank,mitochondrial gene expression (GO:0140053),-0.267572020581016,-0.8835471425552497,0.6577669902912622,0.8618322836974671,1.0,10/42,25.00%,LARS2;TFB2M;NDUFA7;MRPS14;MRPS16;MRPL23;MRPS28;MRPS2;MRPS11;MRPL57
prerank,chromosome organization (GO:0051276),0.25561060071930564,0.8833124021191527,0.6533742331288344,0.9246012965959901,1.0,16/99,12.76%,TCF7L2;SATB1;TOP2B;HDAC8;DDB2;SOX1;MTHFR;SETD7;TCF7L1;MTF2;AXIN2;LATS1;ABL1;HDAC1;CUL4B;EZH1
prerank,regulation of phosphorylation (GO:0042325),-0.22054908203247953,-0.8831747164120829,0.7267441860465116,0.8620901459427857,1.0,36/120,22.02%,FN1;FNIP2;ITGA6;THBS1;PTK2;HSPB1;CORO1C;IKBKB;CCDC88A;APP;EMP2;ZBTB7A;SESN2;NLRC5;CDKN1B;OGT;KCTD20;RAD17;CADM4;NUP37;CCDC88C;MIF;NUP54;NUP85;PSEN1;INHA;PRKRIP1;NOP53;ANG;NUP133;BMP4;NCKAP1L;POM121;EIF6;CDKN1A;CDKN2D
prerank,development of primary male sexual characteristics (GO:0046546),0.3088813593414946,0.8827883465657553,0.6411657559198543,0.9250328132729356,1.0,3/34,5.73%,WNT4;KIT;LRP2
prerank,monocyte chemotaxis (GO:0002548),0.3113551874324752,0.8827618264843127,0.6143911439114391,0.9243419936099408,1.0,5/32,10.07%,ANXA1;IL6;FOLR2;CCL19;CCL4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.23863533653774902,-0.8825078440992625,0.7389033942558747,0.8629369563224506,1.0,31/72,36.62%,UBB;UBC;RPS27A;DDB1;RBX1;RPA1;OGG1;UBA52;POLK;RNASE4;ZC3H12A;EDC3;POLD3;POLD1;GTF2H2;EDC4;XPA;ERCC5;RFC5;ERCC3;PNRC2;GTF2H5;RPA3;ISG20;DNA2;FEN1;RPA2;MEI4;DCP1A;RFC2;DNASE1L1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3237203053866069,-0.8823230636728085,0.6238003838771593,0.8627501239482253,1.0,2/18,3.32%,FTH1;DAB2IP
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3261709065886512,0.8822686549593823,0.6083788706739527,0.9246888778859954,1.0,1/25,0.34%,LEPROT
prerank,generation of neurons (GO:0048699),0.2326402275401876,0.8805543729063561,0.7230320699708455,0.9276974371476219,1.0,21/190,10.68%,DCDC2;AUTS2;WNT4;WNT6;ASCL2;IL1RAPL1;NDNF;PCSK9;ARTN;SDCCAG8;SH3RF1;PTPRD;WNT5B;EN1;RYK;YTHDF2;PAFAH1B1;TUBGCP2;IRX1;ATOH8;NEUROD2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.31308476351023823,-0.8803787652184935,0.6369426751592356,0.8663887660397223,1.0,4/24,3.91%,ACVRL1;DACH1;RPS3;BMPR2
prerank,regulation of cholesterol storage (GO:0010885),-0.3411059399453206,-0.8797101427483474,0.6533066132264529,0.8672461768850388,1.0,11/15,30.27%,SCARB1;PPARD;SREBF2;EHD1;NR1H2;ABCG1;NR1H3;TTC39B;TREM2;LPL;PPARG
prerank,negative regulation of T cell differentiation (GO:0045581),0.40022998591282216,0.8796710800222413,0.6058091286307054,0.9288840659482838,1.0,3/10,13.31%,CTLA4;GLI3;LAG3
prerank,cGMP biosynthetic process (GO:0006182),-0.3886072156496907,-0.8793381173404807,0.6320754716981132,0.8674506133732787,1.0,2/10,4.49%,GUCY1B1;GUCY1A1
prerank,secretory granule organization (GO:0033363),0.41033473651425256,0.87890526684889,0.6122881355932204,0.9298567585720608,1.0,3/10,10.95%,DTNBP1;ABCA1;F2RL3
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21760432688633058,0.8787662165950032,0.7645569620253164,0.9294193575879635,1.0,77/336,17.78%,STXBP4;BCL2;FANCA;UBE2E2;RAD51B;ATRIP;ASH2L;MAP2K6;BAZ1B;DDB2;PLK5;RAD51C;CTLA4;MRNIP;UFL1;INIP;PDS5B;PSME4;SETD7;PARP4;XRCC5;SLF1;BLM;NEK4;WDR48;CDK1;CHCHD6;UVRAG;BCL2L2;FBXO6;IRF3;UBA7;MBD4;PDS5A;ABL1;PRKDC;EPHA2;RTEL1;RBBP6;ZBTB38;IKBKE;MAPKAPK2;CUL4B;CRY1;LIG1;INO80;BOD1L1;MRE11;USP45;CIB1;FANCF;APEX1;BATF;MNAT1;CEP63;UBE2A;HTRA2;BABAM2;WRN;FANCC;BRSK1;RAD18;RAD51;LYN;NIPBL;PML;PHF1;MACROD1;ZDHHC16;REXO4;BACH1;TAOK3;RPAIN;TRRAP;XPC;DTX3L;TAOK2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.36227685773081353,-0.8787226331328328,0.6363636363636364,0.8682046878636169,1.0,6/12,34.76%,MCM4;GINS4;MCM5;MCM6;GINS2;CDC7
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.2927487729656567,-0.8785494459132764,0.6461864406779662,0.867992033614633,1.0,8/27,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;XYLT1;VCAN;CHSY3
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.32664570042742147,-0.8774008851918949,0.6281512605042017,0.8698072470426275,1.0,9/18,31.56%,APOD;GSK3B;CHP1;MDFIC;CTNNA1;OTUD7B;CABP1;SIN3A;MFHAS1
prerank,neutrophil chemotaxis (GO:0030593),-0.25178044174611736,-0.8773217482932993,0.6864608076009501,0.8694126357859858,1.0,7/53,10.16%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,maintenance of protein localization in organelle (GO:0072595),-0.321932796058722,-0.8773010178534668,0.6192384769539078,0.8688671948998662,1.0,9/19,23.68%,HK1;HNRNPU;ARL2BP;HSPA5;BCL3;PINK1;AKT1;SKP1;CHCHD10
prerank,mitochondrial transport (GO:0006839),-0.2603480441259208,-0.877223374258292,0.6811224489795918,0.8684357540129157,1.0,24/53,30.53%,HSP90AA1;FBXO7;TOMM20;BCL2L1;ABCB10;TOMM22;TMEM14C;TIMM9;TIMM10B;TIMM13;BCAP31;TIMM22;SLC25A4;TOMM7;MFN2;BCS1L;SPG7;FLVCR1;FIS1;TIMM44;TSPO;AIP;TOMM34;PMAIP1
prerank,piRNA metabolic process (GO:0034587),0.35267520723436313,0.876672142760835,0.607645875251509,0.9332749415500823,1.0,19/19,64.77%,MYBL1;DDX4;PIWIL4;TDRD9;TDRD12;PIWIL2;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;EXD1;TDRKH;TEX15
prerank,regulation of interferon-gamma production (GO:0032649),-0.24084596228073032,-0.8766691836201256,0.7032710280373832,0.8689764324897518,1.0,24/71,30.53%,PDE4D;SLC7A5;GAS6;IL1R1;CYRIB;ISG15;HSPD1;CD47;NR1H4;LAPTM5;CD274;ZC3H12A;INHA;TRIM27;TXK;SLC11A1;CCR2;VSIR;IL12RB2;TLR7;TLR4;RASGRP1;FADD;ZFPM1
prerank,ubiquinone biosynthetic process (GO:0006744),0.36912866545896894,0.8763598049755514,0.6209677419354839,0.9331885127717011,1.0,5/15,11.44%,FDXR;COQ10A;NDUFA9;COQ8B;COQ6
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.38587195348613906,0.8760198010288219,0.6302186878727635,0.9332089789092476,1.0,1/12,1.07%,PPARA
prerank,rRNA 3'-end processing (GO:0031125),0.39050117244253485,0.8759624561610344,0.6063157894736843,0.9325807376714591,1.0,5/10,18.61%,ERI3;ERI2;EXOSC8;ERI1;EXOSC3
prerank,P-body assembly (GO:0033962),-0.3720026333484615,-0.8759422645100935,0.6402321083172147,0.8698579656703499,1.0,7/12,35.30%,PATL1;LIMD1;EDC3;ATXN2;PATL2;DYNC1H1;RC3H1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.23753695016182994,-0.8757850593948604,0.6957605985037406,0.8695989267152286,1.0,26/69,29.88%,STT3B;TRIM25;HSP90B1;BAG6;DERL1;HSPA5;HERPUD1;TRIM13;ERLIN2;DNAJC10;WFS1;AUP1;RNF5;DNAJB9;FBXO17;TMEM129;VCP;RNF103-CHMP3;UBE2J1;YOD1;SYVN1;FBXO2;RHBDD2;STUB1;FOXRED2;SEC61B
prerank,digestive tract morphogenesis (GO:0048546),0.3714713228313059,0.875666691313922,0.5943204868154158,0.932474906842381,1.0,3/14,10.10%,FGFR2;PDGFRA;BBS7
prerank,high-density lipoprotein particle assembly (GO:0034380),0.39980554053878214,0.8750539000998253,0.6021505376344086,0.9330578998059051,1.0,2/10,13.56%,ABCA1;PRKACB
prerank,positive regulation of cellular respiration (GO:1901857),-0.36976783165013094,-0.8746233085754256,0.6231884057971014,0.8714703805633107,1.0,8/11,40.38%,ISCU;PINK1;VCP;IFNAR1;PRELID1;PARK7;IFNLR1;IL4
prerank,cell differentiation in hindbrain (GO:0021533),-0.3708236211015189,-0.8742680364923634,0.6320754716981132,0.8716158854434207,1.0,7/11,40.73%,KNDC1;GRID2;AGTPBP1;FAIM2;NOG;PROX1;OPHN1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.32497246286404374,0.8736640401412419,0.6078431372549019,0.9352908371847991,1.0,7/27,13.28%,CTPS1;CTPS2;NUDT13;TYMS;TXNRD1;AK1;NME4
prerank,chemical homeostasis (GO:0048878),-0.24138198565111996,-0.8735447714435104,0.7153284671532847,0.8725257936979784,1.0,14/61,17.52%,SLC4A10;NEDD4L;WNK3;ACOX3;AQP4;AQP11;SLC4A8;SLC4A2;NR1D2;TLCD2;VGF;ATP13A2;WNK2;CLN8
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3019909816472858,0.8734545141683464,0.6360360360360361,0.9349740282862316,1.0,2/32,1.89%,CEMIP;PDPK1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.347361311707406,-0.8731072417207608,0.6556016597510373,0.8728587598892136,1.0,4/14,11.27%,ARHGDIB;CALR;VEGFA;YTHDF3
prerank,respiratory electron transport chain (GO:0022904),-0.3439844942660658,-0.8728450918349661,0.66015625,0.8728299047281134,1.0,3/14,10.86%,PPARGC1A;NDUFA5;GPD2
prerank,endochondral bone morphogenesis (GO:0060350),-0.37048489232527326,-0.8726423813606345,0.6332703213610587,0.8726537671252299,1.0,2/11,3.91%,MEF2C;BMPR2
prerank,response to organic cyclic compound (GO:0014070),0.2817828146697696,0.8724574772473319,0.6501706484641638,0.9363878052397422,1.0,6/52,7.77%,FGFR4;IL18;ANXA1;STAT5B;LRRK2;STRN3
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3160980629957147,0.8724520784205878,0.6552380952380953,0.9356531563584288,1.0,4/28,6.89%,ADCY1;EPHA4;PTN;ARC
prerank,positive regulation of transport (GO:0051050),-0.23133109216369385,-0.8722322730818228,0.7774725274725275,0.8729119834643211,1.0,37/85,29.77%,ACTB;GAS6;NEDD4L;RAB27A;GATA2;CALR;DOCK2;GSK3B;CHP1;HIP1R;C2CD5;LMAN2;CD47;SGK1;ACSL3;IL15;FMR1;NUMA1;SLC11A1;MLC1;NR1H3;DLL1;SPAG5;PLAA;CAPN10;FCGR2B;CHCHD10;BAX;SYNGR3;CHRM1;DOC2B;TREM2;BID;IL2RG;ABCA7;TUB;AHSG
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37059116145638027,0.8719301870304543,0.5896414342629482,0.9360492479453625,1.0,4/13,12.88%,LRRK2;NUPR1;TMEM39A;FEZ1
prerank,positive regulation of cyclase activity (GO:0031281),-0.33483391798938517,-0.8719046803538024,0.6391752577319587,0.8729774601195163,1.0,7/14,21.48%,NOS3;MAPK8;CACNA1C;NOS1;NF1;ORAI1;MAPK3
prerank,response to growth factor (GO:0070848),-0.26236677204433567,-0.8718643278903108,0.6574712643678161,0.8724781283773845,1.0,13/41,21.93%,ACVRL1;KLF4;RACK1;BMPR2;TGFBR2;CTNNB1;CPNE3;NOS1;ACVR1;SOX2;AKT1;ACVR1C;HDAC6
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.23396956934149926,-0.8717462799648033,0.7035040431266847,0.872131668342315,1.0,32/80,29.31%,NSF;COPG1;ARF5;KIF26A;TMED2;LMAN2;RAB1A;BNIP1;PICK1;ARFGAP2;TMED10;TMED3;GBF1;SCYL1;TAPBP;KIF3B;PITPNB;RAB1B;KIF11;KIF15;TMEM115;TMED7;KIF4A;RAB6B;USE1;KLC2;KDELR3;COPA;KLC1;ARF3;KIF23;DNAJC28
prerank,proton transmembrane transport (GO:1902600),0.30042121918387726,0.8717319864900631,0.6370235934664247,0.9357299791900215,1.0,5/36,13.20%,ATP1A2;ATP6V0D1;ATP6V0E1;SLC36A2;DMAC2L
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2738396037417404,-0.8717174089815461,0.6460554371002132,0.8715996967802183,1.0,8/38,13.92%,KCNJ2;KCNMA1;FHL1;FLNA;KCNQ1;KCNMB4;KCNN2;KCNJ15
prerank,regulation of T cell activation (GO:0050863),-0.2619907877637184,-0.8716269753863812,0.7017167381974249,0.8712001190580948,1.0,24/42,43.82%,TNFRSF1B;CYRIB;DUSP3;HSPD1;CD47;LAPTM5;JAK3;THY1;METTL3;CCR2;CCL2;LAX1;IL4I1;PTPN22;GPNMB;PRELID1;CCL5;KAT2A;VTCN1;CRTAM;LCK;CCDC88B;TNFSF11;TNFSF9
prerank,plasma membrane organization (GO:0007009),-0.24305824919887237,-0.8716130150235123,0.7054455445544554,0.870646932283133,1.0,13/61,16.27%,SPTBN1;AHNAK2;NSF;FNBP1L;PACSIN2;CAVIN2;MYH9;DYSF;BIN1;WHAMM;ABCD2;TLCD2;STX2
prerank,mesoderm formation (GO:0001707),-0.32543281374228406,-0.8715278433447479,0.6626016260162602,0.8702500355786218,1.0,3/17,3.91%,ITGB1;ITGB4;BMPR2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3628893853341101,0.8712621071210361,0.6326129666011788,0.936085306776021,1.0,3/16,6.51%,IGF1R;MTRF1;BNIP3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2878275588412542,0.8707542182342723,0.6222627737226277,0.9364465051250251,1.0,4/42,10.07%,OXSR1;CXCL13;CCL19;CCL4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3379849365257408,0.8704838290521844,0.6273291925465838,0.9362491389911091,1.0,3/21,8.73%,RAD51B;RAD51C;CDK1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.370336452139362,0.8702603548490093,0.6178861788617886,0.9359707023461135,1.0,3/12,9.66%,CDC14B;PTEN;GOLGA2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3325105595481363,0.8698395103102966,0.6447876447876448,0.9361713480649299,1.0,3/20,12.50%,FDXR;HSD17B10;AKR1B1
prerank,negative regulation of biosynthetic process (GO:0009890),0.3540525800701625,0.8696955168351771,0.5983935742971888,0.9357316173478345,1.0,5/16,17.83%,PPARA;IL6;SLC30A10;ABCB7;TRAP1
prerank,regulation of interleukin-17 production (GO:0032660),0.3067599520620931,0.8696896281719575,0.6459854014598541,0.9350048550776144,1.0,4/31,8.61%,IL18;SPHK1;IL6;SLAMF6
prerank,epidermal cell differentiation (GO:0009913),-0.2636804638511843,-0.8694693398418183,0.6792452830188679,0.8739206829534749,1.0,9/41,20.65%,CLIC4;JAG1;CTNNB1;BCR;WNT16;GLI1;ADAM9;DSP;USH2A
prerank,positive regulation of calcium ion import (GO:0090280),0.368798378709815,0.8692766139754244,0.6120331950207469,0.9351374716699198,1.0,1/12,2.95%,PDGFRB
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.2403847474091567,-0.8692526381084664,0.7096774193548387,0.8738012772811614,1.0,34/63,42.61%,RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;FBXO31;CDKN1B;RPS27L;TNKS1BP1;CDK2;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX;RFWD3;SFN;PIDD1;AURKA;E2F8;RPA2;CCND1;CNOT1;CNOT9;PLK3;CRADD;CCNB1;PRMT1;PCNA;CDC25C;TFDP1;TRIAP1
prerank,axonal transport (GO:0098930),-0.27268443591170033,-0.8690367103989841,0.6847826086956522,0.8736400365218607,1.0,13/36,28.09%,AP3S1;BLOC1S2;SOD1;AP3M2;KIF1A;TMEM108;KIF3B;NEFL;DCTN1;KIF4A;HAP1;KIF1B;SNAPIN
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.32105529720682424,-0.8689401274332016,0.6401590457256461,0.8732436959781998,1.0,10/19,35.90%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR7;TLR4;DHX9;MAVS;TLR8
prerank,positive regulation of T cell activation (GO:0050870),-0.24250396995691242,-0.8689279699349648,0.7263922518159807,0.8726928619492019,1.0,17/62,24.04%,TFRC;SLC7A1;NCK1;PTPRC;CYRIB;XBP1;NCK2;HSPD1;CD81;CD47;CD274;IL15;JAK3;THY1;NCKAP1L;CD80;CCR2
prerank,protein N-linked glycosylation (GO:0006487),-0.23876447639365206,-0.8687160723433395,0.7475961538461539,0.8725020027679439,1.0,27/66,31.22%,ST6GAL1;FUT8;MAGT1;STT3B;KRTCAP2;SLC39A8;MCFD2;RPN1;MGAT1;ALG11;ST3GAL1;TMEM165;DDOST;MGAT5;ALG5;ALG14;MGAT2;ALG1;ALG8;DPM1;UBE2J1;DOLPP1;MGAT5B;ALG3;PMM1;DPAGT1;UGGT1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.2523682163859325,-0.8686350052405508,0.742014742014742,0.8720892699996537,1.0,18/50,24.60%,ACTN4;RPS3;NOD1;LIMS1;PDCD4;APP;RHOA;RTKN2;IFI35;TERF2IP;LAPTM5;NR3C2;IRAK1;PTP4A3;RELA;AGER;LRRC19;TRIM44
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.28434342938111473,-0.8684437842470166,0.6556291390728477,0.871900564707065,1.0,6/29,13.90%,CAV1;THBS1;TNFSF10;PAK2;GPER1;RET
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3447132549922657,0.8682992182064663,0.6260330578512396,0.9364765666645207,1.0,6/18,17.83%,PRKN;NOL3;NME5;NONO;HTRA2;TRAP1
prerank,apical protein localization (GO:0045176),0.3926266624341845,0.868289007466643,0.6157112526539278,0.9357495162373117,1.0,2/10,2.90%,SHROOM3;SHROOM2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3320815535424481,0.8674573212866343,0.6140684410646388,0.9368382439699493,1.0,4/20,10.08%,LHPP;AMPD3;ADSL;GMPS
prerank,negative regulation of cholesterol transport (GO:0032375),0.3935093453103322,0.8671428869566663,0.6141414141414141,0.9367980347471777,1.0,2/10,9.15%,PLA2G10;APOC1
prerank,regulation of centrosome duplication (GO:0010824),-0.2862617760299302,-0.8669968932131894,0.6589473684210526,0.8743218135157805,1.0,19/29,35.78%,CHMP5;CHMP2B;PLK2;CEP295NL;CCNF;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CEP295;CHMP4C;VPS4B;CEP131;NPM1;STIL;TMEM67;PKHD1;XRCC3
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.28126651186620577,0.8669659567731977,0.6643835616438356,0.9364311174539279,1.0,13/51,15.68%,FBN1;SMAD6;SPART;LRP2;NBL1;CHRDL1;FSTL3;LEMD3;SMURF2;BMPR1A;FSTL1;SKI;SMAD4
prerank,DNA-dependent DNA replication (GO:0006261),-0.21339247379367726,-0.866882071969293,0.7795031055900621,0.8739594481476259,1.0,58/128,36.86%,UBB;REV3L;UBC;RPS27A;WRNIP1;PSMD13;PSMF1;PSMB10;PSMB6;RPA1;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;TOPBP1;PSME1;UBA52;PSMB3;WDHD1;PRIM1;MCM8;POLA1;CDK2;POLE4;RECQL;PSMD5;POLE;POLD3;POLB;SIRT7;POLD1;PSMD9;PSMB4;GINS4;MCM5;PSMD10;MCM10;RFC5;POLE3;ORC1;TWNK;RPA3;MCM6;PSMA7;GMNN;DNA2;CDC6;GINS2;HELB;RPA2;CDC7;PSMC5;PSMC1;PSMC4;RFC2;CDC34
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21212893521396523,0.8668538394158933,0.8190104166666666,0.935943662681904,1.0,71/366,17.40%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;IGF2;SSBP2;NCOA2;SOX1;PERM1;TCF7L1;ZFP37;SUFU;THAP1;WWC1;WWC2;GPBP1;UBE2L3;GPBP1L1;MTF2;ZKSCAN5;POLR2A;NFIA;ZNF628;BRCA2;MITF;KAT6B;NFYC;NSD1;NUP107;ABL1;ASCC2;ZBTB11;RBBP6;ZBTB38;MYB;RNF14;SOX13;RNF20;PSPC1;NONO;FOXK2;ESCO1;CLOCK;UBE2V1;CREBBP;NLK;PCGF1;SOX12;SMARCA2;ORC3;PATZ1;ZNHIT3;FZD7;PML;PHF1;TCOF1;IGSF1;REXO4;BACH1;OBI1;TSC1;TRRAP;CTR9
prerank,mitochondrial translational termination (GO:0070126),-0.2264407940433581,-0.8665913842711859,0.7554945054945055,0.8739593340434733,1.0,28/88,29.09%,MRRF;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;AURKAIP1;CHCHD1
prerank,positive regulation of ATPase activity (GO:0032781),0.29912032542940725,0.866441329254531,0.644524236983842,0.9360981660751776,1.0,3/41,2.80%,TPM1;ATP1B3;TNNT2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.29769583347161105,0.8660530130226199,0.6591760299625468,0.9362057540906421,1.0,11/36,16.15%,TCF7L2;PLCB1;TNRC6B;TNRC6A;PDE6G;AGO2;FZD2;MAP3K7;NLK;MOV10;GNG2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.24039777875715748,0.8660016210438849,0.6914893617021277,0.935592434963654,1.0,26/128,16.72%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CEP63;CEP164;BRSK1;SKP2;CDKN2B;BACH1;PPP1R12B
prerank,N-terminal protein amino acid modification (GO:0031365),0.3684053723392646,0.8659955095094641,0.6254980079681275,0.934872051961949,1.0,3/14,12.98%,AANAT;NAA35;NAA60
prerank,Golgi to lysosome transport (GO:0090160),-0.3553666975521248,-0.8659791323871101,0.6434108527131783,0.8746263662414355,1.0,3/11,16.12%,LAMP1;EHD3;LAPTM5
prerank,regulation of interferon-beta production (GO:0032648),0.2775551900602242,0.8658348440303985,0.6649122807017543,0.9345076638774338,1.0,10/46,13.91%,CACTIN;NLRC3;POLR3G;TRIM56;RNF135;RNF216;SIRPA;IRF3;TBK1;POLR3C
prerank,GPI anchor metabolic process (GO:0006505),0.31655687485008543,0.8657728477662617,0.6672862453531598,0.9339147389967892,1.0,5/26,12.88%,PIGU;PIGG;PIGV;PIGC;PIGQ
prerank,early endosome to late endosome transport (GO:0045022),-0.31078096174053627,-0.8657321407972046,0.6618852459016393,0.8745654693396522,1.0,6/20,14.88%,EMP2;SNX16;PTPN23;LMTK2;PIK3C3;HOOK1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3016489561826295,-0.8657135019258492,0.6588486140724946,0.8740170575177825,1.0,10/23,25.32%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;PIP4P2;MTMR1;TPTE
prerank,protein glycosylation (GO:0006486),0.23929520362880086,0.8653821345144506,0.6990881458966566,0.9340362936621688,1.0,14/125,8.47%,B3GALT1;ST3GAL3;GALNT18;GALNTL5;LARGE1;B3GNT5;ST3GAL5;B4GALT1;ALG6;MAN1C1;TET1;ALG2;ALG9;GFPT2
prerank,cGMP-mediated signaling (GO:0019934),0.36273816469355963,0.8650783848927157,0.608421052631579,0.9339845126790737,1.0,1/13,0.87%,IRAG1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.35026207027377987,0.8649346982781078,0.6232741617357002,0.9335699129483557,1.0,8/16,20.57%,BLM;SSBP1;WRN;MCM2;RAD51;PURA;MCM7;RECQL5
prerank,regulation of presynapse assembly (GO:1905606),0.34491546408820883,0.8646616519147293,0.6468172484599589,0.9326963089075276,1.0,6/18,18.25%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA
prerank,regulation of presynapse organization (GO:0099174),0.34491546408820883,0.8646616519147293,0.6468172484599589,0.9326963089075276,1.0,6/18,18.25%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA
prerank,lipid droplet formation (GO:0140042),-0.38615316989108117,-0.8646377642603329,0.6633858267716536,0.8757056170381226,1.0,3/10,17.36%,CDS1;BSCL2;AUP1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.37472429135013086,-0.8644729420376948,0.6454545454545455,0.8754426538520741,1.0,3/10,7.71%,KDR;RACK1;MYOC
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.39445536670770687,0.864237067993346,0.602020202020202,0.9328779797332478,1.0,1/10,1.00%,FGFR2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.37347457948621926,0.8641329126618613,0.6462450592885376,0.9323526557998465,1.0,1/14,1.07%,PPARA
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3013012416935461,0.8639402616303213,0.6537102473498233,0.9320243055502718,1.0,9/35,16.29%,ACSS3;HMGCL;BDH1;GCDH;PAM;BDH2;AWAT2;HMGCLL1;HMGCS2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2538023322331845,-0.8638303863546957,0.7239709443099274,0.8761822618046045,1.0,13/49,16.46%,LRCH1;CST3;F11R;DAB2IP;SH3BP4;CHP1;TMED2;NOS1;SLC39A14;ZCCHC9;RCC2;ATP5IF1;NEIL1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.28861175483279305,0.8638267536526313,0.6637168141592921,0.9315564634349166,1.0,9/41,13.05%,IL34;EPHA4;ACE;DLG4;TGFA;AREG;DLG3;GPRC5B;DOK7
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.20924323918005452,0.8638243692605917,0.8236744759556104,0.9308354412137534,1.0,76/497,14.06%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;IGF2BP1;DAPK1;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;PRDM5;ZEB1;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;VGLL4;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;IKZF4;DPF2;GLI3;SFMBT1;NIBAN2;BCOR;TYMS;SALL1;XRCC5;BIRC5;WWP2;RSF1;ZMYND15;TLE1;KAT8;KAT6B;MDM2;MBTD1;SAMD4A;SMURF2;PDS5A;SCMH1;L3MBTL3;ATOH8;HDAC1;TFAP2A;SMARCE1;TFAP2B;FXR1;ZNF568;ZBTB38;MYB;CRY1;SOX13;CBFA2T2;PSPC1;SHMT1;TSPYL2;NONO;FOXK2;SCML4;TFDP2;CLOCK;ZNF148;KDM5C;CDKN1C
prerank,actin filament network formation (GO:0051639),-0.36146859858427816,-0.8635663110890635,0.6539196940726577,0.8761702770774173,1.0,5/11,16.31%,CARMIL1;ACTN1;PLS3;FHOD3;SPIRE1
prerank,mitochondrial membrane organization (GO:0007006),0.30673016465386826,0.8631034119105373,0.6372007366482505,0.9316699491727539,1.0,7/32,11.48%,BCL2;SLC25A31;BNIP3;MAIP1;CHCHD6;MTX1;MTX2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.31366004364945244,-0.8628768338409769,0.6610526315789473,0.8770033892588771,1.0,7/20,23.77%,HSP90AA1;CDC37;BIRC3;OGT;CASP8;PELI1;PDCD6IP
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.22123053649927496,-0.8627755925545788,0.7721518987341772,0.8766260784154937,1.0,28/112,20.22%,PTPRJ;FOXP1;IL33;CD34;THBS1;GAS6;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IRAK3;IFNGR1;CD47;NR1H4;IFIH1;CX3CR1;MIF;ZC3H12A;PSEN1;TIRAP;TRIM27;TYROBP;FRMD8
prerank,membrane depolarization (GO:0051899),0.30456666450819014,0.8615811664572444,0.6501831501831502,0.9341960436729364,1.0,2/32,4.85%,SCN7A;CACNB4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.24939343364357486,-0.861311636467233,0.710955710955711,0.8789982515890074,1.0,13/53,15.79%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.3285552495937198,-0.8607875956296072,0.6481481481481481,0.8794287174407774,1.0,11/16,46.12%,ACACA;FASN;SCD5;ACLY;SCD;HSD17B8;MLYCD;SLC25A1;PPT2;DIP2A;ACSS1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3160915934327335,-0.8606139712080862,0.6646942800788954,0.8791867071955408,1.0,6/18,18.52%,UBB;UBC;RPS27A;TRIM13;UBA52;RNF5
prerank,protein-containing complex subunit organization (GO:0043933),-0.2162571523494248,-0.860586181419558,0.8096590909090909,0.8786484798716709,1.0,31/109,24.37%,SLC2A1;OCLN;LIN7A;PPARGC1A;PTK2B;REPS2;HES1;WIPF1;CAPZA2;SKAP2;ADD2;CARD10;IL1RAP;APC;CD2AP;ST13;CD74;ELOB;TRAF1;FAS;CD40;NUP54;TAPBP;TFAP4;NUP133;NCKAP1L;KPNA3;CAPZA1;CHCHD10;SHANK1;SPG7
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2737413919130901,-0.8604958161901728,0.6659142212189616,0.8782728067378461,1.0,9/33,21.04%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,cell cycle G2/M phase transition (GO:0044839),0.2391231438516298,0.8604354319713965,0.7038167938931298,0.9359464084788491,1.0,26/129,16.72%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;AKAP8L;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CEP63;CEP164;BRSK1;SKP2;CDKN2B;PPP1R12B
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.26314855493142914,-0.8602344746850241,0.6959619952494062,0.8782203622431781,1.0,11/44,17.34%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;RPS6KA1;MT3;CARD16;RAF1;ARL6IP1
prerank,mRNA 3'-end processing (GO:0031124),-0.23488337348891186,-0.8601543185064975,0.779291553133515,0.8777871638191183,1.0,38/78,34.17%,SRSF2;PABPC1;SRSF1;APP;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;CPSF6;RBM8A;RNPS1;SRSF6;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;CSTF2T;PCF11;CSTF2;THOC3;MAGOH;THOC6;THOC2;EIF4A3;LSM11;SRSF7;ALYREF;CSTF1;CPSF4L;TENT4B;CPSF1;ZC3H11A;MTPAP;DHX38;U2AF1L4;CHTOP
prerank,carboxylic acid catabolic process (GO:0046395),0.3813220532111693,0.859905041996789,0.6348884381338742,0.9363789510680296,1.0,3/12,14.34%,ACOT4;RENBP;NPL
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2986927781947851,-0.8597679751139015,0.6796116504854369,0.8779866110477252,1.0,7/22,18.28%,RASSF2;CALM1;PDGFC;VEGFA;TNKS1BP1;CALM2;GREM1
prerank,plasma membrane tubulation (GO:0097320),-0.3425406974111187,-0.8595981816695899,0.638623326959847,0.8777546174982211,1.0,4/13,12.15%,FNBP1L;PACSIN2;CAVIN2;WHAMM
prerank,histone H2A acetylation (GO:0043968),0.34774531595704017,0.8589846036050892,0.622,0.9376204612567448,1.0,1/16,1.41%,BRD8
prerank,negative regulation of neurogenesis (GO:0050768),0.2978822073641971,0.8587518181090033,0.6600719424460432,0.9373534247509372,1.0,5/34,7.48%,APPL2;LRP4;PTN;IL6;PTEN
prerank,response to chemokine (GO:1990868),0.3627317962931508,0.8587344044747945,0.630801687763713,0.9366596504758409,1.0,2/13,3.63%,OXSR1;RIPOR2
prerank,outer dynein arm assembly (GO:0036158),0.36463477235486064,0.858642449914047,0.6211812627291242,0.9361191850009246,1.0,3/14,15.00%,ODAD3;ODAD1;ODAD2
prerank,protein acylation (GO:0043543),-0.2605638707871959,-0.8584649043717663,0.6915887850467289,0.8794792596118569,1.0,9/38,12.48%,ZDHHC14;ZDHHC15;FOXO1;ZDHHC2;ZDHHC7;ING4;PORCN;HHAT;SELENOK
prerank,transcription by RNA polymerase III (GO:0006383),-0.2880563751991767,-0.858183930223529,0.6754966887417219,0.8794350261113194,1.0,12/27,25.43%,IVNS1ABP;BRF1;SNAPC1;ZC3H8;SNAPC4;CRCP;GTF3C1;RO60;GTF3C2;GTF3C4;POLR2L;SNAPC2
prerank,neuron differentiation (GO:0030182),-0.20183501184522656,-0.8580375620416163,0.842443729903537,0.8791539876035452,1.0,21/165,10.77%,MEF2C;PBX3;TGFB2;RUNX1;ACSL4;WNT9A;TENM2;FZD4;VSX1;SOX4;CTNNB1;MET;ATP8A2;TENM4;VEGFA;WNT16;RUNX2;DDIT4;LHX6;XBP1;IER2
prerank,positive regulation of signaling (GO:0023056),-0.2656011402849593,-0.8579242272244714,0.6887417218543046,0.8788145095872705,1.0,16/37,29.52%,NSF;HOMER1;CLSTN2;EDN1;ECE1;KCTD13;PTPN23;CLSTN3;INPP5F;GRIK2;SOX11;CD80;VAMP3;CLSTN1;RIMS2;SYT1
prerank,interstrand cross-link repair (GO:0036297),0.27738529095468434,0.8576117808291462,0.6937086092715232,0.9375480819027302,1.0,16/53,17.88%,FANCA;ATRIP;RAD51AP2;WDR48;FANCI;DCLRE1A;DCLRE1B;FANCB;FANCF;FANCE;FAAP100;CENPX;FANCC;RAD51;ERCC6L2;FAAP24
prerank,regulation of acute inflammatory response (GO:0002673),0.338901098901099,0.8574254646700802,0.6471774193548387,0.9372111290307173,1.0,18/18,66.15%,IL6;OSMR;ADAM8;KLKB1;PTGES;F12;DNASE1L3;C2CD4A;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;CREB3L3;GSTP1;IL4;IL6ST;NLRP3
prerank,neuron remodeling (GO:0016322),-0.372753416080412,-0.8573910207197162,0.6350093109869647,0.879321040414185,1.0,6/10,25.70%,SCARF1;ANKS1A;APP;C1QA;C3;RND1
prerank,mitochondrion disassembly (GO:0061726),0.29726055903024207,0.8567943192383449,0.6606822262118492,0.9377749115459533,1.0,8/34,15.64%,PRKN;WIPI1;BNIP3;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,water transport (GO:0006833),-0.3527971692842816,-0.8563464706238881,0.6673346693386774,0.8808738038327287,1.0,3/12,15.43%,AQP4;AQP11;CFTR
prerank,melanosome localization (GO:0032400),0.3350843577212704,0.8561453865665232,0.6547842401500938,0.9385041477354314,1.0,5/21,14.67%,SHROOM2;ARL6;GPR143;BBS7;RAB11B
prerank,positive regulation of leukocyte migration (GO:0002687),0.3120924023341215,0.8557669050746602,0.6311926605504588,0.9385439428674894,1.0,4/27,8.41%,PTN;IL6;CSF1;MIA3
prerank,negative regulation of coagulation (GO:0050819),0.36754815894606346,0.8555220154658129,0.6481876332622601,0.9383525682832636,1.0,4/14,12.56%,TFPI;VTN;APOH;SERPINE1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3389090663915678,0.8551997101370191,0.6381322957198443,0.93836061383315,1.0,4/19,16.27%,CHRNE;SLC5A7;NQO1;CHRNB2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.3735884455593261,0.8551930548879829,0.6528066528066528,0.9376604953803114,1.0,5/13,16.03%,ATG10;UBA7;UBA3;DESI1;DESI2
prerank,regulation of cation channel activity (GO:2001257),0.24911238182521261,0.855176813225583,0.704,0.936981470874321,1.0,17/89,12.85%,JPH1;DAPK1;DMD;NLGN2;CRHBP;ANK2;CACNB4;CACNG7;DLG1;MMP9;CAMK2D;DLG4;SELENON;SHISA9;ACTN2;GRIA4;DLG3
prerank,response to gamma radiation (GO:0010332),-0.29367742760993787,-0.8549385128731514,0.6593886462882096,0.8830232013934346,1.0,10/24,25.33%,RPL26;CRYAB;MEN1;TRIM13;ATR;LIG4;TLK2;TMEM109;HRAS;TSPYL5
prerank,neurogenesis (GO:0022008),0.28295397880201334,0.8549182661476179,0.6822107081174439,0.9367905005337205,1.0,6/43,7.93%,LPAR1;FAT4;ANXA1;PCSK9;DAGLB;RYK
prerank,mRNA processing (GO:0006397),-0.18656944223408017,-0.8547532471044941,0.9300411522633745,0.8827883876217691,1.0,89/287,29.46%,HSPA8;NOVA2;HNRNPK;PPARGC1A;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;SRSF5;DDX39B;CPSF3;KIN;HNRNPH2;SRSF9;CPSF6;CWC15;RALY;USP39;RBM8A;POLR2C;XAB2;PRPF18;RNPS1;SNRPC;SRSF6;PRPF40B;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;MTREX;HNRNPUL1;YTHDC1;THOC3;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3;TRA2B;CMTR2;THOC6;SNRPG;GTF2H2;SNRNP35;RBM4B;POLR2L;HNRNPF;HNRNPM;USP49;THOC2;ERN1;PUF60;HNRNPD;LSM8;RBM6;EIF4A3;TFIP11;AURKAIP1;SRSF7;ALYREF;ZCRB1;BUD31;ERCC3;CSTF1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3255039923589407,-0.8543109424520327,0.6329365079365079,0.8830975496420398,1.0,3/15,10.93%,GNAL;ADCY3;SYT10
prerank,smooth muscle tissue development (GO:0048745),-0.3704279957862785,-0.85382125294085,0.6764705882352942,0.8835271237323975,1.0,5/10,20.49%,ENG;STRA6;PTCH1;NF1;BMP4
prerank,maintenance of protein location in nucleus (GO:0051457),-0.30972114469847356,-0.8538076941574176,0.6935817805383023,0.882973399882686,1.0,8/20,23.68%,SYNE1;HNRNPU;ARL2BP;BCL3;RANGAP1;SUN1;SKP1;CHCHD10
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.289761880153652,-0.8537115161809026,0.720164609053498,0.8826017551236172,1.0,9/24,26.71%,SLIT2;LGMN;CCN3;CXCL12;DUSP1;GREM1;CCR2;CREB3;CXCL10
prerank,positive regulation of cell death (GO:0010942),0.2675385617883772,0.8529034129730083,0.7005163511187608,0.940296499119926,1.0,9/59,11.69%,SLC6A13;EFNB2;DKK1;LRRK2;BNIP3;PICALM;AXIN2;EIF2S1;PRODH
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3280691883256899,-0.8527854345439823,0.6455445544554456,0.8838017931844011,1.0,6/15,22.20%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3;C3
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21754177993825413,-0.8520802521207392,0.8085106382978723,0.884611006528308,1.0,27/91,25.20%,HIP1;NSF;SCARB1;STON2;RAB3C;PACSIN2;PTPRC;HIP1R;BET1L;RAB3B;PTPN1;CDH13;CPLX2;MAP2K2;SYT7;INPP5F;RIT2;MAPK3;RAB8A;MBTPS1;CHMP3;RAB8B;RAB3A;LGI3;CPLX1;HAP1;RAB5B
prerank,cytosolic transport (GO:0016482),-0.2159900074654868,-0.8518387036062673,0.8054794520547945,0.8844689182449122,1.0,30/108,22.72%,MYO1D;HEATR5A;MON2;VPS13A;VPS13C;VTI1B;STX6;EMP2;LAMP1;BET1L;SNX16;EVI5;PTPN23;TBC1D10A;LMTK2;EHD3;PIK3C3;HOOK1;LAPTM5;GBF1;SNX1;VPS51;TBC1D10B;SYS1;TRIM27;SNX2;DCTN1;SPAG9;CLN5;AP2A1
prerank,regulation of hemopoiesis (GO:1903706),-0.3732112796047702,-0.8515679862841129,0.655241935483871,0.8844181852190831,1.0,2/10,2.22%,RUNX1;CBFB
prerank,ether lipid biosynthetic process (GO:0008611),-0.3639234977227954,-0.8512287567313139,0.6679920477137177,0.8845234992014935,1.0,5/10,29.82%,FAR1;PLA2G4A;AGPS;DHRS7B;CHPT1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.34200660328261384,-0.8510852178545283,0.6806083650190115,0.8842105701524454,1.0,5/13,18.46%,CPSF7;CPSF6;CPSF2;CSTF2T;CSTF2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.28983695963483547,-0.8507979178059442,0.6759656652360515,0.884203052610654,1.0,9/25,21.93%,ATXN3;BAG6;CUL3;ZYG11B;DERL1;AUP1;RNF5;VCP;HDAC6
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3087277831982976,0.8507424010288143,0.6567717996289425,0.9441986828990272,1.0,2/26,3.71%,ROCK2;EPHA4
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.26956342980421216,-0.8503397214980921,0.6963470319634704,0.8844879832706943,1.0,7/33,14.02%,GLS;GCLM;KYAT1;DDAH1;SLC39A8;ALDH18A1;SIRT4
prerank,reverse cholesterol transport (GO:0043691),0.36197300821524364,0.8502222321315982,0.6313725490196078,0.9445559767200219,1.0,3/13,8.39%,ABCA1;LIPC;ABCA5
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.33847279893275706,-0.8501900839782951,0.6581532416502947,0.8842054945239689,1.0,8/13,40.31%,BLOC1S2;RHOT1;BMF;BAX;PMAIP1;BNIP3L;BAD;RHOT2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2789449058021791,0.849835975739045,0.6606822262118492,0.9445998152634014,1.0,6/44,10.80%,ROCK2;TNRC6B;TNRC6A;YTHDF2;AGO2;METTL14
prerank,negative regulation of GTPase activity (GO:0034260),0.3159518980733883,0.8497585125262316,0.6237816764132553,0.9440313024244835,1.0,3/22,5.48%,GMIP;CPEB2;LRRK2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3232462351195451,-0.8496832009831683,0.6591375770020534,0.8845895853233346,1.0,4/17,12.45%,SLIT2;SFRP4;TMEM204;CASK
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.33741659830207377,-0.849526612531203,0.6598360655737705,0.8842972330955841,1.0,6/14,20.61%,NOS3;EDN1;ECE1;ACE2;AGTR1;ENPEP
prerank,regulation of response to oxidative stress (GO:1902882),0.3815562336306794,0.8489171409720006,0.6609808102345416,0.9450958566578803,1.0,1/11,1.37%,PRKN
prerank,regulation of calcium ion transport (GO:0051924),0.2684149272336407,0.8488567559500161,0.7128205128205128,0.9444935253542599,1.0,9/54,12.63%,STIM1;BCL2;MYLK;ANK2;CACNA1D;CACNA2D1;CCL4;PKD2;PACSIN3
prerank,response to lipid (GO:0033993),0.2442700540640849,0.8488278058281171,0.745398773006135,0.9438297203175519,1.0,8/105,3.68%,FGFR4;PPARA;RBP4;SMAD6;FER;CTSH;ANXA1;STAT5B
prerank,Notch signaling pathway (GO:0007219),0.27016426546876204,0.8486816796069795,0.7087033747779752,0.943423836654415,1.0,14/59,14.12%,RBPJ;NOTCH2;GMDS;SUSD5;MAML3;MAML1;WWC1;TRAF7;ITCH;DTX1;MAML2;PSENEN;SNAI1;CREBBP
prerank,morphogenesis of an epithelium (GO:0002009),0.31361957913204347,0.8486028909657729,0.674373795761079,0.9428741249678859,1.0,3/25,4.95%,FGFR2;ARHGAP12;KDM2B
prerank,positive regulation of nervous system process (GO:0031646),0.33816831664312097,0.8485699466619211,0.645224171539961,0.9422287969737951,1.0,3/18,3.91%,NLGN2;PARD3;ITGAX
prerank,protein K48-linked ubiquitination (GO:0070936),0.27373919574072886,0.8482280234284224,0.6984402079722704,0.9422515795846133,1.0,15/54,17.62%,PRKN;UBE2E2;RNF152;TTC3;AMFR;RNF216;ITCH;KBTBD7;FBXO38;IFI27;UBE2A;SKP2;UBE2H;UBE2E1;DTX3L
prerank,pseudouridine synthesis (GO:0001522),-0.3371427813083029,-0.8479989737481176,0.6782945736434108,0.8866971224134498,1.0,7/13,29.61%,TRUB2;NHP2;PUS7;PUSL1;RPUSD2;NOP10;PUS1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33790218860444987,-0.8479864285902314,0.6928982725527831,0.8861449218485966,1.0,5/14,16.12%,SEMA7A;PLCG2;CD74;CAMK4;LAPTM5
prerank,positive regulation of DNA replication (GO:0045740),-0.3213589405875481,-0.8476423081687953,0.670020120724346,0.8862456028420523,1.0,3/16,12.22%,BCAR3;FAF1;GLI1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3656637900597119,0.8474508204976078,0.6205450733752621,0.9431540533181088,1.0,1/13,0.85%,RBPJ
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3177471140311378,0.8473179447624966,0.660377358490566,0.9427106355728994,1.0,1/25,0.20%,ARHGAP24
prerank,regulation of filopodium assembly (GO:0051489),0.2914271003596365,0.8471250228567644,0.6666666666666666,0.9423906464272306,1.0,7/38,11.28%,DOCK11;DPYSL3;RIPOR2;WASL;CAPZB;PIK3R1;FXR1
prerank,RNA catabolic process (GO:0006401),-0.252777154877628,-0.8470378558033268,0.7384259259259259,0.8868450985679057,1.0,21/46,34.45%,RIDA;RNASE3;MTREX;SUPV3L1;AGO3;METTL3;HSPA1B;ZPR1;NUDT16;ERN1;RNH1;RNASEH2C;HNRNPD;DIS3L2;RNASEH2B;ZFP36;ISG20;DNA2;HSPA1A;FEN1;ZC3H12D
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3649439527031265,-0.8459863867446378,0.6598513011152416,0.8882731659387622,1.0,7/11,33.01%,BAG6;DERL1;AUP1;RNF5;VCP;UGGT1;RNF185
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.34743708413074537,-0.8457580019131288,0.6547842401500938,0.8881574772594291,1.0,4/12,16.77%,RPL26;CD44;CD74;MIF
prerank,keratinocyte differentiation (GO:0030216),-0.27929709302023437,-0.8453246111156525,0.7088888888888889,0.8883888598329913,1.0,4/29,8.27%,CLIC4;JAG1;BCR;WNT16
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.27936190388818666,0.8448104970530625,0.6917808219178082,0.9464441071909139,1.0,7/43,12.49%,ERRFI1;SNX6;STAM2;TGFA;CHMP6;PTPN3;AREG
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3451895068788009,0.8447456761995579,0.6620825147347741,0.945863697899312,1.0,3/16,7.40%,PDE6G;ACP3;PRKCA
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.35868055787776054,-0.8447075628644385,0.6608863198458574,0.8889781971838372,1.0,4/10,29.86%,DLGAP1;NPTXR;NPTX1;CACNG5
prerank,protein destabilization (GO:0031648),-0.2728541247538917,-0.8442543891934694,0.7049891540130152,0.889325685395674,1.0,6/32,9.18%,GSN;FBXL3;SOX17;CUL3;DERL1;SERF2
prerank,response to interferon-beta (GO:0035456),-0.29594466818988774,-0.8437572820757452,0.6996047430830039,0.8897160061582075,1.0,6/22,24.36%,AIM2;NDUFA13;SHFL;BST2;IFITM3;STAT1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3417807368231413,0.8432238062254571,0.6694915254237288,0.9482726388470379,1.0,5/16,12.83%,FOXD1;FGF1;SALL1;PKD2;GDNF
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.30459253905229805,0.843132136673025,0.673992673992674,0.9477413595172852,1.0,6/30,12.49%,DAB2;KLK2;NCOA2;HDAC1;RNF14;AR
prerank,modulation by host of symbiont process (GO:0051851),-0.2728499526887119,-0.8430849972813138,0.7232142857142857,0.8904453615971759,1.0,5/31,15.75%,LEF1;TARDBP;JUN;REST;CX3CR1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.1979442827000272,-0.8430482153246174,0.8653198653198653,0.889939691331349,1.0,46/171,23.55%,NEK7;IQGAP1;TTC28;CAV2;CDK11B;LGMN;BUB3;TGFB1;HNRNPU;APP;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;BTG3;PSMB6;DUSP3;TAL1;PSME3;PSMB5;PSMC3;TMEM8B;PSMD12;PSMB8;CUL1;BRINP2;PSME1;ANAPC16;PSMB3;GBF1;BUB1B;UBE2D1;PSMD5;TFAP4;SKP1;L3MBTL1;BTG1;TTL;ANAPC7;PSMD9;PSMB4;MKI67;EIF4E;AFAP1L2;NEK11
prerank,granulocyte chemotaxis (GO:0071621),-0.24041482763999358,-0.8429377254385807,0.7415458937198067,0.8895779445763131,1.0,11/55,17.86%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD;SCG2;PIP5K1C;GBF1;CCL13
prerank,nuclear membrane disassembly (GO:0051081),0.3545665357997132,0.8428217852901181,0.6178343949044586,0.947674918091603,1.0,4/14,10.07%,PRKCB;PRKCA;CDK1;AKAP8L
prerank,transcription preinitiation complex assembly (GO:0070897),-0.34793097869105466,-0.8426709215610473,0.6806083650190115,0.8894871940248901,1.0,8/12,52.74%,TAF11;POLR1E;TAF1B;TAF7;TBP;TAF7L;BDP1;DR1
prerank,positive regulation of rRNA processing (GO:2000234),-0.37328870724737234,-0.8425461594647207,0.6737044145873321,0.8891477749980026,1.0,3/10,21.08%,BUD23;UTP15;SIRT7
prerank,tRNA 5'-end processing (GO:0099116),-0.32411947613045494,-0.84249361796113,0.7029126213592233,0.8886816056017067,1.0,8/15,28.41%,SSB;POP5;POP4;RPP21;RPP30;TRMT10C;PRORP;POP7
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.23044459208110402,-0.8424214970201932,0.7604938271604939,0.8882461959464192,1.0,19/69,19.14%,MEF2C;PPARGC1A;PTK2B;NGF;LGMN;SOD1;FOXQ1;SIX1;GRN;SET;MSH2;MT3;SIX4;CX3CR1;WFS1;PRKCG;TYRO3;LIG4;PINK1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3337568066699962,-0.8422072339852607,0.6972477064220184,0.8880933809170934,1.0,5/14,33.63%,ADRB2;PRKAR1A;ATP2B4;PKIG;PRKAR2B
prerank,ERAD pathway (GO:0036503),-0.22147024569943624,-0.8419454921976929,0.796875,0.8880117635231045,1.0,32/83,29.88%,ATXN3;STT3B;TRIM25;HSP90B1;BAG6;DERL1;CCDC47;UBXN6;HSPA5;HERPUD1;ERLEC1;TRIM13;ERLIN2;DNAJC10;WFS1;AUP1;RNF5;DNAJB9;GET4;FBXO17;TMEM129;VCP;RNF103-CHMP3;BRSK2;UBE2J1;YOD1;SYVN1;FBXO2;RHBDD2;STUB1;FOXRED2;SEC61B
prerank,response to tumor necrosis factor (GO:0034612),0.2464522642370629,0.8419250421030667,0.7672552166934189,0.9487810304059858,1.0,11/91,11.11%,ADAMTS12;PID1;CRHBP;SPHK1;ZFAND6;CACTIN;ADAMTS7;CCL19;CCL4;GSDME;JAK2
prerank,regulation of viral life cycle (GO:1903900),-0.30216591104008145,-0.8416681631050964,0.7008196721311475,0.8879754046038514,1.0,6/21,19.83%,PPIA;TRIM14;TRIM25;HS3ST5;TYRO3;TRIM27
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.24715271473702052,-0.8416069897806068,0.7333333333333333,0.8875272387351889,1.0,17/47,26.68%,SPOCK2;SERPINE2;SERPINI1;SERPINF1;SERPINB9;GAPDH;BIN1;MT3;SPOCK1;TIMP2;SERPINA2;AKT1;SPOCK3;SORL1;TIMP1;ANXA8L1;ANXA8
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3375018635613245,-0.8413632674839997,0.6742738589211619,0.8874074872327162,1.0,5/14,19.02%,CEPT1;LPIN3;ETNK1;LPIN1;ETNPPL
prerank,neuromuscular process (GO:0050905),-0.3192223676905854,-0.8412854284056669,0.6862348178137652,0.8869938802311766,1.0,4/16,10.74%,GCH1;STRA6;NRXN1;KCNA1
prerank,negative regulation of phosphatase activity (GO:0010923),-0.2806745975972492,-0.8412614342208729,0.6941431670281996,0.8864692792825017,1.0,8/25,16.65%,TGFB2;SEMA4D;TIPRL;GSK3B;CHP1;ZCCHC9;MASTL;BOD1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.28478603606702757,-0.8412533407476506,0.6977225672877847,0.8859131995958524,1.0,11/26,39.78%,CUL3;DUSP1;ANAPC7;NSMCE2;PLK1;DLGAP5;CDC6;ESPL1;UBE2C;ANAPC4;CCNB1
prerank,regulation of synapse maturation (GO:0090128),-0.3630745325771819,-0.8400696144740106,0.6704761904761904,0.8875476031461391,1.0,5/10,15.07%,DAB2IP;ARHGEF15;NRXN1;RELN;CAMK2B
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3582365576146065,-0.8399144550954438,0.6627450980392157,0.8872733865514885,1.0,3/10,8.71%,IQSEC1;MTOR;FGF7
prerank,histone ubiquitination (GO:0016574),0.32062618531342885,0.8397368792446097,0.6593406593406593,0.9525006477876679,1.0,9/21,22.89%,UBR2;CDC73;RNF20;UBE2A;CTR9;UBE2E1;DTX3L;PAF1;WAC
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3252766801470171,0.839662844751056,0.6789883268482491,0.9519338912729792,1.0,2/22,2.73%,APPL2;LTF
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2696774816735672,-0.8394519585645475,0.6967741935483871,0.8875628431963465,1.0,15/29,34.04%,UBB;UBC;RPS27A;DDB1;RBX1;RPA1;UBA52;CETN2;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,L-serine metabolic process (GO:0006563),0.39515234532793825,0.8390565575947853,0.6544276457883369,0.9524578656672201,1.0,3/10,13.02%,CBS;SRR;SHMT1
prerank,negative regulation of autophagy (GO:0010507),0.2614996319043744,0.8385462058328056,0.7112676056338029,0.9527840875330152,1.0,10/54,13.21%,LEPR;BCL2;LRRK2;NUPR1;GOLGA2;WASHC1;RUBCN;KLHL22;LZTS1;FOXK2
prerank,histone H3 deacetylation (GO:0070932),-0.31865257458715923,-0.8384467175744509,0.6825095057034221,0.8888474504985528,1.0,8/15,29.50%,SFPQ;PER1;SIRT7;HDAC9;SMARCAD1;SIRT6;HDAC3;PER2
prerank,response to axon injury (GO:0048678),-0.3082629402000055,-0.8378677107888151,0.7077922077922078,0.889383366090502,1.0,9/18,29.17%,APOD;RTN4RL1;SOD1;TYROBP;SARM1;P2RY12;GAP43;TREM2;MAPK8IP3
prerank,regulation of mast cell degranulation (GO:0043304),0.3529042853208089,0.837297822335996,0.68,0.9546600036778795,1.0,5/14,20.05%,FER;GAB2;LYN;CD84;LGALS9
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.33326123287296705,0.8371784820217758,0.6597353497164461,0.9541906486668629,1.0,6/20,16.26%,TNRC6B;TNRC6A;AGO2;MOV10;CNOT8;CNOT7
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3347837624795237,0.8369809931679979,0.654690618762475,0.9538631420397251,1.0,2/18,3.94%,PRKN;CRHBP
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.29317748150193396,-0.8369724959368064,0.720164609053498,0.8904644766121198,1.0,10/22,30.92%,MVB12B;UBAP1;PTPN23;MVB12A;UBAP1L;PLAA;VPS36;TOM1L1;VPS28;VPS4B
prerank,response to alcohol (GO:0097305),0.30782325240487973,0.8367259498723003,0.6764132553606238,0.9536670424260432,1.0,3/27,8.52%,TGFBR3;CCL19;PMVK
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.32537386184888184,0.8367228932800471,0.6456692913385826,0.9529567310063958,1.0,2/22,4.46%,SASH1;SPHK1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23591087582852,0.8365671791322551,0.7648902821316614,0.9525581114211739,1.0,12/104,10.44%,KSR1;SLC8A3;LTF;SLC8A1;CDK7;BLM;CCNT2;CCNT1;SYAP1;UVRAG;SLC27A1;ABL1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3680392678258185,0.8362203764078338,0.6686991869918699,0.9525196359568827,1.0,1/12,2.36%,INSIG2
prerank,regulation of gluconeogenesis (GO:0006111),0.3025035277976577,0.8361608471289776,0.6583493282149712,0.9519174054670139,1.0,7/27,18.00%,C1QTNF3;SIK1;USP7;CRY1;GCK;NNMT;C1QTNF12
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3504673097345643,-0.8359440007074308,0.673469387755102,0.8917959939471842,1.0,2/12,2.34%,LY6E;GSN
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.2266346177944745,-0.8359267635315992,0.8142493638676844,0.8912663660636827,1.0,25/76,23.48%,RNF144B;CBFA2T3;PTK2;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;ELOB;ARIH2;COP1;LAPTM5;RNF19B;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B
prerank,lytic vacuole organization (GO:0080171),0.29488718394919755,0.8355390029762594,0.7084148727984344,0.9524522697031158,1.0,5/32,6.74%,HOOK2;ABCA1;TPP1;LRRK2;ACP3
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.28014550150168577,-0.8352533925599133,0.6797385620915033,0.891942160945862,1.0,9/28,26.34%,SH3KBP1;CYRIB;HSPD1;CD47;TYROBP;THY1;NCKAP1L;CCR2;CCL2
prerank,organelle assembly (GO:0070925),0.20617005716627118,0.8350408415157097,0.8806888068880688,0.9527572507657178,1.0,94/384,19.41%,DCDC2;ASAP1;INTU;AVIL;TP53INP2;RAB3IP;ARL3;SH3PXD2B;RAB19;DYNC2H1;CDC14B;MAPRE2;CCDC57;IFT80;HAUS4;WIPI1;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;ARL6;CEP19;UBXN2B;IQCB1;ATG14;VTA1;TUBGCP6;YTHDF2;RAB32;TEKT2;TCTN1;SCLT1;ATP6V0D1;STAM2;GOLGA2;TUBGCP2;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;HAUS1;IFT122;ATG9A;EIF2S1;CHMP6;VPS37A;VPS37C;TTC39C;EXOC3;INO80;IFT140;PLA2G4C;CFAP298;CCDC65;WDR90;LMOD1;CEP63;RAB43;CEP164;CFAP70;CFAP410;ATP6V1D;AMBRA1;ATG3;MIS12;RUFY4;EXOC7;EXOC1;DYNC2I1;IRGM;CDS2;VPS37D;CFAP20;ATG16L2;PDE6D;RAB11FIP3;NCOR1;ARF4;RP2;TMEM237;BBS1;TRAF3IP1;IFT81;IFT46;LSM3;DDX3X;LSM14A;BBS2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.24118650536526773,-0.8348552054360835,0.769406392694064,0.8921570843907806,1.0,24/52,28.73%,PPP1R13B;SREBF2;SH3GLB1;NMT1;YWHAB;MAPK8;YWHAG;BBC3;ARIH2;CASP8;VPS11;YWHAQ;YWHAH;PINK1;PPP3R1;TOMM7;HUWE1;MICALL2;YWHAZ;RNF31;PPP3CC;ABLIM3;BID;SFN
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.34829798775912335,-0.8348333038760858,0.6841121495327103,0.8916289455039972,1.0,5/11,32.03%,TASOR;SETDB2;SIRT6;DNMT1;PPHLN1
prerank,iron ion transport (GO:0006826),0.2730504487405039,0.834438501378482,0.7057793345008757,0.9532913623116099,1.0,8/47,10.02%,CP;HEPH;LTF;TFR2;REP15;ATP6V0D1;ATP6V0E1;STEAP3
prerank,regulation of mRNA stability (GO:0043488),-0.2026019751949596,-0.834369669492036,0.9148264984227129,0.8919770860643361,1.0,42/145,23.01%,HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;UBC;RPS27A;PUM2;HNRNPU;YBX1;PSMD13;SET;PSMF1;EIF4G1;ZFP36L1;PSMB10;YTHDF3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;FUS;TENT5A;PSME1;UBA52;RIDA;PSMB3;SERBP1;FASTKD3;PSMD5;PCBP4;PRKCD;AKT1;METTL3;FMR1;SLC11A1;RBM24;PSMD9;PSMB4
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2561223791137195,0.8342373592696793,0.7235099337748344,0.9529881878486913,1.0,1/66,0.03%,IGF1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.30756672044459066,-0.8338743162411459,0.6954813359528488,0.8923191167362067,1.0,8/18,33.21%,MCM4;POLA1;POLE;POLD3;GINS4;LIG3;POLE3;GINS2
prerank,chromatin assembly (GO:0031497),0.2799623875127489,0.8336052836265363,0.669051878354204,0.9535501550434307,1.0,11/38,22.11%,RBBP4;RSF1;KAT6B;SMARCA5;NAP1L3;EZH1;NAA60;NAP1L1;PAF1;ANP32B;SOX9
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.29254851681743504,-0.8335362416655006,0.7072649572649573,0.8924178367341576,1.0,4/22,10.84%,KLF4;MBP;CD44;GCNT2
prerank,response to glucocorticoid (GO:0051384),-0.28129171561212074,-0.833096356387886,0.7183406113537117,0.8926579613456896,1.0,5/26,12.32%,SLIT2;FAM107A;HNRNPU;ZFP36L1;REST
prerank,regulation of mRNA metabolic process (GO:1903311),-0.3547218609371074,-0.8328054639873275,0.6792828685258964,0.8926297530522875,1.0,7/11,33.25%,CDK11B;SRPK1;SAFB2;SLTM;SRPK3;DHX9;IWS1
prerank,aminoglycan catabolic process (GO:0006026),0.29871884675474647,0.8326888029913151,0.6720720720720721,0.9546290442528997,1.0,4/28,7.97%,SDC2;GPC6;GPC3;CTBS
prerank,response to exogenous dsRNA (GO:0043330),0.3264765326730606,0.8326160458682906,0.6781376518218624,0.9540551519437831,1.0,1/18,0.45%,COLEC12
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.28656046205691055,-0.8319356255611988,0.7116182572614108,0.8936814991538059,1.0,9/25,24.36%,ETS1;ABCB10;STAT3;TAL1;ANKRD54;NCKAP1L;MAPK11;HSPA1B;STAT1
prerank,microtubule polymerization (GO:0046785),0.30351623801461375,0.8317187632128654,0.7032136105860114,0.9551200243130518,1.0,9/28,19.95%,CCDC57;TUBGCP6;GOLGA2;TUBGCP2;RANBP9;TUBG1;AKAP9;TPX2;MAP7D3
prerank,histone H4 acetylation (GO:0043967),-0.24160361038159123,-0.8315162687406449,0.7767653758542141,0.893861746207776,1.0,11/47,17.31%,LEF1;MORF4L1;APBB1;ING4;OGT;NAA40;JADE1;KANSL3;RUVBL1;PER1;WDR5
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.27364320019368543,-0.8313079980949816,0.7316561844863732,0.8936683655117073,1.0,6/29,11.27%,HSP90AB1;CDC37;NLRC5;ISG15;PTPN1;YTHDF3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.317499662444933,-0.8309862666712359,0.7129094412331407,0.8937157753397833,1.0,5/16,22.08%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,protein maturation (GO:0051604),-0.21770569135663628,-0.8307639548680463,0.8247978436657682,0.8935572742568666,1.0,24/95,24.17%,ADAM10;F3;CPD;PCSK2;GALNT2;PTCH1;SRGN;TSPAN17;ECE1;FURIN;OGT;CPXM2;HSPD1;DNAJB11;NAA40;GLRX3;PCSK1;ADAMTS3;PSEN1;PCSK5;TYSND1;ISCA1;NNAT;NAA16
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2429271632743868,-0.8306982928092668,0.7893518518518519,0.8931016635060761,1.0,16/48,22.37%,SLIT2;GAS6;PTPRC;NLRC5;ISG15;YTHDF3;IRAK3;NLRP2B;NR1H2;CARD16;SIGIRR;SH2B3;PADI2;METTL3;NR1H3;TRAIP
prerank,aminoglycan metabolic process (GO:0006022),0.3806169035533366,0.8303760543279828,0.6722689075630253,0.9570882099631935,1.0,3/10,9.85%,GAL3ST3;XYLT2;B3GALT6
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.32577603081284273,-0.8298125824817904,0.734225621414914,0.8935586278160237,1.0,3/15,6.82%,AP3S1;BLOC1S2;AP3M2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.32577603081284273,-0.8298125824817904,0.734225621414914,0.8935586278160237,1.0,3/15,6.82%,AP3S1;BLOC1S2;AP3M2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.32323088773622377,0.8295096822839205,0.6943907156673114,0.95810250522807,1.0,3/18,13.45%,PPARA;MIA3;PAG1
prerank,regulation of chemotaxis (GO:0050920),0.3016444016007257,0.8295095990064004,0.7057728119180633,0.9573922735711182,1.0,4/30,7.56%,EFNB2;PDGFRB;PDGFRA;CCL19
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.33276532865188413,-0.8290701545320807,0.7056530214424951,0.8943316546137241,1.0,5/13,18.58%,RPL26;SPRED2;DDX5;EEF1E1;ATR
prerank,regulation of cytoplasmic transport (GO:1903649),0.3647226048004973,0.8289635895005836,0.6812227074235808,0.957762019894942,1.0,3/11,13.41%,LRRK2;USP7;MAPK1
prerank,mRNA polyadenylation (GO:0006378),-0.2822553503722375,-0.8289105418691755,0.7293577981651376,0.8934883405599554,1.0,9/26,18.37%,PABPC1;APP;CPSF3;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;PCF11
prerank,RNA polyadenylation (GO:0043631),-0.2822553503722375,-0.8289105418691755,0.7293577981651376,0.8934883405599554,1.0,9/26,18.37%,PABPC1;APP;CPSF3;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;PCF11
prerank,amide biosynthetic process (GO:0043604),0.269013231215465,0.8287252315574924,0.70298769771529,0.9575415139395848,1.0,9/47,12.14%,DMD;PM20D1;CERS6;CERS5;AANAT;ASL;CERS1;PAM;SLC25A2
prerank,histone H3 acetylation (GO:0043966),-0.2492528900630664,-0.8285798750590703,0.7613636363636364,0.893520885964174,1.0,9/40,19.26%,LEF1;ING4;YEATS2;BRPF1;KAT14;JADE1;PER1;WDR5;SPI1
prerank,renal absorption (GO:0070293),0.37003644206907904,0.8285467479992925,0.659043659043659,0.9572001512265415,1.0,1/10,1.20%,WNK4
prerank,peptidyl-lysine methylation (GO:0018022),0.3036323709151884,0.8280171975343703,0.7084148727984344,0.9575273027704736,1.0,7/26,19.77%,SETD6;SETD7;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4
prerank,modification-dependent protein catabolic process (GO:0019941),0.21641618706084403,0.8278752807465622,0.8559201141226819,0.9570960342475838,1.0,29/193,12.80%,ASB2;RNF43;PRKN;SPSB1;NEDD4;RNF213;FBXW4;RNF217;ZNRF3;TRPC4AP;UBE2L3;TTC3;SIAH2;AMFR;BIRC6;RC3H2;UBE4A;MDM2;ITCH;RNF149;SMURF2;PSMD3;RBBP6;KLHL15;RNF14;RNF20;FBXO11;RCHY1;CDC26
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3614973400033313,0.8277534599494701,0.6688311688311688,0.9566361701706492,1.0,3/11,13.91%,PRKN;P4HB;STK26
prerank,muscle cell migration (GO:0014812),0.377769951277961,0.8276507920374375,0.6343612334801763,0.9561152438677587,1.0,2/10,4.87%,MEGF10;DDR1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2955435065574631,-0.8274355193688634,0.7071129707112971,0.8950130645536774,1.0,5/20,14.97%,DCC;BCL2L1;GSK3B;APPL1;FAS
prerank,receptor clustering (GO:0043113),0.296708666333278,0.827304906296071,0.7060998151571165,0.9561145173709009,1.0,8/27,13.67%,LRP4;PTN;DLG1;DNAJA3;MUSK;DLG4;DLG3;MAGI2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2718335222172149,-0.8272604503411563,0.7170212765957447,0.8947810406821729,1.0,3/29,6.25%,NSF;VTI1B;COPG1
prerank,synaptonemal complex assembly (GO:0007130),0.3507748818064718,0.826997280583965,0.6652542372881356,0.9552771052272641,1.0,2/15,6.34%,HORMAD1;TEX11
prerank,synaptonemal complex organization (GO:0070193),0.3507748818064718,0.826997280583965,0.6652542372881356,0.9552771052272641,1.0,2/15,6.34%,HORMAD1;TEX11
prerank,positive regulation of defense response (GO:0031349),-0.21943588746574383,-0.8268935772569609,0.8475935828877005,0.8949065880495941,1.0,12/89,11.15%,MEF2C;IL33;ETS1;NFKBIA;GPR4;PDE2A;PDCD4;APP;GRN;GBP5;FEM1A;IFI35
prerank,early endosome to Golgi transport (GO:0034498),-0.35250080041295173,-0.8267888178254914,0.693050193050193,0.8945391001800644,1.0,5/11,34.13%,EHD3;SNX1;SNX2;STX5;RBSN
prerank,regulation of stem cell population maintenance (GO:2000036),0.3305450915675645,0.826703777893144,0.6679245283018868,0.9551618218917475,1.0,3/18,11.86%,PTN;NCOA3;CNOT2
prerank,negative regulation of innate immune response (GO:0045824),-0.2632555601770961,-0.8264043432167313,0.7538461538461538,0.894710820185535,1.0,8/34,12.95%,RPS19;SUSD4;GRN;A2M;NLRC5;ISG15;YTHDF3;IRAK3
prerank,alanine transport (GO:0032328),-0.3595332845679113,-0.8260351547280472,0.68762278978389,0.8948131010634668,1.0,4/10,16.40%,SLC6A6;SLC36A1;SLC1A4;SLC36A4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.25238379314581866,0.8258889657763178,0.7482517482517482,0.9560487855135119,1.0,9/71,9.50%,ADAMTS12;PRKN;CLPX;CTSH;ADAMTS7;FBXO44;FBXL17;YME1L1;MDM2
prerank,regulation of lamellipodium organization (GO:1902743),0.3491295983105996,0.8251334986629121,0.657314629258517,0.9567896982726288,1.0,4/14,11.05%,FER;PDPN;CAPZB;EPHA2
prerank,response to interleukin-6 (GO:0070741),-0.35556938400103993,-0.8250313483999463,0.7032136105860114,0.8959676425006821,1.0,3/10,8.87%,ST3GAL6;SBNO2;PTGIS
prerank,regulation of dephosphorylation (GO:0035303),-0.321698842961175,-0.824699047664332,0.7257731958762886,0.8960131411823593,1.0,6/15,27.76%,PPP1R16B;MTMR9;PPP1R16A;SMG5;MTMR1;SMG6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.36187372272215085,-0.8246675839156303,0.7001862197392924,0.894946137179754,1.0,4/10,32.70%,RACK1;PRKCD;SPHK2;NSMAF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.36187372272215085,-0.8246675839156303,0.7001862197392924,0.894946137179754,1.0,4/10,32.70%,RACK1;PRKCD;SPHK2;NSMAF
prerank,regulation of protein localization to cell surface (GO:2000008),0.2905340589306224,0.8243668488070155,0.6884328358208955,0.9575988728625785,1.0,3/33,5.58%,LEPROT;GPD1L;SNX33
prerank,regulation of p38MAPK cascade (GO:1900744),0.2895408360978129,0.8235826809216945,0.6844036697247706,0.9584939786762451,1.0,4/35,6.48%,SASH1;DUSP10;SPHK1;DLG1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.32777558267659734,0.8231546317450747,0.6832298136645962,0.9586240730828735,1.0,8/17,21.35%,AKAP13;ADRA1D;ADRB3;DRD2;ADCY9;ADRA2A;GPR101;RAPGEF2
prerank,positive regulation of viral genome replication (GO:0045070),0.29618586234778405,0.8229776874733284,0.724907063197026,0.9582722361347275,1.0,5/29,8.59%,PPARA;SRPK2;TOP2B;HACD3;PKN2
prerank,negative regulation of immune response (GO:0050777),0.22330188786526542,0.8227888480182397,0.811965811965812,0.9579512065158221,1.0,17/154,11.47%,ADCY5;ADCY1;FER;ADM;FCRLB;CACTIN;PDCD1;IL6;PTH2R;NLRC3;LYAR;PTGIR;GLP1R;ITCH;ADRB3;ENPP3;PCBP2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3001560975794614,-0.8227503727807007,0.7285429141716567,0.8977190609164274,1.0,3/19,5.71%,FBXO7;SREBF2;CAMKK2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3409954471821878,0.8224925392369108,0.6856540084388185,0.9578129268578005,1.0,5/15,16.48%,FSTL3;LEMD3;MAGI2;SKI;IGSF1
prerank,V(D)J recombination (GO:0033151),0.36769680970967733,0.8224675629211368,0.6673960612691466,0.9571599702641587,1.0,3/11,12.75%,XRCC4;PRKDC;LIG1
prerank,neuron apoptotic process (GO:0051402),-0.29806242427517154,-0.8221755519403443,0.7142857142857143,0.8981611235876793,1.0,7/19,18.89%,CIT;TNFRSF21;GAPDH;APP;FAS;CDK5;LIG4
prerank,protein localization to organelle (GO:0033365),-0.2029997627437839,-0.8221612896475601,0.8938356164383562,0.8976258881099592,1.0,38/133,21.68%,RPL11;DNAJA1;PACSIN2;STX1A;CALR;EHD1;SIX1;APP;YBX1;LAMP1;CCDC47;ZBTB7A;TSPAN17;TOR1B;TMEM30A;SSB;ISG15;GBP5;HHEX;RPA1;TOLLIP;CEP68;RIPOR1;BBS9;LMNA;COL1A1;SEC61G;SIX4;GBF1;BICD1;AUP1;SYS1;IFT20;GET4;CTDNEP1;BMP4;FAM83H;VAPA
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3060948190752633,-0.8220928231134054,0.714859437751004,0.8971984648807341,1.0,9/16,26.47%,RYR2;HSPA5;BCAP31;GBF1;SEC16B;VAPA;PPP1R15A;SEC16A;UBAC2
prerank,positive regulation of telomere capping (GO:1904355),-0.3020361068469885,-0.8218652193442675,0.7270875763747454,0.8970455290419226,1.0,2/17,10.52%,NEK7;MAP2K7
prerank,positive regulation of peptidase activity (GO:0010952),-0.2943750435638532,-0.82156684571413,0.7559523809523809,0.897038014587524,1.0,7/20,24.17%,GRN;NDUFA13;PSME3;PSME1;PINK1;VCP;VSIR
prerank,neurotransmitter transport (GO:0006836),0.24896969661887822,0.821364098776485,0.7483333333333333,0.9585968627298482,1.0,3/73,2.16%,ATP1A2;SLC22A2;SLC1A3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.31693144287877206,0.8213345241060582,0.6666666666666666,0.9579574191203818,1.0,4/22,10.14%,NR2F2;PTEN;CDK5RAP1;LATS1
prerank,peroxisomal membrane transport (GO:0015919),-0.2792814216579188,-0.8210210113835691,0.7336065573770492,0.8974166259454099,1.0,12/27,29.55%,ABCD3;ABCD2;PEX1;PEX11B;ABCD4;PEX5;ATAD1;PEX10;RAB8B;PEX16;FIS1;PEX13
prerank,mitotic recombination (GO:0006312),0.34984776501289844,0.8210077698820647,0.6693711967545639,0.9579258318314134,1.0,6/15,23.62%,DMC1;TEP1;RAD51;TPRKB;RAD50;RAD52
prerank,lipid homeostasis (GO:0055088),0.2591656765668179,0.8210013001408105,0.7448275862068966,0.9572353559001406,1.0,6/57,7.55%,ZBTB20;ABCA1;RBP1;PRKAA2;THADA;PRKAA1
prerank,regulation of protein neddylation (GO:2000434),-0.3607157726080344,-0.8209399964300629,0.7047619047619048,0.8969973348412305,1.0,5/10,14.54%,RPL11;RPL5;COPS9;DCUN1D1;DCUN1D2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.33650790704830763,-0.8207256299794229,0.7214022140221402,0.8968338061081962,1.0,5/12,21.68%,PTPN14;TGFB1;BMP4;SIRT7;UHMK1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.35464579424201975,0.8207091393122011,0.6757894736842105,0.9570995114393265,1.0,1/13,1.22%,IL18
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3450174312593718,0.8204992656556751,0.6584867075664622,0.9568001888978255,1.0,2/14,5.48%,PRKN;LRRK2
prerank,cellular response to estradiol stimulus (GO:0071392),0.32981290734197155,0.8202832215369902,0.6992031872509961,0.9565228909054997,1.0,3/18,6.88%,CRHBP;SSTR2;NCOA3
prerank,substrate-dependent cell migration (GO:0006929),-0.3250896327413663,-0.8201763628315214,0.7066420664206642,0.8972652129837431,1.0,4/14,10.61%,SHTN1;ANKS1A;PTPRC;CD2AP
prerank,endothelial tube morphogenesis (GO:0061154),-0.36020242343960945,-0.8199599558271844,0.7093862815884476,0.8970913299605419,1.0,5/10,14.38%,ACVRL1;RHOB;CTNNB1;RHOA;CSNK2B
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2501627580433751,0.8199589237174225,0.7622377622377622,0.9564519274802155,1.0,22/68,23.61%,PCCA;MCCC2;TCN2;MTHFR;FOLR2;SLC19A2;SLC19A1;FLAD1;SHMT1;THTPA;MTHFS;MMAB;NNMT;DHFR;MTHFD2;PDXK;LMBRD1;TCN1;BTD;SLC52A1;FPGS;HLCS
prerank,peptidyl-serine phosphorylation (GO:0018105),0.22398036432051557,0.8197887490928331,0.8219584569732937,0.9560720668593606,1.0,29/153,14.46%,ROCK2;PDPK1;CAMK1D;DMPK;SRPK2;MAPK9;RICTOR;LRRK2;PRKCZ;PRKCB;TTK;PRKCA;PKN2;CDK1;CAMK2D;CLSPN;VRK2;LATS1;PRKDC;RPS6KB1;IKBKE;MAPKAPK2;HIPK3;PRKD2;TBK1;MAPK1;MORC3;NLK;PRKCI
prerank,long-chain fatty acid import into cell (GO:0044539),0.36973141317513164,0.8195313994842072,0.6575052854122622,0.9558559580667203,1.0,3/10,10.77%,ACSL1;SLC27A1;RPS6KB1
prerank,determination of bilateral symmetry (GO:0009855),0.30220080019362183,0.8186689060018991,0.7213114754098361,0.9568580636668229,1.0,6/24,15.00%,ODAD3;DNAH11;ARL6;BBS7;PKD2;ODAD2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3003389186121647,0.8186281432093857,0.6984435797665369,0.9562597097821418,1.0,3/25,5.24%,RBPJ;FOXD1;SULF1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.37074777338003123,0.8185314179426877,0.6439232409381663,0.9557482048454339,1.0,3/10,9.87%,EPHA4;ATRAID;RIC1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.34963544239797006,0.8180855788150836,0.6805845511482255,0.9558935624820688,1.0,3/13,8.14%,ALG6;ALG2;ALG9
prerank,defense response to virus (GO:0051607),0.23399601026714978,0.818055439551541,0.7809983896940419,0.9552692333562476,1.0,11/100,7.98%,BCL2;PLA2G10;IFIT3;IFIT2;RNASEL;TRIM5;ZDHHC1;BNIP3;IL6;TRIM56;RNF135
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.34373384628774933,0.8179736608304461,0.6825396825396826,0.9547394022744511,1.0,1/14,1.22%,IL18
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3446529260915956,0.8178748058001548,0.6673076923076923,0.9542311199520677,1.0,1/14,0.98%,PPP2R2B
prerank,positive regulation of JUN kinase activity (GO:0043507),0.31102402025803916,0.8178057202084049,0.6866537717601547,0.9536859263283691,1.0,2/23,2.62%,SASH1;DKK1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2752810686464876,-0.8175931709961588,0.7510822510822511,0.9006380973366683,1.0,14/28,36.01%,ITGB1;NSFL1C;INSC;NDE1;NUMA1;DCTN1;CLASP2;NDC80;SPDL1;PLK1;ESPL1;PKHD1;CLASP1;NUSAP1
prerank,regulation of chromosome organization (GO:0033044),0.3115393556387384,0.8173063043763396,0.6793893129770993,0.953963905995858,1.0,3/22,7.05%,HDAC8;YLPM1;XRCC5
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3336616610204293,0.8166501355731156,0.6765873015873016,0.9545214662528597,1.0,9/16,22.75%,GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;LAMTOR5;RRAGD
prerank,negative regulation of TORC1 signaling (GO:1904262),0.34610601885401676,0.816611542567257,0.6813627254509018,0.9539079432055841,1.0,3/13,7.34%,SZT2;SESN1;RNF152
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2868254950571986,-0.8160920626185765,0.7415254237288136,0.9027192343938661,1.0,12/22,33.35%,DUSP16;PPP1CA;DUSP8;DUSP1;PPM1A;DUSP6;DUSP4;DUSP18;PPM1F;PPP2CA;DUSP7;PDP1
prerank,microtubule anchoring (GO:0034453),-0.3391234324694113,-0.8159319604630616,0.707983193277311,0.9024551769727751,1.0,7/12,35.23%,BICD1;CLASP2;CAMSAP3;SAXO2;PCM1;BCCIP;CLASP1
prerank,negative regulation of transmembrane transport (GO:0034763),0.3696745746243,0.8152967759147636,0.6765285996055227,0.9556950159266102,1.0,2/10,5.86%,OAZ3;PRKCB
prerank,regulation of endopeptidase activity (GO:0052548),-0.22766149113420997,-0.8152805118313629,0.8021108179419525,0.902992336386745,1.0,15/59,18.58%,SPOCK2;SERPINE2;SERPINI1;SERPINF1;SERPINB9;GAPDH;BIRC3;FURIN;PSME3;PSMB8;SPOCK1;PSME1;ATP13A2;TIMP2;SERPINA2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.3350123270380357,-0.8143569787514188,0.7402061855670103,0.9040350351991779,1.0,3/12,11.74%,FOXP1;ZBTB7A;HEYL
prerank,negative regulation of immune effector process (GO:0002698),-0.3316571236088829,-0.814019718675384,0.7029702970297029,0.9040522415422207,1.0,5/13,14.36%,RPS19;CD55;GRN;APPL1;CD47
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32454800827172015,0.8139782896417868,0.6796116504854369,0.9574892216200144,1.0,3/18,7.85%,PRKN;BNIP3;MCU
prerank,regulation of T cell differentiation (GO:0045580),-0.25725415146218816,-0.8127449987244844,0.7510638297872341,0.905644099996603,1.0,7/33,15.69%,RUNX1;CBFB;NFATC2;SOD1;XBP1;TCF7;CAMK4
prerank,regulation of innate immune response (GO:0045088),0.24849150479007673,0.8124348185470486,0.760797342192691,0.9596950929074383,1.0,7/57,8.18%,APPL2;RNASEL;CACTIN;NLRC3;POLR3G;RNF135;LYAR
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2691276695234954,-0.8123546392466627,0.7597254004576659,0.905782300901645,1.0,12/28,23.41%,UBB;NOD1;UBC;RPS27A;TAB3;AAMP;CASP8;UBA52;IRAK1;TNFAIP3;OTULIN;RELA
prerank,organelle disassembly (GO:1903008),0.28670626259517606,0.8122850961129204,0.7099236641221374,0.9592720611750655,1.0,6/33,10.75%,PLK5;UFL1;CDK1;RETREG1;GOLGA2;TEX264
prerank,negative regulation of developmental growth (GO:0048640),-0.2682218525455978,-0.8119521979672455,0.789010989010989,0.9058948425360915,1.0,12/30,27.61%,DCC;PTCH1;RTN4;CDKN1B;SEMA3G;CDKL3;MT3;RTN4R;CDKN1A;FGFR3;ULK2;FGF13
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3457159841109524,-0.8115577574025705,0.7175572519083969,0.9059803954018304,1.0,4/11,21.08%,MTOR;PIH1D1;NOP53;SIRT7
prerank,nucleotide metabolic process (GO:0009117),0.31239679139839294,0.8114430953606054,0.7140115163147792,0.9601686623998038,1.0,6/23,13.14%,FHIT;CTPS2;NMNAT2;ENPP3;NMNAT1;AK1
prerank,NAD biosynthetic process (GO:0009435),0.31752284370873546,0.8114031322193669,0.6992619926199262,0.9595530861476119,1.0,8/20,17.84%,NMNAT2;NADSYN1;PARP10;PARP9;NMNAT1;NUDT12;QPRT;NNMT
prerank,detection of calcium ion (GO:0005513),-0.32410508306352315,-0.8113627345975424,0.7098039215686275,0.905780306392707,1.0,5/13,15.59%,CALM1;RYR2;KCNMB4;KCNIP2;CALM2
prerank,cell differentiation in spinal cord (GO:0021515),0.3623277162090671,0.8111442234908964,0.7004608294930875,0.9593295373725705,1.0,4/10,21.39%,SOX6;SOX13;MDGA1;DRAXIN
prerank,calcium import into the mitochondrion (GO:0036444),0.372850461821449,0.8110873301403239,0.6760869565217391,0.9587592293457686,1.0,3/10,10.46%,MAIP1;MCU;MICU1
prerank,ether lipid metabolic process (GO:0046485),0.3387999831963031,0.8106965764485823,0.7029702970297029,0.9588216253389293,1.0,2/14,8.84%,AGMO;PAFAH1B1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3657488455266754,0.8096475373982547,0.6794354838709677,0.9601371617469254,1.0,1/11,1.00%,FGFR2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.21892707772781778,0.8094767736568801,0.8335832083958021,0.9597615493603407,1.0,26/158,15.55%,WLS;PRKN;PELI2;LPAR1;LTF;ECM1;TRIM5;AKAP13;GJA1;PRKCB;CXXC5;CCL19;SLC20A1;GOLT1B;IKBKE;CFLAR;GPRC5B;TBK1;MAP3K7;UNC5CL;UBE2V1;MTDH;BIRC2;TRIM62;CX3CL1;TMEM9B
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.343250273360528,-0.8091194337128905,0.7219047619047619,0.9089711000371005,1.0,5/11,20.19%,MAP3K5;PDCD10;STK25;CYP1B1;PRKCD
prerank,nucleotide biosynthetic process (GO:0009165),0.3268335133346978,0.808744951740981,0.6918714555765595,0.9604664753990572,1.0,3/18,5.98%,PRPSAP2;NMNAT2;ADSL
prerank,response to organophosphorus (GO:0046683),-0.3115088640266115,-0.8082502339243675,0.7154471544715447,0.9098888560428666,1.0,2/16,1.90%,ABCC9;TRPC3
prerank,magnesium ion transport (GO:0015693),0.3548943914542517,0.8079656921896308,0.6918489065606361,0.9612660004125723,1.0,2/12,4.48%,SLC41A1;MMGT1
prerank,membrane lipid metabolic process (GO:0006643),-0.28235775840522737,-0.8076758169774945,0.7469879518072289,0.9102327167710683,1.0,4/22,9.70%,ST3GAL6;SERINC1;B4GALT4;CERK
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3536767419181658,0.80732599555096,0.6851485148514852,0.9617893204406195,1.0,2/12,5.98%,PRPSAP2;ADSL
prerank,cellular lipid catabolic process (GO:0044242),0.30006611925110227,0.8073104252453824,0.7388059701492538,0.9611329647056273,1.0,3/27,6.79%,CEL;ACADL;ENPP2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.32802418666661887,-0.8070663707536301,0.7218934911242604,0.910726465557774,1.0,9/14,39.62%,RPS3;CD81;RELA;CARD11;KCNN4;TRAT1;CD226;TESPA1;LCK
prerank,positive regulation of double-strand break repair (GO:2000781),0.2705687660343554,0.8069206039096621,0.7394366197183099,0.9611786356063983,1.0,8/39,13.59%,MRNIP;SLF1;WDR48;SPIRE2;ARID2;PRKDC;PARP9;FANCB
prerank,regulation of cytokinesis (GO:0032465),-0.21192480168615666,-0.8068290626292389,0.8472906403940886,0.9105714062367783,1.0,16/78,17.98%,PKP4;CALM1;SH3GLB1;CIT;PLK2;BCL2L1;CUL3;RHOA;GIT1;PIK3C3;KIF13A;CALM2;PRKCE;KLHL9;ENTR1;CETN2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3298524552191066,-0.8067791325161415,0.70703125,0.910095719835117,1.0,6/12,19.90%,WNK3;CNKSR3;NOS1;AHCYL1;SCN1B;ANK3
prerank,regulation of cell projection organization (GO:0031344),0.35335890272734416,0.8064484696313206,0.6865671641791045,0.9613905928398341,1.0,5/13,15.34%,MACF1;NTNG2;CCL19;MYO9A;MOV10
prerank,protein localization to chromosome (GO:0034502),0.28402212810911204,0.8063938906348491,0.7392120075046904,0.9608132811069304,1.0,6/34,7.25%,MRNIP;TPP1;ACD;XRCC5;SLF1;XRCC4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.34800353328929823,-0.8059513241419535,0.7232824427480916,0.9109072098117859,1.0,7/11,51.80%,NFKBIZ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,cholesterol transport (GO:0030301),0.26246590758143085,0.8058106867564174,0.7469670710571924,0.9611945064261652,1.0,7/45,10.19%,CEL;ABCA1;LIMA1;LIPC;ABCA5;APOC1;SOAT2
prerank,DNA recombination (GO:0006310),0.27861537521898194,0.8056547113492215,0.7330895795246801,0.960835864504536,1.0,9/37,17.10%,RAD51B;RAD51C;DMC1;BLM;RTEL1;MRE11;WRN;RAD51;RPAIN
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.241898680823627,0.8049740413924626,0.7680921052631579,0.9613581691733418,1.0,14/82,14.73%,NINL;ALMS1;HAUS4;CEP152;SDCCAG8;CDK1;PAFAH1B1;NEK10;OFD1;HAUS1;SFI1;CEP57;CEP63;CEP164
prerank,response to ionizing radiation (GO:0010212),0.24812794010594671,0.8049668071946312,0.7777777777777778,0.9606875213617401,1.0,14/70,16.11%,EYA1;ANXA1;MRNIP;INIP;BLM;XRCC4;PRKAA1;NHEJ1;INO80;CLOCK;BABAM2;BRSK1;SWI5;RAD51
prerank,regulation of peptide hormone secretion (GO:0090276),0.2485309720419007,0.8047907934353212,0.7946577629382304,0.9603338222624931,1.0,8/67,7.58%,ITPR1;KCNA5;TFR2;CRHBP;CACNA1D;IL6;PRKCA;RAPGEF4
prerank,regulation of NMDA receptor activity (GO:2000310),0.2835651215653194,0.8047151041121816,0.7175572519083969,0.9597991795857008,1.0,8/32,12.85%,DAPK1;SLC6A9;CRHBP;DLG1;DLG4;ACTN2;GRIA4;DLG3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.290879679386552,0.8047016728199645,0.7518248175182481,0.9591514136478836,1.0,15/29,24.98%,EXOSC8;DCP2;LSM5;CNOT8;CNOT7;EXOSC3;LSM3;LSM1;LSM4;DDX6;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,regulation of BMP signaling pathway (GO:0030510),0.2451152846895871,0.8046453319169141,0.8029801324503312,0.9585624155109326,1.0,17/73,15.68%,RBPJ;SMAD6;FOXD1;SPART;SULF1;ITGA3;LRP2;NBL1;FSTL3;LEMD3;SMURF2;TFAP2B;BMPR1A;FSTL1;CDH5;SKI;SMAD4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.22758469058890013,-0.8045973411634488,0.818407960199005,0.9125838091326117,1.0,18/59,23.41%,DAB2IP;UBB;NFKBIA;IKBKB;UBC;RPS27A;BIRC3;NKIRAS1;CHUK;BCL3;TBKBP1;TAB3;UBA52;SHARPIN;AKT1;RBCK1;FAIM;RELA
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.24226501975765236,0.8045447789461944,0.8112903225806452,0.9580873316151807,1.0,18/73,18.72%,JARID2;IGF2;RBBP4;BAZ1B;RBBP7;MTF2;PRMT7;SMARCA5;TAF1A;POLR1F;POLR1A;CGGBP1;TAF1D;PHF1;PHF2;POLR1G;HDAC4;GLMN
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3203499045683703,-0.8045027189995179,0.7255717255717256,0.912171399327619,1.0,5/14,19.88%,TARDBP;YBX3;HNRNPA0;TIRAP;MYD88
prerank,positive regulation of type I interferon production (GO:0032481),-0.21714034841940136,-0.8044334096507685,0.8654822335025381,0.9117225675409268,1.0,22/73,26.75%,LRRFIP1;HSP90AA1;G3BP1;CTNNB1;GAPDH;CHUK;ISG15;CRCP;OAS2;HSPD1;IFIH1;IRAK1;IRF5;MYD88;POLR3D;NFKB2;RELA;POLR2L;POLR3F;STAT1;CGAS;TLR7
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3216950364969828,0.8037317527473496,0.7137404580152672,0.9588978526245818,1.0,4/18,10.71%,DKK1;SOX6;FRS2;HDAC1
prerank,regulation of mitochondrial fission (GO:0090140),0.30046176502961053,0.8036421056809793,0.7148362235067437,0.9583940194585705,1.0,4/24,7.85%,PRKN;LRRK2;BNIP3;MCU
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3032385656018698,-0.8027119336566669,0.7505030181086519,0.9140612339420476,1.0,6/16,20.49%,SRSF1;PRPF39;CWC15;SNRPC;DCPS;RBM22
prerank,negative regulation of macroautophagy (GO:0016242),0.29534854315121273,0.802454453349784,0.7048872180451128,0.9598529868585272,1.0,11/26,22.12%,LRRK2;NUPR1;RUBCN;TMEM39A;LZTS1;FEZ1;TSC1;PIK3CA;CLEC16A;TSC2;SMG1
prerank,response to glucose (GO:0009749),0.2661672676191177,0.8023140808650768,0.7487001733102253,0.9594125415546162,1.0,6/46,7.95%,TCF7L2;ZBTB20;PRKAA2;IGF1R;PRKAA1;SLC30A8
prerank,regulation of immunoglobulin production (GO:0002637),0.3051856127732542,0.8022662667874966,0.7323943661971831,0.9588195143733056,1.0,2/23,6.76%,RBP4;IL6
prerank,nucleic acid metabolic process (GO:0090304),-0.2155875960831498,-0.8021457874845932,0.8526570048309179,0.9144300213636405,1.0,23/69,26.46%,HNRNPK;RBFOX2;HNRNPU;HNRNPA3;HNRNPH2;DDX54;POLR2C;TOPBP1;HNRNPA0;NT5E;POLR2G;GTF2F2;PCBP1;PTBP1;DDX24;METTL3;WDR74;DUSP11;POLR2L;HNRNPF;HNRNPM;HNRNPD;LSM8
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.27887332547413657,0.8019550329927692,0.7441441441441441,0.9587334155222369,1.0,3/34,6.76%,RBP4;LACC1;IL6
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.29345604889755916,-0.8019186930415872,0.7436440677966102,0.9142120255872898,1.0,9/18,34.09%,EDN1;RFK;AGTR1;PDP2;POR;AGT;NOD2;PDP1;PARK7
prerank,DNA double-strand break processing (GO:0000729),0.3202494549855916,0.8018157680004993,0.7091633466135459,0.9583079599988293,1.0,7/18,23.62%,RNF138;BLM;MRE11;KAT5;RAD50;NBN;RAD52
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3057726460605116,0.8015526180403038,0.7175572519083969,0.9581079977231806,1.0,9/22,25.30%,CCNT2;CCNT1;CDC73;ELL;TCERG1;SUPT4H1;THOC1;BRD4;CDK13
prerank,regulation of chemokine production (GO:0032642),-0.2522561035061556,-0.8005589479476058,0.775599128540305,0.9158947912679494,1.0,16/36,35.47%,FOXP1;IL33;APP;CD74;CSF1R;SIGIRR;ACKR1;AGER;SNAI2;TLR7;TREM2;TLR4;LPL;TSLP;IL7;ADAM17
prerank,regulation of interleukin-13 production (GO:0032656),0.34207027192949857,0.8004332378595853,0.6781376518218624,0.9594852724677372,1.0,2/13,5.49%,IL18;PRKCZ
prerank,positive regulation of receptor internalization (GO:0002092),-0.2795467691976522,-0.8003165871606518,0.7805907172995781,0.9157504777818283,1.0,10/22,21.02%,SFRP4;ARRB1;VEGFA;CD63;PICK1;GREM1;ARRB2;INSR;FMR1;ATAD1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2801959557722152,-0.8000466500954322,0.7423312883435583,0.9150660876685932,1.0,10/21,34.04%,DDB1;RBX1;RPA1;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2801959557722152,-0.8000466500954322,0.7423312883435583,0.9150660876685932,1.0,10/21,34.04%,DDB1;RBX1;RPA1;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,regulation of hippo signaling (GO:0035330),0.3296734225051463,0.7998810138248962,0.686,0.9597938575537214,1.0,4/17,10.50%,VGLL4;WWC1;WWC2;SCHIP1
prerank,glucan catabolic process (GO:0009251),0.3306169888343427,0.7996736852388339,0.7124735729386892,0.9594924102622168,1.0,2/15,4.59%,PHKB;MGAM
prerank,macromolecule catabolic process (GO:0009057),0.2938395387689298,0.799569570447531,0.7205882352941176,0.9589986163909687,1.0,5/26,9.09%,CLPX;NEDD4;TPP1;PIK3R4;UVRAG
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2598046419946354,0.7993772020619989,0.7731239092495636,0.9587031829913113,1.0,6/49,6.28%,KMT2A;MTURN;ASH2L;TNRC6B;TNRC6A;SETD1A
prerank,motile cilium assembly (GO:0044458),0.35929947900320136,0.7991027822663173,0.689161554192229,0.9585522222516653,1.0,12/12,64.10%,DNAAF3;RSPH9;E2F4;MCIDAS;BBOF1;BBS5;SPATA6;ZMYND10;DNAAF1;RSPH6A;CCDC39;CCDC40
prerank,arachidonic acid metabolic process (GO:0019369),-0.2558409510214465,-0.7987985003400904,0.7972350230414746,0.9165196697860428,1.0,8/35,15.18%,MGLL;GPX4;PTGIS;PTGS2;PTGDS;ALOX12;PLA2G4A;CYP1B1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.2804018133989423,0.7983830624804784,0.7408759124087592,0.9591973338793386,1.0,5/33,10.44%,OSER1;ANXA1;IL6;SIRPA;ABL1
prerank,regulation of inclusion body assembly (GO:0090083),0.3596354182295692,0.7975125671239659,0.7270788912579957,0.9600827754423498,1.0,1/11,2.45%,SNCAIP
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2616773857268313,-0.7967485477328969,0.7787610619469026,0.9192459583122091,1.0,11/31,29.63%,TOMM20;HSPD1;ROMO1;PEX1;PEX5;PEX10;TIMM50;PEX16;TIMM44;CHCHD4;DNLZ
prerank,regulation of cytokine production (GO:0001817),0.21929924462571168,0.7967275654182262,0.8674698795180723,0.96076358595114,1.0,11/126,7.89%,C1QTNF3;LGR4;IGF2BP1;PLA2R1;LTF;ANXA1;CCN4;SYT11;IRF8;IL6;TRIM56
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.22532336116832877,-0.7959788989591403,0.8521939953810623,0.9199360387726553,1.0,14/54,23.79%,RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;CDKN1B;TNKS1BP1;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.2983449527581826,-0.7954415980559533,0.7173076923076923,0.920240141903713,1.0,8/17,28.73%,BCL2L1;CLU;BBC3;TIMM50;BAX;FIS1;BID;SFN
prerank,synaptic membrane adhesion (GO:0099560),0.32981952129591774,0.795375237691455,0.7056530214424951,0.9625193157359329,1.0,3/14,12.62%,GPC6;PTPRD;GPC4
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2860417685364837,-0.7952180628699641,0.7645875251509054,0.9200252389915424,1.0,4/20,12.75%,PDE4D;ADRA1B;ADRA1A;ADRB2
prerank,response to cAMP (GO:0051591),0.2675561824861405,0.7952168595237956,0.7476099426386233,0.9621217354650632,1.0,4/37,5.21%,SLC5A5;DUOX2;CRHBP;AANAT
prerank,positive regulation of actin nucleation (GO:0051127),0.3672406110932271,0.7949967366292391,0.7016806722689075,0.9618393498532357,1.0,4/11,13.05%,ABI2;WASF1;WASF3;FCHSD2
prerank,hyaluronan metabolic process (GO:0030212),-0.2800827519228267,-0.7948822740148245,0.7811158798283262,0.9200086990302473,1.0,6/23,8.91%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.29018267568202283,-0.7935340202612117,0.7529880478087649,0.9216506155633234,1.0,4/19,14.08%,SLC26A2;PAPSS2;BPNT2;SLC35B2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24590016040031906,0.7935103340641833,0.79050736497545,0.963841076527131,1.0,12/60,16.40%,FGFR4;SMOC2;PDGFRB;ACD;XRCC5;CCT6A;FBXO4;PRKD2;MAPK1;TCP1;PARN;HGF
prerank,cholesterol efflux (GO:0033344),0.3085446126992025,0.7934806227924476,0.7192660550458716,0.9632282055039372,1.0,4/20,10.19%,ABCA1;ABCA5;APOC1;SOAT2
prerank,positive regulation of bone resorption (GO:0045780),-0.3334650648146697,-0.7934284274637723,0.7330895795246801,0.9212631356787631,1.0,3/11,16.00%,SPP1;TNFRSF11A;PLEKHM1
prerank,organophosphate catabolic process (GO:0046434),0.35595028872709017,0.7932985784444826,0.708984375,0.962864370295489,1.0,11/11,64.43%,ENPP2;ABHD12;PLBD2;PNLIPRP2;APOA2;LIPG;ANGPTL3;PON1;PDXP;NUDT15;PLBD1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2779191367441666,0.7929799280843125,0.7611940298507462,0.9627571737492179,1.0,10/37,18.06%,PRKN;PCSK9;OPTN;TFAP2A;DLG4;PLIN5;SDCBP;EDNRB;TRAP1;NCOR1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.27672639785990644,-0.7929231068803314,0.7854166666666667,0.9214998247824818,1.0,11/24,30.36%,STMN2;STMN1;TPPP;STMN4;TPPP3;STMN3;CKAP5;KIF14;TRPV4;FGF13;NCKAP5L
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3246656825882505,-0.7926909374753062,0.748046875,0.9213172955284843,1.0,4/12,20.87%,STMN2;STMN1;TUBB4A;MAPRE1
prerank,regulation of exosomal secretion (GO:1903541),0.3091930754729792,0.792395882580817,0.7148514851485148,0.9631089739433761,1.0,1/19,1.37%,PRKN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2524091879785281,-0.7922598471975986,0.8270509977827051,0.921467088902206,1.0,9/32,20.17%,RPS19;PGLYRP1;DEFA6;GAPDH;RPL30;ROMO1;RNASE3;CCL13;ANG
prerank,modulation by host of viral genome replication (GO:0044827),0.34285576295641135,0.7922509770527632,0.7114967462039046,0.9626904550865798,1.0,1/13,1.37%,PRKN
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.26372311015207306,0.792214362661083,0.7634011090573013,0.9620917245537923,1.0,4/44,3.96%,WNK4;ATP1B3;NOS1AP;ANK2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.26474990669503595,-0.7921594507082964,0.7918367346938775,0.9210597026479234,1.0,7/28,19.29%,DAB2IP;NGF;BLOC1S2;CASP8AP2;CASP8;SPI1;TNFRSF10B
prerank,cytoplasmic microtubule organization (GO:0031122),0.249058782791496,0.7919320955827477,0.7758913412563667,0.961934897502172,1.0,7/54,9.85%,FIGN;HOOK2;FIGNL2;KATNAL2;DLG1;TUBGCP6;TUBGCP2
prerank,microtubule-based transport (GO:0099111),-0.3267319313612429,-0.791410408329811,0.7490421455938697,0.9216729049517156,1.0,6/12,36.45%,SPAG17;DNAAF2;DYNC1I1;CABYR;CCDC40;DNAAF4
prerank,positive regulation of organelle organization (GO:0010638),-0.25793775740458313,-0.7912957767466456,0.7860169491525424,0.9213023448570499,1.0,8/32,18.89%,PPARGC1A;SYNJ1;GSK3B;C2CD5;SORBS3;ADRB2;SMCR8;LIG4
prerank,cellular response to oxygen levels (GO:0071453),0.36376586074087414,0.7905153993174369,0.7107438016528925,0.9637393392489028,1.0,3/10,9.31%,CPEB4;TMEM199;ATP6V0D1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3110913034297201,0.7902242015528805,0.720532319391635,0.9636307382644321,1.0,3/18,6.98%,ANXA1;SSTR2;UBE2L3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2454279309266356,0.7900107469954792,0.7969283276450512,0.9633165058158362,1.0,19/57,21.11%,HUS1B;CDC14B;MRNIP;BLM;CDK1;CLSPN;MDC1;PRKDC;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;RAD9B;NBN;STK33
prerank,negative regulation of transferase activity (GO:0051348),-0.2656811909488514,-0.7896334260819484,0.7823275862068966,0.9233707583372998,1.0,5/28,11.31%,PINX1;GSK3B;HNRNPU;CDKN1B;MEN1
prerank,sulfur compound catabolic process (GO:0044273),0.2711372699108334,0.789605212544127,0.75,0.9633810588264332,1.0,4/38,5.37%,FMOD;OGN;OMD;PRELP
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.32508208569192226,0.789506445281795,0.7197696737044146,0.9628911137872768,1.0,3/15,6.98%,ANXA1;SSTR2;UBE2L3
prerank,transport along microtubule (GO:0010970),-0.31746924525765013,-0.7894829191271474,0.7474120082815735,0.9230569395099009,1.0,5/13,31.37%,COPG1;APP;CAMSAP3;APBA1;DYNC1I1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.34703044094052526,0.7892753399246095,0.7233201581027668,0.9626227103450105,1.0,2/12,7.24%,METTL4;BLM
prerank,regulation of transferase activity (GO:0051338),0.31685208355845873,0.7880349455021283,0.7372708757637475,0.9641098501999671,1.0,4/17,10.37%,SLAMF8;PARP4;FEM1B;PPP1R3F
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.300387061906991,0.7879506644237317,0.7621722846441947,0.96358633953987,1.0,5/23,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,cellular response to superoxide (GO:0071451),-0.34757610019144647,-0.7879175760840944,0.7540650406504065,0.9249620781520628,1.0,3/10,13.96%,NOS3;SOD1;MT3
prerank,negative regulation of T cell activation (GO:0050868),-0.24848545663281743,-0.7877064433014619,0.8034557235421166,0.9247096426684053,1.0,15/35,33.29%,TNFRSF21;CEACAM1;DUSP3;LAPTM5;CD274;JAK3;NCKAP1L;SDC4;FCGR2B;CEBPB;CD80;LAX1;IL4I1;PTPN22;GPNMB
prerank,mammary gland development (GO:0030879),0.3029967072870798,0.7876632079631587,0.7387218045112782,0.9634195491933989,1.0,5/21,14.40%,WNT4;ARHGAP35;APLN;JAK2;GLI2
prerank,histone deacetylation (GO:0016575),0.26425852705597036,0.7875227999433708,0.7950963222416813,0.9630110743429432,1.0,4/43,4.20%,PRDM5;TBL1XR1;MIDEAS;HDAC8
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3199830907303415,0.7874010848707722,0.7267080745341615,0.962562354080768,1.0,2/16,4.59%,PHKB;MGAM
prerank,positive regulation of ion transport (GO:0043270),0.2527421827505548,0.7873118017152414,0.8013816925734024,0.962054935593044,1.0,13/48,18.18%,GPD1L;MYLK;ANK2;CACNA1D;DLG1;CCL4;SCN3B;ACTN2;GDNF;CHRNB2;DRD2;ANO6;CAMK2A
prerank,protein K63-linked deubiquitination (GO:0070536),-0.25760578697676106,-0.787283198703321,0.7960526315789473,0.924800128614077,1.0,10/31,25.91%,ATXN3;OTUD7A;ZRANB1;USP50;OTUD1;USP8;OTUD7B;TNFAIP3;USP33;YOD1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.19375350183321144,-0.7867105830111952,0.9277456647398844,0.9251461366219438,1.0,35/117,28.60%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;MYH9;RAMP1;ADCY7;PTHLH;CYSLTR1;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;CD81;IAPP;CALCRL;VIPR2;MC5R;YES1;GPR27;HRH2;TSHR;GGT1;GLP2R;NPSR1;ADCYAP1;GNB1;TREM2;GPR20;KARS1;CALCA;CD163
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2761863068374065,-0.7865876290013696,0.7593360995850622,0.9247750474592832,1.0,8/23,26.11%,ITGB1;NSFL1C;INSC;NDE1;NUMA1;DCTN1;NDC80;SPDL1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.33246576184432564,-0.7856293045072654,0.7279843444227005,0.9256635529881935,1.0,4/11,12.32%,FBXO7;RACK1;ATF4;REST
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18201589249267458,-0.785346280475841,0.9659863945578231,0.9255289670308687,1.0,55/184,26.38%,HSP90AA1;UBB;PKD1;BUB3;UBC;RPS27A;CUL3;PSMD13;PSMF1;DDB1;APPL1;ZFP36L1;PSMB10;YWHAG;TUBB4B;DCTN3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;TUBA1A;PSME1;ODF2;ANAPC16;NDE1;UBA52;PSMB3;TUBB4A;ID2;CETN2;CDK2;BUB1B;UBE2D1;CKAP5;PSMD5;TFAP4;HAUS6;SKP1;MAPRE1;DCTN1;CEP41;ANAPC7;PSMD9;PSMB4;NEK11;RGCC;HMMR;KIF14;KNTC1;PSMD10;CDC14A;PCM1
prerank,AMP metabolic process (GO:0046033),0.34059821120044287,0.7852377844311293,0.7223300970873786,0.9649379161259201,1.0,2/13,5.98%,AMPD3;ADSL
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2700690727946796,-0.7851548574626646,0.7848101265822784,0.9252885094010457,1.0,7/24,14.11%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MIEF2;MTCL1
prerank,regulation of defense response to virus (GO:0050688),0.32853738719699893,0.7850411566613645,0.7230443974630021,0.9646029445381138,1.0,5/14,19.05%,RNF216;ITCH;PCBP2;TRAF3IP1;ILRUN
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.34517207794082455,0.7849109330612687,0.7045951859956237,0.9641537467380303,1.0,3/12,8.73%,PRKCB;PRKCA;CDK1
prerank,nucleic acid-templated transcription (GO:0097659),0.2666642644810155,0.7844109098095073,0.8047445255474452,0.9643891063486284,1.0,5/42,10.93%,POLR2D;SCX;THAP1;POLR2A;DTX1
prerank,import into nucleus (GO:0051170),0.23580384316443986,0.7837432311186656,0.8217179902755267,0.9648476586823345,1.0,17/73,22.01%,APPL2;IPO13;PRICKLE1;NUTF2;SMN1;NUP107;TNPO1;NXT2;RPAIN;IPO9;NUP214;KPNB1;GEMIN5;SNRPF;TSC2;TPR;RANBP17
prerank,cellular response to radiation (GO:0071478),-0.24294473103224107,-0.7836074842900885,0.8431372549019608,0.927085238879845,1.0,9/40,21.71%,NET1;RHOB;EEF1D;SPIDR;TNKS1BP1;RAD9A;LIG4;GADD45A;CDKN1A
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2824133363918728,0.7833292308518239,0.7432188065099458,0.964905624799828,1.0,13/30,20.60%,VAMP5;MACF1;KRT18;OPTN;GGA2;BLZF1;GOLPH3L;RAB26;PREPL;BBS1;GOLGA4;BBS2;RAB34
prerank,protein localization to synapse (GO:0035418),-0.3197683865127665,-0.7828658558742514,0.7467889908256881,0.927712834488401,1.0,4/12,13.54%,ZDHHC15;NRXN1;PCLO;BSN
prerank,negative regulation of viral process (GO:0048525),-0.223423724539573,-0.782639263048767,0.8560975609756097,0.9275103536868969,1.0,20/57,24.36%,PPIA;TRIM14;LARP7;ISG15;OAS2;RSAD2;SHFL;SRPK1;TRIM13;IFIH1;FAM111A;N4BP1;BST2;MID2;TRIM27;IFITM3;UBP1;CHMP3;BANF1;STAT1
prerank,protein deacetylation (GO:0006476),-0.23393223737318208,-0.7817347165505312,0.8465346534653465,0.9283277467980737,1.0,14/41,23.56%,FLNA;HDAC5;MORF4L1;RBM14;SIN3B;SIRT4;BRMS1;HDAC11;SIRT7;HDAC7;HDAC9;HDAC6;RCOR3;SIRT6
prerank,positive regulation of axon extension (GO:0045773),-0.2749822137769258,-0.7812916504701867,0.7655310621242485,0.9284616914404423,1.0,4/22,11.59%,SEMA7A;SHTN1;VEGFA;DBNL
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2508677068780406,-0.7811482014094593,0.8333333333333334,0.9281461178417878,1.0,13/33,31.31%,CPSF7;CPSF3;SYMPK;CLP1;CPSF2;CSTF2T;PCF11;CSTF2;MAZ;SNRPG;LSM11;CSTF1;CPSF1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2934513582162813,0.7807098029766375,0.7602230483271375,0.968658456498159,1.0,3/22,5.10%,FANCA;DUSP10;CTLA4
prerank,positive regulation of protein deacetylation (GO:0090312),-0.29922964578081096,-0.780354666978561,0.7461832061068703,0.9288046165449645,1.0,4/14,17.36%,APLNR;AKAP8;BRMS1;CTBP1
prerank,polyol biosynthetic process (GO:0046173),0.3241166931942059,0.7801786521926898,0.7302231237322515,0.9688722786220764,1.0,1/16,1.11%,CYP27A1
prerank,regulation of type I interferon production (GO:0032479),0.22789586308835166,0.780033599828574,0.8467741935483871,0.9684606930138638,1.0,21/84,14.28%,IRF8;XRCC5;POLR3GL;POLR3G;TRIM56;RNF135;RNF216;ITCH;IRF3;UBA7;PRKDC;PCBP2;IKBKE;CYLD;TBK1;ZBP1;MRE11;DDX41;POLR3C;CREBBP;NLRX1
prerank,regulation of multicellular organismal development (GO:2000026),-0.2631575757269233,-0.7792352864330815,0.7995867768595041,0.9299064735611651,1.0,10/25,25.06%,SOX17;BAG6;SPAAR;OAS2;MYSM1;INSR;HPSE;GBX1;DUSP6;RAB14
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.26913918146387505,-0.7787554086000692,0.7858672376873662,0.9300511698605842,1.0,7/25,19.27%,RAC1;RIN3;APP;ANKRD13A;ABCA2;ANKRD13B;PSEN1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.31392039639016833,-0.7785589091407344,0.7590361445783133,0.9297787618121076,1.0,4/13,15.17%,APOD;CHP1;RANGAP1;MDFIC
prerank,Golgi organization (GO:0007030),0.21917696961204725,0.7780090958248946,0.8953125,0.9711424358422679,1.0,19/112,11.12%,TANGO2;OBSL1;DYNC2H1;PLK5;LRRK2;RAB30;FAM174B;MYO18A;OPTN;STX16;UBXN2B;DYM;BLZF1;CDK1;CUL7;TRAPPC8;GOLGA2;TJAP1;VTI1A
prerank,protein targeting (GO:0006605),-0.19444990125273381,-0.7777311884152522,0.9423631123919308,0.930494050420279,1.0,44/118,32.09%,RASSF9;RPL11;FBXO7;TOMM20;ZDHHC14;ZDHHC15;CDC37;GOLGA7;AQP11;CACNG3;ZDHHC2;ZDHHC7;TOMM22;TIMM9;SRPRB;NACA;SEC61G;TIMM10B;TIMM13;BCAP31;ZFAND2B;PEX1;ZDHHC4;TIMM22;TOMM7;MFN2;ZDHHC20;ICMT;SRP14;PEX16;HAP1;RTP4;SEC63;SORL1;FIS1;TIMM44;TSPO;AIP;RABGEF1;TOMM34;ZDHHC18;SPCS3;NACAD;AP4B1
prerank,establishment of protein localization to organelle (GO:0072594),0.23787473331390604,0.7774186664761462,0.8347386172006745,0.9714994635476276,1.0,10/72,13.83%,APPL2;IPO13;HK2;PRICKLE1;LAMP2;NUTF2;NUP107;TNPO1;LAMP5;NXT2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2321090071678373,0.777198907726143,0.8525121555915721,0.9712088790255908,1.0,21/80,18.85%,DENND2A;SNX6;PLEKHJ1;STX16;TMEM87A;RIC1;WASHC1;TMEM87B;VTI1A;SNX12;PHETA1;TRAPPC10;TBC1D17;RAB9A;VPS26A;PREPL;VPS54;VPS35;RHOBTB3;GOSR1;RAB29
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.30348211835364886,-0.7771476467363329,0.7613168724279835,0.9302839612318606,1.0,4/15,15.77%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.30348211835364886,-0.7771476467363329,0.7613168724279835,0.9302839612318606,1.0,4/15,15.77%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,quinone biosynthetic process (GO:1901663),0.32709267283625676,0.7769698445183677,0.724,0.9709248137763699,1.0,4/14,11.44%,FDXR;COQ10A;COQ8B;COQ6
prerank,regulation of leukocyte activation (GO:0002694),-0.3095063432014008,-0.7769519978909388,0.78125,0.9300127290127149,1.0,5/14,16.77%,CD200;GPR137B;GPER1;CD74;MIF
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2704447003065198,-0.7767084667594429,0.7991543340380549,0.9298282833564174,1.0,8/24,28.53%,TTLL7;VKORC1L1;VKORC1;TTLL8;CEP41;TTLL6;AGTPBP1;TTLL2
prerank,base-excision repair (GO:0006284),-0.22976050192725417,-0.7763408831273129,0.8615023474178404,0.9298162169011795,1.0,23/48,34.77%,SMUG1;RPA1;OGG1;POLQ;NEIL1;NEIL3;POLE;POLD3;POLB;NTHL1;POLD1;HUWE1;XPA;POLL;ERCC5;LIG3;RFC5;NEIL2;RPA3;DNA2;FEN1;RPA2;XRCC1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.3164726070237824,0.776256498515895,0.7474949899799599,0.971432419279294,1.0,4/15,16.97%,NLGN2;ZDHHC3;USP46;DRD2
prerank,lipoprotein biosynthetic process (GO:0042158),0.34136256153574174,0.7754695224835154,0.7191489361702128,0.9721252493159351,1.0,2/11,5.75%,ATG10;WIPI1
prerank,apoptotic DNA fragmentation (GO:0006309),0.3200707092529642,0.7754399489831713,0.7344398340248963,0.9715160114987184,1.0,4/16,18.68%,CECR2;DICER1;DFFA;KPNB1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2712529558895684,0.7750155148057406,0.7935606060606061,0.9715226055597206,1.0,5/33,10.51%,MTURN;STAT5B;ARNT;MED1;PRKDC
prerank,mRNA stabilization (GO:0048255),-0.2328730114766815,-0.7746678785736756,0.8452655889145496,0.9317765139002637,1.0,12/40,22.30%,TARDBP;PABPC1;YBX3;HNRNPU;YBX1;FUS;TENT5A;HNRNPA0;TIRAP;MYD88;SLC11A1;RBM24
prerank,protein localization to nucleus (GO:0034504),-0.19744841877256644,-0.7746242280674631,0.9168975069252078,0.9312886017029351,1.0,29/102,21.43%,RPL11;PINX1;CALR;SIX1;HNRNPU;ZBTB7A;PPP1R10;APPL1;TOR1B;ARL2BP;BCL3;STAT3;HHEX;LMNA;COL1A1;SIX4;E2F3;NXT1;HEATR3;CSE1L;NUP85;FAM53C;NOP53;AKT1;SKP1;CTDNEP1;NUP133;BMP4;POM121
prerank,phosphate ion transmembrane transport (GO:0035435),0.3460140680182737,0.7741199428549581,0.7410526315789474,0.9722707247015548,1.0,3/12,9.59%,SLC20A2;SLC25A11;SLC20A1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.25456795141700067,0.7739536578499151,0.7975133214920072,0.9718962192979294,1.0,8/47,12.17%,BMP7;MEDAG;TMEM64;NAPEPLD;LMO3;SYAP1;ASXL2;SOX13
prerank,hexose transmembrane transport (GO:0008645),0.29525879902131036,0.7737388906043573,0.7587548638132295,0.9715709801818898,1.0,3/21,6.09%,SLC2A12;SLC45A3;SLC2A10
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.20370534374498717,-0.7735040344213371,0.9066666666666666,0.9323194148859935,1.0,25/80,26.17%,CAV1;UBE3A;UBB;FAM107A;CUL3;RPS2;BIRC3;DERL1;RBX1;NDFIP2;DCUN1D1;DCUN1D2;WFS1;LAPTM5;SPRTN;UBE2D1;PINK1;NDFIP1;TRIB3;HUWE1;SPSB4;ARRDC3;PTTG1IP;TSPYL5;PSMD10
prerank,cellular response to gamma radiation (GO:0071480),-0.29161297933093394,-0.7729560533390702,0.8048780487804879,0.9325784457167134,1.0,7/17,25.33%,RPL26;CRYAB;ATR;TLK2;TMEM109;HRAS;TSPYL5
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.22733394770082152,-0.7724130303081801,0.8744493392070485,0.9328020441496016,1.0,16/48,30.53%,PDE4D;SLC7A5;IL1R1;CYRIB;ISG15;HSPD1;TRIM27;TXK;SLC11A1;CCR2;IL12RB2;TLR7;TLR4;RASGRP1;FADD;ZFPM1
prerank,regulation of B cell differentiation (GO:0045577),-0.28425441977026117,-0.7715906038630336,0.8229376257545271,0.9334638501274554,1.0,6/17,20.81%,ZFP36L1;XBP1;ID2;INHA;PPP2R3C;NCKAP1L
prerank,fatty acid metabolic process (GO:0006631),0.21717112424992907,0.7714189807609633,0.9065849923430321,0.9747422846809769,1.0,10/115,8.71%,PPARA;ACADSB;ACSL1;CEL;ACOT4;CPT2;ECHDC3;LIPH;LIPC;AASDH
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.24186845704034166,0.7712547348969083,0.8336192109777015,0.9743352172177565,1.0,3/55,2.95%,PID1;PRKN;PDGFRB
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.30230697474243773,-0.7712346264622025,0.7847082494969819,0.933421215961065,1.0,13/15,49.81%,CD55;NKAP;CCR2;SHH;SYK;IL12A;IL23A;EBI3;IHH;IL23R;PNP;HSPH1;IL12B
prerank,superoxide metabolic process (GO:0006801),0.28040257150930753,0.7709978750736,0.7555970149253731,0.9741136091191063,1.0,4/29,4.41%,SOD3;DUOX2;TAFA4;SH3PXD2B
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3144130963632584,0.770764186054844,0.7669322709163346,0.9738230061315016,1.0,4/18,7.50%,PDPN;IL6;SMAD3;DDR2
prerank,protein-DNA complex assembly (GO:0065004),0.21929684312231632,0.7704575108169245,0.8751902587519026,0.9736658232205889,1.0,24/116,17.37%,TCF4;CDK7;DDB2;DMC1;PSME4;PSMA2;PSMA3;RSF1;KAT6B;PSMD8;SMARCA5;PSMD3;NAP1L3;CUL4B;ORC2;NAA60;MNAT1;RAD23B;ORC3;MCM2;RAD51;NAP1L1;ORC6;XPC
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3492951400622756,0.7701068791995803,0.7799145299145299,0.97355377204574,1.0,4/10,16.75%,STAT5B;JAK2;LYN;GHR
prerank,positive regulation of cell communication (GO:0010647),0.2809735741124372,0.7699819235438472,0.7746212121212122,0.9730882155191808,1.0,1/28,0.46%,WLS
prerank,non-motile cilium assembly (GO:1905515),0.2712610319053489,0.7698791752422446,0.7922794117647058,0.9725820639835235,1.0,6/30,11.24%,TTC8;TBC1D32;ARL13A;RPGRIP1L;CEP89;IFT122
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2218124073877723,-0.7694612975207324,0.8827751196172249,0.9353851469631421,1.0,12/47,18.28%,TGFB2;DAB2IP;MID1;PPIA;PDCD10;FOXO1;STK25;EPHB1;FAS;PER1;MAP2K2;GREM1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3109619426241972,0.7692718727151029,0.7655954631379962,0.9729022966894149,1.0,2/18,5.54%,MSRA;MTHFR
prerank,regulation of embryonic development (GO:0045995),0.2653629180729779,0.769099738665068,0.7785977859778598,0.9725101590415861,1.0,7/34,11.91%,PLCB1;PHLDB2;NIBAN2;WDPCP;CDK1;CCSAP;RBM19
prerank,protein complex oligomerization (GO:0051259),0.2283469426043353,0.7688429122704721,0.8715890850722311,0.9722697944617423,1.0,17/85,12.71%,UPB1;ALS2;RNF213;IKZF4;NOL3;ARC;BLM;MCU;RNF135;TMEM120B;YME1L1;GSDMD;MICU1;OXA1L;UGDH;PKD2;NINJ1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3444525340454841,0.768764927569354,0.7149122807017544,0.9717413691713649,1.0,1/11,2.18%,BCL2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.27869430771772646,-0.7687125938183825,0.775330396475771,0.9358776349350512,1.0,5/20,19.22%,ACVRL1;PTCH1;ACVR1;GREM1;DSCAML1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2530741004275018,0.7683024037177312,0.7903225806451613,0.9718063458556553,1.0,8/45,12.19%,NCAM1;SP100;TRIM5;IRF8;CAMK2D;IRF3;JAK2;TRIM26
prerank,selective autophagy (GO:0061912),-0.2159013700969447,-0.7681955139749244,0.8624338624338624,0.9360219708784122,1.0,23/56,35.21%,VIM;UBB;DYNLL2;UBC;RPS27A;MAP1LC3B;WDFY3;CFTR;UBA52;AUP1;PEX5;HDAC6;RAB7A;ULK2;KLHL3;STBD1;DYNC1I1;DYNC1H1;ACBD5;PARK7;PCNT;UFC1;DYNLL1
prerank,regulation of keratinocyte migration (GO:0051547),0.3324170845934512,0.7677553172026259,0.7274590163934426,0.9720481390342948,1.0,3/12,7.48%,MAPRE2;MMP9;PTEN
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3255603052588251,0.767554460862859,0.7609561752988048,0.971717017494671,1.0,1/15,1.27%,STXBP4
prerank,regulation of cell division (GO:0051302),0.23016464433614126,0.7669665505636766,0.8621848739495799,0.97202668084916,1.0,20/72,19.43%,FGFR2;PLK5;FGF1;NCOA3;BLM;BIRC6;PIK3R4;UVRAG;FLCN;ZFYVE26;TXNIP;CIB1;MYO19;CSPP1;ORC6;SETD2;KLHL13;RAB11FIP3;PRPF40A;KIF18B
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.32231477843850576,-0.7669030590301604,0.7687861271676301,0.9373574763006008,1.0,3/12,13.03%,ELOVL5;FADS2;ELOVL1
prerank,photoreceptor cell development (GO:0042461),0.3259180683690954,0.7658501940442553,0.7540322580645161,0.9732210820017105,1.0,2/14,4.11%,TULP1;ARL3
prerank,glycerol metabolic process (GO:0006071),-0.3343954134570765,-0.7655482030059789,0.7956777996070727,0.9387574038442164,1.0,3/10,18.36%,TPI1;PGP;COQ2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.1879385776609048,-0.7654190339290626,0.9570200573065902,0.9383892472941462,1.0,34/116,28.60%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;MYH9;RAMP1;ADCY7;PTHLH;CYSLTR1;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;IAPP;CALCRL;VIPR2;MC5R;YES1;GPR27;HRH2;TSHR;GGT1;FCGR2B;GLP2R;NPSR1;ADCYAP1;GNB1;TREM2;GPR20;CALCA;CD163
prerank,leukotriene metabolic process (GO:0006691),-0.27129774597316764,-0.7652846477498164,0.8004291845493562,0.9380254804625687,1.0,10/19,37.39%,ALOX12;PLA2G4A;GGT1;LTA4H;PLA2G5;ALOX5AP;MGST2;DPEP1;ABCC1;GGT5
prerank,positive regulation of protein import (GO:1904591),-0.24926321682887986,-0.7649978655914746,0.8449438202247191,0.9378914156350515,1.0,11/30,24.56%,CDH1;FLNA;TGFB1;ARHGEF5;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,cellular response to leucine (GO:0071233),-0.33441269792813777,-0.7649473974848273,0.7811320754716982,0.9368643647577757,1.0,3/10,9.55%,SESN3;MTOR;SESN2
prerank,response to leucine (GO:0043201),-0.33441269792813777,-0.7649473974848273,0.7811320754716982,0.9368643647577757,1.0,3/10,9.55%,SESN3;MTOR;SESN2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.32761531072642425,-0.7645477428620953,0.7752380952380953,0.9368588075084121,1.0,5/11,30.96%,LARP7;FBL;EXOSC10;EXOSC5;TENT4B
prerank,autophagosome assembly (GO:0000045),0.2457609506658161,0.7644460773861115,0.8298969072164949,0.9748239503312042,1.0,14/52,17.14%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;TRAPPC8;ATG9A;STX17;RAB43;AMBRA1;ATG3;RUFY4;IRGM;ATG16L2
prerank,protein sumoylation (GO:0016925),0.24604027808038886,0.764028806338572,0.8169014084507042,0.9748288379804585,1.0,4/49,10.15%,EYA1;NDC1;PIAS1;NUP107
prerank,negative regulation of DNA recombination (GO:0045910),0.2504491994064164,0.7636693876372794,0.8043478260869565,0.9747206658963807,1.0,7/43,13.59%,POLR2D;ACD;BLM;POLR2A;RTEL1;KLHL15;FANCB
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3060629646776882,0.7634472909353907,0.7681451612903226,0.9744053120735534,1.0,4/18,12.36%,PDPK1;IGF2;APLN;COL4A3
prerank,tRNA transport (GO:0051031),-0.2437445960748649,-0.7620554109119735,0.8402625820568927,0.9397518632162454,1.0,19/35,46.02%,TOMM20;YBX1;SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;TOMM20L;NUP210
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.257236959383977,-0.7616407952357066,0.8340336134453782,0.9397643217897896,1.0,8/25,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;EAF2;RNF8
prerank,protein ADP-ribosylation (GO:0006471),0.2743804241798941,0.7610385002130309,0.7909090909090909,0.977527295153448,1.0,12/28,25.62%,PARP4;PARP10;PARP12;PARP9;SIRT3;ARF4;TIPARP;PARP14;SIRT5;TNKS2;ART4;PARP2
prerank,recombinational repair (GO:0000725),0.2274686680110917,0.7609682054247918,0.865546218487395,0.9769884373870118,1.0,16/77,16.11%,RAD51B;RAD51AP2;RNF138;HUS1B;RAD51C;BLM;HELQ;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;WRN;SWI5;RAD51
prerank,RNA interference (GO:0016246),-0.29059673572121736,-0.760243162195214,0.7906066536203522,0.9411101334812008,1.0,7/17,31.96%,CLP1;NRDE2;AGO3;TSN;TSNAX;DROSHA;DHX9
prerank,regulation of sister chromatid cohesion (GO:0007063),0.334551112846586,0.7599821052566522,0.7319148936170212,0.9779100752535064,1.0,2/12,9.78%,HDAC8;AXIN2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.23831742798374086,0.7595621005234564,0.8440065681444991,0.9778997031110122,1.0,17/58,21.10%,XRCC5;XRCC4;KDM2A;UVRAG;POLM;MDC1;NHEJ1;PRKDC;DCLRE1A;DCLRE1B;MRE11;BABAM2;IFFO1;UIMC1;KAT5;RAD50;NBN
prerank,UV-damage excision repair (GO:0070914),0.33359399109351184,0.7592070661605875,0.7531645569620253,0.9778174712215781,1.0,4/12,17.37%,DDB2;CUL4B;INO80;XPC
prerank,regulation of axon guidance (GO:1902667),-0.33418230113006064,-0.7584488646543003,0.780114722753346,0.9430816177676534,1.0,4/10,24.83%,VEGFA;ZSWIM6;ZSWIM8;TUBB2B
prerank,regulation of viral transcription (GO:0046782),-0.23384525065095388,-0.7581402792643275,0.8541666666666666,0.942960952834676,1.0,13/39,20.75%,TRIM14;LARP7;POLR2C;NELFCD;TRIM13;MDFIC;POLR2G;GTF2F2;NELFE;MID2;TRIM27;IFITM3;UBP1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3009995351194124,0.7580337857402876,0.7858627858627859,0.9790330007578206,1.0,3/18,10.51%,SLAMF8;ABL1;PRKDC
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2697318035779313,0.7580186259366632,0.8286252354048964,0.9784046120525862,1.0,8/31,20.00%,HSD17B1;FDXR;MOCS2;MOCS1;DHRS11;MOCS3;FDFT1;ALOX5
prerank,innate immune response in mucosa (GO:0002227),0.34566842264908926,0.7575575874755242,0.7440347071583514,0.9784441503433764,1.0,1/10,2.73%,LTF
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.33189489066538114,-0.7573986070852344,0.7891682785299806,0.9428693802136895,1.0,6/10,29.54%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.33189489066538114,-0.7573986070852344,0.7891682785299806,0.9428693802136895,1.0,6/10,29.54%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,regulation of complement activation (GO:0030449),0.25700226876643656,0.7572980139481125,0.8199643493761141,0.9781837632136535,1.0,6/40,11.25%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3508374206678482,0.7567316620762248,0.7394957983193278,0.978447255647054,1.0,2/10,8.77%,PXYLP1;XYLT2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2951166815384354,-0.7565948473680782,0.78,0.9433813808058048,1.0,8/13,29.56%,STX3;HSP90AB1;TMEM35A;TYROBP;MAP1A;TM9SF4;ABCA7;RANGRF
prerank,snRNA metabolic process (GO:0016073),-0.28378811402990745,-0.7560765914256672,0.791231732776618,0.943504186013868,1.0,6/17,23.40%,MEPCE;INTS11;INTS6;INTS1;MTREX;INTS3
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2530852066128327,-0.7560142447008951,0.8761061946902655,0.9430410257065994,1.0,9/28,19.90%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MIEF2;MTCL1;GDI1;ANK3
prerank,peptidyl-lysine modification (GO:0018205),0.21732283738313288,0.7556519705959384,0.9032761310452418,0.9794859330204392,1.0,8/99,10.15%,EYA1;LOXL1;LOXL3;SENP7;NDC1;PIAS1;EEF1AKMT1;NUP107
prerank,DNA damage checkpoint signaling (GO:0000077),-0.25310783127585934,-0.7552886178529854,0.8198198198198198,0.9434892977588359,1.0,9/28,24.74%,TIPRL;CHEK2;DONSON;RAD17;USP28;RAD9A;ATR;DOT1L;CHEK1
prerank,negative regulation of DNA replication (GO:0008156),-0.3074578083233719,-0.755207598481443,0.7909270216962525,0.9430626055539638,1.0,6/13,33.17%,RAD17;S100A11;ATR;GMNC;GMNN;CDC6
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3283515632836189,0.7551332350297935,0.7690677966101694,0.9796140759177115,1.0,4/12,13.28%,APOC4;APOC1;SOAT2;P4HB
prerank,histone acetylation (GO:0016573),-0.20823713077505399,-0.7550298846920765,0.9183673469387755,0.9427323547907787,1.0,13/69,17.31%,LEF1;MORF4L1;APBB1;ING4;MRGBP;YEATS2;NAA40;BRPF1;KAT14;JADE1;RUVBL1;PER1;WDR5
prerank,positive regulation of chromatin organization (GO:1905269),-0.3086215095096011,-0.7548381126948442,0.7758620689655172,0.9424507592358347,1.0,3/12,14.48%,H3-3A;TAL1;TERF2IP
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3323801477224365,0.7547970322439498,0.7821576763485477,0.9788535376977929,1.0,2/11,7.48%,SYNJ2;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3323801477224365,0.7547970322439498,0.7821576763485477,0.9788535376977929,1.0,2/11,7.48%,SYNJ2;PTEN
prerank,regulation of DNA replication (GO:0006275),-0.22175778654459533,-0.7547013739325404,0.892018779342723,0.9420782246282193,1.0,10/49,18.58%,BCAR3;ACVRL1;CCDC88A;FAF1;USP37;GLI1;RAD17;EHMT2;S100A11;ATR
prerank,spindle assembly (GO:0051225),-0.20673823271711897,-0.7543167862702438,0.9149484536082474,0.9420546938475218,1.0,18/67,23.33%,NEK7;STARD9;RPS3;SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;HAUS6;MAPRE1;NUMA1;KIFC1;CLASP2
prerank,negative regulation of protein catabolic process (GO:0042177),0.2539965586053795,0.7540873774971217,0.8105263157894737,0.9792888580739514,1.0,7/40,12.53%,TIMP3;AZIN2;BANP;ATRAID;RIC1;PTPN3;SNX12
prerank,protein polyglutamylation (GO:0018095),-0.3233299791293164,-0.7536949368170355,0.7690839694656488,0.9423235576856057,1.0,4/11,28.53%,TTLL7;CEP41;TTLL6;TTLL2
prerank,sulfate transport (GO:0008272),0.31381140625883347,0.7534845805032379,0.7480314960629921,0.9795707925822006,1.0,3/14,10.43%,SLC13A4;SLC25A11;SLC13A1
prerank,lymphocyte chemotaxis (GO:0048247),-0.24323434809508443,-0.753253748014278,0.8359550561797753,0.9423799564641866,1.0,2/34,2.15%,SLC12A2;GAS6
prerank,ubiquinone metabolic process (GO:0006743),0.3128781822210966,0.7531910584091639,0.7676767676767676,0.9793389642750348,1.0,4/15,11.44%,FDXR;COQ10A;COQ8B;COQ6
prerank,nuclear envelope organization (GO:0006998),-0.2763305171689784,-0.7531902345695014,0.819838056680162,0.9419010154527346,1.0,6/20,20.44%,REEP3;LEMD2;TOR1B;TMEM43;SUN1;CTDNEP1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.25844846508973823,0.7527303454430516,0.8133333333333334,0.9793752501912021,1.0,10/33,16.36%,PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;CDC73;PKD2;CDK4;CDKN2B
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.27278030353304944,-0.7525054316611732,0.8113590263691683,0.9422124004915619,1.0,6/20,16.43%,YWHAB;MET;RNF157;APLP1;STMN1;BICD1
prerank,regulation of microtubule-based process (GO:0032886),0.25793035040561907,0.7522603058379457,0.8266199649737302,0.9794595551847088,1.0,9/36,14.79%,EPHA3;MACF1;PRKAA2;PHLDB2;PRKAA1;ERBB2;CYLD;BICD2;MEMO1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.26823619976454066,0.7521896430594563,0.8015122873345936,0.9789198838594914,1.0,4/30,5.81%,ACSL1;HACD1;ACOT4;HACD3
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3229022431962175,-0.7520585098357863,0.7901701323251418,0.9422440792987117,1.0,2/10,15.96%,KYAT1;QDPR
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2864839693299248,0.7513077187093679,0.793036750483559,0.9796082751358152,1.0,5/23,18.68%,CECR2;DICER1;DFFA;REXO4;KPNB1
prerank,negative regulation of receptor internalization (GO:0002091),-0.3059258701008159,-0.7509789892237421,0.7936802973977695,0.9430762589890855,1.0,7/12,40.90%,RIN3;ANKRD13A;ANKRD13B;ATXN2;WDR54;ANKRD13D;NECAB2
prerank,glutathione metabolic process (GO:0006749),0.254836424247806,0.7506343489055756,0.82793867120954,0.9799652865293403,1.0,3/38,5.01%,GSTM2;GSTT4;GSTT1
prerank,regulation of cellular response to stress (GO:0080135),0.20855552920058046,0.7504463874580611,0.9154929577464789,0.9796157417435442,1.0,19/115,14.12%,ROCK2;PRKN;CRHBP;NDC1;NEK4;AMFR;CAMK2D;NUPR1;HSPA1L;NUP107;ABL1;MLST8;AKT1S1;NPAS2;MAPKAPK2;SLC38A2;HSF1;MAPK1;CREBBP
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.25299535795444883,-0.7501514016258655,0.8158995815899581,0.9436433767483143,1.0,13/25,36.89%,TNFSF10;GPER1;BBC3;PLAUR;PINK1;BIK;BMF;BAX;BID;PMAIP1;HRK;DNM1L;BAD
prerank,histone deubiquitination (GO:0016578),0.29549370268663633,0.7497776089584346,0.7873684210526316,0.9799829255432425,1.0,5/18,21.28%,EPOP;USP7;TRRAP;UIMC1;USP21
prerank,positive regulation of transporter activity (GO:0032411),0.32617652680931436,0.7495973508197842,0.7733887733887734,0.9795841774020967,1.0,1/13,1.68%,KMT2A
prerank,negative regulation of JNK cascade (GO:0046329),0.2619076985703648,0.7494811857219263,0.8168498168498168,0.9791109345358526,1.0,7/31,12.30%,PRKN;DUSP10;SIRPA;ITCH;SH3RF2;CYLD;HIPK3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.30143895446798324,0.7490610048142361,0.7692307692307693,0.9791424333876906,1.0,3/17,8.14%,ALG6;ALG2;ALG9
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.289538483604798,-0.749037662143775,0.8233082706766918,0.9445503021060273,1.0,10/16,45.47%,CLU;CYP51A1;IFNGR1;TREM2;HMGCR;ABCA7;LRP1;IL4;TNF;LRPAP1
prerank,RNA splicing (GO:0008380),-0.19084991661170467,-0.7487952330488088,0.9559228650137741,0.9443050959467448,1.0,15/95,14.31%,MBNL1;PPARGC1A;TARDBP;IVNS1ABP;SRSF2;SF3B1;SF3B2;SFPQ;DDX39B;USP39;RBM8A;PRPF18;RNPS1;SRPK1;FUS
prerank,negative regulation of cell division (GO:0051782),0.32937425540242665,0.7485721448581832,0.7515274949083504,0.9792470408968221,1.0,3/11,17.17%,BLM;TXNIP;ORC6
prerank,mitotic spindle assembly (GO:0090307),-0.22484107130481548,-0.7485469814794277,0.8827586206896552,0.9440912663035669,1.0,17/42,29.89%,SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;KIFC1;CLASP2;KIF4A;KIFC2;SMC3;KIF23;ABRAXAS2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.2417476213147725,-0.7482918482733907,0.8319672131147541,0.943886747744992,1.0,10/31,23.35%,KLF4;FHL1;FAM107A;APC;CDK6;JADE1;CDK2AP2;CDKN1A;CDKN2D;E2F7
prerank,protein-DNA complex disassembly (GO:0032986),-0.2840776872659221,-0.7480809470836739,0.7850098619329389,0.9436132365624031,1.0,3/16,10.76%,RPL23;SET;SMARCD1
prerank,regulation of leukocyte migration (GO:0002685),0.3108526881270429,0.7478918969565321,0.7547169811320755,0.9796474567341219,1.0,3/16,8.41%,ANXA1;HOXA7;MIA3
prerank,positive regulation of cell growth (GO:0030307),0.21435727433309493,0.7476790871317817,0.8949044585987261,0.9793274111660418,1.0,4/96,4.46%,IGF1;BCL2;MACF1;SPHK1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.315635291800081,0.7476733818287697,0.7583333333333333,0.9786939743990227,1.0,1/14,0.72%,IL34
prerank,lipid droplet organization (GO:0034389),-0.26522742703568947,-0.7475027181939328,0.8323108384458078,0.9438146683569729,1.0,4/22,17.36%,PPIA;CDS1;BSCL2;AUP1
prerank,striated muscle cell differentiation (GO:0051146),0.30821837659916435,0.7474482514516142,0.7525773195876289,0.9783855611610484,1.0,4/16,8.94%,CBY1;AKAP13;SIK1;KDM6B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.30791884754406423,-0.7466561350704028,0.8289205702647657,0.9442459342837737,1.0,1/12,0.81%,FOXP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.27561028352092465,0.7464674407464205,0.7992831541218638,0.9791700404933422,1.0,7/26,13.73%,DAB2;KANK2;STRN3;HDAC1;CRY1;CNOT2;CLOCK
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2588976938509966,0.7459024238175823,0.8130841121495327,0.9793288678813183,1.0,4/33,7.99%,IL34;ACIN1;PRKCA;CSF1
prerank,negative regulation of nervous system development (GO:0051961),0.3084480152349483,0.7455206813994237,0.7823408624229979,0.9792379173569993,1.0,2/17,6.76%,APPL2;IL6
prerank,establishment of spindle localization (GO:0051293),-0.28660963436255704,-0.7451059299034841,0.8208092485549133,0.9457495123729718,1.0,10/14,38.02%,MAP4;CFL1;CLASP2;TLE6;ZBED3;DYNC1H1;ESPL1;CLASP1;NUSAP1;NLRP5
prerank,regulation of gene silencing by RNA (GO:0060966),0.23763935183520726,0.7449327941164235,0.8553345388788427,0.978831757610479,1.0,6/50,10.17%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.23763935183520726,0.7449327941164235,0.8553345388788427,0.978831757610479,1.0,6/50,10.17%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.31829046686119006,-0.744883216310088,0.7915057915057915,0.9454942768704547,1.0,9/12,54.32%,SLC11A1;CCR2;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,RNA stabilization (GO:0043489),0.2612980889829495,0.7448747339396972,0.8232044198895028,0.9782859255593761,1.0,7/33,16.41%,PHAX;TRDMT1;AXIN2;TENT2;GDNF;PARN;LARP1
prerank,amino sugar biosynthetic process (GO:0046349),-0.3061038211944679,-0.7448648675977669,0.7743785850860421,0.9449645078974377,1.0,6/12,28.70%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.31924093922867747,-0.7443018192445411,0.7742574257425743,0.9451342748728238,1.0,5/11,24.03%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,regulation of myelination (GO:0031641),0.2791063752571182,0.7441105171925595,0.8261682242990654,0.978781001533225,1.0,6/25,13.79%,PARD3;ITGAX;PTN;CST7;TMEM98;DICER1
prerank,cellular response to UV (GO:0034644),-0.1992611098784569,-0.7438321579248095,0.941025641025641,0.9451607908998108,1.0,25/76,28.21%,RPL26;CRIP1;DDB1;ATF4;MFAP4;COPS9;CARD16;POLK;USP28;N4BP1;ATR;PRKCD;NOC2L;MMP1;METTL3;FMR1;CDKN1A;BMF;POLD1;HYAL2;CHEK1;XPA;TIMP1;OPN3;TMEM161A
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.33108038514800303,0.7437346060908114,0.7827004219409283,0.9787275778226483,1.0,4/11,15.92%,ADM;GRK3;ADRB3;GRK2
prerank,defense response to symbiont (GO:0140546),0.2143756418573451,0.7433517315798587,0.9079159935379645,0.9786373725830627,1.0,9/92,7.89%,BCL2;PLA2G10;IFIT3;IFIT2;RNASEL;TRIM5;BNIP3;IL6;TRIM56
prerank,regulation of neutrophil migration (GO:1902622),-0.3240339451883929,-0.743143119031969,0.8289738430583501,0.9455176591897156,1.0,4/10,20.81%,RAC1;RHOG;JAM3;NCKAP1L
prerank,acute-phase response (GO:0006953),-0.3063742651208981,-0.7425871454151725,0.8090909090909091,0.9456456205451895,1.0,4/12,29.77%,LBP;SIGIRR;CEBPB;AHSG
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2813655859953528,0.7422027909687032,0.7820267686424475,0.9796672937387059,1.0,2/21,5.48%,PRKN;LRRK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.32011112799949376,-0.7421065818127114,0.7957198443579766,0.945697527574603,1.0,3/10,23.45%,CALM1;FMR1;CALM3
prerank,response to peptide (GO:1901652),0.2668535631719509,0.741836936639459,0.8047882136279927,0.9795432976952225,1.0,4/33,7.32%,ANXA1;MMP2;STAT5B;MMP9
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2770696580478006,-0.7413491995131102,0.844017094017094,0.9461589081917947,1.0,4/18,12.72%,RAP1A;GSK3B;SLC4A8;VPS18
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3212568755759486,-0.7410503822093797,0.7797270955165692,0.9459662952563418,1.0,4/10,22.59%,MFSD2A;MTMR9;ABCA3;MTMR1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.24043877587281565,0.7408896415916405,0.8425760286225402,0.9802496229407957,1.0,8/46,10.86%,TIMP3;DUSP10;FBLN1;DLG1;LMO3;PTEN;SIRPA;FLCN
prerank,cellular response to chemokine (GO:1990869),0.24156499861848663,0.7407731176685639,0.8683274021352313,0.9797765253908995,1.0,3/46,3.63%,OXSR1;CXCL13;RIPOR2
prerank,inositol phosphate catabolic process (GO:0071545),-0.301217687825035,-0.7403614547075369,0.818,0.946258742422696,1.0,2/12,5.66%,SYNJ1;NUDT3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2573440147718162,-0.7393995741622336,0.8467741935483871,0.946927591188174,1.0,14/23,44.95%,PLK2;BUB1B;INTS3;CHEK1;CHMP4C;ZWINT;CDK5RAP3;BUB1;PLK3;WEE2;NABP1;AURKB;ZW10;PRCC
prerank,response to interferon-gamma (GO:0034341),-0.20480874926221132,-0.7388105552482296,0.912718204488778,0.9471287086792831,1.0,18/67,22.40%,GCH1;GBP4;GAPDH;AQP4;GBP5;SLC26A6;CD74;SHFL;GBP3;CD47;RPL13A;CD40;CCL13;BST2;IFITM3;SLC11A1;CASP1;CIITA
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2902167304939904,0.7385137315912822,0.8161350844277674,0.9823539311664552,1.0,6/22,16.37%,PHF8;LYAR;RASL11A;ERBB2;SMARCB1;NOL11
prerank,positive regulation of lipid storage (GO:0010884),-0.2647336784023846,-0.7384067568367907,0.815242494226328,0.9470571426934737,1.0,3/21,5.98%,SCARB1;SREBF2;EHD1
prerank,intracellular sterol transport (GO:0032366),0.3189701444004678,0.7382849692700689,0.7704918032786885,0.9820537179623936,1.0,6/13,26.48%,ABCA1;SERAC1;RELCH;ARV1;OSBP;VPS4A
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.29736885982221617,-0.7378437593791979,0.8111332007952287,0.9472041366622659,1.0,8/13,44.25%,NUP54;KPNA4;KPNA3;RGPD1;KPNA2;NUP35;KPNA1;KPNA7
prerank,mitotic spindle organization (GO:0007052),-0.1756093794439775,-0.7377759413832378,0.9907692307692307,0.9467426482351092,1.0,63/153,35.23%,MAP4;SMC1A;CLIP1;FLNA;BUB3;PLK2;DYNLL2;EFHC2;CENPO;RPS27;CHEK2;RHOA;CENPK;ARHGEF10;MZT1;RANGAP1;NUP37;STMN1;TOGARAM1;RCC2;NDE1;RMDN1;WRAP73;CENPU;KIF3B;BUB1B;NUP85;CKAP5;KIF11;PPP1CC;NUP133;MAPRE1;B9D2;VCP;KIFC1;CLASP2;NDC80;KIF4A;KNL1;KIFC2;KNTC1;SPDL1;CDCA8;CEP126;SMC3;KIF23;ZWINT;ABRAXAS2;DYNC1I1;PLK1;BCCIP;NUDC;DLGAP5;DYNC1H1;AURKA;NEK9;TOGARAM2;STIL;PCNT;CDC20;BUB1;DYNLL1;CLASP1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.23814427219096262,-0.7371749893321361,0.851380042462845,0.9469350913716212,1.0,12/31,33.97%,PLCG2;HSPD1;LAPTM5;CD40;IRF5;TIRAP;MAPK11;AGER;TLR4;IL16;MDK;SYK
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.21476392869449273,-0.7369676787019754,0.8671328671328671,0.9466424993808186,1.0,22/45,39.28%,PUM2;APP;GCNT2;PER1;ZC3H7A;EIF2A;NOLC1;YTHDC1;PUM3;EIF4E;PCIF1;RBM4B;DDX25;RPL10;ATXN2;METTL18;MATR3;RC3H1;MAPKAPK5;MTPN;TRIM71;ZC3H10
prerank,regulation of viral genome replication (GO:0045069),0.22737508746827362,0.736430712596123,0.8853820598006644,0.9840405354450751,1.0,7/56,9.82%,PPARA;LTF;RNASEL;SRPK2;HACD3;PKN2;PARP10
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2490176221448298,0.7362298841441911,0.8318425760286225,0.9836750280095908,1.0,7/36,12.05%,PRKN;DUSP10;DLG1;SIRPA;ITCH;SH3RF2;CYLD
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2607691683550563,-0.7359065083795977,0.8389121338912134,0.9463286105702324,1.0,11/20,35.18%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2607691683550563,-0.7359065083795977,0.8389121338912134,0.9463286105702324,1.0,11/20,35.18%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2607691683550563,-0.7359065083795977,0.8389121338912134,0.9463286105702324,1.0,11/20,35.18%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2193107829822778,-0.7356180274552253,0.9121140142517815,0.946145516509115,1.0,19/49,27.99%,GSK3B;CRYAB;HSPA5;CLU;SVIP;NLRP2B;IAPP;RPL13A;RAF1;PPM1A;NOP53;PEX5;JAM3;HDAC6;SORL1;KIF14;THRA;TREM2;TFIP11
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.2832788985660806,-0.7354667628780212,0.808641975308642,0.9458286993298698,1.0,9/15,37.86%,APPL1;STAT3;GBP5;MYD88;TLR4;TLR6;NOD2;TICAM1;HIF1A
prerank,protein import (GO:0017038),0.21540014973395943,0.7351794010286282,0.8754266211604096,0.9844841119963218,1.0,11/84,13.83%,APPL2;IPO13;PXMP2;PRICKLE1;SNX33;LAMP2;NUTF2;NUP107;PXMP4;TNPO1;NXT2
prerank,copper ion transport (GO:0006825),-0.31341650329582166,-0.7351229621839555,0.8203703703703704,0.9457404357534896,1.0,2/11,6.52%,ATOX1;SLC31A1
prerank,antibacterial humoral response (GO:0019731),0.29616601590185204,0.734745755509007,0.7947154471544715,0.9844349409396809,1.0,1/16,2.73%,LTF
prerank,phospholipid metabolic process (GO:0006644),0.22532337407221506,0.7340630931715691,0.9025210084033614,0.9847453390247055,1.0,3/71,2.68%,AGPAT4;PLPP3;PLA2G10
prerank,regulation of cell aging (GO:0090342),-0.3122398297836396,-0.7339432181949584,0.7944444444444444,0.9466339588960665,1.0,3/11,16.77%,RSL1D1;LMNA;MIF
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2668099197632454,-0.732990653117753,0.8253968253968254,0.947215126360284,1.0,7/18,33.16%,GSK3B;HIP1R;SLC35F6;CHCHD10;BAX;BID;HSPA1A
prerank,cellular response to interferon-gamma (GO:0071346),0.2174201207627359,0.7329441015316259,0.9132569558101473,0.9856380686816786,1.0,12/88,12.19%,DAPK1;NCAM1;SP100;TRIM5;IRF8;CCL19;CAMK2D;SIRPA;IRF3;CCL4;JAK2;TRIM26
prerank,icosanoid metabolic process (GO:0006690),-0.2245674849882105,-0.7326866797935145,0.9084507042253521,0.947033321426595,1.0,8/40,15.18%,MGLL;GPX4;PTGIS;PTGS2;PON2;ALOX12;PLA2G4A;CYP1B1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.2653975645914042,-0.7326095457811868,0.8580508474576272,0.9465699944470012,1.0,9/18,31.56%,PPP1R16B;YWHAB;CHP1;ZCCHC9;PPP1R15A;URI1;PPP1R35;ARPP19;MFHAS1
prerank,regulation of chromatin binding (GO:0035561),0.3319245608909477,0.7323671950617503,0.7666666666666667,0.9858138832294682,1.0,4/10,24.44%,PARP9;DTX3L;KDM4D;MED25
prerank,regulation of intracellular transport (GO:0032386),-0.22368414173168316,-0.732325537009304,0.8789237668161435,0.9463531699745322,1.0,11/38,25.13%,REEP5;CRYAB;LAMP1;PTPN1;ATP13A2;INPP5F;NUMA1;MLC1;SPAG5;CAPN10;HAP1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.32365444361556917,-0.7322078679186552,0.795880149812734,0.9459288705122002,1.0,2/10,7.67%,DNAJA1;PDCD4
prerank,neuromuscular synaptic transmission (GO:0007274),0.2939533604612121,0.7320613368368547,0.7932405566600398,0.9855709548763506,1.0,5/18,16.98%,DTNA;FCHSD2;SLC5A7;CHRNB2;ERC2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.32523407505806956,0.732050422473101,0.7531380753138075,0.9849541180237815,1.0,2/10,7.35%,NOS1AP;CACNA2D1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.21893317608133314,-0.7311651679531344,0.8845265588914549,0.9466116369901585,1.0,23/42,39.87%,SMCHD1;SPIDR;UBQLN4;ACTR2;FUS;TERF2IP;POLQ;PPP4R2;SIRT6;CHEK1;SHLD3;RMI2;CGAS;RIF1;SHLD2;PPP4C;HELB;RPA2;FIGNL1;WAS;WRAP53;RADX;TIMELESS
prerank,positive regulation of reproductive process (GO:2000243),0.2593071295924929,0.7309767373846344,0.8263254113345521,0.9857888409587123,1.0,6/31,15.99%,PLA2G10;PLCB1;AGO2;SMURF2;TACR3;SYDE1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2992573165200787,-0.7308793959331089,0.82,0.9464344980268179,1.0,6/13,35.30%,PRR5L;ZC3H12A;GTPBP1;ZC3HAV1;CNOT1;RC3H1
prerank,nuclear pore complex assembly (GO:0051292),0.3355737894488634,0.7299522401488755,0.7592592592592593,0.9865513299358003,1.0,2/10,10.15%,NDC1;NUP107
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2860788789296815,-0.7299370160480941,0.825187969924812,0.9470007868055278,1.0,3/14,19.44%,ADAM10;PSEN1;ABCG1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2343518818377539,0.7297059241547533,0.8465608465608465,0.9862663453746836,1.0,12/52,13.17%,TLN1;TATDN2;TPP1;WIPI1;EXTL1;CUL7;ATP6V0D1;FKBP14;SERP1;EDEM1;TSPYL2;PLA2G4B
prerank,regulation of immune effector process (GO:0002697),0.24578863010974977,0.7292784434985891,0.8546099290780141,0.9861989803643503,1.0,6/41,11.25%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2517791733918211,0.7289282730827835,0.8491921005385996,0.98604104497987,1.0,2/34,5.06%,LGR4;CACTIN
prerank,regulation of myoblast fusion (GO:1901739),0.32180380881456744,0.7281897388703863,0.7489539748953975,0.9864199794263326,1.0,2/11,12.18%,RIPOR2;CFLAR
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.24384169896033656,-0.7281774164120056,0.8831967213114754,0.9484987423095046,1.0,11/27,28.41%,ZC3H12C;TRIR;CPSF3;RNASE4;RPP30;ZC3H12A;PCF11;NHP2;NUDT16;ERN1;POP7
prerank,DNA packaging (GO:0006323),0.30083750139040616,0.7280360707303604,0.78125,0.9860008633457279,1.0,6/16,27.60%,RBBP4;BANF2;AIFM1;NAA10;TP53;KAT6A
prerank,endodermal cell fate commitment (GO:0001711),-0.31434938079073355,-0.7276467573850741,0.8133595284872298,0.9485659735644959,1.0,2/10,17.51%,SOX17;SOX2
prerank,mitotic sister chromatid cohesion (GO:0007064),0.30096536311980115,0.7268833916817043,0.7869198312236287,0.9869233870399724,1.0,6/16,21.84%,PDS5B;MAU2;PDS5A;NIPBL;DSCC1;NAA50
prerank,regulation of regulated secretory pathway (GO:1903305),0.2584727417694378,0.7266071859227834,0.8614035087719298,0.9866450179697431,1.0,4/34,5.48%,DTNBP1;SYT11;SYT12;LRRK2
prerank,phospholipid homeostasis (GO:0055091),0.32211529404575817,0.7263206877801288,0.7730061349693251,0.9864107493913935,1.0,1/11,4.04%,ABCA1
prerank,cellular response to interferon-beta (GO:0035458),-0.2864179701652416,-0.7259980725276673,0.8244274809160306,0.949905608531747,1.0,7/14,43.21%,AIM2;NDUFA13;STAT1;IFITM2;CDC34;UBE2G2;IRF1
prerank,myeloid cell development (GO:0061515),0.2832100548537494,0.7252919476450211,0.8197674418604651,0.9872064204515089,1.0,3/18,10.05%,KIT;LYAR;MED1
prerank,regulation of synapse organization (GO:0050807),0.2688003972250982,0.7249526675503207,0.8323353293413174,0.9870278530902875,1.0,8/26,17.78%,IL1RAPL1;NEDD4;EPHA4;ABL1;CDKL5;GRIPAP1;CHRNB2;PDLIM5
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3159690911453815,0.7246306312100792,0.7780040733197556,0.9868334280909918,1.0,2/11,9.09%,ANXA1;RC3H2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.29197544246949014,0.724585009044691,0.8064516129032258,0.9862637782546738,1.0,3/17,13.45%,PRKN;MDM2;SNAI1
prerank,dendritic cell differentiation (GO:0097028),0.27700112519256115,0.7244972449048723,0.8549019607843137,0.9857528034571185,1.0,7/22,16.13%,IRF8;CCL19;BATF2;AXL;BATF;PRTN3;LYN
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2552022363453976,-0.7242289726186749,0.8505263157894737,0.9514183560008926,1.0,11/21,35.18%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,histone methylation (GO:0016571),0.2659762551011183,0.7240735362594886,0.8348968105065666,0.985657037743517,1.0,8/26,20.81%,SETD6;PRMT7;NSD1;SMYD3;CREBBP;N6AMT1;NSD3;CARM1
prerank,protein kinase A signaling (GO:0010737),0.31424797622732503,0.7237476978804349,0.7922606924643585,0.9854857551572852,1.0,2/12,13.56%,RAB13;PRKACB
prerank,regulation of myeloid cell differentiation (GO:0045637),0.22868752403335924,0.7234890753927836,0.9028475711892797,0.9851967232250504,1.0,14/62,16.13%,KMT2A;MEIS1;ASH2L;TNRC6B;TNRC6A;PRKCB;SETD1A;HDAC1;KMT2B;CDC73;CREBBP;MEIS2;MOV10;LYN
prerank,presynaptic endocytosis (GO:0140238),0.26972535429364736,0.7234467500634916,0.8388888888888889,0.9846339306471199,1.0,3/24,6.00%,CEL;NLGN2;SYNJ2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2665788616798056,-0.7233641113045177,0.8340080971659919,0.9518189705628286,1.0,9/18,39.21%,CORO2B;CHP1;PTP4A3;CEP295;TREM2;CCT3;CCT4;WRAP53;CCT2
prerank,heterocycle biosynthetic process (GO:0018130),-0.287448632240839,-0.7231154921212988,0.8319838056680162,0.9515302515560399,1.0,6/14,34.13%,GCH1;GPHN;LIAS;PYCR2;PYCR1;NFS1
prerank,regulation of histone deacetylation (GO:0031063),0.30705200259943644,0.7224453431530459,0.780040733197556,0.9852791952370581,1.0,4/13,16.19%,CAMK2D;AKAP8L;SAP30BP;NIPBL
prerank,intracellular protein transport (GO:0006886),0.18194831091825817,0.7224130974626058,0.9877717391304348,0.9846913444903455,1.0,62/304,18.85%,RANBP3L;WLS;APPL2;IPO13;KIF13B;SNX6;ARFGAP3;PRICKLE1;RAB19;ACD;SNX9;ARL5A;TBC1D9B;MAIP1;PDCD6;ARL6;STX16;LAMP2;GGA2;SLU7;TBC1D4;RAB32;DNAJC27;NUTF2;RAB22A;RIC1;NUP107;WDR11;IFT27;STX8;OXA1L;SAR1B;TNPO1;TECPR2;STX17;NXT2;ARL4C;TRAK1;RAB43;ARL5B;AP3B1;TBC1D17;CCHCR1;TRAK2;DESI1;COPB2;COPZ2;VPS26A;RPAIN;IPO9;NUP214;VPS35;STX11;IFT22;USP6NL;TBC1D9;TBC1D15;FAM91A1;ARF4;AP4M1;KPNB1;RAB29
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.28097946980172306,0.7219978650213565,0.8234165067178503,0.9846006153038027,1.0,1/20,1.22%,IL18
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.24292877882325067,-0.7215742265623861,0.8653421633554084,0.9526977962896706,1.0,14/29,36.05%,LPCAT3;TMEM86B;LPCAT1;NR1H2;PLA2G4A;NR1H3;PLA2G4F;DBI;PLA2G5;MBOAT2;LPCAT4;PLBD1;PLAAT3;PLB1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.20652287629551652,0.7215468074288486,0.9283489096573209,0.9845442516406215,1.0,19/95,16.19%,RAD51B;RAD51AP2;RNF138;HUS1B;RAD51C;BLM;HELQ;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;FANCB;WRN;MCM2;SWI5;RAD51;NIPBL
prerank,cell junction maintenance (GO:0034331),0.30874772076251095,0.7214448640008335,0.7674897119341564,0.98405211329489,1.0,1/14,2.23%,NLGN2
prerank,myeloid cell differentiation (GO:0030099),-0.21274930015373217,-0.7214293299529818,0.8955916473317865,0.9523135827868547,1.0,16/47,26.33%,RUNX1;RPS19;RPS14;KMT2E;IKZF1;TAL1;ATP5IF1;SPI1;INHA;JAK3;TIRAP;HSPA9;PRKX;CEBPA;FLVCR1;EPO
prerank,regulation of viral release from host cell (GO:1902186),-0.25950937962734505,-0.7212799926348541,0.8583333333333333,0.9519424217738692,1.0,6/21,22.29%,CHMP2B;TRIM25;DDB1;TRIM13;MID2;CHMP3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.30867845716448106,0.7212760012612733,0.8012958963282938,0.9836478263457445,1.0,2/13,11.32%,TPST1;SULT4A1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3248872301264809,0.7206203508802229,0.7887029288702929,0.98323139288675,1.0,4/10,24.77%,ASCC2;MPG;ASCC1;ALKBH3
prerank,DNA dealkylation (GO:0035510),0.3248872301264809,0.7206203508802229,0.7887029288702929,0.98323139288675,1.0,4/10,24.77%,ASCC2;MPG;ASCC1;ALKBH3
prerank,positive regulation of transmembrane transport (GO:0034764),0.3049617974744332,0.7200623227437468,0.8163265306122449,0.9833177630253384,1.0,2/13,6.46%,ACSL1;AZIN2
prerank,histone H4-K16 acetylation (GO:0043984),0.28831429208727855,0.7196078152808293,0.8248031496062992,0.9832971127054451,1.0,3/19,10.66%,KMT2A;KAT8;KANSL1
prerank,erythrocyte development (GO:0048821),-0.31168898717106813,-0.7194452520777137,0.806640625,0.9534741205787435,1.0,4/10,20.81%,ABCB10;ZBTB7A;SH2B3;NCKAP1L
prerank,regulation of neuroblast proliferation (GO:1902692),0.30720911169280796,0.7191353241930551,0.7766599597585513,0.9832520507719552,1.0,6/15,16.97%,LRRK2;PTN;DCT;CX3CL1;SMARCD3;DRD2
prerank,negative regulation of catabolic process (GO:0009895),0.23497038323472189,0.7188767305499837,0.8881118881118881,0.9829429444164565,1.0,6/47,9.15%,PPARA;AZIN2;BANP;PRKAA1;NUPR1;APOC1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3287060193325481,0.7183566539226337,0.797979797979798,0.9829674100166932,1.0,1/10,2.89%,SP100
prerank,nucleosome disassembly (GO:0006337),0.3026552579363716,0.7182735141216434,0.7745302713987474,0.9818444938129512,1.0,5/14,16.34%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.3026552579363716,0.7182735141216434,0.7745302713987474,0.9818444938129512,1.0,5/14,16.34%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,macrophage migration (GO:1905517),0.3068417492358218,0.7182354362563381,0.8028455284552846,0.9812736149273267,1.0,3/13,17.66%,TAFA4;CKLF;EDNRB
prerank,cranial nerve development (GO:0021545),0.3305297514436354,0.7180774084689826,0.7627118644067796,0.9808512254667534,1.0,11/11,66.97%,SALL1;TFAP2A;CHRNB2;ATOH7;CHD7;ERBB3;ISL1;TIFAB;POU4F1;PAX2;TMEM126A
prerank,DNA catabolic process (GO:0006308),0.32569671102184283,0.7171326429404702,0.7777777777777778,0.9814472732920112,1.0,11/11,67.45%,REXO4;DFFB;MUS81;DNASE1L3;SETMAR;DNASE1L2;DNASE1;FBH1;XRN2;DNASE1L1;ISG20
prerank,mitotic sister chromatid segregation (GO:0000070),-0.18460076594831923,-0.7171046502176088,0.9838274932614556,0.9554805364339775,1.0,37/98,32.48%,SMC1A;CHMP5;CHMP2B;PINX1;CUL3;SET;CENPK;CSNK2B;BOD1;WRAP73;CHMP1B;CHMP1A;SMC4;KNSTRN;NCAPH;CHMP3;SPAG5;TEX14;NCAPD3;KIFC1;CHMP7;PDCD6IP;NDC80;REC8;KIF14;SPDL1;CHMP4C;DIS3L2;CDCA8;CEP55;KIF23;ZWINT;KMT5A;VPS4B;PLK1;NUDC;DLGAP5
prerank,neuron projection fasciculation (GO:0106030),0.32662830726379816,0.7170771196170389,0.7777777777777778,0.9809003381910327,1.0,2/10,7.10%,EPHA4;ARHGAP35
prerank,regulation of cytoplasmic translation (GO:2000765),-0.2838394198926328,-0.7169326089557828,0.8662790697674418,0.9551063282955801,1.0,8/14,31.96%,PKM;YBX3;CPEB1;FMR1;RBM24;CNBP;CPEB3;DHX9
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.28726865446297634,0.7159312245231577,0.8144712430426716,0.9816996106488278,1.0,4/17,13.05%,ABI2;WASF1;WASF3;FCHSD2
prerank,gene silencing by miRNA (GO:0035195),0.2606271945022125,0.7151111057594459,0.8566176470588235,0.9821257080624807,1.0,11/32,21.38%,ZC3H7B;TNRC6B;TNRC6A;AGO2;DICER1;MOV10;CNOT8;CNOT7;RBM4;XPO5;AGO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.32597726081010636,0.7124018160006088,0.819327731092437,0.9836922273580164,1.0,4/10,23.17%,BLM;WRN;NBN;SMARCAL1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.32597726081010636,0.7124018160006088,0.819327731092437,0.9836922273580164,1.0,4/10,23.17%,BLM;WRN;NBN;SMARCAL1
prerank,t-circle formation (GO:0090656),0.32597726081010636,0.7124018160006088,0.819327731092437,0.9836922273580164,1.0,4/10,23.17%,BLM;WRN;NBN;SMARCAL1
prerank,necroptotic process (GO:0070266),0.28957116845608083,0.7118892011302362,0.8248031496062992,0.983710406955663,1.0,16/16,71.07%,CYLD;CD14;PGAM5;ITPK1;TRPM7;FASLG;LY96;IPMK;RIPK3;TLR3;MLKL;TICAM2;DNM1L;RIPK1;TICAM1;TLR4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.27611468400966277,0.7111624495284921,0.8307984790874525,0.9840596001656234,1.0,4/20,12.45%,SMOC2;SULF1;APLN;PRKD2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.2915766654383541,-0.7105391694594199,0.8400770712909441,0.9613839228769622,1.0,10/13,34.94%,HES1;PTPRC;JAK3;MGAT5;DOT1L;CRLF2;PTPRT;EGF;TSLP;IL7R
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.2267197052490437,0.7100568678908399,0.8963730569948186,0.9847881355932203,1.0,6/51,8.79%,IL34;PTN;IL6;CSF1;MOSPD2;VEGFB
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2114435890761012,0.7094319684798756,0.9273927392739274,0.9849478543860176,1.0,22/76,19.55%,ANGPT1;PRICKLE1;SPHK1;LRRK2;UBE2L3;RWDD3;WDR48;FANCI;PIAS1;FBXO4;MYCBP2;CRY1;RCHY1;CENPX;BIRC2;AXIN1;TRAF6;HDAC4;TBC1D7;PIAS3;XIAP;DCUN1D5
prerank,somite development (GO:0061053),-0.29379857689750755,-0.7093107663528141,0.833976833976834,0.9621141223334025,1.0,2/11,7.46%,MEOX2;PTCH1
prerank,embryonic axis specification (GO:0000578),0.28631192332968414,0.7090063074409009,0.8023952095808383,0.9848387699447766,1.0,5/15,20.62%,SMAD6;COBL;HOXD8;CXXC4;SMAD2
prerank,histone H4 deacetylation (GO:0070933),0.3252008910887443,0.7083368360090745,0.7684426229508197,0.9849729866783644,1.0,2/10,10.71%,HDAC8;HDAC1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2577774080973289,-0.708012754405617,0.8588235294117647,0.9629233574861628,1.0,8/18,26.99%,MSN;PTPN23;VPS11;MAP2K2;MAPK3;CHMP3;EZR;SNX3
prerank,RNA modification (GO:0009451),-0.19874731628539033,-0.7079177359612566,0.953810623556582,0.9624659925312455,1.0,22/54,32.59%,ADARB1;ADAR;SSB;MEPCE;QTRT1;TSR3;NSUN4;MRM2;THUMPD1;METTL3;ELP5;METTL1;AARS2;PUS7;ADAT2;CDKAL1;QTRT2;NOP10;RBM15;JMJD6;NSUN5;CTU1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.22023153511401963,-0.707897069512579,0.8976034858387799,0.9619501010598779,1.0,15/36,35.47%,SHANK3;ITGB1;EDN1;RELN;ADRB2;GREM1;HDAC6;CCR2;CCL2;BTC;BUD31;EGF;PARK7;NCF1;ADAM17
prerank,regulation of cell cycle process (GO:0010564),0.2000583938615006,0.7076393160333911,0.9529780564263323,0.985200761810857,1.0,25/104,18.81%,OBSL1;HORMAD1;PLK5;CCDC8;CUL9;RPRD1B;BIRC6;YTHDF2;CUL7;PIK3R4;UVRAG;SND1;FLCN;MAD1L1;ZFYVE26;TXLNG;MYO19;CDKN2B;IHO1;SETD2;KLHL13;RAB11FIP3;USP19;PRPF40A;SFRP1
prerank,protein alkylation (GO:0008213),-0.24899930952840832,-0.7076074851432305,0.8778947368421053,0.9617141333978996,1.0,11/22,43.49%,PCMT1;PRMT8;PRMT3;ETFBKMT;ETF1;FAM98B;FAM98A;PRMT1;VCPKMT;METTL21C;METTL21A
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.25825865531841186,-0.7073663098141741,0.8568773234200744,0.961423220644621,1.0,9/18,44.78%,ADAM10;PSEN1;ABCG1;ACHE;ADAM17;CLN3;LDLRAP1;NSG1;PSEN2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2297719864960802,-0.7067360053222154,0.8804347826086957,0.9615383261300439,1.0,12/30,33.54%,SMCHD1;OGG1;UBQLN4;OTUB1;POLQ;SHLD3;RMI2;CGAS;TFIP11;RIF1;SHLD2;HELB
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22347629604182292,0.7066885259100357,0.9019607843137255,0.9857586128257293,1.0,12/48,18.28%,BAZ1B;ARID1B;ZMIZ1;SMARCA5;TAF1A;POLR1F;POLR1A;ZMIZ2;TAF1D;PHF2;POLR1G;ATAD2B
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2568971353338444,-0.7066819184740842,0.883629191321499,0.9610541931052542,1.0,7/18,24.36%,CBL;ST18;STAT3;SPI1;JAK1;CEBPA;STAT1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2878561630540002,0.7054705171732443,0.8203266787658802,0.9865702511709422,1.0,4/18,11.42%,PHF8;LYAR;RASL11A;ERBB2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3081885219317728,0.7049242180693795,0.7753479125248509,0.9865955009733179,1.0,2/12,8.27%,CBS;SRR
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.26230921716071465,-0.7047992212026029,0.8643724696356275,0.9624251724405066,1.0,6/17,22.08%,FURIN;NR1H2;PCSK5;ANGPTL4;HDAC9;NR1H3
prerank,defense response to protozoan (GO:0042832),-0.2923988939541825,-0.7041845525569396,0.8599605522682445,0.9624888186683314,1.0,4/12,21.22%,GBP4;CD40;MYD88;SLC11A1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.31301987698423345,0.704000791099479,0.8217213114754098,0.987090421728272,1.0,1/11,2.89%,SP100
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2541740873499483,-0.7035484418475355,0.8913934426229508,0.9625961877803882,1.0,7/20,24.15%,SREBF2;LPCAT3;NR1H4;ABCA2;MBTPS1;TTC39B;DGKQ
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2862297471006592,-0.7032714971905493,0.8636363636363636,0.9623413991959495,1.0,5/13,24.03%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2657182874229193,0.7031808240501073,0.830078125,0.987421356795374,1.0,1/22,1.28%,BMP7
prerank,determination of left/right symmetry (GO:0007368),0.23946044748672327,0.7026221388616569,0.8917525773195877,0.9874460309113949,1.0,7/36,15.00%,ODAD3;DNAH11;ARL6;BBS7;OFD1;PKD2;ODAD2
prerank,positive regulation of TOR signaling (GO:0032008),0.24202496423882663,0.7018438188762565,0.8821362799263351,0.9877198962606428,1.0,14/40,20.65%,FNIP1;RICTOR;SLC38A9;GPR137C;MLST8;FLCN;KLHL22;SIK3;TELO2;LARS1;MIOS;PIK3CA;CLEC16A;LAMTOR5
prerank,lipoprotein transport (GO:0042953),0.31282263162194046,0.7015366328592627,0.7855670103092783,0.9874885859430085,1.0,2/10,8.41%,PRKCB;MIA3
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.23221519831926918,-0.701503876388964,0.9162995594713657,0.9635648574199055,1.0,10/28,24.56%,CDH1;FLNA;TGFB1;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,establishment of spindle orientation (GO:0051294),0.25302558648681955,0.7013097070614887,0.8939393939393939,0.9871286412041461,1.0,5/28,11.33%,LLGL2;GJA1;UBXN2B;PAFAH1B1;LLGL1
prerank,endosome organization (GO:0007032),0.2376616392973915,0.7011832438139856,0.9061946902654867,0.9866860370326673,1.0,11/41,16.50%,HOOK2;ALS2;SNX33;PLEKHJ1;RAB22A;ARFGEF2;PLEKHF1;EEA1;PHETA1;WASHC4;PI4K2A
prerank,cellular component maintenance (GO:0043954),0.30915352724186385,0.7007397441871568,0.8296593186372746,0.9865750821682011,1.0,2/12,5.54%,IGF1R;ITGA3
prerank,ruffle organization (GO:0031529),0.28559738114020805,0.6996995045425843,0.8011928429423459,0.987163380546344,1.0,2/16,7.18%,TPM1;LIMA1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.266564576352064,0.6988969504531883,0.8579545454545454,0.987484282414716,1.0,7/23,19.94%,PRKN;LRRK2;ABL1;MAPK1;GNG2;SNCA;SLC9A1
prerank,endocytic recycling (GO:0032456),-0.2011886669847548,-0.6987518732566137,0.952914798206278,0.9658087635145983,1.0,15/50,26.99%,EHD4;DENND1B;EHD1;STX6;PTPN23;LMTK2;EHD3;ANKRD50;ENTR1;VPS51;RAB7A;SNX27;RAB14;MICALL2;SNX3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2677942998651005,-0.69806996686947,0.8665338645418327,0.9659533646411973,1.0,9/16,47.12%,TUBB4B;ULBP1;CORO1A;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRK1;LYST
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2588637809855169,0.6978831004644788,0.8653136531365314,0.9879883916638583,1.0,3/25,9.92%,B3GALT1;HAS1;NDST2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.27331616578773843,-0.6976744491826107,0.8835341365461847,0.9657640262389288,1.0,5/15,33.74%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,positive regulation of macrophage migration (GO:1905523),0.27708373094385425,0.697449526501591,0.8548057259713702,0.9878591134803332,1.0,1/19,0.72%,IL34
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2451409574063177,-0.6970783450362636,0.8720472440944882,0.9658243135768866,1.0,4/21,19.27%,ADAM10;MYH9;ADAM9;PSEN1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2168307152507629,0.6963561055514167,0.922824302134647,0.9884729511085677,1.0,15/68,17.08%,CDK7;SSU72;MTERF2;POLR2A;SMN1;TAF1A;POLR1F;POLR1A;TAF1D;WDR33;MNAT1;FIP1L1;CSTF3;POLR1G;CPSF4
prerank,mitochondrial protein processing (GO:0034982),0.3050961629421315,0.6959932020422728,0.8284518828451883,0.9882130271446897,1.0,3/11,16.90%,YME1L1;OMA1;IMMP1L
prerank,negative regulation of bone mineralization (GO:0030502),0.29510362507017174,0.6945494084370211,0.8291139240506329,0.9892504676111916,1.0,2/13,6.35%,ECM1;BCOR
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23438327195069325,-0.6945107361933308,0.9168399168399168,0.9677840116097108,1.0,12/28,39.58%,TNFRSF21;PRKAR1A;CD274;SDC4;CEBPB;CD80;IL4I1;GPNMB;RC3H1;VTCN1;ARG1;CRTAM
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.26331038080673286,-0.6943268948222873,0.8823529411764706,0.9674195739395833,1.0,6/17,21.97%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1
prerank,regulation of TORC1 signaling (GO:1903432),0.24215460396899244,0.6942214693620222,0.8723021582733813,0.9890269925694269,1.0,12/33,20.65%,SZT2;SESN1;RNF152;GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;KPTN;LAMTOR5
prerank,T cell differentiation in thymus (GO:0033077),-0.2733182795468643,-0.6923934220811355,0.8640973630831643,0.9687001713204226,1.0,4/14,18.89%,PTPRC;ZFP36L1;RABL3;LIG4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.26730281483154533,0.6911456370595833,0.8527272727272728,0.9917433533994866,1.0,8/20,22.19%,MEIS1;CDC73;CIB1;MEIS2;CTR9;LDB1;PAF1;HOXA5
prerank,negative regulation of viral genome replication (GO:0045071),0.2286611719306752,0.6893411795064068,0.8872727272727273,0.9930825026010346,1.0,3/40,3.90%,LTF;RNASEL;SRPK2
prerank,ureteric bud morphogenesis (GO:0060675),-0.2591151231920794,-0.6892372383001087,0.8584729981378026,0.9710338823890475,1.0,8/16,34.32%,SIX1;NPNT;BMP2;BMP4;PAX8;FGF2;SHH;PAX2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.28809452035877225,-0.6891022292722175,0.8409961685823755,0.9706321801657912,1.0,4/12,23.23%,WDTC1;CEACAM1;ERLIN2;TRIB3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.2802778046621971,-0.6884565734187202,0.8388998035363457,0.9707218744595355,1.0,5/13,21.97%,SMUG1;NT5C;OGG1;NEIL1;NTHL1
prerank,lymphocyte migration (GO:0072676),-0.22491741019427564,-0.6872134995890534,0.9094922737306843,0.971283512525268,1.0,2/32,3.56%,MSN;S1PR1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.24117846924618716,-0.685819685787019,0.8848614072494669,0.9720251691029516,1.0,3/23,3.96%,PTK2B;NOTCH1;HES1
prerank,organophosphate biosynthetic process (GO:0090407),0.2356408344599775,0.6852425466918854,0.8916967509025271,0.9968560140284372,1.0,11/37,21.26%,AGPAT4;MOCS2;PPIP5K2;ITPKA;MOCS1;GK;MOCS3;GK5;PIP5K1A;IP6K2;PCYT2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.23600921484543175,-0.6847251115355927,0.8941684665226782,0.9724396610956897,1.0,10/24,34.29%,HSP90AA1;AIM2;ZC3H12A;STAT1;TRIM44;CGAS;SIN3A;MAVS;PTPN22;PQBP1
prerank,regulation of response to biotic stimulus (GO:0002831),0.24261193555323102,0.6839468349217669,0.8888888888888888,0.9976348632771307,1.0,2/28,3.24%,APPL2;TRIM5
prerank,termination of RNA polymerase I transcription (GO:0006363),0.23798050272423094,0.6832839474318364,0.8874773139745916,0.9977315110170789,1.0,7/30,16.99%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,protein import into peroxisome membrane (GO:0045046),-0.24434940024037943,-0.6832554153672117,0.8961538461538462,0.973194114677053,1.0,9/22,29.55%,ABCD3;ABCD2;PEX11B;PEX5;ATAD1;RAB8B;PEX16;FIS1;PEX13
prerank,GTP metabolic process (GO:0046039),-0.26292988443304016,-0.6832234393464621,0.8769230769230769,0.9726840980177545,1.0,3/15,13.97%,ENTPD7;IMPDH1;IMPDH2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.26839095182895273,0.6829181153452263,0.8686274509803922,0.9974865216135347,1.0,5/20,16.27%,PLCB1;GNAQ;LY6G6D;GRK2;CHRNB2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2670927872488386,-0.6827193137213221,0.8562874251497006,0.9725822043363076,1.0,5/15,21.92%,ZC3H12A;GSTO2;ATF3;MKNK2;VCP
prerank,programmed necrotic cell death (GO:0097300),0.27070643642072234,0.6822628591543917,0.8493975903614458,0.9975201818684797,1.0,18/18,72.96%,CYLD;CD14;PGAM5;ITPK1;TRPM7;FASLG;PPIF;LY96;IPMK;RIPK3;TLR3;MLKL;TICAM2;DNM1L;RIPK1;TICAM1;TLR4;ALKBH7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.28371297154390773,-0.682020719596646,0.8773946360153256,0.9715951488081157,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.28371297154390773,-0.682020719596646,0.8773946360153256,0.9715951488081157,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.28371297154390773,-0.682020719596646,0.8773946360153256,0.9715951488081157,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,tryptophan catabolic process (GO:0006569),-0.28807028703906523,-0.6815670359598288,0.8696498054474708,0.9714403152802251,1.0,4/11,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,regulation of lipid kinase activity (GO:0043550),0.30080741149127377,0.681365497685888,0.839835728952772,0.9978474335995773,1.0,2/11,10.73%,RBL2;PIK3R1
prerank,DNA conformation change (GO:0071103),0.2785695021794109,0.6808100222385637,0.8609406952965235,0.9978074682497277,1.0,3/17,14.13%,TOP2B;ABL1;TOP1MT
prerank,regulation of mitochondrion organization (GO:0010821),0.219411920651294,0.6800645629821291,0.9240282685512368,0.9979412004096949,1.0,9/47,17.25%,PID1;PRKN;LRRK2;FLCN;PISD;HTRA2;OMA1;MYO19;VPS35
prerank,regulation of DNA recombination (GO:0000018),-0.22390801743166078,-0.6799355753099648,0.9251101321585903,0.9722751705411842,1.0,15/32,34.94%,SPIDR;MSH2;TERF2IP;PPP4R2;SMARCAD1;SIRT6;CHEK1;ALYREF;ZCWPW1;SHLD2;PPP4C;KPNA2;RPA2;FIGNL1;IL7R
prerank,regulation of sensory perception of pain (GO:0051930),-0.2932895263633464,-0.679517236566915,0.8745173745173745,0.9721016123429049,1.0,2/11,5.09%,MGLL;CCN3
prerank,mitotic cell cycle phase transition (GO:0044772),0.17710717058753073,0.6792815217991451,0.9943582510578279,0.9981557552850853,1.0,24/203,12.44%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;EIF4EBP1;HAUS4;CEP152;NASP;PHF8;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;LATS1;OFD1;HAUS1;RPS6KB1;SFI1;CUL4B;CCNE1;CEP57
prerank,intracellular cholesterol transport (GO:0032367),0.28169399132116013,0.6790168311311117,0.8577319587628865,0.997838727443513,1.0,3/15,17.14%,ABCA1;SERAC1;RELCH
prerank,indolalkylamine catabolic process (GO:0046218),-0.2904417349492834,-0.6788564677499649,0.8645038167938931,0.9721651716156863,1.0,4/10,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.22646966199614085,-0.6783978863719403,0.9002267573696145,0.9719967989186851,1.0,8/28,21.04%,PTK2;DAB2IP;CLU;PSMC3;ATP5IF1;LAPTM5;FMR1;CTSC
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.31260939551006645,0.6770817100617914,0.8268041237113402,0.9992124686853379,1.0,4/10,21.85%,SLC45A3;SNCA;IRS2;IRS1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.2898177117736333,0.6766064618568902,0.8529411764705882,0.9990541090318706,1.0,5/13,22.25%,LRRK2;RHOQ;RAB23;AK4;AK3
prerank,positive regulation of protein sumoylation (GO:0033235),0.304525259793775,0.6765000530761647,0.8091286307053942,0.9985502553184792,1.0,4/10,19.02%,RWDD3;PIAS1;HDAC4;PIAS3
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2608559031875314,0.6758855707532202,0.874296435272045,0.9985243122730323,1.0,2/21,4.78%,PPP4R4;PTPA
prerank,regulation of lipid storage (GO:0010883),0.25736245725074797,0.6742563143788552,0.8725490196078431,0.9995122419144765,1.0,4/22,14.04%,PLA2G10;IL6;IKBKE;PLIN5
prerank,regulation of response to stress (GO:0080134),-0.2899853230617203,-0.6738045746126675,0.8595505617977528,0.9753064698156015,1.0,2/10,9.74%,CORO2B;EIF4G1
prerank,natural killer cell mediated immunity (GO:0002228),-0.26100040170434924,-0.6735188131061882,0.883399209486166,0.9749991888826559,1.0,9/15,47.12%,TUBB4B;ULBP1;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRD1;KLRK1;LYST
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.239014392763286,0.6733872944994159,0.8848920863309353,0.9997380900641842,1.0,15/31,24.98%,EXOSC8;DCP2;LSM5;CNOT8;CNOT7;EXOSC3;LSM3;LSM1;LSM4;DDX6;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,positive regulation of mRNA processing (GO:0050685),-0.23823961704361565,-0.6732179291977831,0.9293361884368309,0.9747051748758667,1.0,12/21,48.33%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;NCBP2;CELF3;LEO1;SF3B4;RBM3;TRA2A;NCBP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.2913608136366225,0.6724699340292458,0.8618421052631579,1.0,1.0,2/13,8.90%,IRAK2;PIK3R4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.27204780377012416,-0.6721491103697005,0.8822463768115942,0.9750243189889675,1.0,7/13,32.23%,ETS1;RHOA;IRAK1;FUT9;RELA;ITGB2;MDK
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.25529869037602326,0.6719022554646136,0.8772277227722772,0.9999730850419396,1.0,2/22,6.76%,KIT;IL6
prerank,regulation of axon regeneration (GO:0048679),-0.27714304633216763,-0.6717600104286882,0.8816793893129771,0.9748099442130144,1.0,5/12,21.36%,SCARF1;RTN4RL1;GRN;INPP5F;RTN4R
prerank,RNA methylation (GO:0001510),-0.18663304545158074,-0.6713810789161995,0.9627791563275434,0.9745958052728986,1.0,15/60,23.62%,TFB2M;TRMT61B;MEPCE;BUD23;FBL;ALKBH8;NSUN4;TRMT44;MRM2;TRMT12;METTL3;TYW3;TRMT10C;METTL1;PCIF1
prerank,tRNA modification (GO:0006400),0.21302961814809546,0.6713616240613366,0.9534109816971714,0.9998795510653303,1.0,14/62,18.44%,TRMT9B;PUS3;THADA;LCMT2;TRDMT1;OSGEP;WDR4;MTO1;THUMPD3;DUS2;DTWD1;TYW5;TPRKB;MOCS3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.30290232434373765,0.6705622965295998,0.8152173913043478,1.0,1.0,1/10,6.02%,PDE6G
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.24761819617919603,-0.6686255400661321,0.9049586776859504,0.9762831005987473,1.0,1/17,1.62%,SLC7A5
prerank,autophagosome organization (GO:1905037),0.21723700010484898,0.6684923367294076,0.9263698630136986,1.0,1.0,12/50,17.14%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;ATG9A;RAB43;AMBRA1;ATG3;RUFY4;IRGM;ATG16L2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.281426138642096,0.6683887551720432,0.8522954091816367,1.0,1.0,3/13,10.17%,TNRC6B;TNRC6A;AGO2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.24878903417007847,-0.6683530721857336,0.9300970873786408,0.9759523522847414,1.0,7/17,35.25%,LGMN;CXCL12;CCR2;CREB3;CXCL10;CXCL17;CCL5
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.23424168679639049,-0.6672898225695596,0.8916155419222904,0.9762693216177221,1.0,14/23,36.09%,SIX1;VEGFA;PIK3CD;SIX4;BMP4;PAX8;SIRT6;FGF2;EGF;AGT;MDK;NOG;PAX2;LIF
prerank,gluconeogenesis (GO:0006094),0.2234399780137558,0.6661793877791423,0.9183673469387755,1.0,1.0,6/39,14.14%,RBP4;SLC25A11;CRY1;ENO2;PFKFB1;GPI
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.28401893970349357,-0.6653606223961951,0.8878143133462283,0.977272804606269,1.0,6/11,37.75%,PLCG2;CDH13;TREM2;P2RX5;P2RX3;TRAT1
prerank,regulation of spindle organization (GO:0090224),-0.24884300210600926,-0.6636209501613639,0.9136546184738956,0.9780680153704836,1.0,8/18,46.31%,GNAI1;NUMA1;DCTN1;DYNC1H1;PSRC1;SENP6;RAE1;PARP3
prerank,regulation of lymphocyte activation (GO:0051249),0.28510451321323216,0.6635656929152727,0.8375,1.0,1.0,12/12,71.51%,PAG1;LAT;SIT1;CD4;CD19;LCK;CRTAM;KAT2A;CCL5;THEMIS2;IKZF3;DCAF15
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.22375384550904387,-0.6629727686403672,0.9371196754563894,0.9780506633887566,1.0,7/27,19.97%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC
prerank,Golgi inheritance (GO:0048313),0.28787940009609936,0.6625446127874594,0.8585858585858586,1.0,1.0,3/11,9.66%,PLK5;CDK1;GOLGA2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.23311655312758517,-0.6623653729721903,0.9254901960784314,0.9780027173647023,1.0,5/23,13.07%,PLK2;ARF1;SLC24A2;SLC30A1;PICK1
prerank,negative regulation of protein depolymerization (GO:1901880),0.24854619044910248,0.6619721316862548,0.8790322580645161,1.0,1.0,2/24,7.18%,PLEKHH2;LIMA1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.24717114180408317,-0.6618872513562112,0.9230769230769231,0.9778238717209706,1.0,4/18,15.65%,AGRN;CHRM3;GNA11;RGS10
prerank,synaptic vesicle recycling (GO:0036465),0.23540271972137572,0.6615288350211144,0.9230769230769231,1.0,1.0,3/31,6.00%,CEL;NLGN2;SYNJ2
prerank,acyl-CoA metabolic process (GO:0006637),0.22962111209732344,0.6609251620871198,0.9097605893186004,1.0,1.0,2/35,4.01%,SUCLG2;ACOT4
prerank,axoneme assembly (GO:0035082),0.23650608348107374,0.6606301124509,0.9193548387096774,1.0,1.0,6/30,14.91%,DNAI4;SPAG1;CFAP74;TTC12;CCDC65;DNAAF3
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.25794933974838297,-0.6605689709595408,0.8913043478260869,0.9782745489221172,1.0,5/15,36.30%,PTTG1;ANAPC7;PLK1;CDC6;UBE2C
prerank,homologous chromosome segregation (GO:0045143),0.25222215930397585,0.6599094438235977,0.8829365079365079,1.0,1.0,2/20,8.72%,TERB2;MAJIN
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.21813679283596932,0.6598982704207979,0.9382504288164666,1.0,1.0,8/45,14.63%,BMP7;TOM1L2;SMAD3;TRIM35;PTPN3;GAS1;CDKN1C;CHFR
prerank,regulation of autophagosome maturation (GO:1901096),0.28039854377410783,0.6592195733285038,0.847870182555781,1.0,1.0,7/13,25.44%,UVRAG;RUBCN;TMEM39A;IRGM;CLEC16A;FYCO1;PHF23
prerank,protein lipidation (GO:0006497),0.2052112825109637,0.658816456841433,0.9472817133443163,1.0,1.0,9/59,12.88%,PIGU;ZDHHC1;ATG10;PIGG;WIPI1;ZDHHC3;PIGV;PIGC;PIGQ
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.21496307663604614,-0.6578861143828639,0.9523809523809523,0.9797314722642158,1.0,8/29,20.79%,PUM2;ADAR;DGCR8;LIN28B;ZC3H7A;AGO3;SNIP1;METTL3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.18906994917297193,-0.6575631140135738,0.9447115384615384,0.9794346777250136,1.0,11/50,22.31%,ACTB;HSP90AB1;CDC37;CDKN1B;CCNF;CAMK2N1;CCNG2;GADD45A;CDKN1A;CDKN2D;CCNB2
prerank,cardiolipin metabolic process (GO:0032048),-0.25748795217369536,-0.6566049696451478,0.8897795591182365,0.9796065287922827,1.0,2/13,15.14%,CRLS1;PLA2G4A
prerank,regulation of protein sumoylation (GO:0033233),0.2649631948485853,0.6561242412690791,0.8971428571428571,1.0,1.0,3/17,8.19%,ZMIZ1;RWDD3;PIAS1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.2805418006136837,0.655509694369028,0.8606060606060606,1.0,1.0,1/12,1.72%,UST
prerank,prostanoid metabolic process (GO:0006692),0.27381656116829656,0.6550833875134248,0.8846153846153846,1.0,1.0,3/13,18.80%,PTGR1;ACOX1;PTGR2
prerank,protein import into nucleus (GO:0006606),0.20025737125055904,0.6550665394848963,0.9556650246305419,1.0,1.0,11/66,17.23%,APPL2;IPO13;PRICKLE1;NUTF2;NUP107;TNPO1;NXT2;CBLB;RPAIN;IPO9;NUP214
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.28722068792367544,0.6546908305980349,0.8648068669527897,1.0,1.0,11/11,71.30%,CCT6A;TCP1;DKC1;CCT5;CCT7;CCT8;TERF1;CCT2;WRAP53;CCT4;CCT3
prerank,kinetochore organization (GO:0051383),-0.2635958994055587,-0.6539051698166399,0.9153225806451613,0.9809828352140263,1.0,10/13,53.80%,NDC80;DLGAP5;CENPW;CENPT;CENPF;CDT1;CENPC;CENPH;NUF2;CENPA
prerank,coenzyme A metabolic process (GO:0015936),-0.2530442672407799,-0.6530593454235167,0.9025341130604289,0.9810572859722081,1.0,4/14,29.33%,PPCDC;ACLY;PANK2;PANK3
prerank,regulation of defense response to virus by host (GO:0050691),-0.2118689603159542,-0.6524325956731629,0.9317697228144989,0.9809499979766917,1.0,13/30,35.50%,HSP90AA1;AIM2;ZC3H12A;TNFAIP3;STAT1;TRIM44;CGAS;SIN3A;DHX9;MAVS;PTPN22;PQBP1;IFNLR1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.25919657202745694,0.6522913930363817,0.8678861788617886,1.0,1.0,7/19,21.02%,GFPT2;PMM2;RENBP;UGDH;PGM3;MPI;GMPPB
prerank,positive regulation of chemokine production (GO:0032722),-0.19348799747921563,-0.6520884980857963,0.9635193133047211,0.9806466463514031,1.0,16/44,35.47%,IL33;MBP;APP;CD74;CSF1R;TIRAP;AGER;ADCYAP1;TLR7;TLR4;LPL;MAVS;TSLP;IL7;SYK;ADAM17
prerank,eye photoreceptor cell development (GO:0042462),-0.2514802718280199,-0.6519074184665246,0.9075471698113208,0.9802145333413294,1.0,4/15,20.05%,RP1;VEGFA;RORB;THY1
prerank,cell-cell junction maintenance (GO:0045217),0.297294012133739,0.6518711608531348,0.8516129032258064,1.0,1.0,1/11,2.23%,NLGN2
prerank,regulation of lipid catabolic process (GO:0050994),0.2562374374774525,0.6513474944045937,0.8716356107660456,1.0,1.0,5/19,20.89%,PRKAA1;APOC1;ADRA2A;LONP2;RARRES2
prerank,purine-containing compound salvage (GO:0043101),0.286224488161135,0.6509179334255509,0.8836734693877552,1.0,1.0,4/12,18.21%,AMPD3;ADK;APRT;GMPR2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.28273172617373515,-0.6498900052607395,0.8914285714285715,0.9810578932363352,1.0,6/11,35.96%,CPSF6;NRDE2;NUP153;DHX9;IWS1;NCBP2
prerank,transcription by RNA polymerase I (GO:0006360),0.21839521965700628,0.6492595187622541,0.9147424511545293,1.0,1.0,8/34,16.99%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;TCOF1;POLR1G
prerank,positive regulation of RNA splicing (GO:0033120),-0.2100021696811705,-0.6489470053692402,0.9505376344086022,0.9811314922316224,1.0,11/29,33.16%,RBMXL1;HNRNPLL;RBM22;TRA2B;RBM20;ZPR1;PRDX6;ERN1;DAZAP1;CELF4;HSPA1A
prerank,regulation of telomere capping (GO:1904353),-0.22086183813454952,-0.648923334358846,0.9334763948497854,0.9806171421553129,1.0,1/23,0.72%,NEK7
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.1777884375607366,0.6478553627186999,0.9854862119013063,1.0,1.0,17/145,11.40%,NINL;ALMS1;RAD51B;RAD51C;HAUS4;CEP152;PSME4;PSMA2;SDCCAG8;PSMA3;CDK1;PAFAH1B1;PSMD8;OFD1;HAUS1;PSMD3;SFI1
prerank,sensory perception of taste (GO:0050909),0.2952990648339924,0.6462882081322043,0.860813704496788,1.0,1.0,10/10,70.49%,ASIC3;TAS1R2;PKD2L1;ASIC2;TAS1R3;GNAT3;PKD1L3;TAS1R1;CD36;ASIC1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2968789185351471,0.6442415161330473,0.8461538461538461,1.0,1.0,4/10,20.51%,TGFA;AREG;HBEGF;ADRA2A
prerank,regulation of integrin activation (GO:0033623),0.2710238475920823,0.642922962171656,0.8917322834645669,1.0,1.0,2/15,4.14%,CXCL13;FERMT1
prerank,insulin secretion (GO:0030073),0.25516315068781537,0.6427054608822858,0.8912621359223301,1.0,1.0,5/19,17.50%,ANXA1;SLC30A8;RAB11FIP2;RAB11B;CYB5R4
prerank,positive regulation of secretion (GO:0051047),-0.2702936839111511,-0.6426136848977524,0.9155470249520153,0.98433589390845,1.0,2/11,17.76%,XBP1;ACSL3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23992598459391995,0.6411647063560247,0.8985765124555161,1.0,1.0,2/23,6.13%,GSTM2;EPHX2
prerank,protein processing (GO:0016485),0.18371353615053693,0.6403755218388543,0.9828125,1.0,1.0,5/102,4.11%,AEBP1;KLK2;CTSH;PCSK9;MYRFL
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.2802342916951122,0.6401889141559773,0.8713080168776371,1.0,1.0,2/12,7.55%,CLCN2;H6PD
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.22590248916136743,0.6400034315114067,0.9330783938814532,1.0,1.0,7/28,18.40%,MRNIP;AUNIP;PRKDC;PARP9;HSF1;DTX3L;KDM4D
prerank,DNA integrity checkpoint signaling (GO:0031570),0.22236481700486666,0.6388686314568573,0.9446428571428571,1.0,1.0,10/36,21.10%,ATRIP;HUS1B;CLSPN;FBXO6;CLOCK;CEP63;BRIP1;RAD9B;MAP3K20;NBN
prerank,tRNA methylation (GO:0030488),0.22076409001870756,0.6378553095117631,0.9457092819614711,1.0,1.0,7/34,17.61%,HSD17B10;THADA;LCMT2;TRDMT1;MTO1;THUMPD3;TRMT1L
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.28720266114353854,0.6377740322210601,0.8549450549450549,1.0,1.0,10/10,71.30%,CCT6A;TCP1;DKC1;CCT5;CCT7;CCT8;CCT2;WRAP53;CCT4;CCT3
prerank,mucosal immune response (GO:0002385),0.26510643072799345,0.6375695559262325,0.896551724137931,1.0,1.0,1/15,2.73%,LTF
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.23866822166359558,-0.6368380222933652,0.9278350515463918,0.9876297654963265,1.0,10/18,37.49%,AQP4;CFAP53;SPAG17;RFX3;DNAAF2;ODAD4;CABYR;CCDC40;DNAAF4;CCDC39
prerank,negative regulation of intracellular protein transport (GO:0090317),0.24445269421451615,0.6364517886264133,0.884,1.0,1.0,3/22,6.47%,SP100;LRRK2;SUFU
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2329702669319422,0.6357988788711055,0.911275415896488,1.0,1.0,5/30,11.27%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2494042558333734,-0.6356030540225509,0.927734375,0.9878883932052944,1.0,4/14,18.46%,RTCB;RTRAF;CLP1;CSTF2
prerank,fatty acid transport (GO:0015908),0.2553014317460007,0.6351437094546011,0.8936605316973415,1.0,1.0,2/17,9.87%,ACSL1;SLC27A1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.1993000574754627,-0.6336869151881536,0.9440559440559441,0.9885713674840367,1.0,18/36,40.86%,LEF1;SOX4;XBP1;NKAP;NCKAP1L;SOCS1;VSIR;IL4I1;SHH;VNN1;MDK;IL7;ZAP70;GATA3;TESPA1;IL12RB1;IL4;BCL6
prerank,DNA duplex unwinding (GO:0032508),0.20746859927063815,0.6327886308617142,0.9498269896193772,1.0,1.0,17/50,21.10%,ANXA1;DDB2;BLM;SSBP1;RTEL1;CUL4B;MRE11;RAD23B;WRN;MCM2;RAD51;XPC;PURA;MCM7;RECQL5;RAD50;NBN
prerank,positive regulation of growth (GO:0045927),0.19351745444684845,0.6323906033535587,0.9748743718592965,1.0,1.0,17/64,20.47%,BCL2;PLCB1;SPHK1;ERBB2;KLHL22;ADNP2;S100A9;INO80;CIB1;HYAL1;N6AMT1;SDCBP;SFRP1;DDX3X;TAF9B;USP47;DERL2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.25019704640910756,0.6322427757176734,0.8983050847457628,1.0,1.0,4/18,12.75%,COX19;COX17;OXA1L;COX20
prerank,protein localization to condensed chromosome (GO:1903083),0.27452490855152223,0.6320289668290514,0.8914893617021277,1.0,1.0,3/12,15.71%,TTK;CDK1;MIS12
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.26954416407211723,-0.6314835321792298,0.9334600760456274,0.9894039583955762,1.0,1/11,2.15%,GAS6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.18194439277136498,-0.6308575540787933,0.9804878048780488,0.9892182518375598,1.0,24/53,40.93%,CHRM3;HTR2A;HRH1;CALCRL;MC5R;NPY1R;HRH2;TSHR;NPY;HTR2C;CCL2;CHRM1;AGT;HTR1A;HTR1B;HTR1F;OPRM1;HRH3;CHRM5;CCR1;HTR6;CNR2;HTR1D;SSTR1
prerank,sister chromatid segregation (GO:0000819),0.22375600839218962,0.6301691455482876,0.9360146252285192,1.0,1.0,11/31,20.37%,TOP2B;LATS1;NSL1;KLHL22;DSN1;INO80;MIS12;TUBG1;KIF18A;KIF18B;NCAPG2
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.26411492714660617,-0.6296316721372404,0.9090909090909091,0.9889279467011415,1.0,2/11,10.34%,LARP7;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.26411492714660617,-0.6296316721372404,0.9090909090909091,0.9889279467011415,1.0,2/11,10.34%,LARP7;MEPCE
prerank,heterochromatin assembly (GO:0031507),-0.2329451079655466,-0.6290620760983608,0.9291497975708503,0.9887579237094346,1.0,4/20,19.01%,SMCHD1;H3-3A;BAHD1;NRDE2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2395900544159335,0.6286359222919516,0.9090909090909091,1.0,1.0,3/22,7.12%,PSME4;PSMA2;PSMA3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.24839528274723716,-0.6281997790788921,0.9141716566866267,0.9887241289571375,1.0,2/14,5.06%,CMPK1;ME1
prerank,dermatan sulfate metabolic process (GO:0030205),0.26658165631858577,0.6272269670951598,0.897119341563786,1.0,1.0,1/13,1.72%,UST
prerank,mRNA methylation (GO:0080009),-0.2404027045725845,-0.6271583491282405,0.9128014842300557,0.9888106292495787,1.0,4/15,23.62%,TRMT61B;METTL3;TRMT10C;PCIF1
prerank,axonal transport of mitochondrion (GO:0019896),-0.2673495071819706,-0.6260887225430974,0.8968253968253969,0.9889381071689719,1.0,3/11,25.13%,ACTR10;NEFL;HAP1
prerank,glycogen catabolic process (GO:0005980),0.2600697822755322,0.6255944694952973,0.8956158663883089,1.0,1.0,1/15,1.70%,PHKB
prerank,photoperiodism (GO:0009648),-0.20799741263103982,-0.6244261243400091,0.9607438016528925,0.9893920279829382,1.0,7/28,19.97%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2619015859924441,-0.624217940534311,0.9185185185185185,0.9889905327504015,1.0,2/11,16.90%,CTNNB1;NR4A2
prerank,cobalamin metabolic process (GO:0009235),0.2507567089504972,0.6241491623279581,0.9151873767258383,1.0,1.0,4/17,21.31%,TCN2;MMAB;LMBRD1;TCN1
prerank,DNA strand elongation (GO:0022616),0.2520045003999289,0.6241267916471954,0.9262135922330097,1.0,1.0,8/18,23.20%,DCLRE1B;MRE11;POLD2;MCM7;RAD50;GINS3;NBN;RFC4
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.2858365412064012,0.6221294736316921,0.8997867803837953,1.0,1.0,5/10,21.35%,CCL19;AXL;LYN;LGALS9;RAPGEF2
prerank,phasic smooth muscle contraction (GO:0014821),-0.27273934064224536,-0.622114329922188,0.9198473282442748,0.9896893602124204,1.0,2/10,13.78%,EDN1;PTGER3
prerank,membrane protein proteolysis (GO:0033619),-0.19017271185214557,-0.6210669633988884,0.978021978021978,0.9897244811256003,1.0,8/37,23.41%,ADAM10;TGFB1;MYH9;RET;ADAM9;PSEN1;MBTPS1;RELA
prerank,aromatic amino acid family catabolic process (GO:0009074),0.2599030707716393,0.6210160230781228,0.9,1.0,1.0,3/15,15.20%,FAH;AADAT;GSTZ1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.2545776881726784,0.6207764185578154,0.9135559921414538,1.0,1.0,1/17,3.14%,NOS1AP
prerank,regulation of protein acetylation (GO:1901983),-0.25845234659018623,-0.6200292468521704,0.9295238095238095,0.9897601665319327,1.0,3/12,24.09%,GSK3B;TERF2IP;CEP295
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24637435626049742,0.6192925990592175,0.9089068825910931,1.0,1.0,6/19,18.62%,AMPD3;TYMS;ADK;APRT;GMPR2;POLD2
prerank,regulation of pH (GO:0006885),0.2763539305636499,0.6191382545127523,0.8708333333333333,1.0,1.0,1/11,3.68%,LACC1
prerank,replicative senescence (GO:0090399),-0.2588373191581595,-0.618646175567126,0.9112426035502958,0.9899968931137343,1.0,5/12,24.74%,WNT16;CHEK2;ROMO1;ATR;CHEK1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.22905864638999973,0.6182715174982498,0.921455938697318,1.0,1.0,1/26,1.07%,PPARA
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2448122044001445,0.6182328774031169,0.9410609037328095,1.0,1.0,4/21,13.89%,MITF;MED1;MED13;SRF
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.2592720721580324,-0.6176606786544594,0.93158953722334,0.9900179523370931,1.0,8/11,50.44%,ZFP36L1;AHCYL1;BARD1;NCBP2;LEO1;PAPOLA;NCBP1;ZC3H3
prerank,androgen metabolic process (GO:0008209),0.24507319134105612,0.6174524485390788,0.9138276553106213,1.0,1.0,2/18,10.05%,HSD17B10;MED1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.24676645595521296,0.616307885398409,0.9183266932270916,1.0,1.0,7/17,19.38%,CCNT1;HSF1;RNF20;ZC3H14;CTR9;NUDT21;CDK9
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.18478203721682976,0.6156437756675721,0.9825949367088608,1.0,1.0,12/78,14.19%,NR2F2;CDK7;BLM;PTEN;CCNT2;CCNT1;CDK5RAP1;LATS1;CCNE1;PKD2;CDKN1C;MNAT1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.25806735209734566,-0.6146837641136055,0.9214145383104125,0.9905288321671022,1.0,6/11,33.97%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,cellular response to interleukin-2 (GO:0071352),-0.25806735209734566,-0.6146837641136055,0.9214145383104125,0.9905288321671022,1.0,6/11,33.97%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,membrane lipid catabolic process (GO:0046466),-0.2671052590538833,-0.6143013628071698,0.898989898989899,0.9902107540072492,1.0,2/10,15.18%,SGPL1;CYP1B1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2572707059933401,-0.6139501721005924,0.906187624750499,0.9898485868017911,1.0,4/11,22.89%,TNFRSF21;TYROBP;CD300A;FCGR2B
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.22396696667725652,0.6136971377557585,0.943289224952741,1.0,1.0,6/27,18.87%,LPAR1;F2RL2;F2RL3;GPR157;DRD2;GPR35
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.24086057085957402,0.6131992461310201,0.9273084479371316,1.0,1.0,4/19,15.56%,HNRNPC;ACD;DCP2;STN1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.17118659351600907,0.6119025087297152,0.9955022488755623,1.0,1.0,16/125,12.78%,EML4;KIF2A;ITGB3BP;PTPA;CENPI;TTK;BIRC5;PAFAH1B1;SKA2;NUP107;NSL1;MAD1L1;CENPQ;DSN1;DCTN6;SUN2
prerank,defense response to fungus (GO:0050832),-0.2334244079561176,-0.6116871328056989,0.9357429718875502,0.9904949679653299,1.0,3/17,15.75%,PLCG2;GAPDH;CX3CR1
prerank,cellular response to light stimulus (GO:0071482),-0.16850629143300638,-0.61155821467518,0.9949748743718593,0.9900274769995888,1.0,23/66,36.29%,RPL26;ATF4;COPS9;POLK;USP28;N4BP1;ATR;PRKCD;NOC2L;METTL3;FMR1;BMF;POLD1;GNB1;OPN3;TMEM161A;GPR52;SAG;NPM1;YY1;CDC25A;CASP9;PTPRK
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.20822570558044798,0.6114060283828041,0.9504424778761061,1.0,1.0,7/32,16.99%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.2669190363639263,-0.6112213747051253,0.9092558983666061,0.9896689882607319,1.0,1/10,6.01%,CTNNB1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.26926270446734774,-0.6104985159263502,0.931098696461825,0.9895020062889521,1.0,3/10,23.63%,PIH1D1;RUVBL1;PIH1D2
prerank,cellular response to hydroxyurea (GO:0072711),-0.2654909800543334,-0.6104457204775706,0.9311663479923518,0.9890088526685941,1.0,3/10,21.98%,SPIDR;FMR1;RTF2
prerank,glycogen biosynthetic process (GO:0005978),0.2647619415295936,0.6103229156922333,0.9100642398286938,1.0,1.0,2/12,9.46%,GYS1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.2647619415295936,0.6103229156922333,0.9100642398286938,1.0,1.0,2/12,9.46%,GYS1;NHLRC1
prerank,melanosome transport (GO:0032402),0.24410009247180187,0.6095239778190887,0.9240986717267552,1.0,1.0,4/18,14.67%,ARL6;GPR143;BBS7;RAB11B
prerank,pigment granule transport (GO:0051904),0.24410009247180187,0.6095239778190887,0.9240986717267552,1.0,1.0,4/18,14.67%,ARL6;GPR143;BBS7;RAB11B
prerank,positive regulation of cytokinesis (GO:0032467),0.21107793367496136,0.6094765232397718,0.9531835205992509,1.0,1.0,3/32,8.59%,CXCR5;CDC14B;PKN2
prerank,spliceosomal snRNP assembly (GO:0000387),0.20800897606999402,0.6093963298760713,0.9377224199288257,1.0,1.0,9/38,19.87%,PRMT7;SMN1;PRPF3;COIL;USP4;PRPF6;GEMIN5;LSM4;SNRPF
prerank,ncRNA export from nucleus (GO:0097064),0.20565944463224337,0.6093069208358034,0.9572953736654805,1.0,1.0,3/36,10.15%,PHAX;NDC1;NUP107
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.25270058254926886,0.6080933901267834,0.9014373716632443,1.0,1.0,3/15,10.17%,TNRC6B;TNRC6A;AGO2
prerank,epithelial cell development (GO:0002064),-0.22037911027424545,-0.6069562820720192,0.9478079331941545,0.9902219174125744,1.0,2/20,6.95%,SIPA1L3;ACTA2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.2490025823796463,-0.6068039402011588,0.9161676646706587,0.9897695817828815,1.0,4/12,23.80%,IREB2;SIRT4;ACLY;IDH3A
prerank,tRNA processing (GO:0008033),0.19040163182909467,0.6059702850148498,0.9814502529510961,1.0,1.0,13/61,17.08%,TRMT9B;PUS3;TSEN34;TRNT1;LCMT2;TRDMT1;ZBTB8OS;WDR4;FARS2;TSEN2;DTWD1;TYW5;CPSF4
prerank,negative regulation of hormone secretion (GO:0046888),0.27439398490997724,0.6058752197425064,0.8855421686746988,1.0,1.0,3/10,17.69%,GJA1;IL11;RAB11FIP3
prerank,rRNA methylation (GO:0031167),-0.21422802446618,-0.6057221573205804,0.9613821138211383,0.989779268317525,1.0,6/22,23.15%,TFB2M;BUD23;FBL;NSUN4;MRM2;MRM3
prerank,peptide hormone secretion (GO:0030072),0.22292199847320165,0.6050168534192444,0.9418181818181818,1.0,1.0,3/26,7.95%,ANXA1;IL6;SLC30A8
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2622882186964929,-0.6041827494013925,0.9379699248120301,0.9899927014060635,1.0,7/10,50.23%,NFKBIZ;ZC3H12A;SMAD7;RC3H1;IL4;FOXP3;TBX21
prerank,cholesterol biosynthetic process (GO:0006695),0.21964260620326298,0.6040154349418958,0.9378427787934186,1.0,1.0,5/31,11.27%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,neuromuscular process controlling balance (GO:0050885),0.2648427307002341,0.6035291969182462,0.9066390041493776,1.0,1.0,2/12,8.84%,TPP1;PAFAH1B1
prerank,protein targeting to membrane (GO:0006612),0.1778529940777315,0.6033190456284374,0.988135593220339,1.0,1.0,16/83,17.78%,PARD3;RAB3IP;PXMP2;ZDHHC1;ARL6;ZDHHC3;MICALL1;PXMP4;VPS37A;VPS37C;PRKCI;ATG3;VPS37D;SDCBP;SGTA;TAOK2
prerank,regulation of interferon-alpha production (GO:0032647),-0.20973817550881158,-0.6031136743155526,0.9601593625498008,0.9899317877620065,1.0,9/23,32.19%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR7;TLR4;DHX9;MAVS
prerank,DNA replication (GO:0006260),0.17130080686050142,0.6019493552536893,0.9984591679506933,1.0,1.0,29/105,21.10%,RBMS1;ATRIP;BAZ1A;BLM;NT5M;CDK1;CLSPN;REV1;RFC1;ORC2;CDK2AP1;MRE11;TOP1MT;WRN;ORC3;MCM2;NAP1L1;BRIP1;RNASEH2A;RPAIN;ORC6;POLD2;MCM7;POLG2;RAD9B;KAT5;RECQL5;RAD50;NBN
prerank,covalent chromatin modification (GO:0016569),0.2536894854262601,0.6016500572328268,0.9126819126819127,1.0,1.0,2/14,10.71%,UFL1;HDAC1
prerank,tryptophan metabolic process (GO:0006568),-0.2512774279023065,-0.6016419639099354,0.9393346379647749,0.9900917882088914,1.0,4/11,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,regulation of gene silencing by miRNA (GO:0060964),0.18399171989894972,0.6014934885925926,0.9829642248722317,1.0,1.0,7/62,11.28%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2;FXR1
prerank,autophagy of nucleus (GO:0044804),0.25042607170514675,0.6003693820408008,0.9385245901639344,1.0,1.0,3/16,15.64%,WIPI1;ATG9A;ATG3
prerank,alpha-amino acid metabolic process (GO:1901605),0.2003024741007975,0.5995915171974723,0.9758620689655172,1.0,1.0,7/45,14.80%,CBS;MTHFR;SRR;RIMKLB;KYAT3;AADAT;ASPA
prerank,neuron fate commitment (GO:0048663),0.2520474040552476,0.5985947657783517,0.9172932330827067,1.0,1.0,1/14,3.21%,EPOP
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21062185335024985,0.5979837001127012,0.9531835205992509,1.0,1.0,2/31,6.76%,RBP4;IL6
prerank,DNA modification (GO:0006304),-0.21314742576935305,-0.5977156565468059,0.9572301425661914,0.9914352137607019,1.0,6/22,21.97%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1
prerank,amyloid-beta metabolic process (GO:0050435),0.2418875818041924,0.5976838756839975,0.9433198380566802,1.0,1.0,4/16,16.62%,ACE;PSENEN;NAT8;BACE1
prerank,response to hydroxyurea (GO:0072710),-0.24984947753972128,-0.5943694486635483,0.9347408829174664,0.9924444968325715,1.0,3/11,21.98%,SPIDR;FMR1;RTF2
prerank,zymogen activation (GO:0031638),0.20136818891643693,0.5938845328768624,0.9621621621621622,1.0,1.0,2/39,3.31%,KLK2;CTSH
prerank,snRNA processing (GO:0016180),-0.2256569625339508,-0.5938378410224608,0.9409368635437881,0.9921732326093434,1.0,5/16,23.40%,INTS6L;INTS11;INTS6;INTS1;INTS3
prerank,respiratory chain complex IV assembly (GO:0008535),-0.20955743514646746,-0.5937592516827389,0.9447983014861996,0.9916854531607617,1.0,9/21,29.04%,SMIM20;COA6;FASTKD3;BCS1L;COA3;COA8;COX15;COX16;COA5
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24966919340295168,0.5936814826891801,0.9166666666666666,1.0,1.0,3/15,13.44%,HUS1B;MDC1;MRE11
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2081476332811713,0.5936147170148962,0.9571428571428572,1.0,1.0,8/35,15.47%,ACD;XRCC5;CCT6A;RTEL1;FBXO4;MAPK1;TCP1;PARN
prerank,ncRNA 3'-end processing (GO:0043628),0.2489335408665458,0.5932425270051206,0.9410569105691057,1.0,1.0,4/14,17.81%,TRNT1;INTS8;ERI1;INTS14
prerank,RNA biosynthetic process (GO:0032774),0.2123113650421471,0.5929390006712216,0.9706422018348624,1.0,1.0,4/31,10.63%,POLR2A;RSF1;SMN1;SMARCA5
prerank,mitotic nuclear division (GO:0140014),0.18054030370028398,0.5927893109748567,0.993431855500821,1.0,1.0,18/71,20.69%,SPICE1;KIF2A;KLHDC8B;GOLGA2;OFD1;NSL1;KLHL22;DSN1;INO80;MIS12;TUBG1;KIF18A;KPNB1;LSM14A;KIF18B;TPX2;NCAPG2;SPAST
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.19419092401002364,-0.5913441490815146,0.9739130434782609,0.9922613978516176,1.0,14/29,40.09%,RPS2;FEM1A;DCUN1D1;DCUN1D2;PINK1;TRIB3;ARRDC3;SMAD7;PLK1;PARK7;DCUN1D3;FBXW7;DCUN1D4;LIMK1
prerank,extracellular transport (GO:0006858),0.2595592052226976,0.5908375575410147,0.9248434237995825,1.0,1.0,2/12,11.67%,WWP2;SPA17
prerank,mitochondrial transcription (GO:0006390),0.2682709264227361,0.5908336689947753,0.9081632653061225,1.0,1.0,4/10,23.83%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.23311611916326705,-0.5894799939273672,0.9533468559837728,0.9925624423757324,1.0,2/14,9.26%,PPARGC1A;DDB1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.22446791283754675,-0.5892955496124554,0.9410569105691057,0.9921281598127992,1.0,2/16,7.28%,TNFRSF1B;AHR
prerank,microtubule depolymerization (GO:0007019),0.23628925042722954,0.5890227484026654,0.9350393700787402,1.0,1.0,1/17,1.98%,KIF2A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.22120516322063694,0.587947185005236,0.9424184261036468,1.0,1.0,4/23,15.34%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.21513553226106027,-0.5872205018028991,0.9637096774193549,0.9924854181285575,1.0,6/20,21.75%,PUM2;ZC3H7A;AGO3;SNIP1;TSN;TSNAX
prerank,regulation of lysosomal lumen pH (GO:0035751),0.26176495699586433,0.5872109122798533,0.9166666666666666,1.0,1.0,2/12,9.02%,LRRK2;TMEM199
prerank,placenta development (GO:0001890),0.25002213068437273,0.5871977478798617,0.9127906976744186,1.0,1.0,2/12,8.85%,ASCL2;CUL7
prerank,gastrulation (GO:0007369),0.2375321499832393,0.5845292312414881,0.9386973180076629,1.0,1.0,6/15,25.93%,GPC3;UGDH;SMAD2;LMBRD1;NPHP3;MKKS
prerank,mRNA modification (GO:0016556),0.22281229118357782,0.5836408665233045,0.9463917525773196,1.0,1.0,3/22,10.80%,PUS3;METTL8;METTL14
prerank,eosinophil chemotaxis (GO:0048245),-0.2384964520669709,-0.5831173608559522,0.9401197604790419,0.9931441737614979,1.0,10/14,50.76%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil migration (GO:0072677),-0.2384964520669709,-0.5831173608559522,0.9401197604790419,0.9931441737614979,1.0,10/14,50.76%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,tRNA wobble uridine modification (GO:0002098),0.24728000768373282,0.5827939281849828,0.9248434237995825,1.0,1.0,3/14,18.44%,TRMT9B;MTO1;MOCS3
prerank,smoothened signaling pathway (GO:0007224),-0.1852121729374188,-0.5820936366846274,0.9885057471264368,0.9930475573278335,1.0,9/32,23.92%,PTCH1;DISP2;GLI1;STK36;PTCHD1;DISP3;TTBK2;PTCH2;TCTN3
prerank,regulation of cholesterol transport (GO:0032374),0.22338582356390563,0.5808387761873544,0.9514018691588785,1.0,1.0,3/20,9.15%,ABCA13;ABCA5;APOC1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.22801599089816144,-0.579882788571537,0.9563492063492064,0.9933857765090356,1.0,3/15,11.27%,NLRC5;ISG15;YTHDF3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.21377129428042563,0.5793578213140124,0.9493670886075949,1.0,1.0,2/27,4.13%,SYT11;SYT12
prerank,purine ribonucleotide metabolic process (GO:0009150),0.1768814210888322,0.579348237816076,0.9898819561551433,1.0,1.0,18/68,23.63%,TPST1;AMPD3;ACOT4;LRRK2;EPHA2;SULT4A1;ACOT1;RHOQ;GMPR2;ACBD6;ACOT11;BPNT1;RAB23;ACOT13;AK4;AK3;ACOT6;ACAT1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.2506545988822192,0.5786612204950861,0.9227467811158798,1.0,1.0,1/11,2.58%,GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.2506545988822192,0.5786612204950861,0.9227467811158798,1.0,1.0,1/11,2.58%,GSTM2
prerank,nuclear transport (GO:0051169),0.23586427934371834,0.5783918907674732,0.9365384615384615,1.0,1.0,4/16,18.98%,NUTF2;NXT2;PSIP1;RSRC1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22414006605379752,0.5775840285679629,0.9426386233269598,1.0,1.0,7/19,23.08%,POLR3G;ICE2;AR;POLR3C;ELL;NAB2;ICE1
prerank,positive regulation of organelle assembly (GO:1902117),0.19613795090112834,0.5774482205560932,0.9808695652173913,1.0,1.0,8/44,17.07%,ASAP1;ARHGAP35;STX18;CROCC;CNOT2;RAB3GAP1;CEP120;SDCBP
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.24294370370305124,0.577354466075932,0.9376218323586745,1.0,1.0,1/16,4.05%,TOP2B
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.22223045578013528,-0.5760782254759595,0.9603960396039604,0.9942725443988053,1.0,4/15,18.46%,RTCB;RTRAF;CLP1;CSTF2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.22340998571682133,-0.5757286953877124,0.9623015873015873,0.9938845862664027,1.0,5/14,33.20%,RAB1A;SEC23A;SEC31A;SEC23B;SEC31B
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21669757889809685,0.5756858102863248,0.9561904761904761,1.0,1.0,4/24,15.56%,HNRNPC;ACD;DCP2;STN1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.22466105789709517,-0.574834734551249,0.948559670781893,0.993687709845319,1.0,2/15,14.48%,PINX1;TERF2IP
prerank,defense response to Gram-negative bacterium (GO:0050829),0.18881503253867238,0.5743651952255039,0.9892665474060823,1.0,1.0,6/42,12.56%,LTF;IL6;OPTN;GSDMD;MR1;SERPINE1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.24311556521420713,-0.574079470763412,0.9539594843462247,0.9934365935425695,1.0,5/11,40.38%,XBP1;CIITA;TAF7;PF4;IL4
prerank,ncRNA metabolic process (GO:0034660),0.1982782481410031,0.5739277917639359,0.972875226039783,1.0,1.0,11/37,21.93%,DTD2;AGO2;DICER1;NIFK;PARN;DTD1;TUT4;DDX4;XPO5;PIWIL4;TUT7
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.25546070800903825,0.5738093996972812,0.939203354297694,1.0,1.0,11/11,74.47%,TAS1R2;PKD2L1;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;PKD1L3;RTP3;LPO;RTP4
prerank,tetrapyrrole metabolic process (GO:0033013),0.2274159065737459,0.5733611631000574,0.9455252918287937,1.0,1.0,1/18,3.74%,TCN2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.23179870993826912,0.5708840577838536,0.9555984555984556,1.0,1.0,6/16,22.24%,NUPR1;COX7A2L;PDE12;COX7A2;ATP7A;AK4
prerank,regulation of biosynthetic process (GO:0009889),0.25125533517449167,0.5708634190102173,0.9420600858369099,1.0,1.0,11/11,74.89%,SNCA;ALOX5;PIKFYVE;PCK1;UCP1;MID1IP1;CCN6;GSTP1;SLC25A33;THRSP;SPHK2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.22303557171700827,0.5684505102417939,0.9499036608863198,1.0,1.0,7/21,18.64%,SAMD4A;CNOT2;PARN;CNOT8;CNOT7;CNOT10;TUT4
prerank,apoptotic nuclear changes (GO:0030262),0.2116081939604229,0.5675636388106783,0.9461538461538461,1.0,1.0,4/24,14.93%,ACIN1;CECR2;DICER1;DFFA
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.17942400659049962,-0.5674904938588563,0.9864864864864865,0.9952974607130923,1.0,17/35,42.43%,CDH11;ATP2C1;CDH13;PCDHB14;CDH12;SELP;CDH10;CDH8;PCDHB5;PCDHB9;PCDHB13;PCDHB3;CDH7;CDH20;PCDHB4;CDH19;DCHS1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2591866881818119,0.5671782666723967,0.9343629343629344,1.0,1.0,4/10,20.96%,CDC73;HSF1;NUDT21;PAF1
prerank,cell proliferation in forebrain (GO:0021846),0.25826900144354487,0.5647508961069755,0.9280898876404494,1.0,1.0,10/10,74.19%,CEP120;AKNA;DOCK7;NUMBL;NUMB;WNT3A;HOOK3;WNT7A;PCM1;KIF14
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.23902671010465038,-0.5623661901053012,0.9776536312849162,0.99651017212457,1.0,1/10,3.24%,PDE8A
prerank,peptidyl-lysine acetylation (GO:0018394),0.25800333940897047,0.5621515661345925,0.9222903885480572,1.0,1.0,4/10,20.52%,ESCO1;CREBBP;KAT2B;KAT5
prerank,miRNA metabolic process (GO:0010586),0.2175175919332027,0.559681798826049,0.9604743083003953,1.0,1.0,7/20,21.93%,SND1;AGO2;DICER1;PARN;TUT4;XPO5;TUT7
prerank,sensory perception of pain (GO:0019233),-0.19771798092117915,-0.5586934688503009,0.9685534591194969,0.9971248000811201,1.0,9/21,37.06%,TRPA1;CCR2;CCL2;ALOXE3;P2RX7;NIPSNAP1;KCNA2;PROK2;OPRM1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.21877486929729334,-0.5584956283394936,0.9608610567514677,0.9966639234330386,1.0,4/15,25.12%,RACK1;ORMDL2;PRKCD;SPHK2
prerank,regulation of endocytic recycling (GO:2001135),-0.239062050650288,-0.5570083886104253,0.9698189134808853,0.9965759925869477,1.0,6/11,41.67%,EHD1;INPP5F;SORL1;EIPR1;EHD2;PLA2G3
prerank,tRNA wobble base modification (GO:0002097),0.2363068445631918,0.5540036817306433,0.9534412955465587,1.0,1.0,3/14,18.44%,TRMT9B;MTO1;MOCS3
prerank,protein localization to centrosome (GO:0071539),-0.21047374878773584,-0.5526032398107531,0.9774590163934426,0.9974757409016851,1.0,5/17,33.74%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.24461234751210545,0.5520059895148579,0.9408284023668639,1.0,1.0,2/12,9.35%,HUS1B;CLSPN
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.18094142576929223,-0.5512227020714424,0.9868421052631579,0.9968443355366415,1.0,16/32,46.02%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;NUP210
prerank,tRNA export from nucleus (GO:0006409),-0.18094142576929223,-0.5512227020714424,0.9868421052631579,0.9968443355366415,1.0,16/32,46.02%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;NUP210
prerank,cell cycle G1/S phase transition (GO:0044843),0.1719636485286457,0.5505961707826718,0.9932203389830508,1.0,1.0,10/61,14.83%,CDK7;EIF4EBP1;NASP;PHF8;LATS1;RPS6KB1;CUL4B;CCNE1;MNAT1;CDK4
prerank,snRNA 3'-end processing (GO:0034472),0.21283688347716853,0.5505066178684187,0.9669260700389105,1.0,1.0,5/19,18.61%,INTS8;EXOSC8;TUT1;INTS14;EXOSC3
prerank,neuropeptide signaling pathway (GO:0007218),-0.15384851469121133,-0.5493641475833927,1.0,0.9968925593091441,1.0,12/58,25.74%,SORCS2;CYSLTR1;CYSLTR2;NXPH2;GPR149;GLRA3;SORCS1;NPY;PNOC;SORL1;ADCYAP1;GLRA1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.24993120673227304,0.5486687467958473,0.9395248380129589,1.0,1.0,1/10,2.73%,LTF
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.18066407626863742,0.5456446761227305,0.9910233393177738,1.0,1.0,7/40,14.02%,NEK4;FEM1B;ABL1;FXR1;NPAS2;CRY1;UBE2V1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.1932395803047773,0.5454563677565576,0.9819168173598554,1.0,1.0,4/31,9.66%,CDC14B;UBE2L3;PTEN;GOLGA2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2311535722910209,0.5441745146127646,0.934,1.0,1.0,4/14,23.83%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.21571029354939375,0.5433837673730431,0.9673704414587332,1.0,1.0,6/18,20.24%,CCT6A;DCP2;TCP1;PARN;SHQ1;RUVBL2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.22940254778773705,-0.542698640609951,0.9655172413793104,0.9977314186272453,1.0,4/11,21.53%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.22940254778773705,-0.542698640609951,0.9655172413793104,0.9977314186272453,1.0,4/11,21.53%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.19420572608854014,0.5422351310531782,0.9809523809523809,1.0,1.0,3/31,6.94%,CTLA4;LST1;PDCD1LG2
prerank,regulation of mast cell activation (GO:0033003),0.2400677838448503,0.5412794328713403,0.9430379746835443,1.0,1.0,10/10,76.01%,NECTIN2;LYN;CD84;CD300LF;PLSCR1;HAVCR1;CD226;TSLP;MILR1;CRLF2
prerank,response to light stimulus (GO:0009416),0.17095299427781446,0.5406062038941883,0.9875,1.0,1.0,12/55,17.80%,DDB2;AANAT;REV1;DCT;CRY1;PRIMPOL;CLOCK;UBE2A;GPR88;BRSK1;DRD2;UBE4B
prerank,dopaminergic neuron differentiation (GO:0071542),-0.19496245572738424,-0.5374646274876095,0.979381443298969,0.998619484211105,1.0,7/19,36.00%,CTNNB1;VEGFA;NR4A2;LMX1A;SHH;MANF;LMX1B
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.2190794718741007,-0.5373647444607706,0.9750479846449136,0.9981241484528847,1.0,9/13,54.49%,DUSP1;GEN1;NDC80;XRCC3;CCNB1;PCID2;DYNC1LI1;LCMT1;USP44
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.2169868652735535,-0.5357795318709251,0.9626556016597511,0.9979847556647798,1.0,1/13,2.90%,RPS15
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2263957704162224,0.5350740936392963,0.9629629629629629,1.0,1.0,2/12,10.51%,PLK5;PRKDC
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.1827372990635229,0.5349666274095772,0.9908925318761385,1.0,1.0,5/36,13.36%,PRKN;CSF1;AXL;PARP9;ZBP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.189842193676433,0.5341963302492442,0.9875666074600356,1.0,1.0,7/32,15.47%,ACD;XRCC5;CCT6A;FBXO4;MAPK1;TCP1;PARN
prerank,protein targeting to peroxisome (GO:0006625),0.1891231979854781,0.532958537170461,0.9822134387351779,1.0,1.0,5/29,15.20%,PXMP2;ZFAND6;PXMP4;HACL1;PEX7
prerank,production of siRNA involved in RNA interference (GO:0030422),0.24534974555364686,0.5318319174740231,0.9439655172413793,1.0,1.0,2/10,13.79%,AGO2;DICER1
prerank,autophagy of peroxisome (GO:0030242),-0.21172433963791792,-0.5313202358088821,0.9646365422396856,0.998529557596997,1.0,3/12,20.39%,MAP1LC3B;PIK3C3;PEX5
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.19333504979423805,-0.5309424857242178,0.9839679358717435,0.9980990169994526,1.0,10/19,40.38%,GAS6;XBP1;PPP2R3C;NCKAP1L;MDK;IL7;SYK;ZAP70;GATA3;IL4
prerank,mesenchymal to epithelial transition (GO:0060231),0.23907893114146456,0.5289751491495758,0.9483146067415731,1.0,1.0,2/10,15.69%,SALL1;FZD7
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.22213139101998786,0.5276663707926565,0.9798387096774194,1.0,1.0,3/15,15.25%,ZC3H12B;DICER1;NYNRIN
prerank,positive regulation of chromosome organization (GO:2001252),-0.20606520384458896,-0.5260877468674247,0.9809160305343512,0.9987522851715138,1.0,4/15,23.56%,GNL3;PPP1R10;LIG4;SIRT6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.15648922769273313,0.5242326384252245,0.9983443708609272,1.0,1.0,18/83,19.76%,CDK7;EIF4EBP1;NASP;PHF8;TYMS;LATS1;RPS6KB1;CUL4B;CCNE1;TFDP2;MNAT1;CDK15;CDK4;BACH1;NPAT;CAMK2A;DHFR;CCNE2
prerank,regulation of microtubule-based movement (GO:0060632),-0.22633561398547908,-0.5241853688725187,0.9783889980353635,0.9986433399274238,1.0,4/11,29.62%,LAMP1;HDAC6;HAP1;DYNLT2B
prerank,positive regulation of interferon-beta production (GO:0032728),0.18145969176501808,0.5241430141961623,0.9851851851851852,1.0,1.0,6/33,13.91%,POLR3G;TRIM56;RNF135;IRF3;TBK1;POLR3C
prerank,pre-miRNA processing (GO:0031054),0.22177371151001085,0.5233750213059719,0.9557522123893806,1.0,1.0,5/14,21.93%,AGO2;DICER1;TUT4;AGO1;TUT7
prerank,chromosome condensation (GO:0030261),0.1815655236349267,0.5232453187613857,0.9907063197026023,1.0,1.0,9/36,20.37%,ACIN1;PHF8;CDK1;AKAP8L;BANF2;MCPH1;AIFM1;SMC2;NCAPG2
prerank,regulation of rRNA processing (GO:2000232),0.21541082067512685,0.5229545346242774,0.9726027397260274,1.0,1.0,5/16,19.96%,YTHDF2;DIMT1;SHQ1;RIOK1;KAT2B
prerank,mitochondrion distribution (GO:0048311),0.22706888899983924,0.5227113587468387,0.9690721649484536,1.0,1.0,3/12,15.36%,LRRK2;TRAK1;TRAK2
prerank,DNA alkylation (GO:0006305),-0.19077706669838695,-0.5219395815845336,0.9874739039665971,0.9981124815029312,1.0,7/19,41.07%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,DNA methylation or demethylation (GO:0044728),-0.19077706669838695,-0.5219395815845336,0.9874739039665971,0.9981124815029312,1.0,7/19,41.07%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,dendritic cell migration (GO:0036336),-0.20150509692585591,-0.5214162536286711,0.978515625,0.9977096264617886,1.0,7/16,39.72%,EPS8;TRPM4;CCR2;TRPM2;CCL5;PIK3CG;CCR1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.20936007524115413,-0.5210056572285191,0.9721115537848606,0.9972773575474774,1.0,5/14,33.64%,CMPK1;AK5;NME2;ITPA;DCTPP1
prerank,regulation of platelet activation (GO:0010543),-0.18301513008648568,-0.51811395191898,0.990990990990991,0.9973355261783838,1.0,1/21,0.98%,NOS3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2356811641329497,0.5167713658603296,0.9658119658119658,1.0,1.0,2/10,12.90%,SSBP1;INO80
prerank,regulation of double-strand break repair (GO:2000779),-0.15844836131758805,-0.5154725725756872,0.9976851851851852,0.9973351937634313,1.0,15/39,34.12%,SPIDR;ACTR2;OTUB1;TERF2IP;SPIRE1;PPP4R2;SIRT7;SIRT6;CHEK1;ZCWPW1;SHLD2;PPP4C;MGMT;RPA2;FIGNL1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.22131330317794795,0.5116880110620187,0.9642105263157895,1.0,1.0,2/12,12.50%,FDXR;AKR1B1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.20408935049416532,-0.5115593517655922,0.9865642994241842,0.9975877754849714,1.0,5/13,40.38%,LAMP1;SPHK2;ITGB2;SYK;IL4
prerank,long-term memory (GO:0007616),0.20276266987274322,0.5108330999209529,0.9840954274353877,1.0,1.0,5/19,20.45%,ARC;NFATC4;SLC2A4;CALB1;RASGRF1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.16548324865668276,0.5101291648888668,0.9948542024013722,1.0,1.0,10/51,15.56%,HNRNPC;ACD;XRCC5;CCT6A;FBXO4;DCP2;MAPK1;TCP1;PARN;STN1
prerank,protein methylation (GO:0006479),0.17242240767637387,0.5070221575834689,0.9945255474452555,1.0,1.0,4/40,9.91%,CAMKMT;PRMT7;EEF1AKMT1;NSD1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.2034391762498664,-0.505645864464219,0.9807692307692307,0.9981909518709329,1.0,10/12,52.59%,GNL3;CCT3;GNL3L;CCT4;WRAP53;CCT2;CCT8;CCT7;CCT5;DKC1
prerank,cellular response to pH (GO:0071467),-0.18673908801292133,-0.5042538800488989,0.9775967413441955,0.9979077658191334,1.0,4/17,29.52%,CHP1;RAB11FIP5;MCOLN1;ASIC1
prerank,protein localization to kinetochore (GO:0034501),0.21222875455567705,0.5033680982646921,0.9706498951781971,1.0,1.0,3/14,15.71%,TTK;CDK1;MIS12
prerank,ncRNA catabolic process (GO:0034661),-0.16730473666159534,-0.5030282673811451,0.9916666666666667,0.9976003817265652,1.0,14/28,41.78%,TRIR;LIN28B;MTREX;EXOSC10;NUDT16;DIS3L2;EXOSC5;TENT4B;NUDT16L1;DEDD2;EXOSC2;ERN2;EXOSC9;ZCCHC8
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.20590808484687292,-0.5026184503186669,0.9805825242718447,0.9971510961587124,1.0,7/12,45.42%,RMDN1;BOD1;NDC80;KIF2C;SEH1L;CDT1;CENPC
prerank,negative regulation of lipid catabolic process (GO:0050995),0.20330608648689052,0.5024093995392824,0.9740518962075848,1.0,1.0,3/17,14.04%,PRKAA1;APOC1;PLIN5
prerank,peptidyl-amino acid modification (GO:0018193),-0.21916776501600452,-0.50209026593435,0.9822834645669292,0.9967279123336129,1.0,10/10,78.10%,FKBP10;PDF;APOA1;METAP1D;APOA2;METAP1;METAP2;TTLL4;FKBP7;ATP7A
prerank,primary miRNA processing (GO:0031053),-0.21634461639320013,-0.5019181840739566,0.9823182711198428,0.9962387907453508,1.0,4/10,30.37%,DGCR8;METTL3;SMAD1;DROSHA
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2223064285812965,0.501643694229557,0.9719222462203023,1.0,1.0,4/10,23.30%,FEM1B;CRY1;ETAA1;THOC1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.210061604751894,0.5015077015820277,0.9725158562367865,1.0,1.0,1/14,5.66%,DDX60
prerank,histone mRNA metabolic process (GO:0008334),0.18001995649766722,0.5011016071356594,0.9885714285714285,1.0,1.0,10/27,23.35%,TENT2;TUT1;DCP2;ERI1;TUT4;LSM1;SNRPF;XRN1;TUT7;EXOSC4
prerank,rRNA catabolic process (GO:0016075),-0.19301019599505914,-0.5002111114125187,0.9801192842942346,0.9960143916730078,1.0,8/16,40.49%,TRIR;PELO;EXOSC10;EXOSC5;DEDD2;EXOSC2;ERN2;EXOSC9
prerank,mRNA catabolic process (GO:0006402),0.1661527340262313,0.49859334480553924,0.9944852941176471,1.0,1.0,15/44,23.71%,YTHDF2;NBDY;DHX34;DCP2;NUDT12;LSM5;CNOT10;TUT4;PDE12;AGO1;XRN1;TUT7;THRAP3;EXOSC4;LSM6
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18509476553329213,-0.4985291172119778,0.9897330595482546,0.995777429619099,1.0,5/18,29.63%,TOMM20;ROMO1;TIMM50;TIMM44;DNLZ
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.20158841841369413,0.49814868536316903,0.9897119341563786,1.0,1.0,2/17,8.73%,TTK;CDK1
prerank,positive regulation of DNA recombination (GO:0045911),0.1837012885130599,0.4967832610116981,0.9923371647509579,0.9999890809796614,1.0,3/27,8.47%,MRNIP;WDR48;ARID2
prerank,DNA replication checkpoint signaling (GO:0000076),0.20476091772064564,0.49494069642816807,0.9764705882352941,0.9998281625323735,1.0,2/16,9.35%,HUS1B;CLSPN
prerank,nuclear pore organization (GO:0006999),0.20927360064185,0.4940735492045825,0.9778225806451613,0.9994541999807824,1.0,2/14,10.15%,NDC1;NUP107
prerank,fibrinolysis (GO:0042730),0.21330415096929314,0.4936680453642918,0.9730848861283644,0.9989740989659268,1.0,12/13,59.72%,SERPINE1;PLAU;HRG;PLG;SERPINF2;FGG;PLAT;KRT1;F2;GP1BA;CPB2;SERPINB2
prerank,regulation of DNA metabolic process (GO:0051052),-0.14587214863603942,-0.493550900507219,0.995475113122172,0.996033127255517,1.0,17/44,34.94%,WDR70;WRNIP1;TERF2IP;UBE2V2;SMG5;SIRT7;SMARCAD1;HNRNPD;TOM1L1;SMG6;ALYREF;SUB1;PIF1;HELB;KPNA2;TICRR;IL7R
prerank,acetyl-CoA metabolic process (GO:0006084),-0.19192449341824824,-0.4926808994847232,0.9780876494023905,0.995634867482938,1.0,3/15,19.51%,ACACA;HMGCS1;ACLY
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.20329270501738161,0.49243662563812535,0.9818181818181818,0.9986696951894576,1.0,1/15,3.63%,RIPOR2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.18332325478808137,0.4908089493298971,0.9907578558225508,0.9984606229608617,1.0,6/25,23.30%,CCNT2;CCNT1;ELL;LDB1;SUPT4H1;THOC1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.20786996566230836,0.48935751930204874,0.9708939708939709,0.9982040617147664,1.0,2/12,15.28%,TET1;ATF7IP
prerank,regulation of lipase activity (GO:0060191),0.20653052185519577,0.4886484865998544,0.9763779527559056,0.9977803593336119,1.0,4/13,18.25%,LIPC;PLIN5;LMF1;SNCA
prerank,mitochondrial genome maintenance (GO:0000002),-0.2071380626701481,-0.48765901624421404,0.9824561403508771,0.9958427513374841,1.0,3/11,28.06%,TOP3A;SLC25A4;MEF2A
prerank,mitotic DNA replication (GO:1902969),-0.2076233109124948,-0.4811202758401605,0.9773156899810964,0.9961740562067037,1.0,2/10,17.40%,MCM4;POLA1
prerank,DNA methylation (GO:0006306),-0.16393723756674305,-0.47227312130355437,0.9913978494623656,0.9967968345090676,1.0,6/23,27.18%,KMT2E;PICK1;EHMT2;ZFP57;DNMT1;HELLS
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.1989453198568648,0.46957506854086445,0.9736263736263736,1.0,1.0,14/14,80.12%,CSF1;TRAF6;POU4F2;IFNG;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;ATP6AP1;TYROBP
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.17800314881101859,-0.46513141534643215,0.9920477137176938,0.9970322045265595,1.0,1/16,5.20%,PINX1
prerank,vitamin D metabolic process (GO:0042359),-0.18893545866988581,-0.46498974854248015,0.9920477137176938,0.9965249240276407,1.0,1/13,4.63%,LGMN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.1521448541382485,-0.46214582816848854,1.0,0.9962979480753722,1.0,14/32,42.58%,CDK17;POLA1;ID2;CDK5;E2F7;ZPR1;ORC1;CDC6;ESRRB;RRM2;PCNA;CDK18;TFDP1;CDC45
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.1999506727673099,0.4606271464164545,0.9854166666666667,1.0,1.0,3/13,18.70%,PRPF3;USP4;PRPF6
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.19981788701741648,0.45949167651233636,0.9807321772639692,1.0,1.0,4/11,21.15%,PRKCA;LYN;RDX;PRKCQ
prerank,peptidyl-methionine modification (GO:0018206),0.20168225472349527,0.45503726515233933,0.9898167006109979,1.0,1.0,12/12,79.85%,NAA60;NAA20;NAA15;METAP2;NAA25;METAP1;APOA2;METAP1D;APOA1;PDF;NAA16;NAA30
prerank,dendritic cell chemotaxis (GO:0002407),0.18758239688618245,0.45369187672772543,0.9767932489451476,1.0,1.0,14/14,81.26%,CCL19;CCR6;GPR183;HMGB1;CXCR4;CCR7;CXCR2;CCR5;CCR1;PIK3CG;CCL5;TRPM2;CCR2;TRPM4
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.18363498969405234,-0.45308131938327184,0.9981167608286252,0.9965957374979393,1.0,2/14,13.78%,PTGS2;PTGER3
prerank,regulation of chromosome segregation (GO:0051983),0.17836461039815107,0.4463963434893112,0.9938271604938271,1.0,1.0,3/16,17.10%,HORMAD1;RAD18;IHO1
prerank,cilium-dependent cell motility (GO:0060285),0.1686531850840331,0.44395631920139444,0.9980314960629921,1.0,1.0,3/22,14.01%,DNAH2;TEKT2;CCDC65
prerank,mismatch repair (GO:0006298),0.16128175395125008,0.4412226301323512,0.9902912621359223,1.0,1.0,7/27,18.62%,ABL1;LIG1;MLH1;RNASEH2A;SETD2;XPC;POLD2
prerank,mitotic chromosome condensation (GO:0007076),0.15923037278358765,0.43554990699062285,0.9943181818181818,1.0,1.0,6/26,20.37%,PHF8;CDK1;AKAP8L;MCPH1;SMC2;NCAPG2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.15358542023452876,0.4275424265864604,0.9981785063752276,1.0,1.0,7/29,23.63%,ACOT4;ACOT1;ACBD6;ACOT11;ACOT13;ACOT6;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.15358542023452876,0.4275424265864604,0.9981785063752276,1.0,1.0,7/29,23.63%,ACOT4;ACOT1;ACBD6;ACOT11;ACOT13;ACOT6;ACAT1
prerank,activin receptor signaling pathway (GO:0032924),0.17548604655420513,0.42731179361892174,1.0,0.9995410405510244,1.0,1/15,7.08%,SMAD3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.19040880013147843,0.4210454413526431,0.984375,0.999518185206191,1.0,1/11,7.24%,BLM
prerank,glycine metabolic process (GO:0006544),-0.1734649597326346,-0.4188608846374372,0.994392523364486,0.9982623086470832,1.0,3/12,28.72%,RIDA;GCAT;GLDC
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.18876808784480795,0.41639021052392766,1.0,0.999333158219006,1.0,1/10,6.94%,PDCD1LG2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.13930599466279742,0.4132878090329875,0.99822695035461,0.9990024859438805,1.0,11/40,23.30%,BLM;RTEL1;BOD1L1;PRIMPOL;CENPX;WRN;RAD51;CDK9;ETAA1;SMARCAL1;THOC1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.1614648577661476,0.40700484808501175,0.9979959919839679,0.9988474910820809,1.0,5/16,22.02%,PRKDC;PARP9;DTX3L;KDM4D;SHLD1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.1626695128076343,0.3930846329210633,1.0,0.9990120972608366,1.0,15/15,83.75%,CCT6A;TCP1;SHQ1;RUVBL2;DKC1;CCT5;CCT7;NAF1;CCT8;CCT2;CCT4;NOP10;CCT3;NHP2;RUVBL1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.15778101452955473,0.3530358772333863,1.0,0.9996172851348726,1.0,3/11,20.89%,PPIP5K2;ITPKA;IP6K2
